
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-9001-9300*
  '("'stemness'" ".896+33" "A-C-C-C-T-C-C-A-A-T-C-C-C-G-G" "A-GVGD" "A-chain"
    "A-induced" "A-positive" "A-type" "A067" "A1" "A12" "A12–A18" "A15"
    "A1762T" "A190" "A1c" "A3F" "A3G" "A3H" "A4" "A487A" "A5" "A629I" "A629L"
    "A701D" "A763_Y764insFQEA" "A767_S768insTLA" "A8" "A880T" "AAA" "AAA+-type"
    "AAGGTA" "ABC-like" "ABCA" "ABCB" "ABCG" "ABO" "ACC" "AD-RAD51" "ADMTS3"
    "ADP-ribosylation-like" "ADRB2-null" "ADVIGO" "AEC" "AECTs" "AERS"
    "AF019742" "AG1204" "AG490+U0126" "AG490+wortmannin"
    "AG490+wortmannin+U0126" "AGC" "AHRE" "AHREs" "AIDS-like" "AKT-DN"
    "AKT-dependent" "AKT-substrate" "ALGIG" "ALK-IHC" "ALKBH1" "ALP-activity"
    "ALVA31" "AMF-V5" "AMFR-null" "AMG102" "AML-like" "AMOLT1" "AMPARs" "AMVMs"
    "AN-R" "ANKRD17" "AP-MS" "AP-endonuclase" "AP-endonuclease" "AP1510"
    "AP23846" "AP2a" "AP3CA" "APBS" "APDC" "APOBEC3" "APR-246-01" "AR-ChIP"
    "AR-null" "AR-positive" "AR-positivity" "AR-siRNA-treated" "ARE-F1"
    "ARE-F2" "AREF" "AREF1" "AREF1-LUC" "ARIC" "ARID5A" "ARMC2" "ARTD7" "ARTD8"
    "ARV" "AS-PCR" "AS605240" "ASO3" "ASPSRC1" "ASR" "ASS1P11" "AT9283"
    "AT98283" "ATAD" "ATAD5–RLC’s" "ATCC" "ATG12-shRNA" "ATG12-shRNAs"
    "ATG16L1ΔFBD" "ATG16L1ΔFBD-expressing" "ATG16L1ΔFBD-reconstituted"
    "ATG5–12" "ATM-Ser1981" "ATMi" "ATP-binding-cassette" "ATPlite" "ATPγ"
    "ATPγS" "ATR-mediated" "ATXN2" "AU565Vav1" "AU565Vector" "AURORA" "AVGR8"
    "AX" "AYVM" "Aarhus" "AbinitioRelax" "Abl" "Ac" "AcH3" "AcK" "AccuMax"
    "AceCS2" "Achaete-scute" "Achatz" "Achilles" "ActMat" "Actinin-1"
    "Actinobacteria" "Activ" "Ad-Cre" "Ad-ERE-GFP" "Ad-GFP" "AdCa" "AdCav-1"
    "AdCt" "AdRSV" "Adai" "Adda" "Addgene" "Adenosyl" "Adh" "AdoHcy"
    "Affymetrix" "Africa" "African" "African-American" "African-Americans"
    "Africans" "Ahr" "Ai" "Aims" "Akt-DD" "Akt-activation" "Akt-dependent"
    "Akt-mediated" "Akt1-expressing" "AktCA" "AktDN" "Akti1"
    "Akt–mTORC1–mediated" "Akt–mTORC–mediated" "Akt–β-cat" "Ala+TIMP-2" "Ala18"
    "Albergaria" "Alcino" "Aldrich" "Alessandrini" "Alfa" "Algeria" "Algerians"
    "Alhopuro" "Align-GVGD" "All-atom" "Allelic" "Allostery" "Alonso"
    "AlphaScreen" "Alsbeih" "Alsop" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "Amanda" "America" "American" "Americans" "Amersham" "Amgen" "Amitage"
    "Amsterdam" "Anders" "Andersen" "Anderson" "Andrew" "AngII" "Angele"
    "Angeles" "Ank2-KH" "Anrather" "Apert" "Apg" "Appalachia" "Appalachian"
    "Approximately20%" "Arcadlin" "Arg15" "Arg41" "Arg57Stop" "Arg8–Asp4"
    "Arizona" "Arrayscan" "Artandi" "Artemis-like" "Artus" "AsCAR" "Asano"
    "Ascaris" "Ascl" "Ascl1in" "Ashkenazi" "Ashraf" "Asian" "Asians" "Asp14"
    "Ateeq" "Atl1" "Aurora-Ai" "AuroraA" "Australasia" "Australia" "Austria"
    "Aut" "Auto-modified" "AutoDock" "Avanti" "Axins" "A–E" "A–S4C" "B&C" "B&D"
    "B-1a" "B-Cdk1" "B-boxes" "B-chain" "B-family" "B-helix" "B1" "B2"
    "B220+cells" "B23" "B24–B26" "B26–B30" "B3" "B3GNT" "B56γ" "B6" "B6-biotin"
    "B6-conjugated" "B7–B21" "B8" "B9" "B9-mediated" "B9-sensitive" "B9–B19"
    "BA" "BAALC" "BALB" "BAT" "BAT-bone" "BAT-muscle" "BATS" "BBC" "BBCs"
    "BCAS3" "BCN" "BCOR" "BCR-ABL1" "BCR-antigen" "BCRAT" "BCRs" "BD´s" "BFABP"
    "BGP-15" "BGT226" "BH3-only" "BH4" "BHK" "BHLHB38" "BIN" "BIOMOL" "BLC2"
    "BLOSUM62" "BMDM" "BMDMs" "BME" "BMP-4-like" "BMS" "BMS-536924" "BOA"
    "BOGA" "BOLERO-2" "BPH1" "BPMC" "BRAD1" "BRAFV600D" "BRAFV600E" "BRB796"
    "BRCA-positivity" "BRCA1-2" "BRCA1-CtIP-MRN" "BRCA1-mutation-related"
    "BRCA1-null" "BRCA1-proficient" "BRCA2-mutation-related" "BROMO" "BT12"
    "BT25" "BT5" "BT8" "BTL10" "Ba" "Background" "Bacteroidetes" "Bafilomycin"
    "Baird" "BakS117A" "BakY108A" "Bandyopadhyay" "Banerji" "Banito"
    "Bannayan-Riley-Ruvalcaba-Syndrome" "Bannayan–Riley–Ruvalcaba" "Barcelona"
    "Bardswell" "Barrett" "Barros" "Barros-Silva" "Bartkova" "Baumann"
    "Bc12-associated" "Bcl" "Bcl-2" "Bcl-2-family" "Bcl-XL" "Bcl-Xl"
    "Bcl-xL-1.565-LUC" "Bcl-xL-1.565WT-LUC" "Bcl-xL-ARE-F1-LUC" "Bcl-xL-MT-LUC"
    "Bcl-xL1.565-WT-LUC" "Bcl-xLMT-ARE-F1-LUC" "Bcl-xl" "BeadChip" "Becker"
    "Beckler" "Becton" "Bednarek" "Begg" "Begg's" "Begnami" "Belkhiri"
    "Benjamini" "Bennett" "Bergonie" "Berk" "Berkeley" "Beta-blockers" "Beth"
    "Betzig" "Beyer" "Bfl1" "Bifidobacteria" "Billerica" "Biochem" "Biocoat"
    "Biomax" "Bioproducts" "Biosystems" "Birchmeier" "Birrer" "Birt-Hogg-Dubé"
    "Birt–Hogg–Dubé" "Bissel" "Bissel’s" "BladderCIT" "Blau" "Blc-2" "Boeke"
    "Bogden" "Bohlig" "Boltzmann" "Bonadona" "Bonferroni" "Bonferrroni"
    "Borrmann" "Bortezomib" "Boston" "Bottaro" "Bourdon" "Boussetta" "Bouwman"
    "Boyden" "Brazil" "Brca" "Brennan" "Briant" "Browser" "Bruton" "Bruton's"
    "Bryant" "Bsa" "Buchem" "Burkitt" "Burnette" "B–3D" "C&E" "C-C" "C-PTIO"
    "C-X-X-C" "C-glutamine" "C-induced" "C-lobe" "C-raclopride" "C-terminally"
    "C-θ" "C0" "C0C2" "C1" "C10orf11" "C165" "C1QL1" "C2" "C21orf34"
    "C2C12-GLUT4myc" "C3HC4" "C3ORF14" "C5" "C57Bl" "C57Bl6" "C5orf24" "C6"
    "C635A" "C638A" "C7orf42" "C9" "CAAX" "CACCTG" "CACGTG" "CAPOX" "CARD-CARD"
    "CASTp" "CAV1-AR-PAWR" "CBFβ-RUNX" "CBFβ-Vif-ELOBC" "CCCH" "CCDC38"
    "CCDC80" "CCDC83" "CCDN2" "CCFR" "CCL187" "CCR5-tropic" "CCRT" "CD" "CD35"
    "CD44s" "CD44v" "CD81-ΔCyt-GFP" "CD81ΔCyt" "CD8ζ" "CD90" "CDB3" "CDDS"
    "CDH19" "CDKL3" "CDKNIA" "CE-RFLP" "CEM-174" "CEM-T4" "CEN8" "CEP17"
    "CEP17⩾2" "CEP701" "CFDP1" "CFP-Rad18-WT" "CFU-F" "CG3" "CGEMS" "CGG"
    "CGK773" "CGRRF1" "CHGA" "CHIP" "CHIR258" "CHX-induced" "CIDR" "CIMBA"
    "CK1δ" "CKD4" "CL" "CL-13" "CLIA" "CLL-like" "CLYD" "CM-cysteine" "CN01"
    "CNAG" "CNKI" "CNNA2" "CNP-hEGFRmice" "CNVs" "COHRA" "COL1A" "COLD-PCR"
    "COS-1" "COX11" "CP-751,871" "CP6690550" "CP690,550" "CP690550" "CPT-I"
    "CREA" "CRL2614" "CRL5-Vif" "CRL5-Vif-CBFβ" "CRPCa" "CR–L2" "CSC-like"
    "CSRD" "CSRT" "CTAGTA" "CTC" "CTC1-STN1-TEN1" "CTCCGTGCTGGCCC" "CTG" "CVB"
    "CVB3" "CWR" "CWR-22Rv1" "CXCR4-mediated" "CYB5B" "CYP1A1-luc"
    "CYP1A1-reporter" "CYT387" "Ca1d" "CaMKIIα" "Caco-Kras26" "Caco-Neo"
    "Caco-Neo3" "CacoKras" "Cad19" "Cal12T" "Calbiochem" "Caldwell" "Calmette"
    "Calmette-Guérin" "Camidge" "Campa" "Canada" "Caohuy" "Carboni"
    "Carboxyl-terminal" "Carey" "Carlie" "Carlo" "Carlsbad" "Casablanca"
    "Casanovas" "Case-control" "Caspase-3" "Castleman" "Caucasian-American"
    "Caucasians" "Cav-1-LRP6-mediated" "Cav-1LRP6" "Cav-1–LRP6–mediated"
    "Cav-1–LRP6–stimulated" "Cav-1–V5" "Cav-1–V5-His" "Cav1-GFP-positive"
    "Cav1-mRFP" "Cavsh11" "Cavsh11G" "Cavsi" "Cdc20-dependent" "Cdc25"
    "Cdc42→PAK1" "Cdc42→PAK1→Raf-1-MEK1" "Cdc48" "Cdc48p" "Cedars-Sinai"
    "Celeste" "CellROX" "Cellagen" "Ceppi" "Cg-Prkdcscid" "ChIP" "ChIP-PCR"
    "ChIP-chip" "ChIP-on-chip" "ChIP-qPCR" "ChIP–PCR" "Chae" "Chalmers" "Chan"
    "Chang" "Chang-Claude" "Charcoal-stripping" "Charles" "Chehab" "ChemBridge"
    "Chemically-induced" "Chenguang" "Chi-square" "Chiappetta" "Chicago" "Chk1"
    "Chlamydomonas" "ChoRE-containing" "Choi" "Chompret" "Chou" "Chou-Talalay"
    "Chromatin-IP" "Chromatin-Immunoprecipitation" "Chromogranins" "Chung"
    "Ciocca" "Cisplain" "Citrobacter" "Ciznadijia" "Cks1-R44A" "Cl41" "ClHy"
    "Clara" "Clark" "Clarke" "Clark’s" "Claude" "Cleveland"
    "Clinic-pathological" "ClogP" "Clontech" "Clopper" "Clopper-Pearson" "Cmax"
    "CnT-20" "CoIP" "Cochran" "Cochran’s" "Code" "Collado" "Combo" "CometScore"
    "CompuSyn" "Conclusion" "Conclusions" "Congo" "Congolese" "Connell"
    "Consensus-Finder" "Contraction-stimulated" "Controls" "Conway" "Coomassie"
    "Corbett" "Corp" "Costello" "Covance" "Cowden" "Cowden’s" "Cowin"
    "Cox-regression" "Coxsackievirus" "Cre" "CreERT" "Crohn" "Crohn's"
    "Crohn’s" "Cross-Meta-analysis" "Cross-reference" "Cross-sectional"
    "Cross-validation" "Cruz" "Cs" "Ctf18p" "Cul3-Rbx1-dependent" "Cullin-RING"
    "Cultrone" "Cuneo" "Curcuma" "Curie" "Curtin" "CyberKnife"
    "Cys124-Cys141-Cys135" "CytoID" "Cytoscape" "Czech" "D&E" "D-HDL"
    "D-HDL+PTX" "D-HDL+VPC" "D-Pro" "D-box" "D-loop" "D-type" "D2" "D3" "D5"
    "D684A" "D7" "D770_N771insGT" "D7S522" "D9" "DAB21P" "DBeQ" "DCIS-like"
    "DCIS-shCD44" "DEAA" "DEP-domain-containing" "DEW" "DFNA5" "DFNB31" "DG"
    "DGV" "DHHC" "DHPC" "DHVs" "DIQ" "DIUM" "DL23" "DLD1-F3" "DMEM" "DMFS"
    "DMFT" "DMPC" "DMS53" "DN1" "DN2a" "DN30" "DNA-PKc" "DNA-damage–induced"
    "DNA-protein" "DNAJA2" "DNAJC4" "DNAse-digestion" "DNp73" "DPO" "DPQ"
    "DR-GFP" "DRC" "DRDR1" "DRDR2" "DSBs" "DSEK" "DSPs" "DSS-induced"
    "DSS–induced" "DTP" "DTSSP" "DUALhunter" "DUIM" "DUOX1-depedendent" "DWR"
    "DXA" "Danen" "Dar" "Darby" "Daugherty" "David" "Davies" "Dblx"
    "De-identified" "DeCarli" "DeClue" "DeMartino" "DePinho" "Deininger"
    "Descemet" "Descemets" "Descemet’s" "Dharmacon" "DhhCre" "DiGeorge"
    "Diabetic" "Dickson" "Diego" "Diehn" "Dillner" "Dimethylsulfoxide"
    "Diphenylpyrazoles" "Disord" "Dispropotionate" "Dkk1in" "Dlx5" "Dmel"
    "Dogon" "Dong" "Donghui" "Dose–response" "Dot1" "Double-Strand"
    "Double-thymidine" "Drosophil" "Drosophilia" "Ducruix" "Duffy" "Dulbecco"
    "Dulbecco's" "Dulbecco’s" "Dunnett" "Duolink" "Dupré" "Dutch" "DxD"
    "Dz+KCl" "Dziadziuszko" "E&F" "E-L-E" "E-box" "E-cadherin" "E-twenty-six"
    "E12" "E2-Ubc3" "E2-Ubc5" "E2-liganded" "E2-like" "E2-ubiquitin"
    "E2-ubiquitin-conjugating" "E2F1si" "E2–E3" "E3-ligase" "E3-like" "E44G"
    "E47" "E478K-C-Raf" "E5" "E586K-B-Raf" "E9.5" "EBNA293" "EBP-mediated"
    "EC50=0.07" "EC50s" "ECGC" "ECHDC1" "ECM-GlySer-TM-ICM" "ECM-TM-GlySer-ICM"
    "ECMs" "ECOG" "ED" "EDDM" "EDDMs" "EDIL3" "EGF-like" "EGFR-MoAbs"
    "EGFR-axis" "EGFR-mediated" "EGFR-p53DD" "EGFR–membrane" "EHEC" "EIA"
    "EIGENSOFT" "EIGENSTRAT" "EILSRRPSYR" "EL08-1D2" "ELISAs" "ELISpot" "ELOB"
    "ELOC" "EMBL3" "EMC1501" "EMCN" "EMD→AAA" "EML4-ALK-negative"
    "EML4-ALK-positive" "EMT-like" "ENET" "ENETS" "ENSG00000073050" "ENaC"
    "ENaC's" "EPEC" "EPL" "EPSCs" "ER+ve" "ER-AsiSI" "ER-Golgi"
    "ER-PR-negative" "ER-functions" "ER-negativity" "ER-positivity"
    "ER-protein-positive" "ER-stress-induced" "ER-tag" "ER-ve" "ERB041"
    "ERE-GFP" "ERE-activity" "ERGIC" "ERMS" "ERS3" "ERα-HER2" "ERα-negative"
    "ERα–E2" "ERβs" "ER–ve" "ESC-CM" "ESCRT-1" "ESCRT-I" "ESCRT0"
    "ESCRT0-difficient" "ESCRT0’s" "ESCRT1" "ESCRTO" "ESI-MS" "EST1"
    "ET-18-OCH3" "ETP-ALL" "ETP46464" "ETPs" "ETS-fusion" "ETV" "ETYA"
    "EV-NIH3T3" "EV-expression" "EY" "EZH1" "Eadaravone" "Early-phase" "Easton"
    "Edaravone" "Edinburgh" "Efp" "Egger" "Egger's" "Ehrentraut" "Eighty-one"
    "Eisen" "El" "El-Khamisy" "Elg1p–RLC" "Eliis" "Elston" "Emami" "Empigen"
    "End-stage" "Endolfin" "Engelman" "Ensembl" "Ensemble-based" "Entercoccus"
    "Enterococcus" "Epithelial-mesenchymal" "Epithelial-to-mesenchymal"
    "Eppendorf" "Erb2" "Erb3" "ErbB" "ErbB2-ErbB3" "ErbB2-Src"
    "ErbB2-dependent" "ErbB2-directed" "ErbB2-expressing" "ErbB2-mediated"
    "ErbB2-negative" "ErbB2-positive" "ErbB3" "ErbB3-dependent" "Erk-mediated"
    "Estrada" "Ets1" "Europe" "European" "European-American"
    "European-ancestry" "Europeans" "Ex-Vivo" "Expressed" "Ezzidi" "Eα" "Eμ"
    "F-18-Deoxyglucose" "F-FDG" "F-FDOPA" "F-fluorodihydroxyphenylalanine"
    "F-measurement" "F-statistics" "F1" "F2" "F3" "F3-EpoR-Jak2V617F"
    "F3-Flt3-WT" "F4" "F5" "F507S" "F688A" "F7" "F836-Y844" "F9" "FACScan"
    "FAM86" "FAMILIA" "FANCD2-K561R-complemented" "FANCD2-proficient" "FANCD2L"
    "FANCD2S" "FASAY" "FBCs" "FBG" "FDG-PET" "FDOPA" "FE" "FE-PD" "FERM" "FEUA"
    "FGFR2IIIc" "FGFR4mut" "FGFRIIIb" "FGH" "FHRE" "FHRE-Luc" "FIGO" "FIRDI"
    "FISH" "FK-228" "FK2" "FLAG" "FLAG-E" "FLAG-MYPT1-T696DT853D"
    "FLAG-MYPT1-WT" "FLAG-R" "FLAG-WT-B-Raf" "FLAG-WT-C-Raf"
    "FLAG-epitope-tagged" "FLICA" "FLIM" "FLJ17473" "FLJ94553" "FLP-IN"
    "FLT-PET" "FLT3mut" "FOA" "FOLFOX" "FOM" "FOXM" "FOXO3A3" "FOXO3A3-ER"
    "FOXO3α" "FPT" "FPT-091" "FRFR1" "FTI-276" "FTMap" "FTP" "FTP-091" "FTα"
    "FTβ" "FUTP" "FVC" "FWHM" "Fab-armed" "Fab-complexed" "Factor-2" "Fagagna"
    "Fallot" "Fanc" "Far-red" "Faux" "Fc" "FdUMP" "FdUTP" "FdUrd" "Fedele"
    "Feig" "Feng" "Ferraros" "Fifty-eight" "Fifty-four" "Fifty-nine" "Figure-3"
    "Figure S1" "Figure S2j" "Filho" "Finland" "Finnish" "Finns"
    "Fischer-Posovszky" "Fjorback" "Flag" "Flag-Nrf2-Hek-293" "Flag-Rpt6"
    "Flag-or" "Flag-tag" "Flag-tagged-INrf2" "Flores" "Flt" "Flt3-ITD"
    "Fluoroblok" "Fmurine" "Fn" "FnIII" "FnIII-1" "FnIII-1–FnIII-2" "FnIII-2"
    "FnIII-3" "Foch" "Follow-up" "Forkhead-box" "Formin-2" "Forty-eight"
    "Forty-five" "Forty-seven" "Forty-three" "Forty-two" "Fos-B"
    "Fourteen-week" "Fourty" "Fourty-six" "Fpocket" "Fra-1" "Framingham"
    "France" "Francisco" "Fraumeni" "French" "Fronto" "Fronto-temporal" "Fu"
    "Fuchs" "Fukushima" "Ful" "Fusco" "Förster" "FΚBP" "G-14" "G-PCR" "G-PCRs"
    "G-PRC" "G-actin" "G-banding" "G-couple" "G-coupled" "G-quadruplex"
    "G-quartet" "G-ratio" "G-rich" "G0" "G0–G1" "G1" "G1-S" "G1-to-S-phase"
    "G1764A" "G1G2" "G2" "G2–M" "G469A-B-Raf" "G625I" "G628I" "G75" "G76" "GA"
    "GABAA" "GADD45α" "GATA3-Zip29" "GATA3-miR-29b" "GB-d1" "GCB-like" "GCCATG"
    "GCN4" "GCS" "GC→AT" "GECCO" "GEDF" "GEM-PNST" "GEM-grade" "GENEVA"
    "GES34828" "GFP-PCNA–positive" "GFP-fusion" "GFP-host" "GFP-rab7" "GFPi"
    "GG" "GHS" "GIBCO" "GID" "GL" "GLAUGEN" "GMALL" "GMALL-like" "GN" "GNF"
    "GNFSymAtlas" "GNPVPILIP" "GO-associations" "GO-terms" "GPRC" "GRAMM" "GRE"
    "GROMACS" "GRP78s" "GSE-22" "GSE1090" "GSE1433" "GSE14333" "GSE17538"
    "GSE20916" "GSE5206" "GSE6988" "GSK3β-S9A" "GSM803414" "GST-C21"
    "GST-Hinge" "GST-PAK-CRIB" "GST-TRFH" "GST-TiPARP-H532A" "GST-TiPARP-I631A"
    "GST-TiPARP-I631E" "GST-TiPARP-Y564A" "GST-Ubl" "GST-chTiPARP"
    "GST-chicken" "GST-fusion" "GST-mTiparp" "GST-mouse" "GST-pull" "GST-π"
    "GSW" "GT-8" "GTAR" "GTEx" "GV" "GVGD" "GWASs" "Gab1_G2" "Gab1_PR" "Gab_PR"
    "Gabonese" "Gadd45β" "Gain-of-function" "Galbraith" "Gambia" "Gapdh"
    "Garcinia" "Gaschott" "GenABEL" "Gene-gene" "GeneTrail" "Genebank"
    "Genentech" "Genomatix" "Genome" "Genome-Wide" "Genome-scale" "Genome-wide"
    "Genomewide" "Gensini" "George" "German" "Germann" "Germany" "Gershenwald"
    "Gevry" "Geyer" "Gillespie" "Gilman" "Giordano" "Giotopoulos"
    "GlaxoSmithKline" "Gleason" "GlialCAM" "Gly-Gly-Gly-Ser" "Godon" "Goetz"
    "Gonzalez" "Gorgoulis" "Gorre" "Grab2" "Gray-Schopfer" "Grb2-SOS"
    "Grb2-Sos1" "Greek" "Groep" "Gu" "Gualberto" "Guérin" "GxxxG" "GxxxG-like"
    "Gy" "Gyorffy" "Gö6976" "Gα" "Gα-GDP" "Gβ" "Gβγ" "Gγ" "H&E" "H+-ATPase"
    "H-8" "H-C-Raf" "H-Raf" "H-bond" "H1" "H2-relaxin" "H292-shCTL" "H2AX-γ"
    "H3" "H3H39" "H3K18" "H3K18Ac" "H3K27" "H3K36" "H3K37" "H3K56Ac" "H3K9"
    "H3K9Ac" "H3P38" "H3S10" "H3S10p" "H3S28p" "H3Y41" "H4" "H441" "H4K16"
    "H4K16Ac" "H4K20" "H5N1" "H773_V774insNPH" "H9" "HA-1004" "HA-1077"
    "HA-tag" "HA-ubiquitin" "HADC6" "HCAC6" "HCB" "HCEn" "HCEnC-21" "HCEnC-21T"
    "HCEnT" "HCEnT-21T" "HCOXP" "HCT" "HCT116-Cav-1-AS" "HCT116-Cav-AS"
    "HCT116-shScr" "HCT116-shTAZ" "HD-like" "HD506" "HD506-Q23"
    "HD506-Q23-interacting" "HDA6" "HDA6cdII" "HDAC1cd" "HDAC6cdII" "HDFs"
    "HDMXL" "HEK-V617F-STAT-Rep" "HEK293R" "HER1–4" "HER2+ve" "HER2-ICD"
    "HER2-dependency" "HER2-gene" "HER2-normal" "HER2-positive"
    "HER2-positivity" "HER2-ve" "HER2–ve" "HEY" "HExxH" "HFFs" "HG-U133A"
    "HGF-antagonisms" "HGF-antagonist" "HGF-antagonistic" "HGF-antagonists"
    "HGF-inducers" "HGF-shRNA" "HGF-to-NK4" "HGF-transcriptional" "HGF-β"
    "HHPred" "HHSearch" "HIF-α" "HIF1-α" "HIPPIE" "HIV-1-envelope"
    "HIV-1-envelope-induced" "HIV-1-gp120-induced" "HIV-envelope-induced" "HK"
    "HLA-DQ" "HLI98" "HMLE" "HMLE-Zip29" "HN" "HN-7" "HNSCCs" "HOC-7" "HOSE"
    "HOX-B" "HOXB8" "HPC-like" "HPDE6-c7" "HPFS" "HR-defective"
    "HRG-β1-treated" "HSA21" "HSQC" "HS_5" "HS_6" "HT1080" "HTF"
    "HTLF-mediated" "HUS" "HVT" "HWE" "HWF" "HWFs" "HYE" "Haaf" "Haenszel"
    "Haferkamp" "Half-life" "Hanahan" "Hancock" "Hansen" "HapMap" "Haploview"
    "Hardy-Weinberg" "Harlan" "Hartwell" "Hashimoto" "HbA1c" "Hck" "HeCOG"
    "Heale" "Heap-1" "Heceptin" "Henri" "Henry" "Hepa1c1c7" "Herbig"
    "Hereceptin" "Herman" "Hernandez" "Hernando" "Herpel"
    "Hetero-oligomerization" "High-affinity" "High-grade" "High-resolution"
    "Higher-grade" "Hinton" "His-Mdm2" "His-STAM" "His-UbcH5c" "His42"
    "Histone" "Hochberg" "Hodges" "Hodgkin" "Hoechst" "Hoefen" "Hoeller"
    "Hofman" "Holcman" "Honda" "Hong" "Hooijkaas" "Horta" "Host-Cell"
    "Hoyeraal-Hreidarsson" "Hreidarrson" "Hreidarsson" "Hs_FGFR4_5"
    "Hs_FGFR4_6" "Hscore" "Hscores" "Hsinchu" "Hsp110s" "Hsp70" "Hsp70-based"
    "Hsp90" "Hsu" "Htt-based" "Htt-targeting" "Htt171-18Q" "Htt171-82Q"
    "HuR-sirt1" "Huang" "Huggins" "Hugl-1" "Hui" "Human610" "Human610-Quad"
    "HumanHap610" "HumanOmniExpress" "Huntington" "Huntington’s" "Huntsville"
    "Hutter" "Huveneers" "Hygro" "Hynes" "Hypothesis" "Hz" "I-II" "I-IIA"
    "I-III" "I-Sce" "I-labeled" "I2-PP2A" "I3" "I683A" "IARC" "IBR1"
    "IBR2-biotin" "IBR2-imatinib" "IC50" "IC50s" "ICG-0001" "ICI" "ICI-182"
    "ICM-Chemistry" "ID8-IP" "IDCM" "IDG" "IDG-SW3" "IECs" "IEG" "IEGs"
    "IFN-αR" "IFN-γ-pSTAT1" "IFN-γR" "IFNy" "IGF-1-independent" "IGF-1-induced"
    "IGF-1-like" "IGF-1R-family" "IGF-1Rα" "IGR" "II-III" "II-IV" "IIB-III"
    "III-11" "III-7" "III-IV" "III-like" "IIIA" "IIIC" "IIID" "III–IV" "IIS"
    "IIa" "II–III" "II–IV" "IKKs" "IL-1β-ir" "IL-2R–VE-cad" "IL-6-depentent"
    "IL-6-trans-signaling" "IL-6-trans-signaling-STAT3" "IL-6Rα" "IL-6•sIL-6R"
    "IL-6•sIL-6Rα" "IL-6•sIL-6Rα-STAT3-gp130" "IL6•sIL-6Rα" "ILR2A" "INT"
    "INrf2-A549" "INrf2-null" "INrf2G333C" "IP26" "IP6Ks" "IQ" "IQR" "IQs"
    "IR-treatment" "IR468" "IR485" "IRB" "IRIF" "IRSI" "IR–mediated" "ISGs"
    "ISHD" "ISI" "ISREs" "ITC" "IV-2" "IVS" "IVS5+2" "IVT" "Ibα" "Ig-like"
    "IgG-ChIP" "IgHEL" "Il" "Il-12p40" "Il2rgtm1Wjl" "Illumina" "ImageJ"
    "Immuno-Precipitation" "Immuno-fluorescent" "In-depth" "In-solution"
    "InHepG2" "Inc" "Indianapolis" "Indians" "Infinium" "InsP" "InsPs"
    "Insulin" "IntOGen" "Inter-reader" "Interpretation" "Intra-cellularly"
    "Intra-tumoral" "Invitrogen" "Iowa" "Isabel" "Isobe" "Israel" "Ito" "IκB-β"
    "I–II" "I–III" "I–II–IIIA" "J12" "JAK-STAT3" "JAK2-neoplasia"
    "JAK2-oligomerization" "JAK2mu" "JH1" "JI1" "JIMT1" "JL-BTL10" "JM-A"
    "JMA " "JMDB" "JNJ3887605" "JPT" "JRS" "JV" "JZ" "Jacaranone" "Jacob"
    "Jacobs" "Jak2" "Jak2K539L" "Jak2V617F-dependently" "Jak3A572V" "Japanese"
    "Java" "Jedeszko" "Jewish" "Ji" "Jiang" "Jimor" "Jolla" "Jorgensen"
    "Jorgensen’s" "Joseph" "Jr" "Jun-Hynes" "Jung" "Jurkat-cell" "Jyg" "Jyg-MC"
    "Jäger" "K-11-linked" "K-B-Raf" "K-C-Raf" "K-Ras#26" "K-V" "K12" "K130M"
    "K16" "K18" "K373" "K48-chain" "K48-chains" "K48-conjugate"
    "K48-conjugates" "K48-tetraUb" "K48Ub" "K5" "K6" "K63-chain" "K63-chains"
    "K63-conjugate" "K63-conjugates" "K63-polyubiqiuitin" "K63-tetraUb" "K63Ub"
    "K65–176" "K689E" "K692E" "K713E" "K715E" "K8" "K8-overexpressing"
    "K84-chain" "K84A" "K87A" "K8R" "K9-E19" "KATO" "KBK" "KBrO" "KBrO3" "KCPS"
    "KCPS-II" "KCl-treatment" "KDAC" "KDM4A-overexpressing" "KEGG" "KHG"
    "KINOMEscan" "KLDY" "KMCH" "KOOS" "KR" "KRAS+BRAF" "KRAS+BRAF+PIK3CA+NRAS"
    "KRAS-GTP" "KRAS-status" "KS-like" "KTC" "KXpS" "KY" "KYM" "KYO" "Kang"
    "Kang's" "Kang’s" "Kanner" "Kaplan" "Kaplan-Maier" "Kaplan-Meier"
    "Kaplan–Meier" "Kaposi" "Kaposi's" "Kaposin" "Kaposi’s" "Karamouzis" "Karp"
    "Karposi" "Kaufmann" "Kawakami" "Kcat" "Kd" "Kenworthy" "Khamisy"
    "Khramtsov" "Ki-67" "Ki-67-negative" "Ki-67-positive" "Ki-67–positive"
    "Kidwai" "Kim" "Kip-family" "Kirsten" "Kiyono" "Klaus" "Klein" "Klemm"
    "Klooster" "Knock-down" "Knockouts" "Knudson" "Kojima" "Kolch" "Kong"
    "Korea" "Korean" "Kosrae" "Kovalenko" "Koya" "Koyama" "Koyama-Honda"
    "Kraft" "Kranenburg" "Kras#26" "Kras26" "Krausz" "Krebs" "Kriege" "Krum"
    "Krumins" "Krupple-like" "Kruskal-Wallis" "Kruskal-wallis" "Kruskall"
    "Kruskall-Wallis" "Kruskal–Wallis" "Krüppel-like" "Ku80" "Kuo" "Kurihara"
    "Kusumi" "L-DOPA" "L-MAT" "L1" "L1–CR" "L1–CR–L2" "L2" "L3" "L626fs"
    "L691A" "L86A" "LACP-4-Sox2" "LC3-I" "LC3II" "LC3–I" "LCI95" "LCI95 "
    "LDL-cholesterol" "LEF-1-dependent" "LEF-mediated" "LEF1-binding" "LEOPARD"
    "LFL" "LIMK2b" "LJG" "LLVSASQDGK" "LLVY" "LLVY-AMC" "LMH80" "LNA-193b"
    "LNA-Scramble" "LNCaP-305" "LNCaP-364" "LNCaP-cells" "LNCaP-progression"
    "LNCaP-shATM" "LNCaP-shCon" "LOC57415" "LPX" "LR" "LRD" "LRP6si" "LRPs"
    "LRRLL" "LS-MS" "LSRII" "LTK-14" "LTK14" "LTR" "LUBAC" "LUminescence-based"
    "LV-AR" "LX" "LXRα" "LY-364947" "LY2294002" "LY294402" "Lac" "Lambert"
    "Lamy" "Lange" "Langerhans" "Langsenlehner" "Lanterman" "Late-phase"
    "Latimer" "Latin" "Latin-American" "Latina" "Lauren" "Lef1" "Legius"
    "Lehmann" "Lemin" "Lentiviral-shHMGA2" "Lentiviral-shHmga2" "Letavayova"
    "Levina" "LexA-VP16" "Li" "Li-Fraumeni" "Liang" "Libya" "Licor" "Lieber"
    "Lieber-DeCarli" "LightCycler" "LightShift" "Lindgren" "Lipinski"
    "Lipinski’s" "Lipofectamine2000" "Liu" "Live-cell" "LocusZoom" "Log-rank"
    "Louis" "Lovastatin-like" "Lowe" "Lu" "Luci" "Lugli" "Luminex" "Luo"
    "Lustig" "Luthi-Carter" "Lys-5–57Arg" "Lys-to-Arg" "Lys1648X" "Lyte" "Lévy"
    "M-VAC" "M-category" "M-domain" "M-group" "M-mode" "M-stage" "M0"
    "MA+gp120" "MA-11" "MAC-2B" "MAD2-CDC20-APC" "MAGENTA" "MALT" "MAPkinases"
    "MARK1-4" "MB1547" "MB1589" "MB1823" "MCF-10A-NeuT" "MCF-7Vav1"
    "MCF-7Vector" "MCF10-neoT" "MCF10A-1" "MCF10A-2" "MCF10A-ErbB2" "MCF10A1"
    "MCF12" "MCF7-10b" "MCF7-ErbB2" "MCF7-shBRCA1" "MD4" "MDA-MB" "MDA-MD-231"
    "MDA231-Zip29" "MDACC" "MDM2–E2" "MDMX–p53-selective" "ME-PCR" "MEF2-VP16"
    "MEF2-VP16ERtm" "MEF2-VP16ERtm-transfected" "MEG-01" "MEK-targeted"
    "MEK5-DD" "MEL23" "MEL24" "MELN" "MEM" "MET-binder" "METT22" "MFI" "MGC"
    "MGP" "MHC-I" "MIP-3α" "MIP-3β" "MIP1-β" "MIR4461" "MIV" "MK-2461" "MKA"
    "MKK6-EE" "MKKK" "ML-141" "MLCK-MLC" "MLE10" "MLE10-HGF" "MLN-4924" "MLO"
    "MLO-Y5" "MMP-2-FL-overexpressing" "MMP-2si" "MMP2si" "MMP2si+PAK4-FL"
    "MMP2si+PAK4si" "MMTV-PyMT" "MOI=5" "MOLM" "MOMC" "MOMCs" "MO_1005" "MPD37"
    "MPH" "MPSNT" "MQ" "MRC5VA" "MS" "MSI-phenotype" "MSPR" "MTDC" "MTPY1"
    "MTS" "MVNP-NIH3T3" "MVNP-stably" "MYC–DNA" "MYPT" "MZ" "Madin"
    "Madin-Darby" "Maier" "Malay" "Maleimide-Biotin" "Mandola"
    "Mantel-Haenszel" "Maretzky" "Maria" "Marotta" "Martelli" "Martensson"
    "Martinez" "Martinez-Estrada" "Martino" "Marx" "Maryland" "MassARRAY"
    "Mathew" "Matri" "Matri-gels" "Matrox" "Mauritania" "Mav" "MaxEntScan"
    "MaxEntScan’s" "Mb" "Medema" "Mediterranean" "Meier" "Mel658" "Merck"
    "Merlo" "MetSeek" "Meta-regression" "MetaHIT" "Metacore" "Meth" "Meth-A"
    "Methodology" "Mexican" "Mexican-Americans" "Mfn1" "Mi2" "MiHA" "MiR-20b"
    "Micci" "Michaelson" "Michalek" "Michaud" "Michigan" "MicroRNA-19a"
    "Millipore" "Minogue" "Miranda" "Miranda-Carboni" "Mirus" "Mitelman"
    "MitoTracker" "Mitra" "Mizutani" "Mnk-1" "Mnk-1-T2A2" "Mock-transduced"
    "Model" "MolCart" "Mollinedo" "Molsoft" "Molven" "Mongiat" "Mongiat-Artus"
    "Mono-ADP-ribosylation" "Monocyte-derived" "Monte" "Montgomery" "Mooi"
    "Mora" "Moroccan" "Morris" "Mortusewicz" "Moskaluk" "Mtf2" "Mukerji"
    "Multiseq" "Munoz" "Musculoskelet" "MyStats" "Myc-5YF" "Myc-pY74"
    "Myc-pY74-only" "MycHisA" "Myers" "Myr-AKT" "Myr-GCN4-ICM" "Myr-ICM"
    "Myristoyl" "N-Acetyl-Leu-Leu-Nle-CHO" "N-Acetyl-leu-leu-norleucinal"
    "N-HDL" "N-HDL+PTX" "N-HDL+VPC" "N-HSQC" "N-Oct3" "N-acetyllactosaminide"
    "N-category" "N-dimethylamino" "N-glutamine-derived" "N-labeled"
    "N-methyl-N" "N-methylation" "N-stage" "N0" "N=29" "N=31" "N=6" "NA"
    "NAB2-STAT6-expressing" "NARF2-E6" "NBPF" "NCB" "NCBI" "NCI" "NCI-60"
    "NCI-CTC" "NCI-H522" "NCI-H69" "NCIDS2" "NCPCs" "NCsi" "NCsiRNA"
    "NEMO-deficient" "NEMO-proficient" "NF-E2A" "NF-ΚB" "NF-κB-RE" "NF-κB1"
    "NF1-like" "NFKB" "NFκB1" "NFκBIA" "NGLN4X" "NHANES" "NHL" "NIEL2"
    "NIH-3T3-F4" "NK4-like" "NL4-3" "NMG-10b" "NMG-Wnt10b" "NMIBC" "NNBT" "NNK"
    "NNKAOc" "NNKOAc" "NNSplice" "NO" "NOD-SCID" "NOESY" "NPM-ALK-expressing"
    "NPMB23" "NPcis" "NRVMs" "NSC-319725" "NSC-653010" "NSC-653016" "NSC-87511"
    "NSC-92339" "NSC207895" "NT-shRNA" "NUV" "NVP" "NVP-BEZ258" "NVP-BEZ288"
    "NYP" "NYP-BGJ398" "NZB" "NZW" "Na" "Nagaoka" "Nagi" "Nahta" "Naitza"
    "Najy" "Nakagawa" "Nalabothula" "Nalge" "Nantong" "Nardi" "Nath"
    "Native-American" "Nature" "Nayal" "Ncl-Luc" "Ndounga" "Nef-defective"
    "Netherlands" "Neu" "NeuT-shp63" "Neurofibromatosis-1" "Neve" "Neyman"
    "Ngo" "Ni-NTA" "Ni-beads" "NiNTA" "Niemann" "Niemann-Pick" "Niu" "Niv"
    "NleB-HA" "NleBΔ202" "NleE" "Nnt1p" "Nobel" "Nodal" "Noguiera" "Noman"
    "Nomanbhoy" "Nonaka" "Noonan" "Noonan's" "North" "Norway" "Novartis"
    "Nrf2-293" "Nrf2-Hek293" "Nrf2-null" "Nrf2-specificantibody" "Nui" "Nunc"
    "Nurr77" "Nusse" "O-GlcNAcylate" "O-GlcNAcylated" "O-GlcNAcylates"
    "O-GlcNAcylating" "O-GlcNAcylation" "O-linked-N-acetylglucosamine" "O1"
    "O6-alkylguanine" "O6-mG" "O6-pobG" "OBRa" "OBRb" "OBRf" "OCT3" "OCT4A"
    "OCT4B1" "ODNs" "OHS" "OHS-401" "OHTam" "OHdG" "OMIM" "OMIM#151623" "OMIN"
    "ONCOSEQ" "OPTI" "OPTI-MEM" "ORR" "ORa " "ORs" "OSE151" "OSE2-luciferase"
    "OSSC" "OVCA3" "Ohio" "Okazaki" "Oliveras" "Oliveras-Ferraros" "OncoMap"
    "Oncomine" "One-in-fifty" "One-step" "One-way" "Operation" "Orbitrap"
    "Oris" "Ost4p" "Osterix1-cre" "Otake" "Ouerhani" "OvCa" "Overhauser"
    "Ox-GSK" "Oxford" "Oxford-GlaxoSmithKline" "P0" "P1" "P1-C" "P1282L" "P13K"
    "P16INKA4A" "P1Rs" "P2" "P2-binding" "P2Rs" "P2X" "P2XR" "P2Y" "P2YR"
    "P3-ML" "P38H" "P6" "P692A" "P692R" "P=0" "P=0.0005" "P=0.006" "P=0.007"
    "P=0.009" "P=0.010" "P=0.019" "P=0.02" "P=0.14" "PAGE" "PAK1→MEK1"
    "PAK1→Raf-1-MEK1" "PAK4-FL" "PAK4-FL-induced" "PAK4-FL-treated" "PAK4si"
    "PAK4si+GW2974" "PARG-null" "PARP-10" "PARP-15" "PARP1s" "PARPi"
    "PARylated" "PAS" "PAWR-null" "PBC-MBC" "PC-3M-MM2-derived" "PC3-ML"
    "PCNA-Ni" "PCR-RFLP" "PCR-RFLP-PAGE" "PD+XMD" "PD03" "PD20" "PD20-D2"
    "PD20-K561R" "PDGF" "PDGFRa" "PDK" "PER-ARNT-SIM" "PF-271" "PF-562,271"
    "PF-573,228" "PFS-6" "PFSs" "PGC1-α" "PGHDH" "PHA" "PHD1-3" "PHGDH-only"
    "PI3K-C2α" "PI3K-C2β" "PI3K-and" "PI3K-pathway" "PI3KCA" "PI3Kg"
    "PI3K→Akt→FoxO" "PIK3CA-GS" "PKA-induced" "PKC-β" "PKC-β-deficient"
    "PKC-β-directed" "PKC-β-mediated" "PKC-βI" "PKC-βII" "PKC-βII-NF-κB"
    "PKCβI" "PKCβII" "PKCδ" "PKCζ-targeted-identified" "PKCη" "PKCθ" "PKCι"
    "PKCλ" "PKMTs" "PKRL" "PLEXNB3" "PLINK" "PLP-like" "PLTH" "PLX4720" "PLXB3"
    "PM-to-nuclear" "PM0078199" "PM0078200" "PM0078201" "PM0078202" "PMA"
    "PMA-treatment" "PMR" "PMs" "PND-1186" "PNECs" "POPS" "PP1cβ" "PP1cδ"
    "PP2B" "PPD-B9" "PPII-helical" "PPIs" "PPME-1" "PPRPPKP" "PPXY"
    "PR-coregulator" "PR-negative" "PR-positive" "PRMTs" "PROtech" "PRPRT"
    "PRTE" "PT53" "PTEF-b" "PTEN-null" "PTIO" "PTPome" "PXD" "PXD-101"
    "PXVXRXLKPXR" "PXaan" "PXψPXR" "PYM-Con" "PYM-siTCRP1" "Pagano" "Paget"
    "Paget's" "Paget’s" "Pak" "Pak2-association" "Pakl" "Pan-inhibitors"
    "Pandiella" "Paneth" "Papidus" "Parkinson" "Parlanti" "Parton" "Passos"
    "Patel" "Patla" "Pawitan" "Pcdh" "Pcdhs" "Pcl2" "Pearson" "Pearson's"
    "Pearson’s" "Pearton" "Peeters" "Pellegrini" "Peluso" "Peng" "Perner"
    "Perou" "Peroxisome-proliferator" "Perugia" "Petrie" "Pfizer" "PgR+ve"
    "PgR-ve" "PgR–ve" "Ph1-OS" "Pham" "Phase-contrast" "PhiKan083"
    "Philadelphia" "PhosphoSitePlus" "Phosphoglucose" "Phosphorlyated-S6"
    "Phyliodes" "Phyre" "Piface" "Pimenta" "Pin1Y23A" "Pinnatifida" "Placentia"
    "Pluripetency-associated" "Plymouth" "PocketFinder" "Poisson"
    "Poisson-Boltzmann" "Poly-ADP" "Poly-L-lysine" "Poly-autoubiquitination"
    "PolyPhen-2" "PolyPhen2" "Polyak" "Polyphen" "Polη-C"
    "Polη-WT-reconstituted" "Polη-defective" "Polη-interaction" "Polη-replete"
    "Polη-ΔPLTH" "Polκ+PLTH" "Posovszky" "Post-treatment" "Powell" "Pozo"
    "Prader" "Prenen" "Principal" "Prives" "Prkdcscid" "Pro-SPC"
    "Pro280–Arg287" "Pro280–Arg295" "Profiler" "Promega" "Prostate"
    "Protein-DNA" "PrxI" "Pst" "PubChem" "Puerto" "Pull-down" "PyMT-miR-29b"
    "Pymol" "Pyo" "Pyrococcus" "P = 0" "P = 0.02" "P = 0" "P = 0.001"
    "P = 0.006" "P = 0.04" "Q13491-1" "Q2340fs" "Q9NP29" "Q9UL85" "QQ" "QSAR"
    "QUICKI" "QZ" "QiSampler" "Qiagen" "QikProp" "Quadros" "Quantile–quantile"
    "Quanto" "Queensland" "R-group" "R-interacting" "R-mediated" "R-selective"
    "R-targeted" "R0" "R3" "R306X" "R401H-C-Raf" "R5" "R5-tropic" "R509H-B-Raf"
    "R7" "R8–D4" "R=0.63" "R=4.6" "RAD51-delta-ex9" "RAD51i" "RAF-dimerization"
    "RAF-inhibitor-sensitive" "RALGEF" "RAUL" "RB-C" "RB-MI" "RB-S6"
    "RB-family-mediated" "RB-wt" "RBX2" "RCAS-PDGF" "RCAS-PDGF-HA" "RCAS-TRIM3"
    "REMD" "REzol" "RFC-like" "RFC1–5" "RFC2–5" "RFLP" "RFLP-PAGE"
    "RFLP-PAGE-silver" "RFLP-microfluidic" "RFLP-µ" "RG37" "RGD" "RHC-80267"
    "RHO" "RHS4740-NM" "RIA" "RIHS" "RING-BRCT" "RING-SCD-BRCT" "RIP-Tag2"
    "RIPA" "RJW" "RKG" "RKK" "RLU" "RNA" "RNAPol" "RNASE1" "RNF" "RO-5963"
    "ROESY" "ROMK" "RPL7P3" "RQ-PCR" "RRASL" "RRP1B" "RRSSL" "RSQ" "RSV" "RTK"
    "RTK-ligand" "RTKs" "RTel" "RUNT1" "RVxF" "RWPE" "RXXK" "Rabat" "Rac-GTP"
    "Rac1-GDP" "Rac1-GTP" "Rac1-Pak" "Rac1-activity" "RacGTPases"
    "Rad18-WT-expressing" "Rad18-mediated" "Rad18-null" "Rad18-stimulatory"
    "Rad27p" "Raderschall" "Radiation-induced" "Raf-1" "RagA–D" "Raheja"
    "Rap1-ChIP" "Ras-regulatory" "Rb" "Rb-MI" "Rb-wt" "Re-aggregation"
    "Re-expression" "RecQ-helicase-like" "RefSeq" "Reis" "Reis-Filho" "Rel65"
    "Renilla" "Results" "Rett" "Rev1" "Rfc1p" "Rh-123" "Rheumatology"
    "Rho-GDP-dissociation" "Rho-families" "Rho-family" "Rho-kinase" "RhoA-ROCK"
    "RhoGDIα" "RhoGTPases" "Rican" "Ricans" "Rickard" "Ring-box" "Rip-like"
    "Riva" "Ro-19-8022" "Ro318220" "Robberson" "Roche" "Rochester" "Rock"
    "Rockford" "Rockville" "Rogalla" "Roh" "Roock" "Rosetta" "Rossier"
    "Rossman" "Rossmann" "Rossmann-like" "Roy" "Rpn10" "Rubin" "Ruifrok"
    "Runx2-reporter" "Rushworth" "Ryan" "R–CHO" "R–PTEN" "S-Met"
    "S-adenosyl-L-methionine" "S-and" "S-mediated" "S-methylated" "S-oxide"
    "S1" "S1-M-80" "S100P" "S139H2AX" "S17A" "S1981" "S1B-E" "S1C-E" "S235"
    "S240" "S259" "S289" "S2A–B" "S2C–F" "S2D" "S2D-F" "S2G" "S2H" "S3" "S3-S5"
    "S300HR" "S338" "S3A-C" "S3B–C" "S3D-cofilin" "S3D–E" "S4" "S462TY" "S473A"
    "S473D" "S491" "S497" "S4A-D" "S4A–B" "S4B" "S4C" "S4E" "S4F" "S4G" "S55"
    "S587-L641" "S5E" "S5E-H" "S5a" "S6" "S62" "S62-P63" "S62-T58" "S6K"
    "S6K-mediated" "S7" "S7C" "S7D" "S87A" "S9" "SAH-p53-8" "SANT" "SAXS"
    "SC514" "SCC-90" "SCEs" "SCF-Skp2" "SCH9" "SCL38A3" "SCNAs" "SD-169" "SDF"
    "SDF-1α" "SDS–polyacrylamide" "SEQUEST" "SER33" "SFI" "SFT-10" "SFT-14"
    "SFT-3" "SFT-31" "SFT-44" "SH2-domain" "SH2-like" "SH3-domain"
    "SH3-grooves" "SH3-ligand" "SH3-recognition" "SHANK" "SHC-002"
    "SHP-2-ASO-treated" "SIFT" "SILAC" "SIM2s" "SIRT" "SIRT1shRNA" "SIRT1–3"
    "SIRTs" "SJ-172550" "SKF-38393" "SKHep" "SM" "SMG-11" "SMR-peptide"
    "SMUG1-KD" "SNP" "SNP-SNP" "SNP-by-BMI" "SNP-by-environment"
    "SNP-by-ever-smoking" "SNP-by-pack-years" "SNP-by-smoking" "SNP309T"
    "SNP34091" "SNPper" "SNPs" "SNPsTaqMan" "SOCS" "SOL" "SOM157d" "SOM196b"
    "SOM569" "SPEC-1S" "SPECTs" "SPINK" "SPOUT" "SPSS" "SQ2" "SR"
    "SRC-CRKL-YES" "SRC-family" "SSCA" "SSS" "STAT" "STAT-reporter" "STAT3-YFP"
    "STAT3-dependent" "STAT3s" "STAT6-NAB2" "STATA" "STATH" "SU-5402"
    "SU-DHL-1" "SUa7" "SVXX" "SYBR" "SYTOX" "Saharan" "Sahl" "Saint-Louis"
    "Salamanca" "Sanger" "Sangon" "Santonocito" "Santos" "Saridaki" "Sasai"
    "Sasaki" "Saxton" "Scarff-Bloom-Richardson" "Sce" "SceGFP" "Scheper"
    "Schizosaccharomyces" "Schmidt" "Schmidt-Lanterman" "Schnabel" "Schopfer"
    "Schrodinger" "Schrödinger" "Schultheis" "Scid-Beige" "Scorpion-ARMS" "Scr"
    "Sd" "Sd-homologous" "Seattle" "Sedentary-light" "Sedivy" "Self-Renewal"
    "Self-renewal" "Semi-quantitative" "Senescence-like" "Sephacryl" "Seq"
    "Sequence-specific" "Sequenom" "Ser-19" "Ser-217" "Ser18" "Ser235"
    "Ser267LysfsX19" "Ser65-4EBP1" "Ser807" "SerPro" "Serrano"
    "Severe-Combined" "Shaw" "Shc-tyrosine" "Shibata" "Shlien" "Short-chain"
    "Short-hairpin" "Short-heparin" "Short-interfering" "Shroff" "Sica"
    "Sigma-Aldrich" "Significance" "Silva" "Silvius" "Sinai" "Single-strand"
    "Sirigu" "Sirt1expression" "Sirt1in" "Sirt1mediated" "Sirtuins" "Sixty-six"
    "Skorski" "Skp1-Cul1-F-box" "Skp1-Cullin1-F-box" "Skp2-dependant"
    "Skp2-p27" "Sle3" "Slit-Robo" "Slit2N" "Sloan" "Slupianek" "Smad2" "Smads"
    "Small-molecule" "Smid" "Snail1" "Solver" "Soo" "Sorlie" "Sos1-Grb2-Gab1"
    "Sos1_PR" "Sos1_S1" "Sost" "Souglakos" "SourceForge" "Sox" "Sox2-gene"
    "Sox7" "Spain" "Spanish" "Spearman" "Spearmann" "Spearmann’s" "Spearman’s"
    "SpiroMeta" "Src" "Src-ID8" "Src-cells" "Src-family" "Stacey" "Stanford"
    "Stat6-dependent" "Steady-state" "Steven" "Stommel" "Stress-mediated"
    "StripAssay" "Structural-functional" "Study-population" "Sub-Saharan"
    "Sub-cellular" "Sub-mitochondrial" "Summary-level" "Sung" "Sunnyvale"
    "Superarray" "SureFire" "Suris" "Suris-Swarm" "Suspension-induced" "Suzuki"
    "Sviderskaya" "Sweden" "Sybergreen" "SymAtlas" "Sypro" "SzJ" "S→A" "S→E"
    "T-C" "T-PLL" "T-Scratch" "T-categories" "T-category" "T-effector"
    "T-helper" "T-lineage" "T-lymphoblast" "T-lymphoblastic" "T-lymphoblasts"
    "T-lymphoid" "T-lymphopoiesis" "T-stage" "T1" "T1G3" "T2" "T2-4" "T2-T4"
    "T2-hyperintensities" "T29" "T29H" "T2D" "T2DM" "T2DM-As" "T3" "T308A"
    "T308D" "T315I-Ba" "T3SS" "T4" "T450A" "T47D-14-3-3ζ" "T47D-ErbB2" "T56A"
    "T57" "T58" "T58-P59" "T624I" "T696AT853A" "T7" "T78" "T8" "TACs" "TAE"
    "TAE-226" "TALLA" "TALLs" "TAPBP" "TAT-Control" "TAT-DI1" "TAT-DI1-treated"
    "TAT-SNAP-23" "TAT-Scram" "TAT-syntaxin-4" "TATA" "TAT–3L4F"
    "TAT–3L4F-treated" "TAZ-AXL-CTGF-high" "TAZ-AXL-CTGF-low"
    "TAZ-AXL-CTGF-mediated" "TAZ-TEAD" "TAp63α" "TAp63γ" "TAp73"
    "TAp73-mediated" "TAp73α" "TAp73β" "TBE" "TBS" "TCD" "TCDs" "TCF-dependent"
    "TCF-mediated" "TCH" "TCL1tg" "TCRζ" "TDC" "TEBs" "TFBIND" "TFBS" "TGCA"
    "TGD" "TGFβ3" "TGFβR1" "TGFβR2" "TGMVGA" "TIC" "TIN" "TIN2-V5" "TIRF"
    "TIRF-M" "TIRFM" "TKI298" "TKK" "TM-ICM" "TM-JM" "TMPSS2" "TM–JM" "TM–JM-A"
    "TM–JM–KD" "TN-status" "TNF-Α" "TNF-α-ir" "TOCSY" "TOM" "TOM1-like"
    "TOP-like" "TOPFlash" "TOR1" "TOR2" "TP53-competent" "TPA" "TQTD884"
    "TRA-1-60" "TRA-1-81" "TRA-2-54" "TRAF2-His" "TRAIL-R" "TRAIL-receptor"
    "TRANSFAC" "TRAP-MVNP" "TRAP2A" "TRF2-ChIP" "TRFH" "TRIPZ" "TROSY"
    "TRR-cells" "TTAGGG" "TUM" "Ta" "Table S1" "Taiwan" "Taiwanese" "Talalay"
    "Tamimi" "Tanimoto" "Taqman" "TargetScan" "Tarnow" "Tat-induced"
    "Tat-mediated" "Tat-transduced" "Tazebay" "Tazzite" "Tca" "Tcf"
    "Tcf-transcriptional" "Tcf4" "Teissedre" "Ten-year" "Tessari" "TetOp"
    "Tetralogy" "Tg" "Th17" "Th17-mediated" "TheAKT1" "Thirty-five"
    "Thirty-four" "Thirty-nine" "Thr-696" "Thr-853" "Thr180-Gly-Tyr182" "Thr41"
    "Three-dimensional" "Tiel" "Time-course" "Time-lapse" "Tiparp" "Tokyo"
    "Toll-dependent" "Toll-like" "Tomasz" "Tp20" "Trans-lesion" "TransAM"
    "Trastuzumab" "TriTek" "Trinko" "Triple-modified" "Triple-negative"
    "Tris-HCl" "Triton-X100" "Ts1Cje" "Tsai" "Tu" "Tubastatin"
    "Tumor-Node-Metastasis" "Tumor-Suppressive" "Tumorscape"
    "Tumour-associated" "Tunisia" "Turku" "Twenty-one" "Twenty-seven"
    "Twenty-six" "Twenty-three" "Twenty-two" "Twist" "Two-hybrid" "Tyr-1230"
    "Tyr-1234" "Tyr-1349" "Tyr-P" "Tyr1221" "Tyr1349" "Tyr705" "T→A" "T→E"
    "U-87" "U-shaped" "U-shapes" "U0" "U1026" "U133A" "U2" "U251" "U73122"
    "U87-glioblastoma" "UAF1del" "UAS" "UAS-RNAi" "UBM-mediated" "UBM1" "UBM2"
    "UBMs" "UBP" "UBX" "UBXN6" "UCI" "UCI95" "UCI95 " "UCSC" "ULK" "UM-C1"
    "UM-C2a" "UM-C2b" "UM-SCC-9" "UMPS" "UNC" "UNG-KD" "UOK262" "UPLC-MS" "UPR"
    "UR" "URL" "URLs" "USA" "UTR-region" "UTRs" "UTSCC" "UTSCC42a" "UTSCC8"
    "UV-light" "UVA" "UVC" "UVs" "Ub-chain" "Ub-chains" "Ub-conjugate"
    "Ub-conjugates" "Ub-like" "UbcH1" "Ubiquitin-binding-zinc-finger" "Ubs"
    "Ugi" "Ugi-peptide" "Uhrhammer" "UltraLink" "Undaria" "Uni" "Uniprot"
    "Urbanucci" "Utah" "V-Ki-ras2" "V-ets" "V-set" "V1.546" "V131I" "V2THS"
    "V35–D79" "V35–V89" "V3THS" "V5" "V5-MYPT1" "V5-MYPT1-D884A"
    "V5-MYPT1-T696DT853D" "V5-MYPT1-WT" "V5-tag" "V5-tagged" "V600D" "V600E"
    "V600E+MITF" "V600E-B-Raf-mediated" "V617F" "V687A" "V765insHH"
    "V769_D770insASV" "V774_C775insHV" "VEGAS-Pathway" "VEGF-121"
    "VEGF-receptor" "VGLL3" "VGP" "VGPs" "VI" "VIII-like" "VIVA" "VKKRKRKCLLL"
    "VMAT" "VMD" "VN-adhesion-elevated" "VN-adhesion-induced" "VPC23019"
    "VPC23109" "VS.G" "VSIG4" "VSV-G" "VTA" "VTP" "VTX" "VTX-11e" "VX509"
    "Vadlamudi" "Val340LysfsX6" "Valdes" "Valdes-Mora" "Valencia"
    "Vamp7-positive" "Vanderbilt" "Vassilev" "Vav1SH2-CBl-c" "Vav1SH2-Cbl-c"
    "Vav1SH2-GST" "Vav1SH2-associated" "Veltmaat" "Venice" "Venn" "Ventana"
    "Verhoeff" "Verprolin-homologous" "Vif-ELOBC" "Vina" "Virginia" "Vispe"
    "Voorde" "Vousden" "Vredeveld" "Vugt" "W6" "WASP" "WD4" "WD7" "WHI"
    "WHI-P131" "WHL" "WI" "WL374" "WM" "WNT-ligand" "WNT-ligands"
    "WNT10B-ligand" "WST-1" "WT-AKT2" "WT-CD81" "WT-FOXO1" "WT-Polη" "WT-Rac"
    "WT-Rac-1" "WT-Rac1" "WZA" "Waals" "Waddell" "Wahl" "Wakana" "Walczak"
    "Wald" "Walter" "Warburg" "Washington" "Wassman" "Water-soluble"
    "Web-based" "WebGestalt" "Weigelt" "Weinberg" "White" "Whitehead" "Whitney"
    "Whole-exome" "Whole-genome" "WikiPathways" "Wilcoxon-rank" "Willander"
    "Willi" "Wnt-ligand" "Wnt-reporter" "Wnt–β-cat" "WoLFPSORT" "Wong" "Wts"
    "X-chromosomal" "X-inactivation" "X-irradiation" "X-ray" "X-rays" "X100"
    "X4" "X4-tropic" "XCC1" "XLQ" "XP-V" "XRCC1-194Arg" "XRCC1-399Arg" "XRCC1s"
    "XTT" "XW" "XY" "Xaa" "Xenogen" "Xia" "Xq11-12" "Xq12" "Xu-5-P" "Xunliang"
    "Y-family" "Y12" "Y1230" "Y1234" "Y1349" "Y1515-F1525" "Y23A" "Y2H"
    "Y2H-screen" "Y32F" "Y340" "Y397" "Y74F" "YAP-TEAD" "YES" "YI" "YIL110W"
    "YQX" "YRI" "YW" "YWL" "Yamanaka" "Yes-associated" "Yeung" "Yki" "Yki-GDBD"
    "Yki1SA" "Yki3SA" "Yoder" "York" "Yorkie" "Yoshimoto" "Yu" "Z-driven"
    "ZDOCK" "ZR75" "ZZ" "Zakhartseva" "Zealand" "Zhang" "Zheng" "Zhou" "Zhu"
    "Zieger" "Zimmermann" "Zn" "Zou" "ZsGreen" "a-ketoglutarate" "aBRAF"
    "aPKCs" "aaS252W" "above-discussed" "abraxane" "absense" "absorbance"
    "accelerometer" "accordant" "acetamide" "acethylcholine" "acetyl-H4"
    "acetyl-Lysine" "acetyl-lysine" "acetyl-mimetic" "acetylation-mimetic"
    "acetylcholine" "acetyllactosaminide" "acid-adenylate" "acid-insensitive"
    "acid-phosphatase" "acid-urea" "acinar-ductal" "acral" "actetate"
    "activators" "active-site" "activities" "acute-phase" "add-back" "adduct"
    "adducts" "adenocarcnomas" "adenoma-cancer" "adenoma-independent"
    "adenoma-to-carcinoma" "adenoma–carcinoma" "adenylate" "adenylyl"
    "adherens" "adhesiveness" "adixin" "advanced-stage" "affecteds" "affi"
    "affi-gel" "affinity-purification" "afterBRAF" "agar" "age-associated"
    "age-specific" "agonism" "agreeswith" "air-liquid" "airpin" "algorithm"
    "algorithms" "alia" "alias" "alkG" "alkyl" "alkylG" "all-atom" "all-time"
    "allelemask" "allelotypes" "alloSCT" "allograft" "allosterism" "alone–in"
    "alpha-helices" "alpha-helix" "alpha-negative" "alveoli" "amber99SB"
    "amine-reactive" "amines" "amino-acid" "amino-labeled" "amino-specific"
    "amino-terminal" "amino-terminally" "amino-terminus" "aminoacid"
    "aminophenyl" "amniocytes" "amphigegulin" "amplicon" "analogue-sensitive"
    "analyte" "anastomose" "anchorage-independence" "and-6" "and11.8" "andApc"
    "andAtg3" "andBRAF" "andCyld" "andNf1" "andSox9" "andTiparp"
    "androgen-dependence" "androgen-deprivation" "androgen-independence"
    "androgen-poor" "androgen-scarce" "androgen-tolerant" "and 2J" "aneuploid"
    "aneuploidy" "aneurysm" "aneurysms" "angiocrine" "angiogenesis-dependent"
    "angiogenesis-inhibitor" "angiotensin-IV" "ankyloblepharon-ectodermal"
    "anlagen" "anorexia" "anoxia" "antagomiR" "antagomiRs" "antagonises"
    "anterior-most" "anthracycline-taxane-containing" "anthraquinone"
    "anthropometry" "antichromatin" "antihistone" "antimicrotubule"
    "antiparallel" "antiphosphotyrosine" "antiretrovirals" "antitetraspanin"
    "antitumour" "aphidicholin" "apical-basal" "apical-basolateral" "apocrine"
    "apoptosis-regulatory" "apoptosis-related" "approx" "arachidonate" "areal"
    "arisen" "aromatic-aromatic" "aros" "arrow-heads" "arterioles" "astroglia"
    "at-146" "atera" "athero" "athero-protective" "ation" "atomic-coordinate"
    "attention-deficit" "atypia" "aureus" "autism-spectrum"
    "auto-ADP-ribosylation" "auto-GRP78" "auto-antibodies" "auto-antibody"
    "auto-degradation" "auto-inhibited" "auto-inhibitory" "auto-modification"
    "auto-mono-ADP-ribosyltransferase" "auto-oxidation" "auto-reactive"
    "auto-regulatory" "auto-ribosylation" "autophagosomes" "autoradiography"
    "axial" "axon" "a–d" "b1" "back-crossing" "back-to-back"
    "bacterially-expressed" "bacterially-induced" "bait-independent"
    "bait-specific" "bar-coded" "barbed-ends" "basal-epithelial" "basal-like"
    "basal-type" "base-excision" "base-pair" "batch-to-batch" "bavacizumab"
    "bead-based" "begun" "benzo" "benzofuroxan" "benzylG" "beta-adrenergic"
    "beta-antagonists" "beta-blockers" "beta-strands" "between-study"
    "betweenp27" "bi" "bi-allelic" "bi-directional" "bi-functional" "bi-phasic"
    "bi-potential" "bi-potentiality" "bicelles" "biculatimide" "bidentate"
    "bilayer" "bilayers" "binding-partner" "bio" "bio-functions" "bioassays"
    "biomarkes" "biomolecules" "bioplex" "bioprobe" "biopsies" "biopsy"
    "bivariate" "blindness–the" "blocker" "blockers" "blood-based"
    "blood-borne" "blood-brain" "blood–brain" "blosum62" "blue-green" "bodies"
    "body-associated" "bolus" "bone-marrow" "bone-only" "botulinum" "bp"
    "bp1305" "brachytherapy" "brainstem" "brca1-null" "break-apart"
    "break-induced" "breakpoint" "breakpoints" "breast-like" "bredNf1"
    "bright-field" "brighter" "broad-reaching" "broad-spectrum" "broad-window"
    "broader" "broadest" "bromate" "bromothenylG" "bronchiolo"
    "bronchiolo-alveolar" "brown-like" "buffer-based" "built-in" "burn-induced"
    "bursa" "butoxy" "butyl" "by-itself" "by-products" "byp27" "bypassingBRAF"
    "c-Fos-dependent" "c-Fos-tyrosine" "c3018C" "cBMB" "cDNA-PCR" "cIAP"
    "cLBObs" "cMyBP" "cMyBP-C" "ca.10-fold" "cadherin–pl20" "caecum"
    "cafeteria-style" "café-au-lait" "calcium-calmodulin–dependent"
    "calorimetry" "campothecin" "cancer-preventive" "cancer-propensity"
    "cancers" "caner" "cap-interaction" "capillary-like" "carbonyl"
    "carboplatine" "carboxyl" "carboxyl-terminus" "carboxylmethylguanine"
    "carboxylphenyl" "carboxymethylate" "carboxymethylcysteine"
    "carboxymethylguanine" "cardiac-specific" "carefully-designed" "carnitine"
    "carriers" "cartilage-degrading" "case-control" "case-selective"
    "case–control" "caspase-like" "castration-resistance"
    "castration-sensitive" "catabolite" "catalyse" "cation-π" "caveolin-1α"
    "caveolin-1β" "caveolion-1" "cavin" "cavin-family" "ccRCC" "cdc48" "celiac"
    "cell-autonomous" "cell-by-cell" "cell-cycle-related" "cell-extrinsic"
    "cell-impermeable" "cell-intrinsic" "cell-like" "cell-line-dependent"
    "cell-line-specific" "cell-of-origin" "cell-permeable" "cell-specific"
    "cell-to-cell" "cell-type-specific" "cell-type–specific" "cells"
    "cellswere" "cellulo" "celss" "centroid" "centroids" "cerevisiae"
    "cetuximab+CAPIRI" "cfDNA" "chain-specific" "channel-independent"
    "chaperonins" "charcoal-stripped" "charcoal-stripping" "charge-charge"
    "check-ups" "checkpoint-related" "chelate" "chelates" "chemical-genetics"
    "chemo" "chemo-attract" "chemo-preventative" "chemo-preventive"
    "chemo-radiotherapy" "chemo-therapeutic" "chemoattractant" "chemoprobes"
    "chemoradiotheapy" "chemoradiotherapy" "chemoreristancce" "chemoresistance"
    "chemoresistant" "chemotherapeutic-resistance" "chi-square" "chi-squared"
    "chlorophenyl" "cholesterol-lowering" "cholesterol-rich" "chondroid"
    "chordate" "choreiform" "choroid" "chosen" "chr13∶44680312–57088104"
    "chr20" "chr22" "chr22loss" "chr7" "chromatid" "chromatids" "chromatin-IP"
    "chromatin-immunoprecipitation" "chromatin-remodeling" "chromophobe"
    "chromosome-negative" "chromosome-positive" "circuitry" "cis-element"
    "cis-enhancer" "cis-heterozygous" "cispalin" "cispaltin"
    "cisplatin+siCon+MK2206" "cisplatin+siGRP78+MK2206" "cisplatin-DNA"
    "classifiers" "clastogens" "clear-cut" "clearer" "clinical-trails"
    "clinicians" "clinico" "clinico-pathologic" "clinico-pathological"
    "clone-1" "clone-1-TUM" "clone-2" "closely-related" "coarse-grained"
    "cobalamin" "cobblestone-like" "cochaperone" "codings" "codon"
    "codon-45–mutated" "codons" "coencide" "coiled-coil" "col1α1"
    "cold-activated" "cold-induced" "coli" "collagens" "collectives"
    "collision-induced" "coloca" "colocalises" "colony-forming" "colony-like"
    "combination-treated" "comigrates" "commensal-triggered" "commensals"
    "commonalities" "commonest" "comorbid" "comorbidities" "comp"
    "compensatory-protection" "compound-contacting" "compound-receptor"
    "compound-treated" "concentration-dependently" "concentration-response"
    "conclud" "condesin" "conductance" "conformer" "conformers" "confounders"
    "congeners" "congenita" "conjugate-affinity" "conservedSNP" "constrast"
    "contact-inhibited" "continuum" "contraction-induced"
    "contraction-regulated" "contraction-stimulated" "contri" "contributant"
    "contri­bution" "control-shRNA" "copy-neutral" "copy-number" "coregulators"
    "cornea-to-epidermis" "corner-stone" "cost-effective" "cotransport"
    "counter-intuitive" "counter-screened" "counterscreens" "counterweight"
    "covariate" "covariates" "covariations" "coworkers" "creat" "cremaster"
    "cribri" "cribriform" "cross-activation" "cross-communication"
    "cross-complementation" "cross-contamination" "cross-histology"
    "cross-hybridizing" "cross-interaction" "cross-linker" "cross-membrane"
    "cross-phosphorylation" "cross-platform" "cross-react" "cross-reacting"
    "cross-reactivity" "cross-regulated" "cross-resistance" "cross-sectional"
    "cross-species" "cross-validation" "cryo" "cryo-electron" "cryosections"
    "cryostat" "crypt-villus" "ctivators" "cucurbitacin-I" "cullin-RING"
    "cut-off" "cut-offs" "cut-point" "cut-points" "cycle-to-cycle" "cyclin-cdk"
    "cyclohexamide" "cyst-like" "cystectomy" "cysteine-cluster" "cytP450"
    "cytidine-to-thymidine" "cyto" "cytoB" "cytochalasin-B" "cytodex"
    "cytokine-regulatory" "cytometer" "cytopenias" "cytoplasma"
    "cytoplasmic-only" "cytoskeletal-remodeling" "cytosol-to-nuclear"
    "cytosol-to-nucleus" "c–d" "dFdC" "dHPLC" "dPCA" "daf-15" "daf-16"
    "damage-activated" "damage-associated" "damage-dependent" "damage-induced"
    "damage-inducible" "damage-response" "damage-sensitivity"
    "damage-tolerance" "damage–induced" "dark-red" "dataset" "datasets"
    "day-to-day" "dbGaP" "dbVar" "dbcAMP" "de-convoluted" "de-differentiate"
    "de-differentiated" "de-escalate" "de-esterification" "de-novo"
    "de-polymerizing" "de-polyploidize" "de-recruitment" "de-regulated"
    "de-repression" "de-stabilizing" "de-ubiquitylating" "de-ubiquitylation"
    "decouples" "decresead" "dedifferentiate" "deeper" "deferens"
    "degree-of-freedom" "degron" "dehydrogense" "delE746-A750" "deletant"
    "deletions" "density-independent" "dentin" "dentin-pulp" "deoxynucleotidyl"
    "deoxyribo" "deoxyribo-nucleosides" "deoxyuridine" "dependend"
    "dependent-interactions" "deprivation-induced" "der" "derepresses"
    "dermoscopy" "desferrioxamine" "desmogleins" "destablizes"
    "detachment-induced" "detoxifier" "deubiquitylases" "di-Ub-chains"
    "diabets" "diacyglycerol" "diacylgycerol" "diaminobenzidine" "diap"
    "diap1-lacZ" "diazenyl" "diazoacetate" "dichlorodihydrofluorescein"
    "dideoxy" "dideoxynucleotides" "diet-derived" "diet-induced"
    "dietary-induced" "diet–induced" "difficult-to-treat" "diffraction-limited"
    "diffuse-type" "diffusion-based" "difluorodeoxycytidine" "digitorum"
    "dihydroxyvitamin" "dileucine" "dileucine-motif" "dimerise"
    "dimerization-defective" "dimethylamino" "dimethylsulphoxide" "dimmer"
    "diphenyldiazenylpyrazole" "diphenylfuranopyrimidine"
    "diphenylfuranopyrimidines" "diphenylpyrazole" "diphenylpyrazolo"
    "diphosphate" "diphosphate–ribose" "diphtheria-like" "diplod" "diploid"
    "diploidy" "dipyrimidine" "direct-target" "directly-administered"
    "discrepant" "discriminant" "disease-relevant" "diseasedue" "disequilibium"
    "disodium" "disorder-to-order" "disorderd" "disproptionate" "disrupter"
    "disrupters" "dissociation-association" "distributionin"
    "divide-and-conquer" "docetaxel-gemcitabine" "docitaxol" "docking-domain"
    "doi" "domain-swap" "domains" "dominant-negative" "dominant-negative–based"
    "dormancy" "dose-dependence" "dose-dependently" "dose-escalation"
    "dose-modifying" "dose-proportional" "dose-response" "dose-responses"
    "dose-responsive" "dose–response" "dosings" "dot-like" "double-knockdown"
    "double-knockout" "double-positives" "double-strand" "double-strand-break"
    "doublings" "down-modulation" "down-regulator" "down-regulators"
    "down-regulatory" "down-stream" "downBRAF" "doxycycline-inducibly" "drawn"
    "driven-tumor" "droplets" "drug-concentrations" "drug-efflux" "drug-like"
    "drug-response" "dsDNA" "dsDNA–transgenic" "dual-hijacking" "dual-model"
    "duplexes" "dyn" "dysfunction-induced" "dyslipidemia" "dysplasia"
    "dysplasia-cleft" "dysplasias" "eATP" "eCFP-polι" "eIF4E-4EBP-1" "eQTL"
    "eQTLs" "eSNP" "eSNPs" "eYFP" "early-S" "early-access" "early-onset"
    "early-passage" "early-phase" "early-stage" "echocardiography" "ectoderm"
    "ectodomain" "ectodomains" "ectopically-expressed"
    "ectrodactyly-ectodermal" "edema" "edentulism" "eff" "effecter" "egion"
    "eightfold" "elangiectasia" "electron-density" "electrophoresis-based"
    "elomere" "empty-vector" "encephalomyelitis" "end-of-life" "end-resection"
    "end-stage" "end-to-end" "endocrinology" "endoderm" "endometriod"
    "endometrioid" "endometrium" "endoneurium" "endothelial-mesenchymal"
    "endothelial-specific" "endothelial-to-mesenchymal" "endothelium–each"
    "endotoxemia" "endpoint" "endpoints" "energy-dependent" "energy-sensitive"
    "englerin" "enhancer-of-split" "enhancer–promoter" "ensemble-based"
    "enterococci" "enteroendocrine" "enterophathy" "enterotoxins" "entropy"
    "envelope-induced" "envelope-mediated" "envolve" "enzymes" "eosin"
    "eosinophilia" "eosinophils" "epigallactocatechin"
    "epigallactocatechin-3-gallate" "epigenome" "epiperineurium" "epithelia"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-originated"
    "epithelial-specific" "epithelial-stromal" "epithelial-to-endothelial"
    "epithelial-to-mesenchymal" "epithelial-to-mesenchyme" "epithelioid"
    "epithelium" "epoxyguaiane" "equi" "equi-potency" "erythrocytes"
    "erythroleukaemia" "esophagectomy" "et" "ethanol-fed" "ethoxymorpholine"
    "etopside" "et al" "eu" "euglycemic-hyperinsulinemic" "event-specific"
    "ever-growing" "ever-increasing" "ever-larger" "ever-smokers"
    "ever-smoking" "ex-Z" "ex-lacZ" "exercise-stimulated" "exome" "exon-3"
    "exon-centric" "exons" "expanding-type" "expansile" "expresson"
    "extended-to-turn" "external-beam" "extra-intestinal" "extra-nuclear" "ex "
    "e " "e–f" "e–h" "fIGF-1" "fSNP" "fSNPs" "facie" "factor-7" "faecalis"
    "faeces" "falciparum" "family-wise" "farnesyl" "farnesylcysteine" "farther"
    "farthest" "faster-migrating" "favorable-prognosis" "fecal"
    "feedback-induced" "feedback-regulated" "feedforward" "fiber-type" "fibro"
    "fibro-proliferation" "fibro-vascular" "fibroblast-like" "fibroblasts"
    "fibroblsts" "fifteenNf1" "figitumimab" "fine-grained" "fine-tune"
    "fine-tunes" "fine-tuning" "first-degree" "first-line" "first-order"
    "first-passage" "first-phase" "five-membered" "five-year" "flavonoids"
    "flow-through" "flow–based" "fluid-filled" "fluid-state"
    "fluorescence-intensity" "fluorescent-molecule" "fluorimeter"
    "fluorodeoxyuridine-5" "fluorodeoxyuridylate"
    "fluorodihydroxyphenylalanine" "fluorophore" "fluorophores"
    "fluorothymidine" "fluorouracil-leucovorin-platinol" "fold-containing"
    "fold-enrichment" "follicle" "follow-up" "followingBRAF" "followup"
    "forBRAF" "forebrain" "forestomach" "forgiven" "formalisms" "forp27"
    "fos-like-1" "four-lysine" "four-member" "four-point" "fragilis"
    "frame-shift" "fresh-frozen" "fromCyld" "front-rear" "frozen"
    "fructose-6-phosphate" "fruitflies" "fucothanxin" "full-atom"
    "functionalBRAF" "fungoides" "furiosus" "fusion-mediated" "fusion-negative"
    "fusion-positive" "gDNA" "gain-of" "gain-of-function" "gallate"
    "gallbladder" "gammaH2AX" "gastrectomy" "gastro" "gastro-esophageal"
    "gastrocnemius" "gastrointestinal-tract" "gastroscopy" "gatekeeper"
    "gavage" "gc" "gelatinases" "gender-specific" "gene-2"
    "gene-by-environment" "gene-by-fluoride" "gene-by-smoking" "gene-dense"
    "gene-environment" "gene-gene" "geneID" "genearrays"
    "genetically-engineered" "gene–environment" "gene–gene" "genfitinib"
    "genome" "genome-scale" "genome-wide" "genome-wide–significant" "genomes"
    "genotype-phenotype" "geranylgeranyl" "geratin" "germ-line" "germiline"
    "germline" "germline-mutations" "gero" "gero-preventive" "gero-suppressive"
    "glandular-like" "glans" "glass-base" "glia" "glial-Schwann"
    "glioblastomas" "glioma-relevant" "globular-like" "glomeruli"
    "glomerulonephritis" "glucose-deprivation" "glucose=3.1" "glucosylate"
    "glucuronate" "glutamylcysteine" "gluteraldehyde"
    "gluthatione-S-transferase" "glycinamide" "glycophosphatidylinositol"
    "goes" "gone" "gp120+MA" "gp120-transfection" "grade-II" "grade-III"
    "grade-IV" "greater" "greatest" "green-tea" "groups–Indian" "growth-phase"
    "guaninine" "guidepost" "hAPBT" "hAPBTs" "hBMSCs" "hBak" "hDlg1"
    "hEGFRmice" "hESC" "hESCs" "hESF9" "hHGF" "hHR23" "hHRad23B" "hMSC"
    "hMSCGM" "hMSCs" "hNCPC" "hNCPCs" "hNCSCs" "hNIS" "hRad23A" "hRad23B"
    "hSOCS3" "hace" "haematobium" "haemosiderin" "hairpin-like" "hairpin-loop"
    "half-data" "half-life" "half-lives" "half-maximal" "half-site"
    "half-sites" "hand-in-hand" "haploblocks" "haplogroups" "haplotype"
    "haplotypes" "hard-to-treat" "harpin" "hda1" "head-and-neck" "head-to-tail"
    "health-care" "healthspan" "heat-shock" "heatmap" "heavy-metal"
    "helical-like" "helicase-like" "helix–loop–helix" "hemichannel"
    "hemichannels" "hepatectomy" "hepato" "hepato-trophic"
    "heptanone-etheno-DNA" "hereon" "hetero" "hetero-dimers" "hetero-hexameric"
    "hetero-oligomerization" "heterochromatin-like" "heterocomplexes"
    "heterohexamer" "heterologouspromoter" "heteromers" "hexakisphosphate"
    "hexamers" "hg18" "hidden" "high-ERE" "high-ERE-activity" "high-affinity"
    "high-capacity" "high-confidence" "high-density" "high-dose"
    "high-energetic" "high-expression" "high-frequency" "high-grade"
    "high-level" "high-mobility" "high-penetrance" "high-performance"
    "high-rate" "high-resolution" "high-risk" "high-sensitivity" "high-signal"
    "high-specificity" "high-stage" "high-stringency" "high-titer" "high-yield"
    "higher-grade" "higher-order" "higher-resolution" "highest-ranking"
    "highest-scoring" "highly-aggressive" "highly-conserved" "highly-induced"
    "hilar" "hippocampi" "histidine–tyrosine–glutamate" "histochemistry"
    "histography" "histologies" "histology" "histomorphology"
    "histomorphometry" "histopathology" "histotype" "hoc" "holo" "home-built"
    "homepage" "homo-oligomer" "homo-oligomeric" "homo-oligomerization"
    "homo-oligomerize" "homolog" "homolog-1" "homolog-2" "homologies"
    "homologs" "homologue-1" "homology-2" "homozygotes" "hormonally-intact"
    "hormonally-regulated" "hormone-deprivation" "hormone-naïve"
    "hormone-receptor" "hormone–receptor" "hospho" "host-cell" "hot-spot"
    "hotspot" "house-keeping" "hr" "hsa-miR-101" "hsa-miR-101-1" "hsa-miR-135a"
    "hsa-miR-135a2" "hsa-miR-190" "hsa-miR-190b" "hsa-miR-196" "hsa-miR-196-a2"
    "hsa-miR-615-3p" "hsa-miR-938" "hsa-miR-944" "human-insulin-bound"
    "hydrolysates" "hydroxcholesterol" "hydroxyacid" "hydroxycholesterol"
    "hydroxyl" "hydroxyphenyl" "hydroxypyruvate" "hydroxytryptamine"
    "hygroscopicus" "hyper-fused" "hyper-insulinemia" "hyper-mitogenic"
    "hyperdiploid" "hyperinsulinemia" "hyperosmolarity-induced" "hyperploidy"
    "hyperuricemia" "hypo-phoshorylation" "hypo-phosphorylated"
    "hypo-phosphorylation" "hypodiploid" "hypomorph" "hypomorphicmask"
    "hypophagia" "hypotonia" "i+1" "iGFP" "idiotype" "idodide" "ignal" "ii"
    "iii" "ill-defined" "imager" "imidazole" "immediate-early"
    "immune-checkpoint" "immune-fluorescence" "immune-modulatory"
    "immune-reactivity" "immune-related" "immuno-blot" "immuno-fluorescence"
    "immuno-gold" "immuno-histochemical" "immuno-histochemistry"
    "immuno-negativity" "immuno-precipitation" "immuno-reactivity"
    "immunocomplex" "immunocytochemistry" "immunoglobulin"
    "immunoglobulin-like" "immunohistochemistry" "immunohistochemisty"
    "immunohistology" "immunomarkers" "immunophenotype" "immunophenotypes"
    "immunoprecipitaions" "immunosorbant" "immunotherapies" "immunotherapy"
    "imperfecta" "in-between" "in-depth" "in-frame" "in-gel" "in-silico"
    "in-situ" "in-stent" "in-turn" "in-vitro" "inAtg3" "inCyld" "inTiparp"
    "inact" "inase" "incisures" "indeces" "indels" "indica" "individual-level"
    "indolyl" "indolyl-isoquinoline" "inductors" "inefficacy"
    "inflammation-associated" "inflammation-induced" "inflammation-mediated"
    "inhibites" "inhibitor14" "inhibitors" "initiators" "initio"
    "inmunohistochemistry" "inner-leaflet" "inositides" "inp27" "inpatients"
    "insertions" "instabi" "instabi-lity" "insulin-PI3Ka-Akt"
    "insulin-PI3Kα-Akt" "insulin-bound" "insulin-dependent"
    "insulin-independent" "insulin-induced" "insulin-like" "insulin-stimulated"
    "insulinemia" "integrinβ1" "integrinβ1-FAK-PI3K" "inter-chain"
    "inter-domain" "inter-individual" "inter-island" "inter-observer"
    "inter-origin" "inter-relationship" "inter-strand" "inter-subunit"
    "interactome" "interactomes" "interchain" "interconnectivities"
    "interferon-regulatory" "intermediate-risk" "intermembrane" "interquartile"
    "interspace" "interstrand" "intestinal-specific" "intestinal-type" "intima"
    "intra" "intra-S" "intra-abdominal" "intra-and" "intra-chromosomal"
    "intra-cytoplasmatic" "intra-epithelial" "intra-muscularly"
    "intra-observer" "intra-oral" "intra-strand" "intra-tumoral"
    "intra-vasation" "intramembrane" "intraneoplasia" "intraobserver"
    "intraqstrand" "intrastrand" "intron-exon" "intron-less" "intronexon"
    "invaginations" "invariant" "inwardly-rectifying" "iodoacetate"
    "iodoaceteyl-LC-Biotin" "iodoacetyl" "ion-irradiation" "ionic"
    "ionization-time-of-flight" "isands" "ischemia-reperfusion" "isintegrin"
    "isobutylmethylxanthine" "isobutyrate" "isoenzymes" "isofom" "isoluecine"
    "isomerizes" "isomers" "isopeptide" "isotype" "isotypes" "isovalerate"
    "isozyme" "isozymes" "itogen" "iv" "jelly-body"
    "kappa-light-chain-enhancer" "karyosol" "karyotype" "karyotypes" "kbp"
    "kcal" "kcal " "keratoplasty" "ketoglutarate" "kg" "kick-starting"
    "kilobases" "kinase–dependence" "kit-ligand" "knock-down" "knock-in"
    "knockdowns" "knocked-down" "knockin" "l-DOPA" "lactate-H" "lactone"
    "lambda" "lamella" "lamellipodia-like" "lancelet" "large-cell"
    "large-diameter" "large-insert" "large-scale" "largeT" "larger-scale"
    "larger-scaled" "largested-member" "laser-induced" "late-S" "late-onset"
    "late-phase" "late-stage" "late-stages" "later-onset" "latrunculin"
    "lavage" "left-handed" "left-side" "left-sided" "lenticule"
    "lentiviral-delivered" "lentiviral-mediated" "lentivirally-delivered"
    "lenvirus" "leptomeninges" "lesion-induced" "leucine-rich-repeat"
    "leucocyte-endothelial" "leucovorin-oxaliplatin" "leukemogeneis" "leuvorin"
    "levels" "libitum" "life-long" "life-time" "lifecycle" "lifespan"
    "ligand-independently" "ligand-like" "ligand-receptor" "ligase-substrate"
    "likehood" "likelihood-ratio" "limbic–corticostriatal" "limbus"
    "lincRNA-p21" "lineage-specific" "linescan" "lipid-raft" "lipid-synthesis"
    "lipopolysaccharide" "lipoproteins" "literature-positive" "littermate"
    "littermates" "lity" "live-cell" "lizes" "lobectomies" "locally-advanced"
    "loco-regional" "locus-specific" "log-additive" "log-scale" "log2-ratio"
    "log2-ratios" "logrank" "long-chain" "long-lasting" "long-lived"
    "long-patch" "long-range" "long-speculated" "long-standing" "longa"
    "longer-term" "longus" "loss-and-gain-of-function" "loss-of-function"
    "low-ERE" "low-ERE-activity" "low-ERE-group" "low-abundance"
    "low-adherence" "low-affinity" "low-attachment" "low-conductivity"
    "low-density" "low-dose" "low-energy" "low-fidelity"
    "low-frequency-low-risk" "low-grade" "low-level" "low-molecular-weight"
    "low-penetrance" "low-resolution" "low-responders" "low-stage"
    "low-throughput" "low-to-normal" "low-yield" "lower-affinity" "lower-rate"
    "lox-conditional" "luc2P" "luciferase-reporter" "lucine" "lumbricoides"
    "lumens" "lymph-node" "lymphadenopathy" "lympho" "lympho-proliferative"
    "lymphoblastoid" "lysine-less" "lysine-to-arginine" "lysis"
    "lysosphingolipids" "lysosulfatide" "mAb425" "mBMSCs" "mDBD" "mEPSC"
    "mEPSCs" "mERS1+mERS3" "mESCs" "mGFP-paxillin" "mTOR-pathway"
    "mTOR-targeted" "mTORC1-pathway" "mTORS6K" "mTor" "mach2dat" "macrodomain"
    "macules" "malecarriers" "malignant-like" "maltose-dextrin" "mammaglobin"
    "mammography" "mammoplasty" "mammosphere" "mammospheres" "marker-positive"
    "mask-RNAi" "masse" "mastectomy" "materials" "mean±SD" "mechanisms"
    "mechano" "mechanostat" "media-adventitia" "mediated-transcriptional"
    "megachannel" "megadalton" "melanocortin" "melanocortin-4" "melanogaster"
    "melatonin" "mellitus" "membrane-like" "membrane-protrusion-associated"
    "membrane-proximal" "membrane-skeleton" "meninges" "merlin-absent"
    "mesangium" "mesenchymal-derived" "mesenchymal-subtype-promoting"
    "mesenchyme" "mesoderm" "mesothelium" "meta-cohorts" "meta-gene"
    "meta-regression" "metabolite-SNP" "metagenome" "metallopeptidases"
    "metastatic-suppressive" "metastudies" "methanesulphonate" "methide"
    "methoxyestradiol" "methyl-piperidino-pyrazole" "methyladenine" "methylene"
    "methylnitros" "methylnitros-amino" "methylnitrosamine" "methylnitrosamino"
    "methylphenidate" "methylpyruvate" "methyltransferase-substrate" "mg-1g"
    "miR-101" "miR-130b" "miR-139" "miR-146a" "miR-153" "miR-17" "miR-17–92"
    "miR-18" "miR-18a" "miR-191" "miR-193b∼NF1" "miR-193b∼NF1∼ERK" "miR-196a"
    "miR-19a" "miR-19b" "miR-205" "miR-206" "miR-20a" "miR-22"
    "miR-22-expressing" "miR-23-b" "miR-23b" "miR-26a" "miR-27b" "miR-29a"
    "miR-34b" "miR-451" "miR-9" "miR-939" "miR-Zip29b" "miR-r-21" "miR23a"
    "miR29" "miR29a" "miRISC" "miRNA-148a" "miRNA-18a" "miRNA-22" "miScript"
    "micelles" "micro-channel" "micro-domains" "micro-environment"
    "micro-environmental" "micro-irradiated" "micro-irradiation"
    "micro-printed" "micro-scaling" "micro-strain" "microRNA-29b"
    "microarray-Y2H" "microbiota" "microcluster" "microclusters" "microdomain"
    "microdomains" "microelectrodes" "microenvironment-dependent"
    "microenvironment-epithelial" "microglobulin" "micrographs"
    "micrometastases" "micron-scale" "microregions" "microsatellite"
    "microsatellites" "microscale" "microseconds" "microspheres" "microvessel"
    "microvessels" "mid-1980s" "mid-1990s" "mid-stage" "midline" "minute-2"
    "mir" "mir-192" "mir-194" "mir-215" "mir-27b" "mir-34" "mircoRNA"
    "misbalance" "missense" "mito-GFP" "mito-mRFP" "mitochondrial-mediated"
    "mitogen-associated" "mitogenically-stimulated" "mitoses" "mock-treated"
    "moderate-grade" "modest-but-reproducible" "modi" "modi-fying" "molecuels"
    "molecular-cytogenetic" "molpNPP" "mono-ADP-ribosylated"
    "mono-ADP-ribosyltransferase" "mono-HER1" "mono-HER2" "mono-Ub"
    "mono-domain" "mono-functional" "mono-methylated" "mono-treatment" "monoUb"
    "monoamine" "monocultures" "monocyte-derived" "monocytogenes"
    "monodisperse" "monolayer" "monolayer-aggregates" "monomer-to-dimer"
    "mononucleosomes" "monophosphate" "monotherapy" "monsomy" "morbidities"
    "morpholine" "motile" "mt" "mtp53" "mucosa" "mulitcenter" "multi-caveolar"
    "multi-cellular" "multi-center" "multi-compartmental" "multi-component"
    "multi-directional" "multi-drug" "multi-drug-resistant" "multi-factorial"
    "multi-focal" "multi-functional" "multi-gene" "multi-generational"
    "multi-modal" "multi-modality" "multi-pass" "multi-pathway" "multi-polar"
    "multi-protein" "multi-sensor" "multi-stage" "multi-step" "multicenter"
    "multidomain" "multigene" "multimers" "multipartite" "multiple-SNP"
    "multiple-test" "multiple-testing" "multiprotein" "multisensors"
    "multistage" "multisystem" "multivariate" "muscle-invasive"
    "muscle-specific" "muscularis" "musculature" "musculus" "mutant-like"
    "mutations" "myc-epitope-tagged" "myc-tag" "myelo" "myocardium"
    "myofibroblast-like" "myristate" "n-3-PUFA" "n=10" "n=12" "n=15" "n=20"
    "n=21" "n=3" "n=4" "n=5" "n=6" "nAChR" "nSH3" "nSH3-SH2-cSH3" "nano"
    "nano-LC-ESI-MS" "nano-LC-MS" "nanoLC" "nanoLC-MS" "nanoliposomes"
    "nanosecond" "nanoseconds" "nanovesicles" "naphtalimide" "nasopharynx"
    "naïve" "ncomms2361" "near-UVA" "near-complete" "near-diplod"
    "near-infrared" "near-infrared-based" "near-physiological" "nearest"
    "necrobiopsy" "necroses" "neg" "negative-sense" "nei" "neoT" "neoadjuvant"
    "neoplasias" "nephrectomy" "nephropathy" "nervosa" "nestin-TvA"
    "neu-targeted" "neurite" "neurite-like" "neuro" "neuro-toxicity"
    "neuroAIDS" "neurobiology" "neuroendocrine" "neurofilament-heavy"
    "neuroglioblastomas" "neuroleukin" "neuroligin-4X" "neuroligins"
    "neuronal-like" "neuropathologies" "neuroprobes" "neutral-charge"
    "neutral-charged" "never-smokers" "never-smoking" "nevoid" "nevus-like"
    "newer" "next-generation" "nick-end" "ninety-five" "ninety-one" "nitrogens"
    "nitrophenyl" "nitrosamnine" "nitroso" "nocodozole" "node-negative"
    "node-positive" "nonfat" "nonlymphoid" "nonmalignant" "nonresponders"
    "nonsignificant" "nontarget" "nonwhite" "normal-like" "normal-weight"
    "normalizer" "normals" "nositide" "notch-like" "noveltargets" "nt-long"
    "nt-siRNA" "nth" "nub-Gal4" "nuclear-to-cytoplasmic" "nucleate" "nucleates"
    "nucleo-filaments" "nutrient-scarce" "n = 20" "n = 3" "n = 4" "oS" "ob"
    "observatons" "obtainingNf1" "oci" "oestrogen" "ofBRAF" "ofEGFR" "ofHER2"
    "ofNf1" "off-target" "off-targets" "offs" "ofmTORC1" "oiesin" "oligo"
    "oligo-ADP-ribose" "oligo-DNA" "oligodeoxynucleotide"
    "oligodeoxyribonucleotides" "oligopyrimidine" "omodysplasia" "on-chip"
    "on-line" "oncogene-addiction" "oncogenicBRAF" "oncologists" "oncology"
    "oncomir" "one-by-one" "one-copy" "one-dimensional" "one-fourth" "one-half"
    "one-sided" "one-site" "one-tenth" "one-third" "one-year" "ontogeny"
    "oocytes" "oophorectomy" "open-angle" "operant" "ophthalmology" "orTiparp"
    "oral-related" "organelle" "organelles" "organoid" "oropharynx" "ortholog"
    "orthologue" "orthologues" "orthovandate" "osteoblast-like" "osteoblasts"
    "osteoclast-like" "osteocyte-like" "osteopenia" "otitis" "ouble"
    "outer-membrane" "outs" "outside-in" "outwith" "ovary-associated"
    "over-abundance" "over-abundant" "over-abundantly" "over-activation"
    "over-estimated" "over-fitting" "over-productions" "over-representation"
    "overdosage" "overtaken" "overview" "oxidases" "oxidoreductase-1"
    "oxiloplatin" "oxoG" "oxygens" "p120-null" "p160-ROCK1" "p16inka4a"
    "p185HER2" "p21-dependent" "p21-mediated" "p300-mediated" "p300ΔHAT-HA"
    "p31p32" "p34p35)" "p38-depdendent" "p38-dependend" "p38-depenedent"
    "p38MAPK" "p38i" "p38i-treated" "p38β" "p400-2" "p400-cherry" "p400dead"
    "p4EBP1" "p53-competent" "p53-dependant" "p53-heterozygous"
    "p53-homologous" "p53-null" "p53DD-PTEN" "p53K120Ac" "p53R280T" "p53γ"
    "p53–p21-mediated" "p63α" "p63β" "p63γ" "p6xOSE2-Luc" "p73α" "p73β" "p85α"
    "p95HER" "p95HER2" "p=0.0001" "p=0.0002" "p=0.0004" "p=0.0005" "p=0.00052"
    "p=0.0006" "p=0.0007" "p=0.0008" "p=0.0009" "p=0.001" "p=0.0012" "p=0.0017"
    "p=0.002" "p=0.0022" "p=0.0026" "p=0.003" "p=0.0033" "p=0.0035" "p=0.0045"
    "p=0.0047" "p=0.005" "p=0.0068" "p=0.006805" "p=0.009" "p=0.01" "p=0.0101"
    "p=0.0102" "p=0.0103" "p=0.0119" "p=0.012" "p=0.013" "p=0.0133" "p=0.014"
    "p=0.0160" "p=0.0183" "p=0.019" "p=0.02" "p=0.024" "p=0.0262" "p=0.0265"
    "p=0.0272" "p=0.029" "p=0.03" "p=0.0325" "p=0.033" "p=0.036" "p=0.038"
    "p=0.039" "p=0.04" "p=0.0439" "p=0.0448" "p=0.045" "p=0.047" "p=0.0474"
    "p=0.0483" "p=0.05" "p=0.06" "p=0.068" "p=0.07" "p=0.08" "p=0.09" "p=0.1"
    "p=0.11" "p=0.14" "p=0.1416" "p=0.170" "p=0.2" "p=0.21" "p=0.25" "p=0.28"
    "p=0.31" "p=0.34" "p=0.36" "p=0.475" "p=0.5" "p=0.501" "p=0.55" "p=0.59"
    "p=0.6" "p=0.60" "p=0.64" "p=0.70" "p=0.8" "p=0.9" "p=1.00" "p=1.17e-4"
    "p=2.18×10" "p=2.25e-5" "p=2.26e-12" "p=2.26e-4" "p=2.27e-5" "p=2.94e-5"
    "p=3.64e-5" "p=3×10" "p=4.02e-7" "p=4.34e-4" "p=5.05e-5" "p=5.42e-4"
    "p=5.6×10" "p=5.76e-4" "p=5.90×10" "p=5.93e-4" "p=6.54e-5" "p=6.58e-4"
    "pAU" "pAU-siTCRP1" "pArg150Gln" "pBAR" "pBTM" "pBcl-2" "pCB6" "pCDNA3.1"
    "pCFL" "pCHEK2" "pCHK2" "pCMV4" "pCRKL" "pControl" "pDHB1" "pDHB1-Nef"
    "pDHB1-largeT" "pDkk1" "pEGFR" "pFAK" "pGL2p" "pGL3-Basic" "pGSK3β" "pH"
    "pH-dependence" "pH2AX" "pHER2" "pICIn" "pITAMs" "pIκB" "pJAK1" "pJAK2"
    "pLKO" "pM" "pMIR-REPORT-NF1" "pMad" "pNFκB" "pNPP" "pOSE2-luciferase"
    "pPAK" "pPTEN" "pRb–to–pRb" "pRb–to–total" "pS17" "pS621" "pS87" "pSRα"
    "pSTAT1" "pSTAT3" "pSTAT5" "pSer-Pro" "pStat3" "pT1G2" "pT1G3" "pT2"
    "pT2-4" "pT3" "pT3-4" "pT4" "pT56" "pT696" "pT74" "pT853" "pTaG1" "pTaG1-2"
    "pTaG1-G3" "pTaG2" "pTaG3" "pThr-Pro" "pTyr1007" "pTyr1022" "pY207CRKL"
    "pY333-β-catenin" "pY397" "pY416" "pY654" "pY654-®-catenin"
    "pY654-β-catenin" "pY74" "pY919" "pY955" "pYXN" "pack-years" "pair-wise"
    "paired-end" "paired-like" "paired-pulse" "paired-tissue" "pallium"
    "palmitoyl" "pan-ErbB" "pan-HDACI" "pan-HDACIs" "pan-acetyl" "pan-acetylH3"
    "pan-acetylH4" "pan-acetylation" "pan-endothelial" "pan-inhibitor"
    "pan-negative" "pan-nuclear" "pan-β-catenin-antibody" "pannus" "papilla"
    "para-methyl" "paracrine" "parametrium" "paranodes" "parenchyma" "parieto"
    "parieto-occipital" "parti" "partial-least-squares" "partite"
    "parti­cularly" "passage-16" "passage-31" "passage-8" "passivate" "patho"
    "patho-histological" "patho-physiology" "pathobioants" "pathobiology"
    "pathogen-associated" "pathogen-derived" "pathomechanisms"
    "pathophysiology" "pattern-recognition" "patternless" "pcDNA-INrf2"
    "pcDNA3-GFP" "pcDNA3-HER2" "pcDNA3-HMGA2" "pcDNA3.1" "pcDNAp53" "pen-strep"
    "penetrance" "penetrances" "penetrant" "penile" "peptidases"
    "peptide-alone" "peptides" "peptidoglycan" "peptidylprolyl"
    "percentage–decreasing" "perhaps" "peri-ovarian" "perineurium" "peritoneum"
    "perlecan-binder" "peroxidases" "peroxisome-proliferator" "pf27" "phagein"
    "phagophore" "phallodin" "phalloidin-FITC" "pharma" "pharmacophore"
    "pharmacophores" "phase-contrast" "phenotypes" "phenyl" "phenylsulfonyl"
    "phenylsulphonyl" "phenyltetrazolium" "phlebotomy" "phonotypes" "phopho"
    "phopho-Tyr705" "phoshorylate" "phosohatidylinositol" "phospatidylinositol"
    "phospatidylinositol-3-kinase" "phosphatase-like"
    "phosphatidylinositol-3-OH" "phosphinositide" "phospho-Histone"
    "phospho-Thr" "phospho-Tyr705" "phospho-histone" "phospho1S→A" "phospho3"
    "phosphoThr" "phosphoThr-187" "phosphocycle" "phosphofructose"
    "phosphohydroxypyruvate" "phosphoinositides" "phosphoinositol"
    "phosphoinositol-3-kinase" "phosphopeptide" "phosphopeptides"
    "phosphoproteome" "phosphoryates" "phosphosite" "phosphosulfate"
    "phospho–GSK-3" "photo-activatable" "photo-crosslink" "photo-probes"
    "photo-scan" "photochemical-induced" "photomicrograph" "photomicrographs"
    "phyla" "phyllodes" "physically-distinct" "physiopathology"
    "phytocompounds" "phytohemagluttinin" "picoliter-scale" "pifithrin-α"
    "pingyangmycin" "piperidinylethoxy" "piperindinyl" "pixel" "pixels"
    "placodes" "plamsa" "plasmon" "plastin" "platelet-specific"
    "plateletα-granules" "platinum-DNA" "platinum-based"
    "platinum-based-chemotherapy" "pleiotropy" "pleomorphism" "pleura"
    "plexiform" "plexin-B3" "plexuses" "ploidy" "plug-in" "plus-end"
    "plus-end-directed" "plus-ends" "pmTOR" "pneumonectomies" "pneumophila"
    "pobG" "pocket-targeted" "poliphenols" "poly-A" "poly-ADP-ribose"
    "poly-HEMA-coated" "poly-L-lysine" "polyADP" "polyQ" "polyaminesand"
    "polychemo" "polycomblike" "polyendocrinophathy" "polymegethism"
    "polymerase-1" "polymorphism" "polymorphisms" "polypectomy" "polyphenols"
    "polyploid" "polysomy" "polytherapy" "polyubiqiuitin" "poly­merization"
    "polζ" "polη-Rev1" "polη-binding-proficient" "polη-ι" "polη–ι"
    "polι-fusions" "polι-ubiquitin" "polκ" "pombe" "pons" "pool-based"
    "poor-differentiated" "poor-prognosis" "poorer" "poorest"
    "poorly-differentiated" "population-level" "population-levels" "positron"
    "posseses" "post-DNA" "post-ET" "post-HAART" "post-RT" "post-acquisition"
    "post-burn" "post-chemotherapy" "post-drug" "post-genomic"
    "post-hepatectomy" "post-hoc" "post-infection" "post-inhibitory"
    "post-injection" "post-inoculation" "post-integrative" "post-menopausal"
    "post-menopausally" "post-miR-193b" "post-mitotic" "post-natal"
    "post-operative" "post-proliferative" "post-radiation" "post-relapse"
    "post-replication" "post-replicative" "post-stimulation" "post-surgery"
    "post-synaptic" "post-tests" "post-transcriptional"
    "post-transcriptionally" "post-transfection" "post-translation"
    "post-translational" "post-translationally" "post-transplantation"
    "post-treatment" "postburn" "postlumpectomy" "postmastectomy"
    "potential-dependent" "potentialWT1" "precision-recall" "precursor-like"
    "premalignat" "primary-recurrent" "principal-component" "priori" "prmoter"
    "pro-ADAM17" "pro-Angiogenic" "pro-HGF" "pro-MET" "pro-MMP-2" "pro-MMP-7"
    "pro-SPC" "pro-and" "pro-angiogenic" "pro-angiokines" "pro-apoptic"
    "pro-apoptosis" "pro-autophagic" "pro-carcinogenic" "pro-caspase-8"
    "pro-death" "pro-differentiation" "pro-immune" "pro-inflammatory"
    "pro-invasive" "pro-longevity" "pro-metastatic" "pro-migratory"
    "pro-neural" "pro-proliferation" "pro-proliferative" "pro-survival"
    "pro-thrombotic" "pro-tumorigenic" "proADAM17" "proband" "probands"
    "probeset" "processess" "procollagen" "product-moment" "profilings"
    "progenies" "progenitor-like" "progenitors" "progeny" "progestin"
    "prokaryotes" "proliferation-survival" "proliferator-activated"
    "proliferator–activated" "promoter-reporter" "promoters"
    "promoter–enhancer" "proof-of-concept" "proof-of-mechanism"
    "proof-of-principle" "properties" "propria" "proprotein" "propyl"
    "prospero" "prostaglandin-E" "prostaglandin-E2" "prostaglandins"
    "prostatectomy" "protein-1c" "protein-A" "protein-DNA" "protein-nucleic"
    "protein-peptide" "protein-protein-interactions" "protein-structural"
    "protein-substrate" "proteingp120" "proteins" "protein–DNA" "protein∼90%"
    "proteolipid" "proteome" "proteome-wide" "proteomes" "proteosome"
    "protesomes" "proto" "protocadherin-δ" "protomer" "protooncogene"
    "protrusion-associated" "proven" "pseudo-peptides" "pseudogene"
    "pseudogene-1" "pseudogenes-3" "psycho" "psycho-stimulant" "public-health"
    "pull-down" "pull-downs" "pulldown" "pulldowns" "pulled-down" "pulpitis"
    "pulposus" "pulse-chase" "purinoreceptors" "pvalue" "pyrazole" "pyrazolo"
    "pyridinyl" "pyridyl" "pyrimidin" "pyrimidin-3-yl" "pyroglutamate"
    "p = 0.0002" "p = 0.001" "p = 0.003" "p = 0.013" "p = 0.029" "p = 0.038"
    "p = 0.08" "p = 0.0001" "p = 0.0002" "p = 0.003" "p = 0.0045" "p = 0.009"
    "p = 0.01" "p = 0.02" "p = 0.038" "p = 0.047" "p = 0.05" "p = 0.07"
    "p = 0.08" "p = 0.34" "p≤1.5" "p≤5.6e" "p≤5×10" "q-value" "q-values"
    "q11q13" "q11q14" "q12q21" "q13q15" "qMSP" "qt" "qt-PCR" "quadriceps"
    "quadruplex" "quadruplexes" "quant" "quantile-quantile" "quasispecies"
    "quinuclidinone" "r-square" "r=0.55" "r=0.58" "r=0.67" "raclopride"
    "radiation-induced" "radio-ablative" "radio-iodine" "radio-resistance"
    "radio-toxicity" "radiobiology" "radionuclide" "radioresistance"
    "radioresistant" "raft-associated" "random-effects" "rank-sum" "ransducers"
    "rapalogues" "rarer" "ratTAT–3L4Fpeptide" "re-ChIP" "re-adhere"
    "re-adhesion" "re-aggregate" "re-aggregation" "re-amplified" "re-analyzed"
    "re-appearance" "re-assayed" "re-colonization" "re-distribution"
    "re-emphasized" "re-enter" "re-entered" "re-entering" "re-established"
    "re-establishment" "re-evaluate" "re-evaluation" "re-examined"
    "re-expression" "re-generation" "re-grew" "re-growth" "re-implant"
    "re-induction" "re-infected" "re-initiate" "re-insertion" "re-introduction"
    "re-isolated" "re-ligated" "re-ligation" "re-localization" "re-localized"
    "re-location" "re-phosphorylation" "re-plated" "re-probed" "re-synthesize"
    "reactant" "reaction-restriction" "read-out" "read-outs" "readdress"
    "readout" "readouts" "real-time-PCR" "realtime" "receiver-operator"
    "receptor-1" "receptor-ligand" "receptor-like" "receptor-proximal"
    "recetors" "recombination-mediated" "reconstitutedAtg16l1" "red-stained"
    "reference-structure" "refractoriness" "reg" "regrow" "regrowth" "regs"
    "regulators" "regulome" "reinforcer" "reinforcers" "reinsert"
    "relapse-free-survival" "relatedness" "remindful" "remodeler" "remodelers"
    "replicon" "repressors" "residuals" "resin-bound" "resonsance" "resp"
    "responder" "responders" "restraint-induced" "restriction-like" "retrogene"
    "retrovirus" "reuptake" "reverse-hybridization" "reverse-transcription–PCR"
    "reversion-inducing-cystein-rich" "rfc1-44" "rhEcad" "rhSOST" "rhodanine"
    "ribose" "ribose-5-phosphate" "ribotide" "right-handed" "right-shift"
    "right-side" "right-sided" "risk-associated" "risk-groups" "risk-reducing"
    "risk-screening" "ritonovir" "rmEcad" "rod-like" "rodentium"
    "rolling-circle" "rotamer" "roteasome" "rotein" "rpm" "rrest" "rs10189064"
    "rs10405102" "rs10411210" "rs1042522" "rs1042838" "rs1047100" "rs10505477"
    "rs1051425" "rs1051475" "rs1051475-rs1051476" "rs1051476" "rs10518367"
    "rs1056513" "rs10774214" "rs1078806" "rs10795668" "rs10830963" "rs10911205"
    "rs10911251" "rs10936599" "rs11065987" "rs11066320" "rs11075884"
    "rs11091253" "rs11091253C" "rs11091253CT" "rs11091253TT" "rs11099896"
    "rs11200014" "rs11226" "rs11254" "rs1127051" "rs11632715" "rs11654749"
    "rs11903757" "rs12075" "rs12104221" "rs1219648" "rs12593223" "rs1260326"
    "rs1285441" "rs13240966" "rs1324183" "rs13306465" "rs13387042" "rs1383934"
    "rs1435867" "rs1481012" "rs150319104" "rs150621809" "rs1536482" "rs1540293"
    "rs1580743" "rs1588635" "rs1650697" "rs1650966" "rs1665650" "rs16892766"
    "rs16942" "rs17057381" "rs17663555" "rs1799782" "rs1801123" "rs1801278"
    "rs1801320" "rs1801321" "rs1877431" "rs199832262" "rs2034809" "rs2046210"
    "rs20580" "rs2070529" "rs2070529-rs2070530" "rs2070530" "rs2070531"
    "rs2070531-rs6517481" "rs2070531-rs7276961" "rs2070600" "rs2073416"
    "rs2073601" "rs2228638" "rs2229033" "rs2230774" "rs2235074" "rs2238335"
    "rs2269188" "rs2273773" "rs2279744" "rs2288421" "rs2308327" "rs233716"
    "rs233722" "rs2388896" "rs2420946" "rs2423279" "rs25487" "rs25489"
    "rs2668804" "rs2721051" "rs2805771" "rs2805809" "rs2808693" "rs2808699"
    "rs2850966" "rs2888830" "rs28897686" "rs28897687" "rs28897688" "rs28897729"
    "rs2943641" "rs2981579" "rs2981582" "rs3012642" "rs30240943" "rs3024941"
    "rs3024943" "rs3024944" "rs3024944C" "rs3024944G" "rs3112612" "rs3118520"
    "rs3217810" "rs3217901" "rs324013" "rs324015" "rs36228499" "rs3730017"
    "rs3733402" "rs3741298" "rs374575" "rs3753344" "rs3797896" "rs3802842"
    "rs3818292" "rs4149963" "rs4251631" "rs4444235" "rs4475146" "rs4503064"
    "rs461155" "rs4779584" "rs4865673" "rs4894535" "rs4939827" "rs56304104"
    "rs56356146" "rs566164" "rs574664" "rs579459" "rs59336" "rs5965136"
    "rs635808" "rs647161" "rs6499100" "rs6517481" "rs6517481-rs7276961"
    "rs6596201" "rs6687758" "rs6691170" "rs6983267" "rs7014346" "rs7044529"
    "rs7069102" "rs711" "rs71932930" "rs7203563" "rs7276961" "rs732417"
    "rs752092" "rs75521089" "rs7594321" "rs7607076" "rs7764819" "rs7765379"
    "rs7875482" "rs7925112" "rs7982677" "rs80233386" "rs8040868" "rs8177426"
    "rs8178433" "rs8178435" "rs925488" "rs930847" "rs934167" "rs961253"
    "rs961523" "rs978906" "rs9793739" "rs9922316" "rs9929218" "rs9938149"
    "rs9967593" "rs999788" "rutabaga" "sAC10" "sCD" "sEcad" "sEcad’s" "sHEL"
    "sIL-6Rα" "saline-infused" "salpingo" "salpingo-oophorectomy" "samplings"
    "sapiens" "sapintoxin" "sarcatinib" "sarcomatoid" "sc-514" "sccMap" "sceen"
    "scherichia" "screen-to-screen" "scute" "second-generation" "second-hand"
    "second-line" "second-phase" "second-site" "secondary-structure"
    "secretome" "secretomes" "secretory-inducing" "secretory-luminal"
    "self-activation" "self-assemble" "self-assembly" "self-cleavage"
    "self-digestion" "self-dimerization" "self-dimerize" "self-interaction"
    "self-oligomerize" "self-protection" "self-renew" "self-renewal"
    "self-renewal-promoting" "self-renewing" "self-report" "self-reported"
    "self-ubiquitination" "semi" "semi-empirical" "semi-quantitative" "senesce"
    "senescense" "senescent-like" "sensitizers" "sequelae"
    "sequence-requirements" "sequence-specific" "ser-2" "serine-3"
    "serum-deprivation" "serum-replete" "seven-membered" "seven-β-strand"
    "sevenmaker" "sex-specific" "sh-non-target" "shAMPK" "shATG5" "shATR"
    "shCRKL" "shCTL" "shControl" "shEmpty" "shFGFR2" "shFGFR2s" "shGFP"
    "shHmga2" "shLKB1" "shLuc" "shMock" "shMyc" "shMyc2" "shNT" "shPKCζ"
    "shRFP" "shRNA-A" "shRNA-B" "shRNA-non-induced" "shRNA-scramble" "shRNA1"
    "shRNF" "shRNF2" "shSTAT3" "shScr" "shScrib" "shSkp2" "shTAZ" "shYES"
    "sheddases" "shock-independent" "short-hairpin" "short-interfering"
    "short-term" "shp27-1" "shp27-5" "shp53" "shp63-1" "shp63-2" "shp63-3"
    "shδEF1-treated" "si-ATAD5" "si-Ctrl" "siATM" "siATR" "siB2" "siCon"
    "siControl" "siCtBP1" "siExo" "siExo70-treated" "siGAPDH" "siH2A" "siMT1X"
    "siP53" "siR" "siRNA" "siRNA-DOPC" "siRNA-F" "siROCK1" "siScram"
    "siScramble" "siTCRP1" "siWT" "siWT1" "siWT1-RNA" "side-by-side"
    "side-chain" "side-effect" "side-effects" "side-to-side" "sidechain"
    "sidechains" "sided-UIM" "sigmoid" "signal-to-noise" "signaling-competent"
    "signaling-module" "signaling–including" "silico" "simple-type" "simpler"
    "simplest" "simulation-generated" "single-PCR" "single-SNP"
    "single-base-pair" "single-cell" "single-cell-derived" "single-center"
    "single-copy" "single-domain" "single-life" "single-molecule"
    "single-nucleotide" "single-point-mutated" "single-residue" "single-strand"
    "singnificant" "sirtuin" "site-1" "site-2" "site-3" "site-4" "situ"
    "six-subunit" "size-exclusion" "size-fractionated" "skinfold" "skull-base"
    "slow-cycling" "slow-growing" "slower-migrating" "small-cell"
    "small-cell-lung" "small-diameter" "small-molecule" "small-scale"
    "small-sized" "small-small-x-x-small-small" "smaller-genomic" "smokers"
    "socio" "socio-economic" "soft-agar" "soft-tissue" "software-based"
    "soleus" "solid-related" "solute" "solvent-accessible" "sort-purify" "sown"
    "spatio" "spatio-temporal" "species-specificity" "specifcities"
    "specificantibody" "specificity-determining" "spectrometer"
    "sphere-forming" "sphingosine" "sphingosylphosphorylcholine" "spiked-in"
    "spindle-like" "spindled-to-ovoid" "spinning-disk" "sprout-like"
    "squamous-cell" "ss2080581728" "ss270137548" "ss491228440" "ss491228441"
    "ss491228441G" "ss491228441TG" "ss491228441TT" "ssDNA" "stabiles"
    "stainings" "standard-of-care" "start-site" "stdev " "steady-state"
    "stellate" "stem-cell" "stem-cell-associated" "stem-cell-enriched"
    "stem-like" "stemness" "stent" "stents" "stepwise" "steroid-depleted"
    "sterol-regulatory" "stilbene-2,2" "stomach–intestine" "straight-chain"
    "strain-induced" "strate" "strep" "streptavidin-biotin" "stress-activated"
    "stress-and" "stress-associated" "stress-fibers" "stress-induced"
    "stress-mediated" "stress-protecting" "stress-responsive" "stress-specific"
    "stressful" "stressors" "striata" "stromal-associated"
    "structurally-disorderd" "structurally-flexible" "structure-based"
    "structure-function" "structure–activity" "structure–function"
    "study-population" "studylies" "study–ie" "sub-G0" "sub-G1" "sub-S"
    "sub-analyses" "sub-cellular" "sub-classes" "sub-compartments"
    "sub-cortical" "sub-divided" "sub-domains" "sub-group" "sub-groupings"
    "sub-lines" "sub-membrane" "sub-micromolar" "sub-mitochondrial"
    "sub-nanosecond" "sub-nuclear" "sub-pathways" "sub-tropical" "sub-type"
    "sub-types" "subG1" "subanalyses" "subcategories" "subclass" "subclasses"
    "subconformations" "subfamilies" "sublines" "subnetwork" "subnetworks"
    "subpopulation-specific" "subpopulations" "substituents"
    "substrate-chemotherapeutical" "substrate-docking-site"
    "substrate-selectivity" "substudy" "subtitutions" "subtype" "subvolume"
    "subvolumes" "succinate" "sugar-phosphate" "sulfhydryl" "sulfo-NHS-biotin"
    "sulphydryl" "sun-induced" "sun-sensitive" "super-helical"
    "super-induction" "super-infected" "super-oxide" "superiorities"
    "supernatant" "supernatants" "supernatents" "superoxides" "suppressor-like"
    "supra-physiological" "surface-density" "surface-level" "survival-outcome"
    "suspension-cultured" "suspension-induced" "sustained-phase" "symbiotes"
    "synapse" "synapses" "synaptoneurosome" "synaptoneurosomes"
    "syndrome-associated" "synergism" "synergisms" "synthases"
    "synthesis–defective" "synthesis–deficient" "t-BHQ" "t-BHQ+Etoposide"
    "t-BHQ-mediated" "t-BHQ-treated" "t-DARPP" "t=0" "tJAK2" "tagSNP"
    "tagged-CUL5" "tan-yellow" "tandem-affinity" "taxia" "taxols"
    "telangiectasias" "telomerase-independent" "telomerase-p21-mitochondrial"
    "telomere-related" "temperature-PCR" "temperature-dependence"
    "temperature-sensitive" "temporal-and" "tenoposide" "terbutaline"
    "tertiary-mammospheres" "tertiles" "tetra-Ubs" "tetraUb"
    "tetradecanoylphorbol-13-acetate–treated" "tetrahydrochloride" "tetrapods"
    "tetrazolium" "thaliana" "thatBRAF" "thatCyld" "thatit" "theAKT1" "theGI"
    "theKLF4" "theNf1" "theNotch3" "thePI" "thePI3K-Akt" "thehuman3L4F"
    "themask" "thenestin" "thenestin-TvA" "thep21" "thep27" "therapywere"
    "thereat" "theseregimen" "theta" "theta-burst" "thetelomere" "thewebsite"
    "thiamet" "thinner" "thiol-disulfide" "thiosemicarbazone" "third-line"
    "thread-like" "three-dimensional" "three-edge" "three-gene" "three-helix"
    "three-marker" "three-quarters" "three-step" "three-strand"
    "three-variable" "three-way" "threonine-specific" "thrombi"
    "thrombocythemia" "thrombus" "thru" "tightly-regulated" "time-course"
    "time-dependency" "time-dependently" "time-gradient" "time-lapse"
    "time-point" "time-points" "time-to" "time-to-event" "time-to-fixation"
    "timecourse" "timeframe" "timepoints" "timulation-induced" "tinnitus"
    "tissue-destructive" "tissue-specificity" "titer" "titers" "to1.0" "to100"
    "toBRAF" "tocontribute" "toll-like" "tolyl" "tool-compound" "toolbox"
    "top27" "topologies" "topology" "toxicants" "toxicity-associated"
    "to∼31.9%" "trait-increasing" "tranducer" "trans-dominant"
    "trans-endothelial" "trans-lesion" "trans-membrane" "trans-signaling-STAT3"
    "trans-signaling-gp130-STAT3" "trans-well" "transcription–PCR"
    "transcriptome" "transcriptomes" "transdifferentiate" "transdominant"
    "transducer" "transfectant" "transgenes" "translocations"
    "transmembrane-dimer" "transwell" "tranwell" "treatment-group"
    "treatment-naïve" "tri-modality" "tri-molecule" "tri-partite"
    "tri-phosphate" "trifluoromethyl" "trihydroxystilbene" "trinitrophenyl"
    "triphosphate" "triple-alanine" "triple-modified" "triple-mutant"
    "triple-negative" "triply-deficient" "tris-phenol" "trisomy"
    "trisphosphate" "triyl" "tryptophan-tryptophan-glutamate" "tubal"
    "tubastatin-A" "tubules" "tubulo" "tubulo-vesicular" "tumor-adjacent"
    "tumor-like" "tumor-node-metastasis" "tumor-normal" "tumor-suppressive"
    "tumors" "tumour-associated" "tumour-derived" "tumour-initiating"
    "tumour-selective" "tumour-suppressive" "tumour-suppressor" "tunicate"
    "turn-around" "turn-like" "twenty-five" "twenty-four" "twenty-one"
    "twenty-three" "twice-daily" "two-color" "two-compartment" "two-gene"
    "two-hit" "two-hybrid" "two-independent" "two-part" "two-state" "two-step"
    "two-tailed" "two-thirds" "two-way" "type-1" "type-I" "tyrosine-threonine"
    "ubiquitin-binding-deficient" "ubiquitin-conjugation" "ubiquitin-mimetic"
    "ubiquitination-proteasome" "ubiquitnates" "umirolimus" "un" "uncoupler"
    "under-abundant" "under-appreciated" "under-express" "under-expressed"
    "under-expression" "under-representation" "underdoes" "underexpress"
    "undergoes" "undergone" "underlain" "underlyingBRAF" "underpinnings"
    "undertaken" "undetectalbe" "undifferentiated-type" "univariate" "unmet"
    "unresponsiveness" "untangle" "untangles" "up-to" "upper-right"
    "uracil-DNA" "urea" "ureter" "urothelium" "usedAtg3" "usefullness" "uveal"
    "v-SRC-inducible" "vacuoles" "valerate" "value=0.03" "values" "values "
    "value " "vas" "vascular-protective" "vaso" "vaso-relaxation" "vector-DNAs"
    "vehicle-control" "vehicle-treated" "vera" "vermis" "vesicles"
    "vessel-like" "villus" "vinblastin" "viral-host" "viral-transmitted"
    "visceral-only" "vitro" "viv" "vivo" "viz" "volar" "voltage-sensitive"
    "wallis" "water-soluble" "weakest" "well-conserved" "well-defined"
    "well-differentiated" "well-documented" "well-expressed" "well-folded"
    "well-orchestrated" "well-ordered" "well-powered" "well-recognized"
    "well-regulated" "well-tolerated" "well-used" "western-blotted"
    "western-blotting" "whetherBRAF" "whole-cell" "whole-exome" "whole-genome"
    "whole-tissue" "wide-ranging" "widely-distributed" "wildtype" "with14"
    "withAKT1" "withBRAF" "withdrawn" "withp27" "withvery" "wk" "workers"
    "workflow" "world-wide" "written" "wtBak" "wtsRNAi" "x-ray" "xL" "xeno"
    "xeno-graft" "xylulose-5-phosphate" "x–z" "y-intercept" "y-intercepts"
    "yang" "year-old" "yeast-growth" "yin-yang" "yl" "y–z" "z-score"
    "zVAD-FMK–treated" "zinc-dependent" "zipper-interacting" "zotarolimus"
    "zrin" "zymography" "×10" "×TBE" "×g" "×tail" "× 10" "× 10" "Δ11"
    "Δ144–1100" "Δ144–1102" "Δ182–242" "Δ1–143" "Δ202" "Δ229–242" "Δ4" "Δ716"
    "ΔB670" "ΔC" "ΔCARD-Fpk3" "ΔCBD" "ΔCyt" "ΔD2" "ΔF508-CFTR" "ΔFBD" "ΔHAT"
    "ΔM" "ΔN" "ΔNp63" "ΔNp63α-mediated" "ΔNp63α-negative" "ΔNp63α-positive"
    "ΔNp63γ" "ΔNp73" "ΔPIP" "ΔRB" "ΔRIG-I" "ΔRING" "ΔRad23" "ΔSASA" "ΔVif"
    "ΔWD" "ΔWD1" "ΔWD2" "ΔWD3" "ΔWD4" "ΔWD40" "ΔWD5–ΔWD7" "Δhep" "Δp-value"
    "ΔΦ" "ΔΨm" "Δψm" "ΦX174" "Χ2" "α-1" "α-AR" "α-EGFR" "α-Src" "α-helical"
    "α-helices" "α-helix" "α-nitrogen" "α-subunit" "α-subunits" "α1-adrenergic"
    "α1DN" "α2-AMPK" "α2β1-integrin" "α3" "α3-integrin−dependent" "α4-integrin"
    "α5-integrin" "α5-integrin-GFP" "α5-integrin-positive" "α5-α6" "α5ß1"
    "α6-integrin" "α6β1-induced" "α6β4" "α7-AChR" "α9" "αCT" "β-1"
    "β-CateninSignaling" "β-adrenergic" "β-barrel" "β-cat"
    "β-catenin-complexes" "β-catenin-containing" "β-catenin-mediated"
    "β-catenin-rich" "β-cateninubiquitination" "β-chain" "β-microglobulin"
    "β-oxidation" "β-propeller" "β-sheet" "β-strand" "β-strands" "β-synthase"
    "β-turn" "β-unsaturated" "β1β2" "β3" "β=0.44" "βI" "βII" "βPIX-Halo"
    "βig-h3" "γ-GCS" "γ-aminobutyric" "γ-glutamylcysteine" "γ-radiation"
    "γ-ray" "γ-rays" "γ2A-FRT-TI-Jak2V617F" "γH2A" "γH2AX-positive" "γS"
    "δ-crystallin" "δ2" "δEF1" "δEF1-mediated" "ε-amino" "ζ-associated"
    "κB-luciferase" "μg" "μg " "μl" "μmol" "μmols" "μs" "ρ=0.48" "σ=0.7190"
    "σ=0.72" "χ2" "ω-6" " 0.0001" " 0.022" " 0.528" " 0.647" " 1.8" " 10" " 3"
    " 6.0" " S1" " S2e" " S2i" " S2j" " al" " × 10" " −0.48" "‒75μM" "↑11-fold"
    "↑3-fold" "↑6-fold" "↓3-fold" "↓6-fold" "≍0.26" "≍1" "≧31" "⊗C" "〈-SMA"
    "△21–68"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-9001-9300*
  '("immunomarkers" "apocrine" "mammaglobin" "Albergaria" "Nonaka"
    "negative and had 1+" "27/30" "66/99" "taxols" "chondroid"
    "IHC-defined molecular subtypes" "phyllodes" "4+" "n = 6" "n = 15"
    "oncomine" "the larger mouse ortholog" "oocytes" "HFFs" "AcH3" "anti-AcH3"
    "S5E" "NARF2" "the nucleolar proteome" "a subnuclear organelle" "Formin-2"
    "SILAC" "2 × 10" "S4C" "MZ" "co-author" "1.04–6.73" "399 Gln" "194 Trp"
    "Mediterranean" "194Arg/Trp" "399Arg/Gln" "399Gln" "194Trp" "non-codon"
    "a paradoxical «pro-survival" "Ferraros" "Oliveras" "4q13.3"
    "cetuximab+CAPIRI/CAPOX" "Germany" "Peeters" "Roock" "Saridaki" "Prenen"
    "outwith" "Souglakos" "biomolecules" "HeCOG" "CG3" "p=0.019" "ORR"
    "prognostic/predictive" "p=0.14" "Spearmann’s" "Spearmann" "caecum"
    "62.6 years (range 26–85) underwent excisional or incisional biopsy"
    "biomarkes"
    "Previously genotyped (KRAS, NRAS, BRAF, PIK3CA mutations) formalin-fixed paraffin-embedded tumour biopsies"
    "p=0.31" "=0.25" "p=0.0005" "p=0.024" "hydroxypyruvate" "ketoglutarate"
    "strate" "cribri" "PGHDH" "T→E" "3-phospho-D-glycerate" "3PHP"
    "phosphohydroxypyruvate" "3PG" "shAMPK" "shPKCζ" "aPKCs" "decouples" "2GS6"
    "POPS/POPC" "neutral-charged DMPC lipid bilayers" "Overhauser" "POPC/POPS"
    "int" "GxxxG-like" "ALGIG" "TGMVGA" "μs" "microseconds" "IVs" "rod-like"
    "A629I" "i+1" "NOESY" "isoluecine" "GxxxG" "TROSY" "DHPC" "DMPC" "bicelles"
    "nanosecond" "ECM-TM-GlySer-ICM" "LRRLL" "sidechains" "GGGTGGGS" "FCCS"
    "bilayers" "100 ng/ml" "GCN4" "TAZ-AXL-CTGF-mediated" "sccMap" "AMOLT1"
    "shScr" "shTAZ" "HCT" "GSE1433" "TAZ-AXL-CTGF-low" "MGP"
    "TAZ-AXL-CTGF-high" "GSE17538" "GSE14333" "an ovarian malignancy subtype"
    "MyStats" "GES" "co-overexpressing" "Java" "p  = 0.02" "= 107" "p  = 0.038"
    "p  = 0.023" "p  = 0.002" "p  = 0.01" "= 6" "= 60" "p  = 0.012" "p  = 0.03"
    "= 1" "co-overexpressed" "NFKB" "BCR-ABL1" "Schultheis" "Ehrentraut"
    "lympho" "myelo-" "myelo" "farther" "equi" "pSTAT5" "21q21"
    "-phosphosulfate" "phosphosulfate" "alias" "TFBS" "non-t"
    "aggressive phase MAC-2A/2B" "/B" "MAC-1/2A/2B" "farthest" "MAC-1/2A"
    "MAC-2B" "extranodal NK/TCL" "fungoides" "MAC-2A/2B" "q11q14" "p31p32" "XY"
    "G-banding" "airpin" "eosinophilia" "SH2-like" "Hoeller" "thereat" "H3Y41"
    "FERM" "oiesin" "adixin" "zrin" "JAK2mu" "SOCS2/3" "≤1" "copies/cell"
    "Leukemia/lymphoma" "JAK2V617F" "type-1" "H773_V774insNPH" "_A767insAI"
    "_D770dupAVD" "_V769dupASV" "ofHER2" "ofEGFR" "A763_Y764insFQEA"
    "V769_D770insASV" "indels" "_N771insGT" "_C775insHV" "_V774insNPH"
    "withvery" "co-relation" "TIMP-2/Ala+TIMP-2"
    "protein tyrosine phosphatase-1" "Ala+TIMP-2" "n=15" "≥ 0.2" "1/12" "& C"
    "D & E" "& F" "methyladenine" "‒75μM" "vacuolar type H+-ATPase" "H+-ATPase"
    "fibroblsts" "farnesylcysteine" "Aut" "Apg" "stressful" "non-carrier"
    "Kriege" "Smid" "LN+" "Zakhartseva" "non-BRCA" "non-significantly" "= 1"
    "MDACC" "bavacizumab" "TCH" "abraxane" "0–3" "Neyman" "Alsop" "EOC"
    "P = 0.14" "BRCA 1/2" "95 %CI" "= 1.5" "= 27" "≥ 2" "non-hereditary"
    "Yoder" "Michaud" "processess" "PrxI" "AuroraA" "anti-flag" "ClHy" "NRC"
    "KMCH" "NHC" "AccuMax" "osmosensory organelles" "mechano-" "mechano"
    "astrocytoma/glioblastoma" "Chlamydomonas" "ciliary structure/function"
    "multisensors" "multisensory organelles" "thetelomere" "quadruplex" "RTel"
    "quadruplexes" "GSE-22" "approximately 27 μg/ml" "Casodex/day" "Ku70/80"
    "non-shelterin" "remindful" "1.0 −2.0" "53BP1 and" "anti-bodies"
    "naive CD4 + T cells" "TAP1/2" "U/ml" "pJAK1" "SCC-90" "orthovandate (SOV)"
    "orthovandate" "immunotherapies" "ELISPOT" "pSTAT1" "APM" "Δ C" "W6/32"
    "gero-" "mTOR-" "4EB1" "/4EB1" "Ser1981" "or 2dG" "and 2dG" "RSV" "BRB"
    "2dG" "anti-aging" "mitochondrial electrochemical potential ΔΨm" "CDDS"
    "mTOR/S6K" "aging/senescence" "ΔΨm" "gero" "mTOR/S6-" "mTOR" "mTOR/S6"
    "non-fluorescent" "Ser235/236" "Anrather" "vesicle/plasma membrane"
    "Mollinedo" "CD35" "Boussetta" "component C5a" "Nagaoka" "plastin"
    "latrunculin" "-dox" "dox" "CFL-1/pCFL"
    "namely 0, 0.02, 0.04 and 0.1 μg/ml" "serine-3" "HCOXP" "phosphocycle"
    "radioresistant" "radiobiology" "4,5-dimethylthiazol-2-yl" "× tail" "S3D"
    "Acral" "RALGEF" "Curtin" "20q13.3" "Barcelona" "Berkeley" "Eisen"
    "inmunohistochemistry" "dermoscopy" "Clark’s" "Spanish" "12q" "11q14"
    "localized at 5p15" "volar" "different biological subsets" "1p13.2" "11q13"
    "acral" "11q" "strength/duration" "alia" "osteogenic/anti-resorptive"
    "Sost/ sclerostin" "mature osteoblasts" "IDG" "MLO" "propyl" "rhSOST"
    "anti-osteogenic" "Ki-67-positive cells 8 h" "osteoblast-like"
    "Ki-67-negative cLBObs" "cLBObs" "commonalities" "Sost /sclerostin"
    "Sost /" "mechanostat" "ERB041" "″-" "triyl" "2-phenyl-5,7-bis" "PTHPP"
    "yl" "pyrimidin" "pyrazolo" "trifluoromethyl" "-pyrazole"
    "piperidinylethoxy" "hydroxyphenyl" "= 16" "mg/kg/day" "n = 4" "6q23"
    "vermis" "GlialCAM" "Dispropotionate" "N=6" "disproptionate" "Herman"
    "Bannayan-Riley-Ruvalcaba-Syndrome" "1-2SD" "AMSO" "10q24.32" "2/12" "5/12"
    "the cytogenetic position 6q23.2" "6q23.2" "8/10" "hypotonia" "P38H"
    "glans" "otitis" "Polyphen" "ACMG" "Neuroligins" "OMIN" "Rett" "Kanner"
    "CMA" "3SD" "=12" "hg18" "10q" "Chromogranins" "Cowden’s" "Cowden" "σ=0.72"
    "F-fluorodihydroxyphenylalanine" "FDOPA" "fluorodihydroxyphenylalanine"
    "N/C" "ENET" "ENETS" "Neuroendocrine" "CHGB" "CHGA" "= 0.80" "n=4"
    "p= 0.02" "10.1038/ncomms2361" "doi" "Wassman" "PM0078202" "PM0078201"
    "PM0078200" "thiosemicarbazone" "cellulo" "Zn" "methide"
    "the five-membered ring lactone" "lactone" "Lambert" "rotamer" "centroid"
    "PM0078199" "SourceForge" "PMDB" "NSC-319725" "COMBO" "Jorgensen’s"
    "Jorgensen" "Schrödinger" "Schrodinger" "ADME" "kcal " "NCI/DTP" "_C124A"
    "sulphydryl" "FTMap" "a lower bound chosen" "Fpocket" "1TSR"
    "the p53-stabilizing peptide CDB3" "CDB3" "L1/S3" "quinuclidinone (MQ)"
    "MQ" "quinuclidinone" "Approximately three-quarters" "to 100 "
    "co-transfecting" "μg " "=0.80" "~5%" "I/II" "only beta blockers" "AERS"
    "CESD" "terbutaline" "Solver (APBS)" "Pymol" "APBS" "Solver" "Boltzmann"
    "Poisson" "Myristoyl" "VMD" "Multiseq" "CASTp" "Rosetta" "AbinitioRelax"
    "adenylate" "S17A" "dbcAMP" "AP23846" "phosphoproteome" "anti-hypertensive"
    "Rushworth" "Kolch" "Walter" "co-overexpression" "DVD" "CaaX" "C165/168S"
    "RWPE" "1–6" "S259/621A" "Zimmermann" "Alessandrini" "rotein" "itogen-"
    "itogen" "6–9" "auto-inhibitory" "Niu" "Chenguang" "Ji" "Liang" "Donghui"
    "Hu" "Peng" "Hui" "Huang" "Lemin" "Xunliang" "UPLC-MS" "blocker"
    "VPC 23019" "athero" "isoenzymes" "VPC23109" "VPC23019" "Avanti" "G-couple"
    "anti-thrombotic" "vaso" "G-coupled" "HbA1C" "mL/min" "ng/mg" "Mnk-1/2"
    "Scheper" "Akt/Raf-1" "Smads" "SVXX" "mesangium" "nephropathy"
    "transforming growth factorβ" "Transforming growth factorβ" "& D" "KIM"
    "shScrib" "non-PP1γ" "KADA" "KLDY/KADA" "KLDY" "RVxF" "autoradiography"
    "partite" "Protein Phosphatase 1γ" "co-localises" "K/R" "p53γ" "Bourdon"
    "Powell" "53/197" "Merlo" "carboplatine" "IVS" "Missense" "17p13"
    "p  = 0.0026" "p  = 0.0102" "p  = 0.0001" "p  = 0.0017" "≥50%"
    "p =  0.0026" "GMALL" "ETP/DN1" "T-lineage" "protooncogene"
    "a distinct leukemic subtype" "a specific immature immunophenotype" "sCD"
    "CD2+" "CD13+" "Immunophenotype" "FLT3 mut" "ETPs" "BAALC" "non-ETP"
    "alloSCT" "T-lymphoblastic" "FLT3mut" "TKD"
    "an immature surface immunophenotype" "leukemic subtype" "pathomechanisms"
    "= 19" "n = 20" "≥20" "strong perinuclear K8/K18" "perinuclear K8/K18"
    "Coomassie" "ob/ob" "Empigen" "comigrates" "AcK" "K8/K18" "anti-AcK"
    "anti-acetyl-lysine" "8 pS" "TKK" "GSW" "KBK" "MKA" "phenyltetrazolium"
    "Dimethylsulfoxide" "&F" "B&D" "garcinol/LTK14" "B&C" "duplexes"
    "cytometry/immunostaining" "arrest/apoptosis" "K373/382" "H3K56Ac" "&C"
    "&D" "H3K9Ac" "H3K18Ac" "14-methoxy-isogarcinol" "cells/per" "indica"
    "Garcinia" "the turmeric plant Curcuma longa" "longa" "Curcuma" "H4K16Ac"
    "AX" "H3K18" "LTK-14" "phytocompounds" "H4K16" "γH2A" "Drug-like" "H4K20"
    "Polymorphism" "4–9" "Lu" "Willander" "Alhopuro" "SSCA"
    "fluorescent dideoxynucleotides" "dideoxynucleotides" "T/G" "urothelium"
    "Cystectomy" "Guérin" "Calmette" "NMIBC" "UCB" "–9" "p = 0.013" "p = 0.029"
    "p = 0.003" "T/T" "≤ 0.05" "rs2279744" "p = 0.038" "YWL" "YQX" "LPX" "KY"
    "broadest" "theseregimen" "vinblastin" "cispaltin" "UR" "LR" "sown"
    "nmol/l" "siP53" "these technological superiorities" "posseses"
    "superiorities" "analyte" "passivate" "undetectalbe" "nonresponders" "G-14"
    "CCL187" "Intra-" "RFLP-µ" "V/cm" "ΦX174" "TBE" "HPC" "microscale" "FASS"
    "Mav" "RFLP" "CE" "interspace" "a perfect co-localization" "KBrO 3"
    "gammaH2AX" "OGG1 and XRCC1 subcellular re-localization" "bromate"
    "the carcinogenic agent KBrO" "405-nm" "silencing/removal" "DIQ"
    "the oxidative agent KBrO" "KBrO" "oxoG" "eu-" "eu" "non-targeted"
    "anti-FLAG" "LipoFectamine 2000" "Arizona" "intraobserver" "MALT"
    "ABC-like" "GCB-" "Ventana" "distributionin" "/cell" "≤44" "/ cell" "CEN8"
    "copies/20" "Diploidy" "germinal center B-cell (GCB) subtypes" "GCB" "8q24"
    "diploidy" "= 21" "_at" "Leukemia/Lymphoma" "8p" "studylies"
    "an approximately additional 17 SNPs" "Xq12"
    "previous benign breast biopsies" "BCRAT" "6 previously identified SNPs"
    "phenotypic subtype" "Cochran’s" "Cochran" "the respective datasets"
    "affecteds" "several reproducible SNPs" "rs3112612" "2q35" "rs13387042"
    "16q22.2" "rs11075884" "6q21" "rs566164" "5q13.2" "rs17663555"
    "the NYUMC replication dataset" "the NYUMC dataset" "p≤5×10"
    "2 highly-significant SNPs" "a longer haplotype" "rs2981582" "rs2420946"
    "rs1219648" "rs2981579" "rs11200014" "haplotype (AAGGTA)" "AAGGTA"
    "rs1078806" "NYUMC datasets" "Amitage" "less significant SNPs"
    "disequilibium (LD)" "disequilibium" "shared ancestral haploblocks"
    "haploblocks" "utilized two separate datasets" "workflow"
    "surveillance/prevention" "6q22.33" "/ethnicity" "Jewish (AJ)" "18p" "-4 –"
    "≥3" "– 6" "echocardiography" "ILR2A" "Δ144–1102" "Δ1–143" "PPME-1"
    "littermate" "inact" "2x" "5 mg/kg" "T cell/Treg" "counterweight"
    "IL-15/p38i" "catabolite" "MFI" "OvCa" "LI" "redirect" "p38i"
    "active immunotherapy" "adoptive immunotherapy" "Immunotherapy"
    "Ovarian tumor antigen-specific CD4 + T cells" "to 100 µ" "CD8 +"
    "neuroligins" "WebGestalt" "BFABP" "Cad19" "α4-integrin" "AP2a"
    "1/osteopontin" "α6β4" "rafts/caveolae" "absense" "Ciocca" "p=2.94e-5"
    "desmogleins" "Brennan" "Aarhus" "non-tumoral" "brainstem" "KOOS" "_020742"
    "_004796-specific" "_138970" "_138735" "microsatellites" "PCR/dHPLC"
    "WikiPathways" "Pearson’s" "PLEXNB3 / SEMA5" "Huntsville" "incisures"
    "Lanterman" "Schmidt" "paranodes" "lizes" "coloca" "tinnitus" "22q" "dHPLC"
    "p= 0.009" "p= 0.003" "non-neural" "=2" "2 x" "22q11" "LY-364947"
    "basal/stem cell" "Zip29" "HMLE" "miR29a/b1" "miR-29a" "BALB"
    "microRNA-29b" "de-differentiated" "PI3K → Akt → FoxO" "IRS →"
    "PI3K→Akt→FoxO" "Haplotype" "responder" "Bonferrroni" "rs2943641"
    "non-statistically" "non-diabets" "diabets" "non-diabetes" "kbp"
    "rs1801278" "Ricans" "OHdG" "rs1801123" "QUICKI" "rs934167" "Rican"
    "Puerto" "non-diabetics" "p = 0.029" "p = 0.0005" "mg/dL" "p = 0.005"
    "Cal12T" "Pyo" "~90%" "the related developmental disorders Noonan"
    "LEOPARD" "-fluoro-D-glucose" "2-deoxy-2" "complement exogenous PKCθ"
    "AktCA" "AktDN" "methylpyruvate" "diacylgycerol" "sapintoxin" "DG"
    "epoxyguaiane" "isozyme" "isozymes" "insulinemia" "PKCθ" "englerin" "Nu/Nu"
    "-4-" "Lyte" "the pathogenic SIV quasispecies ΔB670" "ΔB670" "Vina"
    "AutoDock" "diphenylpyrazole" "M-group" "-pyrazole-1-carbothioamide"
    "-5-hydroxy-3-" "nitrophenyl" "diazenyl" "chlorophenyl"
    "diphenyldiazenylpyrazole" "Diphenylpyrazoles" "LTR" "MLSCN"
    "4-amino substituted diphenylfuranopyrimidines" "diphenylfuranopyrimidines"
    "diphenylfuranopyrimidine" "quasispecies" "AIDS-like" "titer"
    "antiretrovirals" "diphenylpyrazolo" "T-lymphoblast" "kcal/mol"
    "Economic Co-operation" "withdrawn" "re-colonization" "Bogden" "Roh"
    "anti-hHGF" "sprout-like" "approximately 12 h" "HWFs" "HWF" "regrow"
    "Economic Co-Operation" "OECD" "Extracellular signal-regulated kinase 1/2"
    "Tyr1221/1222" "–6" "musculus" "nanovesicles" "masse" "just 10 min"
    "siROCK1" "siScram" "siScramble" "hyperinsulinemia" "miRNA-148a"
    "p160-ROCK1" "mAb425" "eosinophils" "angiocrine" "~2-fold" "10min" "~25%"
    "HGF/Met" "non-canonical" "JMDB" "bp/1494" "Angeles" "Mandola" "Hashimoto"
    "Ceppi" "Otake" "pmol/g protein" "-monophosphate" "monophosphate" "CTC"
    "PFSs" "+6" "bp/-6" "ECOG" "glycinamide" "-6" "−6" "1494del" "bp/+6" "= 27"
    "χ 2  " "= 6" "0/106" "=  10" "P  = 0" "non-parametric" "χ 2" "peroxidases"
    "GPRC" "iodoaceteyl-LC-Biotin" "shCTL" "Epithelia" "Calbiochem"
    "isintegrin" "The respiratory epithelium" "non-receptor tyrosine kinases"
    "HER2/Neu" "NAD + /NADH" "NAD+/NADH" "non-stress" "aros" "gapdh"
    "timecourse" "timepoints" "/NADH" "toxicants" "#30" "Drosophil" "inhibites"
    "plamsa" "polytherapy" "HD-like" "Krebs" "anti-neurodegenerative"
    "neuropathologies" "Htt171-82Q" "neuromuscular synapses" "choreiform"
    "multipartite" "Huntington’s" "Caspase 3/7" "≥2 µ" "endotoxemia" "ClogP"
    "QikProp" "realtime" "ABCB1-" "ABCB" "ethoxymorpholine" "centroids"
    "morpholine" "pyrazole" "tolyl" "site-1" "site-2" "site-3" "QZ" "S1-M-80"
    "drug-resistant-" "HEK293/pcDNA3.1" "HEK293/ABCB1" "MCF-7/ADR"
    "glucuronate" "ABCG" "ABCA" "an important co-activator" "Germann" "ser-2"
    "transcriptional initiation/elongation" "co-operatively" "de-recruitment"
    "co-recruitment" "non-processive" "vitro" "co-activate" "co-localisation"
    "CRPCa" "an important androgen receptor (AR) transcriptional co-activator"
    "4H" "non-castrated" "non-treatment" "mESCs" "karyotypes" "OCT3/4"
    "hESF9a 2i" "mesoderm" "endoderm" "our minimal defined medium hESF9"
    "SureFire" "AlphaScreen" "BIO" "hESF9"
    "mitogen-activated protein kinase/extracellular signal-regulated kinase-1/2"
    "extracellular signal-regulated kinase-1/2" "untangles" "GFX" "βI" "βII"
    "Conclusions/Significance" "Mora" "Valdes" "SANT" "Gevry" "Hs-598T cells"
    "siH2A" "alpha-negative" "oS" "remodeler" "20X" "p53+/+" "DPO"
    "BCR-ABL -negative MPNs subtypes" "phlebotomy" "gDNA" "Kruskall" "JH1"
    "9p24" "JAK2 V617F" "essential thrombocythemia" "JAK 2 V617F" "n = 4" "F/"
    "P = 0.006" "physiopathology" "Cdc48p" "_E578Q" "pulldowns" "AdoHcy"
    "ASPSRC1" "UBXN6" "pICIn" "Sm" "internal membrane-like" "thaliana"
    "sapiens" "spectrometer" "Orbitrap" "chaperonins" "AP-MS" "Clarke" "PKMTs"
    "PRMTs" "PKMT" "SPOUT" "N-methylation" "S-adenosyl-L-methionine" "Paget's"
    "Fronto" "UBX" "BLOSUM62" "non-histones" "this dual immunohistochemisty"
    "automated dual ERG-PTEN and ERG-SPINK1 immunohistochemisty" "~10%" "PCPT"
    "Yoshimoto" "Immunohistochemisty" "and 2+" "decreased/absent"
    "dual color immunohistochemistry" "prostatectomy"
    "dual color ERG-PTEN immunohistochemistry" "SPINK1-" "SPINK" "Rubin"
    "P13K/AKT" "phospatidylinositol"
    "recurrent RAF ( BRAF and RAF1 ) gene rearrangements in 1-2" "in 1-2"
    "Ateeq" "Perner" "immunohistochemisty" "~ 20%" "diplod" "FISH+/" "Mitelman"
    "karyotype" "inefficacy" "⩾90%" "⩾2" "HER2 /CEP17" "dimerise"
    "HER2 -minor-A" "-FISH−" "- minor-A" "HER2- all-A" "-FISH+" "-non-A"
    "non-A" "HER2 -all-A" "non-amplified" "- all-A" "non-responders" "HER2 /"
    "Clopper" "dipyrimidine" "midline" "NF2/chr22loss" "non-NF2" "parieto"
    "histological subtype" "TheAKT1" "neoplasias" "= 12" "−14" "chr22" "= 31"
    "ERS3" "−108" "−197" "−316" "−3980" "PHH" "Combo" "A1762T/G1764A (TA)"
    "ATPlite" "S/G2" "Polκ+PLTH" "ΔPLTH" "PLTH" "∼15-fold" "ΔPIP" "Zou"
    "intrastrand" "C-terminally" "Non-catalytic" "Polκ" "soluble PP1cδ"
    "approximately 10 min" "anti–Ser-19" "PP1cδ" "V5-MYPT1-T696DT853D"
    "V5-MYPT1-T696DT853D-" "V5-MYPT1-D884A–" "V5-MYPT1-WT–" "FLAG-MYPT1-"
    "pT853" "pT696" "V5-MYPT1-D884A" "V5-MYPT1-WT" "TQTD884" "MYPT" "parti"
    "6-diamidino-2-phenylindole" "anti-V5" "and 3L4F-F 3" "bioprobe"
    "disrupter" "chemoprobes" "penile" "hypophagia"
    "the important pharmacophores" "pharmacophores" "and 3L4F-F1" "GRAMM"
    "the primary two α -helical subconformations" "subconformations" "REMD"
    "dPCA" "-turn-like" "and 3L4F-F" "reinforcer" "reinforcers" "CSRT"
    "operant" "the limbic–corticostriatal circuitry" "ratTAT–3L4Fpeptide"
    "M 3L4F" "photomicrograph" "TAT–3L4F" "TAT–3L4F-treated" "μ mol/kg"
    "anti-body" "VTA" "Duolink" "disrupters"
    "a saturable and positive allosterism" "allosterism"
    "limbic–corticostriatal circuitry" "neuroprobes" "guidepost" "3L4F"
    "R-mediated" "hydroxytryptamine" "turn-like" "= 0.49" "= 0.70" "= 107"
    "= 2.42" "p = 0.07" "μ mol" "n = 20" "= 60" "q/11" "G α"
    "Fc fragment of IgG1" "the soluble fusion protein FPT-091" "FPT-091" "Fc"
    "FPT" "intermembrane" "amplicon" "HS_6" "FTP-091" "FTP" "Hs_FGFR4_6"
    "Hs_FGFR4_5" "Oris" "_6" "_5" "_FGFR4" "HOSE" "5q31-35" "5q31-35.3"
    "Birrer" "nanoliposomes" "Ig-like" "10 ng/mL" "p21/WAF1" "p21/" "S/TQ"
    "ATMi" "non-irradiated" "SM" "A-C-C-C-T-C-C-A-A-T-C-C-C-G-G" "SR"
    "Haplotypes" "nonmalignant" "amniocytes" "tissue/cell types" "SymAtlas"
    "GNF" "rs1051425" "rs2073416" "rs2073601" "Piface" "rs6517481" "rs1051475"
    "rs7276961" "rs2070531" "rs2070529" "rs374575" "rs2269188" "YRI" "HCB"
    "rs2070530" "C1QL1" "EMCN" "GNFSymAtlas" "Silico" "bcl" "HSA21"
    "overdosage" "trisomy" "rs1051476" "rs461155" "rs11254" "rs711" "fSNPs"
    "fSNP" "ets" "P = 0.02" "= 14" "= 12" "= 11" "χ  2  " "P = 0" "χ  2" "NYP"
    "Stommel" "timeframe" "amphigegulin" "MSPR" "PDGFRa" "anti-phosphotyrosine"
    "NVP" "PI3K/Akt/mammalian target of rapamycin" "P- values" "PI3KCA" "Efp"
    "Ful" "A-type" "ERE" "2 × 10" "Gu" "Our soft agar" "Pak" "Clinicians"
    "pLKO" "Gadd45β" "EGF-treated MCF-7Vav1" "MCF-7Vav1" "Transducer"
    "Vav1SH2-GST" "gluthatione-S-transferase" "AU565Vav1" "MCF-7Vector"
    "AU565Vector" "PDA" "Rho/RacGTPases" "non-hematopoietic" "cytokines/growth"
    "Non-Small" "toolbox" "the post-menopausal patient group perhaps"
    "Positron" "de-convoluted" "pixel" "Ruifrok" "ER–ve" "PgR-ve" "Subtype"
    "HER2-ve" "PgR–ve" "ER-ve" "HER2 -ve" "PgR +ve" "Subtypes" "radionuclide"
    "Beyer" "non-thyroidal" "Tazebay" "HER2+ve" "HER2–ve" "PgR+ve" "ER+ve"
    "hNIS" "Sasaki" "125/2580" "6/208" "51/208" "Sica" "3/7" "histomorphology"
    "5/33" "6/78" "7/61" "4/7" "7/208" "Martelli"
    "clinically relevant molecular subsets" "= 2" "= 0.26" "p  = 0.045" "1/7"
    "Non-small-cell" "non-adenocarcinoma" "Kawakami"
    "FA-associated integrin β3" "non-FA" "Danen" "Huveneers" "longer TALLs"
    "TALLs" "observatons" "±50%" "hidden" "FA-associated molecuels" "molecuels"
    "Holcman" "Kusumi" "Nomanbhoy" "T17N- Ras" "Feig" "Klooster" "isands"
    "geranylgeranyl" "VKKRKRKCLLL" "Sahl" "Suzuki" "atera" "rrest" "PMs" "Hz"
    "Honda" "Koyama" "mGFP" "Kenworthy" "Niv" "Silvius" "Parton" "Chae" "Berk"
    "Hoefen" "Pozo" "Michaelson" "Hancock" "Kuo" "Chang" "Saxton" "areal"
    "∼1/3" "Patla" "cryo" "Venice" "β3" "Rossier" "Shibata" "Goetz" "Burnette"
    "Shroff" "Nayal" "Betzig" "Petrie" "Galbraith" "Approximately 20%"
    "all-time" "mono-treatment" "WHL" "XLQ" "HK" "GL" "Dupré" "Connell" "Nardi"
    "Deininger" "NCB" "Gorre" "RAD51 is" "Luci" "Celeste" "iGFP" "SceGFP"
    "QSAR" "phenylsulphonyl" "affi" "IBR1/2" "-carboxylphenyl" "carboxylphenyl"
    "Vassilev" "phenyl" "IBR1" "indolyl" "phenylsulfonyl" "Boeke" "FOA" "TetOp"
    "Davies" "Pellegrini" "Ito" "Letavayova" "Bryant" "Xia" "Vispe" "Slupianek"
    "Skorski" "Raderschall" "Klein" "Luo" "Robberson" "Sung" "Haaf" "Conway"
    "Baumann" "IBR2" "Non-Obese" "p = 0.013" "CACGTG" "seq" "FOXO3A3-ER" "Ac"
    "2367 intergenic RNAPII" "intergenic RNAPII" "all intergenic RNAPII"
    "FOXO3A3" "DLD1" "RNAPII" "orthologues" "co-regulation" "4 h"
    "auto-regulatory" "JV" "damage/DNA repair" "rs8177426" "rs13240966" "modi"
    "rs574664" "rs1042838" "rs732417" "A/A" "rs3797896" "rs20580" "Andrew" "Cl"
    "Maier" "Czech" "G/G" "= 4" "= 2" "= 0.41" "p = 0.08" "p = 0.0002"
    "p = 0.001" "Dulbecco's" "the associated co-regulators"
    "phosphorylated/total" "siControl" "MELN" "the pure anti-estrogen ICI-182"
    "ICI-182" "ICI" "siB2" "Dblx" "H3/H4" "≥ 10" "condesin"
    "bacterial lipopolysaccharide (LPS)" "exon-3" "DEAA" "ΔRB" "FOXM" "cIAP"
    "non-nuclear" "several Web-based algorithms" "miR-146a" "lymphoma/leukemia"
    "iNOS/NO" "miR-26a/iNOS" "Three Web-based algorithms" "MiR-26a" "PTIO"
    "MEG-01" "FE" "synthases" "miR-26a" "an aggressive subset" "Finns" "Turku"
    "Vanderbilt" "-AR-" "rs1285441" "DHVs" "rs9922316" "64 healthy Finnish"
    "log-transformed dexmedetomidine ED" "ED" "-AR-mediated" "DHV" "ng/"
    "Hscore" "Hscores" "dihydroxyvitamin" "BOGA" "proliferation/viability"
    "poorest" "Δ11" "Δ11/" "= 2" "_s" "X 100" "= 14" "endosomal/lysosomal"
    "all IHC stainings" "the immunohistochemical stainings" "stainings"
    "the mid 90s" "uni-" "uni" "accordant" "Uni-" "Uni" "less advanced T-stage"
    "CIMP" "multistage" "T-stage" "Malmö" "0–1" "tetrahydrochloride"
    "diaminobenzidine" "CKD4" "≤ 5" "global miRNA profilings" "16p11.13"
    "HNSCCs" "42a" "PRPRT" "LNA-193b" "UTSCC" "non-relapsed" "profilings"
    "diazoacetate" "enzymic hydrolysates" "hydrolysates" "carboxymethylate"
    "NOGC" "-bromothenylG" "bromothenylG" "-benzylG" "benzylG" "substituents"
    "re-generation" "readdress" "-alkG" "alkG" "m/z" "GNPVPILIP" "Pst"
    "CTCCGTGCTGGCCC" "-alkylG" "alkylG" "Bsa" "CTAGTA" "-GCCATG" "GCCATG"
    "Alkyl" "Atl1" "pombe" "Schizosaccharomyces" "-CMG-containing"
    "Duplex ODNs" "-carboxymethylcysteine" "carboxymethylcysteine" "ODNs"
    "scherichia" "GC→AT" "human colorectal mucosa" "-carboxylmethylguanine"
    "carboxylmethylguanine" "sigmoid" "-nitroso" "nitroso" "colorectal mucosa"
    "faeces" "heterocyclic amines" "amines" "-alkyl"
    "oligodeoxyribonucleotides" "alkyl"
    "the toxic and mutagenic DNA adduct O  6 -carboxymethylguanine"
    "-carboxymethylguanine" "carboxymethylguanine" "Non-denaturing" "DBeQ"
    "micrographs" "vesicles/cell" "AAA+-type" "cholesterol-rich microdomains"
    "invaginations" "intramembrane" "Cdc48" "exome/genome"
    "the synonymous DKC1 polymorphism" "possible polymorphisms" "A487A"
    "a synonymous DKC1 polymorphism" "A880T" "congenita (DC)" "Hreidarsson"
    "congenita" "HHS" "Hreidarrson" "= 0.001" "X-inactivation" "adhesiveness"
    "IQR" "DSPs" "pannus" "OA" "PTPome" "p38 MAPKs" "forgiven" "disorderd"
    "G1/G2" "PXVXRXLKPXR" "PPRPPKP" "S1/S4" "Ducruix" "sidechain" "ΔSASA" "ΔC"
    "is 1:2" "as 1:11" "a 2:1" "Gab1_PR" "Sos1_PR" "Gab1_G2" "_G2" "Sos1_S1"
    "_PR" "non-competitive" "Sos1-Grb2-Gab1" "PXψPXR" "RXXK" "pYXN" "nSH3"
    "allostery" "Allostery" "# 2" "# 1" "_S" "re-evaluate"
    "meningothelial histology" "the meningothelial subtype" "nevoid"
    "a mutational hotspot" "SCNAs" "leptomeninges" "=11" "p=0.0008" "p=0.009"
    "andBRAF" "hNCSCs" "bypassingBRAF" "expansile" "necropsy" "Prkdcscid"
    "2×10" "V600E+MITF" "oncogenicBRAF" "withBRAF" "followingBRAF" "FOM"
    "underlyingBRAF" "afterBRAF" "hNCPC" "whetherBRAF" "Histology"
    "the soft agar" "downBRAF" "aBRAF" "functionalBRAF" "Tu" "thatBRAF"
    "disassociated follicular epithelium" "NCPCs" "forBRAF" "toBRAF" "hNCPCs"
    "ofBRAF" "1× 10" "X100" "non-obese" "nucleus/cytoplasm" "CreERT" "~10-fold"
    "≤2-fold" "micelles" "anti-death" "separate organelles"
    "mitochondrial localization/import" "Becker"
    "selective/cell-specific mitochondrial import/localization" "RKK"
    "mito-GFP/mito-mRFP" "MitoTracker" "nearly uniform co-localization" "OMM"
    "non-apoptotic" "α6" "Yki/YAP" "Pawitan" "UNC" "YAP/TEAD" "heteromers"
    "wts" "Sd" "unphosphorylatable Yki3SA" "wtsRNAi" "Yki3SA" "Yki1SA"
    "themask" "pMad" "UAS" "diap" "EY" "hypomorphicmask" "allelemask" "GTAR"
    "Wts" "Scute" "GDBD" "Yorkie" "non-phosphorylatable" "non-overlapping"
    "genomewide" "CRL5- Vif-CBFβ" "simplest" "ΔVif" "NL4-3" "DAVID" "STATH"
    "metallopeptidases" "PMA/PHA" "phytohemagluttinin" "myristate"
    "two biological replicates" "RUNT1" "isothermal titration calorimetry"
    "SAXS" "S2D" "co-purify" "FGH" "A3F" "ELOC" "CRL5-Vif- CBFβ" "monodisperse"
    "A3G" "ELOBC" "CRL5-Vif-CBFβ" "CRL5-Vif-" "ELOB" "the viral lifecycle"
    "lifecycle" "nucleate" "RUNX" "a well-defined heterohexamer"
    "heterohexamer" "CRL5" "APOBEC3" "co-precipitating" "S5A" "co-purified"
    "regs" "palmitoyl" "a pathogenic subset" "Th17" "Michalek" "carnitine"
    "reg" "eff" "miR23a/b" "solute" "polyaminesand" "costimulatory recetors"
    "recetors" "AGC" "TSC1/2" "co-opted" "DXD" "pneumophila"
    "Clostridial toxins glucosylate" "glucosylate" "co-ordinately" "Δ202"
    "thiamet" "diphosphate (UDP)" "alpha-helices" "Rossmann" "DxD" "chelates"
    "Rossman" "HHPred/HHSearch" "peptidases" "iodoacetate" "nleE" "NleE" "nleB"
    "EPEC" "HUS" "EHEC" "rodentium" "Citrobacter" "-acetyl-D-glucosamine"
    "NleB" "A/E" "attaching/effacing" "4 h" "~20 %" "~30 %" "ΔRING"
    "receptor-1" "co-activator" "the associated RVP titers"
    "biochemical readouts" "released viral progeny" "re-emphasized" "PD+XMD"
    "EE" "DOX" "XMD" "BIRB" "p-ERK5" "bis" "CVB"
    "the associated phenotypic readouts" "viral readouts"
    "released viral progeny (RVP)" "titers" "formalisms"
    "higher-order statistical covariations" "covariations" "dosings"
    "virulent CVB3 progeny" "furthers" "progeny" "Coxsackievirus" "CVB3"
    "= 0.5" "= 0.8" "= 0.6" "gene-2" "Descemet’s"
    "a posterior corneal lenticule" "keratoplasty (DSEK)" "lenticule" "DSEK"
    "keratoplasty" "Descemet" "polymegethism" "approximately 500 cells/mm 2"
    "cells/mm 2" "IRAK1/4" "IRAK 1/4" "a/β" "CEC" "kappa-light-chain-enhancer"
    "α/β" "interleukin receptor-associated kinase 1/4" "1/4" "Co-treatment"
    "the ventral pons" "pons" "Anderson" "CLIA" "MassARRAY" "Sequenom"
    "CyberKnife" "AYVM" "epidermal growth factor receptor-2" "_Y764insFQEA"
    "Valencia" "Qiagen" "NA" "_N771insSVD" "_D770insASV" "=0.60" "p=0.06"
    "non-squamous" "nonlymphoid" "PKC-βI" "PKC-βII/NF-κB" "− / −animals"
    "− / −and" "necrobiopsy" "Histopathology" "lymphadenopathy" "CLL-like"
    "TCL1tg" "TCL1/CLL" "ELISAs" "KEGG" "mBMSCs" "Fmurine" "HTNC" "− / −stroma"
    "− / −BMSCs" "− / −stromal cells" "PKC-β Is" "EL08-1D2/CLL" "hBMSCs"
    "monocultures" "GeneTrail" "transcriptomes" "e " "cocultures" "EL08-1D2"
    "ex " "15a/16-1" "PKC-βII-NF-κB" "PKC-βII" "Upregulated stromal PKC-βII"
    "5 × 10" "8-week" "C57BL/6" "p = 0.029" "13q14.3" "underwent gastrectomy"
    "KATO" "gastro" "JZ" "YW" "usefullness" "likehood" "CK 5/6-" "Mathew"
    "stem cell/progenitor" "co-immunostained" "8/18-" "CK 8/18" "CK 5/6"
    "Cytokeratin 5/6" "8/18" "G1/ S" "P -values " "P1Rs" "P2Rs" "-diphosphate"
    "purinoreceptors" "COX-2/PGE 2" "eATP" "ATPγS" "ATPγ" "/AA/COX-2" "/AA"
    "P2X" "P2Y" "Eadaravone" "Ro318220" "Gö6976" "CBE" "Edaravone" "2X"
    "Montgomery" "Jedeszko" "pixels" "Biocoat" "Fluoroblok" "DCIS-shCD44"
    "immunocomplex" "CD44v" "CD44s" "BME" "MLCP" "χ2" "Gensini" "0.70–1.31"
    "0.70–1.16" "0.72–1.20" "rs56304104" "rs2230774" "HWE" "only 3 SNPs"
    "rs71932930" "rs978906" "synomnous polymorphism" "Polymorphisms" "2p24"
    "GWASs" "non-stem cell" "RefSeq" "co-regulated" "stdev "
    "initiating/stem cells" "re-growth" "Urbanucci" "Yu" "retrogene" "CWR"
    "hESCs" "SVEC" "co-immunofluorescent" "Subset" "hESC" "stem/initiating"
    "Hodges" "co-regulators" "= 11" "Non-malignant" "cell-like" "integrinβ1"
    "limbus" "Pearton" "transdifferentiate" "Adult central corneal epithelium"
    "TACs" "Dkk1in" "pGSK3β" "pFAK" "integrin β1" "±0.21%" "25.45%±2.00%" "TDC"
    "co-culturing" "ESC-CM" "n = 3" "Groep" "Kang's" "microvessels/mm2"
    "microvessels/mm 2" "Isobe" "Hansen" "Microvessel" "BRCA1-2" "p = 0.04"
    "and 3+ " "2+ " "1+ " "= 26" "p = 0.0045" "p = 0.0001" "Diehn"
    "telomerase/TERT" "MRC-5/SV40" "X-irradiation" "un" "non-telomeric"
    "Kovalenko" "bolus" "Santos" "non-telomere-related" "organelle"
    "cytoplasmic/" "epigenome" "STAT1/3" "–LLTPPG–" "WD7" "WD4" "ΔWD" "TATA"
    "Gilman" "Krumins" "AMVMs" "NRVMs" "Gα s" "HASM" "WoLFPSORT" "SEQUEST"
    "LLVSASQDGK" "CID" "Gγ" "Gβ" "Gα" "Gβ 2" "Gβγ" "co-repressors"
    "docetaxel-based concurrent chemoradiotherapy" "caner"
    "concurrent chemoradiotherapy" "cisplatin/docetaxel" "chemoradiotheapy"
    "chemotherapy/chemoradiotherapy" "FOLFOX" "antimicrotubule" "Fu" "P = 0"
    "–14" "and 3 D" "P  = 0.006" "P  = 0.007" "P  = 0" "EMD→AAA" "ΔCBD"
    "contri" "cyto" "∼80%" "newer" "untangle" "Paneth" "SCH9" "oligopyrimidine"
    "healthspan" "ITP" "Lifespan" "IIS" "fruitflies"
    "the fruitfly Drosophila melanogaster" "orthologue" "OH" "zotarolimus"
    "umirolimus" "hygroscopicus" "Nui" "hybridization identified 2/60"
    "StripAssay" "gene-dense Crohn’s" "gene-dense Crohn"
    "bacterial peptidoglycan (PGN)" "agreeswith" "harpin"
    "the common intestinal commensal bacterium Entercoccus faecalis"
    "Entercoccus" "SHANK" "lipopolysaccharide (LPS)" "LUBAC" "AP1510" "FΚBP"
    "the inducibly active (IA) fusion proteins RIPK2-ΔCARD-Fpk3" "ΔCARD-Fpk3"
    "DHHC" "BMDMs" "these Crohn’s" "transcarbamylase/dihydroorotase (CAD)"
    "avian reticuloendotheliosis viral oncogene homolog" "Genomewide" "Crohn’s"
    "Blau" "peptidoglycan" "ng/µ" "10 ng/ml" "IP6Ks" "hexakisphosphate" "OSE2"
    "InsPs" "diacyglycerol" "U73122" "blockers"
    "the pleiotropic disorder oculodentodigital dysplasia" "hemichannel"
    "hemichannels" "hexamers" "inositol hexakisphosphate kinase 1/2"
    "phospholipase Cγ1" "InsP" "EGCG/PR-B" "nucleo" "cochaperone" "polyphenols"
    "RNAPol" "prmoter" "mDBD" "ECGC" "poliphenols" "+212" "E2/ERα" "IRSI"
    "XETL" "heterocomplexes" "benign breast epithelium" "PR+" "3h" "ER+"
    "collectives" "necroses" "microregions" "parametrium" "FIGO" "microvessels"
    "microvessel" "-histography" "histography" "Eppendorf" "cervical dysplasia"
    "microelectrodes" "hypoxia-associated proteome" "CDKNIA"
    "the HDAC6 selective inhibitor tool-compound tubastatin" "HDA6"
    "oxiloplatin" "leuvorin" "TAPBP" "NBPF" "NUV" "TGD" "FLICA" "HDAC6cdII"
    "bidentate" "HDAC1cd" "cd" "tubastatin" "fluorothymidine" "∼10-fold"
    "caspase-3/7" "Caspase-3/7" "underexpress" "Pearson's" "nephrectomy"
    "chromophobe" "-activated-kinase" "shLKB1" "ccRCC" "-1 α" "n =5" "=21"
    "P =0.006" "μ g" "μ g " "Whitehead" "gastric FFPE" "miR-19b" "miR-19a"
    "non-tumour" "Eastern Europe" "miR-18a" "3 h" "miR-20a" "pathobioants"
    "fragilis" "colonic commensals" "enterotoxins" "Commensals" "symbiotes"
    "the colonic microbiota" "congeners" "enterococci" "commensals"
    "normal colonic mucosa" "viz" "4-hydroxy-2E" "4-hydroperoxy-2-nonenal"
    "4-oxo-2-nonenal" "μmol" "arachidonate" "ETYA" "diffusible clastogens"
    "clastogens" "BSE" "the common intestinal commensal Enterococcus faecalis"
    "celss" "adduct" "carbonyl" "Min/+" "andApc" "-4-hydroxy-2-nonenal"
    "the human intestinal commensal Enterococcus faecalis" "faecalis"
    "Enterococcus" "Non-Targeting" "adenomatous polyposis coli" "Shaw" "Voorde"
    "methylated cfDNA" "PMR" "qMSP" "non-breast" "invasive biopsies"
    "unnecessary subsequent biopsies" "Mammography" "mammography" "cfDNA"
    "≥ 20" "n = 5" "agonism" "hydroxycholesterol" "hydroxcholesterol"
    "antagonises" "a sizeable subset" "Huggins" "Charles" "Nobel" "IKKα/β-"
    "PI3K/Akt/PKCδ" "IKKα/β" "proto" "/Akt/PKCδ/NF-κB" "non-template"
    "lysosulfatide" "sphingosylphosphorylcholine" "lysosphingolipids"
    "tamoxifen-inducible EC-specific PI3K-C2α" "-A-" "phosphoinositides"
    "isofom" "AS605240" "co-operative" "S1P/sphingomyelin" "erythrocytes"
    "sphingosine" "PI3K-C2α" "PI3K-C2β" "lipoproteins (HDL)" "lipoproteins"
    "∼54%" "proteosome" "OSE151" "Capan-1/BRCA2" "T29/vector" "FTI-276"
    "ImageJ" "T29/Aurora-A" "Farnesyl" "FTβ" "GFPi" "constrast" "Ai" "CAAX"
    "farnesyl" "mutated RAS ablated BRCA2 expresson" "expresson" "P = 0"
    "G 0 /G 1" "8–16 h" "Cmax" "ofmTORC1" "Rapalogues" "phospho-ERK1/2"
    "rapalogues" "80 NSCLC" "Comp" "comp" "Greater" "-trisphosphate"
    "trisphosphate" "inositides" "mechanisms/mutations" "non-receptor protein"
    "year-old" "≥5" "monsomy" "colocalises" "hyperploidy" "SCE/cell" "SOM569"
    "foci/cell" "196b-D2" "FANCD2L" "FANCD2S" "MRC5VA" "SOM157d" "SOM196b"
    "SCEs" "PD20" "Uveal" "P =0" "19q" "1p" "Ciznadijia" "Barrett"
    "the p21 heterozygous mice co-infected" "co-infected" "thenestin" "YH/J12"
    "Drosophilia" "RCAS" "prospero" "miRISC" "B-boxes" "Rb" "6 p21"
    "tumor-like" "11p15" "RNF2-" "RNF" "shRNF2-" "shRNF" "lenvirus" "shMock"
    "#2" "shRNF2" "trimethylates" "LipofectAmine 2000" "#1" "p53 +" "MBI"
    "S62/T58" "KYO" "MOLM" "31/60" "retroviruses" "co-transformation"
    "Myc-pY74" "shMyc" "histochemistry" "5YF" "anti-pY74" "Y12/16/22" "Myc-5YF"
    "T58/S62" "Y23A" "normalizer" "isomerizes" "Protein Phosphatase 2A"
    "DCIS-like" "T47D-14-3-3ζ" "ErbB2/FoxM1" "dimethylsulphoxide"
    "non-receptor tyrosine kinase" "tranwell" "20 μg/ml" "14-3-3ζ" "MPSNT"
    "hEGFRmice" "pEGFR" "Wa2/" "pJAK2" "Wa2 +" "nu/nu" "shSTAT3" "n=5"
    "7.1±1.4%" "9.6±1.6%" "200mg/kg" "S462TY" "JAK1/2" "CP690550" "CP6690550"
    "DhhCre" "hypomorph" "NPcis" "DeClue" "dedifferentiate"
    "benign peripheral nerve plexiform" "plexiform" "PNST" "=4" "=5" "Ki67 +"
    "5/5" "= 15" "Achilles" "thru" "non-RMS" "shYES" "Addgene" "phoshorylate"
    "antiphosphotyrosine" "shControl" "musculature" "shCRKL" "ERMS" "pCRKL"
    "shRNA-non-induced" "Ngo" "PAX3/7" "sarcatinib" "pY416" "48 h" "mg/Kg"
    "P =0.0004" "P =0.0006" "P =0.001" "72 h" "11p" "Maretzky" "rmEcad"
    "Akt/ mTOR" "Nahta" "lavage" "some cases releases soluble ectodomain"
    "Akt/mTOR" "pHER2" "cryostat" "IGF-1Rα" "gelatinases" "Plymouth" "BIOMOL"
    "rmEcad/Fc" "exogenous rhEcad/Fc" "rhEcad/Fc" "exogenous sEcad" "Najy"
    "the monoclonal antibodies A12" "PI3K/Akt/mTOR" "sEcad’s"
    "/Akt/mammalian target of rapamycin" "sEcad" "20 μg/mL" "20μg/mL" "A12"
    "H3K9" "re-ligation" "63-kb" "one strong AR-bound enhancer" "-Seq" "Seq"
    "CCDC83" "enhancers" "Bohlig" "22RV1" "H3K27" "clinicians" "V600D/R"
    "V600E/K" "BRAFV600D/R" "D/" "brown-like" "adipogenic inductors"
    "isobutylmethylxanthine" "inductors" "expression/activity"
    "adipose RB1 levels/activity" "levels/activity" "adipogenic/lipogenic"
    "β = 0.44" "and 3T3-L1" "P = 0.04" "r = 0.55" "P = 0.007" "P = 0.02"
    "P = 0.019" "primer/probes" "= 5" "= 19"
    "extracellular signal–regulated kinase 1/2" "Hinton" "RXXS" "RIHS"
    "Noguiera" "Jacaranone" "factor 1α" "PDK" "phosphinositide" "Il" "fl/fl"
    "dependend" "ΔM" "aureus (SAC)" "monocytogenes" "aureus" "BMDM" "Crohn's"
    "lipopolysaccharide" "-1β" "stressors" "2  +" "approximately 300kDa"
    "670kDa" "TOM1-like" "Endolfin" "microglobulin" "ESCRT0’s"
    "at least 100-fold greater" "=8μM" "DUIM" "ouble" "DIUM" "Bafilomycin"
    "ESCRT1" "The Karposi‘s" "Karposi" "ESCRTO" "200-300mg/ml" "150-200nM"
    "UBPs" "GST-hHR23B bound selectively K48-linked tetraUb" "UBP" "TOM"
    "Ub-like" "S5a/Rpn10" "NiNTA" "S5a" "Sephacryl" "tetraUb"
    "pure 26S protesomes" "LLVY" "protesomes" "monoUb" "ESCRT" "megadalton"
    "Ubs" "catalyse" "ESCRT0" "Hrs" "LC-MS/MS" "mono-Ub" "23A" "co-targeting"
    "FISH/IHC" "ADVIGO" "the Karp's" "Karp" "squamous histology" "Gualberto"
    "0.77–2.84" "FISH +/IHC+" "non-SCC" "hilar" "pneumonectomies" "lobectomies"
    "Perugia" "Dziadziuszko" "Nakagawa" "phosphoinositol-3-kinase" "FISH+/IHC+"
    "IHC+" "FISH+" "Fourty" "p = 0.09" "p = 0.08" "= 0.10" "p = 0.59"
    "p = 0.05" "2-3" "intronexon" "10/17" "figitumimab" "feedforward"
    "family-wise error rate (FWER) P value = 0" "non-SFT" "U133A" "MSKCC"
    "Sloan" "breakpoint" "12q13" "A focal 56-kb" "SNV" "_1005" "meninges"
    "patternless" "cellular solitary fibrous tumor/hemangiopericytoma"
    "Michigan" "ONCOSEQ" "Oncology" "EGR" "Transcriptome"
    "recurrent solitary fibrous tumor (SFT)/hemangiopericytoma"
    "/hemangiopericytoma" "Non-targeting" "co-regulator"
    "clinically relevant endpoints" "relatively subjective endpoints"
    "Langsenlehner" "brachytherapy" "telangiectasias" "postmastectomy"
    "postlumpectomy" "Giotopoulos" "Claude" "Alsbeih" "homozygotes"
    "an objective radiologic endpoint" "rs16942" "≥6" "SPECTs" "Wallis" "DRC"
    "SPECT" "polymorphisms (SNP)" "non–small-cell" "= 29" "= 6" "μ L" "rs25487"
    "Joseph" "Jr" "Israel" "Beth" "Caldwell" "Francisco" "Amsterdam" "unmet"
    "Carlie" "Gonzalez" "nonwhite" "Vivo" "Ex" "Tiel" "BMS" "0-1" "substudy"
    "byp27" "Seattle" "stents" "Thep27" "thep27" "interquartile" "stent"
    "LEVBG" "5-bromo-2" "NG2+" "learning/memory" "C-raclopride" "striata"
    "raclopride" "positron" "VMAT" "MPH" "methylphenidate" "neurite"
    "transgenes" "rutabaga" "Costello" "Legius" "de-regulated" "GABAA" "CAMKII"
    "forebrain" "theta" "Morris" "Alcino" "homologs" "23a" "48a" "LRD" "CSRD"
    "ADHD" "low-to-normal IQs" "IQs" "IQ" "skinfold" "macules"
    "Neurofibromatosis-1" "non-neuronal" "1  +" "non-functional" "RAUL" "I:C"
    "PPXY" "ISREs" "IKKs" "-triphosphate" "retinoic acid-inducible-gene-I"
    "ISGs" "Toll-like" "Vadlamudi" "at least 24 h" "β-1" "phosohatidylinositol"
    "re-aggregation" "adherens" "deeper" "Koya" "Hooijkaas" "monotherapy"
    "immunotherapy" "therapywere" "Biopsies" "anti-tumoral" "priori"
    "trastuzumab-refractory
CD44 + CD24 −/low mesenchymal immunophenotypes"
    "immunophenotypes" "inherent unresponsiveness" "unresponsiveness"
    "the CD44 + CD24 −/low mesenchymal immunophenotype"
    "CD44 + CD24 −/low mesenchymal subpopulations" "ontogeny" "immunophenotype"
    "HER1/2" "≈10-fold" "μmol/L" "the Neve's" "Neve" "Adai" "initio"
    "mono-HER1" "mono-HER2" "APDC" "phagein" "Greek" "refractoriness" "CD44 +"
    "Non-transduced" "chromatids" "a statistically significant re-localization"
    "∼53%" "≥10" "∼58%" "TIN" "p300ΔHAT" "TRFH" "GAR" "co-stained" "ΔHAT"
    "TTAGGG" "ation" "anti-acetylated" "the embryonic mammary gland anlagen"
    "CNNA2" "Birchmeier" "Klaus" "Klemm" "Wong" "Martensson" "Lugli" "Geyer"
    "Marotta" "Lehmann" "Sinai" "Chicago" "shGFP" "shHMGA2" "non-TN" "BTL10"
    "Micci" "homepage" "Krum" "MCF7-10b" "MA-11" "Latimer" "ICG-0001"
    "Cellagen" "non-synchronized" "shHmga2" "WZA" "Emami" "GADPH" "WRE"
    "eightfold" "NMG-10b" "NMG" "Tessari" "Martino" "MSA" "qt"
    "embryo mammary placodes" "placodes" "Teissedre" "Lac" "Gyorffy" "ISH"
    "Lustig" "Ohio" "∼15%" "Tamimi" "the embryonic mouse mammary gland anlagen"
    "Zhou" "Fedele" "Fusco" "Rogalla" "Chiappetta" "Peluso" "Carboni" "Miranda"
    "Polyak" "Cowin" "the mammary anlagen" "Veltmaat" "anlagen" "Nusse"
    "Khramtsov" "Carey" "The triple-negative breast cancer (TNBC) subtype"
    "ERBB2/HER2/neu" "normal breast-like" "Sorlie" "Perou" "Banerji" "Filho"
    "Reis" "Weigelt" "p = 0.045" "p = 0.047" "= 0.37" "S- and" "−9" "HER2 +"
    "ER +" "HER2/neu" "KYM" "HbA1c" "rs3818292" "A1c" "genotypes/haplotypes"
    "HNF" "LXRα" "protein-1c" "orthologs" "genotype/haplotype" "Dyslipidemia"
    "= 0" "non-histone" "Tarnow" "normals" "CREA" "FBG" "RIRI" "lambda" "axial"
    "endocrinology" "PDR" "≤5" "fibro" "PTEF" "IL6•sIL-6Rα" "non-target"
    "hSOCS 3" "bioplex" "hSOCS3" "membrane bound IL-6Rα" "WCE" "phopho"
    "postburn" "reactant" "particular Crohn’s" "IL-6•sIL-6Rα" "sIL-6Rα"
    "IL-6Rα" "Xl" "procollagen" "IL-6•sIL-6R" "uveal" "MB1589" "MB1823" "2/13"
    "33/56" "35/56" "11/21" "39/49" "Biomax" "siCtBP1" "co-repressor"
    "a transcriptional co-repressor" "Carboxyl" "=20" "9p21" "deubiquitylases"
    "MPD37" "HLI98" "SJ-172550" "non-genotoxic" "thewebsite"
    "17-allylamino-17-demethoxygeldanamycin" "methanesulphonate (MMS)"
    "methanesulphonate" "NSC207895" "benzofuroxan" "Wahl" "radioresistance"
    "3SA" "the subsequent biological sequelae" "sequelae"
    "a human tumour-associated MDM2 SNP" "Tumour-associated SNPs" "Kaposi's"
    "mir" "Casein kinase 1α" "Hetero" "HDMXL" "antitumour" "BakY108A"
    "campothecin" "HT1080" "phospho3" "phospho1S→A" "EILSRRPSYR" "RRSSL"
    "RRASL" "IASD" "iodoacetyl" "hBak" "wtBak" "α 3–" "amphipathic helices"
    "-helices" "IEF" "10 min" "non-essential" "24 h" "α 3" "Non-activated"
    "-aminoacid" "aminoacid" "hotspot" "FnIII" "-DTI-NH 2"
    "the photo-activatable residue para -azido-Phe" "-azido-Phe" "holo" "IR485"
    "-ectodomain" "invariant" "A-chain" "EDDM" "facie" "the resultant EDDMs"
    "EDDMs" "83-14" "the longer peptide αCT" "L1–CR–L2–" "–αCT" "FnIII-1"
    "L1–CR–L2" "multidomain" "ectodomains" "FnIII-2" "protomer" "interchain"
    "B-chain" "αCT" "Alzheimer’s" "= 11" "P = 0.001" "-14" "insulin/IGF-I"
    "Cav-1–V5-His" "AG1204" "Akti1/2" "effecter" "dehydrogense" "AdCa-" "AdCt-"
    "Cavsh11G" "Cavsh11" "AdCav-1" "AdCt" "AdRSV" "AdCa" "NCsi" "NCsiRNA"
    "LRP6si" "Cavsi" "tumor-adjacent benign prostate epithelia"
    "phosphofructose" "LRPs" "3 H" "pT3" "pT2" "written" "nocodozole"
    "Adenomatous polyposis coli" "Darby" "Madin" "-deoxyuridine" "Faux" "KHG"
    "shRNA1" "re-introduction" "villus" "viv" "TOPflash" "67NR"
    "significantly less motile" "motile" "4T07" "~70%" "KINOMEscan" "Jak3A572V"
    "Jak2K539L" "Profiler" "fluorimeter" "ZsGreen" "HEK-V617F-STAT-Rep" "A572V"
    "CP690,550" "CYT387" "JI1" "erythroleukaemia" "outs" "AT9283"
    "essential thrombocythemia (ET)" "vera (PV)" "thrombocythemia" "vera"
    "Philadelphia" "—Jak2V617F" "Jak2V617F" "CEP701" "= 4"
    "anti-phospho-histone" "≥5cm" "pleura"
    "H 2 O 2 induced PARP1 auto-modification" "histotype"
    "their relative peritumoural mesothelium" "patho" "Chemoresistance"
    "sensitizers" "polyADP" "CO-338" "sarcomatoid" "epithelioid"
    "peritumoural mesothelium" "anti-tumour" "× g" "Edinburgh" "David" "pharma"
    "more robust clinical endpoints" "tertiles" "Dataset"
    "only three absolute D15 Ki67 responders" "20/31" "6/27"
    "absolute D15 Ki67 responders" "85.6±4.1%" "primary biological endpoint"
    "immunohistochemistry (IHC)" "letrozole/everolimus" "letrozole/placebo"
    "-GS" "GS" "= 0.09" "p = 0.07" "p = 0.05" "p = 0.34" "p = 0.038"
    "p = 0.0002" "≤0.05" "Anti-proliferative" "p = 0.02" "= 0.07" "IEG"
    "basic amino acid #146" "#146" "co-existed" "non-pathological" "Phyliodes"
    "-NLSP" "NLSP" "BD´s" "×g" "+FBS" "re-enter" "Co-localize" "´s" "IEGs"
    "human ductal breast carcinoma biopsies" "re-entered" "pPTEN" "E/V"
    "△21–68" "T/V" "and 3D10" "4E3" "MOI" "A-induced" "Gambia" "haemosiderin"
    "multicentric Castleman’s" "multicentric Castleman" "Castleman" "allograft"
    "Kaposin" "Kaposi’s" "Kaposi" "p = 0.009" "Anti-Flag" "∼25%" "FGFRIIIb"
    "FGFR2IIIc" "rs1047100" "selectively target TICs" "BT5" "∼8%" "∼60%"
    "immunohistology" "SMA +" "SMA+" "lentiviral shFGFR2"
    "the lentiviral shFGFR2" "NOD/SCID" "shFGFR2" "shNT"
    "the lentiviral shFGFR2s" "shFGFR2s" "non-TIC" "precursor-like"
    "Approximately 16 mammospheres" "mammospheres" "mammosphere" "non-CD29"
    "FGFR2+" "PyMT" "heterogeneous progenies" "progenies" "TEBs" "non-TICs"
    "TICs" "TIC" "∼66%" "stem-like" "thatit" "thePI" "Cytoscape" "WM"
    "UltraLink" "tocontribute" "ITD" "Flt" "Co-transfection" "Co-localization"
    "Trinko" "several alternatively spliced forms designated OBRa" "Minogue"
    "extracellular signal-regulated kinase 1/2" "OBRb" "OBRf" "hace"
    "co-morbidities" "immunocytochemistry" "OBRa" "pulposus" "3 h" "4/5"
    "pre-treated hAPBTs" "hAPBT" "begun" "phallodin" "RIA/EIA" "RIA" "IP26"
    "isotype" "hAPBTs" "previously using anti-TCR" "Licor" "Imager" "anti-TCR"
    "non-adherent" "non-enzymatic" "co-stimulatory" "non-catalytic" "approx"
    "Chalmers" "Cultrone" "1,25-Dihydroxyvitamin D3" "Gaschott" "Rickard"
    "continuum" "MAPkinases" "further gauge AP-1 co-activation" "co-activation"
    "UDCA" "isovalerate" "valerate" "isobutyrate" "succinate" "HT-29/AP-1"
    "a Pearson's" "Bifidobacteria" "Actinobacteria" "the intestinal microbiota"
    "many bacterial phyla" "Bacteroidetes" "MetaHIT" "metagenome" "fecal"
    "phyla" "using another colonic reporter cell line Caco-2/AP-1"
    "Caco-2/AP-1" "IECs" "misbalance" "specifcities" "subfamilies" "IEC"
    "actetate" "microbiota" "E-Box" "chemoreristancce" "NNKAOc"
    "Such NNK-associated adducts" "pobG" "butyl" "bulky DNA adducts" "CL-13"
    "CL" "organoid" "PNECs" "minimal atypia" "dysplasias" "Ascl1-" "Ascl"
    "indeces" "H441/Ascl1" "CometScore" "TriTek"
    "the chemically active metabolite NNKOAc" "nitrosamnine" "NNKOAc" "Clara"
    "BEAS-2B/MMP-7" "DMS53" "Ascl1 in" "pathobiology" "alkylguanine"
    "methylnitros" "BOA" "premalignat" "non-NE" "E-box" "homologue-1"
    "Achaete-scute" "homolog-1" "neuroendocrine" "scute" "p = 0.047" "sceen"
    "low grade, and endometrioid histologic subtype" "Apert" "genearrays"
    "aaS252W" "OncoMap" "non-endometrioid" "Methodology/Principal" "Chan"
    "shorter DFS" "AJCC" "Zheng" "IDC" "p  = 0.039" "p  = 0.003" "p  = 0.009"
    "= 4" "1±" "Scarff-Bloom-Richardson" "ß1" "es" "siExo" "linescan" "α5"
    "tubulo" "cytoB" "cavin" "mRFP" "re-insertion" "hairpin-like" "redirects"
    "re-adhesion" "TIRF" "subtitutions" "Dmel" "furiosus" "Pyrococcus"
    "RAD51-delta-ex9" "decresead" "pArg150Gln" "chordate" "tunicate" "lancelet"
    "tetrapods" "seven intronic SNPs" "creat" "larger Asian" "race/ethnicity"
    "−135G" "racial/ethnic" "Latina" "rs1801320" ".896+33"
    "site located three bp" "algorithms" "MaxEntScan’s" "entropy" "MaxEntScan"
    "NNSplice" "logit  " "BCFR" "dsDNA" "ssDNA-" "Finnish" "rarer" "PolyPhen-2"
    "= 5" "PolyPhen2" "miR-23b/27b" "P3-ML" "PC3-ML" "antagomiR" "ALVA31"
    "antagomiRs" "MiR-23b/-27b" "CRPC" "miR-27b" "MiR-23b" "micrometastases"
    "miR-23b/-27b" "-27b" "miR-23b" "cells/well" "IIA" "thatCyld" "fromCyld"
    "andCyld" "IGF-1-induced" "K8R" "inCyld" "CLYD" "phosphoinositol" "+ 1"
    "5× 10" "D/S" "non-ubiquitinated" "Talalay" "Chou" "Riva" "=60" "=29"
    "N=31" "nearly every lymphoma histology" "the dual inhibitor BGT226" "=6"
    "Hodgkin" "Burkitt" "histologies" "BGT226" "P=0.009" "P=0.0005" "P=0.01"
    "=0.14" "P=0.03" "-9" "N=3" "non-silencing" "=31" "mmol/L" "IC50" "SPSS"
    "WI" "Mirus" "Sunnyvale" "96-microwell-white-plates" "York" "Rochester"
    "Nunc" "Nalge" "Matrox" "Sangon" "Rockford" "LightShift" "μg" "Rockville"
    "Sweden" "Amersham" "nonfat" "TBS" "rpm" "RIPA" "Placentia" "SYBR"
    "Carlsbad" "Corbett" "ProTech" "PROtech" "REzol" "disodium" "PNPP"
    "Hsinchu" "FIRDI" "pinnatifida" "Billerica" "Millipore" "Merck"
    "Dulbecco’s" "GIBCO/BRL" "Maryland" "anthraquinone" "Tsai" "XL"
    "fucothanxin" "anti-inflammation" "sulfhydryl"
    "predominantly platinum-DNA adducts" "adducts" "Taiwan"
    "the major non-provitamin" "Pinnatifida" "Undaria" "Cisplain" "carboxyl"
    "Pakl" "using Spearman's" "intraepithelial neoplastic epithelium" "= 17"
    "P = 0.009" "≥2" "Estrada" "Martinez" "-KTS" "and 3D" "Sybergreen"
    "endpoint" "–KTS" "#8" "#7" "siWT1" "Dharmacon" "pCMV4" "GFP/WT1" "KTS"
    "E12/E47" "Transwell" "siWT" "non-targeting" "VTP" "HVT" "Congo"
    "rs11091253TT" "rs3024944G" "rs3024944C/C" "rs11091253 CT" "wallis"
    "P=0.007" "CGG" "rs7925112" "rs56356146" "rs3024941"
    "the homozygous ss491228441TT genotypes"
    "the heterozygous genotype ss491228441TG" "ss491228441TG" "SNPper" "SNPS"
    "ss491228440" "- 163C" "- 163T" "Genotype" "Ndounga" "rs324015"
    "lumbricoides" "Ascaris" "rs324013" "Dogon" "haematobium" "Gabonese"
    "enterophathy" "polyendocrinophathy" "Saharan" "rs11091253CT" "rs11091253"
    "ss491228441G" "ss491228441TT" "ss491228441" "rs3024944C" "rs3024944"
    "Congolese" "falciparum" "P=0.05" "P=0.003" "G/A" "P =0.003" "DiGeorge"
    "omodysplasia" "13p32" "1.16–1.48" "rs2228638" "rs2388896" "haplogroups"
    "the pleiotropic 12q24 risk haplotype" "Noonan's" "Noonan"
    "the associated SNPs" "celiac" "around rs11065987" "only one SNP"
    "only two SNPs" "rs233722" "covariate" "codings" "rs7982677" "GenABEL"
    "EIGENSOFT" "rs11065987" "QQ" "EMIM" "multisystem" "13q32" "12q24" "Fallot"
    "Tetralogy" "∼1%" "MetSeek" "Cationic geratin microspheres" "microspheres"
    "geratin" "Meth" "diet-derived flavonoids" "flavonoids" "pM" "Y1234/35"
    "Grab2" "DN30" "Genentech" "AMG102" "Amgen" "xeno" "dormancy" "CD8+" "Jyg"
    "NK4-like" "anti-invasive" "Matri" "gallbladder" "pyroglutamate"
    "bronchiolo" "prostaglandins" "cytoplasma" "both soft agar" "Tcf"
    "Giordano" "MLE10" "mesenchyme" "bio" "dimmer" "Kd" "Bottaro" "hepato"
    "oncologists" "mid-1990s" "mid-1980s" "Anti-tumor" "co-cultured"
    "anti-inflammatory" "immunoglobulin-like" "GFP/mutant" "TOPFlash" "Axins"
    "glycogen synthase kinase-3β"
    "the scaffolding proteins adenomatous polyposis coli (APC)" "coli (APC)"
    "Endometrioid" "histopathology" "Sox" "P = 0.003" "P = 0.045" "P = 0.038"
    "P =0.038" "Dulbecco" "anoxia" "Raheja" "desferrioxamine" "non-activated"
    "RhoGTPases" "normoxic hMSCs" "Activ" "TransAM" "CN01" "MIP-3β" "SDF-1α"
    "normoxic hMSC" "cells/cm 2" "TCDs" "the normoxic hMSCs" "chemoattractants"
    "'stemness'" "hMSCs" "hMSC" "re-plated" "100 ng/mL" "RKG"
    "the virological synapse" "a virological synapse" "coculture" "Anti-HIV-1"
    "Supernatants" "PHA" "anti-HIV" "ΔD2" "Indianapolis" "anti-HIV-1"
    "EGF-like" "chemoattractant" "Slit2N" "20 μg/ml" "16 h" "× 10" "TPA"
    "SKHep" "ɛ" "H3S10" "~2.3" "proteome" "IE" "MSK1/2" "kinase-1/2" "H3S28p"
    "H3S10p" "remodelers" "1/2" "oropharynx" "to 14-3-3" "p53DD" "BBCs"
    "at least five molecular subtypes" "BBC" "p = 0.04" "Non-transformed"
    "Basal-like" "basal-like" "~2%" "~1%" "eQTLs" "rs752092"
    "the publicly available expression quantitative trait locus (eQTL) database GHS"
    "GHS" "GLAUGEN" "ANZRAG" "rs9938149" "1.29–1.68" "rs7044529" "rs4894535"
    "rs2721051" "MAGENTA" "CEU" "Utah" "VEGAS" "OAG" "Kong" "Hong" "Malay"
    "rs930847" "rs2034809" "QIMR" "Queensland" "AVGR8" "BATS" "haplotypes"
    "POAG" "= 1.4–1.88" "ng/μl" "HumanHap610" "1.2 × 10" "1.04 × 10" "1 × 10"
    "= 2.7" "= 1.4" "5 × 10" "IGF-1-independent" "stepwise" "p= 0.06" "p=0.2"
    "cold-induced BAT" "cold-activated BAT" "DXA" "nervosa (AN)" "nervosa"
    "anorexia" "BAT" "= 0.55" "=0.5" "=0.1" "p=0.6" "p= 0.01" "≤ 0.05" "YI"
    "HN" "Camidge" "SNP polymorphism" "Zhang" "9p23-24.1" "9p23-p24.1"
    "5p15.33" "7p11.2" "adenocarcnomas" "9p" "17q25.1" "16p13.3" "8q24.21"
    "7p21.1" "±7.90" "±7.46" "lity" "instabi" "13q14.2" "9p23-24.1 ( PTPRD )"
    "9p21.3" "1p34.3" "allelotypes" "a characteristic histology" "20/95"
    "=0.004" "P =0.05" "10q23" "6p21" "non-small" "17q" "17q12" "_3334delCAAG"
    "_84delTG" "Three distinct pathogenic mutations c" "non-conservative"
    "Uhrhammer" "co-occurrence" "GV" "still no co-segregation" "co-segregation"
    "Easton" "America" "Latin" "Austria" "Netherlands" "Norway" "haplotype"
    "Microsatellite" "Northern Africa" "non-Jewish" "Tazzite" "Algerians"
    "Finland" "medullar histology" "Penetrance" "6/19" "1/10" "UVs"
    "premature stop codon" "a premature stop codon" "3450-01BA" "3371-01A"
    "Dutch" "OC" "the Grand Casablanca" "ASR" "overtaken" "Rabat" "Casablanca"
    "France" "Mauritania" "Libya" "Algeria" "Eastern Africa" "Africa" "GVGD"
    "_799delTT" "Moroccan" "95 % CI" "9/10" "+1" "HER2/ neu" "co-occurring"
    "co-occurred" "c3018C" "CCLE" "VTX-11e" "e" "VTX" "theGI" "shLuc" "GI"
    "RIGER" "shRFP" "doublings" "gatekeeper" "anastomose" "supernatents"
    "co-cultures" "Mitra" "singnificant" "Venn" "~33,000" "secretome" "quant"
    "βig-h3" "nanoLC-MS/MS" "nanoLC" "SDF" "nano" "nanoLC-MS"
    "the respective secretomes" "retrovirus" "immunosorbant" "lumens" "cytodex"
    "Bissel’s" "three-dimensional ECMs" "cellular co-cultures" "ECMs" "Bissel"
    "Harlan" "the medial layer de-differentiate" "de-differentiate" "proteomes"
    "High angiogenic fibroblast supernatants" "secretomes" "stem cell-like"
    "Cleveland" "Precocious aberrant mitoses" "G 1 -4N" "P16INKA4A"
    "pseudogene" "pseudogene-1" "OCT4B1"
    "the pluripotency self-renewal transcription factor OCT4A" "re-entering"
    "polyploid" "pCHK2" "Yamanaka" "Banito" "hereon" "senescense" "OCT4A"
    "repaired DNA entered mitoses" "mitoses" "AURORA" "karyosol"
    "re-evaluation" "SIFT" "Iowa" "NTG" "non-synonymous" "Levina" "KIT +"
    "CD44/CD90" "CD44+/CD90+/cytokeratin+" "CD44+/CD90+" "Herpel" "alveoli"
    "SCCL" "cytopenias" "0.2±0.1-fold" "1.0±0.1-fold" "CD90+"
    "CD117+/cytokeratin+" "10/20" "cytokeratin+/CD117+" "percent CD117+"
    "UCI95 " "LCI95 " "UCI" "Ki-67+" "KIT+" "CD117+" "photomicrographs" "NL"
    "followup" "cytokeratin+" "CD90" "neg" "readouts" "the unique subset" "MPE"
    "p = 0.08" "p = 0.01" "Stem/progenitor" "p = 0.001" "CD133+" "CD44+" "= 17"
    "= 0.01" "stem/progenitor" "G0/G1" "recognition/repair" "Sce" "MRN"
    "Karamouzis" "200 μg/mL" "primer/probe" "12/16" "S1981" "co-activators"
    "PRTE" "nt" "NCBI" "underlain" "eIF4E-" "eIF" "inase" "nositide" "hospho"
    "immunoglobulins" "supernatant" "TOP-like" "intra-" "1.5 h" "Papidus"
    "expression/function" "CTG" "CACCTG" "C/G" "h" "estrogen/ER" "Dillner"
    "δEF1" "12 h" "a definite co-action" "simpler" "Nantong" "gastrectomy"
    "mucosa" "N-category" "chemo-" "auto-antibodies" "= 0.37" "= 0.55"
    "non-tumors" "five-year" "the diagnostic biopsy" "mastectomy" "13 q"
    "Tumorscape" "ploidy" "CGH/SNP" "to 14q32.2" "Waddell" "discriminant"
    "Bergonie" "Curie" "heatmap" "Hochberg" "Benjamini" "situ" "Stanford"
    "nucleates" "Knudson" "14q" "13q" "Human610" "low/no"
    "intensity/expression" "1.12–3.77" "clinico" "Walczak" "microsatellite"
    "p = 0.003" "5- year" "employed split-ubiquitin Y2H" "cobalamin" "Quadros"
    "ERGIC" "reuptake" "Fjorback" "Yeung" "HDFs" "HDF" "MTDC" "Jäger" "Mukerji"
    "lysis" "dileucine" "proteolipid" "Wakana" "ER/Golgi" "Clontech" "largeT"
    "pDHB1" "topologies" "DUALhunter" "9/mortalin" "acetyllactosaminide"
    "VSIG4" "CYB5B" "Ost4p" "classical Y2H" "CD4 + T cells" "ophthalmology"
    "approximately 30 hr" "colony-like" "Ω*cm 2" "wk" "*cm 2" "cotransport"
    "α3" "Na/K" "ionic" "around 30 hr" "HCEnC-21T cells" "70-year-old"
    "non-transduced" "21M+hTERT" "even early-passage primary HCEnCs"
    "21-year-old" "non-proliferative" "Subpopulations" "Fuchs"
    "uniform and functional corneal endothelial monolayers" "Descemets"
    "ectoderm" "HCEn" "HCEnT" "these uniform and hexagonal HCEnCs" "HCEnC"
    "corneal edema" "edema" "HCEnCs" "P = 0.04" "fibroblast-like" "BCOR"
    "regulome" "subnetworks" "interconnectivities" "STRING" "transcriptome"
    "siGAPDH" "NCI" "UMPS" "Hartwell" "refold" "reestablish" "p53+" "72 h"
    "#151623" "Kraft" "the previously implicated SNPs" "non-smoking"
    "SOX9 cause campomelic dysplasia" "the respiratory epithelium" "Andersen"
    "Intergenic SNPs" "the newly associated SNPs" "intergenic SNPs"
    "the three genome-wide significant SNPs" "QUANTO"
    "the genome-wide significant SNPs" "the biological underpinnings"
    "discrepant" "underpinnings" "lymphoblastoid"
    "novel genome-wide significant SNPs" "GlaxoSmithKline" "Oxford" "1.28×10"
    "rs11654749" "The most significant SNP" "1.25×10" "1×10" "5×10" "HTF"
    "a previously implicated AGER SNP" "INT" "4.35×10" "rs7764819"
    "Our next most statistically significant SNP" "rs1435867"
    "the previously implicated SNP" "rs7594321" "nonsignificant" "INT  "
    "5.00×10" "the most significant SNP" "≤1.09" "gc" "residuals" "FVC" "ARMC2"
    "SpiroMeta" "JMA " "pack-years" "JMA" "/FVC" "P  = 0.59" "= 0.27"
    "caspase-like" "Rip-like" "cryosections" "George" "imidazole" "pyridinyl"
    "perineurium" "axonal regrowth" "regrowth" "epiperineurium" "endoneurium"
    "−ir" "ir" "SFI" "Axon" "axons" "sevenmaker" "Myers" "MKKK" "G-ratio"
    "axon" "± 0.9" "p38β" "the Egger's" "Ezzidi" "Tunisia" "Indians" "Nagi"
    "Taiwanese" "T2D" "Mexican" "The Egger's" "The Begg's" "Begg's" "Begg"
    "5G/5G + 4G/5G" "5G/5G" "4G/4G" "4G/5G" "STATA" "insertion/deletion"
    "monomeric and dimeric sHEL" "dimeric sHEL" "monomeric sHEL" "MD4"
    "gluteraldehyde" "sHEL" "TCRζ" "Kcat" "0.5 s" "0.05 s" "Bruton's"
    "guaninine" "Bruton" "~3.3" "/s" "~0.01" "monomeric BCRs" "pITAMs"
    "the antigen-bound BCRs" "microclusters" "antigen-bound BCRs"
    "microcluster" "The monomeric antigens"
    "containing one or two antigen-bound BCRs" "surface-bound antigens"
    "soluble antigens"
    "soluble monomeric and dimeric hen egg lysozyme (HEL) antigens"
    "the cubic subvolume" "nearest" "subvolumes" "subvolume" "Gillespie" "κB"
    "IgHEL" "a peptidic antigen" "soluble multimeric antigens"
    "monomeric antigens" "BCRs" "1 +" "IC 50" "Wnt/β" "proteingp120"
    "ritonovir" "histomorphometry" "molpNPP" "pDkk1" "pControl" "RLU" "pBAR"
    "Osteoblasts" "docitaxol" "12h" "pNPP" "Van Buchem's" "Buchem" "imperfecta"
    "naïve" "osteopenia" "Disord" "Musculoskelet" "p=0.001" "p=0.0002"
    "non-specific" "Kranenburg" "BHK" "Roy" "progestin" "Sasai" "Engelman" "#3"
    "K-Ras#26" "#26" "Y14F" "GEDF" "Kras26" "Immuno" "Kras 26" "Caco" "SOS"
    "pcDNA3" "non–B cells" "NZW" "NZB" "B-1a" "anti-TNP" "trinitrophenyl"
    "immunoglobulin" "auto-reactive" "antihistone" "urea" "≥100" "CD4+ T cells"
    "9G4-positive" "idiotype" "9G4" "a shorter lifespan" "ELISA" "ELISpot"
    "CD4+T cells" "active GN" "antihistone/anti-dsDNA" "isotypes"
    "glomerulonephritis (GN)" "GN" "glomerulonephritis" "anti-dsDNA"
    "antichromatin" "antigens" "Sle3" "~30%" "=15" "P = 0.01" "μ l" "μ g/ml"
    "target/regulator" "endometrioid" "0.01uM" "EC50s" "72h" "SPEC-1S"
    "UPR/GRP78" "endometrium" "IC50s" "0 +" "HER2+" "vessel-like" "Spain"
    "Salamanca" "Pandiella" "and 3+" "oestrogen" "VM" "= 10" "= 0.004"
    "= 0.003" "Rad27p" "kb/min" "prokaryotes" "deoxyuridine" "UAF1del" "ATAD"
    "∼4%" "DNA damage–induced ssDNA" "ssDNA" "subcategories" "spatio"
    "loading/unloading" "Elg1p" "RFC-like" "Okazaki" "replicon" "anti–human"
    "16 h" "destablizes" "B56γ" "Prives" "auto-degradation" "non-redundant"
    "myocardium" "the PKA-treated C0C2" "GSK3β-treated C0C2" "C0C2" "ISHD"
    "IDCM" "Bardswell" "M-domain" "the cardiac-specific M-domain" "cMyBP"
    "Tomasz" "Jimor" "3-year" "Hutter" "TNBC" "BPBC" "Suris" "Eliis" "Elston"
    "atypia" "Bednarek" "PTNM" "+ + +" "+ +" "F-statistics" "interactomes"
    "pallium" "IFNy" "non-pathogenic" "the comprehensive readout"
    "a global overview" "a transcriptional co-regulator" "log2-ratios"
    "log2-ratio" "F-measurement" "samplings" "HIPPIE" "binary classifiers"
    "classifiers" "QiSampler" "≥0.6" "probeset" "HD506" "geneID" "Wilcoxon"
    "diploid" "pBTM" "ActMat" "a quantitative readout" "readout" "LUMIER"
    "intERactome" "polyQ" "cause Huntington’s" "Huntington" "binary PPIs"
    "PPIs" "unspecific Y2H" "Y2H" "PPI" "∼3.5" "= 0.05" "= 0.25" "AHREs"
    "AHRR-" "TiPARP-" "TiPARP" "co-treatment" "Auto-" "coregulators" "CHX-"
    "pre-treated wildtype" "ADPF" "orTiparp" "Gapdh" "Ahrr" "andTiparp" "Ahr"
    "vi" "luc" "chTiPARP" "mTiparp" "auto-ribosylation" "oligo"
    "auto-modification" "auto-" "AHRR" "AHRE" "CCCH" "sirtuins" "HYE"
    "mono-ADP-ribosyltransferase" "inTiparp" "Tiparp"
    "an inducible FAK kinase-inactive knockin" "C57Bl/6" "peritoneum"
    "replicates" "wildtype (WT)" "Scr" "Frozen" "H&E" "the ovarian bursa"
    "the bursa-associated mesothelium" "mesothelium" "&E" "knockin" "TGCA"
    "C57Bl6" "TAE" "Novartis" "PF-271" "Pfizer" "bursa" "ID8" "logrank"
    "8q24.3" "xl" "stabilization/accumulation" "transcription/expression"
    "apoptotic cell death/cell survival" "t-BHQ+Etoposide"
    "detoxification/cytoprotection" "fragmentation/cell survival" "etopside"
    "pGL2b-1.565" "pcDNA" "caspase3/7" "caspases3/7" "Caspases 3/7"
    "Bcl-xLMT-ARE-F1-LUC" "Bcl-xL1.565-WT-LUC" "AREF" "Bcl-xL-1.565-MT-LUC"
    "Bcl-xL-ARE-F1-LUC" "Bcl-xL-1.565WT-LUC" "specificantibody"
    "heterologouspromoter" "8-16h" "caspases 3/7" "forestomach"
    "oxidoreductase-1" "GCS" "glutamylcysteine" "BHQ" "mean ± SD" "re-probed"
    "C2C12-GLUT4myc" "SOL" "PAS" "2DG" "∼55%" "∼100%" "AMPK α2-KD" "quadriceps"
    "uncoupler" "2peak" "o" "FWHM" "confocal fluorescence immunohistochemistry"
    "the oxidative soleus" "gastrocnemius" "Cs" "longus" "digitorum" "soleus"
    "∼20%" "g/mL" "1 ±" "= 0.1" "esophagectomy" "classical Sanger dideoxy"
    "dideoxy" "GAC" "non-small-cell" "10 min" "Mtf2/Pcl2" "residual H3K36"
    "poised/repressed" "peaks/domains" "‘bivalent’ mononucleosomes"
    "previously described ‘poised’ bi-" "bi-" "promoters/nucleosomes" "Co-IP"
    "the previously identified H3K36" "an aromatic H3K36" "co-existence"
    "sequential re-ChIP" "pvalue" "HOXB8" "2–3" "CoIP" "H3K37" "Co-IPs"
    "antiparallel" "a unique H3K36" "the previously reported H3K36"
    "global H3K36" "mononucleosomes" "H3K36"
    "isothermal titration calorimetry (ITC)" "calorimetry (ITC)" "ITC"
    "calorimetry" "homeodomain (PHD)" "co-exist" "polycomblike" "2.2e–16"
    "germiline" "socio" "other actionable oncogene mutations/translocations"
    "mutations/translocations" "6q23–25.42" "15q25" "15q25.1" "confounders"
    "p=0.039" "29/45" "22/97" "this genotype’s" "131/230" "45/101"
    "an actionable oncogene genotype" "Kirsten" "and 3/19" "1/5" "22/53"
    "98/230" "17/155" "27/127" "ethnic SNPs" "Egger's" "Egger" "VS.G" "Steven"
    "both crude and adjusted ORs" "Genotypic ORs" "1.10–1.18" "Jiang" "CNKI"
    "ISI" "1.10–1.59" "GG" "GA" "Genotypes" "Campa" "Stacey" "Africans" "ORs"
    "rs2046210" "= 1.14" "= 1.17" "P  = 0.003" "= 25" "95% CI  "
    "expression/transactivation" "Munoz" "FBCs" "Kidwai" "Noman"
    "anti-hormonal" "FBC" "MBCs" "MBC" "T2-4" "P = 0.001" "P  = 0.001" "Xaa"
    "PXaan" "phosphopeptide" "GROMACS" "the representative conformer"
    "conformer" "conformers" "1F8A" "HSQC" "SerPro" "alpha-helix" "ROESY"
    "TOCSY" "pS87" "RMSD" "nanoseconds" "pBcl-2" "Bcl-2/S87A" "Bcl-2/T56A"
    "phosphopeptides" "Peptidylprolyl" "peptidylprolyl" "isomers" "mircoRNA"
    "Univariate" "167/248" "MiHA" "Ashraf" "Sirtuins" "Sirtuin"
    "Western Europe" "Europe" "Meier" "Kaplan" "sirtuin" "≥5 cm" "= 0.004"
    "tenoposide" "tranducer" "Akt/"
    "vehicle-treated mice administered PC-3M-MM2 cells and 2.2±0.9" "±0.9"
    "imager" "Xenogen" "gavage" "vehicle-treated cells averaged ∼43%" "TaqMan"
    "oncomir" "to∼31.9%" "Boyden" "/G 1 phase" "MTS" "lucine"
    "agonist/antagonist" "growth factor-1" "gallate" "epigallactocatechin"
    "anti-tumor" "si" "∼43%" "∼35%" "∼50%" "4-week" "10 min" "TMPSS2" "Angele"
    "Chk1/2" "shCon" "shATR" "siCon" "siATR" "siATM" "intraneoplasia (PIN)"
    "intraneoplasia" "breakpoints" "ETV" "anti-phospho-Histone" "non-treated"
    "FASAY" "10/24" "stage/grade" "pTaG1-2" "BladderCIT" "Artus" "Mongiat"
    "ORa " "Briant" "Haenszel" "11/336" "pT1G2" "pTaG2" "pTaG1" "Louis" "IGR"
    "Foch" "Henri" "Ouerhani" "Lamy" "Lindgren" "Zieger" "Hernandez" "pT1G3"
    "pT2-4" "propria" "muscularis" "T1G3" "Ta" "= 0.41" "95% CI " "p  = 0.05"
    "=  0" "p  = 0.001" "= 0.49" "= 0.12" "= 0" "= 0.0001" "= 0.25" "envolve"
    "cyclohexamide" "Caohuy" "GRE" "g/ml" "cellswere" "ENaC's" "ENaC"
    "ΔF508-CFTR" "noveltargets" "inpatients" "ROMK" "deferens" "vas" "n  = 3"
    "24 h" "48 h" "an immature and hyperproliferative lung epithelium"
    "paracrine" "non-cancerous" "non-tumor" "similarly treated p38 α F/F"
    "-dichlorodihydrofluorescein" "dichlorodihydrofluorescein" "superoxides"
    "p38α Δhep" "p38 αΔ hep" "Δ hep" "myofibroblast-like" "hepatectomy"
    "Non-cancerous" "×10" "re-expression" "follicle" "≤48"
    "Prophylactic oophorectomy" "pg/mL" "p =0.01" "p =0.03" "nAChR"
    "acethylcholine" "48h" "xL" "24h" "HPDE6-c7" "oxidases" "non-smokers"
    "methylnitrosamine" "oncology" "CSE/NNK" "autophagic vacuoles" "vacuoles"
    "Bcl" "NNK" "butanone" "pyridyl" "methylnitrosamino" "Non-specific"
    "nmol/L" "TAp73α" "Alfa" "TAp73β" "Genomatix" "TFBIND" "p73+/−"
    "present atrophic choroid plexuses" "plexuses" "choroid" "phonotypes"
    "diseasedue" "TAp73" "ΔNp73" "Parkinson" "Niemann" "neuroAIDS"
    "neurobiology" "LJG" "transdominant" "conductance" "megachannel" "pCB6+"
    "pCB+" "Co-expression" "pCB6" "mt" "subG1" "-c" "c" "-b" "Δψm"
    "transfectants" "CRL2614" "transwell" "tetrazolium" "pcDNA 3.1" "μg/mL"
    "WST-1" "IRIF" "p400dead" "fluorophore" "control cells around DSB" "AsiSI"
    "FK2" "RG37" "Sequence-specific DSB" "OHTam" "a unique DSB" "Hoechst"
    "Arrayscan" "brighter" "melanogaster" "cerevisiae" "nucleosomes around DSB"
    "undergoes" "chromatin decompaction around DNA DSBs" "around DSBs" "ΔN"
    "5 B" "hemostasis/thrombosis" "•sIL-6R" "VI" "smaller thrombi"
    "littermates" "F/F" "eYFP" "Tg" "deletant" "Δ/" "arterioles" "cremaster"
    "significantly smaller thrombi" "thrombi" "μg/ml" "G-quartet" "dyn/cm 2"
    "ml/min" "Ibα" "~50%" "WHI" "diphosphate" "non-transcriptional" "thrombus"
    "transducers" "β 1" "C57BL/6J" "pSTAT3" "anti-human" "phosphoryates"
    "phosphorylation/dephosphorylation" "nuclear/cytosolic" "~20%" "α1DN"
    "~ 4-fold" "droplets" "~4-fold" "Renilla" "ribotide (AICAR)" "ribotide"
    "element binding protein-1c" "alcoholic fatty liver goes" "goes" "Xu-5-P"
    "ethanol-fed" "DeCarli" "Lieber" "protein phosphatase 2A" "μL" "to 100"
    "the most significant SNPs" "rs10911205" "the most significant tagSNP"
    "tagSNP" "20q13.33" "The most significant SNPs" "1q31" "CCDN2" "rs3217901"
    "rs59336" "Tokyo" "The most statistically significant SNP" "rs3217810"
    "12p13" "rs10911251" "rs11903757" "the previously identified GWAS SNPs"
    "12q24.21" "1q25.3" "rs4939827" "rs16892766" "= 0" "genfitinib" "1B3"
    "cyst-like" "transfectant" "MycHisA" "FACScan" "3A2" "1B1MycHisA"
    "absorbance" "ErbB" "HNSCC" "Co-Immunoprecipitation" "pcDNA3.1" "WASP"
    "T-lymphoblasts" "activation/inactivation" "CD81-ΔCyt" "broader" "ΔCyt"
    "Förster" "the nonhydrolyzable GTP analogue GTP-γS" "GTP-γS"
    "glycophosphatidylinositol (GPI)" "glycophosphatidylinositol" "lamella"
    "CD81-" "CD" "fluorophores" "Choi" "TIRFM" "coli" "microdomains"
    "encephalomyelitis" "antitetraspanin" "microdomain" "× 10" "UCSC" "PLINK"
    "LocusZoom" "IntOGen" "Haploview" "Browser" "GTEx" "EIGENSTRAT" "dbGaP"
    "CGEMS" "mach2dat" "at 5q31.1" "rs961253" "=0" "bp" "hydroxyacid" "20p12.3"
    "rs6596201" "homeodomain" "5q31.1" "TRANSFAC" "Korean" "rs1665650" "Asian-"
    "Europeans" "CCFR" "GECCO" "=1.17" "12p13.32" "RSQ" "rs4779584" "rs6983267"
    "KCPS" "JPT" "HapMap" "algorithm" "HumanOmniExpress" "BeadChip" "Korea"
    "ACCC" "rs647161" "rs2423279" "rs10774214" "Asian" "95% CIs" "n = 3"
    "P = 0.05" "P -values" "Quanto" "BCAS3" "the renal proximal tubules"
    "Warburg" "PKRL" "subnetwork" "urate concentration–associated SNPs" "URLs"
    "eSNP" "eSNPs" "eQTL"
    "genome-wide significant urate concentration–associated SNPs" "Japanese"
    "African" "Americans" "non-European" "glomeruli" "FEUA"
    "the replicated urate concentration–associated SNPs" "Rheumatology"
    "the urate concentration–associated SNPs" "2,538,056 autosomal SNPs"
    "associated SNPs" "genome-wide significant and suggestive SNPs"
    "X-chromosomal" "additional urate concentration–associated SNPs" "NHGRI"
    "the genome-wide significant index SNPs" "ATXN2"
    "independently associated SNPs" "the 2,450,547 investigated autosomal SNPs"
    "mg/dl" "overview" "hyperuricemia" "tubules" "GUGC" "P -value" "= 3"
    "= 1.9" "≥0.05" "homolog" "the Crohn’s" "Crohn" "non-autophagy"
    "reconstitutedAtg16l1" "DKO" "ULK" "ATG16L1ΔFBD" "ΔFBD" "Δ229–242" "Δ4"
    "co-precipitate" "inAtg3" "E3-like" "phagophore" "bilayer" "200 μg/ml"
    "pCDNA3.1" "using high-grade serous histology" "Multivariate" "= 0.0001"
    "covariates" "Wildtype" "Jewish" "Ashkenazi" "high-grade serous histology"
    "neoadjuvant" "oophorectomy" "salpingo" "=0.0001" "58/70" "15/37" "BROCA"
    "tubal" "p = 0.001" "p = 0.01" "p = 0.003" "Sirt1expression" "Posovszky"
    "Kurihara" "Bonferroni" "co-transfection" "phosphosite" "Luc" "FHRE" "EV-"
    "HEK293R" "pg/ml" "EV" "MVNP" "Paget’s" "Paget" "S/T" "Lipofectamine 2000"
    "Dunnett" "cytometer" "LSRII" "Dickson" "Becton"
    "the last 16 hours co-treated" "co-treated" "_254607" "shSkp2" "_372105"
    "_410220" "V3THS" "shp27-5" "shp27-1" "GIBCO" "DMEM" "strep" "MEM" "OPTI"
    "Hernando" "ATCC" "Lightcycler" "°C/sec" "Sypro" "LightCycler" "μg/μl" "μl"
    "SDS/PAGE" "IVT" "16h" "Bioproducts" "Roche" "Ryan" "Aldrich" "Biochem"
    "Boston" "Promega" "Cruz" "phosphoThr" "Covance" "Invitrogen" "_005983"
    "Biosystems" "TRIPZ" "RHS4740-NM" "_004064" "NYUMC" "Pagano" "Tanimoto"
    "MolCart" "Lipinski’s" "Lipinski" "drug-like" "Waals" "der" "Carlo (BPMC)"
    "BPMC" "Carlo" "Monte" "the crystallographic structure PDB 2ast" "PDB 2ast"
    "co-crystal" "pharmacophore" "non-specifically" "proteins/enzymes"
    "shEmpty" "plasmon" "rhodanine" "UM-C2a" "R-group" "PubChem"
    "Secondary bioassays" "bioassays" "Corp" "ChemBridge" "Diego" "Jolla"
    "Molsoft" "PocketFinder" "counterscreens" "Inc" "isopeptide" "silico"
    "gain/amplification" "Pham" "recurrence/distant" "30/34" "68/99" "Feng"
    "10q23.3" "Asano" "undergone" "p = 0.03" "derepresses" "synaptic AMPARs"
    "AMPARs" "Pcdh" "Pcdhs" "co-endocytosis" "Arcadlin" "non-clustered" "δ2"
    "synaptic re-distribution" "mEPSCs" "Ni" "interactome" "synaptoneurosomes"
    "synaptoneurosome" "pulldown" "egion" "roteasome" "DeMartino" "CaMKIIα"
    "hippocampi" "Ubl" "6-hours" "mEPSC" "nontarget" "EPSCs" "neighboring GFP+"
    "random X-inactivation" "GFP/" "Nurr77" "KO" "excitatory synapses"
    "synapses" "minute-2" "Factor-2" "synapse" "Enhancer" "p38 MAPK"
    "co-authors" "RJW" "ARV" "KTC" "Washington" "Virginia" "ZZ" "DEW" "JRS"
    "XW" "demonstrated both the suggestive P-values" "IRB" "GENEVA" "CIDR"
    "non-Appalachian" "non-Appalachia" "ADMTS3" "10E-5" "the dental papilla"
    "papilla" "rs1383934" "dentin" "rs4251631" "rs17057381" "pulpitis"
    "at least one SNP" "P-values " "suggestive P-values" "P-values" "P-value"
    "P-value " "DFS" "DMFT" "COHRA" "DRDR2" "DRDR1" "ARIC" "HPFS" "AMELX"
    "NHANES" "edentulism" "GWA" "= 3" "Achatz" "Isabel" "Maria" "Amanda"
    "lifespan" "new pathogenic CNVs" "smaller CNVs" "Shlien" "=0.0002"
    "CNVs/genome" "dbVar" "DGV" "genotype-" "contributant" "pH" "arisen"
    "Southern Brazil" "Brazil" "CNVs" "CNV" "penetrant" "~3-fold" "Bonadona"
    "CIMBA" "penetrances" "approximately 100 modifier SNPs" "polypectomy"
    "U-shapes" "Henry" "gastroscopy" "10-year" "malecarriers" "U-shaped"
    "p=0.8" "USA" "the proband's" "proband" "HRs" "non-carriers" "probands"
    "Canada" "Zealand" "Australia" "Australasia" "penetrance" "ureter"
    "mismatches" "p= 0.03" "=0.8" "p=0.01" "=0.9" "SNP309T" "nasopharynx"
    "Chompret" "leukemia/lymphoma" "aneuploid" "R306X" "Exome" "Sanger" "codon"
    "frameshift" "OMIM" "hypodiploid" "hyperdiploid" "PBSCT" "Fraumeni" "Li"
    "exome" "chemo" "silencing/absence" "BZ" "knockdown/inhibition"
    "-1H-benzimidazole-4-carboxamide" "3,4-dihydro-5" "acetamide"
    "dimethylamino" "DPQ" "butoxy" "piperindinyl" "polymerase-1"
    "non-catalytic subunit" "anti-Flag" "3xFlag" "botulinum" "helices" "Phyre"
    "x" "HExxH" "SprT" "Pol κ" "Pol ζ" "PAK4/MMP-2" "PAK4/" "PAK4si-" "∼32.5%"
    "GID" "biotin" "∼70%" "WB" "ANB" "MMP-2si" "sub/G 1 phase" "MMP2si" "Adh"
    "monolayers" "polychemo" "PAK4si" "parenchyma" "=10" "∼30%" "co-IP"
    "Co-immunoprecipitation" "FdUrd" "responders" "FdUTP" "FUTP" "Intra"
    "re-induction" "re-appearance" "sublines" "Ugi" "oligodeoxynucleotide"
    "drawn" "-methylene" "methylene" "RTX" "-fluorodeoxyuridylate"
    "fluorodeoxyuridylate" "FdUMP" "co-localizes" "co-transfected" "DTB"
    "mitochondrial function/dynamics" "multifunctional organelles" "organelles"
    "Co-immunostaining" "G 1 /S" "Jung" "Perhaps" "Dong" "Sirigu" "Bartkova"
    "Alonso" "clearer" "Kaufmann" " S2j" "DDS/p53" "Weinberg" "Hanahan"
    "Haferkamp" "Vredeveld" "Gorgoulis" "senesce" "× 10" "Schwann" "stemness"
    " 10" "relatedness" "MIV" "oci" "elomere-" "elomere" "pCHEK2" "VGPs" "MGC"
    "Gershenwald" "Krausz" "Mooi" "BCN" "Nalabothula" "Chehab" "Figure S1"
    "subclasses" "Clark" "VGP" "IARC" "Soo" "Bandyopadhyay" "Sviderskaya"
    "Kiyono" "Anders" "Lange" "Jacobs" "Medema" "Vugt" " S1" "Passos" "Fagagna"
    "Adda" "Baird" "Schopfer" "et al" "Molven" " al" "Bennett" "commonest"
    "Sedivy" "Herbig" "Serrano" "Collado" "DePinho" "Artandi" "synergisms"
    "synergism" "CompuSyn" "SIRTs" "subclass-" "PXD-101" "PXD"
    "a separate subclass" "subclass" "homologies" "chemoresistant" "dFdC"
    "-difluorodeoxycytidine" "difluorodeoxycytidine" "cell death/apoptosis"
    "Tubastatin" "IIa" "DSBs" "neuro" "Yang" "p38MAPK"
    "increased viral load/infectivity" "Nath" "Alzheimer's" "Alzheimer"
    "56.3±7.5%" "70.1±8.5%" "supernatants" "psycho" "BBB" "CNS" "HAART"
    "inhibitors/siRNA" "/pathways" "undertaken" "American" "15q11-q13" "Willi"
    "Prader" "melanocortin" "Acetylcholine" "acetylcholine" "rs8040868"
    "rs579459" "Naitza" "Schnabel" "DFNB31" "Framingham" "conservedSNP"
    "rs12075" "chemokine receptor/reservoir" "∼10%" "Duffy" "Lowe" "Langerhans"
    "proprotein" "Kosrae" "intron" "Melatonin" "melatonin"
    "The common nonsynonymous SNP rs1056513" "= 2.7E-08" "accelerometer"
    "libitum" "to 1.0E-09" "An intronic SNP" "A nonsynonymous SNP" "rs1056513"
    "one-year" "Anthropometry" "pleiotropy" "European" "German" "French"
    "GIANT" "pathophysiology" "an intronic SNP" "a nonsynonymous SNP" "ABO"
    "anthropometry" "genotype" "Infinium" "Illumina" "GWAS" "FAMILIA" "VIVA"
    "comorbidities" "Mean ± SD" "= 0.05" "= 2.7" "= 3" "non-metastatic"
    "subculture" "invasion/metastasis" "shATM" "control/DNA repair"
    "Superarray" "Pearson" "genotypes" "genomes" "TUM" "soft agar" "clone-2"
    "clone-1" "α6- integrin" "α6-integrin" "stellate" "Ca1d" "neoT" "benzo"
    "184B5" "mammoplasty" "184A1" "elangiectasia" "taxia" "endometriod"
    "MCF10A-2" "MCF10A-1" "non-malignant" "spindle-like" "intraqstrand" "SULT"
    "chemoresistance" "NF-κB1" "chelate" "OHS-401" "LY2294002" "NFκBIA"
    "siTCRP1" "siMT1X" "Tca8113/TCRP1" "ASO3" "Spearman’s" "+++" "++"
    "detoxifier" "NFκB1" "chaperones/heat" "Lipofectamine2000" "pAU"
    "co-immunoprecpitation" "OHS" "OSSC" "Genebank" "pingyangmycin" "Tca/PYM"
    "anti-apoptotic" "P  = 0.01" "anti-cancer" "BMI" "N-stage" "Gleason" "hoc"
    "T2DM" "cystectomy" "= 10" "CC" "mesenchymal/endothelial" "resp"
    "coworkers" "Jacob" "osteoblasts" "Semi" "collagens" "semi"
    "subpopulations" "BD" "7-day" "antigen" "RGD" "MOMC" "MOMCs" "β  1"
    "P = 0.03" "comorbid" "mellitus" "dyslipidemia" "RhoA"
    "human abdominal aortic aneurysm" "human aortic aneurysms" "zymography"
    "− / −mice" "IIID" "IIIC" "IIIA" "deoxynucleotidyl" "straighter" "thinner"
    "Verhoeff" "Aneurysms" "Daugherty" "aortic aneurysms" "aneurysms"
    "phospho-AKT/total" "adventitia" "intima" "ie" "TAA" "aortic aneurysm"
    "AngII" "Aortic aneurysm" "aneurysm" "circuitry" "HER2/"
    "anti-proliferative" "hetero-" "hetero" "agar" "ca.10-fold" "dataset"
    "miScript" "UTRs" "pre-miR-196a" "TargetScan" "Taqman" "Pre"
    "hsa-miR-135a2" "hsa-miR-615-3p" "non-coding" "easier" "FFPE" "yang" "yin"
    "poorer" "monoamine" "glia" "chromosome 17q" "more reliable endpoints"
    "HR: 0.320" "DARPP32/STAT5A" "HR: 0.198" "HR: 0.480" "HR: 0.341"
    "HR: 0.431" "total/subtotal" "biopsy" "CCRT" "DARPP32/STAT5B"
    "DARPP32/STAT3" "DARPP32/STAT1" "52/128" "24/133" "non-informative"
    "Whitney" "non-glioblastomas" "DARPP32/STAT" "mean±SD" "DARPP32 / STAT"
    "the eight available NNBT" "NNBT" "DARPP32/" "Spearman" "bivariate" "17q21"
    "2q32" "Horta" "Pimenta" "Dar" "Belkhiri" "DARPP" "Moskaluk" "Beckler"
    "the neuronal subtype" "ctivators" "ransducers" "ignal" "proneural subtype"
    "astroglia" "subtypes" "the mesenchymal subtype" "subtype" "gone" "Wald"
    "chemoradiotherapy" "95 % CI" "= 0.55" "N  = 3" "= 10" "p  = 0.001"
    "p  = 0.003" "deoxyribo" "triphosphate" "LX" "eosin" "Immunohistochemistry"
    "conclud" "Marx" "perhaps" "Liu" "Begnami" "Mizutani" "Silva" "Barros"
    "Hofman" "Chung" "Hsu" "polysomy" "0/1+" "multicenter" "Kim" "0+" "≥ 5"
    "5-year" "3+" "1+" "Borrmann" "an intestinal type histology" "2+" "IHC"
    "neuroglioblastomas" "univariate" "Lauren" "overexpression/amplification"
    "p=0.70" "p=0.003" "a longer PFS" "=0.59" "p=0.045" "=0.55" "=0.31" "=0.12"
    "p=0.05" "p=0.047" "=0.34" "a significantly longer PFS"
    "a shorter median PFS" "p=1.00" "=1.00" "p=0.09" "p=0.08" "21/44" "17/24"
    "16/24" "a numerically shorter DMFS" "=0.70" "DMFS" "3.2-4.2" "95%CI"
    "95% CI" "PFS" "=0.003" "6/16" "=0.08" "6/138" "=0.045" "10/56"
    "biopsy/tissue" "=0.05" "subanalyses" "=0.047" "_1799GT" "exons" "12/152"
    "partial/complete" "multivariate" "=0.001" "=0.01" "p=0.07" "=0.6" "=0.09"
    "p=0.04" "p=0.03" "HER2 internal initiation codons" "codons" "underdoes"
    "co-localized" "ZDOCK" "DTSSP" "EBNA293" "sheddases" "p185HER2"
    "Heceptin/Trastuzumab" "neuroleukin (NLK)" "neuroleukin"
    "functions/activities" "glycolysis/gluconeogenesis" "Phosphoglucose"
    "Herceptin/Trastuzumab" "constitutively active form p95HER2" "p95HER2"
    "ectodomain" "PCA" "Hynes" "Kojima" "endpoints" "n=3" "anti-tumorigenic"
    "pmTOR" "~54%" "Cribriform" "cribriform" "pleomorphism" "epithelium"
    "dual specificity tyrosine-threonine/PI-3 phosphatase MMAC/PTEN"
    "MMAC/PTEN" "GSK3α/β" "FOXO3α" "acetylation/deacetylation" "LC3 II" "LC3II"
    "CytoID" "TUNEL" "SIRT" "C42B cells" "mol/L" "mg/kg" "-trihydroxystilbene"
    "trihydroxystilbene" "iv" "iii" "ii" "multigene" "ortholog"
    "Non-tumorigenic" "=3" "non-tumorigenic" "1–3" "intra" "re-localization"
    "its sub-cellular re-localization" "proven" "tighter" "4K→A" "eCFP"
    "F507S/P692R" "phenotypes/properties" "weakest"
    "a naturally occurring single nucleotide polymorphism (SNP)"
    "polymorphism (SNP)" "UBM1" "°C" "UBM2" "chosen" "C635A/C638A" "polη–ι"
    "non-covalent" "UBMs" "polκ" "polζ" "replicate" "Polη" "Y-family" "polι"
    "polη" "polη-ι" "UBZ" "co-localization" "co-localize" "∼3-fold" "∼40%"
    "mulitcenter" "Santonocito" "SNPs" "UVC" "Caucasians" "Asians" "SNP"
    "polymorphism" "the epidemiological datasets" "datasets" "metastudies"
    "erroneous DNA processing/synthesis" "processing/synthesis" "DSBR"
    "polymorphisms" "coencide" "naphtalimide" "Godon" "Mortusewicz" "Khamisy"
    "El" "initiators" "macrodomain" "ribose (PAR)" "ribose" "re-location"
    "helix" "URL" "UVA" "BER/SSBR" "Multiprotein" "Parlanti" "Heale"
    "large BER proficient multiprotein" "enhancer" "PhosphoSitePlus"
    "resonsance" "multimers" "Cuneo" "Lévy" "PARBM" "III-like" "VIII-like"
    "nth" "nei" "Uniprot" "19q13.3–13.3" "Ensembl" "kilobases" "reinsert" "bi"
    "hydroxyl" "oxygens" "nitrogens" "-Adenosyl" "Adenosyl"
    "associated multiprotein" "AP-endonuclase" "AP" "chromatid" "UV"
    "disease/cancer" "multiprotein" "SSBR" "multi" "ESI-MS" "NPM/B23"
    "Cdc25B/C" "genome" "DSB" "ubiquitnates" "topology" "greatest" "UbcH1" "HA"
    "de-novo" "XTT" "idodide" "the G2/M phase only 20–24 hrs" "HU" "pre" "Gy"
    "approximately 2 hrs" "hrs" "hr" "CHX"
    "N-Acetyl-leu-leu-norleucinal (ALLN)" "degron" "APC/C" "Zhu"
    "polyubiqiuitin" "RNF20/40" "missense" "Germline" "stabiles" "G1/S"
    "aphidicholin" "-UTR" "UTR" "FACS" "Methoxyestradiol" "methoxyestradiol"
    "anti-metastatic" "Vousden" "mtp53" "b" "Flores" "Fukushima" "monolayer"
    "NeuT" "cell migration/invasion" "non-invasive" "TAp63γ" "TAp63α" "ΔNp63γ"
    "ΔNp63" "shp63" "non-transformed" "ΔNp63α-mediated"
    "human invasive breast cancer biopsies" "hyper"
    "the online microarray database Oncomine" "Oncomine" "greater" "p63α"
    "Hs-578T cells" "Affymetrix" "epithelia" "AEC" "dysplasia" "β1" "biopsies"
    "pY654-β-catenin/p-Smad2" "pY654-β-catenin/HIF1α/Src" "Tag2" "Casanovas"
    "pY654-β-catenin/HIF1α" "aminophenyl" "p" "®-catenin" "non-transfected"
    "non-phosphorylated" "AECTs" "little mesenchymal marker Fn" "wt" "pY654"
    "pY654-β-catenin/" "HIF1α/pY654-β-catenin" "virtually all pY654-β-catenin"
    "immuno" "co-precipitated" "frozen" "vivo" "ex" "-1α" "Fn"
    "pY654-β-catenin" "hypoxia-inducible factor-1α" "enteroendocrine"
    "adenylyl" "trafficking/exocytosis" "sustained/amplification" "~40%"
    "recruitment/mobilization" "sustained/second" "amplifying/sustained"
    "phosphorylation/activation" "PD03" "to 1.0" "=3.1" "ML-141" "pPAK/PAK"
    "/total" "non-diabetic" "recruitment/accumulation" "Cdc42→PAK1"
    "produced/activated" "MEK1/2→ERK1/2" "type 2 diabetic donors lack ~80%"
    "~80%" "Patel" "Kang’s" "Kang" "TCGA" "Genome" "p=0.02" "et" "Bouwman"
    "=0.07" "=0.03" "offs" "≤30%" "subsets" "=0.02" "=0.04" "subset"
    "serous histology" "histology" "aneuploidy" "interstrand" "transducer"
    "BRCA1/2" "BRCA1 /2" "wildtype" "germline" "immunohistochemistry" "PARPi"
    "non-homologous"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-9001-9300*
  '(("CK20−" . SPARSER::PROTEIN)
    ("primary TNCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokeratins and p63" . SPARSER::COLLECTION)
    ("gross cystic disease fluid protein and mammaglobin"
     . SPARSER::COLLECTION)
    ("protein and mammaglobin" . SPARSER::COLLECTION)
    ("an ER-associated gene" . SPARSER::GENE) ("PBC" . SPARSER::PROTEIN)
    ("squamous metaplastic components" . SPARSER::COMPONENT)
    ("either tamoxifen or an aromatase inhibitor" . SPARSER::COLLECTION)
    ("tamoxifen or an aromatase inhibitor" . SPARSER::COLLECTION)
    ("adriamycin" . SPARSER::DRUG) ("TNC" . SPARSER::PROTEIN)
    ("PBCs and MBCs" . SPARSER::COLLECTION)
    ("osseous metaplastic components" . SPARSER::COMPONENT)
    ("TNCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PBCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stromal GATA3" . SPARSER::PROTEIN)
    ("-2, and luminal" . SPARSER::COLLECTION) ("CK20" . SPARSER::PROTEIN)
    ("CK7" . SPARSER::PROTEIN) ("separate isoforms" . SPARSER::ISOFORM)
    ("p21 and FMN2" . SPARSER::COLLECTION)
    ("Skp2 and PA28γ" . SPARSER::COLLECTION)
    ("Skp2 or PA28γ" . SPARSER::COLLECTION)
    ("p14ARF-p53" . SPARSER::COLLECTION)
    ("E2F1 and NF-κB" . SPARSER::COLLECTION)
    ("both an activator and a repressor of transcription"
     . SPARSER::COLLECTION)
    ("ATR/ATM" . SPARSER::COLLECTION) ("separate forms" . SPARSER::FORM)
    ("fmn2" . SPARSER::PROTEIN) ("meiotic" . SPARSER::DRUG)
    ("formin" . SPARSER::PROTEIN) ("Formins" . SPARSER::PROTEIN)
    ("formins" . SPARSER::PROTEIN) ("FMN2 and p21" . SPARSER::COLLECTION)
    ("exogenous FMN2" . SPARSER::PROTEIN) ("protein " . SPARSER::PROTEIN)
    ("exogenous protein" . SPARSER::PROTEIN)
    ("PA28γ and SKP2" . SPARSER::COLLECTION)
    ("SKP2 and FMN2" . SPARSER::COLLECTION)
    ("the proteasome-associated protein PA28γ ( xref ; xref ) and p21 E3 ligase SKP2 ( xref )"
     . SPARSER::COLLECTION)
    ("the proteasome-associated protein PA28γ" . SPARSER::PROTEIN)
    ("Hdm2, puma, and DR5" . SPARSER::COLLECTION)
    ("puma and DR5" . SPARSER::COLLECTION)
    ("p53 or Hdm2" . SPARSER::COLLECTION) ("v-SRC" . SPARSER::COLLECTION)
    ("anti-RelA and anti-AcH3" . SPARSER::COLLECTION)
    ("both E2F1 and NF-κB/RelA" . SPARSER::COLLECTION)
    ("both FMN2 protein ( xref B) and mRNA ( xref C and xref )"
     . SPARSER::COLLECTION)
    ("AcH" . SPARSER::PROTEIN) ("NF-κB/RelA" . SPARSER::COLLECTION)
    ("ARF and NF-κB" . SPARSER::COLLECTION)
    ("this 200 bp minimal fragment" . SPARSER::FRAGMENT)
    ("B–3" . SPARSER::PROTEIN) ("mCherry-N1" . SPARSER::COLLECTION)
    ("p14ARF or p53" . SPARSER::COLLECTION)
    ("NPM1 and fibrillarin (FBL)" . SPARSER::COLLECTION)
    ("other nucleolar proteins" . SPARSER::PROTEIN)
    ("NPM1 and fibrillarin" . SPARSER::COLLECTION) ("FBL" . SPARSER::PROTEIN)
    ("fibrillarin" . SPARSER::PROTEIN) ("NARF-E6" . SPARSER::COLLECTION)
    ("E6 continually targets p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NARF2" . SPARSER::PROTEIN) ("NARF2-E6" . SPARSER::COLLECTION)
    ("IPTG" . SPARSER::MOLECULE) ("NARF" . SPARSER::PROTEIN)
    ("Nucleolar Proteins" . SPARSER::PROTEIN)
    ("the nucleolar proteins" . SPARSER::PROTEIN) ("rRNAs" . SPARSER::RNA)
    ("p53 and ARF" . SPARSER::COLLECTION)
    ("puma and noxa" . SPARSER::COLLECTION) ("noxa" . SPARSER::PROTEIN)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hdm2/Mdm2" . SPARSER::COLLECTION)
    ("NF-κB and E2F1" . SPARSER::COLLECTION)
    ("hypoxia, and DNA " . SPARSER::COLLECTION) ("DNA " . SPARSER::DNA)
    ("Formin" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("PA28γ" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("p21 Protein" . SPARSER::PROTEIN) ("5B" . SPARSER::PROTEIN)
    ("S6D" . SPARSER::PROTEIN) ("FMN2 " . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("FMN2" . SPARSER::PROTEIN) ("YY" . SPARSER::MOLECULE)
    ("194Arg/Trp and 399Arg/Gln" . SPARSER::COLLECTION)
    ("194Arg/Trp" . SPARSER::PROTEIN) ("399Arg/Gln" . SPARSER::PROTEIN)
    ("XRCC1-399Arg/Gln" . SPARSER::PROTEIN-PAIR)
    ("XRCC1-194Arg/Trp" . SPARSER::PROTEIN-PAIR)
    ("Arg/Arg" . SPARSER::COLLECTION) ("Trp/Trp" . SPARSER::COLLECTION)
    ("Arg/Trp" . SPARSER::COLLECTION) ("gene and skin" . SPARSER::COLLECTION)
    ("XRCC1 ( 194 Trp/Trp ) and XRCC1 ( 399 Gln/Gln )" . SPARSER::COLLECTION)
    ("relevant XRCC1 alleles" . SPARSER::ALLELE) ("loco" . SPARSER::PROTEIN)
    ("NPC" . SPARSER::MOLECULE) ("X-ray repair" . SPARSER::PROTEIN)
    ("DP" . SPARSER::PROTEIN) ("GK" . SPARSER::PROTEIN)
    ("a robust biomarker" . SPARSER::MOLECULE)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("HER1/HER4" . SPARSER::COLLECTION)
    ("EGFR and HER4" . SPARSER::COLLECTION)
    ("EGFR/RAS/MAPK" . SPARSER::COLLECTION) ("EREG/AREG" . SPARSER::COLLECTION)
    ("increased tumoural mRNA" . SPARSER::PROTEIN)
    ("NRAS, PIK3CA or KRAS" . SPARSER::COLLECTION)
    ("The only complex genotype" . SPARSER::PROTEIN)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("KRAS, BRAF or PIK3CA" . SPARSER::COLLECTION) ("CG" . SPARSER::PROTEIN)
    ("High EREG tumoural mRNA" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("EGF, TGFa and EGFR" . SPARSER::COLLECTION)
    ("AREG and EREG" . SPARSER::COLLECTION)
    ("BRAF genes and high AREG" . SPARSER::COLLECTION)
    ("the 2-sided p" . SPARSER::PROTEIN)
    ("oxaliplatin (84, 26.7%) or both agents (29, 9.2%)" . SPARSER::COLLECTION)
    ("amphiregulin (AREG)" . SPARSER::PROTEIN) ("TGFa" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN)
    ("additional predictive biomarkers" . SPARSER::MOLECULE)
    ("moAbs" . SPARSER::DRUG) ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("a typical oncogene" . SPARSER::ONCOGENE)
    ("a chimeric IgG1 monoclonal antibody (moAb) and panitumumab"
     . SPARSER::COLLECTION)
    ("moAb" . SPARSER::DRUG)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF and codon" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and its ligands EGF"
     . SPARSER::COLLECTION)
    ("Amphiregulin (AREG) and Epiregulin (EREG)" . SPARSER::COLLECTION)
    ("EREG" . SPARSER::PROTEIN) ("Epiregulin" . SPARSER::PROTEIN)
    ("AREG" . SPARSER::PROTEIN) ("Amphiregulin" . SPARSER::PROTEIN)
    ("TGFA" . SPARSER::PROTEIN)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("SLC26A3" . SPARSER::PROTEIN) ("IGFBP2" . SPARSER::PROTEIN)
    ("CG2" . SPARSER::PROTEIN)
    ("transforming growth factor-a" . SPARSER::PROTEIN)
    ("IgG2" . SPARSER::BIO-COMPLEX) ("Ephrin A2" . SPARSER::PROTEIN)
    ("PKCζ and PSAT1" . SPARSER::COLLECTION)
    ("PKCζ and this critical metabolic enzyme" . SPARSER::COLLECTION)
    ("PHGDH and PKCζ" . SPARSER::COLLECTION)
    ("its triple mutant" . SPARSER::MUTANT)
    ("the PHGDH triple mutant" . SPARSER::MUTANT)
    ("a triple S55/T57/T78 mutant" . SPARSER::MUTANT)
    ("glycerate" . SPARSER::MOLECULE)
    ("PKCζ- or PHGDH-only" . SPARSER::COLLECTION) ("PKCζ-" . SPARSER::PROTEIN)
    ("PKCζ and either PSAT1 or PHGDH" . SPARSER::COLLECTION)
    ("PSAT1 or PHGDH" . SPARSER::COLLECTION)
    ("AMPK and JNK" . SPARSER::COLLECTION)
    ("PHGDH or PSAT1" . SPARSER::COLLECTION)
    ("serine/glycine" . SPARSER::COLLECTION)
    ("PKCζ and PHGDH" . SPARSER::COLLECTION)
    ("aminotransferases" . SPARSER::PROTEIN) ("PSPH" . SPARSER::PROTEIN)
    ("PHP" . SPARSER::PROTEIN) ("PSAT1 and PHGDH" . SPARSER::COLLECTION)
    ("serine, and glycine" . SPARSER::COLLECTION)
    ("serine-glycine" . SPARSER::COLLECTION) ("PG" . SPARSER::PROTEIN)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("aspartate or alanine" . SPARSER::COLLECTION)
    ("serine and glycine" . SPARSER::COLLECTION)
    ("PHGDH/PSAT" . SPARSER::COLLECTION) ("PSAT" . SPARSER::PROTEIN)
    ("an enhanced energetic and metabolic state" . SPARSER::BIO-STATE)
    ("AMPK/ACC" . SPARSER::COLLECTION) ("pepstatin" . SPARSER::DRUG)
    ("aPKC" . SPARSER::PROTEIN) ("subsequent media" . SPARSER::PROTEIN)
    ("the atypical PKC family" . SPARSER::PROTEIN-FAMILY)
    ("a very versatile metabolite" . SPARSER::MOLECULE)
    ("PKCζ and caspase-3" . SPARSER::COLLECTION)
    ("PHGDH and PSAT1" . SPARSER::COLLECTION) ("PHGDH" . SPARSER::PROTEIN)
    ("TiO2" . SPARSER::MOLECULE) ("titanium dioxide" . SPARSER::MOLECULE)
    ("Phosphoserine phosphatase" . SPARSER::PROTEIN)
    ("3-phosphoglycerate dehydrogenase" . SPARSER::PROTEIN)
    ("PSAT1" . SPARSER::PROTEIN) ("active kinase dimers" . SPARSER::DIMER)
    ("active kinase domain dimers" . SPARSER::DIMER)
    ("active dimers" . SPARSER::DIMER)
    ("monomers or dimers" . SPARSER::COLLECTION)
    ("anionic PIP2 lipids" . SPARSER::PROTEIN)
    ("the active kinase dimer" . SPARSER::DIMER)
    ("The anionic lipids" . SPARSER::LIPID)
    ("the inactive TM–JM–KD dimer" . SPARSER::DIMER)
    ("the inactive monomer or dimer" . SPARSER::COLLECTION)
    ("monomer or dimer" . SPARSER::COLLECTION)
    ("the active EGFR dimers" . SPARSER::DIMER)
    ("inactive and active dimers" . SPARSER::DIMER)
    ("inactive and active" . SPARSER::COLLECTION)
    ("anionic POPS lipids around EGFR" . SPARSER::PROTEIN)
    ("anionic membrane lipids" . SPARSER::PROTEIN)
    ("the active EGFR dimer" . SPARSER::DIMER)
    ("the inactive EGFR dimer" . SPARSER::DIMER) ("GOP" . SPARSER::PROTEIN)
    ("JM-B–KD" . SPARSER::COLLECTION)
    ("The symmetric kinase dimer" . SPARSER::DIMER)
    ("the rod-like asymmetric active kinase dimer" . SPARSER::DIMER)
    ("a globular kinase dimer" . SPARSER::DIMER)
    ("the inactive dimer" . SPARSER::DIMER)
    ("the symmetric dimer" . SPARSER::DIMER)
    ("the (inactive) symmetric kinase dimer" . SPARSER::DIMER)
    ("an EGFR inactive dimer" . SPARSER::DIMER)
    ("the anionic lipids" . SPARSER::LIPID)
    ("a transmembrane helix" . SPARSER::PROTEIN)
    ("near-complete EGFRs" . SPARSER::PROTEIN)
    ("complete EGFRs" . SPARSER::PROTEIN)
    ("an N-terminal transmembrane dimer and an antiparallel JM-A helix dimer"
     . SPARSER::COLLECTION)
    ("a monomeric receptor or an inactive dimer" . SPARSER::COLLECTION)
    ("an inactive dimer" . SPARSER::DIMER)
    ("a monomeric receptor" . SPARSER::RECEPTOR)
    ("an active dimer" . SPARSER::DIMER)
    ("active or inactive" . SPARSER::COLLECTION)
    ("the neutral DMPC lipids" . SPARSER::PROTEIN)
    ("the anionic POPS lipids" . SPARSER::PROTEIN)
    ("the JM-A helices and the helix dimer" . SPARSER::COLLECTION)
    ("the amphipathic JM-A helices" . SPARSER::PROTEIN)
    ("the active TM–JM-A dimer" . SPARSER::DIMER)
    ("helices" . SPARSER::PROTEIN) ("transmembrane helices" . SPARSER::PROTEIN)
    ("an inactive EGFR dimer" . SPARSER::DIMER)
    ("an active EGFR dimer" . SPARSER::DIMER)
    ("the active extracellular dimer" . SPARSER::DIMER)
    ("the 2-ligand active extracellular dimer" . SPARSER::DIMER)
    ("a left-handed N-terminal transmembrane dimer" . SPARSER::DIMER)
    ("larger inter-helix" . SPARSER::PROTEIN)
    ("resultant dimers" . SPARSER::DIMER) ("POPS" . SPARSER::MOLECULE)
    ("POPC" . SPARSER::PROTEIN)
    ("the ligand-free inactive EGFR dimer" . SPARSER::DIMER)
    ("An EGFR transmembrane helix" . SPARSER::PROTEIN)
    ("active and inactive EGFR dimers" . SPARSER::DIMER)
    ("active and inactive" . SPARSER::COLLECTION)
    ("The resultant conformation" . SPARSER::BIO-CONFORMATION)
    ("the inactive dimers" . SPARSER::DIMER)
    ("EGFR active dimers" . SPARSER::DIMER)
    ("monomeric EGFR" . SPARSER::PROTEIN) ("anionic lipids" . SPARSER::LIPID)
    ("especially anionic lipids" . SPARSER::LIPID)
    ("both the symmetric kinase dimer and EGFR monomers" . SPARSER::COLLECTION)
    ("both the symmetric kinase dimer" . SPARSER::DIMER)
    ("active dimer" . SPARSER::DIMER) ("inactive dimer" . SPARSER::DIMER)
    ("nearly full-length" . SPARSER::PROTEIN)
    ("intact EGFRs" . SPARSER::PROTEIN) ("inactive dimers" . SPARSER::DIMER)
    ("EGFRs" . SPARSER::PROTEIN) ("the active dimer" . SPARSER::DIMER)
    ("active EGFR dimers" . SPARSER::DIMER)
    ("nearly full-length receptors" . SPARSER::RECEPTOR)
    ("symmetric kinase dimer" . SPARSER::DIMER)
    ("enzymatically active (asymmetric) dimers" . SPARSER::DIMER)
    ("proteins, and EGFR" . SPARSER::COLLECTION)
    ("symmetric (inactive) kinase dimers" . SPARSER::DIMER)
    ("monomers and dimers" . SPARSER::COLLECTION) ("ErbB1" . SPARSER::PROTEIN)
    ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("flexible linkers" . SPARSER::LINKER) ("linkers" . SPARSER::LINKER)
    ("The transmembrane helix" . SPARSER::PROTEIN)
    ("the precise oligomeric state" . SPARSER::BIO-STATE)
    ("the active asymmetric dimer" . SPARSER::DIMER)
    ("a flexible linker (GGGTGGGS)" . SPARSER::LINKER)
    ("the EGF-treated full-length receptor" . SPARSER::RECEPTOR)
    ("a flexible linker" . SPARSER::LINKER)
    ("glycine, serine and threonine" . SPARSER::COLLECTION)
    ("GlySer" . SPARSER::MOLECULE)
    ("activator and receiver" . SPARSER::COLLECTION)
    ("fluorescent phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("An essential part" . SPARSER::COMPONENT)
    ("higher-order oligomers ( xref ) and negative cooperativity"
     . SPARSER::COLLECTION)
    ("active dimeric receptors" . SPARSER::PROTEIN)
    ("inactive monomers" . SPARSER::MONOMER) ("lobe" . SPARSER::PROTEIN)
    ("A single transmembrane helix" . SPARSER::PROTEIN)
    ("the transmembrane helix" . SPARSER::PROTEIN)
    ("intact EGFR" . SPARSER::PROTEIN) ("Texas-Red" . SPARSER::DRUG)
    ("triton X-100" . SPARSER::MOLECULE) ("JM-B" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ANO1 and calcium" . SPARSER::COLLECTION)
    ("FBN1 , CALD1 , MGP and MYL9" . SPARSER::COLLECTION)
    ("aggressive colon cancer" . SPARSER::PROTEIN)
    ("this aggressive type" . TYPE) ("angiomotin" . SPARSER::PROTEIN)
    ("AXL or CTGF" . SPARSER::COLLECTION)
    ("ANO1 and SQLE" . SPARSER::COLLECTION) ("Tretinoin" . SPARSER::DRUG)
    ("amiloride and doxorubicin" . SPARSER::COLLECTION)
    ("Amiloride" . SPARSER::DRUG)
    ("amiloride and tretinoin" . SPARSER::COLLECTION)
    ("Akt3, CCDC80, FBN1, FRMD6, MSRB3, MYL9, PTRF, TAGLN, TNS1, VCAN and ZEB1"
     . SPARSER::COLLECTION)
    ("TAZ-TEAD" . SPARSER::COLLECTION)
    ("TAZ, AXL and CTGF" . SPARSER::COLLECTION)
    ("95% CI = 1.626–3.116" . SPARSER::PROTEIN)
    ("AXL-CTGF" . SPARSER::COLLECTION) ("TAZ-" . SPARSER::PROTEIN)
    ("Runx2-" . SPARSER::PROTEIN) ("PPARgamma" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN) ("Axl" . SPARSER::PROTEIN)
    ("ANO1 or SQLE" . SPARSER::COLLECTION) ("SQLE" . SPARSER::PROTEIN)
    ("amiloride (a potassium sparing diuretic,) and tretinoin (all-trans retinoic acid)"
     . SPARSER::COLLECTION)
    ("connectivity map, amiloride (a potassium sparing diuretic,) and tretinoin (all-trans retinoic acid)"
     . SPARSER::COLLECTION)
    ("tretinoin" . SPARSER::DRUG) ("amiloride" . SPARSER::DRUG)
    ("Map" . SPARSER::PROTEIN)
    ("ANTXR1 , EFEMP2 , SULF1 , TAGLN , VCAN , ZEB1 and ZEB2"
     . SPARSER::COLLECTION)
    ("VCAN" . SPARSER::PROTEIN) ("TAGLN" . SPARSER::PROTEIN)
    ("TAZ-AXL-CTGF" . SPARSER::COLLECTION)
    ("TAZ, AXL or CTGF" . SPARSER::COLLECTION)
    ("AXL and CTGF" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("DOG1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CALD1" . SPARSER::PROTEIN)
    ("FERMT2" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("ACTA2" . SPARSER::PROTEIN) ("PDLIM3" . SPARSER::PROTEIN)
    ("MYL9" . SPARSER::PROTEIN) ("MSRB3" . SPARSER::PROTEIN)
    ("FRMD6" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("ANO1" . SPARSER::PROTEIN)
    ("SULF1" . SPARSER::PROTEIN) ("EFEMP2" . SPARSER::PROTEIN)
    ("ANTXR1" . SPARSER::PROTEIN) ("WWTR1" . SPARSER::PROTEIN)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION)
    ("RUNX1, TBX21 and TGFβ1" . SPARSER::COLLECTION)
    ("IL-4/STAT6" . SPARSER::COLLECTION)
    ("JAK2 and PCM1-JAK2" . SPARSER::COLLECTION)
    ("promoter, or immunomodulator" . SPARSER::COLLECTION)
    ("JAK-tyrosine kinase" . SPARSER::COLLECTION) ("KIR" . SPARSER::PROTEIN)
    ("PCM1-JAK" . SPARSER::COLLECTION)
    ("the minimal tyrosine kinase" . SPARSER::PROTEIN)
    ("ruxolitinib" . SPARSER::DRUG) ("JAK2V617F" . SPARSER::PROTEIN)
    ("methotrexate or SAHA" . SPARSER::COLLECTION)
    ("a conspicuous inflammatory component" . SPARSER::COMPONENT)
    ("significant biologic and therapeutic interest" . SPARSER::COLLECTION)
    ("SOCS2/SOCS3" . SPARSER::COLLECTION) ("pimozide" . SPARSER::DRUG)
    ("acute eosinophilic leukemia" . SPARSER::PROTEIN)
    ("leading PCM1-JAK2 targets SOCS2 and SOCS3" . SPARSER::COLLECTION)
    ("/PCM1-JAK2" . SPARSER::COLLECTION) ("CEL" . SPARSER::PROTEIN)
    ("lymphoid and myeloid" . SPARSER::COLLECTION)
    ("pendrin" . SPARSER::PROTEIN)
    ("Both SOCS2 (2 and 13 sites) and SOCS3 (10 and 9 sites)"
     . SPARSER::COLLECTION)
    ("STAT3 and STAT5A" . SPARSER::COLLECTION)
    ("erythropoietin, GM-CSF, IL10 and interferon" . SPARSER::COLLECTION)
    ("sh-PCM1-JAK2" . SPARSER::COLLECTION)
    ("leading PCM1-JAK2 target" . SPARSER::TARGET-PROTEIN)
    ("methotrexate and SAHA" . SPARSER::COLLECTION)
    ("CD86 and HLA-DR" . SPARSER::COLLECTION)
    ("lymphoid and non-lymphoid" . SPARSER::COLLECTION)
    ("angioimmunoblastic TCL" . SPARSER::PROTEIN) ("TCL" . SPARSER::PROTEIN)
    ("PCM1 or JAK2" . SPARSER::COLLECTION)
    ("PCM1 and intron" . SPARSER::COLLECTION)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SKY" . SPARSER::PROTEIN)
    ("PCM1 and JAK2" . SPARSER::COLLECTION)
    ("SOCS2 and SOCS3" . SPARSER::COLLECTION)
    ("a phenotypically diverse trio" . SPARSER::PROTEIN)
    ("recurrent fusion genes" . SPARSER::GENE)
    ("artificial fusion kinases" . SPARSER::PROTEIN)
    ("the resultant hybrid proteins" . SPARSER::PROTEIN)
    ("B-cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("SSBP2-JAK2" . SPARSER::COLLECTION) ("SEC31A-JAK2" . SPARSER::COLLECTION)
    ("RPN1-JAK2" . SPARSER::COLLECTION)
    ("PAX5/STRN3-JAK2" . SPARSER::COLLECTION)
    ("NFE2-JAK2" . SPARSER::COLLECTION) ("ETV6-JAK2" . SPARSER::COLLECTION)
    ("BCR-JAK2" . SPARSER::COLLECTION)
    ("the amino terminal band 4 .1" . SPARSER::PROTEIN)
    ("JAK-1/2/3" . SPARSER::COLLECTION)
    ("JAKs and their effectors" . SPARSER::COLLECTION)
    ("targets and JAK2" . SPARSER::COLLECTION)
    ("kinases (JAK)" . SPARSER::PROTEIN) ("CNA" . SPARSER::PROTEIN)
    ("a key T-cell developmental gene" . SPARSER::GENE)
    ("a chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("PCM1-JAK2" . SPARSER::COLLECTION) ("trio" . SPARSER::PROTEIN)
    ("TCF1" . SPARSER::PROTEIN) ("interferon-α" . SPARSER::DRUG)
    ("IL9" . SPARSER::PROTEIN) ("STAT-3" . SPARSER::PROTEIN)
    ("HS6ST2" . SPARSER::PROTEIN)
    ("heparan sulfate 6-O-sulfotransferase 2" . SPARSER::PROTEIN)
    ("TUBB6" . SPARSER::PROTEIN) ("beta 6" . SPARSER::PROTEIN)
    ("chromosome 3 open reading frame 14" . SPARSER::PROTEIN)
    ("member 4" . SPARSER::PROTEIN)
    ("solute carrier family 26" . SPARSER::PROTEIN)
    ("TMPRSS3" . SPARSER::PROTEIN)
    ("transmembrane protease, serine 3" . SPARSER::PROTEIN)
    ("SLC36A4" . SPARSER::PROTEIN) ("JAK2 inhibitor TG101348" . SPARSER::DRUG)
    ("IL13RA1" . SPARSER::PROTEIN) ("SLC26A4" . SPARSER::PROTEIN)
    ("e 6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("e 7" . SPARSER::PROTEIN-FAMILY)
    ("p35)" . SPARSER::PROTEIN) ("p31" . SPARSER::PROTEIN)
    ("pH1" . SPARSER::PROTEIN) ("TATA box binding protein" . SPARSER::PROTEIN)
    ("t-butyl" . SPARSER::MOLECULE) ("MAC-2" . SPARSER::PROTEIN)
    ("CD30" . SPARSER::PROTEIN) ("EOL-1" . SPARSER::PROTEIN)
    ("SSBP2" . SPARSER::PROTEIN) ("SEC31A" . SPARSER::PROTEIN)
    ("RPN1" . SPARSER::PROTEIN) ("STRN3" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("NFE2" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN) ("B-ALL" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("HP1α" . SPARSER::PROTEIN)
    ("band 4 .1" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("MAC-1" . SPARSER::PROTEIN) ("PCM1" . SPARSER::PROTEIN)
    ("currently approved EGFR TKIs" . SPARSER::PROTEIN)
    ("taxane or pemetrexed" . SPARSER::COLLECTION)
    ("MAP2K1/MEK1" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("neratinib, afatinib and dacomitinib" . SPARSER::COLLECTION)
    ("dacomitinib" . SPARSER::DRUG) ("afatinib" . SPARSER::DRUG)
    ("EGFR, KRAS, BRAF, NRAS, PIK3CA, MEK1 and AKT" . SPARSER::COLLECTION)
    ("EGFR (exons 19 and 21) and KRAS (exon 2)" . SPARSER::COLLECTION)
    ("REV1" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("VEGFR-2 and FGFR-2" . SPARSER::COLLECTION)
    ("semaphorin" . SPARSER::PROTEIN-FAMILY) ("IPA" . SPARSER::MOLECULE)
    ("E-cadherin and TIMP-2" . SPARSER::COLLECTION)
    ("beta-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("TIMP-2 and E-cadherin" . SPARSER::COLLECTION)
    ("AKT and FAK" . SPARSER::COLLECTION)
    ("E-cadherin and beta-catenin" . SPARSER::COLLECTION)
    ("CAV1 , COL1A and SEMA3A" . SPARSER::COLLECTION)
    ("CEACAM1 , PTGS2 , and FN1" . SPARSER::COLLECTION)
    ("IGFBP3 and CDH1" . SPARSER::COLLECTION)
    ("TIMP-2 (clusters B & F) or Ala+TIMP-2 (clusters D & E)"
     . SPARSER::COLLECTION)
    ("RECK" . SPARSER::PROTEIN) ("cystein" . SPARSER::MOLECULE)
    ("VEGFR2 and FGFR1" . SPARSER::COLLECTION)
    ("VEGF-A or FGF2" . SPARSER::COLLECTION)
    ("MMP14/MT1-MMP" . SPARSER::COLLECTION)
    ("TIMP-2 or Ala+TIMP-2" . SPARSER::COLLECTION)
    ("TIMP-2 and Ala+TIMP-2" . SPARSER::COLLECTION)
    ("MAS 5" . SPARSER::PROTEIN) ("IGFR-1" . SPARSER::PROTEIN)
    ("FGFR-2" . SPARSER::PROTEIN) ("IGFBP- 5" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("IGFBP3" . SPARSER::PROTEIN)
    ("CEACAM6" . SPARSER::PROTEIN) ("DLC-1" . SPARSER::PROTEIN)
    ("EFEMP1" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("Tissue Inhibitor of Metalloproteinase 2" . SPARSER::PROTEIN)
    ("Beclin 1 , Atg5 or Atg7" . SPARSER::COLLECTION)
    ("Atg7" . SPARSER::PROTEIN) ("cytometry and Hoechst" . SPARSER::COLLECTION)
    ("MEFs and Atg5" . SPARSER::COLLECTION)
    ("p62/SQSTM1" . SPARSER::COLLECTION) ("Atg5" . SPARSER::PROTEIN)
    ("K-Ras-" . SPARSER::PROTEIN) ("H-Ras-" . SPARSER::PROTEIN)
    ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("Ras and its effectors" . SPARSER::COLLECTION)
    ("the protein's" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase (PI3K) and Ral-GEF [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("mitogen-activated kinase (MAPK), phosphoinositide-3-kinase (PI3K) and Ral-GEF [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Atg" . SPARSER::DRUG) ("FTS" . SPARSER::PROTEIN)
    ("Salirasib" . SPARSER::DRUG) ("Ras/PI3K/mTOR" . SPARSER::COLLECTION)
    ("Rat-1" . SPARSER::PROTEIN) ("S-6" . SPARSER::PROTEIN)
    ("V-ATPase" . SPARSER::PROTEIN-FAMILY) ("bafilomycin A 1" . SPARSER::DRUG)
    ("Ral-GEF" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("Atg6" . SPARSER::PROTEIN)
    ("larger prospective cohorts" . SPARSER::MOLECULE)
    ("MBC" . SPARSER::PROTEIN) ("MBCs" . SPARSER::PROTEIN)
    ("platinum and anthracyclines" . SPARSER::COLLECTION)
    ("extracellular matrix genes, angiogenesis or lymphangiogenesis promoting"
     . SPARSER::COLLECTION)
    ("polymorphic metastasis efficiency genes" . SPARSER::GENE)
    ("longer TTP" . SPARSER::PROTEIN) ("TTR" . SPARSER::PROTEIN)
    ("bisphosphonates" . SPARSER::MOLECULE)
    ("a shorter TTP" . SPARSER::PROTEIN) ("shorter TTP" . SPARSER::PROTEIN)
    ("significantly shorter TTP" . SPARSER::PROTEIN)
    ("a longer TTP" . SPARSER::PROTEIN)
    ("trastuzumab ( P = 1.0) or lapatinib ( P = 0.11)" . SPARSER::COLLECTION)
    ("taxol or taxotere" . SPARSER::COLLECTION) ("ixabepilone" . SPARSER::DRUG)
    ("taxotere" . SPARSER::DRUG) ("FAC" . SPARSER::PROTEIN)
    ("CMF" . SPARSER::PROTEIN) ("platinum-" . SPARSER::MOLECULE)
    ("SIPA1" . SPARSER::PROTEIN) ("RRP1" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("Group A" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("genes and proteins" . SPARSER::COLLECTION)
    ("IL6 and bcl-2" . SPARSER::COLLECTION)
    ("Ras- or ErbB2-dependent" . SPARSER::COLLECTION)
    ("Ras-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ift88" . SPARSER::PROTEIN)
    ("Hsp90 and the redox regulatory proteins" . SPARSER::COLLECTION)
    ("the transcription factor Gli2" . SPARSER::PROTEIN)
    ("Gli" . SPARSER::PROTEIN) ("HEF1 and AuroraA" . SPARSER::COLLECTION)
    ("ac-α-tubulin" . SPARSER::COLLECTION) ("HDAC6-flag" . SPARSER::COLLECTION)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("Gli1, IL6 and Bcl2" . SPARSER::COLLECTION) ("patched" . SPARSER::PROTEIN)
    ("IFT88, Kif3a or Cep164" . SPARSER::COLLECTION)
    ("Kif3a" . SPARSER::PROTEIN)
    ("acetylated α-tubulin and/or IFT88" . SPARSER::COLLECTION)
    ("IFT88-shRNA" . SPARSER::COLLECTION) ("HEF1" . SPARSER::PROTEIN)
    ("von Hippel-Lindau tumor suppressor" . SPARSER::PROTEIN)
    ("HDAC-6" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("Cep164" . SPARSER::PROTEIN)
    ("CK19" . SPARSER::PROTEIN) ("Tg737" . SPARSER::PROTEIN)
    ("Nek8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFT88" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("androgen and AR" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN)
    ("its associated shelterin components TRF1, TRF2 and TIN2"
     . SPARSER::COLLECTION)
    ("TRF1, TRF2 and TIN2" . SPARSER::COLLECTION)
    ("AR, TRF2 or Rap1" . SPARSER::COLLECTION)
    ("shelterin proteins or shelterin-associated proteins"
     . SPARSER::COLLECTION)
    ("shelterin-associated proteins" . SPARSER::PROTEIN)
    ("activation-induced cytidine deaminase (AID) and ORF2 endonuclease"
     . SPARSER::COLLECTION)
    ("cytidine deaminase (AID)" . SPARSER::PROTEIN)
    ("Ku70 and Ku80" . SPARSER::COLLECTION)
    ("proteins and enzymes" . SPARSER::COLLECTION)
    ("Src-ERK" . SPARSER::COLLECTION) ("AID" . SPARSER::PROTEIN)
    ("telomere dysfunction-induced foci (TIF)" . SPARSER::PROTEIN)
    ("Casodex or MDV3100" . SPARSER::COLLECTION)
    ("a TRF1-associated protein, and RTel" . SPARSER::COLLECTION)
    ("protein, and RTel" . SPARSER::COLLECTION)
    ("guanosine" . SPARSER::MOLECULE) ("TRF2 and Rap1" . SPARSER::COLLECTION)
    ("Rap1, TRF2, and TIN2" . SPARSER::COLLECTION) ("PICh" . SPARSER::PROTEIN)
    ("a mutated DNA" . SPARSER::DNA) ("digoxigenin" . SPARSER::MOLECULE)
    ("Rap1 and TRF2" . SPARSER::COLLECTION)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AR and TIN2" . SPARSER::COLLECTION)
    ("Casodex and actinomycin D" . SPARSER::COLLECTION)
    ("Casodex and cycloheximide" . SPARSER::COLLECTION)
    ("PSA and NKX3.1" . SPARSER::COLLECTION)
    ("foci and γH2AX" . SPARSER::COLLECTION)
    ("immunofluorescent γH2AX or 53BP1 foci" . SPARSER::PROTEIN)
    ("γH2AX or 53BP1" . SPARSER::COLLECTION) ("-siRNA" . SPARSER::COLLECTION)
    ("Casodex and MDV3100" . SPARSER::COLLECTION)
    ("wild-type AR (LAPC4 cells) or mutant AR (LNCaP cells)"
     . SPARSER::COLLECTION)
    ("immunofluorescent γH2AX foci" . SPARSER::PROTEIN)
    ("a newly developed AR antagonist" . SPARSER::MOLECULE)
    ("shelterin and non-shelterin" . SPARSER::COLLECTION)
    ("AR-siRNA" . SPARSER::COLLECTION)
    ("shelterin or non-shelterin" . SPARSER::COLLECTION)
    ("XPF/ERCC1" . SPARSER::COLLECTION) ("ORC" . SPARSER::BIO-COMPLEX)
    ("XPF" . SPARSER::PROTEIN)
    ("TRF1, TRF2, Rap1, TIN2, POT1 and TPP1" . SPARSER::COLLECTION)
    ("AR and androgen" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("bicalutamide" . SPARSER::DRUG)
    ("DNA, and telomere" . SPARSER::COLLECTION)
    ("Histone 3" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("ORF2" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN)
    ("Origin Recognition Complex" . SPARSER::PROTEIN)
    ("TEN1" . SPARSER::PROTEIN) ("STN1" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|) ("SS 3" . SPARSER::PROTEIN)
    ("ligand, and MIP1-α" . SPARSER::COLLECTION) ("CTLs" . SPARSER::PROTEIN)
    ("RANTES and IP-10" . SPARSER::COLLECTION)
    ("immunosuppressive cytokine" . SPARSER::PROTEIN)
    ("complex and not" . SPARSER::COLLECTION) ("Eotaxin" . SPARSER::PROTEIN)
    ("IFN-γ ( xref ) and IFN-α (data not shown)" . SPARSER::COLLECTION)
    ("MIG" . SPARSER::PROTEIN) ("RANTES and IP10" . SPARSER::COLLECTION)
    ("significantly higher basal activated STAT1 and IFN-γ-induced pSTAT1"
     . SPARSER::COLLECTION)
    ("significantly higher basal activated STAT1" . SPARSER::PROTEIN)
    ("calreticulin" . SPARSER::PROTEIN) ("media (CM)" . SPARSER::PROTEIN)
    ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("Both SHP1 ( xref , xref ) and SHP2 ( xref )" . SPARSER::COLLECTION)
    ("SOV" . SPARSER::PROTEIN) ("PCI" . SPARSER::PROTEIN)
    ("SCC-4" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("IFN-γ-STAT1" . SPARSER::COLLECTION)
    ("chemokines, RANTES and IP10" . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN) ("HNC and STAT1" . SPARSER::COLLECTION)
    ("-1 and SHP2" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("HNC" . SPARSER::PROTEIN) ("IL-10R" . SPARSER::PROTEIN)
    ("MIP1" . SPARSER::PROTEIN) ("MIP1-α" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("CXCR3" . SPARSER::PROTEIN)
    ("STAT-1" . SPARSER::PROTEIN) ("MIP-1β" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("IL-1RA" . SPARSER::PROTEIN)
    ("HLA class I molecule" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("shp2" . SPARSER::PROTEIN) ("JAK-2" . SPARSER::PROTEIN)
    ("JAK-1" . SPARSER::PROTEIN) ("TAP2" . SPARSER::PROTEIN)
    ("NOB-1" . SPARSER::PROTEIN) ("TAP1" . SPARSER::PROTEIN)
    ("LMP2" . SPARSER::PROTEIN) ("U3" . SPARSER::PROTEIN)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IP10" . SPARSER::PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("reactive oxidants" . SPARSER::MOLECULE)
    ("the investigated gero-preventive drugs" . SPARSER::DRUG)
    ("mTOR/RP-S6" . SPARSER::COLLECTION)
    ("mTOR, 4EBP1 and RP-S6" . SPARSER::COLLECTION)
    ("phosphatases and kinases" . SPARSER::COLLECTION)
    ("γH2AX or RP-S6" . SPARSER::COLLECTION)
    ("the commercially available phospho-specific Abs" . SPARSER::PROTEIN)
    ("the gero-suppressive drugs" . SPARSER::DRUG)
    ("/RP-S6" . SPARSER::COLLECTION) ("/mTOR" . SPARSER::COLLECTION)
    ("The latter protein" . SPARSER::PROTEIN)
    ("RSV all the studied drugs" . SPARSER::DRUG)
    ("the 40S ribosomal subunit and the most downstream effector"
     . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("ATM-Ser1981" . SPARSER::PROTEIN-PAIR) ("Rh" . SPARSER::MOLECULE)
    ("the strongly fluorescent DCF" . SPARSER::PROTEIN)
    ("DCF" . SPARSER::PROTEIN) ("the respective proteins" . SPARSER::PROTEIN)
    ("RP-S6 and 4EBP1" . SPARSER::COLLECTION)
    ("RP-S6 and the eukaryotic translation initiation factor 4E-binding protein (4EBP1)"
     . SPARSER::COLLECTION)
    ("mTOR, RP-S6 and the eukaryotic translation initiation factor 4E-binding protein (4EBP1)"
     . SPARSER::COLLECTION)
    ("available phospho-specific Abs" . SPARSER::PROTEIN)
    ("γH2AX and RB-S6" . SPARSER::COLLECTION)
    ("DMSO or MeOH" . SPARSER::COLLECTION) ("MeOH" . SPARSER::MOLECULE)
    ("BRB" . SPARSER::MOLECULE)
    ("these gero-suppressive drugs" . SPARSER::DRUG)
    ("ribosomal S6 protein" . SPARSER::PROTEIN)
    ("the studied drugs led to the decrease in expression of γH2AX"
     . SPARSER::DRUG)
    ("resveratrol (RSV)" . SPARSER::PROTEIN) ("ASA" . SPARSER::PROTEIN)
    ("metformin (MF)" . SPARSER::DRUG) ("rapamycin (RAP)" . SPARSER::DRUG)
    ("berberine (BRB)" . SPARSER::MOLECULE) ("Vit" . SPARSER::PROTEIN)
    ("endogenous reactive oxidants as well as mitochondrial electrochemical potential ΔΨm"
     . SPARSER::COLLECTION)
    ("endogenous reactive oxidants" . SPARSER::MOLECULE)
    ("Abs" . SPARSER::PROTEIN) ("Ser235/236" . SPARSER::PROTEIN)
    ("DNA-protective" . SPARSER::DNA) ("kinase (ATM)" . SPARSER::KINASE)
    ("the mitogen- and nutrient-sensing signaling pathways"
     . SPARSER::COLLECTION)
    ("nonhomologous DNA-end joining (NHEJ) mechanism" . SPARSER::DNA)
    ("nonhomologous DNA-end" . SPARSER::DNA)
    ("intracellular ROS and mitochondrial trans-membrane potential ΔΨm"
     . SPARSER::COLLECTION)
    ("mTOR, RP-S6 and 4EBP1" . SPARSER::COLLECTION)
    ("vitamin D3 and aspirin" . SPARSER::COLLECTION)
    ("Potential gero-suppressive agents rapamycin" . SPARSER::DRUG)
    ("berberine" . SPARSER::MOLECULE)
    ("Ser235/236-ribosomal protein" . SPARSER::PROTEIN-PAIR)
    ("RP" . SPARSER::PROTEIN) ("ROS-" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("Ataxia Telangiectasia mutated" . SPARSER::PROTEIN)
    ("RP-S6" . SPARSER::PROTEIN) ("vitamin D3" . SPARSER::MOLECULE)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("receptors and components" . SPARSER::COLLECTION)
    ("receptors and signaling proteins" . SPARSER::COLLECTION)
    ("the secretory vesicle/plasma membrane fraction" . SPARSER::COMPONENT)
    ("receptors, G proteins," . SPARSER::PROTEIN)
    ("receptors, G proteins, and/or cytochrome b" . SPARSER::COLLECTION)
    ("using pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("juglone" . SPARSER::DRUG)
    ("H 2 O 2 and superoxide" . SPARSER::COLLECTION)
    ("superoxide or H 2 O 2" . SPARSER::COLLECTION)
    ("ferricytochrome" . SPARSER::MOLECULE)
    ("SNAP-23 (TAT-SNAP-23) or syntaxin 4 (TAT-syntaxin-4)"
     . SPARSER::COLLECTION)
    ("Pin1, and TNF" . SPARSER::COLLECTION)
    ("GM-CSF and TNF" . SPARSER::COLLECTION)
    ("TNF and PAF" . SPARSER::COLLECTION) ("PAF" . SPARSER::PROTEIN-FAMILY)
    ("the heterodimeric cytochrome b" . SPARSER::PROTEIN)
    ("gp91 phox and p22 phox" . SPARSER::COLLECTION)
    ("pro-inflammatory lipids" . SPARSER::LIPID) ("fMLF" . SPARSER::MOLECULE)
    ("Cytochrome b" . SPARSER::PROTEIN) ("B13" . SPARSER::PROTEIN)
    ("CD66b" . SPARSER::PROTEIN) ("MAPKAPK-2" . SPARSER::PROTEIN)
    ("Latrunculin A" . SPARSER::DRUG) ("syntaxin 4" . SPARSER::PROTEIN)
    ("cytochrome b" . SPARSER::PROTEIN) ("component C" . SPARSER::PROTEIN)
    ("SNAP-23" . SPARSER::PROTEIN) ("syntaxin-4" . SPARSER::PROTEIN)
    ("the S3D mutant CFL-1 and the S3A mutant CFL-1" . SPARSER::COLLECTION)
    ("H2AX and Chk1/2" . SPARSER::COLLECTION)
    ("exogenous phosphorylated cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NBS1, 53BP1, MDC1 and BRCA1" . SPARSER::COLLECTION)
    ("H2AX, Chk1, Chk2, Rad17, NBS1, BRCA1, SMC1, 53BP1, and MDC1"
     . SPARSER::COLLECTION)
    ("sequestering monomeric actin" . SPARSER::PROTEIN)
    ("CFL-1 and PLD1" . SPARSER::COLLECTION)
    ("the molecule’s" . SPARSER::MOLECULE)
    ("phosphatidylcholine (PC)" . SPARSER::MOLECULE) ("PC" . SPARSER::PROTEIN)
    ("CFL-1 and S3D" . SPARSER::COLLECTION)
    ("CFL-1 and S3A" . SPARSER::COLLECTION)
    ("vasodilator-stimulated phosphoprotein (VASP)" . SPARSER::PROTEIN)
    ("actin-associated molecules" . SPARSER::MOLECULE)
    ("p-ERM" . SPARSER::COLLECTION) ("p-VASP" . SPARSER::COLLECTION)
    ("profilin" . SPARSER::PROTEIN)
    ("Both LA (1 μM) and CB (10 μM)" . SPARSER::COLLECTION)
    ("LA and CB" . SPARSER::COLLECTION)
    ("both the S3D mutant cofilin and the S3A mutant cofilin"
     . SPARSER::COLLECTION)
    ("S3D" . SPARSER::PROTEIN)
    ("CFL-1 (S3D-cofilin) and an unphosphorylated mutant"
     . SPARSER::COLLECTION)
    ("S3A-cofilin" . SPARSER::COLLECTION) ("S3D-cofilin" . SPARSER::COLLECTION)
    ("Rad52 and Mre11" . SPARSER::COLLECTION)
    ("Ku70/Ku80" . SPARSER::COLLECTION)
    ("Nbs1 and Rad50" . SPARSER::COLLECTION)
    ("Rad50, Rad51, and BRCA1" . SPARSER::COLLECTION)
    ("CFL-1/p-CFL" . SPARSER::COLLECTION) ("DMF" . SPARSER::DRUG)
    ("p-CFL" . SPARSER::COLLECTION) ("CFL" . SPARSER::PROTEIN)
    ("exogenous wild-type CFL-1" . SPARSER::PROTEIN)
    ("CFL-1 or unphosphorylatable S3A form" . SPARSER::COLLECTION)
    ("unphosphorylatable S3A form" . SPARSER::FORM)
    ("the phosphomimetic S3D form" . SPARSER::FORM)
    ("Rad51 and Rad52" . SPARSER::COLLECTION)
    ("Ku70, Ku80 and Rad51" . SPARSER::COLLECTION)
    ("PNK/XRCC4/DNA ligase IV/XLF" . SPARSER::COLLECTION)
    ("XLF" . SPARSER::PROTEIN) ("PNK" . SPARSER::PROTEIN)
    ("artemis" . SPARSER::PROTEIN) ("PKc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad51/Rad52" . SPARSER::COLLECTION)
    ("inherent nuclease activity" . SPARSER::PROTEIN)
    ("Mre11/Rad50/Nbs1" . SPARSER::COLLECTION)
    ("CFL-1 and phosphoglycerate kinase 1" . SPARSER::COLLECTION)
    ("CFL-1 and ADF" . SPARSER::COLLECTION)
    ("muscle cofilin (CFL-2) and ADF ( xref )" . SPARSER::COLLECTION)
    ("non-muscle cofilin (CFL-1), muscle cofilin (CFL-2) and ADF ( xref )"
     . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION)
    ("Phosphorylated histone H2AX (γ-H2AX) and p53-binding protein-1 (53BP1) foci"
     . SPARSER::COLLECTION)
    ("latrunculin A (LA)" . SPARSER::DRUG) ("CB" . SPARSER::PROTEIN)
    ("proteins, S3D and S3A" . SPARSER::COLLECTION)
    ("/cofilin" . SPARSER::COLLECTION) ("SMC1" . SPARSER::PROTEIN)
    ("Rad17" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("PLD1" . SPARSER::PROTEIN) ("phospholipase D1" . SPARSER::PROTEIN)
    ("LIMK2" . SPARSER::PROTEIN) ("CFl-1" . SPARSER::PROTEIN)
    ("vasodilator-stimulated phosphoprotein" . SPARSER::PROTEIN)
    ("Ku-80" . SPARSER::PROTEIN) ("FMNL1" . SPARSER::PROTEIN)
    ("formin-like protein 1" . SPARSER::PROTEIN)
    ("Wiskott-Aldrich Syndrome protein" . SPARSER::PROTEIN)
    ("ARP2" . SPARSER::PROTEIN) ("profilin-1" . SPARSER::PROTEIN)
    ("H2AXs" . SPARSER::PROTEIN) ("DNA ligase IV" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("nuclease activity" . SPARSER::PROTEIN)
    ("phosphoglycerate kinase 1" . SPARSER::PROTEIN)
    ("SSH1" . SPARSER::PROTEIN) ("slingshot homolog" . SPARSER::PROTEIN)
    ("CFL-2" . SPARSER::PROTEIN) ("latrunculin A" . SPARSER::DRUG)
    ("actin depolymerizing factor" . SPARSER::PROTEIN)
    ("CFL-1" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("NRAS , AURKA or CCND1" . SPARSER::COLLECTION)
    ("AURKA and CCND1" . SPARSER::COLLECTION)
    ("CCND1 or CDK4" . SPARSER::COLLECTION)
    ("germinal MC1R variants" . SPARSER::VARIANT)
    ("CDKN2B and/or MTAP" . SPARSER::COLLECTION)
    ("CDKN2A , CDKN2B and/or MTAP" . SPARSER::COLLECTION)
    ("MTAP" . SPARSER::PROTEIN)
    ("BRAF , NRAS , CDKN2A and MC1R" . SPARSER::COLLECTION)
    ("CCND1 gene (11q13) or TERT gene (5p15.33)" . SPARSER::COLLECTION)
    ("estrogens or strain" . SPARSER::COLLECTION)
    ("ERβ and not ERα that mediates acute reduction in Sost in response to either changes in estrogens"
     . SPARSER::COLLECTION)
    ("Cao" . SPARSER::MOLECULE) ("Col1a1-cre" . SPARSER::COLLECTION)
    ("Prx-cre" . SPARSER::COLLECTION)
    ("osteoclastogenic cytokines" . SPARSER::PROTEIN)
    ("ERα or ERβ" . SPARSER::COLLECTION)
    ("a fully functional ERα" . SPARSER::PROTEIN)
    ("a hypomorphic ERα" . SPARSER::PROTEIN)
    ("parathyroid hormone and EP4" . SPARSER::COLLECTION)
    ("ERβ or ERα" . SPARSER::COLLECTION)
    ("the IGF receptor's" . SPARSER::RECEPTOR)
    ("either estradiol or strain" . SPARSER::COLLECTION)
    ("basal Sost" . SPARSER::PROTEIN)
    ("either ERα and/or ERβ" . SPARSER::COLLECTION)
    ("both intermittent and continuous PTH" . SPARSER::PROTEIN)
    ("PTH" . SPARSER::PROTEIN) ("extracellular sclerostin" . SPARSER::PROTEIN)
    ("exogenous sclerostin" . SPARSER::PROTEIN)
    ("cyclin D1 ( CCND1 , xref  B ) and osteoprotegerin ( OPG , xref  C )"
     . SPARSER::COLLECTION)
    ("osteoprotegerin" . SPARSER::PROTEIN) ("triol (PPT)" . SPARSER::MOLECULE)
    ("DPN" . SPARSER::MOLECULE) ("diarylpropionitrile" . SPARSER::DRUG)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("triol" . SPARSER::MOLECULE)
    ("Exogenous Sclerostin" . SPARSER::PROTEIN) ("MPP" . SPARSER::PROTEIN)
    ("both estradiol and strain" . SPARSER::COLLECTION)
    ("Both Estrogens and Strain" . SPARSER::COLLECTION)
    ("here used subtype-selective receptor agonists" . SPARSER::AGONIST)
    ("estrogenic ligands" . SPARSER::LIGAND)
    ("Sost and sclerostin" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exogenous sclerostin" . SPARSER::PROTEIN)
    ("a nongenomic ERβ agonist" . SPARSER::AGONIST)
    ("The ERβ agonists 2,3-bis(4-hydroxyphenyl)-propionitrile and ERB041 also down-regulated Sost expression in vitro"
     . SPARSER::COLLECTION)
    ("-propionitrile" . SPARSER::DRUG) ("tris" . SPARSER::MOLECULE)
    ("ERB" . SPARSER::PROTEIN) ("propionitrile" . SPARSER::DRUG)
    ("Sclerostin" . SPARSER::PROTEIN) ("/sclerostin" . SPARSER::COLLECTION)
    ("sclerostin" . SPARSER::PROTEIN) ("Sost" . SPARSER::PROTEIN)
    ("Col1a1" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("EP4" . SPARSER::PROTEIN) ("LRP-5" . SPARSER::PROTEIN)
    ("β 2 -microglobulin" . SPARSER::PROTEIN) ("1 A1" . SPARSER::PROTEIN)
    ("ICI 182780" . SPARSER::DRUG) ("17β-Estradiol" . SPARSER::PROTEIN)
    ("low density lipoprotein receptor" . SPARSER::PROTEIN)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("ARM" . SPARSER::PROTEIN) ("severe mental retardation" . SPARSER::PROTEIN)
    ("a distinct cohort" . SPARSER::MOLECULE) ("ADM" . SPARSER::PROTEIN)
    ("phen" . SPARSER::MOLECULE) ("recurrent otitis media" . SPARSER::PROTEIN)
    ("CNTNAP2 [ xref ] and Neuroligins [ xref ]" . SPARSER::COLLECTION)
    ("ile" . SPARSER::AMINO-ACID)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN) ("RAB39B" . SPARSER::PROTEIN)
    ("CNTNAP2" . SPARSER::PROTEIN)
    ("a larger study cohort" . SPARSER::MOLECULE)
    ("pVHL and p53" . SPARSER::COLLECTION)
    ("ATRX or DAXX" . SPARSER::COLLECTION)
    ("ATRX and DAXX" . SPARSER::COLLECTION) ("mTOR/PTEN" . SPARSER::COLLECTION)
    ("Growth Factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("chromogranin" . SPARSER::PROTEIN) ("MCA" . SPARSER::PROTEIN)
    ("X-Linked (ATRX)" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("Deoxyglucose" . SPARSER::MOLECULE) ("SUV" . SPARSER::PROTEIN)
    ("PTEN and nuclear-to-cytoplasmic" . SPARSER::COLLECTION)
    ("PTEN, ATRX, DAXX, CHGA, CHGB, CC-3, VEGF and p53" . SPARSER::COLLECTION)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and CHGB" . SPARSER::COLLECTION)
    ("PTEN, CHGA and ATRX" . SPARSER::COLLECTION) ("DAXX" . SPARSER::PROTEIN)
    ("ATRX" . SPARSER::PROTEIN) ("FAS ligand" . SPARSER::PROTEIN)
    ("Tumor Suppressor Protein" . SPARSER::PROTEIN)
    ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("Death-Associated Protein" . SPARSER::PROTEIN)
    ("X-Linked" . SPARSER::PROTEIN) ("F-18" . SPARSER::PROTEIN)
    ("P10645" . SPARSER::PROTEIN) ("NBP1" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("Von Hippel-Lindau" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("p53 and target" . SPARSER::COLLECTION)
    ("PRIMA-1 or MQ" . SPARSER::COLLECTION)
    ("a much larger molecule" . SPARSER::MOLECULE)
    ("nucleophiles" . SPARSER::MOLECULE) ("quinone" . SPARSER::PROTEIN)
    ("the respective thioester" . SPARSER::MOLECULE)
    ("the seven-membered ring lactone carbonyl group" . SPARSER::MOLECULE)
    ("thioester" . SPARSER::MOLECULE) ("nucleophile" . SPARSER::MOLECULE)
    ("annexin A2, S100A4 and S100A10" . SPARSER::COLLECTION)
    ("PRIMA-1 and MQ" . SPARSER::COLLECTION)
    ("PRIMA-1 and the recently identified allele-specific p53 reactivation compound NSC-319725 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("the cell cycle inhibitor p21 and the proapoptotic gene PUMA"
     . SPARSER::COLLECTION)
    ("PUMA" . SPARSER::PROTEIN) ("p53 and mutants" . SPARSER::COLLECTION)
    ("octanol" . SPARSER::MOLECULE) ("R175H_C124A" . SPARSER::PROTEIN)
    ("otherwise wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either wild-type p53 or various p53 mutants" . SPARSER::COLLECTION)
    ("correct p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and mutant" . SPARSER::COLLECTION)
    ("organic solvent" . SPARSER::MOLECULE)
    ("wild-type p53 and three frequent cancer mutants" . SPARSER::COLLECTION)
    ("TSR" . SPARSER::PROTEIN)
    ("significant or moderate nuclear magnetic resonance (NMR) chemical"
     . SPARSER::MOLECULE)
    ("MIRA-1" . SPARSER::COLLECTION) ("STIMA-1" . SPARSER::COLLECTION)
    ("MIRA" . SPARSER::PROTEIN)
    ("computational solvent mapping" . SPARSER::PROTEIN)
    ("PRIMA-1 and PRIMA-1" . SPARSER::COLLECTION)
    ("full-length and single-point-mutated" . SPARSER::COLLECTION)
    ("Annexin A2" . SPARSER::PROTEIN) ("M −1" . SPARSER::PROTEIN)
    ("cm −1  " . SPARSER::PROTEIN) ("pGl4" . SPARSER::PROTEIN)
    ("S100A10" . SPARSER::PROTEIN) ("annexin A2" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("APR-246" . SPARSER::DRUG)
    ("PRIMA-1" . SPARSER::PROTEIN)
    ("biobehavioral states" . SPARSER::BIO-STATE)
    ("the FDA’s" . SPARSER::PROTEIN) ("catecholamine" . SPARSER::MOLECULE)
    ("ID8" . SPARSER::PROTEIN) ("hexamethonium" . SPARSER::DRUG)
    ("Isoproterenol" . SPARSER::PROTEIN)
    ("isoproterenol or PBS" . SPARSER::COLLECTION)
    ("isoproterenol or terbutaline" . SPARSER::COLLECTION)
    ("xamoterol or propranolol" . SPARSER::COLLECTION)
    ("xamoterol" . SPARSER::DRUG) ("propranolol" . SPARSER::DRUG)
    ("control siRNA or Src-specific siRNA" . SPARSER::COLLECTION)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("Src-ID8" . SPARSER::PROTEIN-PAIR) ("Src or S17A" . SPARSER::COLLECTION)
    ("siRNA or AP23846" . SPARSER::COLLECTION)
    ("Src or PKA" . SPARSER::COLLECTION) ("catecholamines" . SPARSER::MOLECULE)
    ("was run" . SPARSER::PROTEIN-FAMILY) ("hydrated" . SPARSER::MOLECULE)
    ("Src and c-Abl" . SPARSER::COLLECTION)
    ("phospho-aminophosphonic acid-adenylate ester (ANP) and water molecules"
     . SPARSER::COLLECTION)
    ("phospho-aminophosphonic acid-adenylate ester (ANP)" . SPARSER::MOLECULE)
    ("ester (ANP)" . SPARSER::MOLECULE) ("Src or Src" . SPARSER::COLLECTION)
    ("siRNA or PKA" . SPARSER::COLLECTION)
    ("dibutyryl-cAMP" . SPARSER::COLLECTION) ("cAMP/PKA" . SPARSER::COLLECTION)
    ("ADRB1 and ADRB2" . SPARSER::COLLECTION)
    ("ADRB1- or ADRB2-targeted small interfering RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("ADRB1-" . SPARSER::PROTEIN) ("Propranolol" . SPARSER::DRUG)
    ("hydrocortisone" . SPARSER::DRUG)
    ("dasatinib or Src" . SPARSER::COLLECTION)
    ("total and phosphorylated proteins" . SPARSER::PROTEIN)
    ("receptors (ADRB)" . SPARSER::RECEPTOR) ("ADRB" . SPARSER::PROTEIN)
    ("a pivotal molecular target" . SPARSER::TARGET-PROTEIN)
    ("pSrc" . SPARSER::PROTEIN) ("Norepinephrine" . SPARSER::DRUG)
    ("β-arrestin" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("OG2" . SPARSER::PROTEIN) ("KT5720" . SPARSER::DRUG)
    ("E19" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("ADRB1" . SPARSER::PROTEIN) ("ADRB2" . SPARSER::PROTEIN)
    ("MEK-C-Raf" . SPARSER::COLLECTION)
    ("the entire C-Raf and B-Raf" . SPARSER::COLLECTION)
    ("Ras and the 14-3-3 proteins" . SPARSER::COLLECTION)
    ("14-3-3, HSP-70 and HSP-90" . SPARSER::COLLECTION)
    ("MEK-Raf" . SPARSER::COLLECTION) ("Raf-MEK" . SPARSER::COLLECTION)
    ("Raf or MEK" . SPARSER::COLLECTION) ("C-Raf or MEK" . SPARSER::COLLECTION)
    ("mediators, MEK and ERK" . SPARSER::COLLECTION)
    ("myc-C-Raf" . SPARSER::COLLECTION) ("FLAG-MEK-1" . SPARSER::COLLECTION)
    ("Raf and mitogens" . SPARSER::COLLECTION) ("WL" . SPARSER::MOLECULE)
    ("MEK and Ras" . SPARSER::COLLECTION)
    ("either wildtype C-Raf or the RBD/CRD C-Raf mutant" . SPARSER::COLLECTION)
    ("C-Raf or EGF" . SPARSER::COLLECTION)
    ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("C-Raf, MEK-1 or ERK-1" . SPARSER::COLLECTION)
    ("C-Raf/MEK" . SPARSER::COLLECTION) ("HA-ERK-1" . SPARSER::COLLECTION)
    ("FLAG-epitope-tagged MEK-1" . SPARSER::PROTEIN)
    ("MEK-1 and MEK-1" . SPARSER::COLLECTION)
    ("MEK-1 and ERK" . SPARSER::COLLECTION)
    ("directly binding C-Raf" . SPARSER::PROTEIN)
    ("receptor-Ras" . SPARSER::COLLECTION) ("EGF or MEK" . SPARSER::COLLECTION)
    ("MEK and C-Raf" . SPARSER::COLLECTION)
    ("EGF and MEK-1" . SPARSER::COLLECTION)
    ("recombinant bacterially-expressed GST-MEK-1" . SPARSER::COLLECTION)
    ("myc-epitope-tagged C-Raf" . SPARSER::PROTEIN)
    ("GST-MEK-1" . SPARSER::COLLECTION)
    ("C-Raf or MEK-1" . SPARSER::COLLECTION)
    ("32 P-metabolic labeling and 2D phospho-peptide mapping"
     . SPARSER::PROTEIN)
    ("C-Raf-MEK-1" . SPARSER::COLLECTION)
    ("C-Raf and MEK-1" . SPARSER::COLLECTION)
    ("MEK-1 and C-Raf" . SPARSER::COLLECTION)
    ("Ras or Src" . SPARSER::COLLECTION)
    ("growth factors or PMA" . SPARSER::COLLECTION)
    ("PAK and Src" . SPARSER::COLLECTION)
    ("a viral-transmitted oncogene" . SPARSER::ONCOGENE)
    ("PKA and AKT" . SPARSER::COLLECTION)
    ("the active conformation and mutation of key phosphorylation sites"
     . SPARSER::COLLECTION)
    ("C-Raf/c-Raf-1" . SPARSER::COLLECTION) ("C-Raf-MEK" . SPARSER::COLLECTION)
    ("RKIP" . SPARSER::PROTEIN) ("growth factors or Ras" . SPARSER::COLLECTION)
    ("C-Raf and MEK" . SPARSER::COLLECTION) ("HSP-70" . SPARSER::PROTEIN)
    ("MAP3Ks" . SPARSER::PROTEIN-FAMILY)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSP-90" . SPARSER::PROTEIN)
    ("pH 1" . SPARSER::PROTEIN) ("18h" . SPARSER::PROTEIN)
    ("301A" . SPARSER::PROTEIN) ("pMT2" . SPARSER::PROTEIN)
    ("ERK-1" . SPARSER::PROTEIN) ("PKC δ" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN) ("c-Raf-1" . SPARSER::PROTEIN)
    ("Ren" . SPARSER::PROTEIN) ("Prostacyclin" . SPARSER::MOLECULE)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION) ("THP-1" . SPARSER::PROTEIN)
    ("apoM" . SPARSER::PROTEIN) ("S1P and its receptors" . SPARSER::COLLECTION)
    ("toxin and S1PR1" . SPARSER::COLLECTION)
    ("receptors, S1PR1 and S1PR3" . SPARSER::COLLECTION)
    ("HDL and apoA-I" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("S1P receptor 1 (S1PR1) and receptor" . SPARSER::COLLECTION)
    ("Lipids" . SPARSER::LIPID) ("a special antagonist" . SPARSER::MOLECULE)
    ("toxin (PTX)" . SPARSER::MOLECULE)
    ("standard and isolated HDL" . SPARSER::PROTEIN)
    ("The HDL-associated S1P" . SPARSER::PROTEIN)
    ("methanol" . SPARSER::MOLECULE)
    ("triglycerides and lower levels of HDL-c" . SPARSER::COLLECTION)
    ("yrs" . SPARSER::PROTEIN) ("HDLs" . SPARSER::PROTEIN)
    ("enzyme, COX-1 and COX-2" . SPARSER::COLLECTION)
    ("cyclooxygenase (COX) and the downstream diverse prostanoids"
     . SPARSER::COLLECTION)
    ("the downstream diverse prostanoids" . SPARSER::MOLECULE)
    ("HDL and apolipoprotein A-I" . SPARSER::COLLECTION)
    ("normal HDL" . SPARSER::PROTEIN) ("Diabetic HDL" . SPARSER::PROTEIN)
    ("The diabetic HDL" . SPARSER::PROTEIN)
    ("diabetic HDL and S1P" . SPARSER::COLLECTION)
    ("HDL-associated S1P" . SPARSER::PROTEIN)
    ("diabetic HDL" . SPARSER::PROTEIN) ("HDL and S1P" . SPARSER::COLLECTION)
    ("Dysfunctional high-density lipoprotein (HDL)" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG) ("Type2" . SPARSER::PROTEIN)
    ("apolipoprotein M" . SPARSER::PROTEIN) ("SphK2" . SPARSER::PROTEIN)
    ("SphK1" . SPARSER::PROTEIN) ("sphingosine kinase" . SPARSER::PROTEIN)
    ("S1PR3" . SPARSER::PROTEIN) ("S1PR1" . SPARSER::PROTEIN)
    ("PGI2" . SPARSER::PROTEIN) ("HDL-c" . SPARSER::PROTEIN)
    ("LDL-c" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("apoA-I" . SPARSER::PROTEIN)
    ("High-density lipoprotein" . SPARSER::PROTEIN)
    ("PGI-2" . SPARSER::PROTEIN) ("I-2" . SPARSER::PROTEIN)
    ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("Mnk-1 and/or eIF4E" . SPARSER::COLLECTION)
    ("phospho-mimetic eIF4E S209D mutant" . SPARSER::MUTANT)
    ("nonphosphorylatable eIF4E S209A mutant" . SPARSER::MUTANT)
    ("sh-raptor" . SPARSER::COLLECTION) ("eIF4E-eIF4G" . SPARSER::COLLECTION)
    ("Ras and PI 3 kinase" . SPARSER::COLLECTION)
    ("receptors and cytokines" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("PI 3 kinase/Akt" . SPARSER::COLLECTION)
    ("Mnk-1 and Mnk-2" . SPARSER::COLLECTION)
    ("eIF4G and form" . SPARSER::COLLECTION)
    ("eIF4G and 4EBP-1" . SPARSER::COLLECTION)
    ("PI 3 kinase, MEK and Erk1/2" . SPARSER::COLLECTION)
    ("phospho-mimetic aspartic acid" . SPARSER::AMINO-ACID)
    ("PI 3 kinase/MEK/Erk1/2" . SPARSER::COLLECTION)
    ("MEK and Erk1/2" . SPARSER::COLLECTION)
    ("Ly294002 and dominant negative PI 3 kinase expression ( xref and xref )"
     . SPARSER::COLLECTION)
    ("Erk1/2 and eIF4E" . SPARSER::COLLECTION)
    ("MEK/Erk" . SPARSER::COLLECTION)
    ("certain cytokines and stresses use p38 MAPK" . SPARSER::COLLECTION)
    ("eIF4E, certain cytokines and stresses use p38 MAPK"
     . SPARSER::COLLECTION)
    ("the only eIF4E kinase" . SPARSER::KINASE)
    ("mitogen-activated protein kinase signal-integrating kinase-1 (Mnk-1) and Mnk-2"
     . SPARSER::COLLECTION)
    ("Two predominant isoforms" . SPARSER::ISOFORM)
    ("Mnk-2" . SPARSER::PROTEIN) ("eIF4G and RNA" . SPARSER::COLLECTION)
    ("kinase/Akt" . SPARSER::COLLECTION)
    ("transcriptional coactivators or corepressors" . SPARSER::COLLECTION)
    ("coactivators or corepressors" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SARA" . SPARSER::PROTEIN)
    ("Smad 3 and Smad 2" . SPARSER::COLLECTION)
    ("an oligomeric complex" . SPARSER::BIO-COMPLEX)
    ("soluble growth factors and cytokines" . SPARSER::COLLECTION)
    ("4EBP-1-eIF4E" . SPARSER::COLLECTION)
    ("PI 3 kinase and Erk1/2" . SPARSER::COLLECTION)
    ("MEK/Erk1/2" . SPARSER::COLLECTION)
    ("Erk1/2 (extracellular signal regulated kinase1/2) and MEK (mitogen-activated and extracellular signal-regulated kinase kinase)"
     . SPARSER::COLLECTION)
    ("Pi 3 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI 3 K" . SPARSER::PROTEIN-FAMILY) ("Smad 4" . SPARSER::PROTEIN)
    ("Smads 2" . SPARSER::PROTEIN) ("Smad 2" . SPARSER::PROTEIN)
    ("Smad 3" . SPARSER::PROTEIN) ("4EBP-1" . SPARSER::PROTEIN)
    ("EBP-1" . SPARSER::PROTEIN) ("PI 3 kinase" . SPARSER::PROTEIN)
    ("Mnk-1" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase1/2" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("hScrib and PHLPP1" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("PP1γ and hScrib" . SPARSER::COLLECTION)
    ("hScrib-PP1γ" . SPARSER::COLLECTION)
    ("E7 and EJ-ras" . SPARSER::COLLECTION) ("KADA" . SPARSER::MUTANT)
    ("hScrib, PP1γ and pERK" . SPARSER::COLLECTION)
    ("the respective cellular fractions" . SPARSER::COMPONENT)
    ("the PKA phospho-mimic mutant (S1445D) and the non-PP1γ binding mutant (KADA)"
     . SPARSER::COLLECTION)
    ("mutant (KADA)" . SPARSER::MUTANT)
    ("hScrib and the purified PP1γ" . SPARSER::COLLECTION)
    ("PKA or ERK1" . SPARSER::COLLECTION) ("PKA and ERK" . SPARSER::COLLECTION)
    ("hScrib and ERK" . SPARSER::COLLECTION)
    ("hScrib and PP2A" . SPARSER::COLLECTION)
    ("PP1γ and PP2A" . SPARSER::COLLECTION)
    ("hScrib and PP1γ" . SPARSER::COLLECTION)
    ("using purified GST-hScrib P1-C fusion protein and in vitro translated radiolabeled PP1γ"
     . SPARSER::COLLECTION)
    ("GST-hScrib" . SPARSER::COLLECTION)
    ("a major eukaryotic serine/threonine protein phosphatase"
     . SPARSER::PROTEIN)
    ("threonine/tyrosine" . SPARSER::COLLECTION)
    ("the activating kinases and the de-activating protein phosphatases"
     . SPARSER::COLLECTION)
    ("ERK and hScrib" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION) ("Ras and Myc" . SPARSER::COLLECTION)
    ("Scrib or Dlg" . SPARSER::COLLECTION)
    ("proteins, hScrib, hDlg1 and Hugl-1/2" . SPARSER::COLLECTION)
    ("hDlg" . SPARSER::PROTEIN)
    ("the Par complex and the Crumbs complex xref" . SPARSER::COLLECTION)
    ("a tri-partite macromolecular signaling complex" . SPARSER::BIO-COMPLEX)
    ("Scrib" . SPARSER::DRUG) ("PP1γ and ERK" . SPARSER::COLLECTION)
    ("two well-conserved Kinase" . SPARSER::KINASE)
    ("hScrib" . SPARSER::PROTEIN) ("P1-4" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("PDZ1" . SPARSER::PROTEIN)
    ("PHLPP1" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("Hugl-1" . SPARSER::PROTEIN) ("Protein Phosphatase 1" . SPARSER::PROTEIN)
    ("a mutated P53 monomer" . SPARSER::MONOMER)
    ("tetramers and only normal P53 monomers" . SPARSER::COLLECTION)
    ("anthracycline" . SPARSER::MOLECULE)
    ("Claudin-7 , SERPINF1 , and SMYD4" . SPARSER::COLLECTION)
    ("docetaxel, or trastuzumab" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG) ("anthracyclines" . SPARSER::MOLECULE)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("c-myc and survivin" . SPARSER::COLLECTION)
    ("p53, c-myc and survivin" . SPARSER::COLLECTION)
    ("an active tetramer" . SPARSER::TETRAMER)
    ("CBP, CREB, MDM2 and p300" . SPARSER::COLLECTION)
    ("ATM, ATR or Chk2" . SPARSER::COLLECTION)
    ("a 393-amino-acid protein" . SPARSER::PROTEIN)
    ("TP53 or missense" . SPARSER::COLLECTION)
    ("type and location" . SPARSER::COLLECTION) ("Serpinf1" . SPARSER::PROTEIN)
    ("SMYD4" . SPARSER::PROTEIN) ("SERPINF1" . SPARSER::PROTEIN)
    ("Claudin-7" . SPARSER::PROTEIN)
    ("Loss Of Heterozygosity" . SPARSER::PROTEIN)
    ("the routinely performed diagnostic flow cytometry" . SPARSER::PROTEIN)
    ("CD13, and CD117" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("receptor and RAS" . SPARSER::COLLECTION)
    ("Sorafenib, PKC412, TKI258 and AraC" . SPARSER::COLLECTION)
    ("AraC" . SPARSER::DRUG) ("sorafenib and BE13" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG) ("PKC412 and TKI258" . SPARSER::COLLECTION)
    ("Sorafenib" . SPARSER::DRUG) ("FLT3-wt" . SPARSER::COLLECTION)
    ("CD8-" . SPARSER::PROTEIN) ("CD4-" . SPARSER::PROTEIN)
    ("CD1a-" . SPARSER::PROTEIN) ("CD56-" . SPARSER::PROTEIN)
    ("TdT" . SPARSER::PROTEIN) ("NOTCH1 and FLT3" . SPARSER::COLLECTION)
    ("GATA3 and BCL11B" . SPARSER::COLLECTION)
    ("WT1 and MN1" . SPARSER::COLLECTION) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("inhibitors (GSI)" . SPARSER::INHIBITOR)
    ("HES1, DTX1, PTCRA , and MYC" . SPARSER::COLLECTION)
    ("GSI" . SPARSER::PROTEIN) ("PTCRA" . SPARSER::PROTEIN)
    ("TLX1 and TLX3" . SPARSER::COLLECTION)
    ("CD1a and CD8" . SPARSER::COLLECTION)
    ("TLX3/HOX11L2" . SPARSER::COLLECTION) ("TLX/HOX11" . SPARSER::COLLECTION)
    ("HOXA" . SPARSER::PROTEIN) ("TLX" . SPARSER::PROTEIN)
    ("TAL" . SPARSER::MOLECULE) ("an aggressive leukemia" . SPARSER::PROTEIN)
    ("CD33-" . SPARSER::PROTEIN) ("CD5-" . SPARSER::PROTEIN)
    ("Early T-cell precursor acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("BAY 43-9006" . SPARSER::DRUG) ("PKC412" . SPARSER::DRUG)
    ("BCL11B" . SPARSER::PROTEIN) ("MN1" . SPARSER::PROTEIN)
    ("CD64" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("CD7" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("gamma secretase" . SPARSER::PROTEIN) ("DTX1" . SPARSER::PROTEIN)
    ("TLX1" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("HOX11L2" . SPARSER::PROTEIN) ("TLX3" . SPARSER::PROTEIN)
    ("HOX11" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("SIRT1 or SIRT2" . SPARSER::COLLECTION)
    ("energy-sensitive NAD-dependent deacetylases" . SPARSER::PROTEIN)
    ("Nutrient" . SPARSER::MOLECULE) ("HMM" . SPARSER::DRUG)
    ("acetylation-mimetic K207Q mutants" . SPARSER::MUTANT)
    ("an acetyl-mimetic glutamine" . SPARSER::AMINO-ACID)
    ("the last 14 amino acids" . SPARSER::AMINO-ACID)
    ("keratin 8 (K8) and K18" . SPARSER::COLLECTION)
    ("heteropolymers" . SPARSER::MOLECULE) ("keratins" . SPARSER::PROTEIN)
    ("a type II simple epithelial IF" . SPARSER::PROTEIN)
    ("IFs" . SPARSER::PROTEIN) ("Ac-K" . SPARSER::PROTEIN)
    ("E-L" . SPARSER::PROTEIN) ("AGK2" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("FK866" . SPARSER::DRUG)
    ("Sirtuin 2" . SPARSER::PROTEIN) ("2–4 µ" . SPARSER::PROTEIN)
    ("sirtuin 2" . SPARSER::PROTEIN) ("keratin 8" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("Keratin 8" . SPARSER::PROTEIN)
    ("SED" . SPARSER::PROTEIN) ("DMH" . SPARSER::PROTEIN)
    ("Cyclic AMP-response element-binding protein" . SPARSER::PROTEIN)
    ("Bovine serum albumin" . SPARSER::PROTEIN) ("Males" . SPARSER::MOLECULE)
    ("MOF" . SPARSER::PROTEIN) ("Bromodeoxyuridine" . SPARSER::DRUG)
    ("TIP60 and SUV420H2" . SPARSER::COLLECTION)
    ("p53 and TIP60" . SPARSER::COLLECTION)
    ("TIP60 or other HATs" . SPARSER::COLLECTION)
    ("the DNA damage-associated TIP60" . SPARSER::PROTEIN)
    ("currently available lysine acetyltransferase inhibitors"
     . SPARSER::INHIBITOR)
    ("CBP, p300, MOZ and MORF" . SPARSER::COLLECTION)
    ("MORF" . SPARSER::PROTEIN) ("MOZ" . SPARSER::PROTEIN)
    ("garcinol and related molecules" . SPARSER::COLLECTION)
    ("SUV420H2 and H4K20" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("hMOF or the deacetylase SIRT1" . SPARSER::COLLECTION)
    ("hMOF" . SPARSER::PROTEIN) ("MYST" . SPARSER::PROTEIN-FAMILY)
    ("-acetyl" . SPARSER::MOLECULE)
    ("curcumin, garcinol or LTK14" . SPARSER::COLLECTION)
    ("curcumin or garcinol" . SPARSER::COLLECTION)
    ("curcumin and garcinol" . SPARSER::COLLECTION)
    ("Acetyltransferase" . SPARSER::PROTEIN)
    ("histones and p53" . SPARSER::COLLECTION)
    ("histone/p53" . SPARSER::COLLECTION) ("benzophenone" . SPARSER::DRUG)
    ("diferuloylmethane" . SPARSER::DRUG) ("Curcumin" . SPARSER::DRUG)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN)
    ("2/3 and H4K20" . SPARSER::COLLECTION)
    ("sensory proteins" . SPARSER::PROTEIN) ("Enzymes" . SPARSER::ENZYME)
    ("Garcinol" . SPARSER::MOLECULE) ("LTK" . SPARSER::PROTEIN)
    ("garcinol and curcumin" . SPARSER::COLLECTION)
    ("histone and p53" . SPARSER::COLLECTION) ("garcinol" . SPARSER::MOLECULE)
    ("histones and other proteins" . SPARSER::COLLECTION)
    ("SUV4-20H2" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("Monocytic leukemia zinc finger protein" . SPARSER::PROTEIN)
    ("Monocytic leukemia zinc finger protein-related factor"
     . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("C-E" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("SUV420H1" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("H3K4Me3" . SPARSER::PROTEIN) ("SUV420H2" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("PH and PS" . SPARSER::COLLECTION)
    ("PH" . SPARSER::PROTEIN) ("an unfavorable genotype" . SPARSER::PROTEIN)
    ("p53, p16, and pRb" . SPARSER::COLLECTION)
    ("had received intravesical BCG" . SPARSER::DRUG)
    ("pRb or p21" . SPARSER::COLLECTION)
    ("IHC-abnormal p16" . SPARSER::PROTEIN)
    ("any particular exon" . SPARSER::PROTEIN)
    ("p53, p16, pRb and p21" . SPARSER::COLLECTION)
    ("abnormal p16" . SPARSER::PROTEIN)
    ("normal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p21, pRb, p16, and cyclin D1" . SPARSER::COLLECTION)
    ("an essential negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("BCG" . SPARSER::DRUG)
    ("at least one MDM2 SNP309 G allele" . SPARSER::ALLELE)
    ("SO 4" . SPARSER::PROTEIN) ("SNP 309" . SPARSER::PROTEIN)
    ("QM" . SPARSER::PROTEIN) ("HBZ, KY and LPX" . SPARSER::COLLECTION)
    ("HBZ" . SPARSER::PROTEIN) ("VAC" . SPARSER::PROTEIN)
    ("methotrexate" . SPARSER::DRUG) ("Cyclin A/CDK2" . SPARSER::COLLECTION)
    ("pivotal cell cycle inhibitors" . SPARSER::INHIBITOR)
    ("p21 and GADD45α" . SPARSER::COLLECTION)
    ("cyclins/CDKs" . SPARSER::COLLECTION)
    ("cancer-associated p53 mutants" . SPARSER::MUTANT)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("PI and annexin V" . SPARSER::COLLECTION)
    ("cyclin B1 and cyclin" . SPARSER::COLLECTION) ("dsRNAs" . SPARSER::RNA)
    ("siP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B/CDK1" . SPARSER::PROTEIN)
    ("growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("PNA" . SPARSER::PROTEIN) ("pathological type" . TYPE)
    ("solvents" . SPARSER::MOLECULE)
    ("a combined acidic buffer-based dynamic and static absorptive"
     . SPARSER::PROTEIN)
    ("absorptive" . SPARSER::PROTEIN) ("EtBr" . SPARSER::PROTEIN)
    ("type, and tumor" . SPARSER::COLLECTION) ("RSD" . SPARSER::PROTEIN)
    ("the optimal sieving matrix" . SPARSER::PROTEIN-FAMILY)
    ("HPC" . SPARSER::PROTEIN-FAMILY)
    ("highly heterogeneous mixtures" . SPARSER::MOLECULE)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Medicines" . SPARSER::DRUG) ("the metastatic CRC" . SPARSER::PROTEIN)
    ("CCL" . SPARSER::DRUG) ("P21 protein" . SPARSER::PROTEIN)
    ("CX-1" . SPARSER::PROTEIN) ("YOYO-1" . SPARSER::MOLECULE)
    ("highly condensed chromatin" . SPARSER::BIO-COMPLEX)
    ("bright circular foci" . SPARSER::PROTEIN) ("toxic DNA" . SPARSER::DNA)
    ("very few and smaller foci" . SPARSER::PROTEIN)
    ("Neither OGG1 nor XRCC1" . SPARSER::COLLECTION)
    ("euchromatin-" . SPARSER::BIO-COMPLEX) ("OGG1-Flag" . SPARSER::COLLECTION)
    ("soluble proteins" . SPARSER::PROTEIN)
    ("OGG1-DsRed" . SPARSER::COLLECTION) ("parp1" . SPARSER::PROTEIN)
    ("parp" . SPARSER::PROTEIN) ("XRCC1-GFP" . SPARSER::COLLECTION)
    ("OGG1 and other proteins" . SPARSER::COLLECTION)
    ("APE1 and XRCC1" . SPARSER::COLLECTION) ("OGG1-GFP" . SPARSER::COLLECTION)
    ("both allelic forms" . SPARSER::FORM) ("-GFP" . SPARSER::COLLECTION)
    ("XRCC1-DsRed" . SPARSER::COLLECTION)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("OGG1-DsRED" . SPARSER::COLLECTION) ("DsRED" . SPARSER::PROTEIN)
    ("NEIL1 and NEIL2" . SPARSER::COLLECTION)
    ("OGG1 and XRCC1" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("photosensitizer" . SPARSER::DRUG)
    ("SSB and 8-oxoG" . SPARSER::COLLECTION) ("oxidative DNA" . SPARSER::DNA)
    ("an essential scaffold protein" . SPARSER::PROTEIN)
    ("NEIL2" . SPARSER::PROTEIN) ("NEIL1" . SPARSER::PROTEIN)
    ("Ogg1" . SPARSER::PROTEIN) ("PJ-34" . SPARSER::DRUG)
    ("hOGG1" . SPARSER::PROTEIN) ("MYC, BCL2, and BCL6" . SPARSER::COLLECTION)
    ("BLC" . SPARSER::PROTEIN)
    ("FISH and CISH and intraobserver" . SPARSER::COLLECTION)
    ("CISH and intraobserver" . SPARSER::COLLECTION)
    ("chromogen" . SPARSER::MOLECULE) ("bright" . SPARSER::PROTEIN)
    ("positive IHC protein" . SPARSER::PROTEIN)
    ("successful CISH" . SPARSER::PROTEIN)
    ("a new monoclonal antibody" . SPARSER::DRUG) ("GEP" . SPARSER::PROTEIN)
    ("abnormal MYC" . SPARSER::PROTEIN)
    ("more frequent MYC" . SPARSER::PROTEIN)
    ("MYC and CEN8" . SPARSER::COLLECTION)
    ("higher mRNA and positive immunohistochemistry (IHC)"
     . SPARSER::COLLECTION)
    ("discrete MYC" . SPARSER::PROTEIN) ("CISH" . SPARSER::PROTEIN)
    ("MYC Protein" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN) ("c- MYC" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("casual variants" . SPARSER::VARIANT)
    ("genome-wide significance or replicate known variants" . SPARSER::VARIANT)
    ("the NYUMC cohort" . SPARSER::MOLECULE)
    ("FGFR2 and 6 previously identified SNPs" . SPARSER::COLLECTION)
    ("still more risk alleles" . SPARSER::ALLELE)
    ("only common risk alleles or common alleles" . SPARSER::COLLECTION)
    ("the actual causal variant" . SPARSER::VARIANT)
    ("disease-associated variants" . SPARSER::VARIANT)
    ("synonymous variants" . SPARSER::VARIANT)
    ("each genotype (0, 1 or 2 risk alleles) or FGFR2 gene"
     . SPARSER::COLLECTION)
    ("the NYUMC Replication cohort" . SPARSER::MOLECULE)
    ("disease-associated alleles" . SPARSER::ALLELE)
    ("FGFR2, TNRC9, MAP3K1, LSP1, CASP8, SLC4A7, NEK10 and COX11"
     . SPARSER::COLLECTION)
    ("moderate or low penetrance genes" . SPARSER::GENE)
    ("BRCA1, BRCA2 , p53 and PTEN" . SPARSER::COLLECTION)
    ("CHEK2, ATM, HRAS1, BRIP1 , and PALB2" . SPARSER::COLLECTION)
    ("RNF146" . SPARSER::PROTEIN) ("PHKA1" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("NEK10" . SPARSER::PROTEIN)
    ("SLC4A7" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("LSP1" . SPARSER::PROTEIN) ("MAP3K1" . SPARSER::PROTEIN)
    ("TNRC9" . SPARSER::PROTEIN) ("HRAS1" . SPARSER::PROTEIN)
    ("TOX3" . SPARSER::PROTEIN)
    ("the hypertrophic marker ANP" . SPARSER::PROTEIN)
    ("the prohypertrophic transcription factor NFATc3" . SPARSER::PROTEIN)
    ("phosphatase and methyltransferase activity" . SPARSER::COLLECTION)
    ("methyltransferase activity and PP2A" . SPARSER::COLLECTION)
    ("PI3Kα and PI3Kγ" . SPARSER::COLLECTION)
    ("the cardiac hypertrophic marker atrial natriuretic peptide (ANP)"
     . SPARSER::PROTEIN)
    ("ANP" . SPARSER::PROTEIN) ("NFATc" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN)
    ("PI3Kγ and hemagglutinin" . SPARSER::COLLECTION)
    ("PI3Kγ–" . SPARSER::PROTEIN)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–PP2Ac" . SPARSER::COLLECTION) ("PI3Kγ and PP2Ac" . SPARSER::COLLECTION)
    ("PP2Ac, and PPMT-1" . SPARSER::COLLECTION)
    ("PP2Ac–PPMT-1" . SPARSER::COLLECTION)
    ("PP2Ac and PPMT-1" . SPARSER::COLLECTION)
    ("PPMT-1 and PP2Ac" . SPARSER::COLLECTION)
    ("GSK-3–associated PP2A" . SPARSER::PROTEIN)
    ("/PI3Kγ" . SPARSER::COLLECTION) ("PI3Kγ-PP2A" . SPARSER::COLLECTION)
    ("Akt and GSK-3" . SPARSER::COLLECTION)
    ("GSK-3 and PPMT-1" . SPARSER::COLLECTION)
    ("GSK-3α– and GSK-3β–associated methyltransferase activity"
     . SPARSER::COLLECTION)
    ("GSK-3β–associated methyltransferase activity" . SPARSER::PROTEIN)
    ("GSK-3α–" . SPARSER::PROTEIN) ("PPMT-1 or PPME-1" . SPARSER::COLLECTION)
    ("PPMT-1 and PPME-1" . SPARSER::COLLECTION)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("cardiac GSK-3α" . SPARSER::PROTEIN) ("isoproterenol" . SPARSER::PROTEIN)
    ("a prototypical GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3Kγ–Akt–GSK-3" . SPARSER::COLLECTION)
    ("PI3Kα-Akt" . SPARSER::COLLECTION)
    ("PI3Kα–Akt–GSK-3" . SPARSER::COLLECTION)
    ("a heterotrimeric enzyme" . SPARSER::ENZYME)
    ("class 1A and B PI3Ks" . SPARSER::COLLECTION)
    ("Akt and glycogen synthase kinase-3" . SPARSER::COLLECTION)
    ("PI3Kγ and β isoforms ( xref – xref )" . SPARSER::COLLECTION)
    ("lipid or protein" . SPARSER::COLLECTION)
    ("Both PI3Kα and γ isoforms" . SPARSER::COLLECTION)
    ("class 1A and 1B" . SPARSER::COLLECTION)
    ("PP2A–PPMT-1" . SPARSER::COLLECTION)
    ("PPMT-1 and PP2A" . SPARSER::COLLECTION)
    ("heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors"
     . SPARSER::RECEPTOR)
    ("cardiac phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("P81" . SPARSER::PROTEIN) ("S-adenosylmethionine" . SPARSER::DRUG)
    ("Anti–" . SPARSER::ANTIBODY) ("Anti–β" . SPARSER::PROTEIN)
    ("S21" . SPARSER::PROTEIN) ("natriuretic peptide" . SPARSER::PROTEIN)
    ("MYOD1" . SPARSER::PROTEIN)
    ("myogenic differentiation 1" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN)
    ("Methyltransferase activity" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("PP2Ac" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK-3α" . SPARSER::PROTEIN) ("PME-1" . SPARSER::PROTEIN)
    ("class 1B" . SPARSER::PROTEIN) ("class 1A" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("NFATc3" . SPARSER::PROTEIN)
    ("PPMT-1" . SPARSER::PROTEIN) ("PI3Ka" . SPARSER::PROTEIN-FAMILY)
    ("PI3Kα" . SPARSER::PROTEIN) ("ICOSL–ICOS" . SPARSER::COLLECTION)
    ("ICOS" . SPARSER::PROTEIN) ("ICOSL" . SPARSER::PROTEIN)
    ("pro- or anti-tumor" . SPARSER::COLLECTION)
    ("B7-H1 and B7-H4 coinhibitory molecules" . SPARSER::MOLECULE)
    ("B7-H1 and B7-H4" . SPARSER::COLLECTION)
    ("kynurenine" . SPARSER::MOLECULE) ("IDO" . SPARSER::PROTEIN)
    ("kinase, and CREB" . SPARSER::COLLECTION)
    ("p38 and ERK 1/2" . SPARSER::COLLECTION)
    ("the pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("CCR5 and other receptors" . SPARSER::COLLECTION)
    ("CCL19 and CCL21" . SPARSER::COLLECTION)
    ("the B7-H1 (PD-L1) coregulatory molecule" . SPARSER::MOLECULE)
    ("CD80 and CD86 costimulatory molecules" . SPARSER::MOLECULE)
    ("hepsin" . SPARSER::PROTEIN)
    ("both IL-15 and a p38i" . SPARSER::COLLECTION)
    ("IL-15 or p38i" . SPARSER::COLLECTION)
    ("GM-CSF and IL-4" . SPARSER::COLLECTION)
    ("TNFα, IL-1β, and PGE 2" . SPARSER::COLLECTION)
    ("IFNγ and TNFα" . SPARSER::COLLECTION)
    ("IL-15 and/or p38i" . SPARSER::COLLECTION)
    ("a model ovarian tumor antigen" . SPARSER::DRUG)
    ("MEK 1/2 and ERK" . SPARSER::COLLECTION)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("CTLA-4, PD-1, and Foxp3" . SPARSER::COLLECTION)
    ("IL-15/p38" . SPARSER::COLLECTION) ("B7-H4" . SPARSER::PROTEIN)
    ("CCL21" . SPARSER::PROTEIN) ("CCL19" . SPARSER::PROTEIN)
    ("B7-H2" . SPARSER::PROTEIN) ("ICOS-L" . SPARSER::PROTEIN)
    ("Tumor antigen" . SPARSER::DRUG)
    ("serine protease hepsin" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("Brefeldin A" . SPARSER::MOLECULE) ("CCR4" . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("Indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("kallikrein-7" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("DR1" . SPARSER::PROTEIN) ("Cyclosporin A" . SPARSER::MOLECULE)
    ("M 2" . SPARSER::MOLECULE) ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("foxp3" . SPARSER::PROTEIN) ("CCL22" . SPARSER::PROTEIN)
    ("indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("PD-L1" . SPARSER::PROTEIN) ("B7-H1" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-17" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("neurexins and neuroligins" . SPARSER::COLLECTION)
    ("Neurexins and neuroligins" . SPARSER::COLLECTION)
    ("Neurexins" . SPARSER::PROTEIN-FAMILY)
    ("a previous state" . SPARSER::BIO-STATE)
    ("PMP22 and PLP" . SPARSER::COLLECTION) ("DHH" . SPARSER::PROTEIN)
    ("CDH" . SPARSER::PROTEIN) ("Ncad" . SPARSER::PROTEIN)
    ("ErbB3 and MET" . SPARSER::COLLECTION)
    ("gene and 22q" . SPARSER::COLLECTION)
    ("the neural development molecules semaphorin 5A and plexin-B3"
     . SPARSER::COLLECTION)
    ("semaphorin 5A and plexin-B3" . SPARSER::COLLECTION)
    ("MET and its ligand HGF" . SPARSER::COLLECTION)
    ("integrins, CD44 and G-coupled" . SPARSER::COLLECTION)
    ("the PI3K activator MET (4.5-fold, p=2.94e-5) and related genes"
     . SPARSER::COLLECTION)
    ("PAWR" . SPARSER::PROTEIN) ("AR and CAV1" . SPARSER::COLLECTION)
    ("dihydrotestosterone ( AR )" . SPARSER::DRUG)
    ("Neurofascin ( NFASC )" . SPARSER::PROTEIN)
    ("its associated protein doublecortin ( DCX )" . SPARSER::PROTEIN)
    ("doublecortin ( DCX )" . SPARSER::PROTEIN)
    ("doublecortin" . SPARSER::PROTEIN) ("NFASC" . SPARSER::PROTEIN)
    ("Neurofascin" . SPARSER::PROTEIN)
    ("CHL1 ( CHL1 : 8.51-fold, p=1.52e-4) and NrCAM ( NRCAM : 5.50-fold, p=2.26e-4)"
     . SPARSER::COLLECTION)
    ("NRCAM" . SPARSER::PROTEIN) ("NrCAM" . SPARSER::PROTEIN)
    ("CHL1" . SPARSER::PROTEIN) ("HEPACAM" . SPARSER::PROTEIN)
    ("Immunoglobulin superfamily and L1 family proteins" . SPARSER::COLLECTION)
    ("CAV1-DSG2" . SPARSER::COLLECTION)
    ("both DSG2 (−70-fold, p=2.94e-5) and CAV1 genes" . SPARSER::COLLECTION)
    ("NHE-RF1" . SPARSER::COLLECTION) ("NHE" . SPARSER::PROTEIN)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("a controversial state" . SPARSER::BIO-STATE)
    ("TGFβ1 , TGFβR1 and TGFβR2" . SPARSER::COLLECTION)
    ("TGFβ and PAK" . SPARSER::COLLECTION)
    ("NRG1 and ErbB2-ErbB3" . SPARSER::COLLECTION)
    ("MET , AR or CAV1" . SPARSER::COLLECTION)
    ("pre-operative audiological class" . CLASS)
    ("neurexins" . SPARSER::PROTEIN-FAMILY) ("neurexin" . SPARSER::PROTEIN)
    ("at least one exon" . SPARSER::PROTEIN) ("SALSA" . SPARSER::PROTEIN)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen receptor ( AR ) and zinc finger protein" . SPARSER::COLLECTION)
    ("These downregulated genes included NF1 , FOXO4 , androgen receptor ( AR ) and zinc finger protein"
     . SPARSER::COLLECTION)
    ("These downregulated genes included NF1" . SPARSER::PROTEIN)
    ("neurofibromin 1 ( NF1 ) and lymphoid enhancer-binding factor 1 ( LEF1 ) genes"
     . SPARSER::COLLECTION)
    ("the forkhead box O4 ( FOXO4 ), neurofibromin 1 ( NF1 ) and lymphoid enhancer-binding factor 1 ( LEF1 ) genes"
     . SPARSER::COLLECTION)
    ("genes included ErbB2 , NRG1 , EGFR , L1CAM , DCX and ERBB2IP"
     . SPARSER::COLLECTION)
    ("ErbB2 , NRG1 , EGFR , L1CAM , DCX and ERBB2IP" . SPARSER::COLLECTION)
    ("DCX" . SPARSER::PROTEIN)
    ("the upregulated genes included glycoprotein" . SPARSER::PROTEIN)
    ("SEMA3D , MERTK , RELN and CD36" . SPARSER::COLLECTION)
    ("RELN" . SPARSER::PROTEIN) ("MERTK" . SPARSER::PROTEIN)
    ("/ITGB6" . SPARSER::COLLECTION) ("even validated 7 genes" . SPARSER::GENE)
    ("ABI" . SPARSER::PROTEIN-FAMILY) ("HG" . SPARSER::MOLECULE)
    ("the NF2 gene ( xref – xref ) and other tumor-related genes ( xref )"
     . SPARSER::COLLECTION)
    ("ErbB3 ( xref ) and EGFR ( xref )" . SPARSER::COLLECTION)
    ("Rac/PAK" . SPARSER::COLLECTION) ("Schwann" . SPARSER::PROTEIN)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION)
    ("Merlin" . SPARSER::PROTEIN)
    ("merlin or schwannomin" . SPARSER::COLLECTION)
    ("schwannomin" . SPARSER::PROTEIN)
    ("glial-Schwann" . SPARSER::PROTEIN-PAIR)
    ("histological type or NF2 status" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("PMP22" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN) ("SEMA5A" . SPARSER::PROTEIN)
    ("plexin-B" . SPARSER::PROTEIN) ("semaphorin 5A" . SPARSER::PROTEIN)
    ("Phosphoinositide-3-kinase interacting protein 1" . SPARSER::PROTEIN)
    ("Immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("HSPB8" . SPARSER::PROTEIN) ("HSPB6" . SPARSER::PROTEIN)
    ("HSPA4L" . SPARSER::PROTEIN) ("HSPA13" . SPARSER::PROTEIN)
    ("HSPA12A" . SPARSER::PROTEIN) ("desmoglein 2" . SPARSER::PROTEIN)
    ("SLC9A3R1" . SPARSER::PROTEIN) ("RF1" . SPARSER::PROTEIN)
    ("e-12" . SPARSER::PROTEIN) ("TGFβR" . SPARSER::PROTEIN)
    ("e-5" . SPARSER::PROTEIN) ("neuroligin-4" . SPARSER::PROTEIN)
    ("NRXN3" . SPARSER::PROTEIN) ("neurexin-3" . SPARSER::PROTEIN)
    ("neurexin-2" . SPARSER::PROTEIN) ("neurexin-1" . SPARSER::PROTEIN)
    ("IKZF1" . SPARSER::PROTEIN)
    ("lymphoid enhancer-binding factor 1" . SPARSER::PROTEIN)
    ("forkhead box O4" . SPARSER::PROTEIN) ("ERBB2IP" . SPARSER::PROTEIN)
    ("SEMA3D" . SPARSER::PROTEIN) ("class B" . SPARSER::PROTEIN)
    ("RPL18" . SPARSER::PROTEIN) ("IL8RA" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("CX3CL1" . SPARSER::PROTEIN)
    ("WWP1" . SPARSER::PROTEIN) ("SHOX2" . SPARSER::PROTEIN)
    ("RASSF4" . SPARSER::PROTEIN) ("PIK3IP1" . SPARSER::PROTEIN)
    ("PAK3" . SPARSER::PROTEIN) ("NRXN1" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("L1CAM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GRB14" . SPARSER::PROTEIN) ("FLOT1" . SPARSER::PROTEIN)
    ("FABP4" . SPARSER::PROTEIN) ("DSG2" . SPARSER::PROTEIN)
    ("CXCL5" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("CTNNA1" . SPARSER::PROTEIN) ("ATF7IP" . SPARSER::PROTEIN)
    ("ANK3" . SPARSER::PROTEIN) ("ANK2" . SPARSER::PROTEIN)
    ("terminal transferase" . SPARSER::PROTEIN) ("ITGB6" . SPARSER::PROTEIN)
    ("myosin phosphatase target subunit 1" . SPARSER::PROTEIN)
    ("DCAF1" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("band 4.1" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("SEMA5" . SPARSER::PROTEIN) ("ITGA4" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("neuregulin 1" . SPARSER::PROTEIN)
    ("neurofibromin 2" . SPARSER::PROTEIN)
    ("a classical tumour suppressor" . SPARSER::SUPPRESSOR)
    ("pro- and anti-metastatic" . SPARSER::COLLECTION)
    ("GATA3 and miR-29b" . SPARSER::COLLECTION)
    ("LOX , MMPs and VEGFA" . SPARSER::COLLECTION)
    ("mesenchymal traits" . SPARSER::PROTEIN)
    ("E-cadherin and ER" . SPARSER::COLLECTION)
    ("TGFB2 and TGFB3" . SPARSER::COLLECTION)
    ("bona fide miR-29b" . SPARSER::MOLECULE)
    ("ANGPTL4 , LOX , MMP9 and VEGFA" . SPARSER::COLLECTION)
    ("GATA3-Zip29" . SPARSER::PROTEIN-PAIR)
    ("these microenvironmental genes" . SPARSER::GENE)
    ("ANGPTL4, LOX, MMP9 or VEGF-A" . SPARSER::COLLECTION)
    ("ANGPTL4 , LOX , MMP9 , VEGFA , ITGA6 and ITGB1" . SPARSER::COLLECTION)
    ("LOX and VEGF-A" . SPARSER::COLLECTION)
    ("either miR-29b or control mimic" . SPARSER::COLLECTION)
    ("many microenvironmental genes" . SPARSER::GENE)
    ("ITGA6 (CD49f) and ITGB1 (CD29)" . SPARSER::COLLECTION)
    ("pro-metastatic genes" . SPARSER::GENE) ("/CD24" . SPARSER::COLLECTION)
    ("CD49f and CD29" . SPARSER::COLLECTION)
    ("stably knockdown endogenous miRNAs" . SPARSER::PROTEIN)
    ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gata3 and miR-29b" . SPARSER::COLLECTION)
    ("TGF-β and NF-ΚB" . SPARSER::COLLECTION)
    ("TGF-β, TNF-Α or sRANKL" . SPARSER::COLLECTION)
    ("sRANKL" . SPARSER::PROTEIN) ("EMT and components" . SPARSER::COLLECTION)
    ("TGF-β and NF-κB" . SPARSER::COLLECTION) ("-promoter" . SPARSER::PROMOTER)
    ("miR-29b and miR-29c" . SPARSER::COLLECTION)
    ("VEGFA and perhaps other pro-metastatic genes" . SPARSER::GENE)
    ("VEGFA and perhaps" . SPARSER::COLLECTION)
    ("serum VEGF-A and tumour vasculature" . SPARSER::COLLECTION)
    ("MDA231-GATA3 and 4T1-Gata3" . SPARSER::COLLECTION)
    ("EpCAM" . SPARSER::PROTEIN)
    ("RFP (control) or Gata3–GFP" . SPARSER::COLLECTION)
    ("Gata3–GFP" . SPARSER::COLLECTION)
    ("vasculature and macrophage" . SPARSER::COLLECTION)
    ("an immunocompetent model, and human GATA3" . SPARSER::PROTEIN)
    ("pro-metastatic regulators" . SPARSER::REGULATOR)
    ("LOX and MMP9" . SPARSER::COLLECTION)
    ("ITGA6 , ITGB1 and TGFB" . SPARSER::COLLECTION)
    ("TGFB" . SPARSER::PROTEIN) ("NF κB" . SPARSER::PROTEIN)
    ("pCR2" . SPARSER::PROTEIN) ("TGF-βR" . SPARSER::PROTEIN)
    ("TGF-β2" . SPARSER::PROTEIN) ("TGFB3" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("oestrogen-receptor" . SPARSER::PROTEIN)
    ("miR-29c" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("messenger RNAs" . SPARSER::RNA)
    ("Gata3" . SPARSER::PROTEIN) ("ITGA6" . SPARSER::PROTEIN)
    ("ANGPTL4" . SPARSER::PROTEIN) ("miR-29b" . SPARSER::MOLECULE)
    ("glycaemic traits" . SPARSER::PROTEIN)
    ("uncontrolled glucose" . SPARSER::PROTEIN)
    ("both glucose and insulin" . SPARSER::COLLECTION)
    ("variant and rs1801123" . SPARSER::COLLECTION)
    ("gly" . SPARSER::AMINO-ACID) ("C-T, C-C, and T-T" . SPARSER::COLLECTION)
    ("significantly higher HOMR-IR" . SPARSER::COLLECTION)
    ("significantly higher fasting plasma glucose" . SPARSER::MOLECULE)
    ("HOMR-IR" . SPARSER::COLLECTION) ("glyacemic traits" . SPARSER::PROTEIN)
    ("IRS and PPARGC1A" . SPARSER::COLLECTION)
    ("genotypes and DNA" . SPARSER::COLLECTION)
    ("hyperglycemia, hyperinsulinemia, and type 2" . SPARSER::COLLECTION)
    ("glycaemic quantitative traits" . SPARSER::PROTEIN)
    ("GADD45A and DDB1" . SPARSER::COLLECTION)
    ("C-reactive protein (CRP)" . SPARSER::PROTEIN)
    ("classical disease biomarkers" . SPARSER::MOLECULE)
    ("Arginine" . SPARSER::AMINO-ACID)
    ("significantly higher HOMA-IR" . SPARSER::COLLECTION)
    ("related traits" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("T-T" . SPARSER::PROTEIN) ("PPARGC1A" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN)
    ("Insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-T" . SPARSER::PROTEIN) ("Ras/Raf" . SPARSER::COLLECTION)
    ("all the disease-associated Raf mutants" . SPARSER::MUTANT)
    ("disease-associated Raf proteins" . SPARSER::PROTEIN)
    ("Ras, 14-3-3, MEK, Hsp90, or Cdc37" . SPARSER::COLLECTION)
    ("activators or events" . SPARSER::COLLECTION)
    ("EGFR, Ras, and Raf" . SPARSER::COLLECTION)
    ("prominent inducers" . SPARSER::MOLECULE)
    ("EGFR and Ras" . SPARSER::COLLECTION)
    ("The TAT-DI1 peptide or a control TAT-peptide containing"
     . SPARSER::COLLECTION)
    ("GST-DI1" . SPARSER::COLLECTION) ("GFP-DI1" . SPARSER::COLLECTION)
    ("FLAG-C-Raf" . SPARSER::COLLECTION)
    ("moderate, low, and impaired activity B-Raf and C-Raf mutants"
     . SPARSER::MUTANT)
    ("A-B" . SPARSER::PROTEIN)
    ("the disease-associated Raf mutants" . SPARSER::MUTANT)
    ("These disease-associated Raf mutants" . SPARSER::MUTANT)
    ("B-Raf–C-Raf" . SPARSER::COLLECTION)
    ("Disease-associated Raf Mutants" . SPARSER::MUTANT)
    ("Mutants" . SPARSER::MUTANT) ("Raf–Raf" . SPARSER::COLLECTION)
    ("Ras, 14-3-3, Hsp90, or Cdc37" . SPARSER::COLLECTION)
    ("Cdc37" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("FLAG- and Pyo-tagged Raf proteins" . SPARSER::COLLECTION)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY)
    ("C-Raf and B-Raf" . SPARSER::COLLECTION) ("H-B-Raf" . SPARSER::COLLECTION)
    ("Dimer" . SPARSER::DIMER) ("B-Raf or C-Raf" . SPARSER::COLLECTION)
    ("B-Raf and A-Raf" . SPARSER::COLLECTION)
    ("C-Raf and A-Raf" . SPARSER::COLLECTION)
    ("B-Raf and C-Raf" . SPARSER::COLLECTION)
    ("GTPases and B-Raf" . SPARSER::COLLECTION)
    ("Ras–Raf" . SPARSER::COLLECTION) ("Rafs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A-Raf, B-Raf and C-Raf" . SPARSER::COLLECTION)
    ("disease-associated Raf mutants" . SPARSER::MUTANT)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION) ("C-12" . SPARSER::PROTEIN)
    ("DI1" . SPARSER::PROTEIN) ("H-B" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN) ("A-Raf" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN)
    ("a unique molecular target" . SPARSER::TARGET-PROTEIN)
    ("phosphomimetic (S333E) amino acid" . SPARSER::AMINO-ACID)
    ("HSP70 and a protein" . SPARSER::COLLECTION)
    ("the fluorescent phorbol ester SAPD" . SPARSER::PROTEIN)
    ("ester" . SPARSER::MOLECULE)
    ("associated endogenous HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alanine or glutamic acid" . SPARSER::COLLECTION)
    ("the phosphomimetic mutant" . SPARSER::MUTANT) ("Dai" . SPARSER::PROTEIN)
    ("BGP" . SPARSER::PROTEIN) ("hyperglycemia" . SPARSER::PROTEIN)
    ("cell permeable pyruvate" . SPARSER::PROTEIN) ("fasentin" . SPARSER::DRUG)
    ("PKCδ and PKCθ" . SPARSER::COLLECTION)
    ("bind either DAG or phorbol esters ( xref ; xref )" . SPARSER::COLLECTION)
    ("SAPD" . SPARSER::PROTEIN) ("deoxyglucose" . SPARSER::MOLECULE)
    ("VHL, FH, or Folliculin" . SPARSER::COLLECTION)
    ("Folliculin" . SPARSER::PROTEIN) ("FH" . SPARSER::PROTEIN)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCζ and PKCι" . SPARSER::COLLECTION) ("1 – 4" . SPARSER::PROTEIN)
    ("EA 6" . SPARSER::PROTEIN) ("Glut 1" . SPARSER::PROTEIN)
    ("Kinase activity" . SPARSER::PROTEIN) ("PKCγ" . SPARSER::PROTEIN)
    ("heat shock transcription factor" . SPARSER::PROTEIN)
    ("an attractive chemical" . SPARSER::MOLECULE)
    ("the dimerization-defective Nef-4D mutant" . SPARSER::MUTANT)
    ("the conformation or stability" . SPARSER::COLLECTION)
    ("Ala, Leu, and Gln" . SPARSER::COLLECTION) ("‘ligand’" . SPARSER::LIGAND)
    ("PPD" . SPARSER::PROTEIN) ("the Nef-defective mutant" . SPARSER::MUTANT)
    ("cellular kinases or other proteins" . SPARSER::COLLECTION)
    ("c-Src, Lck and Lyn" . SPARSER::COLLECTION)
    ("the 4-amino DFP inhibitors" . SPARSER::INHIBITOR)
    ("220,000 diverse chemical" . SPARSER::MOLECULE)
    ("the 4-amino DFP" . SPARSER::PROTEIN-FAMILY)
    ("DFP" . SPARSER::PROTEIN-FAMILY) ("DFPs" . SPARSER::PROTEIN-FAMILY)
    ("the viral protein" . SPARSER::PROTEIN)
    ("a unique diphenylfuranopyrimidine kinase inhibitor" . SPARSER::INHIBITOR)
    ("Nef-directed antiretroviral drugs" . SPARSER::DRUG)
    ("this single viral protein" . SPARSER::PROTEIN)
    ("CD4/CXCR4/CCR5" . SPARSER::COLLECTION)
    ("viral enzymes and structural proteins" . SPARSER::COLLECTION)
    ("viral enzymes" . SPARSER::ENZYME) ("Vpu" . SPARSER::PROTEIN)
    ("antiretroviral drugs" . SPARSER::DRUG)
    ("diverse chemical library and identified small molecules"
     . SPARSER::MOLECULE)
    ("Hck" . SPARSER::PROTEIN) ("P20" . SPARSER::PROTEIN)
    ("Gag proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gag protein" . SPARSER::PROTEIN) ("MT2" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("Growth factor receptor-bound protein 2-associated binding protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the only wound healing derived factor" . SPARSER::PROTEIN)
    ("the mature 80 kDa receptor" . SPARSER::RECEPTOR)
    ("tocilizumab" . SPARSER::DRUG)
    ("the EGFR ligand antagonistic antibody cetuximab" . SPARSER::DRUG)
    ("b and c" . SPARSER::COLLECTION)
    ("a considerable part" . SPARSER::COMPONENT)
    ("substance" . SPARSER::SUBSTANCE)
    ("ERK1/2, STAT3, and Akt" . SPARSER::COLLECTION)
    ("β-catenin or S100A4" . SPARSER::COLLECTION)
    ("three-dimensional Matrigel" . SPARSER::PROTEIN)
    ("any possible invasion activators" . SPARSER::ACTIVATOR)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("the epidermal growth factor receptor (EGFR) family [ xref , xref ] and cyclooxygenase-2 inhibitors [ xref ]"
     . SPARSER::COLLECTION)
    ("c-Met or epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("Interleukin-6 receptor" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN)
    ("Growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("IL6R" . SPARSER::PROTEIN)
    ("S100A4" . SPARSER::PROTEIN) ("S3I-201" . SPARSER::MOLECULE)
    ("IL6Rα" . SPARSER::PROTEIN) ("EGFR-2" . SPARSER::PROTEIN)
    ("GRB2-associated-binding protein 1" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("interleukin-6 receptor" . SPARSER::PROTEIN)
    ("CD36 and CD47" . SPARSER::COLLECTION) ("Mus" . SPARSER::PROTEIN)
    ("the profound effect decorin" . SPARSER::PROTEIN)
    ("RhoA/ROCK1" . SPARSER::COLLECTION)
    ("Ras/RhoA/ROCK1" . SPARSER::COLLECTION)
    ("EGFR and Met" . SPARSER::COLLECTION) ("spike" . SPARSER::PROTEIN)
    ("the TSP-1 oligomeric form" . SPARSER::FORM)
    ("THBS1 and TSP-1" . SPARSER::COLLECTION)
    ("this matricellular component" . SPARSER::COMPONENT)
    ("soluble anti-angiogenic effectors" . SPARSER::EFFECTOR)
    ("soluble pro-angiogenic mediators" . SPARSER::PROTEIN)
    ("VEGFA , FGF2 , and ENG" . SPARSER::COLLECTION)
    ("THBS1 and TIMP3" . SPARSER::COLLECTION) ("ENG" . SPARSER::PROTEIN)
    ("angiokine" . SPARSER::PROTEIN-FAMILY)
    ("exosomal Cav-1" . SPARSER::PROTEIN) ("exosomal TSP-1" . SPARSER::PROTEIN)
    ("exosomal fractions" . SPARSER::COMPONENT)
    ("pathobiological states" . SPARSER::BIO-STATE)
    ("RNA, and DNA" . SPARSER::COLLECTION)
    ("the EGFR monoclonal blocking antibody" . SPARSER::ANTIBODY)
    ("total secreted TSP-1" . SPARSER::PROTEIN)
    ("a highly anti-angiogenic molecule" . SPARSER::MOLECULE)
    ("cfr" . SPARSER::DRUG) ("Ras/PI3K/RhoA" . SPARSER::COLLECTION)
    ("cellular TSP-1" . SPARSER::PROTEIN)
    ("exogenous soluble decorin" . SPARSER::PROTEIN) ("TSP" . SPARSER::PROTEIN)
    ("monocytes and eosinophils" . SPARSER::COLLECTION)
    ("cGMP" . SPARSER::PROTEIN) ("MMP-9 and VEGFA" . SPARSER::COLLECTION)
    ("kinase and p38" . SPARSER::COLLECTION)
    ("a secreted monomeric glycoprotein" . SPARSER::PROTEIN)
    ("platelets and plateletα-granules" . SPARSER::COLLECTION)
    ("trimer" . SPARSER::TRIMER) ("filamentous protein" . SPARSER::PROTEIN)
    ("an archetypical matricellular component" . SPARSER::COMPONENT)
    ("HIF-1α and VEGFA" . SPARSER::COLLECTION)
    ("thrompspondin-1" . SPARSER::COLLECTION)
    ("β-catenin and Myc" . SPARSER::COLLECTION)
    ("the only antagonistic ligand" . SPARSER::LIGAND)
    ("monomeric decorin" . SPARSER::PROTEIN)
    ("EGFR and ErbB4" . SPARSER::COLLECTION)
    ("highly-induced gene" . SPARSER::GENE) ("SLRP" . SPARSER::PROTEIN)
    ("Proteoglycan" . SPARSER::PROTEIN) ("soluble decorin" . SPARSER::PROTEIN)
    ("Soluble decorin" . SPARSER::PROTEIN)
    ("angiokines" . SPARSER::PROTEIN-FAMILY) ("1-C" . SPARSER::PROTEIN)
    ("mL −1" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("ROCK1 protein" . SPARSER::PROTEIN) ("p160-ROCK" . SPARSER::PROTEIN)
    ("SU11274" . SPARSER::DRUG) ("VEGFR2" . SPARSER::PROTEIN)
    ("CD47" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("TSP-1" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("thrombospondin-1" . SPARSER::PROTEIN) ("MH" . SPARSER::MOLECULE)
    ("Eastern Cooperative Oncology Group" . SPARSER::MOLECULE)
    ("Los" . SPARSER::MOLECULE) ("fluorodeoxyuridine" . SPARSER::DRUG)
    ("dTMP" . SPARSER::MOLECULE) ("mRNA and TS" . SPARSER::COLLECTION)
    ("Pemetrexed" . SPARSER::DRUG)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("gemcitabine, vinorelbine, or taxanes" . SPARSER::COLLECTION)
    ("paclitaxel or docetaxel" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG)
    ("both TS protein and its mRNA" . SPARSER::COLLECTION)
    ("protein and TS" . SPARSER::COLLECTION)
    ("TS and its gene SNPs" . SPARSER::COLLECTION)
    ("protein or TS" . SPARSER::COLLECTION)
    ("Thymidine monophosphate" . SPARSER::THYMIDINE-MONOPHOSPHATE)
    ("C 40" . SPARSER::PROTEIN)
    ("thymidine monophosphate" . SPARSER::THYMIDINE-MONOPHOSPHATE)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("Prx" . SPARSER::PROTEIN) ("peroxiredoxin" . SPARSER::PROTEIN)
    ("enzymes, and redox" . SPARSER::COLLECTION)
    ("Src or ADAM17" . SPARSER::COLLECTION)
    ("thioredoxins or glutaredoxins" . SPARSER::COLLECTION)
    ("glutaredoxins" . SPARSER::PROTEIN) ("thioredoxins" . SPARSER::PROTEIN)
    ("Src and related kinases" . SPARSER::COLLECTION)
    ("defective EGFR" . SPARSER::PROTEIN)
    ("H 2 O 2 or ROS" . SPARSER::COLLECTION)
    ("Src, ADAM17, and EGFR" . SPARSER::COLLECTION)
    ("GPCR or TLR" . SPARSER::COLLECTION)
    ("2 separate DUOX isoforms" . SPARSER::ISOFORM)
    ("Src-EGFR" . SPARSER::COLLECTION)
    ("extracellular H 2 O 2" . SPARSER::DRUG)
    ("P2Y 2 R purinergic receptors" . SPARSER::PROTEIN)
    ("amino-labeled ADAM17" . SPARSER::PROTEIN)
    ("120 kD and 100 kDa" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("Maleimide" . SPARSER::DRUG)
    ("redox-sensitive cysteines within the extracellular region of mature ADAM17"
     . SPARSER::PROTEIN)
    ("mature ADAM17" . SPARSER::PROTEIN)
    ("ADAM17 and EGFR" . SPARSER::COLLECTION) ("Biotin" . SPARSER::PROTEIN)
    ("EZ" . SPARSER::PROTEIN-FAMILY) ("DUOX" . SPARSER::PROTEIN)
    ("c-Src and ADAM17" . SPARSER::COLLECTION)
    ("Src and/or ADAM17" . SPARSER::COLLECTION)
    ("ATP- or EGF-dependent activation of Src, STAT3 or ADAM17 (  xref  )"
     . SPARSER::COLLECTION)
    ("Src, STAT3 or ADAM17" . SPARSER::COLLECTION) ("ATP-" . SPARSER::ATP)
    ("lack functional DUOX1" . SPARSER::PROTEIN)
    ("almost completely lack DUOX1 mRNA and protein" . SPARSER::COLLECTION)
    ("Src and P2Y 2" . SPARSER::COLLECTION) ("Src/EGFR" . SPARSER::COLLECTION)
    ("Src or EGFR" . SPARSER::COLLECTION)
    ("receptors or ADAM17" . SPARSER::COLLECTION) ("SI" . SPARSER::PROTEIN)
    ("Src and/or EGFR" . SPARSER::COLLECTION)
    ("MMP-9 and IL-8" . SPARSER::COLLECTION)
    ("Src/ADAM17/EGFR" . SPARSER::COLLECTION) ("EGTA" . SPARSER::MOLECULE)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("a fluorogenic ADAM17 substrate" . SPARSER::SUBSTRATE)
    ("EGF as well as ATP ( xref )" . SPARSER::COLLECTION)
    ("EGFR ligands and ligand-dependent EGFR dimerization and activation xref"
     . SPARSER::COLLECTION)
    ("exogenous ATP" . SPARSER::ATP)
    ("the major purinergic P2Y receptors" . SPARSER::RECEPTOR)
    ("ADP or UDP" . SPARSER::COLLECTION) ("UTP" . SPARSER::MOLECULE)
    ("MMP-9 or IL-8" . SPARSER::COLLECTION)
    ("EGFR and Src" . SPARSER::COLLECTION) ("major H 2 O 2" . SPARSER::DRUG)
    ("mitochondria-derived H 2 O 2 or related reactive oxygen species (ROS)"
     . SPARSER::COLLECTION)
    ("DUOX1 and DUOX2" . SPARSER::COLLECTION)
    ("oxidative disulfide" . SPARSER::MOLECULE)
    ("purinergic receptors" . SPARSER::PROTEIN)
    ("EGFR, Erb2 and Erb3" . SPARSER::COLLECTION)
    ("HER4/Erb4" . SPARSER::COLLECTION) ("HER3/Erb3" . SPARSER::COLLECTION)
    ("HER1/EGFR/Erb1" . SPARSER::COLLECTION) ("Erb" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGFR)" . SPARSER::PROTEIN)
    ("Src and ADAM17" . SPARSER::COLLECTION)
    ("Src as well as ADAM17" . SPARSER::COLLECTION)
    ("Src and DUOX1" . SPARSER::COLLECTION) ("AG-3" . SPARSER::PROTEIN)
    ("H1.2" . SPARSER::PROTEIN) ("P2Y2" . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("120 kD" . SPARSER::PROTEIN)
    ("ADAM-17" . SPARSER::PROTEIN) ("sulfo-NHS" . SPARSER::DRUG)
    ("N 2" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("HBE1" . SPARSER::PROTEIN) ("P2Y 6" . SPARSER::PROTEIN)
    ("P2Y 1" . SPARSER::PROTEIN) ("purinergic receptor" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("DUOX2" . SPARSER::PROTEIN)
    ("Erb1" . SPARSER::PROTEIN) ("ADAM17" . SPARSER::PROTEIN)
    ("P2Y 2" . SPARSER::PROTEIN) ("DUOX1" . SPARSER::PROTEIN)
    ("circadian promoters" . SPARSER::PROMOTER) ("CLOCK" . SPARSER::PROTEIN)
    ("a myeloid and B-cell proto-oncogene" . SPARSER::COLLECTION)
    ("either DMSO (mock) or celastrol (5 µM) 24 hours post-transfection"
     . SPARSER::COLLECTION)
    ("SIRT1, DBC1 and AROS" . SPARSER::COLLECTION)
    ("Flag-HSF1" . SPARSER::COLLECTION)
    ("either DMSO (mock) or celastrol (5 µM)" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE) ("HSE" . SPARSER::PROTEIN)
    ("available NAD +" . SPARSER::MOLECULE)
    ("NAD + and NADH" . SPARSER::COLLECTION)
    ("HSP70 and HSP27" . SPARSER::COLLECTION)
    ("HSF1-SIRT1" . SPARSER::COLLECTION)
    ("HSF1 and SIRT1" . SPARSER::COLLECTION)
    ("DBC1 and AROS" . SPARSER::COLLECTION) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("NAMPT" . SPARSER::PROTEIN)
    ("HuR, a ubiquitously expressed RNA binding protein, and oxidative stress"
     . SPARSER::COLLECTION)
    ("sirt1" . SPARSER::PROTEIN) ("AROS and DBC1" . SPARSER::COLLECTION)
    ("AROS" . SPARSER::PROTEIN) ("DBC1" . SPARSER::PROTEIN)
    ("hsp27" . SPARSER::PROTEIN) ("BCL11A" . SPARSER::PROTEIN)
    ("α-synuclein" . SPARSER::PROTEIN)
    ("hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("hsp70" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("Tribbles" . SPARSER::PROTEIN-FAMILY)
    ("p53 and p21 Cip1" . SPARSER::COLLECTION)
    ("SB216763 and LiCl" . SPARSER::COLLECTION)
    ("ATF4 and CHOP" . SPARSER::COLLECTION)
    ("death receptor 5 and Bcl-XL" . SPARSER::COLLECTION)
    ("tribbles" . SPARSER::PROTEIN-FAMILY)
    ("CHOP and ATF4" . SPARSER::COLLECTION)
    ("ER stress-responsive genes" . SPARSER::GENE)
    ("p53/p21 Cip1" . SPARSER::COLLECTION)
    ("p21 Cip1/WAF1" . SPARSER::COLLECTION)
    ("p53/p21 Cip1/WAF1" . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION) ("Hepatocytes" . SPARSER::PROTEIN)
    ("p53/p21 cip1" . SPARSER::COLLECTION)
    ("Cystathionine" . SPARSER::MOLECULE) ("MTHFR" . SPARSER::PROTEIN)
    ("CHOP/GADD153" . SPARSER::COLLECTION) ("GRP78/BiP" . SPARSER::COLLECTION)
    ("CEBP" . SPARSER::PROTEIN) ("BiP" . SPARSER::PROTEIN)
    ("TRB3 and p21 Cip1" . SPARSER::COLLECTION) ("pifithrin" . SPARSER::DRUG)
    ("homocysteine" . SPARSER::MOLECULE) ("Homocysteine" . SPARSER::MOLECULE)
    ("SB216763" . SPARSER::DRUG) ("death receptor 5" . SPARSER::PROTEIN)
    ("carbonic anhydrase VI" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATF4" . SPARSER::PROTEIN)
    ("GADD153" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("TRB3" . SPARSER::PROTEIN) ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its targeting pro-apoptotic genes MAPK14/p38" . SPARSER::COLLECTION)
    ("human HD and multiple HD" . SPARSER::COLLECTION)
    ("HD and histone deacetylase" . SPARSER::COLLECTION)
    ("REST/NRSF" . SPARSER::COLLECTION) ("NRSF" . SPARSER::PROTEIN)
    ("MAPK14 and Trp53inp1" . SPARSER::COLLECTION)
    ("Rcor1, HDAC4, Rgs2 and Htt" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("the Tp53inp1 and MAPK14/p38 mRNAs" . SPARSER::COLLECTION)
    ("whose encoded proteins" . SPARSER::PROTEIN) ("NeuN" . SPARSER::PROTEIN)
    ("the other lentivirally-delivered miRNA" . SPARSER::PROTEIN)
    ("Rcor1, Rgs2 and HDAC4" . SPARSER::COLLECTION)
    ("Rcor1 and HDAC4" . SPARSER::COLLECTION)
    ("neuronal genes" . SPARSER::GENE)
    ("both HD and Alzheimer’s" . SPARSER::COLLECTION)
    ("HD and Alzheimer" . SPARSER::COLLECTION)
    ("Huntingtin" . SPARSER::PROTEIN)
    ("HDAC4, Rcor1 and Rgs2" . SPARSER::COLLECTION)
    ("Tp53inp1" . SPARSER::PROTEIN) ("MAPK14/p38" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase 14/p38" . SPARSER::COLLECTION)
    ("Htt" . SPARSER::PROTEIN)
    ("a potentially neuroprotective miRNA" . SPARSER::PROTEIN)
    ("Rgs2" . SPARSER::PROTEIN) ("Rcor1" . SPARSER::PROTEIN)
    ("REST" . SPARSER::PROTEIN) ("Trp53inp1" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("tumor protein p53-inducible nuclear protein 1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 14" . SPARSER::PROTEIN)
    ("regulator of G-protein signaling 2" . SPARSER::PROTEIN)
    ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("BIRB796 and conventional chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("the proinflammatory cytokines" . SPARSER::PROTEIN)
    ("ABCB1 and BIRB796" . SPARSER::COLLECTION)
    ("vinblastine, verapamil, and paclitaxel" . SPARSER::COLLECTION)
    ("vinblastine" . SPARSER::DRUG) ("axitinib" . SPARSER::DRUG)
    ("vandetanib" . SPARSER::DRUG) ("cediranib" . SPARSER::DRUG)
    ("neratinib" . SPARSER::DRUG)
    ("the specific ABCB1 inhibitors and this" . SPARSER::COLLECTION)
    ("BIRB796 and paclitaxel" . SPARSER::COLLECTION)
    ("paclitaxel or BIRB796" . SPARSER::COLLECTION)
    ("BIRB796, or paclitaxel" . SPARSER::COLLECTION)
    ("BIRB796, paclitaxel and BIRB796" . SPARSER::COLLECTION)
    ("BIRB796 or paclitaxel" . SPARSER::COLLECTION)
    ("favorable cation-π type" . TYPE) ("naphthalene" . SPARSER::MOLECULE)
    ("aromatic-aromatic type" . TYPE) ("RRR" . SPARSER::PROTEIN)
    ("Homology" . SPARSER::PROTEIN) ("Cytotoxic" . SPARSER::PROTEIN)
    ("Protein and mRNA" . SPARSER::COLLECTION) ("vanadate" . SPARSER::MOLECULE)
    ("Doxorubicin" . SPARSER::PROTEIN) ("Rhodamine" . SPARSER::PROTEIN)
    ("ABCG2-" . SPARSER::PROTEIN)
    ("doxorubicin and paclitaxel" . SPARSER::COLLECTION)
    ("doxorubicin (5.39, 25.95 and 33.95-reversing fold) and paclitaxel (2.68, 5 and 17.67-reversing fold)"
     . SPARSER::COLLECTION)
    ("doxorubicin (5.08, 8.89 and 17.85-reversing fold) and paclitaxel (2.63, 3.20 and 27.98-reversing fold)"
     . SPARSER::COLLECTION)
    ("2.5, 5 and 10 µM BIRB796 and 10 µM verapamil" . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG)
    ("ABCB1, ABCC1 and ABCG2" . SPARSER::COLLECTION)
    ("ABCG2 and ABCC1" . SPARSER::COLLECTION)
    ("HL60/ADR" . SPARSER::COLLECTION) ("ADR" . SPARSER::PROTEIN)
    ("ABCC1 and ABCG2" . SPARSER::COLLECTION)
    ("MKK3, MKK4, and MKK6" . SPARSER::COLLECTION)
    ("vincristine and doxorubicin" . SPARSER::COLLECTION)
    ("mitoxantrone, topotecan and SN-38" . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG) ("antineoplastic drugs" . SPARSER::DRUG)
    ("doxorubicin, vincristine, paclitaxel, and epipodophyllotoxins"
     . SPARSER::COLLECTION)
    ("epipodophyllotoxins" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("ABCB1, ABCG2 and ABCCs" . SPARSER::COLLECTION)
    ("ABCCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("rhodamine" . SPARSER::PROTEIN)
    ("ABCC1 or ABCG2" . SPARSER::COLLECTION)
    ("ABCB1, ABCG2 and ABCC1" . SPARSER::COLLECTION)
    ("nitrogen atom" . SPARSER::MOLECULE) ("tert -butyl" . SPARSER::MOLECULE)
    ("c-nu" . SPARSER::PROTEIN) ("ATPase Activity" . SPARSER::PROTEIN)
    ("P-Glycoprotein" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE) ("MKK3" . SPARSER::PROTEIN)
    ("SN-38" . SPARSER::DRUG) ("mdr1" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN)
    ("demonstrated p68 (Ddx5) and the highly homologous p72 (Ddx17) protein"
     . SPARSER::COLLECTION)
    ("the pro-migratory NFAT5 transcription factor" . SPARSER::PROTEIN)
    ("the highly homologous p72 (Ddx17) protein" . SPARSER::PROTEIN)
    ("AR and RNAP" . SPARSER::COLLECTION)
    ("These findings directly link p68" . SPARSER::PROTEIN)
    ("Immuno-blot" . SPARSER::COLLECTION) ("Immuno" . SPARSER::PROTEIN)
    ("AR/β-Catenin" . SPARSER::COLLECTION)
    ("p68-β-Catenin" . SPARSER::COLLECTION)
    ("Wnt/β-Catenin" . SPARSER::COLLECTION)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Catenin and the AR" . SPARSER::COLLECTION)
    ("p68, β-Catenin and the AR" . SPARSER::COLLECTION)
    ("AR, β-Catenin and p72" . SPARSER::COLLECTION)
    ("the highly homologous helicase p72" . SPARSER::PROTEIN)
    ("AR and p68" . SPARSER::COLLECTION)
    ("the co-activator β-Catenin and the AR" . SPARSER::COLLECTION)
    ("KLK2 and TMPRSS2" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("the promoter and enhancer regions of androgen" . SPARSER::COLLECTION)
    ("the AR and the androgen responsive PSA gene" . SPARSER::COLLECTION)
    ("Intron" . SPARSER::PROTEIN)
    ("enhancer and promoter" . SPARSER::COLLECTION) ("dsF" . SPARSER::PROTEIN)
    ("elongation and mRNA" . SPARSER::COLLECTION)
    ("a functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Catenin-p68" . SPARSER::COLLECTION)
    ("AR and androgens" . SPARSER::COLLECTION)
    ("immuno-blot" . SPARSER::PROTEIN-PAIR)
    ("demonstrated AR constitutively shuttles β-Catenin" . SPARSER::PROTEIN)
    ("Proportionally less β-Catenin" . SPARSER::PROTEIN)
    ("AR, β-Catenin and p68" . SPARSER::COLLECTION)
    ("β-Catenin and p68" . SPARSER::COLLECTION)
    ("p68 and the highly homologous protein p72 (Ddx17)" . SPARSER::COLLECTION)
    ("the highly homologous protein p72" . SPARSER::PROTEIN)
    ("helicases" . SPARSER::PROTEIN) ("cellular β-Catenin" . SPARSER::PROTEIN)
    ("androgen and Wnt" . SPARSER::COLLECTION)
    ("Akt and GSK-3β" . SPARSER::COLLECTION) ("relaxin" . SPARSER::PROTEIN)
    ("Wnt and androgen" . SPARSER::COLLECTION)
    ("β-Catenin and AR" . SPARSER::COLLECTION) ("RNAP" . SPARSER::PROTEIN)
    ("AR and β-Catenin" . SPARSER::COLLECTION)
    ("p68 and β-Catenin" . SPARSER::COLLECTION) ("C-20" . SPARSER::PROTEIN)
    ("pcDNA 3" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("DdX17" . SPARSER::PROTEIN) ("KLK2" . SPARSER::PROTEIN)
    ("E-P" . SPARSER::PROTEIN) ("Ddx17" . SPARSER::PROTEIN)
    ("p72" . SPARSER::PROTEIN) ("Ddx5" . SPARSER::PROTEIN)
    ("ERK-1/2, PI3K, SMAD, and PKC" . SPARSER::COLLECTION)
    ("GFX and U0126" . SPARSER::COLLECTION)
    ("activin/nodal" . SPARSER::COLLECTION)
    ("TGF-β/activin/nodal" . SPARSER::COLLECTION)
    ("AKT/GSK-3β" . SPARSER::COLLECTION) ("Ding" . SPARSER::PROTEIN)
    ("ERK-1/2 or GSK-3β" . SPARSER::COLLECTION)
    ("PI3-kinase and PDK-1" . SPARSER::COLLECTION)
    ("GSK-3β, ERK-1/2, or AKT" . SPARSER::COLLECTION)
    ("Eng" . SPARSER::PROTEIN) ("PKCε and PKCζ" . SPARSER::COLLECTION)
    ("atypical PKC" . SPARSER::PROTEIN)
    ("PKCζ and PKCι/λ" . SPARSER::COLLECTION)
    ("MEK/ERK-1/2" . SPARSER::COLLECTION) ("SSEA" . SPARSER::PROTEIN)
    ("KSR" . SPARSER::PROTEIN)
    ("U0126 (5 µM) and GFX (5 µM)" . SPARSER::COLLECTION)
    ("NANOG and OCT3/4" . SPARSER::COLLECTION)
    ("U0126 (5 µM) or GFX (5 µM)" . SPARSER::COLLECTION)
    ("PKC and ERK-1/2" . SPARSER::COLLECTION)
    ("ERK-1/2 and PKC" . SPARSER::COLLECTION)
    ("the self-renewal state" . SPARSER::BIO-STATE)
    ("PKCε or PKCζ" . SPARSER::COLLECTION)
    ("PKCδ, and PKCζ" . SPARSER::COLLECTION)
    ("AKT, ERK-1/2 and GSK-3β" . SPARSER::COLLECTION)
    ("PKCδ, PKCε, and PKCζ" . SPARSER::COLLECTION)
    ("PKCδ and PKCε" . SPARSER::COLLECTION)
    ("PKCδ, PKCε or PKCζ" . SPARSER::COLLECTION)
    ("PKCδ or PKCε" . SPARSER::COLLECTION) ("Isoform" . SPARSER::ISOFORM)
    ("PKCδ or ε isoforms" . SPARSER::COLLECTION)
    ("Y-27632, or U0126" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("GFX and PMA" . SPARSER::COLLECTION)
    ("Neither BMP-4 nor activin" . SPARSER::COLLECTION)
    ("AKT, ERK-1/2, or GSK-3β" . SPARSER::COLLECTION)
    ("ERK-1/2 and GSK-3β" . SPARSER::COLLECTION)
    ("AKT, ERK-1/2, and GSK-3β" . SPARSER::COLLECTION)
    ("PKC, and PKC" . SPARSER::COLLECTION)
    ("H-7, H-8, and H-9" . SPARSER::COLLECTION) ("Kenpaullone" . SPARSER::DRUG)
    ("bovine fibronectin (FN)" . SPARSER::PROTEIN)
    ("PKCε and ζ isoforms" . SPARSER::COLLECTION)
    ("GSK-3β and ERK-1/2" . SPARSER::COLLECTION)
    ("GF109203X (GFX)" . SPARSER::DRUG)
    ("the only protein components" . SPARSER::COMPONENT)
    ("oleic acid, and FGF-2" . SPARSER::COLLECTION)
    ("and 3-phosphoinositide-dependent kinase-1" . SPARSER::PROTEIN)
    ("c-Myc, c-Jun, and c-Fos" . SPARSER::COLLECTION)
    ("/protein" . SPARSER::COLLECTION)
    ("growth factor or cytokine" . SPARSER::COLLECTION)
    ("Nodal" . SPARSER::PROTEIN) ("hiPS" . SPARSER::PROTEIN)
    ("FGF-2 and activin" . SPARSER::COLLECTION)
    ("kinase (MEK)" . SPARSER::KINASE) ("PKC/GSK-3β" . SPARSER::COLLECTION)
    ("PKC/ERK-1/2" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase/ERK-1/2" . SPARSER::COLLECTION)
    ("GSK-3β and extracellular signal-regulated kinase-1/2"
     . SPARSER::COLLECTION)
    ("activin" . SPARSER::PROTEIN) ("GFX" . SPARSER::DRUG)
    ("hPS" . SPARSER::PROTEIN) ("AKT-1" . SPARSER::PROTEIN)
    ("PDK-1" . SPARSER::PROTEIN) ("A2B5" . SPARSER::DRUG)
    ("SSEA-1" . SPARSER::PROTEIN) ("TRA-2" . SPARSER::PROTEIN)
    ("Thy-1" . SPARSER::PROTEIN) ("TRA-1" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("lithium chloride" . SPARSER::DRUG)
    ("BMP-4" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("H-9" . SPARSER::PROTEIN) ("H-7" . SPARSER::PROTEIN)
    ("KLF-4" . SPARSER::PROTEIN) ("oleic acid" . SPARSER::MOLECULE)
    ("GSK-3" . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("PKCε" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase-1" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("HER-" . SPARSER::PROTEIN)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("PR and Sp1" . SPARSER::COLLECTION)
    ("histone-acetyltransferase" . SPARSER::COLLECTION)
    ("p53 or ERα" . SPARSER::COLLECTION)
    ("TFF1, PGR or CCND1" . SPARSER::COLLECTION)
    ("the inactive p21 gene" . SPARSER::GENE)
    ("TSA or LBH589" . SPARSER::COLLECTION)
    ("p400 and H2A.Z" . SPARSER::COLLECTION)
    ("H2A.Z and pol" . SPARSER::COLLECTION)
    ("TSA or LBH" . SPARSER::COLLECTION) ("siH" . SPARSER::MOLECULE)
    ("this inactive gene" . SPARSER::GENE)
    ("available H2A.Z" . SPARSER::PROTEIN)
    ("50 or 100 ng/ml TSA ( xref ) and 50 nM LBH589 ( xref )"
     . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG) ("antiestrogens" . SPARSER::DRUG)
    ("ERα-" . SPARSER::PROTEIN) ("p21 CIP1/WAF1" . SPARSER::COLLECTION)
    ("LBH" . SPARSER::PROTEIN) ("Panobinostat" . SPARSER::DRUG)
    ("Trichostatin" . SPARSER::MOLECULE) ("HDACi" . SPARSER::MOLECULE)
    ("TFF1" . SPARSER::PROTEIN) ("Histone H2A.Z" . SPARSER::PROTEIN)
    ("Histone Deacetylase" . SPARSER::PROTEIN) ("TIP60" . SPARSER::PROTEIN)
    ("H2AFZ" . SPARSER::PROTEIN) ("RPLP0" . SPARSER::PROTEIN)
    ("LBH589" . SPARSER::DRUG)
    ("Suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("H2A.Z" . SPARSER::PROTEIN) ("secondary PMF" . SPARSER::PROTEIN)
    ("post-PV PMF (n = 4) and post-ET PMF" . SPARSER::COLLECTION)
    ("allelic mRNA molecules" . SPARSER::MOLECULE)
    ("PV and PMF" . SPARSER::COLLECTION) ("REA" . SPARSER::PROTEIN)
    ("one allele (the heterozygous pattern) or both alleles (the homozygous pattern)"
     . SPARSER::COLLECTION)
    ("almost all PV" . SPARSER::PROTEIN) ("JH" . SPARSER::PROTEIN)
    ("BCR/ABL -negative MPNs" . SPARSER::PROTEIN)
    ("protein tyrosine kinases or related molecules" . SPARSER::COLLECTION)
    ("chronic neutrophilic leukemia" . SPARSER::PROTEIN)
    ("chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("a very heterogeneous complex" . SPARSER::BIO-COMPLEX)
    ("BCR-ABL -negative MPNs" . SPARSER::PROTEIN)
    ("BCR/ABL" . SPARSER::COLLECTION) ("MPNs" . SPARSER::PROTEIN)
    ("1 µL" . SPARSER::PROTEIN) ("WT/WT" . SPARSER::PROTEIN)
    ("kinase-like" . SPARSER::PROTEIN-FAMILY) ("JAK 2" . SPARSER::PROTEIN)
    ("their seemingly innumerable effectors" . SPARSER::EFFECTOR)
    ("yet another winged helix-containing protein" . SPARSER::PROTEIN)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("its associated methyltransferase METTL22" . SPARSER::PROTEIN)
    ("prefoldins" . SPARSER::PROTEIN-FAMILY)
    ("STIP1/Hsp90" . SPARSER::COLLECTION) ("chaperonin" . SPARSER::PROTEIN)
    ("arginine and lysine" . SPARSER::COLLECTION)
    ("METTL21D and AdoMet" . SPARSER::COLLECTION)
    ("wild-type METTL21D and wild-type VCP" . SPARSER::COLLECTION)
    ("methyltransferase and substrate" . SPARSER::COLLECTION)
    ("its unmethylatable mutant" . SPARSER::MUTANT)
    ("an unmethylatable mutant" . SPARSER::MUTANT)
    ("A catalytically inactive mutated form" . SPARSER::FORM)
    ("Given VCP's" . SPARSER::PROTEIN) ("Given VCP" . SPARSER::PROTEIN)
    ("VCP and ASPSCR1 or VCP" . SPARSER::COLLECTION)
    ("ASPSCR1 or VCP" . SPARSER::COLLECTION)
    ("spliceosomal Sm proteins" . SPARSER::PROTEIN)
    ("PRMT5/WD45" . SPARSER::COLLECTION)
    ("METTL22 and KIN" . SPARSER::COLLECTION)
    ("HSPA8 and METTL21D" . SPARSER::COLLECTION)
    ("VCP or ASPSCR1" . SPARSER::COLLECTION)
    ("All methyltransferases and methyl acceptors" . SPARSER::COLLECTION)
    ("cytoplasmic granular foci and METTL23" . SPARSER::COLLECTION)
    ("foci and METTL23" . SPARSER::COLLECTION)
    ("ribosomal subunit RPL3" . SPARSER::PROTEIN)
    ("the four major histones" . SPARSER::PROTEIN)
    ("METTL21C and METT22" . SPARSER::COLLECTION)
    ("HSPA1, HSPA5, and HSPA8" . SPARSER::COLLECTION)
    ("no other methylated peptide" . SPARSER::PEPTIDE)
    ("in fact protein methyltransferases" . SPARSER::PROTEIN)
    ("loose homology" . SPARSER::PROTEIN)
    ("HSPA1, HSPA1L, HSPA2, HSPA5, and HSPA6" . SPARSER::COLLECTION)
    ("LTQ" . SPARSER::MOLECULE) ("peptide (CBP)" . SPARSER::PEPTIDE)
    ("METTL18, CAMKMT, METTL21C, METTL22, METTL23, METTL21A, and METTL21B"
     . SPARSER::COLLECTION)
    ("METTL18, CAMKMT, METTL20, and METTL21B" . SPARSER::COLLECTION)
    ("CAMKMT" . SPARSER::PROTEIN) ("possible substrates" . SPARSER::SUBSTRATE)
    ("methyltransferases and PRMTs" . SPARSER::COLLECTION)
    ("shared distant homology" . SPARSER::PROTEIN)
    ("previously uncharacterized methyltransferases" . SPARSER::PROTEIN)
    ("Kin17/KIN" . SPARSER::COLLECTION)
    ("these substrates, VCP/p97," . SPARSER::SUBSTRATE)
    ("ASPSCR1/UBXD9" . SPARSER::COLLECTION)
    ("distant homology" . SPARSER::PROTEIN)
    ("a previously uncharacterized protein" . SPARSER::PROTEIN)
    ("proteins, p53, and NF-κB" . SPARSER::COLLECTION)
    ("Rubisco" . SPARSER::PROTEIN)
    ("transcriptionally active euchromatin" . SPARSER::BIO-COMPLEX)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("PKMT" . SPARSER::PROTEIN)
    ("methyltransferases (PRMT)" . SPARSER::PROTEIN)
    ("PRMT" . SPARSER::PROTEIN) ("SET" . SPARSER::PROTEIN)
    ("Dicarboxylic amino acids (glutamate, aspartate) and cysteine"
     . SPARSER::COLLECTION)
    ("Dicarboxylic amino acids" . SPARSER::AMINO-ACID)
    ("amino acids, lysine and arginine" . SPARSER::COLLECTION)
    ("histidine, glutamine, and asparagine" . SPARSER::COLLECTION)
    ("AdoMet" . SPARSER::MOLECULE) ("Methyltransferases" . SPARSER::PROTEIN)
    ("physiologically relevant states" . SPARSER::BIO-STATE)
    ("protein or protein" . SPARSER::COLLECTION) ("ALS" . SPARSER::PROTEIN)
    ("HSPA8/Hsc70" . SPARSER::COLLECTION) ("KIN/Kin17" . SPARSER::COLLECTION)
    ("KIN" . SPARSER::PROTEIN) ("methyltransferases" . SPARSER::PROTEIN)
    ("S-adenosyl-L-homocysteine" . SPARSER::MOLECULE)
    ("CCL-2" . SPARSER::PROTEIN) ("SMYD2" . SPARSER::PROTEIN)
    ("FOXK1" . SPARSER::PROTEIN) ("Hsp70s" . SPARSER::PROTEIN)
    ("STIP1" . SPARSER::PROTEIN) ("S-adenosylhomocysteine" . SPARSER::MOLECULE)
    ("WD45" . SPARSER::PROTEIN) ("PRMT5" . SPARSER::PROTEIN)
    ("HSPA6" . SPARSER::PROTEIN) ("HSPA5" . SPARSER::PROTEIN)
    ("HSPA2" . SPARSER::PROTEIN) ("HSPA1L" . SPARSER::PROTEIN)
    ("HSPA1" . SPARSER::PROTEIN) ("CALM2" . SPARSER::PROTEIN)
    ("GRWD1" . SPARSER::PROTEIN)
    ("ribosome biogenesis factor" . SPARSER::PROTEIN)
    ("RPL3" . SPARSER::PROTEIN) ("yeast homolog" . SPARSER::PROTEIN)
    ("METTL20" . SPARSER::PROTEIN) ("HSPD1" . SPARSER::PROTEIN)
    ("METTL21B" . SPARSER::PROTEIN) ("METTL21A" . SPARSER::PROTEIN)
    ("METTL23" . SPARSER::PROTEIN) ("METTL21C" . SPARSER::PROTEIN)
    ("METTL18" . SPARSER::PROTEIN) ("METTL22" . SPARSER::PROTEIN)
    ("UBXD9" . SPARSER::PROTEIN) ("cytochrome C" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN) ("CH 3" . SPARSER::MOLECULE)
    ("ASPSCR1" . SPARSER::PROTEIN) ("METTL21D" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("HSPA8" . SPARSER::PROTEIN)
    ("Kin17" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and ERG" . SPARSER::COLLECTION) ("Antibody" . SPARSER::PROTEIN)
    ("ERG/SPINK1" . SPARSER::COLLECTION) ("ERG/PTEN" . SPARSER::COLLECTION)
    ("adjacent foci" . SPARSER::PROTEIN)
    ("novel anti-ERG monoclonal antibodies" . SPARSER::ANTIBODY)
    ("intact genomic PTEN" . SPARSER::PROTEIN)
    ("FISH or reverse transcriptase" . SPARSER::COLLECTION)
    ("robust PTEN" . SPARSER::PROTEIN)
    ("the secondary smaller foci" . SPARSER::PROTEIN)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION)
    ("prognostic molecular biomarkers" . SPARSER::MOLECULE)
    ("neighboring foci" . SPARSER::PROTEIN) ("normal PTEN" . SPARSER::PROTEIN)
    ("FISH and immunohistochemisty" . SPARSER::COLLECTION)
    ("FISH and positive immunohistochemisty (true negative)"
     . SPARSER::COLLECTION)
    ("FISH and negative immunohistochemisty (true positive)"
     . SPARSER::COLLECTION)
    ("intact PTEN" . SPARSER::PROTEIN)
    ("ERG , PTEN and SPINK1" . SPARSER::COLLECTION)
    ("ERG and PTEN" . SPARSER::COLLECTION)
    ("FISH and polymerase" . SPARSER::COLLECTION)
    ("mTOR, P13K and MEK" . SPARSER::COLLECTION)
    ("BAD , CASP3 and CASP9" . SPARSER::COLLECTION) ("FKHR" . SPARSER::PROTEIN)
    ("a key tumor suppressor gene" . SPARSER::PROTEIN)
    ("BRAF and RAF1" . SPARSER::COLLECTION)
    ("TMPRSS2:ERG" . SPARSER::BIO-COMPLEX)
    ("ERG, ETV1, ETV4 and ETV5" . SPARSER::COLLECTION)
    ("heterogeneous SPINK1" . SPARSER::PROTEIN)
    ("the homogenous ERG" . SPARSER::PROTEIN)
    ("ERG and SPINK1" . SPARSER::COLLECTION)
    ("ERG-SPINK1" . SPARSER::COLLECTION) ("ERG-PTEN" . SPARSER::COLLECTION)
    ("PCA3" . SPARSER::RNA) ("prostate cancer antigen 3" . SPARSER::RNA)
    ("P13" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN)
    ("serine peptidase inhibitor, Kazal type 1" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("ETV4" . SPARSER::PROTEIN)
    ("SPINK1" . SPARSER::PROTEIN)
    ("BRAF , NRAS and PIK3CA" . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION) ("-FISH+" . SPARSER::COLLECTION)
    ("RRs" . SPARSER::MOLECULE) ("FISH− and HER2-" . SPARSER::COLLECTION)
    ("FISH+" . SPARSER::PROTEIN) ("HER2-FISH" . SPARSER::COLLECTION)
    ("HER2-FISH+" . SPARSER::PROTEIN-PAIR)
    ("This last group" . SPARSER::MOLECULE) ("-CNG" . SPARSER::COLLECTION)
    ("MoAb" . SPARSER::DRUG) ("Cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("KRAS , NRAS , BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("HER3 (ErbB-3) and HER4 (ErbB-4)" . SPARSER::COLLECTION)
    ("PI3K/PTEN/AKT" . SPARSER::COLLECTION)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("EGFR/ErbB-1" . SPARSER::COLLECTION)
    ("MoAbs" . SPARSER::DRUG) ("FISH−" . SPARSER::PROTEIN)
    ("HER2-" . SPARSER::PROTEIN)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("mCRC" . SPARSER::PROTEIN) ("A'" . SPARSER::PROTEIN)
    ("ErbB-3" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("ErbB-1" . SPARSER::PROTEIN) ("an allelic fraction" . SPARSER::COMPONENT)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("both a core promoter fragment (−132 to +5 relative to the TSS) and the full core promoter (−200 to +73)"
     . SPARSER::COLLECTION)
    ("-CCCCTTCCGGG-3" . SPARSER::COLLECTION) ("GGAA" . SPARSER::PROTEIN)
    ("cytidine" . SPARSER::MOLECULE) ("chr1" . SPARSER::PROTEIN)
    ("TRAF7 and KLF4" . SPARSER::COLLECTION)
    ("a recurrent L412F variant" . SPARSER::VARIANT)
    ("these five genes and/or evidence for chromosome 22 loss"
     . SPARSER::COLLECTION)
    ("CREBBP" . SPARSER::PROTEIN) ("receptor ( SMO )" . SPARSER::RECEPTOR)
    ("v-akt murine thymoma viral oncogene homolog 1" . SPARSER::PROTEIN)
    ("v-akt" . SPARSER::COLLECTION) ("akt" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("c-FLIP" . SPARSER::PROTEIN)
    ("MEKK3" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 7" . SPARSER::PROTEIN)
    ("Neurofibromin 2" . SPARSER::PROTEIN) ("TRAF7" . SPARSER::PROTEIN)
    ("RB/E2F" . SPARSER::COLLECTION)
    ("E2F1 siRNA (E2F1si) or a scrambled siRNA (SC)" . SPARSER::COLLECTION)
    ("siRNA (SC)" . SPARSER::PROTEIN)
    ("retinoblastoma protein (RB)" . SPARSER::PROTEIN)
    ("the E2F1 transcription factor(14) and E2F1" . SPARSER::COLLECTION)
    ("ERS1, ERS3 or both ERS1 and ERS3" . SPARSER::COLLECTION)
    ("ERS1 and ERS3" . SPARSER::COLLECTION)
    ("mERS1, mERS2, mERS3, and mERS1+mERS3" . SPARSER::COLLECTION)
    ("mERS" . SPARSER::PROTEIN) ("ERS1, ERS2, and ERS3" . SPARSER::COLLECTION)
    ("p(−316/+1) and p(−197/+1)" . SPARSER::COLLECTION)
    ("p(−3980/+1), p(−316/+1) and p(−197/+1)" . SPARSER::COLLECTION)
    ("PHH" . SPARSER::PROTEIN) ("CIP/KIP" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN) ("CIP" . SPARSER::PROTEIN)
    ("TA and Combo" . SPARSER::COLLECTION)
    ("HBeAg and HBV core protein" . SPARSER::COLLECTION)
    ("HBeAg and hepatitis B core protein" . SPARSER::COLLECTION)
    ("TA, and Combo" . SPARSER::COLLECTION) ("HBeAg" . SPARSER::PROTEIN)
    ("cell cycle regulators and cellular proliferation" . SPARSER::COLLECTION)
    ("p21 and other cell cycle regulators" . SPARSER::COLLECTION)
    ("SKP2, p21 and other cell cycle regulators" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("CDK2 and Cyclin E" . SPARSER::COLLECTION)
    ("p21, p27, and p57" . SPARSER::COLLECTION)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("Mapping" . SPARSER::PROTEIN)
    ("hepatocytes and HCC" . SPARSER::COLLECTION) ("HBx" . SPARSER::PROTEIN)
    ("ERS2" . SPARSER::PROTEIN) ("ERS1" . SPARSER::PROTEIN)
    ("Ha-Ras" . SPARSER::PROTEIN) ("Polη-Rad18" . SPARSER::COLLECTION)
    ("Rad18-PCNA" . SPARSER::COLLECTION)
    ("alternative and inappropriate TLS polymerases" . SPARSER::PROTEIN)
    ("NBS1 ( xref ) and Chk1 ( xref )" . SPARSER::COLLECTION)
    ("Rev1 ( xref ), Rad18 ( xref ), NBS1 ( xref ) and Chk1 ( xref )"
     . SPARSER::COLLECTION)
    ("its relevant substrate" . SPARSER::SUBSTRATE)
    ("p53, and DNA" . SPARSER::COLLECTION) ("POLH" . SPARSER::PROTEIN)
    ("Polη and full-length" . SPARSER::COLLECTION)
    ("Polι and Polκ" . SPARSER::COLLECTION)
    ("Polη-ΔPLTH" . SPARSER::PROTEIN-PAIR)
    ("polymerase–PCNA" . SPARSER::COLLECTION)
    ("Polη and Polκ" . SPARSER::COLLECTION)
    ("Spartan and Polη" . SPARSER::COLLECTION)
    ("FLAG-Spartan" . SPARSER::COLLECTION) ("FLAG-Polη" . SPARSER::COLLECTION)
    ("PCNA and Rad18" . SPARSER::COLLECTION)
    ("‘Spartan’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only 300 C-terminal amino acids" . SPARSER::AMINO-ACID)
    ("FLAG-ubiquitin" . SPARSER::COLLECTION) ("HA-Rad18" . SPARSER::COLLECTION)
    ("PCNA-Ni" . SPARSER::PROTEIN-PAIR) ("PCNA–Rad18" . SPARSER::COLLECTION)
    ("Rad18–PCNA" . SPARSER::COLLECTION)
    ("-complemented" . SPARSER::COLLECTION) ("Polη-" . SPARSER::PROTEIN)
    ("PIP" . SPARSER::PROTEIN) ("Polη–PCNA" . SPARSER::COLLECTION)
    ("Rad18-complemented" . SPARSER::COLLECTION) ("CFP" . SPARSER::PROTEIN)
    ("Ub-ligase activity" . SPARSER::COLLECTION) ("Rad18-" . SPARSER::PROTEIN)
    ("Rad18 and Polη" . SPARSER::COLLECTION)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BPDE" . SPARSER::DRUG)
    ("ATR/Chk1" . SPARSER::COLLECTION)
    ("Polη-complemented" . SPARSER::COLLECTION) ("PRR" . SPARSER::PROTEIN)
    ("p53 and Chk1" . SPARSER::COLLECTION) ("Polη–Rad18" . SPARSER::COLLECTION)
    ("Cdc7 and Chk1" . SPARSER::COLLECTION)
    ("Rad18–Polη" . SPARSER::COLLECTION)
    ("Spartan or alternative putative mediators" . SPARSER::COLLECTION)
    ("Rad18–Rad6" . SPARSER::COLLECTION) ("HTLF" . SPARSER::PROTEIN)
    ("SHPRH" . SPARSER::PROTEIN)
    ("UV light and other ubiquitous genotoxins ( xref )" . SPARSER::COLLECTION)
    ("other ubiquitous genotoxins" . SPARSER::MOLECULE)
    ("UV light" . SPARSER::PROTEIN)
    ("Polη, Polι, Polκ and Rev1" . SPARSER::COLLECTION)
    ("inherently error-prone DNA polymerases" . SPARSER::PROTEIN)
    ("ubiquitous genotoxins" . SPARSER::MOLECULE)
    ("genotoxins" . SPARSER::MOLECULE) ("Rad18 and PCNA" . SPARSER::COLLECTION)
    ("Rad6/Rad18" . SPARSER::COLLECTION) ("UV-damaged DNA" . SPARSER::DNA)
    ("variant (XPV)" . SPARSER::VARIANT) ("XPV" . SPARSER::PROTEIN)
    ("Trans" . SPARSER::PROTEIN-FAMILY) ("Cdc7" . SPARSER::PROTEIN)
    ("SNM1A" . SPARSER::PROTEIN) ("ZRANB3" . SPARSER::PROTEIN)
    ("DNA polymerase eta" . SPARSER::PROTEIN) ("pinch" . SPARSER::PROTEIN)
    ("Bcl-2, BAD, and caspases" . SPARSER::COLLECTION)
    ("MYPT3 and MBS85" . SPARSER::COLLECTION)
    ("siRNA and V5-MYPT1-WT" . SPARSER::COLLECTION)
    ("-annexin V" . SPARSER::COLLECTION) ("MPs" . SPARSER::PROTEIN)
    ("ZIPK" . SPARSER::PROTEIN)
    ("antibody, and phalloidin" . SPARSER::COLLECTION)
    ("FLAG-MYPT1-T696DT853D and FLAG-MYPT1-T696DT853D" . SPARSER::PROTEIN)
    ("DT" . SPARSER::PROTEIN) ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("amino-terminally V5-tagged mouse MYPT1" . SPARSER::PROTEIN)
    ("GST-fused" . SPARSER::COLLECTION) ("-GST" . SPARSER::COLLECTION)
    ("–glutathione S -transferase" . SPARSER::COLLECTION)
    ("MYPT1-" . SPARSER::PROTEIN) ("FLAG-MYPT1" . SPARSER::COLLECTION)
    ("the major initiator caspase (caspase-8) or the downstream executioner caspase (caspase-3)"
     . SPARSER::COLLECTION)
    ("the nonselective caspase inhibitor zVAD-FMK" . SPARSER::DRUG)
    ("IETD-CHO" . SPARSER::COLLECTION)
    ("phosphatase and myosin" . SPARSER::COLLECTION)
    ("a trimeric holoenzyme" . SPARSER::PROTEIN)
    ("a 20-kDa" . SPARSER::COLLECTION) ("MP" . SPARSER::PROTEIN)
    ("the myosin regulatory light chain (MRLC)" . SPARSER::PROTEIN)
    ("MRLC" . SPARSER::PROTEIN)
    ("ROCK-I and its substrate" . SPARSER::COLLECTION)
    ("kinases and myosin phosphatase" . SPARSER::COLLECTION)
    ("ZVAD-FMK" . SPARSER::DRUG) ("nV5" . SPARSER::PROTEIN)
    ("death-associated protein kinase" . SPARSER::PROTEIN)
    ("MBS85" . SPARSER::PROTEIN) ("MYPT3" . SPARSER::PROTEIN)
    ("ROCK-II" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("zVAD-FMK" . SPARSER::DRUG) ("PP1c" . SPARSER::PROTEIN)
    ("myosin-binding subunit" . SPARSER::PROTEIN) ("ROCK-I" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN)
    ("myosin phosphatase targeting subunit 1" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN)
    ("peptide 3L4F and new peptide" . SPARSER::COLLECTION)
    ("Arg-Gly-Asp" . SPARSER::COLLECTION)
    ("3L4F or peptide" . SPARSER::COLLECTION)
    ("3L4F and its derivatives" . SPARSER::COLLECTION)
    ("the receptor (present studies) and the phosphorylation state"
     . SPARSER::COLLECTION)
    ("signalosome" . SPARSER::PROTEIN)
    ("Both the human 3L4F and rat TAT–3L4F peptides" . SPARSER::COLLECTION)
    ("-helix" . SPARSER::COLLECTION)
    ("α -Helical 3L4F-F 1 conformations" . SPARSER::BIO-CONFORMATION)
    ("3L4F or 3L4F-F" . SPARSER::COLLECTION) ("3L4F" . SPARSER::PROTEIN)
    ("3L4F-F 3" . SPARSER::COLLECTION)
    ("that WAY163909 and the combination" . SPARSER::COLLECTION)
    ("max" . SPARSER::PROTEIN)
    ("the 5-HT 2C R–PTEN complex and its disruption" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN)
    ("fluorescent nucleotides" . SPARSER::NUCLEOTIDE)
    ("the secondary antibodies" . SPARSER::ANTIBODY)
    ("the two secondary antibodies" . SPARSER::ANTIBODY)
    ("Oligonucleotides" . SPARSER::MOLECULE)
    ("therapeutic chemical" . SPARSER::MOLECULE)
    ("phospholipase" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN)
    ("peptide or small-molecule" . SPARSER::COLLECTION)
    ("protein phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("Serotonin" . SPARSER::MOLECULE) ("converting enzyme" . SPARSER::PROTEIN)
    ("5-HT 2B" . SPARSER::PROTEIN) ("5-HT 2" . SPARSER::PROTEIN)
    ("CO 3" . SPARSER::PROTEIN) ("Membrane protein" . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN) ("TAT–3" . SPARSER::PROTEIN)
    ("F 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β -cyclodextrin" . SPARSER::MOLECULE)
    ("6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy) pyrid-5-yl)carbamoyl)indoline"
     . SPARSER::DRUG)
    ("SB242084" . SPARSER::DRUG) ("WAY163909" . SPARSER::DRUG)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("5- HT 2C" . SPARSER::PROTEIN) ("5-HT 2A" . SPARSER::PROTEIN)
    ("tensin homolog" . SPARSER::PROTEIN) ("5-HT 2C" . SPARSER::PROTEIN)
    ("5-HT 2C receptor" . SPARSER::PROTEIN)
    ("Notch3 ( xref ) and NAC1 ( xref )" . SPARSER::COLLECTION)
    ("FGFs and FGFR4" . SPARSER::COLLECTION)
    ("FGFR4/FGFR1" . SPARSER::COLLECTION)
    ("FGFR4 and an IgG Fc fragment" . SPARSER::COLLECTION)
    ("NF-κB and WNT" . SPARSER::COLLECTION)
    ("FGF1 and FGFR4" . SPARSER::COLLECTION)
    ("kinase or intermembrane" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR4" . SPARSER::COLLECTION)
    ("FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("both FGFRs and FGF ligands" . SPARSER::COLLECTION)
    ("protein and siRNA" . SPARSER::COLLECTION) ("DOPC" . SPARSER::DRUG)
    ("Trap" . SPARSER::PROTEIN) ("mut" . SPARSER::PROTEIN)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("CXCR4 and BNIP3" . SPARSER::COLLECTION)
    ("MAPK, NF-κB, and WNT" . SPARSER::COLLECTION)
    ("NF-κB, and WNT" . SPARSER::COLLECTION)
    ("exogenous FGF1" . SPARSER::PROTEIN)
    ("successful FGFR4" . SPARSER::PROTEIN)
    ("the receptor’s" . SPARSER::RECEPTOR)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("Prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("platinum and taxane" . SPARSER::COLLECTION)
    ("siRNAs and FGFR4" . SPARSER::COLLECTION) ("NAC1" . SPARSER::PROTEIN)
    ("Fc fragment of IgG" . SPARSER::PROTEIN) ("D1-3" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN)
    ("fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("the p53-induced large intergenic noncoding RNA" . SPARSER::RNA)
    ("lincRNA" . SPARSER::RNA)
    ("hnRNP K and other p53 regulators" . SPARSER::COLLECTION)
    ("just p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("—ATM" . SPARSER::COLLECTION)
    ("HDM2/Mdm2" . SPARSER::COLLECTION) ("p53- and DNA" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ser/Thr→Ala" . SPARSER::COLLECTION)
    ("hnRNP K siRNA-treated cells complemented" . SPARSER::PROTEIN)
    ("p21/WAF1" . SPARSER::COLLECTION) ("HA-hnRNP K" . SPARSER::COLLECTION)
    ("KU-55933 or wortmannin" . SPARSER::COLLECTION)
    ("hnRNP K and HDM2" . SPARSER::COLLECTION)
    ("HDM2-hnRNP K" . SPARSER::COLLECTION)
    ("which targets hnRNP K" . SPARSER::PROTEIN)
    ("Ala-Gln" . SPARSER::COLLECTION)
    ("HA-epitope tagged wild-type hnRNP K" . SPARSER::PROTEIN)
    ("Ser/Thr-Gln" . SPARSER::COLLECTION) ("TQ" . SPARSER::DRUG)
    ("p53, CHK2 and BRCA1" . SPARSER::COLLECTION)
    ("kinases and proteins" . SPARSER::COLLECTION) ("KNS" . SPARSER::PROTEIN)
    ("hnRNP" . SPARSER::PROTEIN)
    ("a p53 transcriptional cofactor" . SPARSER::MOLECULE)
    ("Protein-A" . SPARSER::PROTEIN) ("β-tubulin" . SPARSER::PROTEIN)
    ("CBX4" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("HDM2" . SPARSER::PROTEIN)
    ("p53 regulator" . SPARSER::PROTEIN)
    ("Heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("hnRNP K" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("ALR" . SPARSER::PROTEIN)
    ("transient myeloproliferative leukemia" . SPARSER::PROTEIN)
    ("RUNX1 and ERG" . SPARSER::COLLECTION)
    ("BACH1 (transcriptional regulator of megakaryocytic differentiation process) and SON (homologous sequence with MYC family of oncoproteins)"
     . SPARSER::COLLECTION)
    ("SON" . SPARSER::PROTEIN) ("MAGEA3 and ATP1A1" . SPARSER::COLLECTION)
    ("approximately 8000 genes" . SPARSER::GENE)
    ("autosomal genes" . SPARSER::GENE) ("fetuses" . SPARSER::PROTEIN)
    ("KLK8, KRT16, and LCK" . SPARSER::COLLECTION)
    ("GCNT2, MASP1, LOC338328, PCSK4, ICAM1, LPPR4, SLC25A21, H1F0 and ATP1A1"
     . SPARSER::COLLECTION)
    ("CYB" . SPARSER::PROTEIN) ("HRB" . SPARSER::PROTEIN)
    ("IG" . SPARSER::MOLECULE)
    ("DS, rs2070531, rs6517481 and rs7276961" . SPARSER::COLLECTION)
    ("DS and rs711" . SPARSER::COLLECTION) ("BF and BH" . SPARSER::COLLECTION)
    ("‘A’ allele" . SPARSER::PROTEIN) ("BF" . SPARSER::MOLECULE)
    ("KLK8, LCK, RELA, S100A8, S100A9, TRRAP, and GATA3" . SPARSER::COLLECTION)
    ("ABCB8, ABP1, KLK8, LCK, MAG, PRSS8, RELA, S100A9, SP1, THBS1, TRRAP, and HLA-DOA"
     . SPARSER::COLLECTION)
    ("RELA" . SPARSER::PROTEIN) ("TRRAP" . SPARSER::PROTEIN)
    ("MAG" . SPARSER::PROTEIN) ("Target" . SPARSER::TARGET-PROTEIN)
    ("acute megakaryoblastic leukemia" . SPARSER::PROTEIN)
    ("ETS2 and ERG" . SPARSER::COLLECTION)
    ("a transcriptional activator as well as a repressor"
     . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("oxidative enzymes" . SPARSER::ENZYME)
    ("Xenobiotic" . SPARSER::MOLECULE) ("AhR" . SPARSER::PROTEIN)
    ("childhood acute leukemia" . SPARSER::PROTEIN) ("HSA" . SPARSER::PROTEIN)
    ("SIM2 and ETS2" . SPARSER::COLLECTION)
    ("ETS2 and SIM2" . SPARSER::COLLECTION)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("BACH1" . SPARSER::PROTEIN) ("KRT16" . SPARSER::PROTEIN)
    ("H1F0" . SPARSER::PROTEIN) ("SLC25A21" . SPARSER::PROTEIN)
    ("LPPR4" . SPARSER::PROTEIN) ("PCSK4" . SPARSER::PROTEIN)
    ("LOC338328" . SPARSER::PROTEIN) ("MASP1" . SPARSER::PROTEIN)
    ("GCNT2" . SPARSER::PROTEIN) ("MDR 2" . SPARSER::PROTEIN)
    ("C-G" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("C-C-T" . SPARSER::PROTEIN) ("A’" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("HLA-DOA" . SPARSER::PROTEIN)
    ("THBS1" . SPARSER::PROTEIN) ("S100A9" . SPARSER::PROTEIN)
    ("ABP1" . SPARSER::PROTEIN) ("ABCB8" . SPARSER::PROTEIN)
    ("SCARB1" . SPARSER::PROTEIN) ("PRSS8" . SPARSER::PROTEIN)
    ("MAGEE1" . SPARSER::PROTEIN) ("MAGEA3" . SPARSER::PROTEIN)
    ("GNB2L1" . SPARSER::PROTEIN) ("CEACAM1" . SPARSER::PROTEIN)
    ("C4BPB" . SPARSER::PROTEIN) ("C4BPA" . SPARSER::PROTEIN)
    ("SLC25A2" . SPARSER::PROTEIN) ("FXYD5" . SPARSER::PROTEIN)
    ("ATP1A4" . SPARSER::PROTEIN) ("ATP1A1" . SPARSER::PROTEIN)
    ("PDE6D" . SPARSER::PROTEIN) ("KLK8" . SPARSER::PROTEIN)
    ("beta 8" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("AhR/ARNT" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("SIM2" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("homolog 2" . SPARSER::PROTEIN) ("phenylindole" . SPARSER::MOLECULE)
    ("FGF8 and FGF10" . SPARSER::COLLECTION)
    ("ERBB2 and FGFR1" . SPARSER::COLLECTION)
    ("VEGFR and FGFR" . SPARSER::COLLECTION)
    ("PDGFR or VEGFR" . SPARSER::COLLECTION)
    ("AEE788 or dovitinib" . SPARSER::COLLECTION)
    ("PDGFR and VEGFR" . SPARSER::COLLECTION)
    ("the PI3K/mTOR inhibitor or the pan ErbB inhibitor" . SPARSER::COLLECTION)
    ("Erk and PI3K" . SPARSER::COLLECTION)
    ("EGFR or ErbB2/ErbB3" . SPARSER::COLLECTION)
    ("Akt or PI3K" . SPARSER::COLLECTION)
    ("the receptor [ xref , xref ] or downstream targets [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("antibodies or kinase" . SPARSER::COLLECTION)
    ("dovitinib and AEE788" . SPARSER::COLLECTION)
    ("heparin binding EGF (HB-EGF) and TGFalpha" . SPARSER::COLLECTION)
    ("TGFalpha" . SPARSER::PROTEIN) ("Areg" . SPARSER::PROTEIN)
    ("MuSK" . SPARSER::PROTEIN) ("FGFR-1, -2 and -3" . SPARSER::COLLECTION)
    ("FGFR2 (B9 to 10) and FGFR3 (B11 to 12)" . SPARSER::COLLECTION)
    ("Heregulin (HRG)" . SPARSER::PROTEIN) ("NVP-BEZ235-" . SPARSER::DRUG)
    ("dovitinib or NVP-BEZ235" . SPARSER::COLLECTION)
    ("VEGFRs" . SPARSER::PROTEIN)
    ("dovitinib- and dovitinib" . SPARSER::COLLECTION)
    ("dovitinib-" . SPARSER::DRUG) ("Caspase-3 and CD31" . SPARSER::COLLECTION)
    ("dovitinib and NVP-BEZ235" . SPARSER::COLLECTION)
    ("Dovitinib" . SPARSER::DRUG)
    ("NVP-BEZ235 and dovitinib" . SPARSER::COLLECTION)
    ("Erk and PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("AEE788 and dovitinib" . SPARSER::COLLECTION)
    ("FRS2/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("FGFRs and ligands" . SPARSER::COLLECTION)
    ("Balb/c" . SPARSER::COLLECTION)
    ("highly relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("FGFR1 or FGF3" . SPARSER::COLLECTION)
    ("The fibroblast growth factor receptors (FGFRs) and their ligands"
     . SPARSER::COLLECTION)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("receptors and FGFRs" . SPARSER::COLLECTION)
    ("FGFR/FRS2/Erk" . SPARSER::COLLECTION)
    ("NVP-BEZ235 or dovitinib" . SPARSER::COLLECTION)
    ("FGFR and ErbB" . SPARSER::COLLECTION) ("FRS2/Erk" . SPARSER::COLLECTION)
    ("a PI3K/mTOR inhibitor (NVP-BEZ235) or a pan-ErbB inhibitor (AEE788)"
     . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("PTK787" . SPARSER::DRUG)
    ("HB-EGF" . SPARSER::PROTEIN) ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophage-stimulating protein receptor" . SPARSER::PROTEIN)
    ("FGFR-1" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("P-Erk" . SPARSER::PROTEIN) ("P-S6" . SPARSER::PROTEIN)
    ("histone-H3" . SPARSER::PROTEIN) ("S-M" . SPARSER::PROTEIN)
    ("FGF3" . SPARSER::PROTEIN) ("AEE788" . SPARSER::DRUG)
    ("NVP-BEZ235" . SPARSER::DRUG) ("Ki67 and ERE" . SPARSER::COLLECTION)
    ("ERα, FOXA1, and GATA3" . SPARSER::COLLECTION)
    ("just one many ER target genes" . SPARSER::GENE)
    ("Sp1 or AP-1" . SPARSER::COLLECTION)
    ("antiestrogenic drugs" . SPARSER::DRUG)
    ("Tamoxifen or Fulvestrant" . SPARSER::COLLECTION)
    ("Ki67 and Bcl-2" . SPARSER::COLLECTION)
    ("Ki67 [ xref ] and Bcl-2 [ xref ]" . SPARSER::COLLECTION)
    ("HDAC6, IGFBP4, and IGFBP5" . SPARSER::COLLECTION)
    ("ER and its target genes" . SPARSER::COLLECTION)
    ("FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("FOXA1 ( xref B) and GATA3 ( xref C)" . SPARSER::COLLECTION)
    ("ER and three ER target genes" . SPARSER::COLLECTION)
    ("FOXA1, GATA3, and PgR" . SPARSER::COLLECTION)
    ("PgR, which is influenced by many transcriptional cofactors"
     . SPARSER::PROTEIN)
    ("many transcriptional cofactors" . SPARSER::PROTEIN)
    ("ER, PgR, and HER2" . SPARSER::COLLECTION)
    ("antiestrogen" . SPARSER::DRUG) ("Fulvestrant" . SPARSER::DRUG)
    ("Tam" . SPARSER::PROTEIN)
    ("ER and the ER target genes" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("estrogen [ xref , xref ] or protein phosphorylation by kinases such as mitogen-activated protein kinase (MAPK)"
     . SPARSER::COLLECTION)
    ("Ki67, FOXA1, and GATA3" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG) ("ERE-GFP" . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("classical molecular biomarkers" . SPARSER::MOLECULE)
    ("IGFBP4" . SPARSER::PROTEIN) ("EGR3" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("CKIα and p53" . SPARSER::COLLECTION) ("Vav1/Rac1" . SPARSER::COLLECTION)
    ("MAT" . SPARSER::PROTEIN) ("Vav1-Rac" . SPARSER::COLLECTION)
    ("inhibitors of the actin cytoskeleton or protein kinase C (PKC) reverse"
     . SPARSER::COLLECTION)
    ("promyelocytic" . SPARSER::PROTEIN)
    ("formed smaller foci" . SPARSER::PROTEIN)
    ("EGF and CSF1" . SPARSER::COLLECTION)
    ("smaller cohorts" . SPARSER::MOLECULE)
    ("caspase 3 and Gadd45β" . SPARSER::COLLECTION)
    ("p21, Gadd45β and Sestrin" . SPARSER::COLLECTION)
    ("Sestrin" . SPARSER::PROTEIN-FAMILY)
    ("Cdc25A, Cdk1, Cyclin B2 and Cyclin E" . SPARSER::COLLECTION)
    ("Sestrins and Noxa" . SPARSER::COLLECTION)
    ("Sestrins" . SPARSER::PROTEIN-FAMILY)
    ("significantly larger foci" . SPARSER::PROTEIN)
    ("significantly smaller foci" . SPARSER::PROTEIN)
    ("GST-PAK" . SPARSER::COLLECTION) ("Rac/Cdc42" . SPARSER::COLLECTION)
    ("GST–PAK" . SPARSER::COLLECTION) ("GST-GFP" . SPARSER::COLLECTION)
    ("Vav1-" . SPARSER::PROTEIN)
    ("an upstream activator of Rac1, RhoA and possibly Cdc42 signaling pathways"
     . SPARSER::COLLECTION)
    ("EGF and AU565Vector and AU565Vav1" . SPARSER::COLLECTION)
    ("GFP-GST" . SPARSER::COLLECTION) ("Vav1 and Cbl-c" . SPARSER::COLLECTION)
    ("Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("Cbl, Cbl-b and Cbl-c" . SPARSER::COLLECTION) ("pGL3-" . SPARSER::PROTEIN)
    ("trk" . SPARSER::PROTEIN) ("NFAT and NF- κB" . SPARSER::COLLECTION)
    ("ERK-MAP kinase" . SPARSER::COLLECTION) ("CKIα" . SPARSER::PROTEIN)
    ("NB4" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("Cyclin B2" . SPARSER::PROTEIN) ("Gadd153" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 activated kinase 1" . SPARSER::PROTEIN) ("CBl-c" . SPARSER::PROTEIN)
    ("Cbl-b" . SPARSER::PROTEIN) ("vav 1" . SPARSER::PROTEIN)
    ("vav1" . SPARSER::PROTEIN) ("Ubiquitin Ligase" . SPARSER::PROTEIN)
    ("Cbl-c" . SPARSER::PROTEIN) ("VAV1" . SPARSER::PROTEIN)
    ("Dual- Luciferase" . SPARSER::PROTEIN) ("CSF1" . SPARSER::PROTEIN)
    ("NF- κB" . SPARSER::PROTEIN)
    ("Guanine Nucleotide Exchange Factor" . SPARSER::GEF)
    ("cbl-c" . SPARSER::PROTEIN) ("TcO" . SPARSER::MOLECULE)
    ("tamoxifen and other chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("ER and hNIS" . SPARSER::COLLECTION) ("IF and DAB" . SPARSER::COLLECTION)
    ("secondary antibodies" . SPARSER::ANTIBODY) ("dual IF" . SPARSER::PROTEIN)
    ("HER2 (membrane receptor) and hNIS co-localize" . SPARSER::COLLECTION)
    ("only 70% HER2" . SPARSER::PROTEIN) ("Subtypes" . SPARSER::PROTEIN)
    ("A classic example" . SPARSER::EXAMPLE) ("lactating" . SPARSER::MOLECULE)
    ("PgR" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("symporter" . SPARSER::PROTEIN) ("Cell Membrane" . SPARSER::PROTEIN)
    ("tween20" . SPARSER::MOLECULE) ("sodium iodide" . SPARSER::MOLECULE)
    ("an EGFR TKI or an ALK inhibitor" . SPARSER::COLLECTION)
    ("concurrent EGFR" . SPARSER::PROTEIN)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("two relevant molecules" . SPARSER::MOLECULE)
    ("new chemotherapeutic drugs" . SPARSER::DRUG)
    ("normal KRAS" . SPARSER::PROTEIN) ("normal EGFR" . SPARSER::PROTEIN)
    ("ALK-IF" . SPARSER::COLLECTION)
    ("the squamous carcinoma component" . SPARSER::COMPONENT)
    ("micropapillary component" . SPARSER::COMPONENT)
    ("the predominant variant" . SPARSER::VARIANT)
    ("EML4 and exon" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("EGFR/KRAS" . SPARSER::COLLECTION) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("Membrane-associated FA proteins" . SPARSER::PROTEIN)
    ("integrins and Rac1" . SPARSER::COLLECTION)
    ("its GEF(s) as well as its activating greater" . SPARSER::COLLECTION)
    ("the activated Rac1 became more prone" . SPARSER::PROTEIN-FAMILY)
    ("Tiam1 and DOCK180" . SPARSER::COLLECTION)
    ("Tiam1 and Vav2" . SPARSER::COLLECTION)
    ("practically all PIX molecules" . SPARSER::MOLECULE)
    ("only 50–150 fluorescent Rac1 or mutant molecules" . SPARSER::MOLECULE)
    ("Rac1 or mutant" . SPARSER::COLLECTION) ("doxycyclin" . SPARSER::MOLECULE)
    ("Rac1 and other membrane molecules" . SPARSER::COLLECTION)
    ("FA (perhaps such as the actin-based membrane skeleton) and/or small FA"
     . SPARSER::COLLECTION)
    ("Cerione" . SPARSER::PROTEIN)
    ("Rac1 and its mutants" . SPARSER::COLLECTION)
    ("Rac1 and PIX" . SPARSER::COLLECTION)
    ("αPIX, and βPIX" . SPARSER::COLLECTION) ("PMs" . SPARSER::PROTEIN)
    ("the membrane-associated molecules and the bulk mGFP-paxillin"
     . SPARSER::COLLECTION)
    ("the membrane-associated molecules" . SPARSER::MOLECULE)
    ("Halo-Rac1, Halo-αPIX, or βPIX-Halo" . SPARSER::COLLECTION)
    ("Rac1, αPIX, and βPIX" . SPARSER::COLLECTION)
    ("Rac1 or αPIX" . SPARSER::COLLECTION)
    ("Halo-Rac1 or Halo-αPIX" . SPARSER::COLLECTION) ("TMR" . SPARSER::PROTEIN)
    ("tetramethylrhodamine" . SPARSER::MOLECULE) ("mGFP" . SPARSER::PROTEIN)
    ("the FA's" . SPARSER::PROTEIN) ("mGFP-paxillin" . SPARSER::COLLECTION)
    ("The micro-printed fibronectin" . SPARSER::PROTEIN)
    ("the micro-printed fibronectin" . SPARSER::PROTEIN)
    ("Rac1 or PIX" . SPARSER::COLLECTION) ("Molecules" . SPARSER::MOLECULE)
    ("FA-associated molecules" . SPARSER::MOLECULE)
    ("dominant-negative (DN) T17N Rac1 molecules" . SPARSER::MOLECULE)
    ("Rac1 (mostly in the form bound by RhoGDI [Hancock and Hall, xref ; Michaelson et al., xref ]) and PIXs"
     . SPARSER::COLLECTION)
    ("PIXs" . SPARSER::PROTEIN) ("Hua" . SPARSER::PROTEIN)
    ("Rac1 and its activator αPIX and βPIX" . SPARSER::COLLECTION)
    ("transferrin receptor, Thy1, and integrin" . SPARSER::COLLECTION)
    ("PALM" . SPARSER::PROTEIN)
    ("integrins and other integrin-associated molecules (FA-protein islands)"
     . SPARSER::COLLECTION)
    ("other integrin-associated molecules" . SPARSER::MOLECULE)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transferrin receptor and Thy1" . SPARSER::COLLECTION)
    ("steadily existing FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIX" . SPARSER::PROTEIN) ("αPIX and βPIX" . SPARSER::COLLECTION)
    ("FA-protein" . SPARSER::COLLECTION) ("tag7" . SPARSER::PROTEIN)
    ("Vav2" . SPARSER::PROTEIN) ("DOCK180" . SPARSER::PROTEIN)
    ("Rac 1" . SPARSER::PROTEIN) ("N- Ras" . SPARSER::PROTEIN)
    ("Thy1" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("βPIX" . SPARSER::PROTEIN) ("αPIX" . SPARSER::PROTEIN)
    ("ARC" . SPARSER::PROTEIN)
    ("CMH and EG designed and performed" . SPARSER::COLLECTION)
    ("CMH" . SPARSER::MOLECULE) ("GW" . SPARSER::PROTEIN)
    ("directly binds RAD51" . SPARSER::PROTEIN)
    ("IBR2 and imatinib" . SPARSER::COLLECTION)
    ("IBR2 or imatinib" . SPARSER::COLLECTION)
    ("Rad51 and γ-H2AX" . SPARSER::COLLECTION)
    ("imatinib, dasatinib and nilotinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG) ("Lactacystin" . SPARSER::DRUG)
    ("RAD50, ERK and phosphor-ERK" . SPARSER::COLLECTION)
    ("functional RAD51" . SPARSER::PROTEIN)
    ("siRNA and IBR2" . SPARSER::COLLECTION)
    ("either RAD51 siRNA (RAD51i) or luciferase siRNA (Luci)"
     . SPARSER::COLLECTION)
    ("NBS1, 53BP1and BRCA1" . SPARSER::COLLECTION)
    ("two nonfluorescent GFP derivatives" . SPARSER::DERIVATIVE)
    ("a fluorescent GFP" . SPARSER::PROTEIN) ("IBR2" . SPARSER::PROTEIN)
    ("IBR2-biotin" . SPARSER::PROTEIN-PAIR)
    ("phenylalanines" . SPARSER::AMINO-ACID)
    ("IBR2 directly and specifically binds RAD51" . SPARSER::PROTEIN)
    ("BRC-RAD51" . SPARSER::COLLECTION)
    ("RAD51 or the BRC" . SPARSER::COLLECTION)
    ("GST-BRC" . SPARSER::COLLECTION)
    ("a toxic metabolite" . SPARSER::MOLECULE)
    ("the TetOp-driven URA3 gene" . SPARSER::GENE) ("GAL1-" . SPARSER::PROTEIN)
    ("TetR-BRC" . SPARSER::COLLECTION) ("TetR" . SPARSER::PROTEIN-FAMILY)
    ("nucleo-protein filaments (Davies et al, xref ) and IR-induced foci (Chen et al, xref )"
     . SPARSER::COLLECTION)
    ("BRC/RAD51" . SPARSER::COLLECTION) ("RAD51-BRC" . SPARSER::COLLECTION)
    ("Sak" . SPARSER::PROTEIN)
    ("tumour-selective inhibitors" . SPARSER::INHIBITOR)
    ("an attractive target molecule" . SPARSER::MOLECULE)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("homologous DNA" . SPARSER::DNA)
    ("nucleo-filaments" . SPARSER::PROTEIN-PAIR)
    ("the essential recombinase RAD51" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("p84" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("benzyl group" . SPARSER::MOLECULE) ("URA3" . SPARSER::PROTEIN)
    ("GAL1" . SPARSER::PROTEIN) ("nucleo-protein" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("Bcr-abl" . SPARSER::PROTEIN)
    ("chromatin architecture around differently responding target genes"
     . SPARSER::GENE)
    ("responding target genes" . SPARSER::GENE)
    ("enhancers and chromatin" . SPARSER::COLLECTION)
    ("GATA and CTCF" . SPARSER::COLLECTION) ("CTCF" . SPARSER::PROTEIN)
    ("enhancers and RNAPII" . SPARSER::COLLECTION)
    ("acetyltransferase and FOXOs" . SPARSER::COLLECTION)
    ("distal FOXO3" . SPARSER::PROTEIN)
    ("FOXA1 and FOXO3" . SPARSER::COLLECTION)
    ("GATA and RUNX" . SPARSER::COLLECTION)
    ("similarly open compacted chromatin" . SPARSER::BIO-COMPLEX)
    ("AP-1, GATA, RUNX and SP1" . SPARSER::COLLECTION)
    ("several antiviral genes" . SPARSER::GENE)
    ("RNAPII and mRNA" . SPARSER::COLLECTION)
    ("FOXO and MYC" . SPARSER::COLLECTION)
    ("a previously reported FOXO3-induced negative regulator"
     . SPARSER::NEGATIVE-REGULATOR)
    ("slightly around other FOXO3" . SPARSER::PROTEIN)
    ("four intergenic FOXO3" . SPARSER::PROTEIN)
    ("regions around FOXO3-induced target genes" . SPARSER::GENE)
    ("the distal intergenic endogenous and exogenous FOXO3" . SPARSER::PROTEIN)
    ("4OHT and PKB" . SPARSER::COLLECTION)
    ("exogenous FOXO3" . SPARSER::PROTEIN)
    ("intergenic FOXO3" . SPARSER::PROTEIN)
    ("FOXO3A3-ER faithfully mimics endogenous FOXO3" . SPARSER::PROTEIN)
    ("distant enhancers" . SPARSER::PROTEIN)
    ("distant FOXO3" . SPARSER::PROTEIN) ("Enhancers" . SPARSER::PROTEIN)
    ("elegans and Drosophila" . SPARSER::COLLECTION)
    ("RUNX ( xref ) and SP-1 ( xref )" . SPARSER::COLLECTION)
    ("several previously described target gene promoters" . SPARSER::PROMOTER)
    ("CCNG2 and KLF6" . SPARSER::COLLECTION)
    ("eukaryotic genes" . SPARSER::GENE)
    ("cell-cycle-related genes" . SPARSER::GENE)
    ("a previously identified FOXO target" . SPARSER::TARGET-PROTEIN)
    ("NOXA" . SPARSER::PROTEIN)
    ("receptors and other signalling components" . SPARSER::COLLECTION)
    ("EGF, TGF, TNF, WNT and Rho" . SPARSER::COLLECTION)
    ("PI3K/PKB" . SPARSER::COLLECTION) ("RICTOR" . SPARSER::PROTEIN)
    ("IGF1R and IRS2" . SPARSER::COLLECTION) ("DLD1" . SPARSER::PROTEIN)
    ("the characteristic FOXO" . SPARSER::PROTEIN-FAMILY)
    ("DLD1-F3" . SPARSER::COLLECTION) ("DL" . SPARSER::MOLECULE)
    ("DLD" . SPARSER::PROTEIN) ("RNAPII" . SPARSER::PROTEIN)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("adjacent genes and pre-existence" . SPARSER::COLLECTION)
    ("enhancers and target genes" . SPARSER::COLLECTION)
    ("FOXO3 and RNA polymerase II" . SPARSER::COLLECTION)
    ("RNA polymerase II and FOXO3" . SPARSER::COLLECTION)
    ("s 25" . SPARSER::PROTEIN) ("RBP1" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("4-Hydroxy-tamoxifen" . SPARSER::DRUG)
    ("ID1" . SPARSER::PROTEIN) ("KLF5" . SPARSER::PROTEIN)
    ("H3K27Ac" . SPARSER::MOLECULE) ("KLF6" . SPARSER::PROTEIN)
    ("CCNG2" . SPARSER::PROTEIN) ("PRDX3" . SPARSER::PROTEIN)
    ("MXI1" . SPARSER::PROTEIN) ("PMAIP1" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("4OHT" . SPARSER::DRUG)
    ("C. elegans)" . SPARSER::PROTEIN) ("Foxo1" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("DS" . SPARSER::PROTEIN) ("MDS and polymorphisms" . SPARSER::COLLECTION)
    ("primary and secondary MDS" . SPARSER::PROTEIN)
    ("LIG1 , RAD52 , MSH3 and GPX3" . SPARSER::COLLECTION)
    ("CD3 and CD14" . SPARSER::COLLECTION)
    ("monocytes and CD14" . SPARSER::COLLECTION)
    ("TOP3A and RMI1" . SPARSER::COLLECTION)
    ("GSTP1 (glutathione S-transferase pi 1) and EPO (Erythropoietin) genes"
     . SPARSER::COLLECTION)
    ("MTR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase R) , RMI1 (RecQ mediated genome instability 1), GSTP1 (glutathione S-transferase pi 1) and EPO (Erythropoietin) genes"
     . SPARSER::COLLECTION)
    ("Erythropoietin" . SPARSER::PROTEIN) ("EPO" . SPARSER::PROTEIN)
    ("the heterozygous T/A genotype and MDS" . SPARSER::COLLECTION)
    ("gene and susceptibility" . SPARSER::COLLECTION)
    ("NFKB1 , AP-1 or STAT" . SPARSER::COLLECTION)
    ("progesterone receptor ( PGR )" . SPARSER::PROTEIN)
    ("the homozygous G/G genotype" . SPARSER::PROTEIN)
    ("the heterozygous C/G genotype" . SPARSER::PROTEIN)
    ("organic hydroperoxide" . SPARSER::MOLECULE)
    ("MDS and the rs8177426 SNP" . SPARSER::COLLECTION)
    ("DNA damage-response genes and DNA repair genes" . SPARSER::COLLECTION)
    ("EXO 1 (exonuclease 1) and rs7607076" . SPARSER::COLLECTION)
    ("RecQ" . SPARSER::PROTEIN-FAMILY) ("BLM" . SPARSER::PROTEIN)
    ("the homozygous A/A genotype" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("the heterozygous A/G genotype" . SPARSER::PROTEIN)
    ("MDS and a polymorphism" . SPARSER::COLLECTION)
    ("the homozygous C/C genotype and MDS" . SPARSER::COLLECTION)
    ("genotype and MDS" . SPARSER::COLLECTION) ("PGR" . SPARSER::PROTEIN)
    ("the c-ros oncogene 1 ( ROS1 ) gene (p = 0.001) and aurora kinase A ( STK6/AURKA) gene (p = 0.0002)"
     . SPARSER::COLLECTION)
    ("STK6/AURKA" . SPARSER::COLLECTION)
    ("significant heterozygous and homozygous variants" . SPARSER::VARIANT)
    ("erythropoietin" . SPARSER::PROTEIN) ("acute leukemia" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("ROS1 and STK6" . SPARSER::COLLECTION)
    ("transmembrane transporters" . SPARSER::PROTEIN)
    ("ABCB1 and SLC4A2" . SPARSER::COLLECTION)
    ("oxidative damage/DNA repair genes" . SPARSER::GENE)
    ("LIG1, RAD52, MSH3 and GPX3" . SPARSER::COLLECTION)
    ("TOP3A" . SPARSER::PROTEIN)
    ("RecQ mediated genome instability 1" . SPARSER::PROTEIN)
    ("RMI1" . SPARSER::PROTEIN)
    ("5-methyltetrahydrofolate-homocysteine methyltransferase reductase"
     . SPARSER::PROTEIN)
    ("glutathione peroxidase 3" . SPARSER::PROTEIN)
    ("exonuclease 1" . SPARSER::PROTEIN) ("EXO 1" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("family B" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("solute carrier family 4" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN)
    ("c-ros oncogene 1" . SPARSER::PROTEIN)
    ("glutathione S-transferase pi 1" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN) ("STK6" . SPARSER::PROTEIN)
    ("SLC4A2" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("GPX3" . SPARSER::PROTEIN) ("dextran" . SPARSER::DEXTRAN)
    ("DCC" . SPARSER::PROTEIN)
    ("ERα and a key regulator" . SPARSER::COLLECTION)
    ("a key inducer" . SPARSER::PROTEIN)
    ("ERα and RhoGDIα" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("histones and ERα" . SPARSER::COLLECTION)
    ("ERα and RhoB" . SPARSER::COLLECTION)
    ("ER transcriptional co-factors and RNA polymerase II"
     . SPARSER::COLLECTION)
    ("co-factors and RNA polymerase II" . SPARSER::COLLECTION)
    ("E 2 and luciferase" . SPARSER::COLLECTION)
    ("E 2 (from 1 to 0.53) and much lighter" . SPARSER::COLLECTION)
    ("RhoB and estrogen" . SPARSER::COLLECTION) ("siB" . SPARSER::DRUG)
    ("Rho-GDI or Dblx" . SPARSER::COLLECTION)
    ("ERα and Rho-GDI" . SPARSER::COLLECTION) ("RhoGEF" . SPARSER::PROTEIN)
    ("exchange factors (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("RhoA and RhoC" . SPARSER::COLLECTION) ("RhoC" . SPARSER::PROTEIN)
    ("GTP and GDP" . SPARSER::COLLECTION)
    ("ERα and growth factor" . SPARSER::COLLECTION)
    ("Hormone" . SPARSER::MOLECULE) ("RhoB and ERα" . SPARSER::COLLECTION)
    ("ERα and other major co-regulators" . SPARSER::COLLECTION)
    ("RhoB" . SPARSER::PROTEIN) ("p185 erbB2" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("Rho-GDI α" . SPARSER::PROTEIN)
    ("Tiam1" . SPARSER::PROTEIN)
    ("immediate early response" . SPARSER::PROTEIN)
    ("caspase-8 or caspase-3" . SPARSER::COLLECTION)
    ("premature chromatin condensation" . SPARSER::PROTEIN-FAMILY)
    ("nt-siRNA" . SPARSER::PROTEIN-PAIR) ("RB-wt" . SPARSER::PROTEIN-PAIR)
    ("RB and β-catenin" . SPARSER::COLLECTION)
    ("TRAF2, caspase-8, FADD, and IκB" . SPARSER::COLLECTION)
    ("TNFR1, RIPK1, TRADD, FLIP, and XIAP" . SPARSER::COLLECTION)
    ("irrelevant shRNA" . SPARSER::PROTEIN)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("c-IAP" . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNFRI" . SPARSER::PROTEIN)
    ("efficiently knocked-down β-catenin" . SPARSER::PROTEIN)
    ("stably knocked-down β-catenin" . SPARSER::PROTEIN)
    ("3 different lentiviral shRNAs" . SPARSER::RNA)
    ("preceded TNF/CHX-induced nuclear condensation" . SPARSER::PROTEIN-FAMILY)
    ("caspase-3, and PARP1" . SPARSER::COLLECTION) ("zVADfmk" . SPARSER::DRUG)
    ("TNF/CHX" . SPARSER::COLLECTION)
    ("TNFR1, TRADD, RIPK1, TRAF2, cIAP, FADD, FLIP, and caspase-8"
     . SPARSER::COLLECTION)
    ("codon-45–mutated β-catenin" . SPARSER::PROTEIN)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("Ki67, cyclin D1, and c-Myc" . SPARSER::COLLECTION)
    ("TNFR1 and caspase-8" . SPARSER::COLLECTION)
    ("AOM/DSS" . SPARSER::COLLECTION) ("AOM" . SPARSER::PROTEIN)
    ("TNFR1 and pro-caspase-8" . SPARSER::COLLECTION)
    ("DSS" . SPARSER::PROTEIN) ("fragments—" . SPARSER::FRAGMENT)
    ("Ahi1 or FOXM" . SPARSER::COLLECTION) ("Ahi1" . SPARSER::PROTEIN)
    ("DKK" . SPARSER::PROTEIN)
    ("a homo-oligomeric complex" . SPARSER::BIO-COMPLEX)
    ("caspase-8 and FLIP" . SPARSER::COLLECTION)
    ("caspase-8-FLIP" . SPARSER::COLLECTION) ("FLIP" . SPARSER::PROTEIN)
    ("caspase-8 and FADD" . SPARSER::COLLECTION)
    ("TNF receptor 1 (TNFR1) and its signaling complex" . SPARSER::COLLECTION)
    ("TRADD, RIPK1, TRAF2, and cIAP" . SPARSER::COLLECTION)
    ("TNF and its downstream inflammatory effector" . SPARSER::COLLECTION)
    ("β-catenin or RB" . SPARSER::COLLECTION)
    ("preceded chromatin condensation" . SPARSER::PROTEIN-FAMILY)
    ("AR-A014418" . SPARSER::DRUG) ("GC3" . SPARSER::PROTEIN)
    ("RIPK3" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("an oncogene or a tumor suppressor" . SPARSER::COLLECTION)
    ("JNK, HuR, and tristetraprolin" . SPARSER::COLLECTION)
    ("tristetraprolin" . SPARSER::PROTEIN) ("HuR" . SPARSER::PROTEIN)
    ("STAT3/EGFR" . SPARSER::COLLECTION)
    ("the T lymphoblastic leukemia/lymphoma cell line Jurkat"
     . SPARSER::PROTEIN)
    ("ALK-" . SPARSER::PROTEIN)
    ("toll-like receptor 7 or CD23" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN) ("carboxy-" . SPARSER::MOLECULE)
    ("the mature form" . SPARSER::FORM)
    ("mRNA and miR-26a" . SPARSER::COLLECTION)
    ("STAT3 and the CTDSPL gene" . SPARSER::COLLECTION)
    ("ALK/STAT3" . SPARSER::COLLECTION)
    ("Neither ALK nor STAT3 siRNA" . SPARSER::COLLECTION)
    ("ALK, pSTAT3 and iNOS" . SPARSER::COLLECTION)
    ("CTDSPL" . SPARSER::PROTEIN) ("NPM-" . SPARSER::PROTEIN)
    ("NPM-ALK/STAT3" . SPARSER::COLLECTION)
    ("a posttranscriptional suppressor" . SPARSER::SUPPRESSOR)
    ("TAE684 and PF-2341066" . SPARSER::COLLECTION) ("MEG" . SPARSER::DRUG)
    ("iNOS and nitrotyrosine" . SPARSER::COLLECTION)
    ("nitrotyrosine" . SPARSER::MOLECULE) ("DNA-repair" . SPARSER::DNA)
    ("inflammatory mediators and cytokines" . SPARSER::COLLECTION)
    ("mediators and cytokines" . SPARSER::COLLECTION)
    ("nNOS and eNOS" . SPARSER::COLLECTION) ("nNOS" . SPARSER::PROTEIN)
    ("NOSs" . SPARSER::PROTEIN)
    ("Grb2, Shc, IRS-1 and SNT" . SPARSER::COLLECTION)
    ("SNT" . SPARSER::PROTEIN)
    ("nucleophosmin-anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("an iNOS inhibitor and NO scavenger" . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN)
    ("KH-type splicing regulatory protein" . SPARSER::PROTEIN)
    ("toll-like receptor 7" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("MIR26A2" . SPARSER::MIR-26A2)
    ("PF-2341066" . SPARSER::DRUG) ("TAE684" . SPARSER::DRUG)
    ("CTDSP2" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("Nitric oxide" . SPARSER::MOLECULE)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MIR26A1" . SPARSER::MIR-26A1)
    ("types and diseases" . SPARSER::COLLECTION)
    ("rare allelic variants" . SPARSER::VARIANT)
    ("dexmedetomidine and phenylephrine" . SPARSER::COLLECTION)
    ("Rho kinase, PKC, and phosphatidylinositol 3-kinase"
     . SPARSER::COLLECTION)
    ("MEK and MAPK" . SPARSER::COLLECTION)
    ("biologically plausible genes" . SPARSER::GENE)
    ("phenylephrine" . SPARSER::DRUG) ("PRKCB" . SPARSER::PROTEIN)
    ("cyclase activity and cAMP" . SPARSER::COLLECTION) ("-type" . TYPE)
    ("ins" . SPARSER::PROTEIN)
    ("the most selective clinically available α 2 -AR agonist"
     . SPARSER::AGONIST)
    ("norepinephrine" . SPARSER::DRUG)
    ("vasoactive agonists" . SPARSER::AGONIST) ("-ARs" . SPARSER::COLLECTION)
    ("dexmedetomidine" . SPARSER::DRUG) ("-AR" . SPARSER::COLLECTION)
    ("-Adrenoceptors" . SPARSER::COLLECTION)
    ("Adrenoceptors" . SPARSER::PROTEIN) ("NXPH1" . SPARSER::PROTEIN)
    ("RGS20" . SPARSER::PROTEIN) ("cyclase activity" . SPARSER::PROTEIN)
    ("ADRA1A" . SPARSER::PROTEIN) ("ADRA2B" . SPARSER::PROTEIN)
    ("low nuclear VDR or high nuclear CTSL" . SPARSER::COLLECTION)
    ("cystatins" . SPARSER::PROTEIN)
    ("neu, estrogen and progesterone" . SPARSER::COLLECTION)
    ("CTSL, 53BP1, and VDR" . SPARSER::COLLECTION)
    ("vitamin D or CTSL" . SPARSER::COLLECTION)
    ("IR or PARPi" . SPARSER::COLLECTION)
    ("vitamin D and cathepsin" . SPARSER::COLLECTION)
    ("Vitamin D and cathepsin" . SPARSER::COLLECTION)
    ("vitamin D or cathepsin" . SPARSER::COLLECTION)
    ("53BP1 and nuclear CTSL" . SPARSER::COLLECTION)
    ("53BP1 mRNA and/or protein" . SPARSER::COLLECTION)
    ("VDR, CTSL, and 53BP1—for" . SPARSER::COLLECTION)
    ("VDR and 53BP1" . SPARSER::COLLECTION)
    ("VDR and cystatin D" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("53BP1 and CTSL" . SPARSER::COLLECTION)
    ("nuclear CTSL (P = 0.95) and low Hscores" . SPARSER::COLLECTION)
    ("BRCA1 ( n = 18) or BRCA2 ( n = 14)" . SPARSER::COLLECTION)
    ("Ki67, ER, CTSL, 53BP1, and VDR" . SPARSER::COLLECTION)
    ("vitamin D and IR" . SPARSER::COLLECTION)
    ("BRCA1 or CTSL" . SPARSER::COLLECTION)
    ("53BP1 and RAD51" . SPARSER::COLLECTION)
    ("BRCA1-deficient cells partially rescues HR" . SPARSER::PROTEIN)
    ("cathepsin" . SPARSER::PROTEIN) ("CTSL and 53BP1" . SPARSER::COLLECTION)
    ("53BP1 or CTSL" . SPARSER::COLLECTION)
    ("CTSL, VDR, and 53BP1" . SPARSER::COLLECTION)
    ("receptor (VDR)" . SPARSER::RECEPTOR)
    ("53BP1 and vitamin D" . SPARSER::COLLECTION)
    ("cathepsin L (CTSL)" . SPARSER::PROTEIN)
    ("cisplatin and mitomycin C" . SPARSER::COLLECTION)
    ("CtIP and the Mre11–Rad50–Nbs1 complex" . SPARSER::COLLECTION)
    ("Mre11–Rad50–Nbs1" . SPARSER::COLLECTION)
    ("ATM, Chk2, or p53" . SPARSER::COLLECTION)
    ("receptor, and 53BP1" . SPARSER::COLLECTION) ("CTSL" . SPARSER::PROTEIN)
    ("genotoxic drugs" . SPARSER::DRUG) ("steroid hormone" . SPARSER::MOLECULE)
    ("Erα" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("M 1" . SPARSER::MOLECULE)
    ("cystatin D" . SPARSER::PROTEIN) ("cathepsin L" . SPARSER::PROTEIN)
    ("Cathepsin L" . SPARSER::PROTEIN)
    ("investigative CRC biomarkers" . SPARSER::MOLECULE)
    ("TNM-stages" . SPARSER::MOLECULE)
    ("MSI and cell cycle regulators cyclin D1 and p21" . SPARSER::COLLECTION)
    ("cyclin D1 and p21" . SPARSER::COLLECTION)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("the TMA-technique" . SPARSER::MOLECULE)
    ("TMA-technique" . SPARSER::MOLECULE)
    ("leucovorin or 5-fluorouracil " . SPARSER::COLLECTION)
    ("MSI or beta-catenin" . SPARSER::COLLECTION)
    ("leucovorin " . SPARSER::DRUG) ("fluorouracil " . SPARSER::DRUG)
    ("fraction and intensity" . SPARSER::COLLECTION)
    ("p53, p21, p27 and cyclin D1" . SPARSER::COLLECTION)
    ("FU" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("hereditary nonpolyposis colon cancer (HNPCC)" . SPARSER::PROTEIN)
    ("colon cancer (HNPCC)" . SPARSER::PROTEIN)
    ("MLH1 , MSH2 , MSH6 , and PMS2" . SPARSER::COLLECTION)
    ("Wnt-receptors" . SPARSER::COLLECTION)
    ("p53, and loss of heterozygosity" . SPARSER::COLLECTION)
    ("MSI and beta-catenin" . SPARSER::COLLECTION)
    ("P53 and p27" . SPARSER::COLLECTION) ("incident CRC" . SPARSER::PROTEIN)
    ("p21, p27 and p53" . SPARSER::COLLECTION)
    ("p21, p27, cyclin D1 and p53" . SPARSER::COLLECTION)
    ("Beta-catenin" . SPARSER::PROTEIN)
    ("p16 and cyclin D1" . SPARSER::COLLECTION)
    ("PHD1 and PHD2" . SPARSER::COLLECTION) ("PHD1-3" . SPARSER::COLLECTION)
    ("p16 and HIF-1α or HIF-2α" . SPARSER::COLLECTION)
    ("HIF-1α or HIF-2α" . SPARSER::COLLECTION)
    ("CDK4/6 and cyclin D1" . SPARSER::COLLECTION)
    ("CDK4 and cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1, CKD4 and p16" . SPARSER::COLLECTION)
    ("p16 and both PHD1 ( P = 0.032) and PHD2 ( P = 0.027)"
     . SPARSER::COLLECTION)
    ("both PHD1 ( P = 0.032) and PHD2 ( P = 0.027)" . SPARSER::COLLECTION)
    ("cyclin D1, CDK4 and p16 and hypoxia-inducible factor"
     . SPARSER::COLLECTION)
    ("p16 and hypoxia-inducible factor" . SPARSER::COLLECTION)
    ("cyclin D1 and p16" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("cyclin D1 and its regulators" . SPARSER::COLLECTION)
    ("CDK4 and p16" . SPARSER::COLLECTION)
    ("The gene and its product" . SPARSER::COLLECTION)
    ("its hypophosphorylated E2F-associated state" . SPARSER::BIO-STATE)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("cyclin D1, CDK4 and p16" . SPARSER::COLLECTION)
    ("tumor suppressor gene ( RB )" . SPARSER::PROTEIN)
    ("p16-cyclin D1-CDK4/6-RB" . SPARSER::COLLECTION)
    ("PHD3" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN) ("CDKN2" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("miR-193b and PER2" . SPARSER::COLLECTION)
    ("miR-193b and p-ERK" . SPARSER::COLLECTION)
    ("NF1 and ERK" . SPARSER::COLLECTION) ("Raf and MEK" . SPARSER::COLLECTION)
    ("Dicer, Drosha or DGCR8" . SPARSER::COLLECTION)
    ("Dicer, Drosha, DGCR8, AGO2 or XPO5" . SPARSER::COLLECTION)
    ("A global miRNA" . SPARSER::PROTEIN)
    ("a MEK/ERK kinase 1/2 pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("miR-193b and NF1" . SPARSER::COLLECTION)
    ("MiR-193b Directly Targets NF1" . SPARSER::PROTEIN)
    ("NF1 and PER2" . SPARSER::COLLECTION)
    ("PER2 and NF1" . SPARSER::COLLECTION)
    ("PER2, DUSP1 and NF1" . SPARSER::COLLECTION) ("SCL" . SPARSER::PROTEIN)
    ("LNA" . SPARSER::PROTEIN) ("our comprehensive miRNA" . SPARSER::PROTEIN)
    ("our global miRNA" . SPARSER::PROTEIN) ("the largest classes" . CLASS)
    ("global miRNA" . SPARSER::PROTEIN) ("Micro-RNAs" . SPARSER::MICRO-RNA)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XPO5" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN) ("RAS-GDP" . SPARSER::PROTEIN)
    ("ST3GAL3" . SPARSER::PROTEIN)
    ("Negative Regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("P-ERK" . SPARSER::PROTEIN) ("L34" . SPARSER::PROTEIN)
    ("FL-2" . SPARSER::PROTEIN) ("DUSP1" . SPARSER::PROTEIN)
    ("ST3GAL4" . SPARSER::PROTEIN) ("TP53INP1" . SPARSER::PROTEIN)
    ("FABP3" . SPARSER::PROTEIN) ("SLC38A3" . SPARSER::PROTEIN)
    ("SARM1" . SPARSER::PROTEIN) ("PER2" . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("neurofibromin 1" . SPARSER::PROTEIN)
    ("miR-193b" . SPARSER::MOLECULE) ("MiR-193b" . SPARSER::MOLECULE)
    ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("the presumed promutagenic lesion ( xref ) O  6 -CMG" . SPARSER::MOLECULE)
    ("the MGMT tryptic peptide" . SPARSER::PEPTIDE)
    ("Indeed ODNs containing O  6 -CMG inactivated MGMT" . SPARSER::PROTEIN)
    ("ODN and MGMT" . SPARSER::COLLECTION) ("azaserine" . SPARSER::DRUG)
    ("NOGC-treated DNA" . SPARSER::DNA) ("ada and ogt" . SPARSER::COLLECTION)
    ("this tryptic fragment" . SPARSER::FRAGMENT)
    ("carboxymethyl" . SPARSER::MOLECULE)
    ("the tryptic fragment" . SPARSER::FRAGMENT) ("-GAA" . SPARSER::COLLECTION)
    ("GAA" . SPARSER::PROTEIN) ("-MeG or O  6" . SPARSER::COLLECTION)
    ("-methylated substrate DNA" . SPARSER::DNA)
    ("-MeG and O  6" . SPARSER::COLLECTION) ("ODN" . SPARSER::PROTEIN)
    ("Ogt and MGMT" . SPARSER::COLLECTION)
    ("-alkylguanines" . SPARSER::COLLECTION) ("Ogt" . SPARSER::PROTEIN)
    ("alkylguanines" . SPARSER::PROTEIN) ("ada or ogt" . SPARSER::COLLECTION)
    ("ogt" . SPARSER::PROTEIN) ("ada" . SPARSER::PROTEIN)
    ("O  6 -methylguanine DNA methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("potent mutagens and other DNA-reactive agents ( xref , xref )"
     . SPARSER::COLLECTION)
    ("DNA-reactive" . SPARSER::DNA) ("AAs" . SPARSER::MOLECULE)
    ("CRCs" . SPARSER::PROTEIN)
    ("the known MGMT substrate O  6 -methylguanine ( O  6 -MeG) or O  6 -CMG"
     . SPARSER::COLLECTION)
    ("-MeG" . SPARSER::DRUG) ("-methylguanine" . SPARSER::MOLECULE)
    ("MeG" . SPARSER::DRUG)
    ("the DNA damage reversal protein O  6 -methylguanine-DNA methyltransferase (MGMT)"
     . SPARSER::PROTEIN)
    ("O  6 -methylguanine-DNA methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("-alkylguanine" . SPARSER::COLLECTION) ("alkylguanine" . SPARSER::PROTEIN)
    ("-CMG" . SPARSER::MOLECULE) ("CMG" . SPARSER::MOLECULE)
    ("carboxymethyl group" . SPARSER::MOLECULE) ("C-3" . SPARSER::PROTEIN)
    ("K- ras" . SPARSER::PROTEIN)
    ("O  6 -methylguanine DNA methyltransferase" . SPARSER::PROTEIN)
    ("O  6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("O  6" . SPARSER::PROTEIN) ("Spt23" . SPARSER::PROTEIN)
    ("VCP/p97" . SPARSER::COLLECTION) ("distinct cofactors" . SPARSER::PROTEIN)
    ("oligomerized CAV1" . SPARSER::PROTEIN)
    ("CAV1 oligomers or larger assemblies" . SPARSER::COLLECTION)
    ("the muscle-specific CAV3 variant" . SPARSER::VARIANT)
    ("an amphipathic α helix" . SPARSER::PROTEIN)
    ("ubiquitin and CAV1" . SPARSER::COLLECTION)
    ("HA- and LAMP1-specific antibodies ( xref , A and B )"
     . SPARSER::COLLECTION)
    ("HA-" . SPARSER::PROTEIN) ("cellular ubiquitin" . SPARSER::PROTEIN)
    ("bafilomycin A1 or NH 4 Cl" . SPARSER::COLLECTION)
    ("VCP-" . SPARSER::PROTEIN) ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("CAV1-HA" . SPARSER::COLLECTION) ("UBXD1-mCherry" . SPARSER::COLLECTION)
    ("the lysine-less variant CAV1(K5–176K) or the N-terminal lysine mutant CAV1(K5–57R)"
     . SPARSER::COLLECTION)
    ("VCP-myc" . SPARSER::COLLECTION)
    ("endogenous VCP or transiently overexpressed VCP" . SPARSER::COLLECTION)
    ("VCP and UBXD1" . SPARSER::COLLECTION) ("GFP-RAB5" . SPARSER::COLLECTION)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("clathrin and early endosomal antigen" . SPARSER::COLLECTION)
    ("VCP-Ufd1-Npl4" . SPARSER::COLLECTION)
    ("its heterodimeric cofactor Ufd1-Npl4" . SPARSER::COLLECTION)
    ("Ufd1-Npl4" . SPARSER::COLLECTION)
    ("a multifunctional hexameric AAA+-type ATPase" . SPARSER::PROTEIN)
    ("valosin-containing protein, p97, or Cdc48" . SPARSER::COLLECTION)
    ("monoubiquitin" . SPARSER::PROTEIN)
    ("rapidly forms SDS-resistant oligomers" . SPARSER::MOLECULE)
    ("Caveolins" . SPARSER::PROTEIN-FAMILY)
    ("the muscle-specific caveolin-3" . SPARSER::PROTEIN)
    ("endo-" . SPARSER::PROTEIN) ("endo" . SPARSER::PROTEIN)
    ("VCP or UBXD1" . SPARSER::COLLECTION)
    ("the AAA+-type ATPase VCP and its cofactor UBXD1" . SPARSER::COLLECTION)
    ("VCP-UBXD1" . SPARSER::COLLECTION) ("CAV3" . SPARSER::PROTEIN)
    ("Y14F" . SPARSER::PROTEIN) ("di-glycine" . SPARSER::MOLECULE)
    ("B–D" . SPARSER::PROTEIN) ("K65" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("Ammonium chloride" . SPARSER::MOLECULE)
    ("bafilomycin A1" . SPARSER::DRUG) ("LAMP1" . SPARSER::PROTEIN)
    ("RAB5" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("Npl4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ufd1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("valosin-containing protein" . SPARSER::PROTEIN)
    ("caveolin-3" . SPARSER::PROTEIN) ("caveolin-2" . SPARSER::PROTEIN)
    ("UBXD1" . SPARSER::PROTEIN) ("HUMARA" . SPARSER::PROTEIN)
    ("the genes responsible" . SPARSER::GENE)
    ("all causative genes" . SPARSER::GENE)
    ("a severe variant" . SPARSER::VARIANT) ("microcephaly" . SPARSER::PROTEIN)
    ("DKC1" . SPARSER::PROTEIN) ("Etanercept" . SPARSER::DRUG)
    ("kinase (CSK)" . SPARSER::KINASE)
    ("regenerate active FAK" . SPARSER::PROTEIN) ("CSK" . SPARSER::PROTEIN)
    ("Rho- and Ras-GTPases" . SPARSER::COLLECTION)
    ("Rho-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("their associated adaptor proteins" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("Ras and Rho-families" . SPARSER::COLLECTION)
    ("adhesion molecules (Cadherin-11, ICAM-1 and VCAM-1) and the chemokine CXCL10 ( xref , xref , xref , xref – xref )"
     . SPARSER::COLLECTION)
    ("MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("Cadherin-11, ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("a prominent inflammatory cytokine" . SPARSER::PROTEIN)
    ("JNK, p38 and ERK" . SPARSER::COLLECTION)
    ("IL6 , IL8 , MMP3 or MMP10" . SPARSER::COLLECTION)
    ("MMP1 , MMP2 , MMP9 , MMP13 , CTSK , CXCL10 , CDH11 , ICAM1 and VCAM1"
     . SPARSER::COLLECTION)
    ("Cathepsin K (CTSK)" . SPARSER::PROTEIN)
    ("the inflammatory cytokines interleukin 6 (IL-6) and interleukin"
     . SPARSER::COLLECTION)
    ("Intercellular Adhesion Molecule 1 (ICAM-1) and Vascular Cell Adhesion Molecule 1 (VCAM-1)"
     . SPARSER::COLLECTION)
    ("Vascular Cell Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("CTSK" . SPARSER::PROTEIN)
    ("multiple inflammatory cytokines" . SPARSER::PROTEIN)
    ("FBS or platelet-derived growth factor (PDGF)" . SPARSER::COLLECTION)
    ("FBS or platelet-derived growth factor" . SPARSER::COLLECTION)
    ("Extracellular signal Regulated Kinase (ERK) and p38 MAPKs ( xref )"
     . SPARSER::COLLECTION)
    ("c-Jun N-terminal Kinase (JNK), Extracellular signal Regulated Kinase (ERK) and p38 MAPKs ( xref )"
     . SPARSER::COLLECTION)
    ("Kinase (JNK)" . SPARSER::KINASE) ("Ctl" . SPARSER::PROTEIN)
    ("a cell-permeable antisense oligonucleotide (ASO)" . SPARSER::MOLECULE)
    ("oligonucleotide (ASO)" . SPARSER::MOLECULE)
    ("RA and OA FLS" . SPARSER::COLLECTION)
    ("unstimulated RA or OA FLS" . SPARSER::COLLECTION)
    ("TNF or IL-1" . SPARSER::COLLECTION)
    ("PTP and promoter" . SPARSER::COLLECTION)
    ("3 separate FLS" . SPARSER::PROTEIN)
    ("a very upstream promoter" . SPARSER::PROMOTER)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("proto-oncogene and drug" . SPARSER::COLLECTION)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("the Eyes Absent PTPs" . SPARSER::PROTEIN) ("EYA" . SPARSER::PROTEIN)
    ("the tyrosine-specific PTPs and several subfamilies"
     . SPARSER::COLLECTION)
    ("the phosphoinositol-specific Phosphatase and Tensin Homolog (PTEN) and the dual-specificity (phosphoserine/phosphothreonine and phosphotyrosine) MAP Kinase Phosphatase 1 (MKP-1)"
     . SPARSER::COLLECTION)
    ("Phosphatase and Tensin Homolog (PTEN)" . SPARSER::PROTEIN)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Fibroblast Growth Factor (FGF) and Platelet-Derived Growth Factor (PDGF)"
     . SPARSER::COLLECTION)
    ("key pathogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("protein tyrosine kinases (PTKs) and phosphatases (PTPs)"
     . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pathogenic effectors" . SPARSER::EFFECTOR)
    ("kinase and mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("a cell-permeable antisense oligonucleotide" . SPARSER::MOLECULE)
    ("cell-permeable antisense oligonucleotides" . SPARSER::MOLECULE)
    ("PTP" . SPARSER::PROTEIN)
    ("proteases and inflammatory cytokines" . SPARSER::COLLECTION)
    ("FLS" . SPARSER::PROTEIN) ("MMP10" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("VCAM1" . SPARSER::PROTEIN)
    ("Cell Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("Intercellular Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("CDH11" . SPARSER::PROTEIN) ("Cadherin-11" . SPARSER::PROTEIN)
    ("CXCL10" . SPARSER::PROTEIN)
    ("C-X-C motif chemokine 10" . SPARSER::PROTEIN)
    ("Cathepsin K" . SPARSER::PROTEIN)
    ("Extracellular signal Regulated Kinase" . SPARSER::PROTEIN)
    ("PTP-2" . SPARSER::PROTEIN) ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("PDGF-BB" . SPARSER::PROTEIN) ("UBASH3A" . SPARSER::PROTEIN)
    ("SSU72" . SPARSER::PROTEIN) ("ACP1" . SPARSER::PROTEIN)
    ("MAP Kinase Phosphatase 1" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin Homolog" . SPARSER::PROTEIN)
    ("Derived Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fibroblast Growth Factor" . SPARSER::PROTEIN-FAMILY)
    ("Gab1 and Sos1" . SPARSER::COLLECTION) ("MET/RON" . SPARSER::COLLECTION)
    ("steric hindrance and vice versa" . SPARSER::PROTEIN)
    ("Gab1-Grb2" . SPARSER::COLLECTION) ("Gab1-MET/RON" . SPARSER::COLLECTION)
    ("MET and RON" . SPARSER::COLLECTION) ("RON" . SPARSER::PROTEIN)
    ("Sos1 guanine nucleotide exchange factor and the Gab1"
     . SPARSER::COLLECTION)
    ("the Cbl ubiquitin ligase ( xref ; xref ; xref ) and the p27kip1 cell cycle inhibitor ( xref )"
     . SPARSER::COLLECTION)
    ("the dynamin endocytic GTPase" . SPARSER::GTPASE)
    ("Grb2-LAT" . SPARSER::COLLECTION)
    ("Grb2-Sos1 and Grb2-Gab1 binary complexes" . SPARSER::BIO-COMPLEX)
    ("these macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("such a ternary complex" . SPARSER::BIO-COMPLEX)
    ("Sos1-Grb2-Gab1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("protein and vice versa" . SPARSER::COLLECTION)
    ("Multi-protein" . SPARSER::COLLECTION) ("MonA" . SPARSER::PROTEIN)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("the composite Sos1-Grb2-Gab1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("Gab1 and vice versa" . SPARSER::COLLECTION)
    ("a much tighter 3 10 -helical conformation" . SPARSER::BIO-CONFORMATION)
    ("a left-handed PPII-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("PPII" . SPARSER::PROTEIN) ("x" . SPARSER::PROTEIN)
    ("two distinct Grb2-Sos1 and Grb2-Gab1 binary complexes instead of a composite Sos1-Grb2-Gab1 ternary complex"
     . SPARSER::COLLECTION)
    ("two distinct Grb2-Sos1 and Grb2-Gab1 binary complexes"
     . SPARSER::BIO-COMPLEX)
    ("the Sos1-Grb2-Gab1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("the much shorter peptide" . SPARSER::PEPTIDE) ("mer" . SPARSER::PROTEIN)
    ("Sos1 (Sos1_PR) and Gab1 (Gab1_PR)" . SPARSER::COLLECTION)
    ("Grb2 and vice versa" . SPARSER::COLLECTION)
    ("two physically-distinct Grb2-Sos1 and Grb2-Gab1 binary signaling complexes"
     . SPARSER::BIO-COMPLEX)
    ("a Grb2-Sos1-Gab1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("Grb2-Sos1-Gab1" . SPARSER::COLLECTION)
    ("Sos1-Grb2-Gab1 ternary signaling complex" . SPARSER::BIO-COMPLEX)
    ("the Shp2 tyrosine phosphatase and the PI3K kinase" . SPARSER::COLLECTION)
    ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("the Sos1 guanine nucleotide exchange factor and the Gab1"
     . SPARSER::COLLECTION)
    ("effectors and regulators" . SPARSER::COLLECTION)
    ("Ras and Akt" . SPARSER::COLLECTION)
    ("our study sheds new light" . SPARSER::PROTEIN)
    ("both the Grb2-Sos1 and Grb2-Gab1 binary complexes"
     . SPARSER::BIO-COMPLEX)
    ("Sos1 and Gab1" . SPARSER::COLLECTION) ("Grb2-Sos1" . SPARSER::COLLECTION)
    ("cSH3" . SPARSER::PROTEIN)
    ("a composite Sos1-Grb2-Gab1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("Grb2-Gab1 binary signaling complexes" . SPARSER::BIO-COMPLEX)
    ("nucleotide exchange factor and Gab1" . SPARSER::COLLECTION)
    ("Grb2-Gab1" . SPARSER::COLLECTION) ("Sos1" . SPARSER::PROTEIN)
    ("Sos" . SPARSER::PROTEIN) ("p27kip1" . SPARSER::PROTEIN)
    ("77kD" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("SMO and AKT1" . SPARSER::COLLECTION)
    ("AKT1 and MTOR" . SPARSER::COLLECTION)
    ("SMO , AKT1 , and MTOR" . SPARSER::COLLECTION) ("hME" . SPARSER::PROTEIN)
    ("AKT1-" . SPARSER::PROTEIN) ("MTOR-" . SPARSER::PROTEIN)
    ("particular histopathologic subtypes" . SPARSER::PROTEIN)
    ("NF2 or SMO" . SPARSER::COLLECTION)
    ("The allelic fractions" . SPARSER::COMPONENT)
    ("Both KDM5C (also known as JARID1C) and KDM6A" . SPARSER::COLLECTION)
    ("SNF5 and INI1" . SPARSER::COLLECTION)
    ("KDM5C , KDM6A , and SMARCB1" . SPARSER::COLLECTION)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("TP53, APC , CBL , STK11 and NOTCH2" . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN)
    ("NF2 , KDM5C , SMO , and AKT1" . SPARSER::COLLECTION)
    ("RGPD3 and CD300C" . SPARSER::COLLECTION) ("CD300C" . SPARSER::PROTEIN)
    ("NF2 (before exon 2) and TCF20" . SPARSER::COLLECTION)
    ("NF1, NF2 , and CDK14" . SPARSER::COLLECTION)
    ("chr5 and chr20" . SPARSER::COLLECTION)
    ("sequenced 645 known cancer-associated genes" . SPARSER::GENE)
    ("AKT1 (E17K) and SMO (W535L)" . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN) ("k 2" . SPARSER::PROTEIN)
    ("l 32" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("INI1" . SPARSER::PROTEIN)
    ("SNF5" . SPARSER::PROTEIN) ("JARID1C" . SPARSER::PROTEIN)
    ("SMARCB1" . SPARSER::PROTEIN) ("KDM6A" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN) ("RGPD3" . SPARSER::PROTEIN)
    ("KDM5C" . SPARSER::PROTEIN) ("TCF20" . SPARSER::PROTEIN)
    ("NEGR1" . SPARSER::PROTEIN) ("DAL-1" . SPARSER::PROTEIN)
    ("chr5" . SPARSER::PROTEIN) ("Cip1" . SPARSER::PROTEIN)
    ("Cip" . SPARSER::PROTEIN) ("Mitf" . SPARSER::PROTEIN)
    ("MITF and mutant" . SPARSER::COLLECTION)
    ("p16 INK4a and p16 INK4a" . SPARSER::COLLECTION)
    ("nestin or BrdU" . SPARSER::COLLECTION)
    ("Myc and Ras" . SPARSER::COLLECTION) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("MITF and hNCPCs" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("CDK2 and CDK4" . SPARSER::COLLECTION)
    ("MITF and tyrosinase" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN) ("MEK and ERK" . SPARSER::COLLECTION)
    ("blasticidin" . SPARSER::MOLECULE)
    ("MITF or tyrosinase" . SPARSER::COLLECTION)
    ("tyrosinase" . SPARSER::PROTEIN)
    ("CDK2, CDK4, MITF and EST1/2" . SPARSER::COLLECTION)
    ("Cot1" . SPARSER::PROTEIN) ("p16 ink4a" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN) ("Oct3" . SPARSER::PROTEIN)
    ("Ets1" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("PLX-4720" . SPARSER::DRUG) ("EST1" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN)
    ("PGE2 and lipopolysaccharide" . SPARSER::COLLECTION)
    ("CCK" . SPARSER::PROTEIN)
    ("the transformed cells active K-Ras" . SPARSER::PROTEIN)
    ("LSL-KRasG12D" . SPARSER::COLLECTION) ("KRasG" . SPARSER::PROTEIN)
    ("LSL-KrasG12D" . SPARSER::COLLECTION) ("pdx-Cre" . SPARSER::COLLECTION)
    ("KrasG" . SPARSER::PROTEIN) ("N-Ras or H-Ras" . SPARSER::COLLECTION)
    ("Panc-Ras" . SPARSER::COLLECTION) ("Panc" . SPARSER::PROTEIN)
    ("the entire Ras family" . SPARSER::PROTEIN) ("stimulants" . SPARSER::DRUG)
    ("pdx1" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("H-Ras" . SPARSER::PROTEIN) ("Ras family" . SPARSER::PROTEIN)
    ("fortuitously targets EGFP" . SPARSER::PROTEIN)
    ("importing other COX8-RFP" . SPARSER::COLLECTION)
    ("COX8-RFP" . SPARSER::COLLECTION)
    ("a highly active/toxic protein" . SPARSER::PROTEIN)
    ("α5–α6" . SPARSER::COLLECTION) ("α6" . SPARSER::PROTEIN)
    ("lysines instead of arginines" . SPARSER::COLLECTION)
    ("mitochondria and ER" . SPARSER::COLLECTION)
    ("many dual targeted mitochondrial proteins" . SPARSER::PROTEIN)
    ("SSS" . SPARSER::PROTEIN) ("GGG" . SPARSER::MOLECULE)
    ("the most divergent Bcl-x L proteins" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The longer construct Bcl-x L (1-85)-EGFP" . SPARSER::COLLECTION)
    ("-EGFP" . SPARSER::COLLECTION) ("PDI" . SPARSER::PROTEIN)
    ("membrane potential-dependent MitoTracker Red" . SPARSER::MOLECULE)
    ("the central helical hairpin α5-α6" . SPARSER::PROTEIN-PAIR)
    ("α5-α6" . SPARSER::PROTEIN-PAIR) ("IMM" . SPARSER::PROTEIN)
    ("anti- and pro-death" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("Tom22" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PINK1" . SPARSER::PROTEIN)
    ("COX8" . SPARSER::PROTEIN) ("TOM20" . SPARSER::PROTEIN)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP synthase" . SPARSER::PROTEIN)
    ("disulfide isomerase" . SPARSER::PROTEIN) ("COX8A" . SPARSER::PROTEIN)
    ("Mask/MASK1" . SPARSER::COLLECTION)
    ("Mask and its mammalian homolog MASK1" . SPARSER::COLLECTION)
    ("KRAS, NRAS and MYC" . SPARSER::COLLECTION)
    ("si-MASK1" . SPARSER::COLLECTION)
    ("endogenous MASK1 and YAP form" . SPARSER::COLLECTION)
    ("MASK" . SPARSER::PROTEIN) ("PLA" . SPARSER::PROTEIN)
    ("MASK1 and YAP form" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("TAZ" . SPARSER::PROTEIN) ("Ank2 and KH" . SPARSER::COLLECTION)
    ("Ank1" . SPARSER::PROTEIN) ("Ank2" . SPARSER::PROTEIN)
    ("V5-tagged Yki" . SPARSER::PROTEIN) ("Mask and Yki" . SPARSER::COLLECTION)
    ("at least part" . SPARSER::COMPONENT) ("Yki and Sd" . SPARSER::COLLECTION)
    ("even non-phosphorylatable Yki" . SPARSER::PROTEIN)
    ("Fat, Ex, and Hpo" . SPARSER::COLLECTION) ("Ex" . SPARSER::PROTEIN)
    ("Fat" . SPARSER::PROTEIN) ("fat , ex , or hpo" . SPARSER::COLLECTION)
    ("hpo , ex , or fat" . SPARSER::COLLECTION)
    ("yki or mask" . SPARSER::COLLECTION)
    ("fat, ex , or hpo" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("fat, ex , and hpo" . SPARSER::COLLECTION)
    ("mask or yki" . SPARSER::COLLECTION) ("hpo" . SPARSER::PROTEIN)
    ("Dpp" . SPARSER::MOLECULE) ("yki" . SPARSER::PROTEIN)
    ("ex" . SPARSER::PROTEIN) ("ex-lacZ" . SPARSER::COLLECTION)
    ("UAS-mask" . SPARSER::COLLECTION) ("ey-GAL4" . SPARSER::COLLECTION)
    ("imaginal discs" . SPARSER::BIO-COMPLEX)
    ("homozygous mutant" . SPARSER::MUTANT)
    ("MASK1 (also known as ANKHD1) and MASK2 (also known as GTAR or ANKRD17)"
     . SPARSER::COLLECTION)
    ("Ankyrin" . SPARSER::PROTEIN) ("Ank1, and Ank2" . SPARSER::COLLECTION)
    ("Ank" . SPARSER::PROTEIN) ("GDBD" . SPARSER::PROTEIN)
    ("mask" . SPARSER::PROTEIN)
    ("Mats as well as actin regulators [ xref ]" . SPARSER::COLLECTION)
    ("Mats" . SPARSER::PROTEIN) ("Sav" . SPARSER::PROTEIN)
    ("Kibra" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hpo" . SPARSER::PROTEIN)
    ("Yki-GDBD" . SPARSER::COLLECTION) ("UAS-luciferase" . SPARSER::COLLECTION)
    ("KH" . SPARSER::MOLECULE) ("ankyrin" . SPARSER::PROTEIN)
    ("Mask" . SPARSER::PROTEIN)
    ("The Drosophila Yorkie (Yki) protein and its mammalian homolog Yes-associated protein (YAP)"
     . SPARSER::COLLECTION)
    ("its mammalian homolog Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("Yki" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("ANKRD1" . SPARSER::PROTEIN) ("TEAD3" . SPARSER::PROTEIN)
    ("Cubitus interruptus" . SPARSER::PROTEIN) ("MASK2" . SPARSER::PROTEIN)
    ("ANKHD1" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("MASK1" . SPARSER::PROTEIN)
    ("a cellular ubiquitin ligase" . SPARSER::PROTEIN)
    ("HDAC3/NCOR" . SPARSER::COLLECTION) ("NCOR" . SPARSER::PROTEIN)
    ("RUNX2 or RUNX3" . SPARSER::COLLECTION)
    ("T-bet and IL2" . SPARSER::COLLECTION)
    ("a unique T cell receptor" . SPARSER::RECEPTOR)
    ("PMA and PHA" . SPARSER::COLLECTION)
    ("simultaneously bind Vif and RUNX" . SPARSER::COLLECTION)
    ("RUNX and Vif" . SPARSER::COLLECTION)
    ("RUNX1, RUNX2 and RUNX3" . SPARSER::COLLECTION)
    ("RUNX1-CBFβ" . SPARSER::COLLECTION) ("co-precipitated" . SPARSER::PROTEIN)
    ("This modular receptor" . SPARSER::RECEPTOR)
    ("a well-ordered complex" . SPARSER::BIO-COMPLEX)
    ("ELOBC and CUL5" . SPARSER::COLLECTION)
    ("a well-ordered substrate receptor" . SPARSER::RECEPTOR)
    ("Vif and the RUNX1 binding partner CBFβ" . SPARSER::COLLECTION)
    ("PMA and ionomycin" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("FAT" . SPARSER::PROTEIN) ("interferon gamma (IFNG)" . SPARSER::PROTEIN)
    ("interleukins and their receptors (e.g., IL4, IL10, IL7R)"
     . SPARSER::COLLECTION)
    ("a salivary protein" . SPARSER::PROTEIN)
    ("the MHC II DQ beta subunit HLA-DQB1" . SPARSER::PROTEIN)
    ("T-bet/TBX21" . SPARSER::COLLECTION) ("MME" . SPARSER::PROTEIN)
    ("interleukins" . SPARSER::PROTEIN) ("IFNG" . SPARSER::PROTEIN)
    ("Vif and the transcription cofactor CBFβ" . SPARSER::COLLECTION)
    ("Vif-CBFβ" . SPARSER::COLLECTION)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("co-purified" . SPARSER::PROTEIN) ("Vif bound CBFβ" . SPARSER::PROTEIN)
    ("Vif or CBFβ" . SPARSER::COLLECTION)
    ("RUNX1 and Vif" . SPARSER::COLLECTION)
    ("RUNX2 and RUNX3" . SPARSER::COLLECTION)
    ("Vif/ELOBC" . SPARSER::COLLECTION) ("CBFβ-Vif" . SPARSER::COLLECTION)
    ("Vif and RUNX" . SPARSER::COLLECTION) ("CRL5-" . SPARSER::PROTEIN)
    ("the hetero-hexameric complex" . SPARSER::BIO-COMPLEX)
    ("CRL5-SOCS2" . SPARSER::COLLECTION)
    ("well-ordered monomeric complex" . SPARSER::BIO-COMPLEX)
    ("CBFβ and ELOBC" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("SOCS2/ELOBC" . SPARSER::COLLECTION) ("x-ray" . SPARSER::COLLECTION)
    ("CRL5, CBFβ and substrates" . SPARSER::COLLECTION)
    ("only 192 amino acids" . SPARSER::AMINO-ACID) ("rod" . SPARSER::PROTEIN)
    ("alanine or serine" . SPARSER::COLLECTION)
    ("at least three different A3 enzymes and CUL5" . SPARSER::COLLECTION)
    ("enzymes and CUL5" . SPARSER::COLLECTION)
    ("CBFβ and Vif" . SPARSER::COLLECTION)
    ("Vif, ELOBC and CBFβ" . SPARSER::COLLECTION)
    ("chymotrypsin" . SPARSER::PROTEIN)
    ("ELOBC and CBFβ" . SPARSER::COLLECTION)
    ("CBFβ-Vif-ELOBC" . SPARSER::COLLECTION) ("ELOBC" . SPARSER::PROTEIN)
    ("Vif-ELOBC and CBFβ-Vif-ELOBC" . SPARSER::COLLECTION)
    ("Vif-ELOBC" . SPARSER::COLLECTION)
    ("primate lentiviral Vif" . SPARSER::PROTEIN)
    ("RUNX and CBFβ" . SPARSER::COLLECTION) ("RUNX" . SPARSER::PROTEIN)
    ("CBFβ-RUNX" . SPARSER::COLLECTION)
    ("a well-ordered Vif E3 ligase" . SPARSER::LIGASE)
    ("Vif and CBFβ" . SPARSER::COLLECTION)
    ("Vif, CBFβ and ELOBC" . SPARSER::COLLECTION)
    ("CUL5/RBX2" . SPARSER::COLLECTION)
    ("the CRL5 complex and the CRL5-Vif-CBFβ complex" . SPARSER::COLLECTION)
    ("RBX2 and the adaptors ELOB" . SPARSER::COLLECTION)
    ("the lentiviral accessory protein Vif" . SPARSER::PROTEIN)
    ("CBFβ and RUNX" . SPARSER::COLLECTION)
    ("Heterodimers" . SPARSER::HETERODIMER)
    ("Vif simultaneously hijacks CRL5 and CBFβ" . SPARSER::COLLECTION)
    ("CRL5 and CBFβ" . SPARSER::COLLECTION)
    ("CRL5-Vif-CBFβ" . SPARSER::COLLECTION) ("CRL5" . SPARSER::PROTEIN)
    ("a well-ordered CRL5-Vif complex" . SPARSER::BIO-COMPLEX)
    ("CRL5-Vif" . SPARSER::COLLECTION)
    ("The HIV-1 accessory protein Vif" . SPARSER::PROTEIN)
    ("APOBEC" . SPARSER::BIO-COMPLEX) ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("Vif" . SPARSER::PROTEIN) ("UbcH5b" . SPARSER::PROTEIN)
    ("UBE2R1" . SPARSER::PROTEIN) ("E. coli )" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("ADAMTS19" . SPARSER::PROTEIN) ("TNFSF8" . SPARSER::PROTEIN)
    ("TNFRSF10D" . SPARSER::PROTEIN) ("IL7R" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("TBX21" . SPARSER::PROTEIN)
    ("beta subunit" . SPARSER::PROTEIN) ("interferon gamma" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("RUNX2" . SPARSER::PROTEIN)
    ("RUNX 1" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("RBX2" . SPARSER::PROTEIN)
    ("CUL5" . SPARSER::PROTEIN) ("cytidine deaminase" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("CBFβ" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("Klf2" . SPARSER::PROTEIN)
    ("IL-12 and rapamycin" . SPARSER::COLLECTION)
    ("eomesodermin" . SPARSER::PROTEIN) ("CPT1a" . SPARSER::PROTEIN)
    ("IL-7 and IL-15" . SPARSER::COLLECTION)
    ("homeostatic cytokines" . SPARSER::PROTEIN)
    ("Effector" . SPARSER::EFFECTOR)
    ("a Th2-mediated autoimmune cerebellar ataxia" . SPARSER::PROTEIN)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("exogenous TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("palmitoyltransferase" . SPARSER::PROTEIN) ("etomoxir" . SPARSER::DRUG)
    ("VDAC" . SPARSER::PROTEIN)
    ("the ribosomal S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("lipid and cholesterol" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE)
    ("an oxidative substrate" . SPARSER::SUBSTRATE)
    ("glutaminase" . SPARSER::PROTEIN)
    ("Slc3a2 and Slc7a5" . SPARSER::COLLECTION) ("Slc7a5" . SPARSER::PROTEIN)
    ("Slc3a2" . SPARSER::PROTEIN) ("antiporter" . SPARSER::PROTEIN)
    ("harmful ROS" . SPARSER::PROTEIN) ("Glutamine" . SPARSER::AMINO-ACID)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("NADH" . SPARSER::MOLECULE)
    ("hexokinase and phosphofructokinase" . SPARSER::COLLECTION)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("lipids, amino acids and nucleotides" . SPARSER::COLLECTION)
    ("the translational repressor 4E-BP1" . SPARSER::PROTEIN)
    ("HIF and Myc" . SPARSER::COLLECTION)
    ("Myc and HIF-1α" . SPARSER::COLLECTION)
    ("antigen and costimulatory recetors" . SPARSER::COLLECTION)
    ("glucocorticoid-" . SPARSER::PROTEIN) ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("Protor" . SPARSER::PROTEIN-FAMILY)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("essential amino acids" . SPARSER::AMINO-ACID) ("RagA" . SPARSER::PROTEIN)
    ("Kinase (AMPK)" . SPARSER::KINASE)
    ("adaptor protein and DEP-domain-containing" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sec13" . SPARSER::PROTEIN)
    ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("oxygen, cancer cells and T cells" . SPARSER::COLLECTION)
    ("cytokine and costimulatory receptors" . SPARSER::COLLECTION)
    ("costimulatory receptors" . SPARSER::PROTEIN) ("S1P1" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate receptor 1" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("L-selectin" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("CPT1" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("IL4" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("FoxP3" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("voltage dependent" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("PGC1α" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("S6 Kinase" . SPARSER::PROTEIN-FAMILY) ("SREBP1" . SPARSER::PROTEIN)
    ("sterol regulatory element-binding protein 1" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("3a2" . SPARSER::PROTEIN)
    ("CD98" . SPARSER::PROTEIN) ("regulated kinase 1" . SPARSER::PROTEIN)
    ("mSIN1" . SPARSER::PROTEIN) ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brain)" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("enteric" . SPARSER::PROTEIN) ("nleB (AAA)" . SPARSER::PROTEIN)
    ("Rho and Ras" . SPARSER::COLLECTION) ("OGT and OGA" . SPARSER::COLLECTION)
    ("O-GlcNAcylated GAPDH" . SPARSER::PROTEIN)
    ("NF-κB components and increases NF-κB activity ( xref , xref )"
     . SPARSER::COLLECTION)
    ("NF-κB, p38, and JNK" . SPARSER::COLLECTION)
    ("p38 or NF-κB" . SPARSER::COLLECTION)
    ("TRAF2 and TRAF5" . SPARSER::COLLECTION)
    ("Siah1 and GAPDH" . SPARSER::COLLECTION)
    ("Neither NleB nor TMG" . SPARSER::COLLECTION)
    ("NleB(AAA)" . SPARSER::PROTEIN) ("GAPDH/TRAF2" . SPARSER::COLLECTION)
    ("NTA" . SPARSER::MOLECULE) ("hexosamine" . SPARSER::MOLECULE)
    ("NleB and NleB" . SPARSER::COLLECTION) ("TNF/TRAF2" . SPARSER::COLLECTION)
    ("TMG" . SPARSER::PROTEIN) ("NleB and UDP-GlcNAc" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("UDP-GlcNAc" . SPARSER::MOLECULE) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("OGA" . SPARSER::PROTEIN) ("OGT" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE) ("UDP" . SPARSER::UDP)
    ("glycogenin" . SPARSER::PROTEIN)
    ("Glycogenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the eukaryotic glycogenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycogenins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DAD" . SPARSER::PROTEIN)
    ("the divalent cation" . SPARSER::MOLECULE)
    ("glycosyltransferases" . SPARSER::PROTEIN)
    ("glycosyltransferase" . SPARSER::PROTEIN)
    ("GAPDH-TRAF2" . SPARSER::COLLECTION)
    ("GAPDH and TRAF2" . SPARSER::COLLECTION) ("bromopyruvate" . SPARSER::DRUG)
    ("oxalate (PO)" . SPARSER::MOLECULE) ("oxalate" . SPARSER::MOLECULE)
    ("TNF/NF-κB" . SPARSER::COLLECTION)
    ("p300/CREB binding protein" . SPARSER::COLLECTION)
    ("GAPDH-Myc" . SPARSER::COLLECTION) ("GAPDH-3" . SPARSER::COLLECTION)
    ("GAPDH-NleB" . SPARSER::COLLECTION)
    ("subsequently causes GAPDH" . SPARSER::PROTEIN)
    ("NleB-GAPDH" . SPARSER::COLLECTION) ("NleC-FLAG" . SPARSER::COLLECTION)
    ("NleB-FLAG" . SPARSER::COLLECTION) ("/p" . SPARSER::COLLECTION)
    ("TRAF2-FLAG" . SPARSER::COLLECTION)
    ("RANKL and CD40L" . SPARSER::COLLECTION)
    ("the TNFR-associated death domain protein (TRADD)" . SPARSER::PROTEIN)
    ("protein (TRADD)" . SPARSER::PROTEIN)
    ("NleB and NleE" . SPARSER::COLLECTION) ("nleB" . SPARSER::PROTEIN)
    ("NleB" . SPARSER::PROTEIN) ("NleB-HA" . SPARSER::COLLECTION)
    ("SS" . SPARSER::PROTEIN)
    ("polyubiquitination and NF-κB" . SPARSER::COLLECTION)
    ("TRAF2-GAPDH" . SPARSER::COLLECTION) ("glucosamine" . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("Uev1a" . SPARSER::PROTEIN) ("GC 2" . SPARSER::PROTEIN)
    ("UTR-3" . SPARSER::PROTEIN) ("UTR-2" . SPARSER::PROTEIN)
    ("UTR-1" . SPARSER::PROTEIN) ("GT-A" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("TRAF5" . SPARSER::PROTEIN) ("Alpha-crystallin" . SPARSER::PROTEIN)
    ("UDP-" . SPARSER::PROTEIN) ("N -acetylglucosamine" . SPARSER::MOLECULE)
    ("O-GlcNAcase" . SPARSER::PROTEIN)
    ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("glycogenin 1" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("receptor-interacting protein 1" . SPARSER::PROTEIN)
    ("NF-κ B" . SPARSER::PROTEIN) ("O-GlcNAc" . SPARSER::PROTEIN)
    ("TNF receptor associated factor 2" . SPARSER::PROTEIN)
    ("autocrine proinflammatory cytokines" . SPARSER::PROTEIN)
    ("viral proteases" . SPARSER::PROTEIN) ("EE" . SPARSER::PROTEIN)
    ("p38–ERK1/2" . SPARSER::COLLECTION) ("amine" . SPARSER::MOLECULE)
    ("MKK6-EE" . SPARSER::COLLECTION)
    ("ERK5 and host-cell survival" . SPARSER::COLLECTION)
    ("DOX" . SPARSER::DRUG) ("doxycycline (DOX)" . SPARSER::MOLECULE)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("XMD" . SPARSER::MOLECULE) ("XMD8-92 (XMD)" . SPARSER::MOLECULE)
    ("a dual MEK1/2–MEK5 inhibitor" . SPARSER::INHIBITOR)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("MEK1/2–MEK5" . SPARSER::COLLECTION) ("MEK5–ERK5" . SPARSER::COLLECTION)
    ("p38 and ERK5" . SPARSER::COLLECTION) ("sorbitol" . SPARSER::PROTEIN)
    ("BIRB" . SPARSER::DRUG) ("p38–ERK5" . SPARSER::COLLECTION)
    ("p-ERK1/2, p-ERK5, and p-p38" . SPARSER::COLLECTION)
    ("kinases, RSK and MK2" . SPARSER::COLLECTION)
    ("p38 and ERKs" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 or ERK5 and p38" . SPARSER::COLLECTION)
    ("p38 or ERK5 and p38" . SPARSER::COLLECTION)
    ("ERK5 and p38" . SPARSER::COLLECTION) ("ERK–p38" . SPARSER::COLLECTION)
    ("MEK5-ERK5" . SPARSER::COLLECTION)
    ("ERK1/2 and ERK5" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("Thr–Glu–Tyr" . SPARSER::COLLECTION) ("bis" . SPARSER::PROTEIN)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("ERKs and p38" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("phospho-proteins and readouts" . SPARSER::COLLECTION)
    ("Principal components" . SPARSER::COMPONENT)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("principal components" . SPARSER::COMPONENT)
    ("p-Hsp27" . SPARSER::COLLECTION) ("p-GSK3β" . SPARSER::COLLECTION)
    ("Sham" . SPARSER::DRUG) ("ATF2, CREB, and IκBα" . SPARSER::COLLECTION)
    ("p38 and Hsp27" . SPARSER::COLLECTION)
    ("substantially more complex" . SPARSER::BIO-COMPLEX)
    ("caspase and viral readouts" . SPARSER::COLLECTION)
    ("the VP1 capsid protein and the titers" . SPARSER::COLLECTION)
    ("caspases, caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("Each phospho-protein and host-cell readout" . SPARSER::COLLECTION)
    ("apoptotic caspases" . SPARSER::PROTEIN)
    ("ERK1/2, ERK5, and p38 MAPK" . SPARSER::COLLECTION)
    ("ERK and p38 MAPK" . SPARSER::COLLECTION) ("HMGB-1" . SPARSER::PROTEIN)
    ("p-RSK" . SPARSER::PROTEIN) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("DEVD-CHO" . SPARSER::DRUG) ("XMD8-92" . SPARSER::MOLECULE)
    ("MEK5" . SPARSER::PROTEIN) ("PD184352" . SPARSER::DRUG)
    ("p-ERK1" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-protein" . SPARSER::PROTEIN)
    ("Phospho-Protein" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("p38 and NF-κB" . SPARSER::COLLECTION)
    ("the main immediate downstream mediators" . SPARSER::PROTEIN)
    ("sulfasalazine and SB203580" . SPARSER::COLLECTION)
    ("IRAK, PI 3-kinase, AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("IL-1β and FGF2" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("NF-κB and/or AP-1" . SPARSER::COLLECTION)
    ("anti-NF-κB and AP-1" . SPARSER::COLLECTION)
    ("SB203580 and sulfasalazine" . SPARSER::COLLECTION)
    ("p38 and p65" . SPARSER::COLLECTION) ("Sulfasalazine" . SPARSER::DRUG)
    ("sulfasalazine" . SPARSER::DRUG)
    ("NF-κB ( xref ; xref ) and IL-1β" . SPARSER::COLLECTION)
    ("SU5402, IL-1Ra and IRAK1/4" . SPARSER::COLLECTION)
    ("TRAF6 and vice versa" . SPARSER::COLLECTION)
    ("SU5402 and IL-1Ra" . SPARSER::COLLECTION)
    ("Akt, IKK, and p38" . SPARSER::COLLECTION)
    ("IRAK and PI 3-kinase" . SPARSER::COLLECTION)
    ("IL-1β, and co-treatment" . SPARSER::COLLECTION)
    ("IL-1β or FGF2" . SPARSER::COLLECTION)
    ("antagonist, or IL-1Ra" . SPARSER::COLLECTION)
    ("Akt, p38, and IKK" . SPARSER::COLLECTION)
    ("PI 3-kinase, p38 and NF-κB" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("metalloproteinase-1" . SPARSER::COLLECTION)
    ("IRAK and TRAF6" . SPARSER::COLLECTION)
    ("both activator protein 1 (AP-1) and nuclear factor kappa-light-chain-enhancer"
     . SPARSER::COLLECTION)
    ("interleukin receptor-associated kinase (IRAK)" . SPARSER::KINASE)
    ("IRAK4, and tumor necrosis factor" . SPARSER::COLLECTION)
    ("IRAK" . SPARSER::PROTEIN)
    ("either activator protein 1 or nuclear factor kappa-light-chain-enhancer"
     . SPARSER::COLLECTION)
    ("activator protein 1 and nuclear factor kappa-light-chain-enhancer"
     . SPARSER::COLLECTION)
    ("Phosphatidyl inositol 3-kinase or interleukin receptor-associated kinase 1/4 antagonists"
     . SPARSER::MOLECULE)
    ("inositol 3-kinase or interleukin" . SPARSER::COLLECTION)
    ("p38 and inhibitor" . SPARSER::COLLECTION)
    ("Phosphatidyl" . SPARSER::MOLECULE)
    ("a major pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("Transcription factor" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG) ("lamin B1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("IRAK 1" . SPARSER::PROTEIN)
    ("SU5402" . SPARSER::DRUG) ("IL-1ra" . SPARSER::PROTEIN)
    ("IL-1Ra" . SPARSER::PROTEIN)
    ("interleukin 1 receptor type 1" . SPARSER::PROTEIN)
    ("IRAK4" . SPARSER::PROTEIN) ("Interleukin-1β" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin 1β" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN)
    ("Interleukin-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("Interleukin1β" . SPARSER::PROTEIN) ("Interleukin 1β" . SPARSER::PROTEIN)
    ("antibody and tyrosine kinase" . SPARSER::COLLECTION)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("lapatinib, trastuzumab, and bevacizumab" . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN)
    ("trastuzumab, and anti-vascular endothelial" . SPARSER::COLLECTION)
    ("targetable oncogenes" . SPARSER::ONCOGENE)
    ("a proline or a serine" . SPARSER::COLLECTION)
    ("only three exon 20 insertion variants" . SPARSER::VARIANT)
    ("varieties" . SPARSER::VARIETY) ("TTF" . SPARSER::PROTEIN)
    ("serine and valine" . SPARSER::COLLECTION)
    ("ALK and ROS1" . SPARSER::COLLECTION) ("AUY922" . SPARSER::DRUG)
    ("serine residue" . SPARSER::MOLECULE) ("PKB/AKT" . SPARSER::COLLECTION)
    ("variety " . SPARSER::VARIETY)
    ("an orally available PKC-β inhibitor" . SPARSER::INHIBITOR)
    ("Enzastaurin" . SPARSER::DRUG) ("functional NF-κB" . SPARSER::PROTEIN)
    ("APCs" . SPARSER::PROTEIN) ("Icam1" . SPARSER::PROTEIN)
    ("Icam" . SPARSER::PROTEIN-FAMILY)
    ("the PKC-associated kinase (PKK)" . SPARSER::KINASE)
    ("PKK" . SPARSER::PROTEIN) ("calcium, and protein" . SPARSER::COLLECTION)
    ("heterogeneous complex" . SPARSER::BIO-COMPLEX) ("MCL" . SPARSER::PROTEIN)
    ("Mib-1" . SPARSER::PROTEIN) ("Mib" . SPARSER::PROTEIN)
    ("IL-1 and IL-15" . SPARSER::COLLECTION)
    ("IL-1α, IL-1β, and IL-15" . SPARSER::COLLECTION)
    ("IL-1α and IL-15" . SPARSER::COLLECTION)
    ("cytokine-receptors" . SPARSER::COLLECTION)
    ("Proinflammatory Cytokines" . SPARSER::PROTEIN)
    ("Cytokines" . SPARSER::PROTEIN) ("NEMO/NF-κB" . SPARSER::COLLECTION)
    ("HTNC" . SPARSER::PROTEIN) ("protein (HTNC)" . SPARSER::PROTEIN)
    ("Nemo" . SPARSER::PROTEIN)
    ("IKK1 (IKKα) and the essential regulatory subunit NEMO"
     . SPARSER::COLLECTION)
    ("the essential regulatory subunit NEMO" . SPARSER::PROTEIN)
    ("stromal NF-κB" . SPARSER::PROTEIN) ("Bcl10" . SPARSER::PROTEIN)
    ("p50, p65, and c-REL" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("fmk" . SPARSER::PROTEIN)
    ("NEMO/IKKγ" . SPARSER::COLLECTION) ("Stromal NF-κB" . SPARSER::PROTEIN)
    ("types " . TYPE) ("Prkcb" . SPARSER::PROTEIN)
    ("a more aggressive variant" . SPARSER::VARIANT)
    ("PKC-α and PKC-β" . SPARSER::COLLECTION)
    ("a heterogeneous mixture" . SPARSER::MOLECULE)
    ("PKC-α or PKC-βI" . SPARSER::COLLECTION)
    ("classical PKC isoforms" . SPARSER::ISOFORM)
    ("Bcl2 and BimEL" . SPARSER::COLLECTION) ("BimEL" . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN) ("CAFs" . SPARSER::PROTEIN)
    ("NOTCH1 , MYD88 , and SF3B1" . SPARSER::COLLECTION)
    ("SF3B1" . SPARSER::PROTEIN) ("Tcl1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD2" . SPARSER::PROTEIN) ("αLβ2" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("CD79a" . SPARSER::PROTEIN)
    ("TCL1" . SPARSER::PROTEIN) ("IKK1" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("c-REL" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("MALT1" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("CXCL16" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("MYD88" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("MET-TKI" . SPARSER::COLLECTION)
    ("AKT, ERK, and STAT3" . SPARSER::COLLECTION) ("gold" . SPARSER::MOLECULE)
    ("MET, AKT, ERK, and STAT3" . SPARSER::COLLECTION)
    ("JNJ38877605 and SGX523" . SPARSER::COLLECTION)
    ("MET-TKIs" . SPARSER::COLLECTION)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PF-02341066" . SPARSER::DRUG) ("SGX523" . SPARSER::MOLECULE)
    ("JNJ38877605" . SPARSER::DRUG) ("State" . SPARSER::BIO-STATE)
    ("Smooth muscle" . SPARSER::PROTEIN) ("pRB and NRF1" . SPARSER::COLLECTION)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("CK14 and the new myoepithelial marker P63" . SPARSER::COLLECTION)
    ("the new myoepithelial marker P63" . SPARSER::PROTEIN)
    ("CK8 and CK18" . SPARSER::COLLECTION)
    ("CK5, CK6, and CK14" . SPARSER::COLLECTION) ("MaSCs" . SPARSER::PROTEIN)
    ("Multi" . SPARSER::PROTEIN)
    ("Cyclin D1 and CK 8/18 or CK 5/6" . SPARSER::COLLECTION)
    ("Cyclin D1 and CK 5/6" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("Cyclin D1, CK 5/6 and CK 8/18" . SPARSER::COLLECTION)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY) ("NRF1" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("Cyclin D1 " . SPARSER::PROTEIN)
    ("CK 8" . SPARSER::PROTEIN) ("CK 5" . SPARSER::PROTEIN)
    ("Cytokeratin 5" . SPARSER::PROTEIN)
    ("receptor/PKCs/NADPH oxidase" . SPARSER::COLLECTION)
    ("STAT3/Jak2" . SPARSER::COLLECTION)
    ("A 2 , and A 3" . SPARSER::COLLECTION) ("uridine" . SPARSER::PROTEIN)
    ("XR" . SPARSER::PROTEIN)
    ("a ROS inhibitor (Edaravone) and the inhibitors" . SPARSER::COLLECTION)
    ("DPI or APO" . SPARSER::COLLECTION)
    ("the small GTPase Rac and the two specialized cytosolic proteins p67 phox and p47 phox"
     . SPARSER::COLLECTION)
    ("p67 phox and p47 phox" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE)
    ("Extracellular adenosine" . SPARSER::PROTEIN)
    ("PKC, NADPH oxidase, Jak2, and STAT3" . SPARSER::COLLECTION)
    ("ROS and PGE 2" . SPARSER::COLLECTION)
    ("cPLA 2 , PKCα, PKCι, PKCμ, p47 phox , Jak2, or STAT3"
     . SPARSER::COLLECTION)
    ("receptors, PKCs, NADPH oxidase, Jak2, and STAT3" . SPARSER::COLLECTION)
    ("receptor/PKC/NADPH oxidase/Jak2/STAT3/cPLA 2" . SPARSER::COLLECTION)
    ("COPD" . SPARSER::PROTEIN)
    ("PKCs, ROS, Jak2, and STAT3" . SPARSER::COLLECTION)
    ("AA and ATPγS" . SPARSER::COLLECTION)
    ("cPLA 2 or COX-2" . SPARSER::COLLECTION)
    ("cPLA 2 and COX-2" . SPARSER::COLLECTION)
    ("PKC/NADPH oxidase/ROS" . SPARSER::COLLECTION)
    ("p47 phox , PKCα, PKCι, and PKCμ" . SPARSER::COLLECTION)
    ("PKCs/ROS" . SPARSER::COLLECTION)
    ("receptor/Jak2/STAT3" . SPARSER::COLLECTION)
    ("Jak2 or STAT3" . SPARSER::COLLECTION)
    ("AG490, CBE, PPADS, and suramin" . SPARSER::COLLECTION)
    ("CBE" . SPARSER::PROTEIN)
    ("receptor-associated kinases" . SPARSER::KINASE)
    ("Jak2 (AG490) and STAT3 (CBE)" . SPARSER::COLLECTION)
    ("PPADS or suramin" . SPARSER::COLLECTION)
    ("antagonists, suramin and PPADS" . SPARSER::COLLECTION)
    ("DPI and apocynin" . SPARSER::COLLECTION) ("APO" . SPARSER::PROTEIN)
    ("NADPH oxidase/ROS" . SPARSER::COLLECTION)
    ("NADPH Oxidase/ROS" . SPARSER::COLLECTION)
    ("ATPγS and PMA" . SPARSER::COLLECTION)
    ("PKCα, PKCι, and PKCμ" . SPARSER::COLLECTION)
    ("Jak2/STAT3" . SPARSER::COLLECTION)
    ("at least three cytosolic subunits" . SPARSER::FRAGMENT)
    ("a multimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("p47 phox , p67 phox , and p40 phox" . SPARSER::COLLECTION)
    ("cellular macromolecules" . SPARSER::MOLECULE)
    ("Excessive ROS" . SPARSER::PROTEIN)
    ("purinergic P2X and P2Y receptors" . SPARSER::RECEPTOR)
    ("ion channels and GTP" . SPARSER::COLLECTION)
    ("enzymes and structural proteins" . SPARSER::COLLECTION)
    ("endotoxins" . SPARSER::MOLECULE) ("mitogens" . SPARSER::MITOGEN)
    ("PGs" . SPARSER::MOLECULE) ("COXs" . SPARSER::PROTEIN)
    ("receptor/PKC/NADPH oxidase/ROS/Jak2/STAT3/cPLA 2" . SPARSER::COLLECTION)
    ("Jak2 and STAT3" . SPARSER::COLLECTION)
    ("receptor, PKC, and NADPH oxidase" . SPARSER::COLLECTION)
    ("PPADS and suramin" . SPARSER::COLLECTION)
    ("PKCα, PKCι, PKCμ, p47 phox , Jak2, STAT3, and cPLA 2"
     . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE) ("diphenyleneiodonium" . SPARSER::DRUG)
    ("Rottlerin" . SPARSER::DRUG) ("suramin" . SPARSER::DRUG)
    ("PPADS" . SPARSER::MOLECULE) ("purinoceptors" . SPARSER::PROTEIN)
    ("cyclooxygenase (COX)-2 and its metabolite prostaglandin E 2 (PGE 2 )"
     . SPARSER::COLLECTION)
    ("gp91 phox" . SPARSER::PROTEIN) ("ATPγs" . SPARSER::PROTEIN)
    ("phospholipase A 2" . SPARSER::PROTEIN) ("TXA 2" . SPARSER::MOLECULE)
    ("thromboxane A 2" . SPARSER::MOLECULE) ("PGI 2" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("NADPH Oxidase" . SPARSER::PROTEIN)
    ("p40 phox" . SPARSER::PROTEIN) ("p67 phox" . SPARSER::PROTEIN)
    ("GF109203X" . SPARSER::DRUG) ("cPLA 2" . SPARSER::PROTEIN)
    ("p47 phox" . SPARSER::PROTEIN) ("PKCμ" . SPARSER::PROTEIN)
    ("PKCι" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("Gö6983" . SPARSER::DRUG) ("ATPγS" . SPARSER::PROTEIN)
    ("a key molecule regulated by STAT3 in wound healing and cancer xref"
     . SPARSER::COLLECTION)
    ("uPA and STAT3" . SPARSER::COLLECTION) ("plasmin" . SPARSER::PROTEIN)
    ("MMP-9 and MMP-14" . SPARSER::COLLECTION)
    ("CD44/STAT3" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9 and MMP-14" . SPARSER::COLLECTION)
    ("STAT3-JAK2" . SPARSER::COLLECTION)
    ("STAT3 and JAK2" . SPARSER::COLLECTION)
    ("CD44-STAT3-JAK2" . SPARSER::COLLECTION)
    ("exogenous ligands" . SPARSER::LIGAND)
    ("CD44 and Nanog" . SPARSER::COLLECTION) ("Hyaluronan" . SPARSER::PROTEIN)
    ("CD44-shRNA" . SPARSER::COLLECTION) ("uPA and uPAR" . SPARSER::COLLECTION)
    ("uPAR" . SPARSER::PROTEIN)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("preventive therapeutics" . SPARSER::THERAPEUTICS)
    ("MMP-9 and uPA" . SPARSER::COLLECTION)
    ("MMP-13, MMP-14, MMP-15, MMP-16, and uPA" . SPARSER::COLLECTION)
    ("CD44 (DCIS-shCD44) or Luciferase (DCIS-shLuc)" . SPARSER::COLLECTION)
    ("shCD" . SPARSER::PROTEIN) ("MMP-9, MMP-14 and uPA" . SPARSER::COLLECTION)
    ("the possible intracellular kinases" . SPARSER::KINASE)
    ("JAK2 and Src" . SPARSER::COLLECTION)
    ("JAK2, and BXL0124" . SPARSER::COLLECTION)
    ("CD44, STAT3 and JAK2" . SPARSER::COLLECTION)
    ("CD44 and pSTAT3" . SPARSER::COLLECTION) ("VDR" . SPARSER::PROTEIN)
    ("STAT3, Akt, Erk and NFκB" . SPARSER::COLLECTION)
    ("CD44 (CD44s, 85 kDa) and pSTAT3" . SPARSER::COLLECTION)
    ("pErk, pAkt and pNFκB" . SPARSER::COLLECTION)
    ("pAkt, pErk, pSTAT3 and NFκB" . SPARSER::COLLECTION)
    ("pErk" . SPARSER::PROTEIN)
    ("CD44, MMP-2, MMP-9, and uPA" . SPARSER::COLLECTION)
    ("CD44, MMP-2, MMP-9, MMP-13, MMP-14, MMP-15, MMP-16, TIMP-1, TIMP-2 and uPA"
     . SPARSER::COLLECTION)
    ("BXL0124 (1 and 10 nM) or 1α" . SPARSER::COLLECTION)
    ("Analog" . SPARSER::ANALOG) ("intracellular kinases" . SPARSER::KINASE)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("hyaluronan and osteopontin" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN) ("CD44-STAT3" . SPARSER::COLLECTION)
    ("matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("uPA" . SPARSER::PROTEIN)
    ("STAT3 and Janus kinase 2" . SPARSER::COLLECTION)
    ("CD44 and STAT3" . SPARSER::COLLECTION) ("HAS1" . SPARSER::PROTEIN)
    ("synthase 1" . SPARSER::PROTEIN) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("Vitamin D" . SPARSER::MOLECULE) ("TIMP-2" . SPARSER::PROTEIN)
    ("MMP-16" . SPARSER::PROTEIN) ("MMP-15" . SPARSER::PROTEIN)
    ("MMP-14" . SPARSER::PROTEIN) ("BXL0124" . SPARSER::DRUG)
    ("vitamin D" . SPARSER::MOLECULE)
    ("an attractive candidate gene" . SPARSER::GENE)
    ("ROCK2 and other genes" . SPARSER::COLLECTION)
    ("calponin" . SPARSER::PROTEIN)
    ("phosphatase (MLCP)" . SPARSER::PHOSPHATASE)
    ("RhoA/ROCK" . SPARSER::COLLECTION) ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("nitrogen and uric acid" . SPARSER::COLLECTION)
    ("Rho/Rho kinase" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("ROCK1 (chromosome loci 18q11) and ROCK2 (chromosome loci 2p24)"
     . SPARSER::COLLECTION)
    ("alpha-adducin" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN) ("Rho kinase" . SPARSER::PROTEIN)
    ("ROCK2" . SPARSER::PROTEIN)
    ("artificially engineered exogenous proteins" . SPARSER::PROTEIN)
    ("available promoters" . SPARSER::PROMOTER)
    ("Nanog or Oct4" . SPARSER::COLLECTION)
    ("as yet undefined transcriptional co-factors" . SPARSER::MOLECULE)
    ("Sox2 and/or its target genes" . SPARSER::COLLECTION)
    ("Sox2 and its target genes" . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN)
    ("previously undefined Sox2-targets FGF5, NR5A2 and Pdx1"
     . SPARSER::COLLECTION)
    ("FGF5, NR5A2 and Pdx1" . SPARSER::COLLECTION)
    ("c-Kit and Runx2" . SPARSER::COLLECTION)
    ("the stem cell-associated genes" . SPARSER::GENE)
    ("Oct4 and Nanog" . SPARSER::COLLECTION)
    ("common embryonic stem cell target genes or modulating Nanog expression xref"
     . SPARSER::COLLECTION)
    ("ectopically-expressed lentiviral Sox2" . SPARSER::PROTEIN)
    ("CD133 or PSA" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN)
    ("four distinct Sox2" . SPARSER::PROTEIN)
    ("Sox2 or Control GFP" . SPARSER::COLLECTION)
    ("LNCaP-Sox2" . SPARSER::PROTEIN-PAIR)
    ("LNCaP-GFP" . SPARSER::PROTEIN-PAIR)
    ("lentiviral Sox2" . SPARSER::PROTEIN)
    ("chronic anti-androgen" . SPARSER::DRUG)
    ("Anti-Androgen in Vitro and Castration" . SPARSER::COLLECTION)
    ("either 10 µM MDV3100 or vehicle" . SPARSER::COLLECTION)
    ("AR-Chromatin" . SPARSER::COLLECTION) ("enhancer" . SPARSER::PROTEIN)
    ("secreted total secreted PSA" . SPARSER::PROTEIN)
    ("PC-3, Du145, and LNCaP" . SPARSER::COLLECTION)
    ("Nanog and Oct4" . SPARSER::COLLECTION)
    ("Sox2, Nanog, and Oct4" . SPARSER::COLLECTION)
    ("mRNA and Protein" . SPARSER::COLLECTION) ("LV" . SPARSER::MOLECULE)
    ("Chromogranin" . SPARSER::PROTEIN) ("PSCA" . SPARSER::PROTEIN)
    ("Sox2 and p63" . SPARSER::COLLECTION) ("Antigen (PSA)" . SPARSER::PROTEIN)
    ("Antigen" . SPARSER::PROTEIN) ("cis-enhancer" . SPARSER::PROTEIN-PAIR)
    ("c-Myc and Klf4" . SPARSER::COLLECTION)
    ("Sox2, Oct4, and Nanog" . SPARSER::COLLECTION) ("SRY" . SPARSER::PROTEIN)
    ("Androgen Receptor (AR)" . SPARSER::PROTEIN) ("NR5A2" . SPARSER::PROTEIN)
    ("Androgen-Receptor" . SPARSER::PROTEIN) ("Anti-Androgens" . SPARSER::DRUG)
    ("Anti-Androgen" . SPARSER::DRUG) ("R-1" . SPARSER::PROTEIN)
    ("NanogP8" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("D6D" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("Prostate-Specific Antigen" . SPARSER::PROTEIN)
    ("Du145" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor 5" . SPARSER::PROTEIN)
    ("FGF5" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("FAK and GSK3β" . SPARSER::COLLECTION)
    ("Akt and GSK3β" . SPARSER::COLLECTION) ("LEF/TCF" . SPARSER::COLLECTION)
    ("/TCF" . SPARSER::COLLECTION)
    ("β-catenin/Tcf4/survivin" . SPARSER::COLLECTION)
    ("Noggin/BMP" . SPARSER::COLLECTION) ("Noggin" . SPARSER::PROTEIN)
    ("Wortmannin or LY294002" . SPARSER::COLLECTION)
    ("FAK-PI3K/Akt" . SPARSER::COLLECTION) ("LSCs" . SPARSER::PROTEIN)
    ("chemokines and other growth modulatory proteins" . SPARSER::COLLECTION)
    ("other growth modulatory proteins" . SPARSER::PROTEIN)
    ("CSF" . SPARSER::PROTEIN) ("LIF" . SPARSER::PROTEIN)
    ("Wnt3a−" . SPARSER::PROTEIN) ("Wnt3a and Dkk1" . SPARSER::COLLECTION)
    ("inhibitor, pFAK, pAkt, and pGSK3β" . SPARSER::COLLECTION)
    ("FAK inhibitor or GSK3β inhibitor" . SPARSER::COLLECTION)
    ("p63 and ABCG2" . SPARSER::COLLECTION)
    ("siRNA-TERT" . SPARSER::COLLECTION)
    ("TERT, telomerase activity, ROS, Δψm, and the changes"
     . SPARSER::COLLECTION)
    ("undifferentiated state and cellular lineage" . SPARSER::COLLECTION)
    ("the positively corneal epithelial-specific marker CK3"
     . SPARSER::PROTEIN)
    ("FAK-" . SPARSER::PROTEIN) ("FAK/Wnt" . SPARSER::COLLECTION)
    ("integrinβ1-FAK-PI3K/Akt" . SPARSER::COLLECTION)
    ("oncostatin M" . SPARSER::PROTEIN)
    ("macrophage-colony stimulating factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-11" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("DCF-DA" . SPARSER::DRUG) ("CK3" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN)
    ("VEGF, HIF-1α, and MVD" . SPARSER::COLLECTION)
    ("anti-FVIII-RA" . SPARSER::COLLECTION) ("FVIII" . SPARSER::PROTEIN)
    ("MVD and HIF-1α" . SPARSER::COLLECTION)
    ("ER, PR and HER2/neu" . SPARSER::COLLECTION) ("Ali" . SPARSER::PROTEIN)
    ("the sporadic control group" . SPARSER::MOLECULE)
    ("A significantly higher MVD" . SPARSER::PROTEIN)
    ("sporadic tumors MVD" . SPARSER::PROTEIN)
    ("HIF-1α and MVD" . SPARSER::COLLECTION)
    ("VEGF, HIF-1α and MVD" . SPARSER::COLLECTION)
    ("VEGF and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("enzymes and VEGF" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("HIF-1α and hypoxia" . SPARSER::COLLECTION)
    ("VEGF and VEGFR-2" . SPARSER::COLLECTION)
    ("its receptor VEGFR-1 (flt-1) or VEGFR-2 (flk-1)" . SPARSER::COLLECTION)
    ("cell adhesion molecules and extracellular matrix proteins xref"
     . SPARSER::COLLECTION)
    ("pro-angiogenic growth factor" . SPARSER::GROWTH-FACTOR)
    ("VEGF and HIF-1α and microvessel" . SPARSER::COLLECTION)
    ("HIF-1α and microvessel" . SPARSER::COLLECTION) ("MVD" . SPARSER::PROTEIN)
    ("HIF-1α and BRCA1" . SPARSER::COLLECTION) ("F11" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1 alpha" . SPARSER::PROTEIN)
    ("flk-1" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("flt-1" . SPARSER::PROTEIN) ("VEGFR-1" . SPARSER::PROTEIN)
    ("MCF7 and MRC-5/SV40" . SPARSER::COLLECTION) ("Mitosox" . SPARSER::DRUG)
    ("myc-TERT" . SPARSER::COLLECTION) ("mitosox" . SPARSER::DRUG)
    ("mito" . SPARSER::DRUG) ("foci and TERT" . SPARSER::COLLECTION)
    ("H 2 O 2 and etoposide" . SPARSER::COLLECTION)
    ("mitochondrial TERT" . SPARSER::PROTEIN) ("imetelstat" . SPARSER::DRUG)
    ("its catalytic subunit (TERT) as well as the RNA component (TERC or TR)"
     . SPARSER::COLLECTION)
    ("catalytic subunit (TERT)" . SPARSER::PROTEIN)
    ("TERC or TR" . SPARSER::COLLECTION) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TERC" . SPARSER::PROTEIN) ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("U 87" . SPARSER::PROTEIN)
    ("heterotrimeric Gβγ proteins" . SPARSER::PROTEIN)
    ("heterotrimeric G-proteins" . SPARSER::PROTEIN)
    ("TFIID" . SPARSER::PROTEIN) ("tilt" . SPARSER::DRUG)
    ("MEF2A, NFAT, STAT1, and STAT3" . SPARSER::COLLECTION)
    ("receptors and integrins" . SPARSER::COLLECTION)
    ("insulin-like growth factor-1, and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("SERPIN" . SPARSER::PROTEIN) ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFAT and STAT1/3" . SPARSER::COLLECTION)
    ("p65 or GATA4" . SPARSER::COLLECTION)
    ("α-actinin-4 and HDAC" . SPARSER::COLLECTION)
    ("TAF/TBP" . SPARSER::COLLECTION) ("MEF2A-HDAC" . SPARSER::COLLECTION)
    ("the MEF2A and TBP/TAF complex" . SPARSER::COLLECTION)
    ("TBP and TAF" . SPARSER::COLLECTION) ("TBP/TAF" . SPARSER::COLLECTION)
    ("the MEF2A and TATA-binding protein (TBP) and transcription activating factor (TAF) complex"
     . SPARSER::COLLECTION)
    ("TATA-binding protein (TBP) and transcription activating factor (TAF) complex"
     . SPARSER::COLLECTION)
    ("protein (TBP)" . SPARSER::PROTEIN) ("TAF" . SPARSER::PROTEIN)
    ("TBP" . SPARSER::PROTEIN) ("α-actinin-4-HDAC" . SPARSER::COLLECTION)
    ("α-actinin-4 and the α-actinin-associated HDACs" . SPARSER::COLLECTION)
    ("the α-actinin-associated HDACs" . SPARSER::PROTEIN)
    ("candesartan" . SPARSER::DRUG) ("MEF2-luciferase" . SPARSER::COLLECTION)
    ("Normal Gq" . SPARSER::DRUG) ("c" . SPARSER::PROTEIN)
    ("Gq" . SPARSER::DRUG) ("α-actinin-4 and HDAC5" . SPARSER::COLLECTION)
    ("MEF2A and histones" . SPARSER::COLLECTION) ("HASM" . SPARSER::PROTEIN)
    ("dobutamine" . SPARSER::DRUG)
    ("prohypertrophic agonists" . SPARSER::AGONIST)
    ("spiked" . SPARSER::PROTEIN)
    ("nuclear proteins and/or shuttling proteins" . SPARSER::COLLECTION)
    ("ribosomal RNA-binding proteins and the proteins" . SPARSER::COLLECTION)
    ("ribosomal RNA-binding proteins" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("integrins, Gα, GAPDH and cytochrome b5" . SPARSER::COLLECTION)
    ("cytosol subcellular fractions" . SPARSER::COMPONENT)
    ("losartan" . SPARSER::PROTEIN) ("-PLC" . SPARSER::COLLECTION)
    ("HEK-AT 1" . SPARSER::COLLECTION) ("kappaB" . SPARSER::PROTEIN)
    ("NFAT" . SPARSER::PROTEIN)
    ("diverse GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chromatin-associated proteins" . SPARSER::PROTEIN)
    ("a typical GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("the quiescent heterotrimeric G-proteins" . SPARSER::PROTEIN)
    ("a functionally inseparable Gβγ complex" . SPARSER::BIO-COMPLEX)
    ("approximately 2% genes" . SPARSER::GENE) ("Agonist" . SPARSER::AGONIST)
    ("subunits, Gα and Gβγ" . SPARSER::COLLECTION)
    ("interleukin-1" . SPARSER::PROTEIN) ("Cdc4" . SPARSER::PROTEIN)
    ("WD1" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("α-actinin" . SPARSER::PROTEIN) ("Gα q" . SPARSER::PROTEIN)
    ("cytochrome b5" . SPARSER::PROTEIN) ("GNB2" . SPARSER::PROTEIN)
    ("ID 3" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("α-actinin-4" . SPARSER::PROTEIN) ("α-actinin-1" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("Gαq" . SPARSER::PROTEIN)
    ("5-HT" . SPARSER::PROTEIN) ("AT 1" . SPARSER::PROTEIN)
    ("Gβ 5" . SPARSER::PROTEIN) ("GRK5" . SPARSER::PROTEIN)
    ("β-arrestins" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("myocyte enhancer factor 2A" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN)
    ("cisplatin- or docetaxel-based concurrent chemoradiotherapy"
     . SPARSER::COLLECTION)
    ("cell DNA-damage" . SPARSER::DNA)
    ("paclitaxel, cisplatin and 5-FU" . SPARSER::COLLECTION)
    ("Cisplatin-" . SPARSER::DRUG) ("TC-NER" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN) ("docetaxel-" . SPARSER::DRUG)
    ("cisplatin or docetaxel" . SPARSER::COLLECTION)
    ("RR and mOS" . SPARSER::COLLECTION) ("antimetabolite" . SPARSER::DRUG)
    ("male and the majority" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("predictive and prognostic biomarker" . SPARSER::MOLECULE)
    ("Cisplatin or docetaxel" . SPARSER::COLLECTION) ("taxane" . SPARSER::DRUG)
    ("cross-complementing" . SPARSER::PROTEIN) ("DPD" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN)
    ("underwent first-line cisplatin-" . SPARSER::DRUG)
    ("chemoradiotherapy (HR 0.12; 95%CI 0.04–0.37; P <0.001) group and higher risk"
     . SPARSER::COLLECTION)
    ("cisplatin-" . SPARSER::DRUG) ("DNAse I" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("p-glycoprotein" . SPARSER::PROTEIN)
    ("cadherin–p120" . SPARSER::COLLECTION)
    ("RhoA, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("p120-" . SPARSER::PROTEIN)
    ("IL-2R or IL-2R–VE-cad" . SPARSER::COLLECTION)
    ("VE-cadherin–p120" . SPARSER::COLLECTION)
    ("IL-2R– and IL-2R–VE-cad" . SPARSER::COLLECTION)
    ("IL-2R–" . SPARSER::PROTEIN)
    ("IL-2R and the three chimeric receptors" . SPARSER::COLLECTION)
    ("exogenous p120" . SPARSER::PROTEIN)
    ("IL-2R and p120" . SPARSER::COLLECTION)
    ("IL-2R and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and p120" . SPARSER::COLLECTION)
    ("the chimeric cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CBD" . SPARSER::DRUG) ("EMD" . SPARSER::PROTEIN)
    ("cadherins as well as integrins ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("MECs" . SPARSER::PROTEIN) ("p120 and the cadherin" . SPARSER::COLLECTION)
    ("p120 or β-catenin" . SPARSER::COLLECTION)
    ("p120 and VE-cadherin" . SPARSER::COLLECTION)
    ("C-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("Armadillo-family proteins p120-catenin (p120) and β-catenin"
     . SPARSER::COLLECTION)
    ("vascular barrier" . SPARSER::PROTEIN)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p120 and β-catenin" . SPARSER::COLLECTION)
    ("cadherin–catenin" . SPARSER::COLLECTION)
    ("p120-catenin and β-catenin" . SPARSER::COLLECTION)
    ("β-Catenin and p120-catenin" . SPARSER::COLLECTION)
    ("l -glutamine" . SPARSER::MOLECULE) ("PECAM-1" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN) ("interleukin-2 receptor" . SPARSER::PROTEIN)
    ("C-cadherin" . SPARSER::PROTEIN) ("p120" . SPARSER::PROTEIN)
    ("mTORC1-specific inhibitors and mTOR-independent activators"
     . SPARSER::COLLECTION)
    ("‘rapamycin’" . SPARSER::DRUG) ("Hyper" . SPARSER::PROTEIN)
    ("PGC-1α and the transcription factor YY-1" . SPARSER::COLLECTION)
    ("Tor1 and Sch9" . SPARSER::COLLECTION)
    ("Msn2, Msn4 and Gis1" . SPARSER::COLLECTION) ("Msn2" . SPARSER::PROTEIN)
    ("xenobiotic" . SPARSER::MOLECULE) ("BPs" . SPARSER::PROTEIN)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("Rps6kb1" . SPARSER::PROTEIN)
    ("hif-1" . SPARSER::PROTEIN) ("hif" . SPARSER::PROTEIN-FAMILY)
    ("S6K and the translation initiation factors eIF4E and eIF4G"
     . SPARSER::COLLECTION)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("AKT, and mTORC1" . SPARSER::COLLECTION)
    ("dominant-negative alleles" . SPARSER::ALLELE)
    ("mTOR and S6K" . SPARSER::COLLECTION)
    ("mTOR and several other components" . SPARSER::COLLECTION)
    ("mTOR ( let-363 ) or the mTORC1 component raptor ( daf-15 )"
     . SPARSER::COLLECTION)
    ("daf" . SPARSER::PROTEIN) ("raptor" . SPARSER::PROTEIN)
    ("SCH" . SPARSER::PROTEIN)
    ("the hypoxic response transcription factor HIF-1α ( xref ) as well as the peroxisome-proliferator-activated receptor coactivator PGC-1α"
     . SPARSER::COLLECTION)
    ("ribosomal protein S6 kinases (S6Ks) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("at least two mTORC1 substrates" . SPARSER::SUBSTRATE)
    ("PI(3)K and AKT" . SPARSER::COLLECTION) ("Rapamycins" . SPARSER::DRUG)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("genetic mediators of rapamycin’s" . SPARSER::PROTEIN)
    ("TOR" . SPARSER::PROTEIN)
    ("rapamycin and several derivative" . SPARSER::COLLECTION)
    ("‘rapamycins’" . SPARSER::DRUG) ("rapamycins" . SPARSER::DRUG)
    ("ridaforolimus" . SPARSER::DRUG) ("immunosuppressant" . SPARSER::DRUG)
    ("sirolimus" . SPARSER::DRUG) ("leading target" . SPARSER::TARGET-PROTEIN)
    ("YY-1" . SPARSER::PROTEIN) ("SKN-1" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN)
    ("transcription factor SKN-1" . SPARSER::PROTEIN)
    ("Gis1" . SPARSER::PROTEIN) ("Msn4" . SPARSER::PROTEIN)
    ("Rim15" . SPARSER::PROTEIN) ("Sch9" . SPARSER::PROTEIN)
    ("Tor1" . SPARSER::PROTEIN) ("S6k1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gcn4" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("lactic acid" . SPARSER::MOLECULE) ("CRTC-1" . SPARSER::PROTEIN)
    ("DAF-16" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("let-363" . SPARSER::PROTEIN)
    ("peroxisome-proliferator-activated receptor" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("S6Ks" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("FK506-binding protein" . SPARSER::PROTEIN)
    ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("melting (HRM)" . SPARSER::DRUG) ("formalin" . SPARSER::MOLECULE)
    ("12 and 13 of the KRAS gene and BRAF mutation V600E"
     . SPARSER::COLLECTION)
    ("KRAS-BRAF" . SPARSER::COLLECTION)
    ("potentially causative variants" . SPARSER::VARIANT)
    ("just NOD2" . SPARSER::PROTEIN) ("PGN" . SPARSER::PROTEIN)
    ("the RNA-binding protein FUS and its interacting partner FUSIP1"
     . SPARSER::COLLECTION)
    ("NOD2 and other core components" . SPARSER::COLLECTION)
    ("proteases (USP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("USP2 and USP36" . SPARSER::COLLECTION) ("USP" . SPARSER::PROTEIN)
    ("NOD2 and RIPK2" . SPARSER::COLLECTION)
    ("RNF31 and SHARPIN" . SPARSER::COLLECTION)
    ("RIPK2, NEMO, NF-κB1, RelA, and subunits" . SPARSER::COLLECTION)
    ("RNF31 and UBE2D3" . SPARSER::COLLECTION)
    ("SHANK-associated RH domain–interacting protein (SHARPIN)"
     . SPARSER::PROTEIN)
    ("protein (SHARPIN)" . SPARSER::PROTEIN) ("SHARPIN" . SPARSER::PROTEIN)
    ("RH" . SPARSER::MOLECULE) ("complex (LUBAC)" . SPARSER::BIO-COMPLEX)
    ("RNF31 ( xref ) and ZDHHC2 ( xref )" . SPARSER::COLLECTION)
    ("RNF31 and ZDHHC2" . SPARSER::COLLECTION)
    ("NOD2 or IA" . SPARSER::COLLECTION)
    ("RIPK2 or RIPK1" . SPARSER::COLLECTION) ("active (IA)" . SPARSER::ACTIVE)
    ("active (CA)" . SPARSER::ACTIVE) ("RIPK1-" . SPARSER::PROTEIN)
    ("ZDHHC2 and RNF31" . SPARSER::COLLECTION)
    ("ring finger protein 31 (RNF31) and zinc finger" . SPARSER::COLLECTION)
    ("RIPK1 and RIPK2" . SPARSER::COLLECTION) ("Ncf1" . SPARSER::PROTEIN)
    ("other genome-wide siRNA" . SPARSER::PROTEIN)
    ("NOD2 and Crohn" . SPARSER::COLLECTION)
    ("WW domain binding protein 11 (WBP11) and fused" . SPARSER::COLLECTION)
    ("FUS" . SPARSER::PROTEIN) ("CYBB" . SPARSER::PROTEIN)
    ("neutrophil" . SPARSER::PROTEIN)
    ("tumor susceptibility gene 101 (TSG101) and vacuolar protein sorting 28 (VPS28)"
     . SPARSER::COLLECTION)
    ("vacuolar protein" . SPARSER::PROTEIN)
    ("ATG4A, ATG4B, and γ-aminobutyric" . SPARSER::COLLECTION)
    ("GABARAP" . SPARSER::PROTEIN) ("NEMO-" . SPARSER::PROTEIN)
    ("RIPK2-" . SPARSER::PROTEIN)
    ("synthetase/aspartate" . SPARSER::COLLECTION)
    ("carbamoyl" . SPARSER::MOLECULE) ("KL" . SPARSER::PROTEIN)
    ("Klotho" . SPARSER::PROTEIN) ("PRKCD" . SPARSER::PROTEIN)
    ("RIPK2 and other core components" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN) ("NOD2–NF-κB" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("the pro-inflammatory chemokine interleukin-8" . SPARSER::PROTEIN)
    ("NOD2 and NF-κB" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("bacterial peptidoglycan fragments containing muramyl dipeptide (MDP)"
     . SPARSER::MOLECULE)
    ("dipeptide (MDP)" . SPARSER::MOLECULE) ("dipeptide" . SPARSER::MOLECULE)
    ("muramyl" . SPARSER::MOLECULE) ("NOD2-" . SPARSER::PROTEIN)
    ("FUSIP1" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("NOD1" . SPARSER::PROTEIN) ("USP36" . SPARSER::PROTEIN)
    ("USP2" . SPARSER::PROTEIN) ("PARK2" . SPARSER::PROTEIN)
    ("PPM1L" . SPARSER::PROTEIN) ("1 like" . SPARSER::PROTEIN)
    ("magnesium-dependent" . SPARSER::PROTEIN) ("UBE2D3" . SPARSER::PROTEIN)
    ("RBCK1" . SPARSER::PROTEIN)
    ("RanBP-type and C3HC4-type zinc finger containing 1" . SPARSER::PROTEIN)
    ("FK506" . SPARSER::DRUG) ("ZDHHC2" . SPARSER::PROTEIN)
    ("RNF31" . SPARSER::PROTEIN) ("ring finger protein 31" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN) ("WBP11" . SPARSER::PROTEIN)
    ("WW domain binding protein 11" . SPARSER::PROTEIN)
    ("NOXA1" . SPARSER::PROTEIN)
    ("NADPH oxidase activator 1" . SPARSER::PROTEIN)
    ("cytochrome b-245" . SPARSER::PROTEIN) ("NCF1" . SPARSER::PROTEIN)
    ("ATG4A" . SPARSER::PROTEIN) ("VPS28" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("regulatory subunit B" . SPARSER::PROTEIN) ("PPP2R5E" . SPARSER::PROTEIN)
    ("PDLIM2" . SPARSER::PROTEIN) ("CSNK2A2" . SPARSER::PROTEIN)
    ("RIPK2" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("osteogenic cues" . SPARSER::PROTEIN-FAMILY)
    ("hOCN-Cre" . SPARSER::COLLECTION)
    ("intermittent parathyroid hormone" . SPARSER::PROTEIN)
    ("IP6K1 and the second messenger InsP" . SPARSER::COLLECTION)
    ("Runx2-responsive osteogenic genes" . SPARSER::GENE)
    ("IMPK and IP6Ks" . SPARSER::COLLECTION) ("IMPK" . SPARSER::PROTEIN)
    ("DAG and InsP" . SPARSER::COLLECTION)
    ("IPMK and IP6K1" . SPARSER::COLLECTION)
    ("IPMK and IP6K" . SPARSER::COLLECTION)
    ("PLCγ1/IPMK/IP6K/PKCδ" . SPARSER::COLLECTION)
    ("Iα1, osteocalcin and Osterix" . SPARSER::COLLECTION)
    ("Osterix" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("osteogenic genes" . SPARSER::GENE)
    ("Runx2 and PKCδ" . SPARSER::COLLECTION)
    ("IP6K1 or IP6K2" . SPARSER::COLLECTION)
    ("IP6K1 and IP6K2" . SPARSER::COLLECTION)
    ("kinases, IP6K1, IP6K2 and IP6K3" . SPARSER::COLLECTION)
    ("OSE2" . SPARSER::PROTEIN) ("IPMK" . SPARSER::PROTEIN)
    ("polyphosphate and pyrophosphate" . SPARSER::COLLECTION)
    ("pyrophosphate" . SPARSER::MOLECULE)
    ("polyphosphates and pyrophosphates" . SPARSER::COLLECTION)
    ("OSE2-luciferase" . SPARSER::COLLECTION) ("RHC" . SPARSER::PROTEIN)
    ("lipase" . SPARSER::PROTEIN) ("DAG" . SPARSER::DAG)
    ("Inositol" . SPARSER::PROTEIN) ("PLCγ and PKCδ" . SPARSER::COLLECTION)
    ("Runx2-luciferase" . SPARSER::COLLECTION) ("OCH" . SPARSER::PROTEIN)
    ("PLC" . SPARSER::PROTEIN) ("pSFFV-Cx43" . SPARSER::COLLECTION)
    ("pSFFV-neo" . SPARSER::COLLECTION) ("neo" . SPARSER::PROTEIN)
    ("Gja1" . SPARSER::PROTEIN)
    ("small molecules and second messengers" . SPARSER::COLLECTION)
    ("connexins" . SPARSER::PROTEIN-FAMILY)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biologically relevant mediators" . SPARSER::PROTEIN)
    ("the water-soluble inositol polyphosphates" . SPARSER::MOLECULE)
    ("Cx43-gap" . SPARSER::COLLECTION) ("polyphosphates" . SPARSER::MOLECULE)
    ("PKCδ and Runx2" . SPARSER::COLLECTION)
    ("pyrophosphates" . SPARSER::MOLECULE)
    ("polyphosphate" . SPARSER::MOLECULE)
    ("parathyroid hormone" . SPARSER::PROTEIN) ("Cx45" . SPARSER::PROTEIN)
    ("H 12" . SPARSER::PROTEIN) ("Iα1" . SPARSER::PROTEIN)
    ("IP6K3" . SPARSER::PROTEIN) ("IP6" . SPARSER::DRUG)
    ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("RPL13" . SPARSER::PROTEIN) ("IP6K2" . SPARSER::PROTEIN)
    ("IP6K1" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("2-APB" . SPARSER::MOLECULE) ("N2" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("IP6K" . SPARSER::PROTEIN)
    ("inositol hexakisphosphate kinase 1" . SPARSER::PROTEIN)
    ("inositol polyphosphate multikinase" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN)
    ("fibroblast growth factor-2" . SPARSER::PROTEIN)
    ("Connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a tripartite complex" . SPARSER::BIO-COMPLEX)
    ("PR-B, HDAC1, and NCoR" . SPARSER::COLLECTION)
    ("the tripartite corepressor complex PR-B/NCoR/HDAC1"
     . SPARSER::COLLECTION)
    ("PR-B/NCoR/HDAC1" . SPARSER::COLLECTION)
    ("chaperones and receptor" . SPARSER::COLLECTION)
    ("PREs" . SPARSER::PROTEIN) ("p38 and CK2" . SPARSER::COLLECTION)
    ("PR-A and PR-B" . SPARSER::COLLECTION)
    ("p38 and p42/44" . SPARSER::COLLECTION)
    ("PR-B/Hsp90" . SPARSER::COLLECTION) ("raf1" . SPARSER::PROTEIN)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsp90/p-38MAPK" . SPARSER::COLLECTION) ("HER2−" . SPARSER::PROTEIN)
    ("phytochemicals" . SPARSER::DRUG)
    ("PR-B, NCoR and HDAC1" . SPARSER::COLLECTION)
    ("p-38/CK2" . SPARSER::COLLECTION)
    ("PR-B, HDAC1 and NCoR" . SPARSER::COLLECTION)
    ("the tripartite complex" . SPARSER::BIO-COMPLEX)
    ("HDAC-1 and HDAC-3" . SPARSER::COLLECTION)
    ("NCoR, DAX-1, and SMRT" . SPARSER::COLLECTION) ("SMRT" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN) ("PR-B or PR-A" . SPARSER::COLLECTION)
    ("Hsp90 and PR-B" . SPARSER::COLLECTION)
    ("Hsp90/PR-B" . SPARSER::COLLECTION) ("p38/CK2" . SPARSER::COLLECTION)
    ("TBB" . SPARSER::PROTEIN) ("CK2 and p-p38" . SPARSER::COLLECTION)
    ("p42/p44 MAPK" . SPARSER::COLLECTION) ("PR-A/Hsp90" . SPARSER::COLLECTION)
    ("PR and Hsp90" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::COLLECTION)
    ("a mutated half-PRE oligonucleotide" . SPARSER::MOLECULE)
    ("the first transcriptional ATG" . SPARSER::DRUG)
    ("CCAAT" . SPARSER::PROTEIN)
    ("EGCG (20 μM and 40 μM) significantly down-regulated ERα"
     . SPARSER::PROTEIN)
    ("effectively opposing estrogen’s" . SPARSER::MOLECULE)
    ("ERK/MAPK" . SPARSER::COLLECTION) ("MAPK and AKT" . SPARSER::COLLECTION)
    ("IRS1, pS2 and cyclin D1" . SPARSER::COLLECTION)
    ("CD1" . SPARSER::PROTEIN) ("that EGCG’s" . SPARSER::DRUG)
    ("ISK" . SPARSER::PROTEIN) ("PRs" . SPARSER::PROTEIN)
    ("the ERα proximal promoter" . SPARSER::PROMOTER)
    ("isoflavones" . SPARSER::MOLECULE) ("GR and PR" . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN)
    ("receptor, AKT, NF-κB, and CDKs" . SPARSER::COLLECTION)
    ("IGF/IGF-1" . SPARSER::COLLECTION) ("catechin" . SPARSER::MOLECULE)
    ("epigallocatechin gallate (EGCG)" . SPARSER::DRUG)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("Estrogens" . SPARSER::MOLECULE)
    ("NCoR and HDAC1" . SPARSER::COLLECTION) ("NCoR" . SPARSER::PROTEIN)
    ("PRE" . SPARSER::PROTEIN) ("/CK2" . SPARSER::COLLECTION)
    ("protein, mRNA and gene" . SPARSER::COLLECTION)
    ("p-38" . SPARSER::PROTEIN) ("HDAC-3" . SPARSER::PROTEIN)
    ("HDAC-1" . SPARSER::PROTEIN) ("DAX-1" . SPARSER::PROTEIN)
    ("PD169316" . SPARSER::DRUG) ("p44 MAPK" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("USF1" . SPARSER::PROTEIN)
    ("CREB-2" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("PR-A" . SPARSER::PROTEIN) ("PD 169316" . SPARSER::DRUG)
    ("epigallocatechin gallate" . SPARSER::DRUG) ("ERβ" . SPARSER::PROTEIN)
    ("PR-B" . SPARSER::PROTEIN) ("Epigallocatechin gallate" . SPARSER::DRUG)
    ("E-cadherin and the hypoxia-associated proteins" . SPARSER::COLLECTION)
    ("both HIF-1 α and its target genes GLUT-1" . SPARSER::COLLECTION)
    ("more recent cohort" . SPARSER::MOLECULE)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("DAB" . SPARSER::MOLECULE) ("VIP" . SPARSER::PROTEIN)
    ("the hypoxia-associated proteins (GLUT-1 and CA IX) and E-cadherin"
     . SPARSER::COLLECTION)
    ("the hypoxia-associated proteins" . SPARSER::PROTEIN)
    ("hypoxia-associated proteins" . SPARSER::PROTEIN)
    ("hypoxia and hypoxia-associated proteome" . SPARSER::COLLECTION)
    ("subregions" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("WB" . SPARSER::PROTEIN) ("western blot (WB)" . SPARSER::PROTEIN)
    ("hypoxia-associated marker proteins" . SPARSER::PROTEIN)
    ("SNAIL" . SPARSER::PROTEIN) ("GLUT-1-" . SPARSER::PROTEIN)
    ("anhydrase" . SPARSER::PROTEIN) ("GLUT" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("HF 2" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor -1" . SPARSER::PROTEIN)
    ("GLUT-1" . SPARSER::PROTEIN) ("Acetyl-" . SPARSER::MOLECULE)
    ("XAF1 and BAX" . SPARSER::COLLECTION)
    ("p21WAF1/CIP1" . SPARSER::COLLECTION)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("several oncogenic client proteins" . SPARSER::PROTEIN)
    ("HSP90 and α -tubulin" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("a new HDACI" . SPARSER::MOLECULE)
    ("a new HDAC6 inhibitor ACY-1215" . SPARSER::DRUG)
    ("bortezomib" . SPARSER::DRUG) ("particular HDAC6" . SPARSER::PROTEIN)
    ("XAF1, PIP5KL1 and RAD23B" . SPARSER::COLLECTION)
    ("the pro-apoptotic factors XAF1 (gene encoding XIAP-associated factor 1, an antagonist of X-linked inhibitor of apoptosis protein) and BAX (gene encoding Bcl-2-associated X protein)"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic factors XAF1" . SPARSER::PROTEIN)
    ("XIAP" . SPARSER::PROTEIN)
    ("XAF1 , PIP5KL1 , BAX , SRD5A1 , DHCR24 , TAPBP , PTPRG , IPO7 and RAD23B"
     . SPARSER::COLLECTION)
    ("PTPRG" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("subsequent fragmented DNA" . SPARSER::DNA)
    ("largely HDAC Class I" . SPARSER::PROTEIN)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("The characteristic increased sub-G1 fraction" . SPARSER::COMPONENT)
    ("8 different histological types" . TYPE) ("chlorambucil" . SPARSER::DRUG)
    ("a recognised client protein" . SPARSER::PROTEIN)
    ("HDACs, and sirtuins" . SPARSER::COLLECTION)
    ("solvent" . SPARSER::MOLECULE) ("cdII" . SPARSER::PROTEIN)
    ("HDAC1 and HDAC6" . SPARSER::COLLECTION)
    ("hydroxamate" . SPARSER::MOLECULE)
    ("naturally occurring pan HDACIs trichostatin" . SPARSER::MOLECULE)
    ("tubacin" . SPARSER::DRUG)
    ("HSP90, α -tubulin, cortactin and peroxiredoxins" . SPARSER::COLLECTION)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("cortactin" . SPARSER::PROTEIN)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("vorinostat (SAHA) and romidepsin" . SPARSER::COLLECTION)
    ("romidepsin" . SPARSER::DRUG) ("vorinostat" . SPARSER::DRUG)
    ("histones and various cellular proteins" . SPARSER::COLLECTION)
    ("α -tubulin and HSP90" . SPARSER::COLLECTION) ("FLT" . SPARSER::PROTEIN)
    ("ACY-1215" . SPARSER::DRUG) ("HDAC6 inhibitor ACY-1215" . SPARSER::DRUG)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("HIST2H2AC" . SPARSER::PROTEIN) ("RAD23B" . SPARSER::PROTEIN)
    ("IPO7" . SPARSER::PROTEIN) ("DHCR24" . SPARSER::PROTEIN)
    ("SRD5A1" . SPARSER::PROTEIN) ("PIP5KL1" . SPARSER::PROTEIN)
    ("XAF1" . SPARSER::PROTEIN) ("FHL1" . SPARSER::PROTEIN)
    ("BST2" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("HS15" . SPARSER::PROTEIN) ("CK14" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("VHL and HIF" . SPARSER::COLLECTION)
    ("VHL and HIF-1 α" . SPARSER::COLLECTION) ("VHL" . SPARSER::PROTEIN)
    ("clearly less LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pg " . SPARSER::MOLECULE) ("adiponectin" . SPARSER::PROTEIN)
    ("noneffective scrambled control shRNA" . SPARSER::PROTEIN)
    ("Wilcoxon" . SPARSER::PROTEIN) ("folliculin" . SPARSER::PROTEIN)
    ("at least 12 other substrates" . SPARSER::SUBSTRATE)
    ("LKB1 or serine/threonine kinase 11" . SPARSER::COLLECTION)
    ("kinase-" . SPARSER::KINASE)
    ("several histological forms" . SPARSER::FORM)
    ("-AMP activated protein kinase" . SPARSER::COLLECTION)
    ("HIF-2 α" . SPARSER::PROTEIN) ("HIF-1 α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("von Hippel–Lindau" . SPARSER::PROTEIN) ("as 2 " . SPARSER::PROTEIN)
    ("β- actin" . SPARSER::PROTEIN) ("fumarate hydratase" . SPARSER::PROTEIN)
    ("MARK1" . SPARSER::PROTEIN)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("AMP activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the antiapoptotic gene Bcl-xL and the cell-proliferation gene c-Myc"
     . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("adenocarcinostatic drugs" . SPARSER::DRUG)
    ("a strong inducer" . SPARSER::PROTEIN)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("Survivin, STAT3, pSTAT3, Bcl-xL, and c-Myc" . SPARSER::COLLECTION)
    ("Bcl-xL and c-Myc" . SPARSER::COLLECTION)
    ("mRNA and miR-18a" . SPARSER::COLLECTION)
    ("pcDNA-GL3" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("six mature miRNAs" . SPARSER::PROTEIN)
    ("cell proliferation-associated proteins" . SPARSER::PROTEIN)
    ("Bcl-xL, Mcl-1, Bcl-2, Fas, cyclin D1, Survivin, and c-Myc"
     . SPARSER::COLLECTION)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("Regulators" . SPARSER::REGULATOR)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("nascent mRNA" . SPARSER::PROTEIN)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("Survivin, Bcl-xL, and c-Myc" . SPARSER::COLLECTION)
    ("MicroRNA" . SPARSER::RNA)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("C13orf25" . SPARSER::PROTEIN) ("N-term" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("Argonaute 2" . SPARSER::PROTEIN)
    ("GL3" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE) ("single-stranded RNA" . SPARSER::RNA)
    ("PIAS3" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("DNA and help" . SPARSER::COLLECTION) ("enterotoxin" . SPARSER::PROTEIN)
    ("polyketide" . SPARSER::MOLECULE)
    ("inositol, and TNF-α" . SPARSER::COLLECTION)
    ("Superoxide" . SPARSER::MOLECULE) ("kin" . SPARSER::PROTEIN)
    ("stochastically damage DNA" . SPARSER::DNA)
    ("an amphiphilic aldehyde" . SPARSER::MOLECULE)
    ("extracellular superoxide" . SPARSER::MOLECULE)
    ("sporadic CRC" . SPARSER::PROTEIN)
    ("These reactive aldehydes" . SPARSER::MOLECULE)
    ("amphiphilic aldehydes" . SPARSER::MOLECULE)
    ("aldehydes" . SPARSER::MOLECULE)
    ("the colonic stroma and tissue macrophages" . SPARSER::PROTEIN)
    ("shams" . SPARSER::DRUG) ("sham" . SPARSER::DRUG)
    ("Il10" . SPARSER::PROTEIN) ("electrophile" . SPARSER::MOLECULE)
    ("BSO" . SPARSER::DRUG) ("Glutathione" . SPARSER::DRUG)
    ("Celecoxib" . SPARSER::DRUG) ("mixtures" . SPARSER::MOLECULE)
    ("celecoxib" . SPARSER::DRUG) ("Cox1 or Alox5" . SPARSER::COLLECTION)
    ("COX-1 or ALOX5" . SPARSER::COLLECTION)
    ("macrophages, Cox1 and Alox5" . SPARSER::COLLECTION)
    ("COX-1 and ALOX5" . SPARSER::COLLECTION)
    ("AA861 and ETYA" . SPARSER::COLLECTION)
    ("an ALOX5-specific inhibitor and a dual COX/LOX inhibitor"
     . SPARSER::COLLECTION)
    ("a dual COX/LOX inhibitor" . SPARSER::INHIBITOR)
    ("COX/LOX" . SPARSER::COLLECTION)
    ("cyclooxygenases and lipoxygenases" . SPARSER::COLLECTION)
    ("polyunsaturated fatty acid, and 4-HNE" . SPARSER::COLLECTION)
    ("LOX and COX" . SPARSER::COLLECTION)
    ("a pro-carcinogenic enzyme" . SPARSER::ENZYME)
    ("colonic macrophages" . SPARSER::PROTEIN) ("mutagen" . SPARSER::MOLECULE)
    ("poison" . SPARSER::MOLECULE)
    ("the diffusible mediators" . SPARSER::PROTEIN)
    ("macrophages and causes CRC" . SPARSER::COLLECTION)
    ("heme" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("mucosal macrophages" . SPARSER::PROTEIN)
    ("COX-2 and ALOX5" . SPARSER::COLLECTION)
    ("hydroperoxides" . SPARSER::MOLECULE)
    ("bifunctional electrophiles" . SPARSER::MOLECULE)
    ("ascorbate" . SPARSER::MOLECULE) ("prostanoid" . SPARSER::MOLECULE)
    ("β-unsaturated aldehyde" . SPARSER::MOLECULE)
    ("These bifunctional electrophiles" . SPARSER::MOLECULE)
    ("electrophiles" . SPARSER::MOLECULE) ("hydroperoxy" . SPARSER::MOLECULE)
    ("PGE 2 and PGD 2" . SPARSER::COLLECTION)
    ("COX-2 or ALOX5" . SPARSER::COLLECTION) ("NSAIDs" . SPARSER::DRUG)
    ("ALOX5 or 5-lipoxygenase" . SPARSER::COLLECTION)
    ("Cyclooxygenases (COX) and lipoxygenases (LOX)" . SPARSER::COLLECTION)
    ("lipoxins" . SPARSER::MOLECULE) ("leukotrienes" . SPARSER::MOLECULE)
    ("prostanoids" . SPARSER::MOLECULE)
    ("lipoxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a procarcinogenic enzyme" . SPARSER::ENZYME)
    ("Alox5 and Cox1" . SPARSER::COLLECTION)
    ("Cox1 and Alox5" . SPARSER::COLLECTION)
    ("COX-2 and 4-HNE" . SPARSER::COLLECTION) ("Alox5" . SPARSER::PROTEIN)
    ("COX and LOX" . SPARSER::COLLECTION)
    ("cyclooxygenase (COX) and lipoxygenase (LOX)" . SPARSER::COLLECTION)
    ("this reactive aldehyde" . SPARSER::MOLECULE)
    ("macrophages and interleukin-10" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE) ("LOX" . SPARSER::PROTEIN)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COX" . SPARSER::PROTEIN)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("HNE" . SPARSER::PROTEIN)
    ("PGH 2" . SPARSER::MOLECULE) ("α-tocopherol" . SPARSER::MOLECULE)
    ("AA861" . SPARSER::DRUG) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("PGD 2" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("arachidonate 5-lipoxygenase activating protein" . SPARSER::PROTEIN)
    ("5-lipoxygenase" . SPARSER::PROTEIN) ("ALOX5" . SPARSER::PROTEIN)
    ("arachidonate 5-lipoxygenase" . SPARSER::PROTEIN)
    ("COX-1" . SPARSER::PROTEIN) ("Cox2" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("Cox1" . SPARSER::PROTEIN)
    ("centralized biomaterial bank" . SPARSER::PROTEIN)
    ("PIK3CA or TP53" . SPARSER::COLLECTION)
    ("MAT1 or JAG2" . SPARSER::COLLECTION)
    ("DNA and cfDNA" . SPARSER::COLLECTION)
    ("a strong and realistic cohort" . SPARSER::MOLECULE)
    ("age-matched healthy cohorts" . SPARSER::MOLECULE)
    ("the most frequently methylated genes" . SPARSER::GENE)
    ("still no single gene" . SPARSER::GENE)
    ("blood-based biomarkers" . SPARSER::MOLECULE)
    ("SFRP1 , SFRP2 , SFRP5 , DKK3 , and WIF1" . SPARSER::COLLECTION)
    ("MSP and qMSP" . SPARSER::COLLECTION)
    ("ITIH5, DKK3 , and RASSF1A" . SPARSER::COLLECTION)
    ("DKK3 and ITIH5" . SPARSER::COLLECTION)
    ("SFRP1 and SFRP2" . SPARSER::COLLECTION)
    ("ITIH5 , WIF1 , and DKK3" . SPARSER::COLLECTION)
    ("SFRP1 , SFRP2 , and SFRP5" . SPARSER::COLLECTION)
    ("SFRP1 and ITIH5" . SPARSER::COLLECTION)
    ("DKK3 ( P = 0.003) and ITIH5 ( P = 0.007)" . SPARSER::COLLECTION)
    ("DNA and serum" . SPARSER::COLLECTION)
    ("SFRP1 , SFRP2 , SFRP5 , ITIH5 , DKK3 , and WIF1" . SPARSER::COLLECTION)
    ("qualitative MSP" . SPARSER::PROTEIN) ("MSP" . SPARSER::PROTEIN)
    ("SFRP1, SFRP2, SFRP5, WIF1, DKK3, ITIH5 , and RASSF1A"
     . SPARSER::COLLECTION)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("RASSF1A and APC" . SPARSER::COLLECTION)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("ITIH5 , DKK3 , and RASSF1A" . SPARSER::COLLECTION)
    ("ITIH5 and DKK3" . SPARSER::COLLECTION) ("Sera" . SPARSER::PROTEIN)
    ("SFRP1 , SFRP2 , SFRP5, ITIH5 , WIF1 , DKK3 , and RASSF1A"
     . SPARSER::COLLECTION)
    ("robust blood-based biomarkers" . SPARSER::MOLECULE)
    ("Wnt inhibitory factor 1" . SPARSER::PROTEIN)
    ("secreted frizzled-related protein 5" . SPARSER::PROTEIN)
    ("secreted frizzled-related protein 2" . SPARSER::PROTEIN)
    ("secreted frizzled-related protein 1" . SPARSER::PROTEIN)
    ("Ras association domain family member 1" . SPARSER::PROTEIN)
    ("inter-alpha-trypsin inhibitor" . SPARSER::PROTEIN)
    ("Dickkopf 3" . SPARSER::PROTEIN) ("JAG2" . SPARSER::PROTEIN)
    ("MAT1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pT1-2" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("DKK3" . SPARSER::PROTEIN)
    ("WIF1" . SPARSER::PROTEIN) ("ITIH5" . SPARSER::PROTEIN)
    ("SFRP5" . SPARSER::PROTEIN) ("SFRP2" . SPARSER::PROTEIN)
    ("SFRP1" . SPARSER::PROTEIN)
    ("sterol biosynthetic xref genes" . SPARSER::GENE)
    ("ABCA1 and SR-BI" . SPARSER::COLLECTION)
    ("SR-BI, ABCA1, and ABCG1" . SPARSER::COLLECTION)
    ("AR, SREBP-2 and LXR" . SPARSER::COLLECTION)
    ("this residual androgen" . SPARSER::PROTEIN)
    ("LXR and SREBP-2" . SPARSER::COLLECTION) ("sterols" . SPARSER::MOLECULE)
    ("oxysterol" . SPARSER::MOLECULE) ("their basal media" . SPARSER::PROTEIN)
    ("testosterone and casodex" . SPARSER::COLLECTION)
    ("CS-FBS" . SPARSER::COLLECTION) ("CS" . SPARSER::PROTEIN)
    ("media-androgen" . SPARSER::COLLECTION)
    ("either androgens ( xref ) or anti-androgens ( xref )"
     . SPARSER::COLLECTION)
    ("testosterone and dihydrotestosterone" . SPARSER::COLLECTION)
    ("charcoal-stripped FBS" . SPARSER::PROTEIN) ("Scap" . SPARSER::PROTEIN)
    ("oxysterols" . SPARSER::MOLECULE) ("LDLR" . SPARSER::PROTEIN)
    ("HMGCR" . SPARSER::PROTEIN)
    ("sterol regulatory element-binding protein isoform 2 (SREBP-2) and liver X receptor (LXR)"
     . SPARSER::COLLECTION)
    ("CR-PCa" . SPARSER::COLLECTION) ("blood-androgen" . SPARSER::PROTEIN)
    ("casodex" . SPARSER::DRUG) ("SREBP-2 and LXR" . SPARSER::COLLECTION)
    ("sterol-regulatory element-binding protein 2 (SREBP-2) and liver X receptor (LXR)"
     . SPARSER::COLLECTION)
    ("receptor (LXR)" . SPARSER::RECEPTOR) ("B-5" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG) ("SR-BI" . SPARSER::PROTEIN)
    ("AF-1" . SPARSER::PROTEIN) ("ABCG1" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("anti-androgen" . SPARSER::DRUG)
    ("SREBP-2" . SPARSER::PROTEIN)
    ("c-Met receptor-, PI3K-, Akt-, PKCδ-, IKKα/β-, and NF-κB-dependent pathways"
     . SPARSER::COLLECTION)
    ("PKCδ-" . SPARSER::PROTEIN) ("receptor-" . SPARSER::RECEPTOR)
    ("the pathological state" . SPARSER::BIO-STATE)
    ("the normal biological state" . SPARSER::BIO-STATE)
    ("CREB and p53" . SPARSER::COLLECTION)
    ("c-Met, PI3K, Akt, PKCδ, and NF-κB" . SPARSER::COLLECTION)
    ("MMP-2, c-Met, PI3K, Akt, PKCδ, and NF-κB" . SPARSER::COLLECTION)
    ("receptor, PI3K, Akt, PKCδ, and NF-κB" . SPARSER::COLLECTION)
    ("directly-administered exogenous HGF" . SPARSER::PROTEIN)
    ("receptor, PI3K, Akt, and PKCδ" . SPARSER::COLLECTION)
    ("p85, Akt, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("c-Met and PKCδ" . SPARSER::COLLECTION)
    ("rottlerin, PDTC, and TPCK" . SPARSER::COLLECTION)
    ("κB" . SPARSER::PROTEIN) ("κB-luciferase" . SPARSER::COLLECTION)
    ("IκBα and p65" . SPARSER::COLLECTION)
    ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("c-Jun or SP-1" . SPARSER::COLLECTION)
    ("AP-1 and SP-1" . SPARSER::COLLECTION)
    ("c-Jun and SP-1" . SPARSER::COLLECTION)
    ("NF-κB, AP-1, and SP-1" . SPARSER::COLLECTION)
    ("TPCK" . SPARSER::MOLECULE) ("PDTC" . SPARSER::DRUG)
    ("PI3K, Akt, and PKCδ" . SPARSER::COLLECTION) ("rottlerin" . SPARSER::DRUG)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("p85 and Akt" . SPARSER::COLLECTION) ("p85 or Akt" . SPARSER::COLLECTION)
    ("PI3K (Ly294002 and wortmannin) or Akt inhibitor" . SPARSER::COLLECTION)
    ("Ly294002 and wortmannin" . SPARSER::COLLECTION)
    ("Ly294002 and wortmannin, or Akt" . SPARSER::COLLECTION)
    ("wortmannin, or Akt" . SPARSER::COLLECTION)
    ("PI3K, Akt, and PKCβ" . SPARSER::COLLECTION)
    ("HGF-shRNA" . SPARSER::PROTEIN-PAIR)
    ("MMP-2 or control siRNA" . SPARSER::COLLECTION)
    ("MMP-1, −9, and −13 expression" . SPARSER::COLLECTION)
    ("MMP-1, −2, −3, −9, and −13 xref" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2, MMP-3, MMP-9, and MMP-13" . SPARSER::COLLECTION)
    ("cytokines, growth factors, chemokines, and MMPs" . SPARSER::COLLECTION)
    ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("HGF and c-Met" . SPARSER::COLLECTION)
    ("a heterodimeric molecule" . SPARSER::MOLECULE)
    ("PI3K, Akt, PKCδ, and NF-κB" . SPARSER::COLLECTION)
    ("-kinase" . SPARSER::KINASE) ("PKCβ" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("Ly294002" . SPARSER::MOLECULE) ("SP-1" . SPARSER::PROTEIN)
    ("beta chain" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("particular S1P" . SPARSER::PROTEIN) ("EDG-3/S1P 3" . SPARSER::COLLECTION)
    ("EDG" . SPARSER::PROTEIN)
    ("S1P, sphingosylphosphorylcholine and lysosulfatide"
     . SPARSER::COLLECTION)
    ("apolipoprotein" . SPARSER::MOLECULE)
    ("prostacyclin and nitric oxide" . SPARSER::COLLECTION)
    ("prostacyclin" . SPARSER::MOLECULE)
    ("unilateral limb ischemia" . SPARSER::PROTEIN)
    ("classical PI3K inhibitors" . SPARSER::INHIBITOR)
    ("PI3Ks/PtdIns" . SPARSER::COLLECTION)
    ("a distinct phosphoinositide" . SPARSER::PROTEIN)
    ("the S1P- and HDL 3 -mediated EC" . SPARSER::COLLECTION)
    ("Rac1 or RhoA" . SPARSER::COLLECTION) ("retinas" . SPARSER::DRUG)
    ("two distinct siRNAs and two inhibitors" . SPARSER::COLLECTION)
    ("mainly target p110γ" . SPARSER::PROTEIN)
    ("lysophospholipid" . SPARSER::MOLECULE)
    ("these classical PI3K inhibitors" . SPARSER::INHIBITOR)
    ("inositol" . SPARSER::PROTEIN) ("myo" . SPARSER::PROTEIN)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("classical PI3K inhibitors wortmannin and LY294002" . SPARSER::COLLECTION)
    ("ERK or Akt" . SPARSER::COLLECTION) ("Akt or ERK" . SPARSER::COLLECTION)
    ("the distinct PI3Ks" . SPARSER::PROTEIN)
    ("each distinct PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p110γ and PI3K-C2β" . SPARSER::COLLECTION)
    ("class II PI3Ks (mainly PI3K-C2β) and p110γ" . SPARSER::COLLECTION)
    ("PI3Ks and p110γ" . SPARSER::COLLECTION)
    ("two distinct siRNAs" . SPARSER::PROTEIN)
    ("the only other PI3K isoform" . SPARSER::ISOFORM)
    ("Two distinct siRNAs" . SPARSER::PROTEIN)
    ("the classical inhibitors" . SPARSER::INHIBITOR)
    ("generic inhibitors" . SPARSER::INHIBITOR)
    ("wortmannin and LY294402" . SPARSER::COLLECTION)
    ("p110β and p110γ" . SPARSER::COLLECTION)
    ("generic PI3K inhibitors" . SPARSER::INHIBITOR)
    ("generic or isoform-specific PI3K inhibitors" . SPARSER::INHIBITOR)
    ("lysophospholipids" . SPARSER::MOLECULE)
    ("the classical PI3K inhibitor wortmannin" . SPARSER::MOLECULE)
    ("Isoforms" . SPARSER::ISOFORM) ("S1P and HDL" . SPARSER::COLLECTION)
    ("LPA" . SPARSER::LPA)
    ("the class IA p110β and the class IB p110γ" . SPARSER::COLLECTION)
    ("at least two class I isoforms" . SPARSER::ISOFORM)
    ("EDG-1/S1P 1" . SPARSER::COLLECTION)
    ("albumin and lipoproteins" . SPARSER::COLLECTION)
    ("lyase" . SPARSER::PROTEIN) ("sphingomyelinase" . SPARSER::PROTEIN)
    ("sphingomyelin" . SPARSER::MOLECULE) ("sphingolipids" . SPARSER::MOLECULE)
    ("distinct PI3Ks" . SPARSER::PROTEIN)
    ("the only class III PI3K isoform" . SPARSER::ISOFORM)
    ("IA and IB" . SPARSER::COLLECTION) ("S1P-" . SPARSER::PROTEIN)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("selectively target individual isoforms" . SPARSER::ISOFORM)
    ("S1P 3" . SPARSER::PROTEIN) ("EDG-3" . SPARSER::PROTEIN)
    ("SR-B1" . SPARSER::PROTEIN)
    ("scavenger receptor class B member 1" . SPARSER::PROTEIN)
    ("apolipoprotein A-I" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("TGX221" . SPARSER::DRUG) ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("AS252424" . SPARSER::DRUG) ("p110β" . SPARSER::PROTEIN)
    ("S1P 1" . SPARSER::PROTEIN) ("EDG-1" . SPARSER::PROTEIN)
    ("S1P receptor 1" . SPARSER::PROTEIN)
    ("Sphingosine 1-phosphate" . SPARSER::DRUG) ("hVps34" . SPARSER::PROTEIN)
    ("PtdIns3 P" . SPARSER::MOLECULE)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p110γ" . SPARSER::PROTEIN)
    ("S1P" . SPARSER::PROTEIN) ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("PI3Ks" . SPARSER::PROTEIN) ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("RAS/Aurora-A" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("RAS, Aurora-A, and BRCA2" . SPARSER::COLLECTION)
    ("RAS or BRCA2" . SPARSER::COLLECTION)
    ("mitotic checkpoint proteins" . SPARSER::PROTEIN)
    ("Aurora-A, Aurora-B, and PLK1" . SPARSER::COLLECTION)
    ("ATM, CHK1, and CHK2" . SPARSER::COLLECTION)
    ("BRCA1 and centrobin" . SPARSER::COLLECTION)
    ("centrobin" . SPARSER::PROTEIN) ("mitotic HOC-7" . SPARSER::PROTEIN)
    ("KRAS and Aurora-A" . SPARSER::COLLECTION) ("FTI" . SPARSER::DRUG)
    ("Aurora-A or introducing BRCA2" . SPARSER::COLLECTION)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGFBP-3 and farnesyl" . SPARSER::COLLECTION)
    ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("lower BRCA2 and higher Aurora-A" . SPARSER::COLLECTION)
    ("HOC" . SPARSER::PROTEIN) ("OSE" . SPARSER::PROTEIN)
    ("RAS or Aurora-A" . SPARSER::COLLECTION)
    ("Aurora-A and RAS" . SPARSER::COLLECTION)
    ("Aurora-A or RAS" . SPARSER::COLLECTION)
    ("BRCA2 and Aurora-A" . SPARSER::COLLECTION)
    ("RAS/RAF" . SPARSER::COLLECTION) ("Aurora-A ( AURKA )" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN) ("Aurora-A and BRCA2" . SPARSER::COLLECTION)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("USP11" . SPARSER::PROTEIN) ("Aurora-B" . SPARSER::PROTEIN)
    ("To-Pro-3" . SPARSER::MOLECULE)
    ("insulin-like growth factor binding protein 3" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN)
    ("a SRC and an mTOR inhibitor" . SPARSER::COLLECTION)
    ("rapamycin and analogues" . SPARSER::COLLECTION)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG)
    ("EGFR, KRAS, PI3K, LKB1, PTEN, and AKT" . SPARSER::COLLECTION)
    ("SRC inhibitor and EGFR inhibitor" . SPARSER::COLLECTION)
    ("Philadelphia chromosome-positive acute lymphoblastic leukemia"
     . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("PI3K-AKT, MAPK, and JAK-STAT" . SPARSER::COLLECTION)
    ("Torin2 and dasatanib" . SPARSER::COLLECTION)
    ("dasatanib" . SPARSER::DRUG) ("dasatinib or PP242" . SPARSER::COLLECTION)
    ("EGFR, PIK3CA, or AKT" . SPARSER::COLLECTION)
    ("pAKT(S473) and pS6(S235/236)" . SPARSER::COLLECTION)
    ("Dasatinib or Torin2" . SPARSER::COLLECTION)
    ("Dasatanib and Torin2" . SPARSER::COLLECTION)
    ("Dasatanib" . SPARSER::DRUG)
    ("rapamycin or everolimus" . SPARSER::COLLECTION)
    ("PP2 or Dasatinib" . SPARSER::COLLECTION)
    ("PP2, Dasatinib, and Torin1" . SPARSER::COLLECTION)
    ("Lapatinib or Gefitinib" . SPARSER::COLLECTION)
    ("pSRC, pAKT, and pERK" . SPARSER::COLLECTION) ("pSRC" . SPARSER::PROTEIN)
    ("kinases, and dasatinib" . SPARSER::COLLECTION)
    ("multi-BCR/ABL" . SPARSER::COLLECTION)
    ("LCK, and LYN" . SPARSER::COLLECTION) ("LCK" . SPARSER::PROTEIN)
    ("HCK, ABL1, and SYK" . SPARSER::COLLECTION)
    ("Notch1, SRC, PTK6, and YES1" . SPARSER::COLLECTION)
    ("SYK" . SPARSER::PROTEIN) ("Notch1 and SRC" . SPARSER::COLLECTION)
    ("SRC and YES1" . SPARSER::COLLECTION)
    ("EGFR and downstream kinases" . SPARSER::COLLECTION)
    ("PP242 and Torin1" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("the proximate kinase" . SPARSER::KINASE)
    ("LY294002 and Wortmannin" . SPARSER::COLLECTION)
    ("only two AKT isoforms" . SPARSER::ISOFORM)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("PI3K and mTORC2" . SPARSER::COLLECTION)
    ("KRAS, EGFR, PIK3CA, PTEN and LKB1" . SPARSER::COLLECTION)
    ("S6kinase and Grb10" . SPARSER::COLLECTION)
    ("ribosome and protein" . SPARSER::COLLECTION)
    ("S6 kinases and eIF4E" . SPARSER::COLLECTION)
    ("proteins, eNOS, BAD and IKKα" . SPARSER::COLLECTION)
    ("AKT and PDK1" . SPARSER::COLLECTION)
    ("a regulatory p85 subunit and a catalytic p110 subunit"
     . SPARSER::COLLECTION)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("TP53, CDKN2A, PTEN, NF1, and LKB1" . SPARSER::COLLECTION)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("several pathologic subtypes" . SPARSER::PROTEIN)
    ("SRC and mTOR" . SPARSER::COLLECTION)
    ("PP2 and dasatinib" . SPARSER::COLLECTION)
    ("EGFR or PIK3CA" . SPARSER::COLLECTION) ("FKBP12" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("Notch 3" . SPARSER::PROTEIN)
    ("PI3K -AKT" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("PTK6" . SPARSER::PROTEIN) ("YES1" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("Torin2" . SPARSER::DRUG) ("Hes1" . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE) ("Torin1" . SPARSER::DRUG)
    ("Grb10" . SPARSER::PROTEIN) ("S6kinase" . SPARSER::PROTEIN-FAMILY)
    ("4EBPs" . SPARSER::PROTEIN) ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("FA/BRCA" . SPARSER::COLLECTION) ("normal SCE" . SPARSER::PROTEIN)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("spontaneous HR" . SPARSER::PROTEIN)
    ("double-strand break-induced HR" . SPARSER::PROTEIN)
    ("exogenous DNA" . SPARSER::DNA) ("ICL" . SPARSER::PROTEIN)
    ("RAD51 and SCE" . SPARSER::COLLECTION)
    ("normal S-phase-associated SCE" . SPARSER::PROTEIN)
    ("controlling spontaneous HR and SCE" . SPARSER::COLLECTION)
    ("SCE and RAD51" . SPARSER::COLLECTION) ("Mel" . SPARSER::PROTEIN)
    ("bisulphite" . SPARSER::MOLECULE) ("STCs" . SPARSER::PROTEIN)
    ("SOM" . SPARSER::PROTEIN) ("spontaneously forms foci" . SPARSER::PROTEIN)
    ("ICLs" . SPARSER::PROTEIN) ("FA" . SPARSER::PROTEIN)
    ("HR and SCE" . SPARSER::COLLECTION) ("spontaneous SCE" . SPARSER::PROTEIN)
    ("FANCD2-complemented" . SPARSER::COLLECTION)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY) ("Set 3" . SPARSER::PROTEIN)
    ("Set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Set 1" . SPARSER::PROTEIN)
    ("p25" . SPARSER::PROTEIN) ("bD2" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("Rad51C" . SPARSER::PROTEIN) ("Rad51D" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN)
    ("p21, and cyclin D1 and cdk4" . SPARSER::COLLECTION)
    ("cyclin D1 and cdk4" . SPARSER::COLLECTION)
    ("actinin-4 and myosin V" . SPARSER::COLLECTION)
    ("PDGFR, EGFR, CDKN2C, PTEN, MET, CDKN2A, CDK6, CDK4, MDM2, MDM4 and PTPRD"
     . SPARSER::COLLECTION)
    ("the wild type p21 and the non-cyclin-cdk binding mutant"
     . SPARSER::COLLECTION)
    ("cyclin-cdk" . SPARSER::COLLECTION) ("cyclin-cdks" . SPARSER::COLLECTION)
    ("cyclin D-cdk4" . SPARSER::COLLECTION) ("cdks" . SPARSER::PROTEIN)
    ("Cyclin-cdk" . SPARSER::COLLECTION)
    ("the wild type protein and the mutants" . SPARSER::COLLECTION)
    ("TRIM3 and the fraction" . SPARSER::COLLECTION)
    ("any reliable immunohistochemical reagents" . SPARSER::MOLECULE)
    ("TRIMs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RBCC" . SPARSER::PROTEIN)
    ("TRIM3 and p21" . SPARSER::COLLECTION) ("strong Id1" . SPARSER::PROTEIN)
    ("RCAS" . SPARSER::PROTEIN)
    ("PDGF-HA and the scrambled shRNA" . SPARSER::COLLECTION)
    ("PDGF-HA and the shRNA" . SPARSER::COLLECTION)
    ("shRNA and RCAS-PDGF-HA" . SPARSER::COLLECTION)
    ("RCAS-TRIM3" . SPARSER::COLLECTION)
    ("a lentiviral shRNA" . SPARSER::PROTEIN)
    ("ABP/filamin" . SPARSER::COLLECTION) ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("ABP" . SPARSER::PROTEIN) ("TvA" . SPARSER::MOLECULE)
    ("nestin" . SPARSER::PROTEIN)
    ("Brat, TRIM32 and mei-P26" . SPARSER::COLLECTION)
    ("numb and prospero" . SPARSER::COLLECTION) ("numb" . SPARSER::PROTEIN)
    ("mei" . SPARSER::MOLECULE)
    ("three other mammalian paralogs (TRIM2, TRIM32 and TRIM71) and orthologs"
     . SPARSER::COLLECTION)
    ("TRIM2, TRIM32 and TRIM71" . SPARSER::COLLECTION)
    ("Mei" . SPARSER::MOLECULE) ("Brat" . SPARSER::PROTEIN)
    ("BROMO" . SPARSER::MOLECULE) ("SPRY" . SPARSER::PROTEIN)
    ("cyclin D1-cdk4" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BCH-1" . SPARSER::PROTEIN)
    ("DF-1" . SPARSER::PROTEIN) ("myosin V" . SPARSER::PROTEIN)
    ("actinin-4" . SPARSER::PROTEIN) ("CDKN2C" . SPARSER::PROTEIN)
    ("B-box" . SPARSER::PROTEIN) ("olig2" . SPARSER::PROTEIN)
    ("Ago1" . SPARSER::PROTEIN) ("Ncl-1" . SPARSER::PROTEIN)
    ("P26" . SPARSER::PROTEIN) ("TRIM71" . SPARSER::PROTEIN)
    ("TRIM32" . SPARSER::PROTEIN) ("TRIM2" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("TRIM3" . SPARSER::PROTEIN) ("anti-viral" . SPARSER::DRUG)
    ("Bmi-1 and RNF2" . SPARSER::COLLECTION)
    ("RNF2, p53 and MDM2" . SPARSER::COLLECTION)
    ("DNA or histone modification" . SPARSER::COLLECTION)
    ("p53 and MDM2 protein" . SPARSER::COLLECTION)
    ("protein and MDM2" . SPARSER::COLLECTION)
    ("RNF2/p53/MDM2" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("RNF2 and p53" . SPARSER::COLLECTION)
    ("CDKN1A and GDF15" . SPARSER::COLLECTION)
    ("p21 and GDF15" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION) ("Cdkn2a" . SPARSER::PROTEIN)
    ("Rnf2" . SPARSER::PROTEIN) ("very few PRC1" . SPARSER::PROTEIN)
    ("p57, p27, RUNX3, E-cadherin and FBXO32" . SPARSER::COLLECTION)
    ("the PRC2 member Ezh2 and the PRC1 member Bmi1" . SPARSER::COLLECTION)
    ("key developmental regulators" . SPARSER::REGULATOR)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("the Ezh2-catalyzed histone" . SPARSER::PROTEIN)
    ("PRC1 and PCR2" . SPARSER::COLLECTION)
    ("BMI-1/Bmi-1" . SPARSER::COLLECTION)
    ("RING2/Ring1B" . SPARSER::COLLECTION)
    ("RING1/Ring1A" . SPARSER::COLLECTION)
    ("Suz12 and Eed" . SPARSER::COLLECTION) ("Ezh2/Kmt6" . SPARSER::COLLECTION)
    ("Eed" . SPARSER::PROTEIN) ("homeotic (Hox) genes" . SPARSER::GENE)
    ("Hox" . SPARSER::PROTEIN) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("Polycomb" . SPARSER::PROTEIN) ("Ring1B/Ring2" . SPARSER::COLLECTION)
    ("pRK5" . SPARSER::PROTEIN) ("EF2" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("MDM2 protein" . SPARSER::PROTEIN)
    ("bmi-1" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("FBXO32" . SPARSER::PROTEIN) ("RUNX3" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("RING2" . SPARSER::PROTEIN) ("Ring1A" . SPARSER::PROTEIN)
    ("RING1" . SPARSER::PROTEIN) ("H3K27Me3" . SPARSER::PROTEIN)
    ("Kmt6" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("Ring2" . SPARSER::PROTEIN) ("Ring1B" . SPARSER::PROTEIN)
    ("RNF2" . SPARSER::PROTEIN) ("Abl or Bcr-Abl" . SPARSER::COLLECTION)
    ("calpain" . SPARSER::PROTEIN)
    ("the full-length or the truncated form" . SPARSER::COLLECTION)
    ("the tubulin-associated protein Rack1" . SPARSER::PROTEIN)
    ("Rack1" . SPARSER::PROTEIN) ("tubulins" . SPARSER::PROTEIN)
    ("Myc-Nick" . SPARSER::COLLECTION) ("Calpain" . SPARSER::PROTEIN)
    ("Nick" . SPARSER::PROTEIN) ("bHLH-LZ" . SPARSER::COLLECTION)
    ("an essential effector" . SPARSER::EFFECTOR)
    ("Estrogen Receptor (ER)" . SPARSER::PROTEIN)
    ("which binds Pin1" . SPARSER::PROTEIN)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("Myc-PP2A" . SPARSER::COLLECTION)
    ("ERK, JNK or p38" . SPARSER::COLLECTION)
    ("Myc and pY74" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("driving oncogene" . SPARSER::ONCOGENE)
    ("ER or PR, p53 or HER2" . SPARSER::COLLECTION)
    ("PR, p53 or HER2" . SPARSER::COLLECTION)
    ("phospho-Abl, Myc-pY74 and total Myc" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcr-Abl (WT or a kinasedefective mutant: KD) and Myc (WT or Y74F; the 5YF mutant was not efficiently expressed in this assay and was not studied further)"
     . SPARSER::COLLECTION)
    ("Myc and Bcr-Abl" . SPARSER::COLLECTION)
    ("Bcr-Abl/Myc" . SPARSER::COLLECTION) ("Myc and Abl" . SPARSER::COLLECTION)
    ("GFP-Abl" . SPARSER::COLLECTION)
    ("a different cross-reacting protein" . SPARSER::PROTEIN)
    ("Abl and simultaneously knocked down Myc" . SPARSER::COLLECTION)
    ("GST-Myc" . SPARSER::COLLECTION) ("Abl and ATP" . SPARSER::COLLECTION)
    ("a secondary kinase" . SPARSER::KINASE) ("antiserum" . SPARSER::PROTEIN)
    ("Phenylalanine" . SPARSER::AMINO-ACID) ("Tyrosines" . SPARSER::AMINO-ACID)
    ("only full-length Myc" . SPARSER::PROTEIN)
    ("the major phospho-tyrosines" . SPARSER::MOLECULE)
    ("YF" . SPARSER::MOLECULE) ("generic phospho-tyrosine" . SPARSER::MOLECULE)
    ("Pin1 and Myc" . SPARSER::COLLECTION) ("GST-Pin1" . SPARSER::COLLECTION)
    ("Alanine" . SPARSER::AMINO-ACID) ("Abl or Pin1" . SPARSER::COLLECTION)
    ("Flag-Myc" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("Abl and Pin1" . SPARSER::COLLECTION)
    ("Myc, Pin1, p300 or Abl" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("Ncl-Luc" . SPARSER::COLLECTION) ("Ncl" . SPARSER::PROTEIN)
    ("Pin1, p300 and Abl" . SPARSER::COLLECTION)
    ("Pin1 and Abl" . SPARSER::COLLECTION)
    ("Serine and Threonine" . SPARSER::COLLECTION)
    ("p38-MAP Kinase" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION)
    ("p53, p73, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("Serine or Threonine" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("the cellular Myc protein" . SPARSER::PROTEIN)
    ("Myc-pY74" . SPARSER::COLLECTION) ("Pin1 and p300" . SPARSER::COLLECTION)
    ("The Tyrosine kinase c-Abl (or Abl) and the prolyl-isomerase Pin1"
     . SPARSER::COLLECTION)
    ("prolyl" . SPARSER::PROTEIN) ("Abl" . SPARSER::PROTEIN)
    ("tetrazolium violet" . SPARSER::MOLECULE) ("MnCl 2" . SPARSER::DRUG)
    ("p-Y" . SPARSER::PROTEIN) ("p-S" . SPARSER::PROTEIN)
    ("K-19" . SPARSER::PROTEIN) ("Myc 1" . SPARSER::PROTEIN)
    ("pCDNA3" . SPARSER::PROTEIN) ("Myc/Max" . SPARSER::PROTEIN)
    ("SRC-3" . SPARSER::PROTEIN) ("Promyelocytic leukemia" . SPARSER::PROTEIN)
    ("phospho-Tyrosine" . SPARSER::MOLECULE) ("c- myc" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("Phospho-Tyrosine" . SPARSER::MOLECULE)
    ("phospho-tyrosines" . SPARSER::MOLECULE) ("STI571" . SPARSER::DRUG)
    ("P63" . SPARSER::PROTEIN) ("P59" . SPARSER::PROTEIN)
    ("a chain" . SPARSER::PROTEIN)
    ("histone acetyl-transferase" . SPARSER::PROTEIN)
    ("Myc protein" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("acetyl-transferase" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY) ("robust DNA" . SPARSER::DNA)
    ("survivin and PLK1" . SPARSER::COLLECTION)
    ("FoxM1 and 14-3-3ζ" . SPARSER::COLLECTION)
    ("MCF10A-FoxM1 and T47D-14-3-3ζ" . SPARSER::COLLECTION)
    ("ErbB2 and 14-3-3ζ" . SPARSER::COLLECTION)
    ("FoxM1 and its transcriptional targets" . SPARSER::COLLECTION)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB2, 14-3-3ζ and FoxM1" . SPARSER::COLLECTION)
    ("FoxM1 and its transcriptional target MMP2" . SPARSER::COLLECTION)
    ("FoxM1 and its target MMP2" . SPARSER::COLLECTION)
    ("ErbB2 and IR" . SPARSER::COLLECTION)
    ("ErbB2-negative breast cancer cells MCF7" . SPARSER::PROTEIN)
    ("ErbB2 and FoxM1" . SPARSER::COLLECTION)
    ("pathological matrix" . SPARSER::PROTEIN-FAMILY)
    ("a zinc-dependent endopeptidase" . SPARSER::PROTEIN)
    ("Survivin, PLK1 and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("ErbB2 and c-Src" . SPARSER::COLLECTION)
    ("AG1478 or PP2" . SPARSER::COLLECTION)
    ("Lapatinib and Dasatinib" . SPARSER::COLLECTION)
    ("hydrogen peroxide and the radiomimetic drug neocarzinostatin"
     . SPARSER::COLLECTION)
    ("the radiomimetic drug neocarzinostatin" . SPARSER::PROTEIN)
    ("both NAC ( xref ) and Trolox ( xref )" . SPARSER::COLLECTION)
    ("Trolox" . SPARSER::MOLECULE)
    ("ErbB2, FoxM1 and 14-3-3ζ" . SPARSER::COLLECTION)
    ("ErbB2, Src, Akt or FoxM1" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND) ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("rays" . SPARSER::PROTEIN) ("PP1A" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("FoxM1" . SPARSER::PROTEIN) ("EGFR or STAT3" . SPARSER::COLLECTION)
    ("shRNA or the non-specific inhibitor curcumin" . SPARSER::COLLECTION)
    ("Egfr" . SPARSER::PROTEIN) ("Nf1 and EGFR" . SPARSER::COLLECTION)
    ("aggressive GEM-PNST" . SPARSER::COLLECTION)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("total JAK2 (tJAK2) and pSTAT3" . SPARSER::COLLECTION)
    ("EGFR/JAK2/STAT3" . SPARSER::COLLECTION) ("non-target" . SPARSER::PROTEIN)
    ("sh-non-target" . SPARSER::PROTEIN-PAIR)
    ("target JAK as well as STAT" . SPARSER::COLLECTION)
    ("pAKT or pERK" . SPARSER::COLLECTION) ("MECA" . SPARSER::PROTEIN-FAMILY)
    ("HPF" . SPARSER::PROTEIN) ("JAK1 or JAK2" . SPARSER::COLLECTION)
    ("The JAK1/AK2 inhibitor AZD1480 ( xref ) and JAK 1" . SPARSER::COLLECTION)
    ("JAK1/AK2" . SPARSER::COLLECTION)
    ("STAT3 or the Stat kinases JAK 1" . SPARSER::COLLECTION)
    ("JAK and JAK2/STAT3 inhibitors" . SPARSER::COLLECTION)
    ("GEM-grade III PNSTs" . SPARSER::PROTEIN)
    ("GEM-grade III PNST" . SPARSER::PROTEIN)
    ("CNP-hEGFR" . SPARSER::COLLECTION) ("hEGFR" . SPARSER::PROTEIN)
    ("CNP" . SPARSER::PROTEIN) ("GEM-PNSTs" . SPARSER::COLLECTION)
    ("PNSTs" . SPARSER::PROTEIN) ("PNST" . SPARSER::PROTEIN)
    ("cucurbitacin" . SPARSER::MOLECULE)
    ("EGFR-src-STAT3" . SPARSER::COLLECTION) ("DNA-promoter" . SPARSER::DNA)
    ("a latent transcription factor" . SPARSER::PROTEIN)
    ("Nf1 and p53" . SPARSER::COLLECTION)
    ("a 170 kDa transmembrane tyrosine kinase" . SPARSER::PROTEIN)
    ("EGFR or erbB1" . SPARSER::COLLECTION)
    ("Hyperactive Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-STAT3" . SPARSER::COLLECTION) ("GEM-PNST" . SPARSER::COLLECTION)
    ("GEM" . SPARSER::PROTEIN) ("l -phenylalanine" . SPARSER::MOLECULE)
    ("OSI-774" . SPARSER::DRUG) ("AZD1480" . SPARSER::DRUG)
    ("AK2" . SPARSER::PROTEIN) ("JAK 1" . SPARSER::PROTEIN)
    ("S100β" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("erbB1" . SPARSER::PROTEIN) ("FLLL32" . SPARSER::DRUG)
    ("dasatinib or saracatinib" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTor" . SPARSER::COLLECTION) ("mTor" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG) ("HGF/MET" . SPARSER::COLLECTION)
    ("IRS-4/CRKII/CRKL" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("src" . SPARSER::PROTEIN) ("saracatinib" . SPARSER::DRUG)
    ("Dasatinib" . SPARSER::DRUG)
    ("their respective antibodies" . SPARSER::ANTIBODY)
    ("FYN or SRC" . SPARSER::COLLECTION)
    ("antiphosphotyrosine western blot" . SPARSER::PROTEIN)
    ("HCK" . SPARSER::PROTEIN) ("LYN" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN) ("PI3K/AKTt/mTOR" . SPARSER::COLLECTION)
    ("the doxycycline-treated shCRKL-induced group" . SPARSER::MOLECULE)
    ("Doxycycline" . SPARSER::DRUG) ("shRNA or CRKL" . SPARSER::COLLECTION)
    ("a control shRNA (panels 1 and 3) or a 3" . SPARSER::COLLECTION)
    ("recombinant exogenous CRKL" . SPARSER::PROTEIN)
    ("an exogenous recombinant CRKL" . SPARSER::PROTEIN)
    ("exogenous wild-type CRKL" . SPARSER::PROTEIN)
    ("exogenous CRKL" . SPARSER::PROTEIN) ("CNAs" . SPARSER::PROTEIN)
    ("normal skeletal muscle" . SPARSER::PROTEIN)
    ("CRKL and pCRKL" . SPARSER::COLLECTION)
    ("both alveolar and embryonal subtypes" . SPARSER::PROTEIN)
    ("two major histological subtypes" . SPARSER::PROTEIN)
    ("PI3KAKT/mTOR" . SPARSER::COLLECTION) ("CRK" . SPARSER::PROTEIN)
    ("CRKL" . SPARSER::PROTEIN) ("P-Y" . SPARSER::PROTEIN)
    ("AZD 0530" . SPARSER::DRUG) ("EA6" . SPARSER::PROTEIN)
    ("PAX-3" . SPARSER::PROTEIN) ("GAB-1" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("IRS-4" . SPARSER::PROTEIN)
    ("BCR–ABL" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("FOXO1A" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("which binds HER/IGF-1R" . SPARSER::COLLECTION)
    ("TGF-β and/or MMPs" . SPARSER::COLLECTION)
    ("enhanced pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines and TGF-β" . SPARSER::COLLECTION)
    ("cytokines and TGF-β" . SPARSER::COLLECTION) ("Fong" . SPARSER::PROTEIN)
    ("ADAM" . SPARSER::PROTEIN)
    ("platelets and a variety" . SPARSER::COLLECTION)
    ("mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("mTOR/p70 S6-kinase/4EBP1" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt/p70S6K" . SPARSER::COLLECTION)
    ("the PI3K inhibitor (LY294002) and MEK inhibitor (PD98059)"
     . SPARSER::COLLECTION)
    ("mTOR and its substrates 4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("HER and IGF-1R" . SPARSER::COLLECTION)
    ("HER1/EGFR" . SPARSER::COLLECTION)
    ("MT1-MMP, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("pro-invasive MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("peritoneal lavage fluid all contained E-cadherin mRNA"
     . SPARSER::PROTEIN)
    ("metastatic foci" . SPARSER::PROTEIN)
    ("Akt, mTOR, 4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("The PI3K inhibitor LY294002 and the MEK inhibitor PD98059"
     . SPARSER::COLLECTION)
    ("ERK1/2, Akt, mTOR, 4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("MEK and PI3K" . SPARSER::COLLECTION)
    ("ERK and Akt/mTOR" . SPARSER::COLLECTION)
    ("Canertinib, Lapatinib and Gefitinib" . SPARSER::COLLECTION)
    ("HER1, ERK1/2, Akt, p70S6K and PI3K" . SPARSER::COLLECTION)
    ("HER1, ERK1/2, pAkt and p70S6K" . SPARSER::COLLECTION)
    ("HER1 and HER2" . SPARSER::COLLECTION) ("Canertinib" . SPARSER::DRUG)
    ("HER and IGF-1" . SPARSER::COLLECTION)
    ("HER1, HER2 and IGF-1" . SPARSER::COLLECTION)
    ("HER1, HER2 or IGF-1R" . SPARSER::COLLECTION)
    ("mTOR and its downstream effectors 4EBP1 and p70S6K"
     . SPARSER::COLLECTION)
    ("HER1, HER2 and IGF-1Rα" . SPARSER::COLLECTION)
    ("HER1, HER2 and IGF-1R" . SPARSER::COLLECTION)
    ("HER1, HER2 or IGF-1Rα" . SPARSER::COLLECTION)
    ("HER/IGF-1R" . SPARSER::COLLECTION)
    ("collagenases and gelatinases" . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PA" . SPARSER::PROTEIN)
    ("Ilomastat" . SPARSER::DRUG) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("-active" . SPARSER::ACTIVE) ("80kDa" . SPARSER::PROTEIN)
    ("FL-Ecad and sEcad" . SPARSER::COLLECTION)
    ("HER/IGF-1" . SPARSER::COLLECTION)
    ("pro-invasive MMPs" . SPARSER::PROTEIN)
    ("HER1, PI3K, Akt and ERK1/2" . SPARSER::COLLECTION)
    ("HER2-HER3" . SPARSER::COLLECTION) ("HER2 and HER3" . SPARSER::COLLECTION)
    ("IGF-1R and HER1" . SPARSER::COLLECTION)
    ("HER1 and IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1R, MAPK, PI3K and Akt" . SPARSER::COLLECTION)
    ("K5-HER2" . SPARSER::COLLECTION)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("The human epidermal growth factor receptor (HER) and insulin-like growth factor receptor (IGF-1R) families"
     . SPARSER::COLLECTION)
    ("ADAMs" . SPARSER::PROTEIN) ("overt SCCs" . SPARSER::PROTEIN)
    ("cutaneous SCCs" . SPARSER::PROTEIN)
    ("MAPK and PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("HER, PI3K or MEK" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-2 (MMP-2) and MMP-9" . SPARSER::COLLECTION)
    ("kinase (MAPK)" . SPARSER::KINASE)
    ("the human epidermal growth factor receptor (HER) and insulin growth factor-1 receptor (IGF-1R) family"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (HER)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SCCs" . SPARSER::PROTEIN) ("Ecad" . SPARSER::PROTEIN)
    ("a soluble ectodomain fragment" . SPARSER::FRAGMENT)
    ("SKH-1" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("prostaglandin E 2" . SPARSER::MOLECULE) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GM6001" . SPARSER::DRUG)
    ("E-cad" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("around NOV promoter" . SPARSER::PROMOTER)
    ("AR and/or EZH2" . SPARSER::COLLECTION) ("dys" . SPARSER::PROTEIN)
    ("a previously characterized EZH2 target gene" . SPARSER::GENE)
    ("EZH2 and AR" . SPARSER::COLLECTION)
    ("histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) and methylation inhibitor 5-azacytidine"
     . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid (SAHA) and methylation inhibitor 5-azacytidine"
     . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid (SAHA)" . SPARSER::DRUG)
    ("azacytidine" . SPARSER::DRUG)
    ("the repressive chromatin" . SPARSER::PROTEIN)
    ("repressive H3K27me3" . SPARSER::PROTEIN)
    ("The Bgl II-digested DNA" . SPARSER::DNA) ("Bgl" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("NOV and PSA" . SPARSER::COLLECTION)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION)
    ("reverse transcriptase–" . SPARSER::PROTEIN)
    ("AMIGO2, PKIB, LRRN1, CXCR7 and SERPINI1" . SPARSER::COLLECTION)
    ("PKIB" . SPARSER::PROTEIN) ("UGT2B17 and MET" . SPARSER::COLLECTION)
    ("UGT2B17, MET, CCDC83 and NOV" . SPARSER::COLLECTION)
    ("4 unique genes" . SPARSER::GENE) ("enhancers" . SPARSER::PROTEIN)
    ("WISP-2 and CCN6" . SPARSER::COLLECTION) ("CCN" . SPARSER::PROTEIN-FAMILY)
    ("AR and EZH2" . SPARSER::COLLECTION)
    ("repressive chromatin" . SPARSER::PROTEIN) ("polycomb" . SPARSER::PROTEIN)
    ("NOV" . SPARSER::PROTEIN) ("K19" . SPARSER::PROTEIN)
    ("CNR1" . SPARSER::PROTEIN) ("SLIT2" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("polymerase II" . SPARSER::PROTEIN) ("MDV3100" . SPARSER::DRUG)
    ("SERPINI1" . SPARSER::PROTEIN) ("CXCR7" . SPARSER::PROTEIN)
    ("LRRN1" . SPARSER::PROTEIN) ("AMIGO2" . SPARSER::PROTEIN)
    ("UGT2B17" . SPARSER::PROTEIN) ("methyl-transferase" . SPARSER::PROTEIN)
    ("Cx43" . SPARSER::PROTEIN) ("connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gap junction protein" . SPARSER::PROTEIN) ("WISP-3" . SPARSER::PROTEIN)
    ("CCN6" . SPARSER::PROTEIN) ("WISP-2" . SPARSER::PROTEIN)
    ("WISP-1" . SPARSER::PROTEIN) ("CCN4" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("CCN1" . SPARSER::PROTEIN) ("CCN3" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("GM" . SPARSER::PROTEIN)
    ("a more inclusive variety" . SPARSER::VARIETY)
    ("the pathogenetic gene sequence variants" . SPARSER::VARIANT)
    ("valine" . SPARSER::AMINO-ACID)
    ("RAS , RAF , and MEK" . SPARSER::COLLECTION)
    ("Dabrafenib" . SPARSER::DRUG)
    ("LCP BRAFV600R and WM266 BRAFV600D" . SPARSER::COLLECTION)
    ("M257 wild-type BRAF, LCP BRAFV600R and WM266 BRAFV600D"
     . SPARSER::COLLECTION)
    ("LCP" . SPARSER::PROTEIN) ("BRAFV" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("GSK2118436" . SPARSER::DRUG) ("RB1 and UCP1" . SPARSER::COLLECTION)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("the hyperplasic component" . SPARSER::COMPONENT)
    ("adipose pRb" . SPARSER::PROTEIN)
    ("the brown adipocyte–related genes Ucp1 and Prdm16" . SPARSER::COLLECTION)
    ("Ucp1 and Prdm16" . SPARSER::COLLECTION)
    ("brown adipocyte–related genes" . SPARSER::GENE)
    ("Pparγ, Adipoq , and Fasn" . SPARSER::COLLECTION)
    ("Prdm16 and Ucp1" . SPARSER::COLLECTION) ("Ucp1" . SPARSER::PROTEIN)
    ("Fasn" . SPARSER::PROTEIN) ("Adipoq" . SPARSER::PROTEIN)
    ("preadipocytes" . SPARSER::PROTEIN) ("high-fat" . SPARSER::PROTEIN)
    ("PPARγ and GLUT4" . SPARSER::COLLECTION)
    ("IRS1 , FASN , ACC , and LEP" . SPARSER::COLLECTION)
    ("FASN" . SPARSER::PROTEIN) ("LEP" . SPARSER::PROTEIN)
    ("SAT" . SPARSER::PROTEIN)
    ("a peroxisome proliferator–activated receptor (PPAR)γ ligand"
     . SPARSER::MOLECULE)
    ("standard adipogenic inducers" . SPARSER::MOLECULE)
    ("EBP" . SPARSER::PROTEIN) ("pRb" . SPARSER::PROTEIN)
    ("adipogenic genes" . SPARSER::GENE) ("Adipose RB1" . SPARSER::PROTEIN)
    ("PPARγ and IRS1" . SPARSER::COLLECTION) ("HOMA-IR" . SPARSER::COLLECTION)
    ("Rb1" . SPARSER::PROTEIN) ("UCP1" . SPARSER::PROTEIN)
    ("Pparγ" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("Prdm16" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("a pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("apoptin" . SPARSER::PROTEIN)
    ("BAD, MDM2 and FOXO1" . SPARSER::COLLECTION)
    ("which targets HIF1α" . SPARSER::PROTEIN)
    ("extracellular annexin-V" . SPARSER::PROTEIN)
    ("reduced Annexin-V ( xref ) and cleaved-PARP ( xref )"
     . SPARSER::COLLECTION)
    ("H 2 O 2 and LY294002" . SPARSER::COLLECTION)
    ("Bright" . SPARSER::PROTEIN) ("AKT and pVHL" . SPARSER::COLLECTION)
    ("Hydrogen peroxide and super oxide anion (O 2  − )" . SPARSER::COLLECTION)
    ("HIF1α and pVHL" . SPARSER::COLLECTION)
    ("a regulatory HIF1α subunit and the constitutively expressed HIF1β subunit"
     . SPARSER::COLLECTION)
    ("the basic helix-loop-helix (bHLH) and PER-ARNT-SIM (PAS) families"
     . SPARSER::COLLECTION)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("xanthine" . SPARSER::MOLECULE)
    ("receptor tyrosine kinases (RTK) and G-protein coupled receptors (GPCR)"
     . SPARSER::COLLECTION)
    ("receptors (GPCR)" . SPARSER::RECEPTOR) ("pVHL" . SPARSER::PROTEIN)
    ("CXCR4 and AKT" . SPARSER::COLLECTION) ("chk2" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("L19" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("von Hippel–Lindau protein" . SPARSER::PROTEIN)
    ("HIF1β" . SPARSER::PROTEIN) ("hydroxyl radicals" . SPARSER::MOLECULE)
    ("G-protein coupled" . SPARSER::PROTEIN)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the essential mTORC1 binding protein Raptor" . SPARSER::PROTEIN)
    ("resident and recruited macrophages" . SPARSER::PROTEIN)
    ("p38/MK2" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("TSC2/mTOR" . SPARSER::COLLECTION)
    ("these immunomodulatory cytokines" . SPARSER::PROTEIN)
    ("arsenite and anisomycin" . SPARSER::COLLECTION)
    ("cytokines and other inflammatory molecules" . SPARSER::COLLECTION)
    ("Monocytes" . SPARSER::PROTEIN)
    ("IL-12p70 or IL-12p40" . SPARSER::COLLECTION)
    ("p38 and PI3K" . SPARSER::COLLECTION)
    ("anisomycin or UV exposure" . SPARSER::COLLECTION)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("PI3K and p38" . SPARSER::COLLECTION)
    ("human LPS- or anisomycin-activated monocytes ( xref )"
     . SPARSER::COLLECTION)
    ("wortmannin or BIRB796" . SPARSER::COLLECTION)
    ("PI3K and p38α" . SPARSER::COLLECTION)
    ("growth factors or TLR" . SPARSER::COLLECTION)
    ("either wild-type TSC2 or a S1210A TSC2 mutant" . SPARSER::COLLECTION)
    ("Tsc2" . SPARSER::PROTEIN) ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("p38-MK2" . SPARSER::COLLECTION) ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("LPS or anisomycin" . SPARSER::COLLECTION)
    ("a catalytic-dead mutant of MK2 (K79R) or its wild-type control"
     . SPARSER::COLLECTION)
    ("anisomycin, or L" . SPARSER::COLLECTION)
    ("LPS- or SAC-stimulated macrophages ( xref )" . SPARSER::COLLECTION)
    ("LPS-" . SPARSER::PROTEIN) ("LPS or SAC" . SPARSER::COLLECTION)
    ("IL-12 or IL-10" . SPARSER::COLLECTION)
    ("BIRB796 and SB203580" . SPARSER::COLLECTION)
    ("4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("p38 or its downstream kinase MK2" . SPARSER::COLLECTION)
    ("p70S6K and 4EBP1" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("p38 and mTOR" . SPARSER::COLLECTION) ("DCs" . SPARSER::MOLECULE)
    ("p38 or mTOR" . SPARSER::COLLECTION) ("SB203580-" . SPARSER::DRUG)
    ("SB203580 or BIRB796" . SPARSER::COLLECTION)
    ("IL-1β, IL-23, or TNF-α" . SPARSER::COLLECTION)
    ("IL-12p40 and IL-12p70" . SPARSER::COLLECTION)
    ("macrophages (BMDM)" . SPARSER::PROTEIN)
    ("IL-12/IL-10" . SPARSER::COLLECTION)
    ("TLR ligands or environmental stress" . SPARSER::COLLECTION)
    ("p38α and MK2" . SPARSER::COLLECTION) ("TSC2-mTOR" . SPARSER::COLLECTION)
    ("PI3K-TSC2-mTOR" . SPARSER::COLLECTION)
    ("an infectious trigger" . SPARSER::PROTEIN)
    ("TNF-α and IL-12p40" . SPARSER::COLLECTION)
    ("monocytes or macrophages" . SPARSER::COLLECTION)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("wortmannin or mTOR" . SPARSER::COLLECTION)
    ("monocytes, macrophages or myeloid" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("Akt, and mechanistic target of rapamycin" . SPARSER::COLLECTION)
    ("IL-10 and IL-12" . SPARSER::COLLECTION)
    ("proinflammatory IL-12" . SPARSER::PROTEIN)
    ("so far p38 inhibitors" . SPARSER::INHIBITOR)
    ("p38α, p38β, and p38γ" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("MAPK-activated protein kinase" . SPARSER::COLLECTION)
    ("arsenite or anisomycin" . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG) ("arsenite" . SPARSER::DRUG)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38α and PI3K" . SPARSER::COLLECTION)
    ("IL-12 and IL-10" . SPARSER::COLLECTION)
    ("interleukin" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("p40" . SPARSER::PROTEIN) ("costimulatory molecule" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("IkBα" . SPARSER::PROTEIN) ("p-MK2" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE) ("kit 2" . SPARSER::PROTEIN)
    ("Mk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p85β" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("Tuberous sclerosis 2" . SPARSER::PROTEIN) ("BIRB796" . SPARSER::DRUG)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("cyclo-oxygenase 2" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-12" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("other still-unidentified multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("proteins and TOM1" . SPARSER::COLLECTION)
    ("TOM1 or the TOM1-like (TOM1L1 and TOM1L2) complexes"
     . SPARSER::COLLECTION)
    ("TOM1L1 and TOM1L2" . SPARSER::COLLECTION)
    ("Tollip and Endolfin" . SPARSER::COLLECTION) ("Rad23B" . SPARSER::PROTEIN)
    ("generally membrane proteins" . SPARSER::PROTEIN)
    ("Ubl-UbA" . SPARSER::COLLECTION) ("UbA" . SPARSER::PROTEIN)
    ("pure hHR23A" . SPARSER::PROTEIN)
    ("STAM and at least 100-fold greater" . SPARSER::COLLECTION)
    ("proteins or ESCRT0" . SPARSER::COLLECTION)
    ("VHS and DIUM" . SPARSER::COLLECTION)
    ("isolated α-helical UBDs" . SPARSER::PROTEIN)
    ("STAM and a DUIM" . SPARSER::COLLECTION)
    ("an additional α-helical UBD" . SPARSER::PROTEIN)
    ("the α-helical class" . CLASS) ("These α-helical UBDs" . SPARSER::PROTEIN)
    ("OM" . SPARSER::PROTEIN) ("tetra" . SPARSER::MOLECULE)
    ("pure proteasomes" . SPARSER::PROTEIN)
    ("K63 and K48-conjugates" . SPARSER::COLLECTION)
    ("the 26S-associated DUBs, USP14, Uch37, and Rpn11" . SPARSER::COLLECTION)
    ("Rpn10 and Rpn13" . SPARSER::COLLECTION)
    ("DUBs, USP14, Uch37, and Rpn11" . SPARSER::COLLECTION)
    ("the 26S-associated DUBs" . SPARSER::PROTEIN)
    ("proteasomes and MHC" . SPARSER::COLLECTION)
    ("the MHC Class I conformational antibody and a fluorescently tagged transferrin"
     . SPARSER::COLLECTION)
    ("the MHC Class I conformational antibody" . SPARSER::PROTEIN)
    ("immature Class I" . SPARSER::PROTEIN)
    ("mature Class 1" . SPARSER::PROTEIN-FAMILY)
    ("mature Class I" . SPARSER::PROTEIN)
    ("the viral ligase K3" . SPARSER::PROTEIN)
    ("K63 or K48-conjugates" . SPARSER::COLLECTION) ("UBD-" . SPARSER::PROTEIN)
    ("the pure Rad23 and ESCRT0 proteins" . SPARSER::PROTEIN)
    ("Rad23 and ESCRT0" . SPARSER::COLLECTION)
    ("hHR23B and ESCRT0" . SPARSER::COLLECTION)
    ("hHR23A and hHR23B" . SPARSER::COLLECTION) ("GGL" . SPARSER::PROTEIN)
    ("pure recombinant hHR23A or hHR23B" . SPARSER::COLLECTION)
    ("The resin-bound Ub" . SPARSER::PROTEIN)
    ("hHR23A or hHR23B" . SPARSER::COLLECTION)
    ("hHR23B and hHR23A" . SPARSER::COLLECTION)
    ("K63- or K48-conjugates" . SPARSER::COLLECTION)
    ("STAM-VHS" . SPARSER::COLLECTION) ("ps" . SPARSER::PROTEIN)
    ("VHS" . SPARSER::PROTEIN) ("K63 or K48-tetraUb" . SPARSER::COLLECTION)
    ("K63-Sic1" . SPARSER::COLLECTION)
    ("the resin-bound ubiquitinated Nedd4 or E6AP" . SPARSER::COLLECTION)
    ("Nedd4 or E6AP" . SPARSER::COLLECTION)
    ("ATP and either K63- or K48-tetraUb" . SPARSER::COLLECTION)
    ("E6AP or Nedd4" . SPARSER::COLLECTION)
    ("K63- or K48-tetraUb" . SPARSER::COLLECTION)
    ("pure K63-tetramers" . SPARSER::TETRAMER)
    ("resin-bound GST-Hrs" . SPARSER::COLLECTION)
    ("GST-Hrs" . SPARSER::COLLECTION) ("tetramers" . SPARSER::TETRAMER)
    ("The resin-bound polyubiquitinated E6AP and Nedd4" . SPARSER::COLLECTION)
    ("proteins, hHR23A, hHR23B, Hrs and STAM" . SPARSER::COLLECTION)
    ("UBD-proteins" . SPARSER::COLLECTION)
    ("Hrs, STAM and TOM1" . SPARSER::COLLECTION)
    ("USP5 and USP13" . SPARSER::COLLECTION)
    ("FAF1 and UFD1" . SPARSER::COLLECTION) ("p97/VCP" . SPARSER::COLLECTION)
    ("VCP" . SPARSER::PROTEIN)
    ("the other predominant proteins" . SPARSER::PROTEIN)
    ("hHR23A" . SPARSER::PROTEIN) ("TOM1, and Tollip" . SPARSER::COLLECTION)
    ("Tollip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hrs, STAM, Vps37 and Epsin" . SPARSER::COLLECTION)
    ("Epsin" . SPARSER::PROTEIN) ("UBA-Ubl" . SPARSER::COLLECTION)
    ("UBA" . SPARSER::PROTEIN) ("90kDa" . SPARSER::PROTEIN)
    ("UBD" . SPARSER::PROTEIN)
    ("K63- and K48-specific binding proteins" . SPARSER::COLLECTION)
    ("Triton" . SPARSER::MOLECULE)
    ("these cellular proteins and the K63-conjugates" . SPARSER::COLLECTION)
    ("the K63-associated proteins" . SPARSER::PROTEIN)
    ("multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("K63-Ub" . SPARSER::COLLECTION)
    ("the fresh resin-bound ubiquitinated Nedd4" . SPARSER::PROTEIN)
    ("the resin-bound ubiquitinated Nedd4" . SPARSER::PROTEIN)
    ("Sic1 and Nedd4" . SPARSER::COLLECTION)
    ("the pure proteasomes" . SPARSER::PROTEIN)
    ("Sic1-Ub" . SPARSER::COLLECTION) ("Nedd4 and E6AP" . SPARSER::COLLECTION)
    ("the resin-bound substrates and lysate" . SPARSER::COLLECTION)
    ("cysteine and metallo-proteinases" . SPARSER::COLLECTION)
    ("the resin-bound substrates" . SPARSER::SUBSTRATE)
    ("metallo-proteinases" . SPARSER::COLLECTION)
    ("oPT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phenanthroline" . SPARSER::MOLECULE)
    ("E6AP and Nedd4" . SPARSER::COLLECTION)
    ("resin-bound Nedd4" . SPARSER::PROTEIN)
    ("shorter K63- or K48-chains" . SPARSER::COLLECTION)
    ("K63- or K48-chains" . SPARSER::COLLECTION)
    ("proteasomes and Ub-chains" . SPARSER::COLLECTION)
    ("Nedd4-K63" . SPARSER::COLLECTION)
    ("The washed resin-bound ubiquitinated proteins" . SPARSER::PROTEIN)
    ("Nedd4 homogenous K63-polyUb" . SPARSER::COLLECTION)
    ("homogenous K48-polyUb" . SPARSER::PROTEIN)
    ("ligases, E6AP or Nedd4" . SPARSER::COLLECTION)
    ("E1, E2, Ub and ATP" . SPARSER::COLLECTION)
    ("resin-bound K63- and K48-polyubiquitinated proteins"
     . SPARSER::COLLECTION)
    ("resin-bound K63-" . SPARSER::PROTEIN) ("K63-" . SPARSER::PROTEIN)
    ("K63-polyUb" . SPARSER::COLLECTION)
    ("these chain-specific UBPs" . SPARSER::PROTEIN)
    ("UBPs" . SPARSER::PROTEIN)
    ("the 26S-associated deubiquitinating enzymes" . SPARSER::ENZYME)
    ("Usp14, Uch37 or Rpn11" . SPARSER::COLLECTION)
    ("Uch37" . SPARSER::PROTEIN) ("Usp14" . SPARSER::PROTEIN)
    ("ubiquitinated proteins Rpn10 (S5a) and Rpn13 ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("K63-polyubiquitinated" . SPARSER::COLLECTION)
    ("the proximal Ub" . SPARSER::PROTEIN)
    ("at least seven different types" . TYPE)
    ("E1, E2 and E3" . SPARSER::COLLECTION) ("polyUb" . SPARSER::PROTEIN)
    ("hHR23B" . SPARSER::PROTEIN) ("STAM and Hrs" . SPARSER::COLLECTION)
    ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STAM" . SPARSER::PROTEIN)
    ("K63-ubiquitin" . SPARSER::COLLECTION) ("UbcH5" . SPARSER::PROTEIN)
    ("STAM1" . SPARSER::PROTEIN) ("TOM1L1" . SPARSER::PROTEIN)
    ("USP14" . SPARSER::PROTEIN) ("β2m" . SPARSER::PROTEIN)
    ("β2microglobulin" . SPARSER::PROTEIN)
    ("Class 1" . SPARSER::PROTEIN-FAMILY) ("TSG101" . SPARSER::PROTEIN)
    ("K3" . SPARSER::PROTEIN) ("peptidase activity" . SPARSER::PROTEIN)
    ("HHR23A" . SPARSER::PROTEIN) ("HHR23B" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("USP13" . SPARSER::PROTEIN)
    ("Ataxin 3" . SPARSER::PROTEIN) ("USP25" . SPARSER::PROTEIN)
    ("HUWE1" . SPARSER::PROTEIN) ("p97" . SPARSER::PROTEIN)
    ("UFD1" . SPARSER::PROTEIN) ("FAF1" . SPARSER::PROTEIN)
    ("TOM1L2" . SPARSER::PROTEIN) ("TOM1" . SPARSER::PROTEIN)
    ("Vps37" . SPARSER::PROTEIN-FAMILY) ("Sic1" . SPARSER::PROTEIN)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("Nedd4" . SPARSER::PROTEIN)
    ("E6AP" . SPARSER::PROTEIN) ("Rpn11" . SPARSER::PROTEIN)
    ("Rpn13" . SPARSER::PROTEIN) ("Rpn10" . SPARSER::PROTEIN)
    ("K29" . SPARSER::PROTEIN) ("K11" . SPARSER::PROTEIN)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("EGFR and IGF-IR" . SPARSER::COLLECTION)
    ("EGFR or IGF1R" . SPARSER::COLLECTION)
    ("EGF and IGF" . SPARSER::COLLECTION) ("this histological type" . TYPE)
    ("IGF1R or IGF1R" . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("Figitumumab" . SPARSER::DRUG) ("fIGF-1" . SPARSER::COLLECTION)
    ("fIGF" . SPARSER::PROTEIN)
    ("the IGFIR and other molecules" . SPARSER::COLLECTION)
    ("IGFIR" . SPARSER::PROTEIN) ("the experimental arm" . SPARSER::PROTEIN)
    ("figitumumab" . SPARSER::DRUG)
    ("mAbs and tyrosine kinase" . SPARSER::COLLECTION)
    ("the most relevant biomarkers" . SPARSER::MOLECULE)
    ("IGF1R and EGFR, and group III" . SPARSER::COLLECTION)
    ("EGFR, and group III" . SPARSER::COLLECTION)
    ("FISH and protein" . SPARSER::COLLECTION)
    ("IGF1R (HR 1.18; 95 % CI 0.68–2.03, p = 0.53, and HR 1.42; 95 % CI 0.87–2.33, p = 0.15, respectively) or EGFR (HR 1.61; 95 % CI 0.93–2.77, p = 0.08, and HR 1.39; 95 % CI 0.85–2.27, p = 0.15, respectively)"
     . SPARSER::COLLECTION)
    ("IGF1R (HR 1.48; 95% CI 0.77–2.84, p = 0.10, and HR 1.55; 95 % CI 0.93–2.59, p = 0.08, respectively) or EGFR (HR 1.48; 95 % CI 0.77–2.84, p = 0.23, and HR 0.98; 95 % CI 0.56–1.71, p = 0.95, respectively)"
     . SPARSER::COLLECTION)
    ("The histological types" . TYPE)
    ("protein and gene" . SPARSER::COLLECTION)
    ("EGFR and IGF1R" . SPARSER::COLLECTION)
    ("Currently several IGF1R inhibitors" . SPARSER::INHIBITOR)
    ("antibodies and tyrosine kinase" . SPARSER::COLLECTION)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("/AKT/BAD" . SPARSER::COLLECTION)
    ("a transmembrane heterotetrameric protein" . SPARSER::PROTEIN)
    ("IGF1R/EGFR" . SPARSER::COLLECTION) ("CNG" . SPARSER::PROTEIN)
    ("IGF1R and EGFR" . SPARSER::COLLECTION)
    ("IGF1R and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("IGF2R" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("group III" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("Texas red" . SPARSER::DRUG) ("M1" . SPARSER::MOLECULE)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("Insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("EGR1 and EGR2" . SPARSER::COLLECTION) ("RBPJ" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("EGR2" . SPARSER::PROTEIN)
    ("attractive drug" . SPARSER::DRUG)
    ("FGFR1 and NTRK1" . SPARSER::COLLECTION) ("PDGFD" . SPARSER::PROTEIN)
    ("1,222 genes (some peaks mapped to more than 1 gene) and these 1,222 genes"
     . SPARSER::COLLECTION)
    ("a larger variant" . SPARSER::VARIANT)
    ("the respective fusion proteins" . SPARSER::PROTEIN)
    ("six representative NAB2-STAT6 fusion proteins" . SPARSER::PROTEIN)
    ("NCD" . SPARSER::PROTEIN-FAMILY) ("EBD" . SPARSER::PROTEIN)
    ("shorter variants" . SPARSER::VARIANT) ("DNA-level" . SPARSER::DNA)
    ("TP53 , KRAS , BRAF , or PIK3CA" . SPARSER::COLLECTION)
    ("metastatic SFT" . SPARSER::PROTEIN)
    ("a meningeal malignant SFT" . SPARSER::PROTEIN)
    ("actionable therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("EGR" . SPARSER::PROTEIN) ("SFT" . SPARSER::PROTEIN)
    ("Ex1" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("NAB1" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("Chr12" . SPARSER::PROTEIN) ("etc" . SPARSER::PROTEIN)
    ("TGFβ1 , XRCC1 , and BRCA1" . SPARSER::COLLECTION)
    ("AG or GG" . SPARSER::COLLECTION)
    ("the BRCA1-associated genome surveillance complex" . SPARSER::BIO-COMPLEX)
    ("only 4 heterozygotes" . SPARSER::PROTEIN) ("SOMA" . SPARSER::DRUG)
    ("allele and grade" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("the ancestral allele" . SPARSER::ALLELE)
    ("All the patients underwent pre- and post-radiation SPECTs"
     . SPARSER::COLLECTION)
    ("All the patients underwent pre-" . SPARSER::PROTEIN)
    ("usable DNA" . SPARSER::DNA)
    ("adenine, guanine, thymine, and cytosine" . SPARSER::COLLECTION)
    ("Genotypes" . SPARSER::PROTEIN) ("XRCC1 and BRCA1" . SPARSER::COLLECTION)
    ("β 1" . SPARSER::PROTEIN) ("LIG4" . SPARSER::PROTEIN)
    ("IL12RB2" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("MSH3" . SPARSER::PROTEIN) ("XRCC6" . SPARSER::PROTEIN)
    ("XRCC3" . SPARSER::PROTEIN) ("SOD2" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("VA" . SPARSER::MOLECULE)
    ("directly link thep27 Kip1 -838C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("statin" . SPARSER::MOLECULE) ("Allele" . SPARSER::ALLELE)
    ("a prospective cohort" . SPARSER::MOLECULE)
    ("Simvastatin" . SPARSER::DRUG) ("Tsc1" . SPARSER::PROTEIN)
    ("TSC" . SPARSER::PROTEIN) ("cAMP or Ras" . SPARSER::COLLECTION)
    ("distinct neuronal populations differentially" . SPARSER::PROTEIN)
    ("DAT and vesicular monoamine transporter" . SPARSER::COLLECTION)
    ("presynaptic dopamine transporters" . SPARSER::PROTEIN)
    ("dopamine- and cAMP-regulated phosphoprotein-" . SPARSER::COLLECTION)
    ("cAMP-regulated phosphoprotein-" . SPARSER::PROTEIN)
    ("dopamine-" . SPARSER::PROTEIN) ("striatum" . SPARSER::PROTEIN)
    ("transporter (DAT)" . SPARSER::PROTEIN) ("DAT" . SPARSER::PROTEIN)
    ("DA" . SPARSER::MOLECULE) ("Dopamine" . SPARSER::DRUG)
    ("dideoxyadenosine (DDA)" . SPARSER::DRUG) ("DDA" . SPARSER::DRUG)
    ("dideoxyadenosine" . SPARSER::DRUG) ("Forskolin" . SPARSER::PROTEIN)
    ("Rolipram" . SPARSER::DRUG) ("NF1-GAP" . SPARSER::COLLECTION)
    ("BLBP" . SPARSER::PROTEIN) ("-AC" . SPARSER::COLLECTION)
    ("PI3K or the MAPK kinase MEK" . SPARSER::COLLECTION)
    ("HRas" . SPARSER::PROTEIN) ("Ras-MEK/MAPK" . SPARSER::COLLECTION)
    ("-Cre" . SPARSER::COLLECTION) ("Synapsin-I-Cre" . SPARSER::COLLECTION)
    ("GABA" . SPARSER::MOLECULE) ("GFAP" . SPARSER::PROTEIN)
    ("CKO" . SPARSER::PROTEIN) ("Lovastatin" . SPARSER::DRUG)
    ("K-Ras or N-Ras" . SPARSER::COLLECTION)
    ("Ras and MEK" . SPARSER::COLLECTION)
    ("K-Ras and N-Ras" . SPARSER::COLLECTION) ("NRas" . SPARSER::PROTEIN)
    ("KRas" . SPARSER::PROTEIN) ("LTP" . SPARSER::PROTEIN)
    ("the Drosophila and murine Nf1 homologs" . SPARSER::COLLECTION)
    ("MEK/MAPK" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("guanosine triphosphate (GTP)" . SPARSER::MOLECULE)
    ("Exon" . SPARSER::PROTEIN) ("GRD" . SPARSER::PROTEIN)
    ("Neurofibromin" . SPARSER::PROTEIN)
    ("social cues" . SPARSER::PROTEIN-FAMILY) ("iris" . SPARSER::PROTEIN)
    ("Lisch" . SPARSER::PROTEIN) ("Nf1" . SPARSER::PROTEIN)
    ("NG2" . SPARSER::PROTEIN) ("dopamine)" . SPARSER::PROTEIN)
    ("vesicular monoamine transporter" . SPARSER::PROTEIN)
    ("cAMP-regulated phosphoprotein" . SPARSER::PROTEIN)
    ("phosphodiesterase-4" . SPARSER::PROTEIN) ("dNf1" . SPARSER::PROTEIN)
    ("AC1" . SPARSER::PROTEIN) ("spred1" . SPARSER::PROTEIN)
    ("SPRED1" . SPARSER::PROTEIN) ("synapsin-I" . SPARSER::PROTEIN)
    ("Ca 2+/Calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Dlx5" . SPARSER::PROTEIN) ("Distal-less Homeobox 5" . SPARSER::PROTEIN)
    ("Synapsin-I" . SPARSER::PROTEIN)
    ("Glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN) ("p21-Ras" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN) ("Rnf11" . SPARSER::PROTEIN)
    ("A20 and RNF11" . SPARSER::COLLECTION)
    ("TAX1BP1 and ABIN1" . SPARSER::COLLECTION) ("UBDs" . SPARSER::PROTEIN)
    ("molecule or scaffold" . SPARSER::COLLECTION)
    ("the A20 antiviral ubiquitin-editing complex" . SPARSER::BIO-COMPLEX)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("the A20 antiviral complex" . SPARSER::BIO-COMPLEX)
    ("TRAF3 and TBK1" . SPARSER::COLLECTION) ("Optineurin" . SPARSER::PROTEIN)
    ("A20, TAX1BP1, ABIN1 and RNF11" . SPARSER::COLLECTION)
    ("ligases or deubiquitinases" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("innate antiviral inhibitory proteins" . SPARSER::PROTEIN)
    ("TRIM28, TRIM38, ISG56, optineurin, MIP-T3, Triad3a, NLRP4, RAUL, TRIP, NLRC5, DUBA, ITCH, A20, TAX1BP1 and ABIN1"
     . SPARSER::COLLECTION)
    ("Triad3a" . SPARSER::PROTEIN) ("TRIM21/Ro52" . SPARSER::COLLECTION)
    ("ITCH" . SPARSER::PROTEIN) ("DUBA" . SPARSER::PROTEIN)
    ("TRIP" . SPARSER::PROTEIN) ("TAX1BP1, Itch and A20" . SPARSER::COLLECTION)
    ("an antiviral A20 ubiquitin-editing complex" . SPARSER::BIO-COMPLEX)
    ("TRAF3 and TBK1/IKKi" . SPARSER::COLLECTION)
    ("A20 and TAX1BP1" . SPARSER::COLLECTION)
    ("TRAF3 and IKKi" . SPARSER::COLLECTION)
    ("A20, TAX1BP1, ABIN1 and CYLD" . SPARSER::COLLECTION)
    ("TBK1 or IKKi" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("alanine (G2A) and the tyrosine" . SPARSER::COLLECTION)
    ("RNF11-GFP" . SPARSER::COLLECTION)
    ("Itch and Smurf2" . SPARSER::COLLECTION)
    ("Myc-RNF11" . SPARSER::COLLECTION) ("VSV-GFP" . SPARSER::COLLECTION)
    ("A20, TAX1BP1, and ABIN1" . SPARSER::COLLECTION)
    ("A20, TAX1BP1 and ABIN1" . SPARSER::COLLECTION)
    ("an antiviral ubiquitin-editing complex" . SPARSER::BIO-COMPLEX)
    ("A20, TAX1BP1, Itch and ABIN1" . SPARSER::COLLECTION)
    ("RIG-I/MDA5" . SPARSER::COLLECTION)
    ("A20, TAX1BP1, Itch and RNF11" . SPARSER::COLLECTION)
    ("RIP1 and TRAF6" . SPARSER::COLLECTION)
    ("polyubiquitination and TNF" . SPARSER::COLLECTION)
    ("negative regulators of the NF-κB and antiviral signaling pathways"
     . SPARSER::COLLECTION)
    ("A20, TAX1BP1, and Itch" . SPARSER::COLLECTION)
    ("Smad2 and the TGF-β receptor" . SPARSER::COLLECTION)
    ("UbcH5a, b and c" . SPARSER::COLLECTION)
    ("Itch, Smurf1, and Smurf2" . SPARSER::COLLECTION)
    ("Itch" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("response elements (ISREs) and the induction" . SPARSER::COLLECTION)
    ("TBK1 and IKKi" . SPARSER::COLLECTION)
    ("the noncanonical IκB kinases (IKKs) IKKi" . SPARSER::PROTEIN)
    ("VISA, Cardif, or MAVS" . SPARSER::COLLECTION) ("MAVS" . SPARSER::PROTEIN)
    ("Cardif" . SPARSER::PROTEIN) ("VISA" . SPARSER::PROTEIN)
    ("RIG-I and melanoma differentiation-associated gene 5"
     . SPARSER::COLLECTION)
    ("PAMPs" . SPARSER::PROTEIN)
    ("two major classes of PRRs, Toll-like receptors (TLRs) and the retinoic acid-inducible-gene-I (RIG-I)-like helicase receptors (RLRs) xref"
     . SPARSER::COLLECTION)
    ("RLRs" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("IFN-α and IFN-β" . SPARSER::COLLECTION) ("IFN-αβ" . SPARSER::DRUG)
    ("PRRs" . SPARSER::PROTEIN) ("PAMP" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA)
    ("a rapid nonspecific antiviral state" . SPARSER::BIO-STATE)
    ("the noncanonical IKK kinases TBK1/IKKi" . SPARSER::COLLECTION)
    ("TBK1/IKKi" . SPARSER::COLLECTION) ("IKKi" . SPARSER::PROTEIN)
    ("viral RNA and trigger antiviral signaling pathways that upregulate IFN transcription"
     . SPARSER::COLLECTION)
    ("viral RNA" . SPARSER::RNA) ("IFN" . SPARSER::DRUG)
    ("IFNs" . SPARSER::DRUG) ("TG -3" . SPARSER::PROTEIN)
    ("C -3" . SPARSER::PROTEIN) ("–3 µ" . SPARSER::PROTEIN)
    ("Nrdp1" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("NLRC5" . SPARSER::PROTEIN) ("NLRP4" . SPARSER::PROTEIN)
    ("MIP-T3" . SPARSER::PROTEIN) ("ISG56" . SPARSER::PROTEIN)
    ("TRIM38" . SPARSER::PROTEIN) ("TRIM28" . SPARSER::PROTEIN)
    ("Ro52" . SPARSER::PROTEIN) ("TRIM21" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("NLRX1" . SPARSER::PROTEIN)
    ("RNF125" . SPARSER::PROTEIN) ("Tax1bp1" . SPARSER::PROTEIN)
    ("G2A" . SPARSER::PROTEIN) ("ABIN1" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("UbcH5a" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzymes" . SPARSER::PROTEIN-FAMILY)
    ("Smurf2" . SPARSER::PROTEIN) ("Smurf1" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("TANK-binding kinase 1" . SPARSER::PROTEIN) ("IPS-1" . SPARSER::PROTEIN)
    ("TRIM25" . SPARSER::PROTEIN) ("MDA5" . SPARSER::PROTEIN)
    ("melanoma differentiation-associated gene 5" . SPARSER::PROTEIN)
    ("TAX1BP1" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("RNF11" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("Adherent Proteins" . SPARSER::PROTEIN)
    ("E-cadherin, occludin, and F-actin" . SPARSER::COLLECTION)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("Occludin and ZO-1" . SPARSER::COLLECTION) ("Occludin" . SPARSER::PROTEIN)
    ("α-catenin and β-catenin" . SPARSER::COLLECTION)
    ("the adherent complex" . SPARSER::BIO-COMPLEX)
    ("a membrane-associated protein" . SPARSER::PROTEIN)
    ("-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, occludin, and ZO-1" . SPARSER::COLLECTION)
    ("the former protein" . SPARSER::PROTEIN)
    ("the latter protein" . SPARSER::PROTEIN)
    ("two adherent proteins" . SPARSER::PROTEIN)
    ("the adherent complexes" . SPARSER::BIO-COMPLEX)
    ("E-cadherin, occludin, β-catenin, and ZO-1" . SPARSER::COLLECTION)
    ("other Adherent Proteins" . SPARSER::PROTEIN)
    ("E-cadherin or occludin" . SPARSER::COLLECTION)
    ("proteins and F-actin" . SPARSER::COLLECTION)
    ("the MEK inhibitors and the localization" . SPARSER::COLLECTION)
    ("E-cadherin, and occludin" . SPARSER::COLLECTION)
    ("PD98059 and U0126" . SPARSER::COLLECTION)
    ("occludin, E-cadherin, and β-catenin" . SPARSER::COLLECTION)
    ("ErbB3 and ErbB2" . SPARSER::COLLECTION)
    ("E-cadherin and occludin" . SPARSER::COLLECTION)
    ("the adherent proteins" . SPARSER::PROTEIN)
    ("proteins, E-cadherin and occludin" . SPARSER::COLLECTION)
    ("Akt and p38" . SPARSER::COLLECTION)
    ("ErbB3 or ErbB4" . SPARSER::COLLECTION) ("ErbB4" . SPARSER::PROTEIN)
    ("heregulins" . SPARSER::DRUG) ("HRGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRG1, HRG2, HRG3, and HRG4" . SPARSER::COLLECTION)
    ("HGF and EGF" . SPARSER::COLLECTION)
    ("occludin and claudin" . SPARSER::COLLECTION)
    ("β-catenin, p120-catenin, and α-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, occludin, and claudin" . SPARSER::COLLECTION)
    ("claudin" . SPARSER::PROTEIN) ("Nectins" . SPARSER::PROTEIN)
    ("The adherent proteins" . SPARSER::PROTEIN)
    ("adherent proteins" . SPARSER::PROTEIN) ("HRG-β1" . SPARSER::COLLECTION)
    ("HRG" . SPARSER::PROTEIN) ("Heregulin" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("SB202190" . SPARSER::DRUG)
    ("Anti-ErbB2" . SPARSER::DRUG) ("p120 catenin" . SPARSER::PROTEIN)
    ("anti-ErbB2" . SPARSER::DRUG) ("ErbB3" . SPARSER::PROTEIN)
    ("HRG4" . SPARSER::PROTEIN) ("HRG1" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("β1" . SPARSER::PROTEIN)
    ("pro-immune cytokines (such as interleukin-2) or immune checkpoint inhibitors (such as monoclonal antibodies targeting CTLA-4, PD1 or PDL1)"
     . SPARSER::COLLECTION)
    ("pro-immune cytokines" . SPARSER::PROTEIN)
    ("CTLA-4, PD1 or PDL1" . SPARSER::COLLECTION)
    ("antigens and re-establishment" . SPARSER::COLLECTION)
    ("our group and others" . SPARSER::COLLECTION)
    ("ipilimumab" . SPARSER::DRUG) ("available antibodies" . SPARSER::ANTIBODY)
    ("TIM3 and PD1" . SPARSER::COLLECTION) ("perforin" . SPARSER::PROTEIN)
    ("TGF-beta and IL-10" . SPARSER::COLLECTION)
    ("decreased immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("TYRP-2, and GP100" . SPARSER::COLLECTION) ("MART" . SPARSER::PROTEIN)
    ("immune-modulatory cytokines" . SPARSER::PROTEIN) ("MDAs" . SPARSER::DRUG)
    ("BRAF and MEK" . SPARSER::COLLECTION)
    ("TIM-3 and PD1" . SPARSER::COLLECTION)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("immunomodulatory cytokines" . SPARSER::PROTEIN)
    ("CTLA-4" . SPARSER::PROTEIN) ("interleukin-2" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("TGF-beta" . SPARSER::PROTEIN)
    ("GP100" . SPARSER::DRUG) ("TYRP-2" . SPARSER::PROTEIN)
    ("TYRP-1" . SPARSER::PROTEIN) ("Granzyme B" . SPARSER::PROTEIN)
    ("TIM3" . SPARSER::PROTEIN) ("gp100" . SPARSER::DRUG)
    ("HMB-45" . SPARSER::DRUG) ("MART-1" . SPARSER::PROTEIN)
    ("PDL1" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("TIM-3" . SPARSER::PROTEIN) ("SQSTM1/p62" . SPARSER::COLLECTION)
    ("lysosomotropic autophagy inhibitors" . SPARSER::INHIBITOR)
    ("a therapeutic strategy employ chloroquine or its derivative
hydroxychloroquine"
     . SPARSER::COLLECTION)
    ("hydroxychloroquine" . SPARSER::DRUG) ("chloroquine" . SPARSER::PROTEIN)
    ("AMPK and mTOR" . SPARSER::COLLECTION) ("catabolism" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("a
trastuzumab-unresponsive CD44 + CD24 −/low mesenchymal cellular state"
     . SPARSER::BIO-STATE)
    ("erlotinib, gefitinib, and lapatinib" . SPARSER::COLLECTION)
    ("doxorubicin, 5-fluorouracil,
cisplatin, vinorelbine, and paclitaxel"
     . SPARSER::COLLECTION)
    ("undifferentiated
CD44 + CD24 −/low antigenic states"
     . SPARSER::BIO-STATE)
    ("trastuzumab and b" . SPARSER::COLLECTION) ("post-EMT" . SPARSER::PROTEIN)
    ("the undifferentiated CD44 + CD24 −/low antigenic state"
     . SPARSER::BIO-STATE)
    ("DAPK-1 and TGFβ" . SPARSER::COLLECTION) ("DAPK-1-" . SPARSER::PROTEIN)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("the three pro-autophagic genes" . SPARSER::GENE)
    ("DAPK1 , TGFB1 , and ATG12" . SPARSER::COLLECTION)
    ("ATG12 and ATG5" . SPARSER::COLLECTION)
    ("doxorubicin, 5-fluorouracil, cisplatin, vinorelbine, and paclitaxel"
     . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG)
    ("gefitinib, erlotinib, and lapatinib" . SPARSER::COLLECTION)
    ("ATG12-shRNA" . SPARSER::PROTEIN-PAIR)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DAPK1 and ATG12" . SPARSER::COLLECTION)
    ("the essential autophagy gene ATG12" . SPARSER::PROTEIN)
    ("the
multifunctional cytokine TGFβ1"
     . SPARSER::PROTEIN)
    ("Transforming Growth Factor-β1" . SPARSER::PROTEIN-PAIR)
    ("CDKN2A/p16" . SPARSER::COLLECTION) ("alpha- 2" . SPARSER::PROTEIN)
    ("autophagic pathway genes" . SPARSER::GENE)
    ("dual HER1/HER2 ( i.e., lapatinib) inhibitors" . SPARSER::INHIBITOR)
    ("PI3K and PTEN" . SPARSER::COLLECTION)
    ("ATG6/Beclin1" . SPARSER::COLLECTION)
    ("molecular drugs that specifically target one or several members"
     . SPARSER::COLLECTION)
    ("HER1/HER2" . SPARSER::COLLECTION)
    ("trastuzumab, erlotinib, gefitinib, and lapatinib" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG)
    ("trastuzumab and other HER1/2-targeting drugs" . SPARSER::COLLECTION)
    ("autophagic vesicle formation ATG12" . SPARSER::PROTEIN)
    ("the autophagic genes" . SPARSER::GENE) ("GW572016" . SPARSER::DRUG)
    ("1K" . SPARSER::PROTEIN) ("ZD1839" . SPARSER::DRUG)
    ("Tyrosine Kinase" . SPARSER::PROTEIN) ("Spautin-1" . SPARSER::DRUG)
    ("Lys05" . SPARSER::DRUG)
    ("fatty
acid"
     . SPARSER::MOLECULE)
    ("MAP1B" . SPARSER::PROTEIN)
    ("microtubule-associated
protein"
     . SPARSER::PROTEIN)
    ("DAPK-1" . SPARSER::PROTEIN)
    ("death-associated
protein kinase-1"
     . SPARSER::PROTEIN)
    ("ATG4B" . SPARSER::PROTEIN) ("beclin1" . SPARSER::PROTEIN)
    ("homolog
( S. cerevisiae )"
     . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("Death-Associated Protein Kinase 1" . SPARSER::PROTEIN)
    ("DAPK1" . SPARSER::PROTEIN) ("PRKAA2" . SPARSER::PROTEIN)
    ("Ceroid-Lipofuscinosis" . SPARSER::PROTEIN) ("CLN3" . SPARSER::PROTEIN)
    ("membrane
protein"
     . SPARSER::PROTEIN)
    ("member 1" . SPARSER::PROTEIN)
    ("Heat Shock Protein 90" . SPARSER::PROTEIN)
    ("HSP90AA1" . SPARSER::PROTEIN)
    ("BCL2-antagonist/killer 1" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("ATG6" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN)
    ("acetyltransferase and deacetylases" . SPARSER::COLLECTION)
    ("BP" . SPARSER::PROTEIN)
    ("53BP1-associated telomere foci" . SPARSER::PROTEIN)
    ("ATM-" . SPARSER::PROTEIN) ("TRF2-" . SPARSER::PROTEIN)
    ("nontelomeric DNA-damage" . SPARSER::DNA)
    ("TRF2 and K293R proteins" . SPARSER::COLLECTION)
    ("TIF" . SPARSER::PROTEIN) ("the telomeric foci" . SPARSER::PROTEIN)
    ("The resulting telomere dysfunction-induced foci" . SPARSER::PROTEIN)
    ("TRF2 and TIN2" . SPARSER::COLLECTION)
    ("p300 siRNA and control siRNA ()" . SPARSER::COLLECTION)
    ("TIN2, POT1 and RAP1" . SPARSER::COLLECTION)
    ("p300ΔHAT" . SPARSER::PROTEIN) ("p300ΔHAT-HA" . SPARSER::PROTEIN-PAIR)
    ("coenzyme" . SPARSER::MOLECULE) ("GST-TRF2" . SPARSER::COLLECTION)
    ("GST-Myb" . SPARSER::COLLECTION) ("TRF" . SPARSER::PROTEIN)
    ("TRF2-Myc" . SPARSER::COLLECTION)
    ("glycine and arginine" . SPARSER::COLLECTION) ("Myb" . SPARSER::PROTEIN)
    ("anti-TRF1 and anti-Flag" . SPARSER::COLLECTION)
    ("anti-TRF2 and anti-Flag" . SPARSER::COLLECTION)
    ("Flag-TRF1" . SPARSER::COLLECTION) ("TRF2 and p300" . SPARSER::COLLECTION)
    ("p300-HA" . SPARSER::COLLECTION) ("Flag-TRF2" . SPARSER::COLLECTION)
    ("acetyltransferases, p300 and PCAF" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN) ("arginines" . SPARSER::AMINO-ACID)
    ("TRF1 or TRF2" . SPARSER::COLLECTION) ("APB" . SPARSER::PROTEIN)
    ("APBs" . SPARSER::PROTEIN) ("PNUTS and MCPH1" . SPARSER::COLLECTION)
    ("PNUTS" . SPARSER::PROTEIN) ("Apollo" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("Artemis" . SPARSER::PROTEIN)
    ("p53/p21" . SPARSER::COLLECTION)
    ("Mre11/Nbs1/Rad50" . SPARSER::COLLECTION)
    ("TIN2, RAP1 and TPP1" . SPARSER::COLLECTION)
    ("TRF1 and TRF2" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN) ("Siah 1" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("SMC5" . SPARSER::PROTEIN) ("MMS21" . SPARSER::PROTEIN)
    ("Siah1" . SPARSER::PROTEIN) ("DDX39" . SPARSER::PROTEIN)
    ("MCPH1" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("TIN2" . SPARSER::PROTEIN) ("POT1" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("TRF2" . SPARSER::PROTEIN)
    ("Wnt10b/β-catenin/HMGA2" . SPARSER::COLLECTION)
    ("HMGA2 as well as WNT10B" . SPARSER::COLLECTION)
    ("Wnt10b/β-catenin/Hmga2" . SPARSER::COLLECTION)
    ("Hmga2 and HMGA2" . SPARSER::COLLECTION)
    ("HMGA2 and its downstream target CNNA2" . SPARSER::COLLECTION)
    ("WNT10B or another Wnt-ligand (Klemm et al, xref )" . SPARSER::COLLECTION)
    ("sporadic colon cancer" . SPARSER::PROTEIN)
    ("WNT1 or WNT3A" . SPARSER::COLLECTION)
    ("β-catenin, Axin2 , CK5 and CK6" . SPARSER::COLLECTION)
    ("ERα, PR or HER2" . SPARSER::COLLECTION)
    ("its subsequent downstream target CCNA2" . SPARSER::PROTEIN)
    ("CBP, LEF-1 and TCF-4" . SPARSER::COLLECTION)
    ("LEF-1 or TCF-4" . SPARSER::COLLECTION)
    ("LEF-1 and TCF-4" . SPARSER::COLLECTION)
    ("RNA Polymerase II (RNA Pol II) and β-CATENIN" . SPARSER::COLLECTION)
    ("β-catenin and CBP" . SPARSER::COLLECTION)
    ("HMGA2 and CCNA2" . SPARSER::COLLECTION)
    ("HMGA2 and its downstream target CCNA2" . SPARSER::COLLECTION)
    ("HMGA2 and its known downstream target CCNA2" . SPARSER::COLLECTION)
    ("WNT10B , HMGA2 and CCNA2" . SPARSER::COLLECTION)
    ("pcDNA3-WNT10B" . SPARSER::COLLECTION) ("pcDNA3" . SPARSER::PROTEIN)
    ("moderately rescue both CCNA2 (>30% p < 0.05) and CCNB2 (60% p = 0.01)"
     . SPARSER::COLLECTION)
    ("moderately rescue both CCNA2" . SPARSER::PROTEIN)
    ("pcDNA3-GFP and pcDNA3-HMGA2" . SPARSER::COLLECTION)
    ("pcDNA3-HMGA2" . SPARSER::PROTEIN-PAIR)
    ("pcDNA3-GFP" . SPARSER::COLLECTION)
    ("HMGA2 , CCNA2 and CCNB2" . SPARSER::COLLECTION)
    ("Cyclins , HMGA2 , and BIRC5" . SPARSER::COLLECTION)
    ("its downstream targets (CCNA2 and CCNB2) and BIRC5"
     . SPARSER::COLLECTION)
    ("CDK4 and CDK2" . SPARSER::COLLECTION)
    ("Cyclin D1/CDK4" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("HMGA2, Cyclin A2, CDK2, CDK4, E2F1 and PCNA" . SPARSER::COLLECTION)
    ("LEF-1, TCF4 and CBP" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either ICG-001 or Wnt-C59 treatment" . SPARSER::COLLECTION)
    ("-ligand" . SPARSER::LIGAND) ("XBP1 and pS2" . SPARSER::COLLECTION)
    ("c-myc , CCND1 and DKK1" . SPARSER::COLLECTION)
    ("HMGA2 and BMI-1" . SPARSER::COLLECTION)
    ("HMGA2 (>30-fold) and BMI-1 (>5-fold)" . SPARSER::COLLECTION)
    ("HMGA2 and HMGA1" . SPARSER::COLLECTION)
    ("WNT10B , HMGA2 , HMGA1 and BMI-1" . SPARSER::COLLECTION)
    ("MCF7-" . SPARSER::PROTEIN) ("/TN" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HMGA2 and the proliferation marker PCNA ( xref )" . SPARSER::COLLECTION)
    ("β-CATENIN and CBP" . SPARSER::COLLECTION)
    ("-inhibitor" . SPARSER::INHIBITOR) ("Ccna2" . SPARSER::PROTEIN)
    ("Hmga2 or the control GFP ( xref )" . SPARSER::COLLECTION)
    ("β-catenin/CBP" . SPARSER::COLLECTION)
    ("β-catenin/p300" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION) ("gene (GADPH)" . SPARSER::GENE)
    ("NMG" . SPARSER::PROTEIN) ("WRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the Hmga2 proximal promoter" . SPARSER::PROMOTER)
    ("NMG-Wnt10b" . SPARSER::PROTEIN-PAIR)
    ("a previously unrecognized Wnt target gene" . SPARSER::GENE)
    ("response elements (WRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("-Wnt10b" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCNA2 and CCNB2" . SPARSER::COLLECTION) ("Rb/E2F1" . SPARSER::COLLECTION)
    ("Wnt10b/β-catenin" . SPARSER::COLLECTION)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("the self-renewal marker HMGA2" . SPARSER::PROTEIN)
    ("Neither Hmga1 nor Hmga2" . SPARSER::COLLECTION)
    ("Hmga2 and Hmga1" . SPARSER::COLLECTION) ("Hmga1" . SPARSER::PROTEIN)
    ("Hmga2" . SPARSER::PROTEIN) ("Hmga" . SPARSER::PROTEIN-FAMILY)
    ("the basal-epithelial markers CK5 and CK6" . SPARSER::COLLECTION)
    ("CK5 and CK6" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("MMTV-neu2" . SPARSER::COLLECTION)
    ("both luminal and glandular epithelial cells ( xref )"
     . SPARSER::COLLECTION)
    ("ERα and PR" . SPARSER::COLLECTION)
    ("WNT10B and WNT1" . SPARSER::COLLECTION)
    ("both β-CATENIN [ i.e. non-phospho (active) β-catenin (SER33/37/Thr41) vs. a pan-β-catenin-antibody] and AXIN2"
     . SPARSER::COLLECTION)
    ("SER" . SPARSER::AMINO-ACID)
    ("MMTV-Wnt10b-IRES-LacZ" . SPARSER::COLLECTION)
    ("a well-known canonical Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WNT10B and β-CATENIN" . SPARSER::COLLECTION)
    ("Cohort" . SPARSER::MOLECULE) ("Bank" . SPARSER::PROTEIN)
    ("canonical Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HMGA2, and HMGA2" . SPARSER::COLLECTION)
    ("WNT10B and HMGA2" . SPARSER::COLLECTION)
    ("HMGA1a and HMGA1c" . SPARSER::COLLECTION)
    ("HMGA" . SPARSER::PROTEIN-FAMILY)
    ("Wnt10b and MMTV-ΔN-" . SPARSER::COLLECTION)
    ("MMTV-Wnt1" . SPARSER::COLLECTION)
    ("Wnt /β-catenin" . SPARSER::COLLECTION) ("Pal" . SPARSER::PROTEIN)
    ("ER and HER2" . SPARSER::COLLECTION) ("herceptin" . SPARSER::DRUG)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("ERBB2/HER2" . SPARSER::COLLECTION)
    ("modulators or siRNA" . SPARSER::COLLECTION)
    ("ERα, PR and HER2" . SPARSER::COLLECTION) ("i.e. S" . SPARSER::MOLECULE)
    ("WNT3A" . SPARSER::PROTEIN) ("TCF-4" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN) ("pS2" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("BMI-1" . SPARSER::PROTEIN)
    ("ICG-001" . SPARSER::DRUG) ("Tcf4" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("family member 2" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("neu2" . SPARSER::PROTEIN) ("WNT1" . SPARSER::PROTEIN)
    ("β-CATENIN" . SPARSER::PROTEIN) ("CCNB2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("HMGA family" . SPARSER::PROTEIN-FAMILY)
    ("HMGA1c" . SPARSER::PROTEIN) ("HMGA1a" . SPARSER::PROTEIN)
    ("CUL4A" . SPARSER::PROTEIN) ("Wnt /β" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("Wnt10b" . SPARSER::PROTEIN)
    ("WNT10B" . SPARSER::PROTEIN) ("Hemoglobin" . SPARSER::MOLECULE)
    ("Sterol" . SPARSER::PROTEIN) ("Peroxisome" . SPARSER::PROTEIN)
    ("the SIRT1 gene and dietary PUFA" . SPARSER::COLLECTION)
    ("dietary PUFA" . SPARSER::MOLECULE) ("n-3 or n-6" . SPARSER::COLLECTION)
    ("gene and diabetes" . SPARSER::COLLECTION)
    ("Almost all genetic variants" . SPARSER::VARIANT)
    ("gene and lipid" . SPARSER::COLLECTION)
    ("high LDL-C and low HDL-C" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE)
    ("the common SIRT1 variants and dietary n-3 and n-6 PUFAs intake"
     . SPARSER::COLLECTION)
    ("n-3 and n-6" . SPARSER::COLLECTION) ("AMPK/SIRT1" . SPARSER::COLLECTION)
    ("serum triglyceride and increase HDL-cholesterol" . SPARSER::COLLECTION)
    ("fish" . SPARSER::PROTEIN) ("n-6 and n-3" . SPARSER::COLLECTION)
    ("AMP-activated protein kinase (AMPK) and sterol response element-binding protein-1c (SREBP-1c)"
     . SPARSER::COLLECTION)
    ("PPAR" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("chromatin silencing and transcriptional repression through histone deacetylation"
     . SPARSER::COLLECTION)
    ("target substrates and tissue-specificity" . SPARSER::COLLECTION)
    ("SIRT1-SIRT7" . SPARSER::COLLECTION) ("HDL" . SPARSER::PROTEIN)
    ("dietary n-6" . SPARSER::PROTEIN)
    ("LDL-C and HDL-C" . SPARSER::COLLECTION)
    ("the SIRT1 gene and dietary n-6/n-3 PUFA intake ratio"
     . SPARSER::COLLECTION)
    ("n-6/n-3" . SPARSER::COLLECTION) ("PUFA" . SPARSER::MOLECULE)
    ("SIRT1 and PUFAs" . SPARSER::COLLECTION) ("LXR" . SPARSER::PROTEIN)
    ("PUFAs" . SPARSER::MOLECULE)
    ("Polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("Peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("High density lipoprotein" . SPARSER::PROTEIN)
    ("Low density lipoprotein" . SPARSER::PROTEIN) ("HbA1" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("PGC1" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("n-3" . SPARSER::PROTEIN) ("n-6" . SPARSER::PROTEIN)
    ("PPARα" . SPARSER::PROTEIN) ("LXRβ" . SPARSER::PROTEIN)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("Yan" . SPARSER::PROTEIN)
    ("albumin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MPV" . SPARSER::MOLECULE)
    ("DBP" . SPARSER::PROTEIN) ("SBP" . SPARSER::PROTEIN)
    ("PAI-1 and TGF- β" . SPARSER::COLLECTION)
    ("ICAM1, IL-1, coagulation factor III, and VEGF" . SPARSER::COLLECTION)
    ("introns" . SPARSER::PROTEIN) ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("coagulation factor III" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN)
    ("Cycline" . SPARSER::PROTEIN-FAMILY)
    ("cell cycle regulatory genes and anti-apoptotic genes ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("IL-6-STAT3" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("a cell permeable STAT3 inhibitor" . SPARSER::INHIBITOR)
    ("collagen and fibronectin" . SPARSER::COLLECTION)
    ("type I and VI, and fibronectin" . SPARSER::COLLECTION)
    ("PTEF-b" . SPARSER::PROTEIN-PAIR) ("b" . SPARSER::PROTEIN)
    ("elongation factor-b" . SPARSER::PROTEIN-PAIR)
    ("gp130 or gp130" . SPARSER::COLLECTION) ("primary HSF" . SPARSER::PROTEIN)
    ("collagen, cytokines and chemokines" . SPARSER::COLLECTION)
    ("a soluble IL-6 receptor" . SPARSER::PROTEIN)
    ("STAT3 siRNA or non-target control siRNA and total RNA"
     . SPARSER::COLLECTION)
    ("siRNA or non-target" . SPARSER::COLLECTION)
    ("Cyclin D1, c-Myc, and Bcl-xl" . SPARSER::COLLECTION)
    ("Col1A2 and FN" . SPARSER::COLLECTION)
    ("two principal ECM molecules" . SPARSER::MOLECULE)
    ("gp130-phycoerythrin (PE)" . SPARSER::COLLECTION)
    ("gp130-phycoerythrin" . SPARSER::COLLECTION)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY)
    ("HSFs and NFs" . SPARSER::COLLECTION) ("NFs" . SPARSER::PROTEIN)
    ("panel A-C (10X) and D-F (20X)" . SPARSER::COLLECTION)
    ("a cell permeable STAT3 peptide inhibitor" . SPARSER::INHIBITOR)
    ("gp130-STAT3" . SPARSER::COLLECTION)
    ("inflammatory colon cancer" . SPARSER::PROTEIN)
    ("differential mRNA" . SPARSER::PROTEIN)
    ("a soluble IL-6•sIL-6Rα complex" . SPARSER::BIO-COMPLEX)
    ("particularly isoforms -1 and -3" . SPARSER::COLLECTION)
    ("-1 and -3" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("JAKs" . SPARSER::PROTEIN)
    ("a membrane-bound hexameric IL-6•IL-Rα•gp130 high-affinity complex"
     . SPARSER::BIO-COMPLEX)
    ("IL-6 and soluble IL-6Rα (sIL-6Rα) binding cell-surface glycoprotein 130 (gp130)"
     . SPARSER::COLLECTION)
    ("soluble IL-6Rα (sIL-6Rα) binding cell-surface glycoprotein 130"
     . SPARSER::PROTEIN)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("silicone" . SPARSER::MOLECULE)
    ("Cyclin D1, Bcl-Xl and c-Myc" . SPARSER::COLLECTION)
    ("FN and Col1A2" . SPARSER::COLLECTION) ("Col1A2" . SPARSER::PROTEIN)
    ("HSFs" . SPARSER::PROTEIN) ("HSF" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("CDK-9" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("Gp130" . SPARSER::PROTEIN)
    ("β - actin" . SPARSER::PROTEIN) ("H-I" . SPARSER::PROTEIN)
    ("D-F" . SPARSER::PROTEIN) ("fibronectin 1" . SPARSER::PROTEIN)
    ("glycoprotein 130" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("Brca1 and p16INK4a" . SPARSER::COLLECTION)
    ("melanoma associated miRNAs" . SPARSER::PROTEIN)
    ("HIPK2 and Arf" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MIA" . SPARSER::PROTEIN)
    ("MC1R, MMP-8, and β-catenin" . SPARSER::COLLECTION)
    ("Brca1 and Brca2" . SPARSER::COLLECTION)
    ("Brca1 and CtBP1" . SPARSER::COLLECTION)
    ("Fanc" . SPARSER::PROTEIN-FAMILY) ("MMC" . SPARSER::PROTEIN)
    ("p16INK4a and CtBP1" . SPARSER::COLLECTION)
    ("CtBP1 and p16INK4a" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("Brca2 and Brca1" . SPARSER::COLLECTION)
    ("CDKN2A/MTS1" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("p16INK4a and Brca1" . SPARSER::COLLECTION) ("HIPK2" . SPARSER::PROTEIN)
    ("melanoma inhibitory activity" . SPARSER::PROTEIN)
    ("MMP-8" . SPARSER::PROTEIN) ("MC1R" . SPARSER::PROTEIN)
    ("Id1" . SPARSER::PROTEIN) ("Brca2" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("MTS1" . SPARSER::PROTEIN)
    ("multiple tumor suppressor 1" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("CtBP1" . SPARSER::PROTEIN) ("MDM2- and MDMX-" . SPARSER::COLLECTION)
    ("MDMX-" . SPARSER::PROTEIN) ("MDM2-" . SPARSER::PROTEIN)
    ("currently only one MDM2 antagonist" . SPARSER::MOLECULE)
    ("MET and MDM2" . SPARSER::COLLECTION)
    ("a DNA damage-activated kinase" . SPARSER::KINASE)
    ("ATM and MET" . SPARSER::COLLECTION) ("HGFR" . SPARSER::PROTEIN)
    ("selumetinib" . SPARSER::DRUG) ("AKT and p53" . SPARSER::COLLECTION)
    ("MDMX and/or p53" . SPARSER::COLLECTION)
    ("enzyme or enzymes" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("MPD" . SPARSER::PROTEIN)
    ("HLI" . SPARSER::MOLECULE)
    ("the chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("SAH" . SPARSER::MOLECULE) ("this dual inhibitor" . SPARSER::INHIBITOR)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("MDM2–MDMX" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR) ("RO" . SPARSER::PROTEIN)
    ("dual antagonists" . SPARSER::MOLECULE) ("MDMX–p53" . SPARSER::COLLECTION)
    ("topotecan" . SPARSER::DRUG)
    ("nutlin 3a and MI-219" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST)
    ("yielded synergistic cytotoxic" . SPARSER::PROTEIN)
    ("MDMX, and nutlin 3a" . SPARSER::COLLECTION)
    ("MDM2–p53" . SPARSER::COLLECTION) ("tanespimycin" . SPARSER::DRUG)
    ("AAG" . SPARSER::PROTEIN) ("MDM2 and E2" . SPARSER::COLLECTION)
    ("p53–MDMX" . SPARSER::COLLECTION) ("p53–MDM2" . SPARSER::COLLECTION)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("NMYC and MDM2" . SPARSER::COLLECTION) ("NMYC" . SPARSER::PROTEIN)
    ("MDMX and RAS" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("MDMX and MDM2" . SPARSER::COLLECTION)
    ("virus-induced cellular miRNAs" . SPARSER::PROTEIN)
    ("p53-miRNA" . SPARSER::COLLECTION) ("genotoxin" . SPARSER::MOLECULE)
    ("CHK" . SPARSER::PROTEIN) ("ABL" . SPARSER::PROTEIN)
    ("MYC and MDM2 or MDMX" . SPARSER::COLLECTION)
    ("another potent mitogen and an oncogene" . SPARSER::COLLECTION)
    ("MDM2 and/or MDMX antagonists" . SPARSER::COLLECTION)
    ("MDM2 or MDMX" . SPARSER::COLLECTION)
    ("p53–MDM2–MDMX" . SPARSER::COLLECTION)
    ("MDM2–MDMX–p53" . SPARSER::COLLECTION)
    ("peptidic MDM2 and MDMX inhibitors" . SPARSER::INHIBITOR)
    ("MDM" . SPARSER::PROTEIN) ("MDM2 and MDMX" . SPARSER::COLLECTION)
    ("HDMX and MDM4" . SPARSER::COLLECTION) ("HDMX" . SPARSER::PROTEIN)
    ("MDMX" . SPARSER::PROTEIN) ("Nutlin 3a" . SPARSER::DRUG)
    ("PI3K–AKT" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("GDF15" . SPARSER::PROTEIN)
    ("MIC1" . SPARSER::PROTEIN)
    ("macrophage inhibitory cytokine 1" . SPARSER::PROTEIN)
    ("RO5045337" . SPARSER::DRUG) ("RG7112" . SPARSER::DRUG)
    ("MI-219" . SPARSER::DRUG) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("nutlin 3a" . SPARSER::DRUG) ("vIRF4" . SPARSER::PROTEIN)
    ("mir-34a" . SPARSER::MOLECULE)
    ("protein phosphatase 1D" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("CK1α" . SPARSER::PROTEIN) ("Casein kinase 1" . SPARSER::PROTEIN)
    ("IRF8" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("Bim and Mcl-1" . SPARSER::COLLECTION)
    ("Bak-protein" . SPARSER::COLLECTION) ("helix" . SPARSER::PROTEIN)
    ("digitonin" . SPARSER::MOLECULE) ("thiourea" . SPARSER::MOLECULE)
    ("ASB" . SPARSER::PROTEIN) ("detergent" . SPARSER::MOLECULE)
    ("Bid, Bim and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("etoposide, camptothecin or staurosporine" . SPARSER::COLLECTION)
    ("etoposide or campothecin" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("pervanadate" . SPARSER::PROTEIN)
    ("etoposide, staurosporine or camptothecin" . SPARSER::COLLECTION)
    ("homo-oligomers" . SPARSER::PROTEIN) ("staurosporine" . SPARSER::DRUG)
    ("primary MEFs" . SPARSER::PROTEIN)
    ("Only one serine" . SPARSER::AMINO-ACID)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("phospho1" . SPARSER::PROTEIN)
    ("EL" . SPARSER::PROTEIN) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("acetamido" . SPARSER::MOLECULE)
    ("serine, threonine and tyrosine" . SPARSER::COLLECTION)
    ("-phosphatase" . SPARSER::PHOSPHATASE)
    ("orthovanadate" . SPARSER::MOLECULE)
    ("efficiently extract Bak" . SPARSER::PROTEIN)
    ("detergents" . SPARSER::MOLECULE)
    ("alanine or cysteine" . SPARSER::COLLECTION) ("IEF" . SPARSER::PROTEIN)
    ("symmetric homodimers" . SPARSER::HOMODIMER)
    ("α 5-helix" . SPARSER::PROTEIN-PAIR)
    ("Two other pro-apoptotic proteins, Bak and Bax" . SPARSER::COLLECTION)
    ("proteins, Bak and Bax" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("Bid and Bim" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("1D-IEF" . SPARSER::COLLECTION) ("Bak and Bax" . SPARSER::COLLECTION)
    ("Bak" . SPARSER::PROTEIN) ("1,10-phenanthroline" . SPARSER::MOLECULE)
    ("pH 3" . SPARSER::MOLECULE) ("PTPN5" . SPARSER::PROTEIN)
    ("ASB-14" . SPARSER::PROTEIN) ("phospho2" . SPARSER::PROTEIN)
    ("α 5" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("deuterium" . SPARSER::MOLECULE) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("-Tyr" . SPARSER::COLLECTION) ("Pap" . SPARSER::MOLECULE)
    ("azido" . SPARSER::MOLECULE) ("para" . SPARSER::PROTEIN-FAMILY)
    ("A3 and Glu" . SPARSER::COLLECTION) ("B12 and Leu" . SPARSER::COLLECTION)
    ("Ile" . SPARSER::AMINO-ACID)
    ("a long-speculated  xref  induced fit" . SPARSER::PROTEIN-FAMILY)
    ("homodimers" . SPARSER::HOMODIMER) ("the IR310" . SPARSER::PROTEIN)
    ("The Fab-complexed forms" . SPARSER::FORM)
    ("the resultant electron-density difference maps" . SPARSER::PROTEIN)
    ("a Fab fragment" . SPARSER::FRAGMENT)
    ("human-insulin-bound IR310" . SPARSER::PROTEIN)
    ("the L1–CR–L2– (FnIII-1)–αCT(704–719) homodimeric construct IR593"
     . SPARSER::PROTEIN)
    ("the L1–CR construct IR310" . SPARSER::PROTEIN)
    ("-insulin receptor" . SPARSER::COLLECTION) ("apo" . SPARSER::PROTEIN)
    ("one insulin receptor α-chain and the central β-sheet"
     . SPARSER::COLLECTION)
    ("FnIII-3" . SPARSER::COLLECTION) ("FnIII-1" . SPARSER::COLLECTION)
    ("A1–A8, A12–A18 and B9–B19" . SPARSER::COLLECTION)
    ("disulphide" . SPARSER::MOLECULE)
    ("insulin receptor and IGF1R" . SPARSER::COLLECTION)
    ("heavy chain" . SPARSER::PROTEIN) ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A ‘" . SPARSER::PROTEIN) ("CCP4" . SPARSER::PROTEIN)
    ("l −1" . SPARSER::PROTEIN) ("Mono Q" . SPARSER::DRUG)
    ("butyric acid" . SPARSER::MOLECULE) ("DNA2" . SPARSER::PROTEIN)
    ("MX2" . SPARSER::PROTEIN) ("insulin-receptor" . SPARSER::PROTEIN)
    ("B15" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B22" . SPARSER::PROTEIN) ("B-factor" . SPARSER::PROTEIN)
    ("CC 1" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("A1–A" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("LRP6 or Cav-1" . SPARSER::COLLECTION) ("IGF-1R/IR" . SPARSER::COLLECTION)
    ("HK2 and/or Glut3" . SPARSER::COLLECTION)
    ("Akt–" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HK2 or Glut3" . SPARSER::COLLECTION)
    ("PKM2, ENO1, LDHA, or PDK1" . SPARSER::COLLECTION)
    ("PC-3 or LNCaP" . SPARSER::COLLECTION) ("LDHA" . SPARSER::PROTEIN)
    ("neurofilament-heavy polypeptide" . SPARSER::PEPTIDE)
    ("dehydrogenase" . SPARSER::PROTEIN) ("—1" . SPARSER::PROTEIN)
    ("Cav-1–LRP6–IGF-IR/IR" . SPARSER::COLLECTION)
    ("IR, IGF-IR, and Cav-1" . SPARSER::COLLECTION)
    ("IR and LRP6" . SPARSER::COLLECTION) ("LRP6-Flag" . SPARSER::COLLECTION)
    ("IR, IGF-IR, and LRP6" . SPARSER::COLLECTION)
    ("Cav-1, LRP6, IR, and IGF-IR" . SPARSER::COLLECTION)
    ("IR or IGF-IR" . SPARSER::COLLECTION)
    ("IR, P-Akt, and P-S6K" . SPARSER::COLLECTION)
    ("Akt, and S6K" . SPARSER::COLLECTION) ("IR/IGF-IR" . SPARSER::COLLECTION)
    ("IGF-IR (100%, 70% respectively) and IR (100%, 72%, respectively)"
     . SPARSER::COLLECTION)
    ("siRNA and IGF-IR" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("P-S6K, and Rapa" . SPARSER::COLLECTION)
    ("Akt and its downstream effector mTORC1" . SPARSER::COLLECTION)
    ("Rapa" . SPARSER::DRUG) ("Akti" . SPARSER::PROTEIN)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION)
    ("Cav-1 or LRP6" . SPARSER::COLLECTION)
    ("Glut3 and HK2" . SPARSER::COLLECTION)
    ("Glut3 (3.1-, 1.5-, and 14-fold, respectively) and moderately increased active β-cat and HK2 (1.2- and 1.3-fold, respectively)"
     . SPARSER::COLLECTION)
    ("Glut3, and HK2" . SPARSER::COLLECTION)
    ("Wnt3a and Cav-1" . SPARSER::COLLECTION)
    ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("Cav-1– and LRP6-specific siRNAs (i.e. Cavsi, LRP6si)"
     . SPARSER::COLLECTION)
    ("Cav-1–" . SPARSER::PROTEIN) ("Cav-1–LRP6" . SPARSER::COLLECTION)
    ("mTORC" . SPARSER::PROTEIN)
    ("total and phosphorylated LRP6" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN)
    ("acetyl-CoA and NADPH" . SPARSER::COLLECTION) ("NADPH" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE) ("ser" . SPARSER::AMINO-ACID)
    ("PI3K and Akt or Ras and MAPK" . SPARSER::COLLECTION)
    ("Akt or Ras and MAPK" . SPARSER::COLLECTION)
    ("Ras and MAPK" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("IR and IGF-IR" . SPARSER::COLLECTION)
    ("LRP6 and Cav-1" . SPARSER::COLLECTION) ("FZD–LRP6" . SPARSER::COLLECTION)
    ("Axin" . SPARSER::PROTEIN) ("primary PCa" . SPARSER::PROTEIN)
    ("genes or proteins" . SPARSER::COLLECTION)
    ("Wnt–" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biologically active soluble Cav-1 protein" . SPARSER::PROTEIN)
    ("Akt–mTORC1" . SPARSER::COLLECTION)
    ("HK2 and Glut3" . SPARSER::COLLECTION)
    ("LNCaP, PC-3, and DU145" . SPARSER::COLLECTION)
    ("Cav-1 and LRP6" . SPARSER::COLLECTION) ("PC-3" . SPARSER::PROTEIN)
    ("IGF-IR/IR" . SPARSER::COLLECTION)
    ("Cav-1 and low-density lipoprotein receptor–related protein 6"
     . SPARSER::COLLECTION)
    ("Wnt-β-catenin" . SPARSER::COLLECTION)
    ("a plasma membrane–associated protein" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("GLUT3" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN) ("enolase 1" . SPARSER::PROTEIN)
    ("P-S6K" . SPARSER::PROTEIN) ("AG1024" . SPARSER::DRUG)
    ("GSK3 β" . SPARSER::PROTEIN)
    ("insulin-like growth factor I" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("Glut3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HK2" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("LRP6" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor–related protein 6" . SPARSER::PROTEIN)
    ("Caveolin 1" . SPARSER::PROTEIN) ("bromo" . SPARSER::MOLECULE)
    ("Asef" . SPARSER::PROTEIN)
    ("these protrusion-associated complexes" . SPARSER::BIO-COMPLEX)
    ("the membrane-protrusion-associated APC/β-catenin complex"
     . SPARSER::BIO-COMPLEX)
    ("Dlg and Scribble" . SPARSER::COLLECTION) ("Scribble" . SPARSER::PROTEIN)
    ("Dlg" . SPARSER::PROTEIN) ("GSK3β and CK1" . SPARSER::COLLECTION)
    ("protrusion-associated β-catenin" . SPARSER::PROTEIN)
    ("an exogenous stabilized mutant β-catenin" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) and Src [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Rac-specific guanine-exchange factors [ xref - xref ] and mDia"
     . SPARSER::COLLECTION)
    ("Asef1 and Asef2" . SPARSER::COLLECTION) ("mDia" . SPARSER::PROTEIN)
    ("IQGAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JRP and KHG" . SPARSER::COLLECTION) ("JRP" . SPARSER::PROTEIN)
    ("antibiotic" . SPARSER::DRUG)
    ("β-catenin/E-cadherin" . SPARSER::COLLECTION)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("microtubule-associated APC" . SPARSER::PROTEIN)
    ("KAP3/Kif3" . SPARSER::COLLECTION) ("tubulin" . SPARSER::PROTEIN)
    ("EB1" . SPARSER::PROTEIN)
    ("these protrusion-associated APC/β-catenin" . SPARSER::COLLECTION)
    ("protrusion-associated puncta" . SPARSER::PROTEIN)
    ("growth factors/cytokine" . SPARSER::COLLECTION)
    ("SHC" . SPARSER::PROTEIN) ("β-catenin and APC" . SPARSER::COLLECTION)
    ("E-cadherin or β-catenin" . SPARSER::COLLECTION)
    ("neither β-catenin nor APC" . SPARSER::COLLECTION)
    ("NR" . SPARSER::PROTEIN) ("anti-β-catenin" . SPARSER::COLLECTION)
    ("APC [ xref ] and exogenous mutant β-catenin [ xref ]"
     . SPARSER::COLLECTION)
    ("exogenous mutant β-catenin" . SPARSER::PROTEIN)
    ("APC/β-catenin" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("The adenomatous polyposis coli ( APC ) tumor suppressor gene"
     . SPARSER::PROTEIN)
    ("FAP" . SPARSER::PROTEIN) ("APC and β-catenin" . SPARSER::COLLECTION)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("Asef2" . SPARSER::PROTEIN) ("Asef1" . SPARSER::PROTEIN)
    ("APC2" . SPARSER::PROTEIN) ("Kif3" . SPARSER::PROTEIN)
    ("KAP3" . SPARSER::PROTEIN) ("APC 1" . SPARSER::PROTEIN)
    ("Reverse-Transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Middle T antigen" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AC" . SPARSER::PROTEIN) ("Tofacitinib" . SPARSER::DRUG)
    ("AZD1152 and Danusertib" . SPARSER::COLLECTION)
    ("a Jak and an Aurora kinase inhibitor" . SPARSER::COLLECTION)
    ("Myeloid" . SPARSER::PROTEIN)
    ("the Jak or the Aurora kinase inhibitors" . SPARSER::COLLECTION)
    ("in general Jak inhibitors" . SPARSER::INHIBITOR)
    ("VX680, AZD1152, Danusertib and SNS314" . SPARSER::COLLECTION)
    ("whose main target" . SPARSER::TARGET-PROTEIN)
    ("Jak2V617F and Aurora kinases" . SPARSER::COLLECTION)
    ("VX680 and Sunitinib" . SPARSER::COLLECTION)
    ("TG101348 and CYT387 in intact cells" . SPARSER::COLLECTION)
    ("clearly less active" . SPARSER::ACTIVE)
    ("STAT5, STAT3 and STAT1" . SPARSER::COLLECTION)
    ("kinase inhibitor and the recently reported fact that Jaks do not necessarily need to be phosphorylated to be active"
     . SPARSER::COLLECTION)
    ("cytokine/cytokine-receptor/Jak" . SPARSER::COLLECTION)
    ("analogue-sensitive mutants" . SPARSER::MUTANT)
    ("Jak1 and Jak3" . SPARSER::COLLECTION)
    ("VX680 and TG101209" . SPARSER::COLLECTION)
    ("TG101209 ( xref ) or TG101348 ( xref )" . SPARSER::COLLECTION)
    ("VX680 and erythroid" . SPARSER::COLLECTION)
    ("Jak and Aurora kinase inhibitors" . SPARSER::COLLECTION)
    ("the Jak or Aurora kinase inhibitors" . SPARSER::COLLECTION)
    ("AZD1152, Danusertib and SNS314" . SPARSER::COLLECTION)
    ("SNS" . SPARSER::PROTEIN) ("Danusertib" . SPARSER::DRUG)
    ("kinase and Jak" . SPARSER::COLLECTION)
    ("erythroid and myeloid" . SPARSER::COLLECTION)
    ("VX680 and CEP701" . SPARSER::COLLECTION)
    ("TG101348 and CYT387" . SPARSER::COLLECTION)
    ("its respective target kinases" . SPARSER::PROTEIN)
    ("FRT" . SPARSER::PROTEIN) ("the fluorescent protein" . SPARSER::PROTEIN)
    ("the fluorescent ZsGreen protein" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN) ("fluorescent proteins" . SPARSER::PROTEIN)
    ("STAT3-YFP" . SPARSER::COLLECTION)
    ("the fluorescent read-out protein" . SPARSER::PROTEIN)
    ("Jak2 and Jak3" . SPARSER::COLLECTION) ("CMK" . SPARSER::PROTEIN)
    ("Jak2V617F or Jak2K539L" . SPARSER::COLLECTION)
    ("HEK-EpoR" . SPARSER::COLLECTION)
    ("Sunitinib, VX680, WP1066 and AG490" . SPARSER::COLLECTION)
    ("Sunitinib and WP1066" . SPARSER::COLLECTION)
    ("AG490, LFM-A13 and JNJ7706621" . SPARSER::COLLECTION)
    ("VX680, Sunitinib, WP1066, AG490, LFM-A13 and JNJ7706621"
     . SPARSER::COLLECTION)
    ("TG101348 and CYT387 showed the same effects" . SPARSER::COLLECTION)
    ("TG101209 and JI1 reduced proliferation of HEL cells very effectively"
     . SPARSER::COLLECTION)
    ("Jak2V617F" . SPARSER::PROTEIN) ("Sunitinib" . SPARSER::DRUG)
    ("JI" . SPARSER::PROTEIN) ("CYT" . SPARSER::MOLECULE)
    ("Jak1 and Jak2" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("the last few years new and potent inhibitors" . SPARSER::INHIBITOR)
    ("phosphoinositide-3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("Jaks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jak1, Jak2, Jak3 and Tyk2" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PMF" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN)
    ("a Janus and an Aurora kinase inhibitor" . SPARSER::COLLECTION)
    ("GLPG0634" . SPARSER::DRUG) ("LY3009104" . SPARSER::DRUG)
    ("SB1518" . SPARSER::DRUG) ("LY2784544" . SPARSER::DRUG)
    ("cytokine-receptor" . SPARSER::PROTEIN) ("AZD1152" . SPARSER::DRUG)
    ("Aurora kinase A" . SPARSER::PROTEIN)
    ("Aurora kinase B" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("110 kD)" . SPARSER::PROTEIN)
    ("130 kD" . SPARSER::PROTEIN) ("LFM-A13" . SPARSER::DRUG)
    ("WP1066" . SPARSER::DRUG) ("Inhibitor 1" . SPARSER::PROTEIN)
    ("VX680" . SPARSER::DRUG) ("TG101348" . SPARSER::DRUG)
    ("TG101209" . SPARSER::DRUG) ("JNJ7706621" . SPARSER::DRUG)
    ("INCB018424" . SPARSER::DRUG) ("Tyk2" . SPARSER::PROTEIN)
    ("Jak3" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("an essential cofactor" . SPARSER::MOLECULE)
    ("Cks and other cell cycle-related regulators" . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION) ("Cks1/Cks2" . SPARSER::COLLECTION)
    ("Cks2 and p27 kip1" . SPARSER::COLLECTION)
    ("nitrosamines" . SPARSER::MOLECULE) ("Cks1 or Cks2" . SPARSER::COLLECTION)
    ("proteins and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("Cks1 and Cks2" . SPARSER::COLLECTION) ("Cks" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cks2" . SPARSER::PROTEIN) ("PARP1 and SIRT1" . SPARSER::COLLECTION)
    ("MPM" . SPARSER::MOLECULE) ("4E-BP1/eIF4E" . SPARSER::COLLECTION)
    ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("the most aggressive sarcomatoid MMe" . SPARSER::PROTEIN)
    ("topoisomerase I or II inhibitors" . SPARSER::INHIBITOR)
    ("iron" . SPARSER::MOLECULE) ("REN" . SPARSER::PROTEIN)
    ("the biphasic MMe" . SPARSER::PROTEIN)
    ("Intense nuclear PARP1" . SPARSER::PROTEIN)
    ("epithelioid ( n = 30) MMe and their relative peritumoural mesothelium (magnification 20×)"
     . SPARSER::COLLECTION)
    ("a well-defined cohort" . SPARSER::MOLECULE)
    ("PARP1/SIRT1" . SPARSER::COLLECTION)
    ("HMGB1 and TNFα" . SPARSER::COLLECTION) ("HMCs" . SPARSER::PROTEIN)
    ("Asbestos" . SPARSER::MOLECULE) ("asbestos" . SPARSER::MOLECULE)
    ("MMe" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE) ("RNAse A" . SPARSER::PROTEIN)
    ("PF-01367338" . SPARSER::DRUG) ("AG014699" . SPARSER::DRUG)
    ("ADP–ribose" . SPARSER::MOLECULE) ("RICTOR-mTOR" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("cis-platin" . SPARSER::DRUG) ("Medicine" . SPARSER::DRUG)
    ("PI3K or AKT" . SPARSER::COLLECTION) ("subtle Ki67" . SPARSER::PROTEIN)
    ("Ki67 and pS6" . SPARSER::COLLECTION)
    ("molecular predictive biomarkers" . SPARSER::MOLECULE)
    ("pS6 and the main endpoint" . SPARSER::COLLECTION)
    ("arm-" . SPARSER::PROTEIN) ("genotypes" . SPARSER::PROTEIN)
    ("Genotype and Anti-proliferative" . SPARSER::COLLECTION)
    ("treatment arm and the continuous PIK3CA GS" . SPARSER::COLLECTION)
    ("Genotype" . SPARSER::PROTEIN) ("genotype" . SPARSER::PROTEIN)
    ("the global trial cohort" . SPARSER::MOLECULE)
    ("everolimus or everolimus" . SPARSER::COLLECTION)
    ("-GS" . SPARSER::COLLECTION) ("GS" . SPARSER::PROTEIN)
    ("a nonsteroidal aromatase inhibitor" . SPARSER::INHIBITOR)
    ("/AKT/mammalian Target Of Rapamycin" . SPARSER::COLLECTION)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("PIK3CA-GS" . SPARSER::COLLECTION)
    ("letrozole and everolimus" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("letrozole" . SPARSER::DRUG)
    ("De-" . SPARSER::MOLECULE) ("p110α" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN)
    ("mammalian Target Of Rapamycin" . SPARSER::PROTEIN)
    ("p21Cip1/WAF1" . SPARSER::COLLECTION)
    ("cytoplasmic Fra-1 and/or c-Fos (that activate phospholipid biosynthesis)"
     . SPARSER::COLLECTION)
    ("AP-1-c-Fos" . SPARSER::COLLECTION) ("AP-1-Fra-1" . SPARSER::COLLECTION)
    ("c-Fos/Fra-1" . SPARSER::COLLECTION)
    ("c-Fos or Fra-1" . SPARSER::COLLECTION)
    ("AP-1-c-Fos/Fra-1" . SPARSER::COLLECTION) ("NLSP" . SPARSER::PEPTIDE)
    ("Peptide (NLSP)" . SPARSER::PEPTIDE)
    ("Fra-1 or c-Fos" . SPARSER::COLLECTION)
    ("recombinant Fra-1 (third column) or c-Fos (fourth column)"
     . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("KCl, Fra-1 and c-Fos" . SPARSER::COLLECTION)
    ("homogenate (TH)" . SPARSER::PROTEIN) ("homogenate" . SPARSER::PROTEIN)
    ("calnexin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Fos and Fra-1" . SPARSER::COLLECTION)
    ("both Fra-1 (upper panels) and c-Fos (lower panels)"
     . SPARSER::COLLECTION)
    ("–FBS" . SPARSER::COLLECTION) ("Vimentin" . SPARSER::PROTEIN)
    ("Ser and Thr" . SPARSER::COLLECTION) ("Fra-1-AP-1" . SPARSER::COLLECTION)
    ("fosl1" . SPARSER::PROTEIN) ("c-Fos/ER" . SPARSER::COLLECTION)
    ("mostly Jun proteins" . SPARSER::PROTEIN)
    ("Fos proteins only form heterodimers" . SPARSER::HETERODIMER)
    ("The Fos proteins (c-Fos, Fra-1, Fra-2 and Fos-B) and the Jun proteins (c-Jun, JunB and JunD)"
     . SPARSER::COLLECTION)
    ("c-Fos, Fra-1, Fra-2 and Fos-B" . SPARSER::COLLECTION)
    ("c-Jun, JunB and JunD" . SPARSER::COLLECTION) ("JunD" . SPARSER::PROTEIN)
    ("JunB" . SPARSER::PROTEIN) ("fos and jun" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fra-1 and c-Fos" . SPARSER::COLLECTION)
    ("Fra-1 and/or c-Fos" . SPARSER::COLLECTION)
    ("its basic amino acids" . SPARSER::AMINO-ACID)
    ("phospholipid" . SPARSER::PHOSPHOLIPID) ("WAF1" . SPARSER::PROTEIN)
    ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antigen-1" . SPARSER::PROTEIN) ("Fra-2" . SPARSER::PROTEIN)
    ("Immediate Early" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("PTEN/AKT" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("CAM and nude mice allograft" . SPARSER::COLLECTION)
    ("PTEN or GSK-3β" . SPARSER::COLLECTION)
    ("PTEN/GSK-3β" . SPARSER::COLLECTION)
    ("VEGF and b-FGF" . SPARSER::COLLECTION)
    ("mTOR/p70S6K1" . SPARSER::COLLECTION)
    ("vGPCR and Kaposin" . SPARSER::COLLECTION)
    ("vIL-6 and Tat-induced" . SPARSER::COLLECTION)
    ("Tat-transduced 4E3 group" . SPARSER::MOLECULE)
    ("hemorrhagic necrotic foci" . SPARSER::PROTEIN)
    ("the Tat-transduced 4E3 cell group" . SPARSER::MOLECULE)
    ("AKT and GSK-3β" . SPARSER::COLLECTION)
    ("PTEN, PI3K, AKT, and GSK-3β" . SPARSER::COLLECTION)
    ("RTA" . SPARSER::PROTEIN)
    ("a trans activative transcription protein" . SPARSER::PROTEIN)
    ("VEGF, b-FGF, and cyclin D1" . SPARSER::COLLECTION)
    ("hemorrhagic foci" . SPARSER::PROTEIN)
    ("PI3K/PTEN/AKT/GSK-3β" . SPARSER::COLLECTION)
    ("NF-AT and NF-κB" . SPARSER::COLLECTION) ("vGPCR" . SPARSER::PROTEIN)
    ("cellular IL-6 and VEGF" . SPARSER::COLLECTION)
    ("IL-6 and VEGF" . SPARSER::COLLECTION)
    ("cellular IL-6" . SPARSER::PROTEIN)
    ("90 genes and 25 mature miRNAs xref" . SPARSER::COLLECTION)
    ("iatrogenic KS" . SPARSER::PROTEIN) ("MCD" . SPARSER::PROTEIN)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("PTEN and GSK-3β" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("KS" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("p70S6K1" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("p85" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("gp80" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("vIL-6" . SPARSER::PROTEIN)
    ("FGFR2 and other genes" . SPARSER::COLLECTION)
    ("FGFR2 , FOXA1 , GABRA4 , SDC4 , CSF3 , ETNK1 , and CDC42BPG"
     . SPARSER::COLLECTION)
    ("VEGFR and PDGFR" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("an orally bioavailable kinase inhibitor" . SPARSER::INHIBITOR)
    ("FGFR2IIIb and FGFR2IIIc" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN) ("FGF10–FGFR2IIIb" . SPARSER::COLLECTION)
    ("the self-renewal regulators" . SPARSER::REGULATOR)
    ("FGFR2 and FGF10" . SPARSER::COLLECTION)
    ("essential regulators" . SPARSER::REGULATOR) ("FGFR2-" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("FGFR2−" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN)
    ("FGFR2 and its downstream targets" . SPARSER::COLLECTION)
    ("FGFR2 and Erk1/2" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("lineage-specific markers K18" . SPARSER::PROTEIN)
    ("lentiviral short hairpin RNAs" . SPARSER::RNA)
    ("FOXA1 , FGFR2 , and GABRA4" . SPARSER::COLLECTION)
    ("PyMT" . SPARSER::PROTEIN) ("‘TICs’" . SPARSER::PROTEIN)
    ("K18 and K14" . SPARSER::COLLECTION)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myoepithelial cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("1,000 secondary non-CD29 high CD24" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN) ("med" . SPARSER::PROTEIN)
    ("CD29 and CD24" . SPARSER::COLLECTION) ("MMTV-PyMT" . SPARSER::COLLECTION)
    ("MMTV" . SPARSER::PROTEIN) ("bipotent TICs" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN) ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cytokeratin 18" . SPARSER::PROTEIN) ("H-2k" . SPARSER::PROTEIN)
    ("FGFR2IIIb" . SPARSER::PROTEIN) ("FGF10" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("TKI258" . SPARSER::DRUG)
    ("Kinase Activity" . SPARSER::PROTEIN) ("FRS2" . SPARSER::PROTEIN)
    ("CDC42BPG" . SPARSER::PROTEIN)
    ("CDC42 binding protein kinase gamma" . SPARSER::PROTEIN)
    ("ETNK1" . SPARSER::PROTEIN) ("ethanolamine kinase 1" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("CSF3" . SPARSER::PROTEIN)
    ("colony stimulating factor 3" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("GABRA4" . SPARSER::PROTEIN) ("alpha 4" . SPARSER::PROTEIN)
    ("gamma-aminobutyric acid" . SPARSER::MOLECULE) ("SDC4" . SPARSER::PROTEIN)
    ("syndecan 4" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("SHP2 and Gab2" . SPARSER::COLLECTION)
    ("Syk and ZAP70" . SPARSER::COLLECTION)
    ("Lyn and Src" . SPARSER::COLLECTION) ("Epo" . SPARSER::PROTEIN)
    ("NAFT-AP1" . SPARSER::COLLECTION) ("Cbl or Src" . SPARSER::COLLECTION)
    ("Cbl-Flt3" . SPARSER::COLLECTION) ("PDGFR-SLAP" . SPARSER::COLLECTION)
    ("EpoR" . SPARSER::PROTEIN) ("PDGFR" . SPARSER::PROTEIN)
    ("multiple receptor and non-receptor protein tyrosine kinases as well as adaptor proteins ( xref )"
     . SPARSER::COLLECTION)
    ("receptor and non-receptor protein" . SPARSER::COLLECTION)
    ("APL" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("the external stimuli SLAP" . SPARSER::PROTEIN)
    ("Gab2 and Shc" . SPARSER::COLLECTION)
    ("Gab2, Shp2 and Shc" . SPARSER::COLLECTION)
    ("the adaptor protein Gab2 or the protein tyrosine phosphatase Shp2"
     . SPARSER::COLLECTION)
    ("shRNA and SLAP" . SPARSER::COLLECTION)
    ("Akt, Erk 1/2 and p38" . SPARSER::COLLECTION)
    ("Ras/Erk" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("SLAP shRNA or control shRNA (Ba/F3 cells lack endogenous Flt3 expression)"
     . SPARSER::COLLECTION)
    ("pY572, pY793, pY919 and pY955" . SPARSER::COLLECTION)
    ("SLAP-Flt3" . SPARSER::COLLECTION) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("Phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("SLAP (data not shown) and SLAP" . SPARSER::COLLECTION)
    ("Flt3-SLAP" . SPARSER::COLLECTION) ("SLAP and Flt3" . SPARSER::COLLECTION)
    ("proximal components" . SPARSER::COMPONENT)
    ("Akt, Erk and p38" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("T-cell receptor (TCR)" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("signal transduction molecules containing Src homology 2 (SH2) or phosphotyrosine binding (PTB) domains"
     . SPARSER::COLLECTION)
    ("PTB" . SPARSER::PROTEIN) ("ligand (FL)" . SPARSER::MOLECULE)
    ("-Akt" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cKit" . SPARSER::PROTEIN) ("Flt3-ITD" . SPARSER::COLLECTION)
    ("PI3K-Akt and MAPK" . SPARSER::COLLECTION)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("adaptor protein (SLAP)" . SPARSER::PROTEIN) ("SLAP" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("interleukin-3" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("Gab2" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("Ras-GAP" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src-like" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("discs" . SPARSER::BIO-COMPLEX) ("Yin" . SPARSER::PROTEIN)
    ("bFGF and IGF-I" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("JAK, PI3K or MEK" . SPARSER::COLLECTION)
    ("normal intervertebral disc" . SPARSER::BIO-COMPLEX)
    ("PI3K (wortmannin) or MEK (U0126)" . SPARSER::COLLECTION)
    ("JAK (AG490), PI3K (wortmannin) or MEK (U0126)" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JAK-" . SPARSER::PROTEIN)
    ("U0126, AG490 and wortmannin" . SPARSER::COLLECTION)
    ("ERK1/2, STAT3 and Akt" . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("wortmannin and U0126" . SPARSER::COLLECTION)
    ("AG490 or U0126" . SPARSER::COLLECTION)
    ("wortmannin (PI3K inhibitor) or U0126 (MEK inhibitor)"
     . SPARSER::COLLECTION)
    ("total and phosphorylated STAT3, Akt, and ERK1/2" . SPARSER::COLLECTION)
    ("STAT3, Akt, and ERK1/2" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("STAT3, Akt and ERK" . SPARSER::COLLECTION) ("OBRs" . SPARSER::PROTEIN)
    ("Receptors" . SPARSER::RECEPTOR) ("IBSP and FBN1" . SPARSER::COLLECTION)
    ("IBSP" . SPARSER::PROTEIN)
    ("type II and cytokeratin" . SPARSER::COLLECTION)
    ("collagenase" . SPARSER::PROTEIN) ("SHP-2-" . SPARSER::PROTEIN)
    ("JAK/STAT" . SPARSER::COLLECTION) ("OBR" . SPARSER::PROTEIN)
    ("exogenous leptin" . SPARSER::PROTEIN)
    ("intervertebral disc" . SPARSER::BIO-COMPLEX) ("OB" . SPARSER::PROTEIN)
    ("IVD" . SPARSER::PROTEIN)
    ("AG490, Wortmannin or U0126" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION)
    ("STAT3, Akt and ERK1/2" . SPARSER::COLLECTION)
    ("PCNA and Ki-67" . SPARSER::COLLECTION) ("leptin" . SPARSER::PROTEIN)
    ("Leptin" . SPARSER::PROTEIN) ("disc" . SPARSER::BIO-COMPLEX)
    ("SP2" . SPARSER::PROTEIN) ("Green fluorescent" . SPARSER::PROTEIN)
    ("a 20 µ" . SPARSER::PROTEIN) ("Leptin receptor" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("FBN1" . SPARSER::PROTEIN) ("SHP-2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AG490" . SPARSER::DRUG) ("CCK8" . SPARSER::PROTEIN)
    ("Vav1-Pyk2" . SPARSER::COLLECTION) ("Fyn and actin" . SPARSER::COLLECTION)
    ("Nck-Vav1" . SPARSER::COLLECTION)
    ("WASp and Arp2/3" . SPARSER::COLLECTION) ("Nck" . SPARSER::PROTEIN)
    ("LAT or SLP-76" . SPARSER::COLLECTION)
    ("T cell-APC or T cell-target cell" . SPARSER::COLLECTION)
    ("soluble TCR-specific antibodies" . SPARSER::ANTIBODY)
    ("ICAM-1, VCAM-1, or fibronectin" . SPARSER::COLLECTION)
    ("FAK and/or Pyk2" . SPARSER::COLLECTION)
    ("the FAK or FAK/Pyk2 inhibitor" . SPARSER::COLLECTION)
    ("FAK/Pyk2" . SPARSER::COLLECTION) ("FAK or Pyk2" . SPARSER::COLLECTION)
    ("FAK or FAK and Pyk2" . SPARSER::COLLECTION)
    ("a FAK kinase inhibitor or an inhibitor" . SPARSER::COLLECTION)
    ("Lck/Fyn" . SPARSER::COLLECTION) ("–1 µ" . SPARSER::PROTEIN)
    ("wortmannin or LY294002" . SPARSER::COLLECTION)
    ("Erk1/Erk2" . SPARSER::COLLECTION)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("LacZ or a Fyn-specific shRNA ( xref and xref )" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN)
    ("cytochalasin D or latrunculin B" . SPARSER::COLLECTION)
    ("glass" . SPARSER::MOLECULE)
    ("stained using FITC-phallodin" . SPARSER::MOLECULE)
    ("using FITC-phallodin" . SPARSER::MOLECULE)
    ("FITC-phallodin" . SPARSER::MOLECULE)
    ("1% bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("RPMI" . SPARSER::PROTEIN) ("jasplakinolide" . SPARSER::DRUG)
    ("Cytochalasin D and latrunculin B" . SPARSER::COLLECTION)
    ("cytochalasin D and latrunculin B" . SPARSER::COLLECTION)
    ("the less stimulatory anti-TCR antibody" . SPARSER::ANTIBODY)
    ("two different agonistic anti-TCR antibodies" . SPARSER::ANTIBODY)
    ("the stimulatory antibody" . SPARSER::PROTEIN)
    ("stimulatory TCR-specific antibodies" . SPARSER::ANTIBODY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAK and Pyk2" . SPARSER::COLLECTION) ("fyn" . SPARSER::PROTEIN)
    ("Focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2)"
     . SPARSER::COLLECTION)
    ("LAT, or SLP-76" . SPARSER::COLLECTION)
    ("GTPases, WAVE2, WASp, and Arp2/3" . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION) ("LAT and SLP-76" . SPARSER::COLLECTION)
    ("Lck and/or Fyn" . SPARSER::COLLECTION)
    ("the Src family kinases (SFK), Lck and/or Fyn" . SPARSER::COLLECTION)
    ("kinases (SFK)" . SPARSER::PROTEIN) ("WASp" . SPARSER::PROTEIN)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("Fyn and Pyk2" . SPARSER::COLLECTION) ("PF573228" . SPARSER::DRUG)
    ("anti-CD28" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("PD184161" . SPARSER::DRUG)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("Cytochalasin D" . SPARSER::DRUG)
    ("latrunculin B" . SPARSER::DRUG) ("cytochalasin D" . SPARSER::DRUG)
    ("1–2 µ" . SPARSER::PROTEIN)
    ("proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("WAVE2" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN)
    ("This increased dietary fat" . SPARSER::PROTEIN)
    ("butyrate and PKC" . SPARSER::COLLECTION)
    ("butyrate and other SCFAs" . SPARSER::COLLECTION)
    ("deoxycholate" . SPARSER::MOLECULE) ("diacylglycerols" . SPARSER::DAG)
    ("PMA or butyrate" . SPARSER::COLLECTION)
    ("ERK1/2 and AP-1" . SPARSER::COLLECTION)
    ("JNK nor p38" . SPARSER::COLLECTION)
    ("Thymic Stromal Lymphopoietin (TSLP)" . SPARSER::PROTEIN)
    ("TSLP" . SPARSER::PROTEIN)
    ("butyrate and 1,25-dihydroxy-Vitamin D3" . SPARSER::COLLECTION)
    ("cdk1 as well as inducing differentiation-specific genes"
     . SPARSER::COLLECTION)
    ("PMA/butyrate" . SPARSER::COLLECTION)
    ("some bacterial metabolites" . SPARSER::PROTEIN)
    ("other bacterial metabolites" . SPARSER::PROTEIN)
    ("NFkappaB" . SPARSER::PROTEIN)
    ("Butyrate and propionate" . SPARSER::COLLECTION)
    ("bacterial conditioned media" . SPARSER::PROTEIN)
    ("major bacterial metabolites" . SPARSER::PROTEIN)
    ("activator (PMA)" . SPARSER::ACTIVATOR)
    ("the bacterial metabolites" . SPARSER::PROTEIN)
    ("p38, ERK1/2 and JNK 3" . SPARSER::COLLECTION)
    ("PKC and MEK/ERK" . SPARSER::COLLECTION)
    ("PMA and Butyrate" . SPARSER::COLLECTION)
    ("PMA and butyrate" . SPARSER::COLLECTION)
    ("gauge" . SPARSER::PROTEIN-FAMILY) ("DCA" . SPARSER::PROTEIN)
    ("butyrate or TSA" . SPARSER::COLLECTION)
    ("butyrate or TSA and PMA" . SPARSER::COLLECTION)
    ("TSA and PMA" . SPARSER::COLLECTION) ("PMA and TSA" . SPARSER::COLLECTION)
    ("SCFAs and PMA" . SPARSER::COLLECTION)
    ("AP-1-luciferase" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE)
    ("Butyrate and PMA" . SPARSER::COLLECTION)
    ("propionate, butyrate, succinate and lactate" . SPARSER::COLLECTION)
    ("formate" . SPARSER::MOLECULE) ("Propionate" . SPARSER::MOLECULE)
    ("butyrate and propionate" . SPARSER::COLLECTION)
    ("the major metabolites" . SPARSER::PROTEIN)
    ("The major metabolites" . SPARSER::PROTEIN)
    ("Bacterial metabolites" . SPARSER::PROTEIN)
    ("butyrate and AP-1" . SPARSER::COLLECTION)
    ("butyrate and PMA" . SPARSER::COLLECTION)
    ("single bacterial metabolites" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13- acetate (PMA)" . SPARSER::DRUG)
    ("diacylglycerol" . SPARSER::PROTEIN) ("Phorbol" . SPARSER::DRUG)
    ("esters" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-2, IL-3, IL-4, IL-6, IL-8, and tumor necrosis factor"
     . SPARSER::COLLECTION)
    ("a dimeric complex" . SPARSER::BIO-COMPLEX)
    ("Jun and Fos" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the key SCFA" . SPARSER::MOLECULE) ("Butyrate" . SPARSER::PROTEIN)
    ("propionate, and butyrate" . SPARSER::COLLECTION)
    ("fatty-acids (SCFA)" . SPARSER::MOLECULE) ("SCFA" . SPARSER::MOLECULE)
    ("polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("three closely interacting components" . SPARSER::COMPONENT)
    ("c-fos and ERK1/2" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("propionate and butyrate" . SPARSER::COLLECTION)
    ("butyrate" . SPARSER::PROTEIN) ("propionate" . SPARSER::MOLECULE)
    ("SCFAs" . SPARSER::MOLECULE) ("bacterial metabolites" . SPARSER::PROTEIN)
    ("Thymic Stromal Lymphopoietin" . SPARSER::PROTEIN)
    ("1,25-Dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("Vitamin D3" . SPARSER::MOLECULE) ("cdk1" . SPARSER::PROTEIN)
    ("JNK 3" . SPARSER::PROTEIN) ("pAP1" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phorbol-12-myristate-13- acetate" . SPARSER::DRUG)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-4" . SPARSER::PROTEIN) ("IL-3" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("fatty-acids" . SPARSER::MOLECULE)
    ("short chain" . SPARSER::PROTEIN)
    ("Ascl1/MMP-7/MGMT" . SPARSER::COLLECTION) ("Tobacco" . SPARSER::DRUG)
    ("the alkylating anti-cancer drug cisplatin and non-alkylating anti-cancer drugs etoposide and docetaxel"
     . SPARSER::COLLECTION)
    ("cisplatin and non-alkylating anti-cancer drugs etoposide and docetaxel"
     . SPARSER::COLLECTION)
    ("etoposide and docetaxel" . SPARSER::COLLECTION)
    ("methylnitrosourea" . SPARSER::DRUG) ("CC10-Ascl1" . SPARSER::COLLECTION)
    ("Ascl1 and MGMT" . SPARSER::COLLECTION)
    ("O6-alkylguanine" . SPARSER::PROTEIN-PAIR) ("O6-" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("its ultimate carcinogenic form" . SPARSER::FORM)
    ("CGRP and PGP 9.5" . SPARSER::COLLECTION) ("CGRP" . SPARSER::PROTEIN)
    ("NEBs" . SPARSER::PROTEIN) ("CC10 and type II" . SPARSER::COLLECTION)
    ("SPC" . SPARSER::PROTEIN) ("MGMT and MMP-7" . SPARSER::COLLECTION)
    ("hyper- and dysplasias" . SPARSER::COLLECTION)
    ("hyper-" . SPARSER::PROTEIN) ("CC10-hASH1" . SPARSER::COLLECTION)
    ("Ascl1 and MMP-7" . SPARSER::COLLECTION)
    ("cisplatin (0, 0.5, 5, and 50 µM) and etoposide or docetaxel (0, 1, 10, or 100 µM)"
     . SPARSER::COLLECTION)
    ("etoposide or docetaxel" . SPARSER::COLLECTION)
    ("three first-line chemotherapeutic drugs" . SPARSER::DRUG)
    ("cisplatin, etoposide and docetaxel" . SPARSER::COLLECTION)
    ("cytosine" . SPARSER::NUCLEOBASE)
    ("a secretory protein" . SPARSER::PROTEIN) ("DMS" . SPARSER::DRUG)
    ("MGMT and Ascl1" . SPARSER::COLLECTION)
    ("nitrosamine 4-(methylnitros-amino)-1-(3-pyridyl)-1-butanone"
     . SPARSER::COLLECTION)
    ("ketone" . SPARSER::MOLECULE) ("butanone" . SPARSER::PROTEIN)
    ("-CANNTG-3" . SPARSER::COLLECTION)
    ("MMP-7 and MGMT" . SPARSER::COLLECTION)
    ("Ascl1, MMP-7 and MGMT" . SPARSER::COLLECTION)
    ("nitrosamine" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-7 (MMP-7) and O(6)-methylguanine-DNA methyltransferase (MGMT)"
     . SPARSER::COLLECTION)
    ("-methylguanine-DNA methyltransferase (MGMT)" . SPARSER::COLLECTION)
    ("-methylguanine-DNA methyltransferase" . SPARSER::COLLECTION)
    ("Ascl1" . SPARSER::PROTEIN) ("p450" . SPARSER::PROTEIN-FAMILY)
    ("PGP 9.5" . SPARSER::PROTEIN) ("surfactant protein C" . SPARSER::PROTEIN)
    ("hASH1" . SPARSER::PROTEIN) ("anti-mitotic" . SPARSER::MOLECULE)
    ("topoisomerase-II" . SPARSER::PROTEIN) ("O 6" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("PGP9.5" . SPARSER::PROTEIN)
    ("calcitonin gene-related peptide" . SPARSER::PROTEIN)
    ("CC10" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("Cis-diamminedichloroplatinum" . SPARSER::DRUG)
    ("MMP7" . SPARSER::PROTEIN) ("O6" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE)
    ("methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-7" . SPARSER::PROTEIN)
    ("PIK3CA , KRAS and FGFR2" . SPARSER::COLLECTION)
    ("the oncogenes CTNNB1 and tumor suppressor genes PTEN and P53"
     . SPARSER::COLLECTION)
    ("PTEN and P53" . SPARSER::COLLECTION)
    ("NRAS , HRAS , EGFR and BRAF" . SPARSER::COLLECTION)
    ("KRAS and FGFR2" . SPARSER::COLLECTION)
    ("/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("BRAF and EGFR" . SPARSER::COLLECTION)
    ("KRAS , PIK3CA and FGFR2" . SPARSER::COLLECTION)
    ("aaS" . SPARSER::MOLECULE) ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("PIK3CA (14.6%) and FGFR2 (10.4%)" . SPARSER::COLLECTION)
    ("HRAS (1.5%) and NRAS (1.5%)" . SPARSER::COLLECTION)
    ("FGFR2, KRAS, PIK3CA, PTEN, PT53 and CTNNB1" . SPARSER::COLLECTION)
    ("adjuvant and systemic treatment of recurrent or metastatic endometrial cancer"
     . SPARSER::COLLECTION)
    ("p53 and p16" . SPARSER::COLLECTION)
    ("PTEN and KRAS" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("FGFR2 , KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("the types and frequency" . SPARSER::COLLECTION)
    ("Hec1" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("Skp2 and Skp2B" . SPARSER::COLLECTION)
    ("Skp2B" . SPARSER::PROTEIN) ("CDK2 and Cdc14B" . SPARSER::COLLECTION)
    ("Cdc14B" . SPARSER::PROTEIN) ("Skp2 and Akt1" . SPARSER::COLLECTION)
    ("PKC-SKP2-AKT" . SPARSER::COLLECTION) ("rank " . SPARSER::PROTEIN)
    ("Cdh1" . SPARSER::PROTEIN) ("Gao" . SPARSER::PROTEIN)
    ("Skp2 and p27" . SPARSER::COLLECTION)
    ("c-myc, p21, p57, and p130" . SPARSER::COLLECTION)
    ("the cyclin-dependent kinase inhibitor p27 and the activator"
     . SPARSER::COLLECTION)
    ("S-phase kinase-associated protein" . SPARSER::PROTEIN)
    ("Skp2 and p" . SPARSER::COLLECTION)
    ("cytoplasmic Skp2, p-Akt1, and p27 expression" . SPARSER::COLLECTION)
    ("p-Akt1" . SPARSER::COLLECTION) ("Cdc14" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SKP2" . SPARSER::PROTEIN) ("atypical protein kinase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("cavin-1/PTRF" . SPARSER::COLLECTION) ("Vamp7" . SPARSER::PROTEIN)
    ("Cav1 and α5ß1" . SPARSER::COLLECTION)
    ("ß1 integrin or integrin-linked kinase (ILK)" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE) ("Keratinocytes" . SPARSER::PROTEIN)
    ("caveolar components" . SPARSER::COMPONENT)
    ("the main caveolar component" . SPARSER::COMPONENT)
    ("Cav1 and vinculin" . SPARSER::COLLECTION)
    ("endogenous Cav1 and the focal adhesion protein vinculin"
     . SPARSER::COLLECTION)
    ("two-independent siRNAs" . SPARSER::PROTEIN)
    ("α5-integrin-GFP" . SPARSER::COLLECTION) ("α5" . SPARSER::PROTEIN)
    ("Cav1 and α5-integrin" . SPARSER::COLLECTION)
    ("α5-integrin" . SPARSER::PROTEIN-PAIR)
    ("Cav1 and integrins" . SPARSER::COLLECTION)
    ("GFP-VAMP7" . SPARSER::COLLECTION) ("rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTs" . SPARSER::PROTEIN) ("the peripheral Cav1" . SPARSER::PROTEIN)
    ("nocodazole and cytochalasin-B" . SPARSER::COLLECTION)
    ("Cav1-GFP" . SPARSER::COLLECTION) ("PTRF/cavin-1" . SPARSER::COLLECTION)
    ("mRFP" . SPARSER::PROTEIN) ("Cav1-mRFP" . SPARSER::COLLECTION)
    ("trypsinization" . SPARSER::PROTEIN) ("integrin-" . SPARSER::PROTEIN)
    ("PtdIns" . SPARSER::PROTEIN) ("Exo70-GFP" . SPARSER::COLLECTION)
    ("Exo70-mCherry" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RalA and ARF6" . SPARSER::COLLECTION) ("RalA" . SPARSER::PROTEIN)
    ("Phospholipid" . SPARSER::PHOSPHOLIPID)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84"
     . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec5" . SPARSER::PROTEIN)
    ("Sec3" . SPARSER::PROTEIN) ("/cavin-1" . SPARSER::COLLECTION)
    ("PTRF" . SPARSER::PROTEIN) ("integrin or vinculin" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("IRE2" . SPARSER::PROTEIN) ("A 20" . SPARSER::PROTEIN)
    ("Caveolin1" . SPARSER::PROTEIN) ("EXOC7" . SPARSER::PROTEIN)
    ("Cavin-1" . SPARSER::PROTEIN) ("VAMP7" . SPARSER::PROTEIN)
    ("ARF6" . SPARSER::PROTEIN) ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("cavin-1" . SPARSER::PROTEIN)
    ("Polymerase I and Transcript Release Factor" . SPARSER::PROTEIN)
    ("Cav1" . SPARSER::PROTEIN) ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAD51C and RAD51D" . SPARSER::COLLECTION)
    ("the attributable fraction" . SPARSER::COMPONENT)
    ("ATM and 8.8×10" . SPARSER::COLLECTION) ("PMSA" . SPARSER::PROTEIN)
    ("full-length archaeal RAD51" . SPARSER::PROTEIN)
    ("RAD52 and RAD54" . SPARSER::COLLECTION) ("DNA-strand" . SPARSER::DNA)
    ("BRCA2-RAD51" . SPARSER::COLLECTION) ("nucleoprotein" . SPARSER::PROTEIN)
    ("BRC" . SPARSER::PROTEIN) ("intron-exon" . SPARSER::COLLECTION)
    ("cryptic" . SPARSER::PROTEIN)
    ("a functional acceptor" . SPARSER::MOLECULE)
    ("a slightly higher MES" . SPARSER::MOLECULE) ("MES" . SPARSER::MOLECULE)
    ("acceptors" . SPARSER::MOLECULE)
    ("Two intronic variants" . SPARSER::VARIANT)
    ("intronic variants" . SPARSER::VARIANT) ("pArg" . SPARSER::PROTEIN)
    ("et al . screened 46 Australian BRCA1 and BRCA2 -negative breast cancer families"
     . SPARSER::PROTEIN-FAMILY)
    ("other biologically relevant genes" . SPARSER::GENE)
    ("ATM and CHEK2" . SPARSER::COLLECTION)
    ("paralogs, RAD51C, RAD51D, and XRCC2" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 , TP53 , ATM , BRIP1 , CHEK2 and PALB2"
     . SPARSER::COLLECTION)
    ("PCR2" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("Biomarkers" . SPARSER::MOLECULE)
    ("Rac1 or indirectly increase Rac1 inhibitory proteins"
     . SPARSER::COLLECTION)
    ("indirectly increase Rac1 inhibitory proteins" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEFs" . SPARSER::PROTEIN)
    ("Slug, Snail, Zeb1 or Zeb2" . SPARSER::COLLECTION)
    ("Zeb2" . SPARSER::PROTEIN) ("Zeb1" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("E-cadherin and Rac1" . SPARSER::COLLECTION)
    ("miRs and miR" . SPARSER::COLLECTION)
    ("discrete polycistronic pri-miRNAs" . SPARSER::RNA)
    ("an incurable, castration-resistant and metastatic form" . SPARSER::FORM)
    ("novel biomarkers and therapeutic agents" . SPARSER::COLLECTION)
    ("MiRs" . SPARSER::PROTEIN) ("complementary mRNA" . SPARSER::PROTEIN)
    ("Jak-STAT" . SPARSER::PROTEIN) ("TGF-Beta" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("anti-neoplastic" . SPARSER::DRUG) ("small nuclear RNA" . SPARSER::RNA)
    ("pri-miRNAs" . SPARSER::RNA) ("IIB" . SPARSER::PROTEIN)
    ("underwent radical" . SPARSER::MOLECULE)
    ("Glut1, and glucose" . SPARSER::COLLECTION)
    ("Glut1 and Glut4 and glucose" . SPARSER::COLLECTION)
    ("Glut4 and glucose" . SPARSER::COLLECTION)
    ("Glut1 and Glut4" . SPARSER::COLLECTION)
    ("PI3K-Akt and NF-κB" . SPARSER::COLLECTION)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("IGF-1 and EGF" . SPARSER::COLLECTION) ("Cyld" . SPARSER::PROTEIN)
    ("ubiquitination-deficient K8R Akt mutant or cancer-associated E17K Akt mutant"
     . SPARSER::COLLECTION)
    ("wild-type Akt, ubiquitination-deficient K8R Akt mutant or cancer-associated E17K Akt mutant"
     . SPARSER::COLLECTION)
    ("cancer-associated E17K Akt mutant" . SPARSER::MUTANT)
    ("CYLD and the Akt-AAA mutant ( xref )" . SPARSER::COLLECTION)
    ("T308D/S473D" . SPARSER::PROTEIN) ("Akt and CYLD" . SPARSER::COLLECTION)
    ("both wild-type Akt and the ubiquitination-deficient K8R mutant ( 6 )"
     . SPARSER::COLLECTION)
    ("CYLD and Akt" . SPARSER::COLLECTION)
    ("Akt and TRAF6" . SPARSER::COLLECTION)
    ("CYLD and TRAF6" . SPARSER::COLLECTION)
    ("Akt2 and Akt3" . SPARSER::COLLECTION)
    ("wild-type primary MEFs" . SPARSER::PROTEIN)
    ("a bona fide DUB" . SPARSER::PROTEIN)
    ("TRAF6 and Skp2" . SPARSER::COLLECTION) ("FC" . SPARSER::PROTEIN)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("Akt1 and Akt2" . SPARSER::COLLECTION) ("DUBs" . SPARSER::PROTEIN)
    ("the E3 ligase S-phase kinase-associated protein 2 (Skp2) SCF"
     . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN) ("CYLD" . SPARSER::PROTEIN)
    ("enzyme (DUB)" . SPARSER::ENZYME) ("DUB" . SPARSER::PROTEIN)
    ("NP- 40" . SPARSER::DRUG) ("N-Ethylmaleimide" . SPARSER::MOLECULE)
    ("USP22" . SPARSER::PROTEIN) ("USP26" . SPARSER::PROTEIN)
    ("USP21" . SPARSER::PROTEIN) ("USP10" . SPARSER::PROTEIN)
    ("USP8" . SPARSER::PROTEIN) ("USP5" . SPARSER::PROTEIN)
    ("USP3" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("Glut4" . SPARSER::PROTEIN) ("Glut1" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 6" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("mTORC2" . SPARSER::PROTEIN)
    ("potentially bypass PI3K inhibitors" . SPARSER::INHIBITOR)
    ("the two dual inhibitors" . SPARSER::INHIBITOR)
    ("the dual inhibitors" . SPARSER::INHIBITOR)
    ("the two dual PI3K/MTOR inhibitors" . SPARSER::INHIBITOR)
    ("the PI3K inhibitor and the PAK1 inhibitor (P<0.01, Fisher’s exact test)"
     . SPARSER::COLLECTION)
    ("PI3K and PAK1" . SPARSER::COLLECTION)
    ("three separate shRNA" . SPARSER::PROTEIN)
    ("only 2 genes" . SPARSER::GENE)
    ("BKM120 (N=60, P<0.01) and BGT226 (N=31, P<0.05)" . SPARSER::COLLECTION)
    ("the dual PI3K/MTOR inhibitors" . SPARSER::INHIBITOR)
    ("AKT and Actin" . SPARSER::COLLECTION)
    ("Wilcoxon-rank" . SPARSER::PROTEIN-PAIR)
    ("the dual PI3K and MTOR inhibitors BEZ235" . SPARSER::DRUG)
    ("PI3K and MTOR" . SPARSER::COLLECTION)
    ("the dual inhibitor BEZ235" . SPARSER::DRUG)
    ("the PI3K inhibitor (BKM120) and a dual PI3K/MTOR inhibitor (BEZ235)"
     . SPARSER::COLLECTION)
    ("a dual PI3K/MTOR inhibitor" . SPARSER::INHIBITOR)
    ("BEZ235 and BGT226" . SPARSER::COLLECTION)
    ("a selective PI3K inhibitor and 2 separate dual PI3K/MTOR inhibitors"
     . SPARSER::INHIBITOR)
    ("three separate small molecule inhibitors" . SPARSER::INHIBITOR)
    ("mammalian target of rapamycin (MTOR)" . SPARSER::PROTEIN)
    ("the selective PI3K inhibitor BKM120 and the dual PI3K/MTOR inhibitors BEZ235"
     . SPARSER::COLLECTION)
    ("the dual PI3K/MTOR inhibitors BEZ235" . SPARSER::DRUG)
    ("PI3K/MTOR" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("GSK3" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN) ("PI3K inhibitor BEZ235" . SPARSER::DRUG)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-S6" . SPARSER::PROTEIN)
    ("GSK3 alpha" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("IPA-3" . SPARSER::MOLECULE) ("BKM120" . SPARSER::DRUG)
    ("p110" . SPARSER::PROTEIN) ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("BEZ235" . SPARSER::DRUG) ("PI3K inhibitor BKM120" . SPARSER::DRUG)
    ("LSD" . SPARSER::DRUG) ("pRL-TK" . SPARSER::COLLECTION)
    ("TransIL-LT1" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("Reagent" . SPARSER::MOLECULE) ("avidin-HRP" . SPARSER::COLLECTION)
    ("HRP" . SPARSER::PROTEIN) ("avidin" . SPARSER::PROTEIN)
    ("-AGTTGAGGGGACTTTCCCAGGC-3" . SPARSER::COLLECTION)
    ("Media" . SPARSER::PROTEIN) ("TM" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN) ("PVDF" . SPARSER::DRUG)
    ("p-ERK and p-p38" . SPARSER::COLLECTION) ("p-JNK" . SPARSER::COLLECTION)
    ("-GTGGGGCGCCCCAGGCACCA-3" . SPARSER::COLLECTION)
    ("-GGCTGCATATAGGATTCCGTC-3" . SPARSER::COLLECTION)
    ("-AGCTGGAGTCTATTCCTGGATT-3" . SPARSER::COLLECTION)
    ("-CTCCAGGTACCGCCCAGCTTCC-3" . SPARSER::COLLECTION)
    ("-CCCTGGGAATTTGGCGACGTAA-3" . SPARSER::COLLECTION)
    ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NaOH" . SPARSER::MOLECULE)
    ("PBS" . SPARSER::PROTEIN) ("ACP" . SPARSER::PROTEIN)
    ("ethanol and FBS" . SPARSER::COLLECTION) ("lycopene" . SPARSER::DRUG)
    ("p38 inhibitor (SB203580) and PI3K inhibitor (LY294002)"
     . SPARSER::COLLECTION)
    ("/stress-activated protein kinase" . SPARSER::COLLECTION)
    ("MAPK/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("amino acids (NEAA)" . SPARSER::AMINO-ACID)
    ("pyruvate, and non-essential" . SPARSER::COLLECTION)
    ("NEAA" . SPARSER::PROTEIN) ("NFκB-" . SPARSER::PROTEIN)
    ("FRAP/mTOR" . SPARSER::COLLECTION) ("FRAP" . SPARSER::PROTEIN)
    ("curcumin and emodin" . SPARSER::COLLECTION) ("emodin" . SPARSER::DRUG)
    ("JNK and p38" . SPARSER::COLLECTION) ("MERK/ERK" . SPARSER::COLLECTION)
    ("ERK1/2, p38, AKT and PI3K" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins BAD (Bcl-2-associated death protein) and caspase-9 [ xref ]"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins BAD" . SPARSER::PROTEIN)
    ("TP and ERCC1" . SPARSER::COLLECTION) ("si-ERCC1" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("genistein, parthenolide, flavopiridol and gliotoxin"
     . SPARSER::COLLECTION)
    ("gliotoxin" . SPARSER::DRUG) ("flavopiridol" . SPARSER::DRUG)
    ("parthenolide" . SPARSER::MOLECULE) ("genistein" . SPARSER::PROTEIN)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and survivin" . SPARSER::COLLECTION)
    ("p53 or Bax" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL or IAPs" . SPARSER::COLLECTION)
    ("the ERK inhibitor or PI3K inhibitor" . SPARSER::COLLECTION)
    ("p38 inhibitor (SB203580; 20 μM) or PI3K inhibitor (LY294002; 20 μM)"
     . SPARSER::COLLECTION)
    ("ERK, p38 and PI3K/AKT" . SPARSER::COLLECTION)
    ("ERK, p38 and JNK" . SPARSER::COLLECTION)
    ("p38, ERK, and JNK" . SPARSER::COLLECTION)
    ("fucoxanthin, NAI and cisplatin" . SPARSER::COLLECTION)
    ("inhibitor (NAI)" . SPARSER::INHIBITOR) ("NAI" . SPARSER::MOLECULE)
    ("CYP3A4 and MDR1" . SPARSER::COLLECTION) ("PXR" . SPARSER::PROTEIN)
    ("carotenoids" . SPARSER::MOLECULE) ("Fucoxanthin" . SPARSER::DRUG)
    ("gemcitabine" . SPARSER::DRUG) ("docetaxel" . SPARSER::DRUG)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("cisplatin and microtubule-interfering agents" . SPARSER::COLLECTION)
    ("hypoxia, and Fas" . SPARSER::COLLECTION)
    ("thymidine phosphorylase (TP)" . SPARSER::PROTEIN)
    ("glutathione" . SPARSER::DRUG) ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("malignant HCC" . SPARSER::PROTEIN)
    ("unresectable HCC" . SPARSER::PROTEIN)
    ("fucoxanthin and cisplatin" . SPARSER::COLLECTION)
    ("ERCC1 and TP" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("carotenoid" . SPARSER::MOLECULE) ("provitamin" . SPARSER::MOLECULE)
    ("fucoxanthin" . SPARSER::DRUG) ("LT1" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("p -nitrophenyl" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("SRC-1" . SPARSER::PROTEIN) ("pregnane X receptor" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("cis -diamminedichloroplatinum" . SPARSER::DRUG)
    ("thymidine phosphorylase" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("Rac1, Rock1 and Pak1" . SPARSER::COLLECTION)
    ("paclitaxel and cytochalasin" . SPARSER::COLLECTION)
    ("cytochalasin" . SPARSER::MOLECULE) ("Drugs" . SPARSER::DRUG)
    ("destrin (ADF)" . SPARSER::PROTEIN)
    ("cofilin1 and cofilin2" . SPARSER::COLLECTION) ("ADF" . SPARSER::PROTEIN)
    ("destrin" . SPARSER::PROTEIN)
    ("Rho-Rac1-ROCK1/PAK1-LIMK1-Cofilins" . SPARSER::COLLECTION)
    ("cofilins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cofilins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21-activated protein kinase1" . SPARSER::COLLECTION)
    ("Rock1 and Pak1" . SPARSER::COLLECTION)
    ("Rho, Rac and Cdc42" . SPARSER::COLLECTION) ("Pak4" . SPARSER::PROTEIN)
    ("92 percent homology" . SPARSER::PROTEIN)
    ("65 percent amino acid homology" . SPARSER::PROTEIN)
    ("Rock1 and Rock2" . SPARSER::COLLECTION)
    ("Rocks" . SPARSER::PROTEIN-FAMILY)
    ("subtypes, Rock1 and Rock2" . SPARSER::COLLECTION)
    ("Rock2" . SPARSER::PROTEIN)
    ("an important biological regulator" . SPARSER::REGULATOR)
    ("Cdc42 and Rac" . SPARSER::COLLECTION) ("p22" . SPARSER::PROTEIN)
    ("Rac1, Pak1, and Rock1" . SPARSER::COLLECTION)
    ("Rac1, Pak1 and Rock1" . SPARSER::COLLECTION) ("Rock1" . SPARSER::PROTEIN)
    ("actin-depolymerizing factor" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("cofilin1" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN)
    ("Rho-associated protein kinase 1" . SPARSER::PROTEIN)
    ("LIMK-2" . SPARSER::PROTEIN) ("LIMK-1" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA)
    ("superoxide anion" . SPARSER::MOLECULE)
    ("small G-protein" . SPARSER::PROTEIN) ("Substance P" . SPARSER::PROTEIN)
    ("H–E" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("P21-activated kinase 1" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("Short-interfering RNA" . SPARSER::RNA)
    ("the junctional complex" . SPARSER::BIO-COMPLEX)
    ("a junctional complex" . SPARSER::BIO-COMPLEX)
    ("catenins" . SPARSER::PROTEIN-FAMILY)
    ("immunoglobulin superfamily and cadherins" . SPARSER::COLLECTION)
    ("selectins" . SPARSER::PROTEIN)
    ("these findings link WT1’s" . SPARSER::PROTEIN)
    ("siWT1 RNA or RISC oligonucleotides" . SPARSER::COLLECTION)
    ("RISC or siWT1" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("the −403 proximal promoter" . SPARSER::PROMOTER)
    ("the proximal −403 bp E-cadherin promoter" . SPARSER::PROMOTER)
    ("pGFP/WT1" . SPARSER::COLLECTION) ("WT1 and EGR-1" . SPARSER::COLLECTION)
    ("WT1, EGR-1 and SP1" . SPARSER::COLLECTION) ("RNA (MOCK)" . SPARSER::RNA)
    ("the E-cadherin proximal promoter" . SPARSER::PROMOTER)
    ("KTS" . SPARSER::MOLECULE) ("tripeptide" . SPARSER::MOLECULE)
    ("ZEB-1 and ZEB-2" . SPARSER::COLLECTION)
    ("the proximal E-cadherin promoter" . SPARSER::PROMOTER)
    ("WT1 and E-cadherin" . SPARSER::COLLECTION)
    ("one such transcription factor, WT1 in high Gleason grade prostate tumor tissues, and its absence in non-neoplastic or benign prostatic hyperplasia tissues"
     . SPARSER::COLLECTION)
    ("PCa" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("ETS-1" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("EGR-1" . SPARSER::PROTEIN)
    ("SIP-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZEB-2" . SPARSER::PROTEIN)
    ("ZEB-1" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("FN, and VTP" . SPARSER::COLLECTION) ("MN" . SPARSER::PROTEIN)
    ("NF-κB and/or c-Rel" . SPARSER::COLLECTION)
    ("IL10RA and TNFRSF18" . SPARSER::COLLECTION)
    ("their respective gene" . SPARSER::GENE)
    ("haemoglobin" . SPARSER::MOLECULE)
    ("STAT6 and IL10RA" . SPARSER::COLLECTION)
    ("STAT6 (rs3024941/rs30240943/rs3024944) and IL10RA (rs56356146/rs7925112/ss491228441)"
     . SPARSER::COLLECTION)
    ("FOXP3, IL10RB and TNFRSF18" . SPARSER::COLLECTION)
    ("IL10RA and - 163C/T variants" . SPARSER::COLLECTION)
    ("FOXP3 , IL10RA , IL10RB , STAT6 and TNFRSF18" . SPARSER::COLLECTION)
    ("IL10RA and IL10RB" . SPARSER::COLLECTION)
    ("severe forms" . SPARSER::FORM)
    ("STAT6 (rs3024941, rs3024943, rs3024944) and TNFRSF18 (ss2080581728, rs3753344)"
     . SPARSER::COLLECTION)
    ("FOXP3 (ss270137548, rs11091253), IL10RA (rs56356146, rs7925112), IL10RB (rs8178433, rs8178435, rs999788), STAT6 (rs3024941, rs3024943, rs3024944) and TNFRSF18 (ss2080581728, rs3753344)"
     . SPARSER::COLLECTION)
    ("c-Rel" . SPARSER::PROTEIN) ("group I" . SPARSER::PROTEIN)
    ("TCF-1" . SPARSER::PROTEIN) ("dominant and recessive" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("IL10R" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("member 18" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("interleukin 10" . SPARSER::PROTEIN)
    ("forkhead box P3" . SPARSER::PROTEIN) ("TNFRSF18" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("IL10RB" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN)
    ("endothelial neuropilin-1" . SPARSER::PROTEIN)
    ("growth factor and semaphorin families" . SPARSER::COLLECTION)
    ("Valine" . SPARSER::AMINO-ACID) ("Isoleucine" . SPARSER::AMINO-ACID)
    ("GATA" . SPARSER::PROTEIN) ("glypican" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TOF, and GPC5" . SPARSER::COLLECTION)
    ("glycosyl-phosphatidylinositol" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("proteoglycans" . SPARSER::PROTEIN) ("sulphate" . SPARSER::MOLECULE)
    ("heparan" . SPARSER::MOLECULE)
    ("Glypicans" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TOF and an evolutionarily selected haplotype" . SPARSER::COLLECTION)
    ("PTPN11 (rs11066320) and TOF" . SPARSER::COLLECTION)
    ("UK, Dutch and Canadian TOF" . SPARSER::COLLECTION)
    ("Canadian TOF" . SPARSER::PROTEIN)
    ("the top 10 principal components" . SPARSER::COMPONENT)
    ("cyanotic CHD" . SPARSER::PROTEIN) ("sporadic CHD" . SPARSER::PROTEIN)
    ("TOF" . SPARSER::PROTEIN)
    ("semaphorin families" . SPARSER::PROTEIN-FAMILY)
    ("Neuropilin-1" . SPARSER::PROTEIN) ("NRP1" . SPARSER::PROTEIN)
    ("neuropilin-1" . SPARSER::PROTEIN) ("GPC6" . SPARSER::PROTEIN)
    ("GPC3" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("glypican family" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("Y chromosome" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("tyrosine-protein phosphatase non-receptor type 11" . SPARSER::PROTEIN)
    ("non-syndromic" . SPARSER::PROTEIN) ("glypican 5" . SPARSER::PROTEIN)
    ("diagnostic antibody" . SPARSER::PROTEIN)
    ("anti-HGF antibody (AMG102) and anti-MET antibody (MetMab)"
     . SPARSER::COLLECTION)
    ("MSC and macrophages" . SPARSER::COLLECTION)
    ("NK4 cDNA-transfected autologous macrophage" . SPARSER::PROTEIN)
    ("-repressor" . SPARSER::REPRESSOR) ("AKT-mTOR" . SPARSER::COLLECTION)
    ("These drugs or natural products" . SPARSER::COLLECTION)
    ("catechins" . SPARSER::MOLECULE)
    ("a classic type COX2 inhibitor" . SPARSER::INHIBITOR)
    ("Soluble MET-Sema" . SPARSER::COLLECTION)
    ("MET-Sema" . SPARSER::COLLECTION) ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a structural homology" . SPARSER::PROTEIN)
    ("angiotensin" . SPARSER::PROTEIN) ("decorin" . SPARSER::PROTEIN)
    ("proteoglycan" . SPARSER::PROTEIN) ("Decorin" . SPARSER::PROTEIN)
    ("PHA-665752 or SU-11274" . SPARSER::COLLECTION)
    ("small-sized TK inhibitors" . SPARSER::INHIBITOR)
    ("monovalent antibody" . SPARSER::PROTEIN)
    ("a single Fab-armed monoclonal antibody" . SPARSER::DRUG)
    ("MetMab" . SPARSER::DRUG) ("VEGF-" . SPARSER::PROTEIN)
    ("Rilotumumab" . SPARSER::DRUG) ("AMG" . SPARSER::PROTEIN)
    ("HGF or its receptor" . SPARSER::COLLECTION) ("Toxin" . SPARSER::MOLECULE)
    ("NK1 and NK2" . SPARSER::COLLECTION) ("ribozyme" . SPARSER::RNA)
    ("Nanog, Sox2, Klf4, Oct4 and c-Myc" . SPARSER::COLLECTION)
    ("local HGF" . SPARSER::PROTEIN) ("CTL" . SPARSER::PROTEIN)
    ("EGF-receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("Adriamycin, cisplatin and 5FU" . SPARSER::COLLECTION)
    ("Adriamycin" . SPARSER::DRUG)
    ("neither HGF nor NK4" . SPARSER::COLLECTION) ("HGF-" . SPARSER::PROTEIN)
    ("HGF, or co-cultured" . SPARSER::COLLECTION)
    ("kallikrein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin-G and MMP" . SPARSER::COLLECTION)
    ("NK4 and remnant HGF-β [ xref , xref ]" . SPARSER::COLLECTION)
    ("chymase" . SPARSER::PROTEIN) ("mast cell" . SPARSER::PROTEIN)
    ("perlecan-fibronectin" . SPARSER::COLLECTION)
    ("NK4-perlecan" . SPARSER::COLLECTION)
    ("fibronectin-perlecan" . SPARSER::COLLECTION)
    ("Perlecan" . SPARSER::PROTEIN) ("trap" . SPARSER::PROTEIN)
    ("fibronectin-integrin" . SPARSER::COLLECTION)
    ("HGF and VEGF" . SPARSER::COLLECTION)
    ("MET and KDR/VEGF-receptor" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("b-FGF and VEGF" . SPARSER::COLLECTION)
    ("Vascular EC" . SPARSER::PROTEIN) ("MET, and HGF" . SPARSER::COLLECTION)
    ("a complete antagonist" . SPARSER::MOLECULE)
    ("NK1 (composed of hairpin-loop and K1 domain) and NK2 (hairpin-loop and K1–K2 domains)"
     . SPARSER::COLLECTION)
    ("K1–K2" . SPARSER::COLLECTION) ("Asn" . SPARSER::AMINO-ACID)
    ("elastase" . SPARSER::PROTEIN)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("HGF and MET" . SPARSER::COLLECTION)
    ("tumor-associated macrophages (TAM)" . SPARSER::PROTEIN)
    ("TAM" . SPARSER::PROTEIN) ("indomethacin" . SPARSER::DRUG)
    ("prostaglandin" . SPARSER::PROTEIN) ("SDF1-CXCR4" . SPARSER::COLLECTION)
    ("MET/PI3-kinase/ERK" . SPARSER::COLLECTION)
    ("integrin-tetraspanin" . SPARSER::COLLECTION)
    ("suspension-induced anoikis" . SPARSER::PROTEIN)
    ("PI3-kinase and ERK-1/2" . SPARSER::COLLECTION)
    ("endothelial occludin" . SPARSER::PROTEIN) ("occludin" . SPARSER::PROTEIN)
    ("HIF1-MET" . SPARSER::COLLECTION)
    ("Such local hypoxia" . SPARSER::PROTEIN) ("HGF-Ets" . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ECM and integrins" . SPARSER::COLLECTION)
    ("condensations" . SPARSER::PROTEIN-FAMILY)
    ("cdc42/Rac/PAK" . SPARSER::COLLECTION) ("Ras-Rab5" . SPARSER::COLLECTION)
    ("cadherin–cadherin" . SPARSER::COLLECTION)
    ("cadherins and intracellular catenin molecules" . SPARSER::COLLECTION)
    ("-mutants" . SPARSER::MUTANT) ("PRCs" . SPARSER::PROTEIN)
    ("EGFR-TKIs" . SPARSER::COLLECTION) ("Iressa" . SPARSER::DRUG)
    ("Gefitinib" . SPARSER::DRUG) ("EGF-TKI" . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN)
    ("phospho-MET and β-catenin" . SPARSER::COLLECTION)
    ("c-Myc and cyclin-D1" . SPARSER::COLLECTION)
    ("HGF-transgene" . SPARSER::COLLECTION) ("aberrant MET" . SPARSER::PROTEIN)
    ("MLE" . SPARSER::PROTEIN) ("other sporadic types" . TYPE)
    ("intrinsic HGF" . SPARSER::PROTEIN)
    ("HGF-antisense" . SPARSER::COLLECTION)
    ("PI-3kinase, PLC-γ, Shp-2, and Crk-2" . SPARSER::COLLECTION)
    ("Ras-ERK" . SPARSER::COLLECTION) ("Grb2-SOS" . SPARSER::PROTEIN-PAIR)
    ("MET–MET" . SPARSER::COLLECTION)
    ("the first 519 amino aids form" . SPARSER::FORM)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("HOS" . SPARSER::PROTEIN)
    ("HGF/SF" . SPARSER::COLLECTION) ("-derived factor" . SPARSER::COLLECTION)
    ("SF" . SPARSER::PROTEIN) ("K1–K4" . SPARSER::COLLECTION)
    ("a biological barrier" . SPARSER::PROTEIN)
    ("matrix (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("HGF–MET" . SPARSER::COLLECTION) ("perlecan" . SPARSER::PROTEIN)
    ("antagonists" . SPARSER::MOLECULE) ("COX2" . SPARSER::PROTEIN)
    ("SU-11274" . SPARSER::DRUG) ("c-Cbl" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE) ("PHA-665752" . SPARSER::DRUG)
    ("Klf4" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("serine-protease" . SPARSER::PROTEIN)
    ("cathepsin-G" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("NK2" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN) ("b-FGF" . SPARSER::DRUG)
    ("IL-10" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("hypoxia-induced factor-1" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("etc ." . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("Fas-ligand" . SPARSER::PROTEIN) ("cyclin-D1" . SPARSER::PROTEIN)
    ("PI3Kinase" . SPARSER::PROTEIN) ("Crk-2" . SPARSER::PROTEIN)
    ("Shp-2" . SPARSER::PROTEIN) ("PLC-γ" . SPARSER::PROTEIN-FAMILY)
    ("PI-3kinase" . SPARSER::PROTEIN) ("Gab-1" . SPARSER::PROTEIN)
    ("Sema domain" . SPARSER::PROTEIN) ("HGF-receptor" . SPARSER::PROTEIN)
    ("NK1" . SPARSER::PROTEIN) ("orphan receptor" . SPARSER::PROTEIN)
    ("Scatter factor" . SPARSER::PROTEIN) ("α-chain" . SPARSER::PROTEIN)
    ("K1" . SPARSER::PROTEIN) ("NK4" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("-catenin/TCF/LEF-1" . SPARSER::COLLECTION)
    ("β-catenin and TCF4" . SPARSER::COLLECTION)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("β-catenin, APC and Axins" . SPARSER::COLLECTION)
    ("Myc/TCF4" . SPARSER::COLLECTION) ("HA/β-catenin" . SPARSER::COLLECTION)
    ("Flag/Sox7" . SPARSER::COLLECTION) ("Flag/TCF4" . SPARSER::COLLECTION)
    ("RFP/Sox7" . SPARSER::COLLECTION)
    ("Sox7, β-catenin and TCF4" . SPARSER::COLLECTION)
    ("β-catenin/TCF/LEF" . SPARSER::COLLECTION)
    ("β-catenin, CyclinD1 and C-myc" . SPARSER::COLLECTION)
    ("CyclinD1 and C-myc" . SPARSER::COLLECTION)
    ("C-myc and CyclinD1" . SPARSER::COLLECTION)
    ("CyclinD1 , C-myc and FGF9" . SPARSER::COLLECTION)
    ("CyclinD1 and FGF9" . SPARSER::COLLECTION)
    ("Sox7 and β-catenin" . SPARSER::COLLECTION)
    ("Cyclin D1 ( P < 0.001) and FGF9 ( P = 0.003)" . SPARSER::COLLECTION)
    ("Sox7, β-catenin, CyclinD1 and FGF9" . SPARSER::COLLECTION)
    ("FGF9 and SFN" . SPARSER::COLLECTION)
    ("Fibroblast growth factor 9 ( FGF9 ) and Stratifin ( SFN ) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Stratifin ( SFN )" . SPARSER::PROTEIN) ("SFN" . SPARSER::PROTEIN)
    ("Stratifin" . SPARSER::PROTEIN)
    ("β-catenin , APC and Axins" . SPARSER::COLLECTION)
    ("Axin1 and Axin2" . SPARSER::COLLECTION) ("conductin" . SPARSER::PROTEIN)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Type II or non-endometrioid" . SPARSER::COLLECTION)
    ("β-catenin/TCF/LEF-1" . SPARSER::COLLECTION) ("OEA" . SPARSER::MOLECULE)
    ("β-catenin or TCF4" . SPARSER::COLLECTION)
    ("Cyclin D1 and C-myc" . SPARSER::COLLECTION)
    ("β-catenin ( P =0.038) and its downstream targets" . SPARSER::COLLECTION)
    ("CyclinD1 ( P <0.001) and FGF9 ( P <0.001)" . SPARSER::COLLECTION)
    ("β−catenin" . SPARSER::PROTEIN) ("Sox-7" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 9" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("C-Myc" . SPARSER::PROTEIN)
    ("Cyclin-D" . SPARSER::PROTEIN) ("Wnt3A" . SPARSER::PROTEIN)
    ("Axin1" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("C-myc" . SPARSER::PROTEIN)
    ("Wnt-1" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("Sox7" . SPARSER::PROTEIN) ("bovine serum albumin" . SPARSER::PROTEIN)
    ("tumor necrosis factor-" . SPARSER::PROTEIN)
    ("chemokine-1" . SPARSER::COLLECTION) ("selenium" . SPARSER::MOLECULE)
    ("transferrin" . SPARSER::PROTEIN) ("BSA" . SPARSER::PROTEIN)
    ("both activated HIF-1 and GTP-bound RhoA" . SPARSER::COLLECTION)
    ("DFO" . SPARSER::MOLECULE)
    ("an active HIF-1 heterodimer" . SPARSER::HETERODIMER)
    ("a heterodimeric protein" . SPARSER::PROTEIN)
    ("subunits, HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("CX3CR1 and CXCR4" . SPARSER::COLLECTION)
    ("acute hypoxia" . SPARSER::PROTEIN)
    ("cytokines and TNF-α" . SPARSER::COLLECTION)
    ("family and TNF-α" . SPARSER::COLLECTION) ("IL" . SPARSER::PROTEIN)
    ("chemokines and inflammatory cytokines" . SPARSER::COLLECTION)
    ("growth factors, chemokines and inflammatory cytokines"
     . SPARSER::COLLECTION)
    ("normal oxygen" . SPARSER::MOLECULE)
    ("the mutated oligonucleotide" . SPARSER::MOLECULE)
    ("HIF-1 and RhoA" . SPARSER::COLLECTION)
    ("G-proteins and other biologically active substances [ xref ]"
     . SPARSER::COLLECTION)
    ("integrins, G-proteins and other biologically active substances [ xref ]"
     . SPARSER::COLLECTION)
    ("other biologically active substances" . SPARSER::SUBSTANCE)
    ("functional RhoA" . SPARSER::PROTEIN) ("substances" . SPARSER::SUBSTANCE)
    ("IL-1β, IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("PDGF-AB, MIP-1α, BCA-1 and GROα" . SPARSER::COLLECTION)
    ("HGF, PDGF-AB and EGF" . SPARSER::COLLECTION)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("IGF-1 and MIP-3β" . SPARSER::COLLECTION)
    ("Fractalkine" . SPARSER::PROTEIN) ("bFGF" . SPARSER::PROTEIN)
    ("VEGF, SDF-1, and angiopoietin-1" . SPARSER::COLLECTION)
    ("hypoxia and/or normoxia" . SPARSER::COLLECTION)
    ("CD34 (progenitors/endothelial cells) or CD45 (leukocytes)"
     . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("multipotent MSC" . SPARSER::PROTEIN)
    ("CD73, CD90 and CD105" . SPARSER::COLLECTION)
    ("cytokines and cytokines" . SPARSER::COLLECTION)
    ("growth factors and inflammatory cytokines" . SPARSER::COLLECTION)
    ("soluble chemokines, growth factors and inflammatory cytokines"
     . SPARSER::COLLECTION)
    ("soluble chemokines" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN) ("MSCs" . SPARSER::PROTEIN)
    ("hypoxic MSC" . SPARSER::PROTEIN) ("calpeptin" . SPARSER::MOLECULE)
    ("MSC" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("CX3CR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("per 1" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor -1" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE) ("GROα" . SPARSER::PROTEIN)
    ("BCA-1" . SPARSER::PROTEIN) ("MIP-1α" . SPARSER::PROTEIN)
    ("MIP-3" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein" . SPARSER::PROTEIN)
    ("PDGF-AB" . SPARSER::PROTEIN)
    ("platelet-derived growth factor-AB" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD166" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD 73" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("LAR" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("Rac/LIMK1/cofilin" . SPARSER::COLLECTION)
    ("human primary macrophages" . SPARSER::PROTEIN)
    ("Rac1-LIMK1-cofilin" . SPARSER::COLLECTION)
    ("co-receptors, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("Rac1 and actin" . SPARSER::COLLECTION)
    ("GTPases, Rac1 and cdc42" . SPARSER::COLLECTION)
    ("Robo-actin" . SPARSER::COLLECTION)
    ("the cortical actin" . SPARSER::PROTEIN)
    ("CD4-CXCR4" . SPARSER::COLLECTION)
    ("The cortical actin" . SPARSER::PROTEIN)
    ("receptors/co-receptors" . SPARSER::COLLECTION)
    ("the viral envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor, CD4 and co-receptors" . SPARSER::COLLECTION)
    ("CXCR4/CCR5" . SPARSER::COLLECTION) ("lymphoid" . SPARSER::PROTEIN)
    ("LIMK1 and cofilin" . SPARSER::COLLECTION) ("agarose" . SPARSER::MOLECULE)
    ("Rac1/LIMK1/cofilin" . SPARSER::COLLECTION)
    ("Rac1 and the LIM domain kinase (LIMK)" . SPARSER::COLLECTION)
    ("the Rho GTPase, Rac1 and the LIM domain kinase (LIMK)"
     . SPARSER::COLLECTION)
    ("kinase (LIMK)" . SPARSER::KINASE) ("Actin" . SPARSER::PROTEIN)
    ("Robo1/actin" . SPARSER::COLLECTION) ("proviral HIV-1 DNA" . SPARSER::DNA)
    ("LTR-Alu" . SPARSER::COLLECTION) ("Alu" . SPARSER::PROTEIN)
    ("BlaM-Vpr" . SPARSER::COLLECTION) ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD4, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("BaL" . SPARSER::PROTEIN)
    ("VSV" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("CD4 and/or co-receptors (CXCR4 or CCR5)" . SPARSER::COLLECTION)
    ("fibronectin type III and immunoglobulin" . SPARSER::COLLECTION)
    ("Ig" . SPARSER::MOLECULE) ("kDa " . SPARSER::PROTEIN)
    ("LRRs" . SPARSER::PROTEIN) ("Slit2/Robo1" . SPARSER::COLLECTION)
    ("Slit1, Slit2 and Slit3" . SPARSER::COLLECTION)
    ("Slit1" . SPARSER::PROTEIN) ("Robo" . SPARSER::PROTEIN-FAMILY)
    ("Roundabout" . SPARSER::PROTEIN)
    ("large secretory glycoproteins" . SPARSER::PROTEIN)
    ("Rac1, LIMK and cofilin" . SPARSER::COLLECTION)
    ("Robo1-actin" . SPARSER::COLLECTION)
    ("CXCR4 and CCR5-tropic" . SPARSER::COLLECTION)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("R-E" . SPARSER::PROTEIN)
    ("N protein" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdc42" . SPARSER::PROTEIN) ("srGAP1" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LIMK1" . SPARSER::PROTEIN) ("β-lactamase" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("MT4" . SPARSER::PROTEIN)
    ("guanosine triphosphates" . SPARSER::MOLECULE)
    ("fibronectin type III" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("Slit3" . SPARSER::PROTEIN) ("Robo1" . SPARSER::PROTEIN)
    ("Slit2" . SPARSER::PROTEIN) ("target IE genes" . SPARSER::GENE)
    ("FOS/JUN" . SPARSER::COLLECTION) ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2 and MSK1" . SPARSER::COLLECTION)
    ("ERK1/2, p38 MAPK and JNK" . SPARSER::COLLECTION)
    ("STAT3 and VAV3" . SPARSER::COLLECTION) ("the IE genes" . SPARSER::GENE)
    ("alcohol and U0126" . SPARSER::COLLECTION)
    ("alcohol and/or U0126" . SPARSER::COLLECTION) ("alcohol-" . SPARSER::DRUG)
    ("MEK1/2, ERK1/2, MSK1 and H3S10" . SPARSER::COLLECTION)
    ("protein and MAPK" . SPARSER::COLLECTION)
    ("immediate-early (IE) genes" . SPARSER::GENE)
    ("stress-activated ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-fos and c-jun" . SPARSER::COLLECTION) ("PKB/Akt" . SPARSER::COLLECTION)
    ("c-fos , c-jun and MKP-1" . SPARSER::COLLECTION)
    ("alcohol and acetaldehyde" . SPARSER::COLLECTION)
    ("acetaldehyde" . SPARSER::MOLECULE) ("Histones" . SPARSER::PROTEIN)
    ("RTKs" . SPARSER::PROTEIN) ("SAPK/JNK" . SPARSER::COLLECTION)
    ("stress-activated protein kinase/c-Jun" . SPARSER::COLLECTION)
    ("retinoic acid, folate or estrogen" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE) ("immediate-early gene" . SPARSER::GENE)
    ("mitogen-" . SPARSER::MITOGEN) ("c-ros" . SPARSER::PROTEIN)
    ("differentially expressed proteins" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("VAV3" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKKα" . SPARSER::PROTEIN) ("Rsk2" . SPARSER::PROTEIN)
    ("PIM1" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("VRK1" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-fos" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN)
    ("stress-activated protein kinase 1" . SPARSER::PROTEIN)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("EGFR and p53" . SPARSER::COLLECTION)
    ("EGFR and/or p53DD" . SPARSER::COLLECTION)
    ("AKT and EGFR" . SPARSER::COLLECTION)
    ("EGFR-p53DD-PTEN" . SPARSER::COLLECTION)
    ("p53DD or EGFR" . SPARSER::COLLECTION) ("p53DD" . SPARSER::PROTEIN)
    ("ctrl" . SPARSER::PROTEIN)
    ("wildtype EGFR and/or p53DD" . SPARSER::COLLECTION)
    ("p53DD-PTEN −/− and EGFR-PTEN −/−" . SPARSER::COLLECTION)
    ("EGFR-PTEN" . SPARSER::COLLECTION) ("p53DD-PTEN" . SPARSER::COLLECTION)
    ("EGFR-p53DD" . SPARSER::COLLECTION)
    ("mutant nor a PTEN-null mutant" . SPARSER::COLLECTION)
    ("EGFR or p53DD" . SPARSER::COLLECTION) ("EGFR-" . SPARSER::PROTEIN)
    ("EGFR, p53DD or losing PTEN" . SPARSER::COLLECTION)
    ("overnight and total protein" . SPARSER::PROTEIN)
    ("EGFR, p53DD or PTEN" . SPARSER::COLLECTION)
    ("EGFR , TP53 or PTEN" . SPARSER::COLLECTION)
    ("PTEN, EGFR and p53" . SPARSER::COLLECTION)
    ("total and phosphorylated EGFR" . SPARSER::PROTEIN)
    ("EGFR, p53 or PTEN" . SPARSER::COLLECTION) ("delE" . SPARSER::PROTEIN)
    ("p53 and the phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR), p53 and the phosphatase and tensin homolog"
     . SPARSER::COLLECTION)
    ("onco-proteins" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("p53 or EGFR" . SPARSER::COLLECTION)
    ("EGFR, p53 and PTEN" . SPARSER::COLLECTION)
    ("the most aggressive and lethal types" . TYPE)
    ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("H- Ras" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("PCDH8" . SPARSER::PROTEIN)
    ("the associated collagen genes" . SPARSER::GENE)
    ("most quantitative traits" . SPARSER::PROTEIN)
    ("either set 1 (European ancestry) or set 2 (Asian ancestry)"
     . SPARSER::COLLECTION)
    ("LRRK1 ( P = 1.04 × 10 −11 , R  2 = 3.4%) and CHSY1 ( P = 1.2 × 10 −6 , R  2 = 1.8%)"
     . SPARSER::COLLECTION)
    ("collagen or ECM" . SPARSER::COLLECTION) ("PTGDS" . SPARSER::PROTEIN)
    ("a single associated nearby gene" . SPARSER::GENE)
    ("COL5A1 (OR = 1.37, 95% CI = 1.19–1.57, P = 8 × 10 −6 for rs7044529) and ZNF469 (OR = 1.25, 95% CI = 1.11–1.40, P = 1.9 × 10 −4 for rs9938149)"
     . SPARSER::COLLECTION)
    ("NF1B (OR = 1.33, 95% CI = 1.18–1.51, P = 5.2 × 10 −6 for rs1324183), COL5A1 (OR = 1.37, 95% CI = 1.19–1.57, P = 8 × 10 −6 for rs7044529) and ZNF469 (OR = 1.25, 95% CI = 1.11–1.40, P = 1.9 × 10 −4 for rs9938149)"
     . SPARSER::COLLECTION)
    ("RXRA-COL5A1" . SPARSER::COLLECTION)
    ("ZNF469 , COL5A1 and COL8A2" . SPARSER::COLLECTION)
    ("collagen and ECM" . SPARSER::COLLECTION)
    ("fibrillar collagen (Fisher’s P = 4.8 × 10 −6 , 0.022 after correction) and ECM part (Fisher’s P = 5.2 × 10 −6 , 0.024 after correction)"
     . SPARSER::COLLECTION)
    ("fibrillar collagen" . SPARSER::PROTEIN) ("PDGFRA" . SPARSER::PROTEIN)
    ("ECM and collagen" . SPARSER::COLLECTION)
    ("connective tissue components" . SPARSER::COMPONENT)
    ("HAPLN1 , and molecules" . SPARSER::COLLECTION)
    ("the genome-wide significant genes" . SPARSER::GENE)
    ("COL2A1 , COL5A1 , COL5A2 , COL5A3 , COL11A1 and COL11A2"
     . SPARSER::COLLECTION)
    ("proteinaceous ECM" . SPARSER::PROTEIN)
    ("collagen and collagen" . SPARSER::COLLECTION)
    ("CWC27 and ADAMTS6" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("IBTK , C7orf42 and 9p23" . SPARSER::COLLECTION)
    ("MPDZ" . SPARSER::PROTEIN) ("IBTK" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN)
    ("COL5A1 , AKAP13 and ZNF469" . SPARSER::COLLECTION)
    ("RXRA" . SPARSER::PROTEIN)
    ("FOXO1 , AKAP13 and ZNF469" . SPARSER::COLLECTION)
    ("SGCG" . SPARSER::PROTEIN) ("UK" . SPARSER::PROTEIN)
    ("often correlated quantitative traits" . SPARSER::PROTEIN)
    ("FOXO1 and FNDC3B" . SPARSER::COLLECTION)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LCN12" . SPARSER::PROTEIN)
    ("PRDM5" . SPARSER::PROTEIN) ("HAPLN1" . SPARSER::PROTEIN)
    ("COL11A2" . SPARSER::PROTEIN) ("COL11A1" . SPARSER::PROTEIN)
    ("COL5A3" . SPARSER::PROTEIN) ("COL5A2" . SPARSER::PROTEIN)
    ("COL2A1" . SPARSER::PROTEIN) ("ADAMTS6" . SPARSER::PROTEIN)
    ("CWC27" . SPARSER::PROTEIN) ("COL4A3" . SPARSER::PROTEIN)
    ("NF1B" . SPARSER::PROTEIN) ("USP37" . SPARSER::PROTEIN)
    ("CHSY1" . SPARSER::PROTEIN) ("LRRK1" . SPARSER::PROTEIN)
    ("AKAP13" . SPARSER::PROTEIN) ("FGF9" . SPARSER::PROTEIN)
    ("set 1" . SPARSER::PROTEIN) ("COL8A2" . SPARSER::PROTEIN)
    ("COL5A1" . SPARSER::PROTEIN) ("ZNF469" . SPARSER::PROTEIN)
    ("FNDC3B" . SPARSER::PROTEIN)
    ("IGFBP-2 and BAT and IGFBP-2" . SPARSER::COLLECTION)
    ("IGF-1 and IGFBP-2" . SPARSER::COLLECTION)
    ("IGFBP-2 and BAT" . SPARSER::COLLECTION) ("HC" . SPARSER::PROTEIN)
    ("FDG" . SPARSER::PROTEIN) ("IGFBP-2 and IGF-1" . SPARSER::COLLECTION)
    ("IGFBP-2 and bone marrow fat" . SPARSER::COLLECTION)
    ("BMP" . SPARSER::PROTEIN) ("IGF-1 and BAT" . SPARSER::COLLECTION)
    ("IGFBP-2 and both BAT" . SPARSER::COLLECTION)
    ("MRI, IGF-1 and IGFBP-2" . SPARSER::COLLECTION) ("MRI" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("Pref-1" . SPARSER::PROTEIN)
    ("BMP7" . SPARSER::PROTEIN) ("IGFBP-2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN) ("KN" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("MYCL" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("NPM-ALK" . SPARSER::COLLECTION)
    ("MYCL1, EGFR, MYC and ERBB2" . SPARSER::COLLECTION)
    ("CDKN2A and RB1" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("TP53, EGFR and KRAS" . SPARSER::COLLECTION)
    ("histological subtypes" . SPARSER::PROTEIN) ("mucin" . SPARSER::PROTEIN)
    ("Multiple fusion variants of EML4-ALK and notable clinicopathological characteristics"
     . SPARSER::COLLECTION)
    ("a unique example" . SPARSER::EXAMPLE)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTPRD" . SPARSER::PROTEIN) ("isoform 2" . SPARSER::PROTEIN)
    ("C-CBL" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN) ("TNFSF6" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("MUC4" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("MYCL1" . SPARSER::PROTEIN) ("p34" . SPARSER::PROTEIN)
    ("the ductal invasive type" . TYPE) ("ER/PR" . SPARSER::COLLECTION)
    ("delG" . SPARSER::PROTEIN) ("an Algerian cohort" . SPARSER::MOLECULE)
    ("A, and an intronic variant" . SPARSER::VARIANT)
    ("ovarian cancer family" . SPARSER::PROTEIN-FAMILY)
    ("delC" . SPARSER::PROTEIN)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("hereditary BC genes" . SPARSER::GENE)
    ("protective genes or environmental factors" . SPARSER::COLLECTION)
    ("Miki" . SPARSER::PROTEIN) ("thymine" . SPARSER::MOLECULE)
    ("Algerian and Tunisian BC families" . SPARSER::PROTEIN-FAMILY)
    ("BRCA 2" . SPARSER::PROTEIN) ("10C" . SPARSER::PROTEIN)
    ("C 20" . SPARSER::PROTEIN) ("class C" . SPARSER::PROTEIN)
    ("irreversible-RAF and ERK" . SPARSER::COLLECTION)
    ("nonfunctional protein" . SPARSER::PROTEIN)
    ("B-RAF and NF1" . SPARSER::COLLECTION) ("B-RAF/MEK" . SPARSER::COLLECTION)
    ("B-RAF or NRAS" . SPARSER::COLLECTION) ("5 B-RAF" . SPARSER::PROTEIN-PAIR)
    ("tumor suppressor gene and negative regulator" . SPARSER::COLLECTION)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION) ("/NF1" . SPARSER::COLLECTION)
    ("significantly less protein" . SPARSER::PROTEIN)
    ("GDC0879 and the MEK inhibitor AZD6244" . SPARSER::COLLECTION)
    ("the selective RAF inhibitors PLX4720, PLX4032, GDC0879 and the MEK inhibitor AZD6244"
     . SPARSER::COLLECTION)
    ("NF1/C-RAF" . SPARSER::COLLECTION)
    ("a biochemical state" . SPARSER::BIO-STATE)
    ("PLX4720 and AZD6244" . SPARSER::COLLECTION)
    ("RAF/MEK" . SPARSER::COLLECTION) ("B-RAF and C-RAF" . SPARSER::COLLECTION)
    ("NF1 and C-RAF" . SPARSER::COLLECTION) ("C-RAF/NF1" . SPARSER::COLLECTION)
    ("C-RAF and NF1" . SPARSER::COLLECTION)
    ("B-RAF/NRAS" . SPARSER::COLLECTION)
    ("B-RAF and NRAS" . SPARSER::COLLECTION) ("RAS-GAP" . SPARSER::COLLECTION)
    ("RAS-GTPase activating protein" . SPARSER::COLLECTION)
    ("Only 31 genes" . SPARSER::GENE)
    ("the DMSO-treated arm" . SPARSER::PROTEIN)
    ("the PLX4720-treated arm" . SPARSER::PROTEIN)
    ("lentiviral library DNA" . SPARSER::DNA)
    ("red fluorescent protein" . SPARSER::PROTEIN)
    ("either DMSO or 3 μM" . SPARSER::COLLECTION)
    ("approximately 16,600 genes" . SPARSER::GENE)
    ("B-RAF or MEK" . SPARSER::COLLECTION) ("MET" . SPARSER::PROTEIN)
    ("COT" . SPARSER::PROTEIN) ("B-RAF and MEK" . SPARSER::COLLECTION)
    ("vemurafenib or dabrafenib, or MEK" . SPARSER::COLLECTION)
    ("dabrafenib, or MEK" . SPARSER::COLLECTION) ("trametinib" . SPARSER::DRUG)
    ("the irreversible RAF inhibitor AZ628 and an ERK inhibitor"
     . SPARSER::COLLECTION)
    ("RAF and MEK" . SPARSER::COLLECTION) ("neurofibromin" . SPARSER::PROTEIN)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("tween 20" . SPARSER::MOLECULE) ("TX-100" . SPARSER::DRUG)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F10" . SPARSER::PROTEIN)
    ("A-RAF" . SPARSER::PROTEIN) ("GDC0879" . SPARSER::DRUG)
    ("PLX4032" . SPARSER::DRUG) ("FRA1" . SPARSER::PROTEIN)
    ("AZD6244" . SPARSER::DRUG) ("RAS-GTP" . SPARSER::PROTEIN)
    ("shNF1" . SPARSER::PROTEIN) ("PLX4720" . SPARSER::DRUG)
    ("MAP3K8" . SPARSER::PROTEIN) ("C-RAF" . SPARSER::PROTEIN)
    ("AZ628" . SPARSER::DRUG) ("NF1" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("injectable ECM" . SPARSER::PROTEIN)
    ("ECM proteins as well as HGF" . SPARSER::COLLECTION)
    ("HGF-cMET" . SPARSER::COLLECTION) ("VEGF and HGF" . SPARSER::COLLECTION)
    ("HA or LA" . SPARSER::COLLECTION) ("versican" . SPARSER::PROTEIN)
    ("cMET" . SPARSER::PROTEIN) ("β 2 and α v β 3" . SPARSER::COLLECTION)
    ("ECM-fibronectin" . SPARSER::COLLECTION)
    ("heparin, collagen and fibrin" . SPARSER::COLLECTION)
    ("spiking" . SPARSER::PROTEIN)
    ("HGF and fibronectin" . SPARSER::COLLECTION)
    ("monomeric collagen" . SPARSER::PROTEIN)
    ("dimeric and trimeric collagen" . SPARSER::PROTEIN)
    ("Col1A1 and PCOLCE" . SPARSER::COLLECTION)
    ("LA and HA" . SPARSER::COLLECTION)
    ("MMP2, βig-h3 and fibronectin" . SPARSER::COLLECTION)
    ("clusterin" . SPARSER::PROTEIN)
    ("trypsin and the resulting peptides" . SPARSER::COLLECTION)
    ("size-fractionated protein" . SPARSER::PROTEIN)
    ("SCF/c-Kit" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and stromal cell derived factor (SDF)"
     . SPARSER::COLLECTION)
    ("derived factor (SDF)" . SPARSER::PROTEIN) ("VEGFC" . SPARSER::PROTEIN)
    ("angiopoietin" . SPARSER::PROTEIN)
    ("SPARC, Col1A1 and PCOLCE" . SPARSER::COLLECTION)
    ("SPARC" . SPARSER::PROTEIN) ("PCOLCE" . SPARSER::PROTEIN)
    ("alpha-1" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("hepatocyte growth factor (HGF) and fibronectin" . SPARSER::COLLECTION)
    ("three-dimensional fibrin" . SPARSER::PROTEIN)
    ("fibrin" . SPARSER::PROTEIN) ("scaffolds" . SPARSER::SCAFFOLD)
    ("ECM, proteases and growth factors" . SPARSER::COLLECTION)
    ("proteases and angiogenic growth factors" . SPARSER::COLLECTION)
    ("angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("proteins and pro-angiogenic" . SPARSER::COLLECTION)
    ("hepatocyte growth factor and fibronectin" . SPARSER::COLLECTION)
    ("HGF receptor" . SPARSER::PROTEIN) ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α 1 β 1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("Ang-1" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN)
    ("secreted protein acidic and rich in cysteine" . SPARSER::PROTEIN)
    ("procollagen C-endopeptidase enhancer" . SPARSER::PROTEIN)
    ("IGFBP7" . SPARSER::PROTEIN)
    ("insulin-like growth factor-binding protein 7" . SPARSER::PROTEIN)
    ("Col1A1" . SPARSER::PROTEIN) ("ig-h3" . SPARSER::PROTEIN)
    ("beta-induced" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("von Willebrand Factor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("P21CIP1 and P16INKA4A" . SPARSER::COLLECTION)
    ("si- or shRNA" . SPARSER::COLLECTION) ("si-" . SPARSER::PROTEIN)
    ("TP53 and P21CIP1" . SPARSER::COLLECTION)
    ("functional TP53" . SPARSER::PROTEIN)
    ("strong sa-β-gal" . SPARSER::PROTEIN) ("weak sa-β-gal" . SPARSER::PROTEIN)
    ("Tp53" . SPARSER::PROTEIN) ("centrosomes" . SPARSER::PROTEIN)
    ("cytometry and DNA" . SPARSER::COLLECTION)
    ("its own promoter or the promoters" . SPARSER::COLLECTION)
    ("reagent" . SPARSER::MOLECULE) ("OCT4-pseudogene 1" . SPARSER::COLLECTION)
    ("pseudogenes-1" . SPARSER::COLLECTION)
    ("TP53-siRNA" . SPARSER::COLLECTION)
    ("TP53 and OCT4A" . SPARSER::COLLECTION)
    ("TP53, OCT4A and P21CIP1" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("LC3B and P62" . SPARSER::COLLECTION)
    ("the mitotic cycling fraction" . SPARSER::COMPONENT)
    ("RAD51/γH2AX" . SPARSER::COLLECTION)
    ("Phosphorylated CHK2 (pCHK2) and γH2AX" . SPARSER::COLLECTION)
    ("the topoisomerase II inhibitor etoposide (ETO)" . SPARSER::DRUG)
    ("etoposide (ETO)" . SPARSER::PROTEIN) ("ETO" . SPARSER::PROTEIN)
    ("hyper" . SPARSER::PROTEIN) ("SOX2 and NANOG" . SPARSER::COLLECTION)
    ("KLF4 and c-MYC" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("iPS" . SPARSER::PROTEIN) ("CDKN2A/P16INK4A" . SPARSER::COLLECTION)
    ("sh- or si-RNA" . SPARSER::COLLECTION) ("sh-" . SPARSER::PROTEIN-FAMILY)
    ("Phosphorylated CHK2 and RAD51/γH2AX-positive nuclear foci"
     . SPARSER::COLLECTION)
    ("BF1" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("PG1" . SPARSER::PROTEIN) ("G 1 -2" . SPARSER::PROTEIN)
    ("pseudogene 1" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("G 1 -4" . SPARSER::PROTEIN) ("P62" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("P16INK4A" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("P21CIP1" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("TBKBP1 and NAP1" . SPARSER::COLLECTION)
    ("adapter protein TNF receptor-associated receptor" . SPARSER::RECEPTOR)
    ("oligomer" . SPARSER::MOLECULE) ("ischemia" . SPARSER::PROTEIN)
    ("TBK1 and OPTN" . SPARSER::COLLECTION)
    ("matrix, SIFT and PolyPhen2" . SPARSER::COLLECTION)
    ("five intronic variants" . SPARSER::VARIANT)
    ("TRAF family member-associated NFKB activator (TANK)" . SPARSER::PROTEIN)
    ("a unique protein" . SPARSER::PROTEIN) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("pSS-FS-TBK1" . SPARSER::COLLECTION) ("pSS" . SPARSER::PROTEIN-FAMILY)
    ("TBK1 and two other genes ( TLR4 and OPTN )" . SPARSER::COLLECTION)
    ("intracellular proteins and/or organelles" . SPARSER::COLLECTION)
    ("Mendelian forms" . SPARSER::FORM)
    ("MYOC, OPTN, WDR36, NTF4, TBK1 and ASB10" . SPARSER::COLLECTION)
    ("MYOC" . SPARSER::PROTEIN) ("Hg" . SPARSER::MOLECULE)
    ("nine unique variants" . SPARSER::VARIANT)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("TAP" . SPARSER::PROTEIN)
    ("TLR4 and OPTN" . SPARSER::COLLECTION)
    ("NFKB activator" . SPARSER::PROTEIN) ("S-protein" . SPARSER::PROTEIN)
    ("3xFLAG" . SPARSER::PROTEIN) ("S-antigen" . SPARSER::PROTEIN)
    ("RNA 1" . SPARSER::PROTEIN-FAMILY) ("ELOVL5" . SPARSER::PROTEIN)
    ("member 5" . SPARSER::PROTEIN)
    ("long-chain fatty acid" . SPARSER::MOLECULE) ("SRBD1" . SPARSER::PROTEIN)
    ("S1 RNA binding domain 1" . SPARSER::PROTEIN)
    ("toll-like receptor 4" . SPARSER::PROTEIN) ("ASB10" . SPARSER::PROTEIN)
    ("NTF4" . SPARSER::PROTEIN) ("WDR36" . SPARSER::PROTEIN)
    ("open angle" . SPARSER::PROTEIN) ("TBKBP1" . SPARSER::PROTEIN)
    ("NAP1" . SPARSER::PROTEIN) ("TANK binding kinase 1" . SPARSER::PROTEIN)
    ("cytokeratin, CD90 and CD44" . SPARSER::COLLECTION)
    ("TKs" . SPARSER::PROTEIN) ("TK" . SPARSER::PROTEIN)
    ("abl" . SPARSER::PROTEIN)
    ("effectively targeting constitutively activated bcr-abl in CML and KIT"
     . SPARSER::COLLECTION)
    ("trypsin" . SPARSER::PROTEIN) ("trypsinized" . SPARSER::PROTEIN)
    ("Imatinib" . SPARSER::DRUG) ("CD44, CD90 and CD133" . SPARSER::COLLECTION)
    ("the parenchymal component" . SPARSER::COMPONENT)
    ("cytokeratin, CD117, αSMA and Ki-67" . SPARSER::COLLECTION)
    ("KIT-" . SPARSER::PROTEIN) ("CD117-" . SPARSER::PROTEIN)
    ("CD117 and the proliferation marker Ki-67" . SPARSER::COLLECTION)
    ("cytokeratin, CD117 and the proliferation marker Ki-67"
     . SPARSER::COLLECTION)
    ("Formalin" . SPARSER::MOLECULE) ("NSCL" . SPARSER::PROTEIN)
    ("/CD117" . SPARSER::COLLECTION) ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("imatinib" . SPARSER::DRUG) ("CD117 (KIT)" . SPARSER::PROTEIN)
    ("CD44, CD90, CD117 and CD133" . SPARSER::COLLECTION)
    ("Stem Cell factor" . SPARSER::PROTEIN) ("bcr-abl" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("A-C" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("ammonium chloride" . SPARSER::MOLECULE)
    ("PBS-A" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("AE3" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("E2F1 and E2F4" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("CBP-" . SPARSER::PROTEIN) ("ATM and CHK2" . SPARSER::COLLECTION)
    ("ATM-CHK2" . SPARSER::COLLECTION) ("ATR-CHK1" . SPARSER::COLLECTION)
    ("CPT- and IR-induced BRCA1 foci" . SPARSER::COLLECTION)
    ("NCS-" . SPARSER::PROTEIN) ("RPA32 and RPA70" . SPARSER::COLLECTION)
    ("RPA and RAD51" . SPARSER::COLLECTION)
    ("CtIP and MRE11/RAD50/NBS1" . SPARSER::COLLECTION)
    ("MRE11/RAD50/NBS1" . SPARSER::COLLECTION)
    ("RPA-CHK1" . SPARSER::COLLECTION) ("E2F1/E2F4" . SPARSER::COLLECTION)
    ("CBP and p300, E2F1 and E2F4" . SPARSER::COLLECTION)
    ("p300, E2F1 and E2F4" . SPARSER::COLLECTION)
    ("K18 and histone" . SPARSER::COLLECTION) ("lysines" . SPARSER::AMINO-ACID)
    ("A–B" . SPARSER::PROTEIN) ("MRE11, RAD50, and NBS1" . SPARSER::COLLECTION)
    ("KU70, KU80, DNA-PKcs, and XRCC4" . SPARSER::COLLECTION)
    ("representative genes" . SPARSER::GENE) ("CPT-" . SPARSER::PROTEIN)
    ("CBP and/or p300 ( xref )" . SPARSER::COLLECTION)
    ("RAD51 and BRCA1" . SPARSER::COLLECTION)
    ("homologous DNAs" . SPARSER::DNA)
    ("RPA70/RPA32/RPA16" . SPARSER::COLLECTION)
    ("CtIP-MRN-BRCA1" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("CBP or p300" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("the homologous HATs CBP and p300" . SPARSER::COLLECTION)
    ("Chromosomal DNA and histones form" . SPARSER::COLLECTION)
    ("CBP and/or p300" . SPARSER::COLLECTION)
    ("BRCA1 and RAD51" . SPARSER::COLLECTION)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("HATs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetyltransferases" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("K5" . SPARSER::PROTEIN) ("KU80" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("pS4" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("RPA16" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("KU70" . SPARSER::PROTEIN)
    ("single-strand DNA-binding protein" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("Pyrimidine" . SPARSER::DRUG) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("solely YB-1 mRNA" . SPARSER::PROTEIN)
    ("Akt and downstream substrates ( xref )" . SPARSER::COLLECTION)
    ("S6 ribosomal protein (rpS6) and Akt" . SPARSER::COLLECTION)
    ("eIF4E and eIF2α" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("p70S6K" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("rpS" . SPARSER::PROTEIN) ("S6 kinase and 4E-BP" . SPARSER::COLLECTION)
    ("their polysomal fraction" . SPARSER::COMPONENT)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-methionine" . SPARSER::COLLECTION)
    ("the polysomal fraction" . SPARSER::COMPONENT)
    ("translated polysomal mRNPs" . SPARSER::BIO-COMPLEX)
    ("GAPDH" . SPARSER::PROTEIN) ("polysomal mRNPs" . SPARSER::BIO-COMPLEX)
    ("a polysomal fraction" . SPARSER::COMPONENT)
    ("Fractions" . SPARSER::COMPONENT) ("mRNP" . SPARSER::BIO-COMPLEX)
    ("mRNA and YB-1" . SPARSER::COLLECTION)
    ("Northern blot" . SPARSER::PROTEIN) ("-Met" . SPARSER::COLLECTION)
    ("which makes YB-1" . SPARSER::PROTEIN)
    ("virtually all DNA- and mRNA-dependent events in eukaryotic cells"
     . SPARSER::COLLECTION)
    ("virtually all DNA-" . SPARSER::DNA) ("DNA-" . SPARSER::DNA)
    ("DNA and RNA" . SPARSER::COLLECTION) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("YB-1 and YB-1" . SPARSER::COLLECTION)
    ("a eukaryotic protein" . SPARSER::PROTEIN)
    ("O-Methyltransferase" . SPARSER::PROTEIN) ("m 7 G" . SPARSER::MOLECULE)
    ("beta-globin" . SPARSER::PROTEIN) ("SP6" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("T-5" . SPARSER::PROTEIN)
    ("K 2" . SPARSER::PROTEIN) ("Membrane-bound" . SPARSER::PROTEIN)
    ("rpL7" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("Mnk1" . SPARSER::PROTEIN)
    ("pp242" . SPARSER::DRUG) ("ribosomal protein" . SPARSER::PROTEIN)
    ("4E-BP" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("YB-1" . SPARSER::PROTEIN) ("Snail and Slug" . SPARSER::COLLECTION)
    ("Slug" . SPARSER::PROTEIN) ("TGF-β and BMP-6" . SPARSER::COLLECTION)
    ("p21 and E-cadherin" . SPARSER::COLLECTION)
    ("DNMT3B and HDAC1" . SPARSER::COLLECTION)
    ("homeodomain" . SPARSER::PROTEIN)
    ("DNA methyltransferase (DNMT) and/or histone deacetylase (HDAC) inhibitors"
     . SPARSER::COLLECTION)
    ("methyltransferase (DNMT)" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("methyltransferase" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("loss of heterozygosity, or ER" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("fulvestrant" . SPARSER::DRUG) ("TESS" . SPARSER::PROTEIN)
    ("PI-103 or BAY 11-7082" . SPARSER::COLLECTION)
    ("PKI" . SPARSER::PROTEIN-FAMILY) ("PI3K and NF-κB" . SPARSER::COLLECTION)
    ("Ov" . SPARSER::MOLECULE)
    ("zinc finger-homeodomain" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN) ("SERM" . SPARSER::DRUG)
    ("SERMs" . SPARSER::DRUG) ("ER-α and tamoxifen" . SPARSER::COLLECTION)
    ("PI3K or NF-κB" . SPARSER::COLLECTION) ("BMP-6" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN) ("DNMT3B" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("BAY 11-7082" . SPARSER::DRUG) ("ICI 182,780" . SPARSER::DRUG)
    ("CCK-8" . SPARSER::PROTEIN) ("BAY11-7082" . SPARSER::DRUG)
    ("PI-103" . SPARSER::DRUG) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogen-receptor" . SPARSER::PROTEIN)
    ("17β-estradiol" . SPARSER::PROTEIN)
    ("tumoral p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the same molecules or signal pathways" . SPARSER::COLLECTION)
    ("a typical stress response gene as well as a tumor suppressor xref"
     . SPARSER::COLLECTION)
    ("a typical stress response gene" . SPARSER::GENE)
    ("sera" . SPARSER::PROTEIN) ("low p53 and high JWA" . SPARSER::COLLECTION)
    ("platinol" . SPARSER::DRUG) ("HR " . SPARSER::PROTEIN)
    ("fluorouracil-" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("leucovorin" . SPARSER::DRUG) ("Adjuvant" . SPARSER::DRUG)
    ("type and tumor" . SPARSER::COLLECTION)
    ("respective cohort" . SPARSER::MOLECULE)
    ("candidate prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("JWA and XRCC1" . SPARSER::COLLECTION)
    ("p53 and JWA" . SPARSER::COLLECTION) ("JWA" . SPARSER::PROTEIN)
    ("IRS 5" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("ARL6ip5" . SPARSER::PROTEIN)
    ("BRCA2 and other relevant genes" . SPARSER::COLLECTION)
    ("other relevant genes" . SPARSER::GENE)
    ("BRCA2 and RB1" . SPARSER::COLLECTION) ("hg" . SPARSER::MOLECULE)
    ("GSEA and SNP/CGH" . SPARSER::COLLECTION)
    ("five BRCA2 and eight BRCAX" . SPARSER::COLLECTION)
    ("CGH and SNP" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("BRCA2 and BRCAX" . SPARSER::COLLECTION) ("BRCAX" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("breast cancer 1 ( BRCA1 ) and BRCA2" . SPARSER::COLLECTION)
    ("chr13" . SPARSER::PROTEIN) ("RP11" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("possible biomarker" . SPARSER::MOLECULE)
    ("clathrin" . SPARSER::PROTEIN)
    ("TRAIL-R1 or TRAIL-R2" . SPARSER::COLLECTION)
    ("a considerable fraction" . SPARSER::COMPONENT)
    ("KRAS4A or MSI-phenotype" . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("long-rank" . SPARSER::PROTEIN)
    ("the respective TRAIL-receptors" . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("the TRAIL-binding soluble decoy receptor OPG" . SPARSER::PROTEIN)
    ("EGF-R and VEGF-R" . SPARSER::COLLECTION)
    ("cetuximab, panitumumab or bevacizumab" . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG)
    ("TRAIL-R1 and TRAIL-R2" . SPARSER::COLLECTION)
    ("almost all CRC" . SPARSER::PROTEIN) ("MSI" . SPARSER::PROTEIN)
    ("TNF-related apoptosis inducing ligand (TRAIL)" . SPARSER::PROTEIN)
    ("TRAIL-receptors" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("TRAIL-receptor 1" . SPARSER::PROTEIN)
    ("decoy receptor" . SPARSER::PROTEIN) ("VEGF-R" . SPARSER::PROTEIN)
    ("EGF-R" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN)
    ("TNF-related apoptosis inducing ligand" . SPARSER::PROTEIN)
    ("GPM6B and CD320" . SPARSER::COLLECTION)
    ("BAP31 and CLDN10" . SPARSER::COLLECTION)
    ("discussed four proteins" . SPARSER::PROTEIN)
    ("claudin 1, claudin 6 and claudin 9" . SPARSER::COLLECTION)
    ("BBB" . SPARSER::PROTEIN) ("claudins" . SPARSER::PROTEIN)
    ("Cbl" . SPARSER::PROTEIN)
    ("CD320 Molecule/Transcobalamin" . SPARSER::COLLECTION)
    ("Transcobalamin" . SPARSER::PROTEIN)
    ("a viral protein" . SPARSER::PROTEIN)
    ("an ubiquitous protein" . SPARSER::PROTEIN)
    ("transporter (SERT)" . SPARSER::PROTEIN) ("SERT" . SPARSER::PROTEIN)
    ("a stress-mediated regulator" . SPARSER::REGULATOR)
    ("nanotubes" . SPARSER::MOLECULE) ("PMEPA1/TMEPAI" . SPARSER::COLLECTION)
    ("TMEPAI" . SPARSER::PROTEIN) ("HSPA9/mortalin" . SPARSER::COLLECTION)
    ("SMR" . SPARSER::PROTEIN)
    ("Jäger et al., only four cellular proteins ACOT8, NMT1, MTDC and EXOC4"
     . SPARSER::COLLECTION)
    ("ACOT8, NMT1, MTDC and EXOC4" . SPARSER::COLLECTION)
    ("hydrolase" . SPARSER::PROTEIN)
    ("even more complex" . SPARSER::BIO-COMPLEX)
    ("exactly one prey protein" . SPARSER::PROTEIN)
    ("CD4 and PLP-like" . SPARSER::COLLECTION)
    ("alanines" . SPARSER::AMINO-ACID) ("leucines" . SPARSER::AMINO-ACID)
    ("purified Nef protein and synthetic FITC-labeled peptides"
     . SPARSER::COLLECTION)
    ("GPM6B or PLP1" . SPARSER::COLLECTION) ("PLP" . SPARSER::PROTEIN)
    ("GPM6B and GPM6A" . SPARSER::COLLECTION)
    ("GPM6A and PLP1" . SPARSER::COLLECTION)
    ("GPM6B and CD4" . SPARSER::COLLECTION)
    ("GFP-CLDN10" . SPARSER::COLLECTION)
    ("commercially available primary antibodies" . SPARSER::ANTIBODY)
    ("the respective endogenous proteins" . SPARSER::PROTEIN)
    ("GFP-GPM6B" . SPARSER::COLLECTION)
    ("CLDN10 and GPM6B" . SPARSER::COLLECTION)
    ("GFP-BAP31" . SPARSER::COLLECTION) ("pNef-DsRed" . SPARSER::COLLECTION)
    ("pGFP-GPM6B" . SPARSER::COLLECTION) ("pGFP-CLDN10" . SPARSER::COLLECTION)
    ("pGFP-CD320" . SPARSER::COLLECTION) ("pGFP-BAP31" . SPARSER::COLLECTION)
    ("CLDN10, and GPM6B" . SPARSER::COLLECTION)
    ("BAP31 and ITGB1" . SPARSER::COLLECTION) ("Lex" . SPARSER::DRUG)
    ("precipitable immune complexes" . SPARSER::BIO-COMPLEX)
    ("at least one transmembrane domain (TM)" . SPARSER::PROTEIN)
    ("VKORC1L1, SLC31A2, ATP13A2 and ATP6AP1" . SPARSER::COLLECTION)
    ("transcobalamin-bound vitamin B12 (CD320/TCblR) and Vitamin K epoxide reductase complex"
     . SPARSER::COLLECTION)
    ("V-type proton ATPase subunit S1 (ATP6AP1) and N-acetyllactosaminide beta-1"
     . SPARSER::COLLECTION)
    ("the neuronal membrane glycoprotein M6B" . SPARSER::PROTEIN)
    ("mortalin" . SPARSER::PROTEIN) ("epoxide" . SPARSER::MOLECULE)
    ("transcobalamin" . SPARSER::PROTEIN) ("/lacZ" . SPARSER::COLLECTION)
    ("/Ade" . SPARSER::COLLECTION) ("Ade" . SPARSER::PROTEIN)
    ("Preys" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pDHB" . SPARSER::PROTEIN)
    ("LexA" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("further Nef binding host cell proteins" . SPARSER::PROTEIN)
    ("monocyte-macrophage" . SPARSER::PROTEIN)
    ("CD320/TCblR" . SPARSER::COLLECTION) ("TCblR" . SPARSER::PROTEIN)
    ("split-ubiquitin" . SPARSER::PROTEIN)
    ("membrane-associated proteins or other proteins" . SPARSER::COLLECTION)
    ("integral membrane proteins, membrane-associated proteins or other proteins"
     . SPARSER::COLLECTION)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("different conformational states" . SPARSER::BIO-STATE)
    ("P78369" . SPARSER::PROTEIN) ("Q9NPF0" . SPARSER::PROTEIN)
    ("P51572" . SPARSER::PROTEIN) ("pDL2" . SPARSER::PROTEIN)
    ("SF2" . SPARSER::PROTEIN) ("Claudin 7" . SPARSER::PROTEIN)
    ("claudin 9" . SPARSER::PROTEIN) ("claudin 6" . SPARSER::PROTEIN)
    ("claudin 1" . SPARSER::PROTEIN) ("claudin 10" . SPARSER::PROTEIN)
    ("short cytoplasmic tail" . SPARSER::PROTEIN)
    ("CD4 molecule" . SPARSER::PROTEIN) ("B 12" . SPARSER::PROTEIN)
    ("CD320 molecule" . SPARSER::PROTEIN) ("CD320 Molecule" . SPARSER::PROTEIN)
    ("clathrin adaptor protein" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("p20" . SPARSER::PROTEIN)
    ("Receptor-associated Protein" . SPARSER::PROTEIN)
    ("5-HT4" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("Glycoprotein M6B" . SPARSER::PROTEIN) ("NMT1" . SPARSER::PROTEIN)
    ("ACOT8" . SPARSER::PROTEIN) ("Pak2" . SPARSER::PROTEIN)
    ("RPS20" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("EXOC6" . SPARSER::PROTEIN) ("EXOC4" . SPARSER::PROTEIN)
    ("EXOC3" . SPARSER::PROTEIN) ("EXOC2" . SPARSER::PROTEIN)
    ("EXOC1" . SPARSER::PROTEIN) ("PLP1" . SPARSER::PROTEIN)
    ("Cos-7" . SPARSER::PROTEIN) ("PEB1" . SPARSER::PROTEIN)
    ("transmembrane domain (TM)" . SPARSER::PROTEIN)
    ("B3GNT1" . SPARSER::PROTEIN)
    ("N-acetylglucosaminyltransferase" . SPARSER::PROTEIN)
    ("beta-1" . SPARSER::PROTEIN) ("ATP6AP1" . SPARSER::PROTEIN)
    ("V-type proton ATPase subunit S1" . SPARSER::PROTEIN)
    ("ATP13A2" . SPARSER::PROTEIN)
    ("Probable cation-transporting ATPase 13A2" . SPARSER::PROTEIN)
    ("Phosphatidylethanolamine binding protein 1" . SPARSER::PROTEIN)
    ("SLC31A2" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Solute carrier family" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("Claudin 10" . SPARSER::PROTEIN)
    ("prolyl 4-hydroxylase" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("Chimerin 1" . SPARSER::PROTEIN) ("Integrin beta-1" . SPARSER::PROTEIN)
    ("OCIA domain containing 1" . SPARSER::PROTEIN)
    ("VKORC1L1" . SPARSER::PROTEIN) ("B12" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("Cytochrome B5" . SPARSER::PROTEIN)
    ("Tetraspanin 7" . SPARSER::PROTEIN)
    ("glycoprotein M6A" . SPARSER::PROTEIN)
    ("glycoprotein M6B" . SPARSER::PROTEIN) ("pPR3" . SPARSER::PROTEIN)
    ("PEBP1" . SPARSER::PROTEIN) ("APR-3" . SPARSER::PROTEIN)
    ("HSPA9" . SPARSER::PROTEIN) ("CLDN10" . SPARSER::PROTEIN)
    ("PH4" . SPARSER::PROTEIN) ("CHN1" . SPARSER::PROTEIN)
    ("OCIAD1" . SPARSER::PROTEIN) ("PMEPA1" . SPARSER::PROTEIN)
    ("CD320" . SPARSER::PROTEIN) ("CYB5" . SPARSER::PROTEIN)
    ("TSPAN7" . SPARSER::PROTEIN) ("BAP31" . SPARSER::PROTEIN)
    ("GPM6A" . SPARSER::PROTEIN) ("GPM6B" . SPARSER::PROTEIN)
    ("HCEnC-21 and HCEnC-21T cells actively pump lactate" . SPARSER::MOLECULE)
    ("lactate and proton" . SPARSER::COLLECTION)
    ("the leaky barrier" . SPARSER::PROTEIN)
    ("the junctional complexes" . SPARSER::BIO-COMPLEX)
    ("a leaky barrier" . SPARSER::PROTEIN)
    ("p53 and readily upregulated phospho-p53" . SPARSER::COLLECTION)
    ("p21 CIP1 and p16" . SPARSER::COLLECTION)
    ("CDKs and their binding partners cyclins" . SPARSER::COLLECTION)
    ("INK4 and p21 CIP1" . SPARSER::COLLECTION)
    ("cyclin D and CDK4" . SPARSER::COLLECTION) ("Lactate" . SPARSER::LACTATE)
    ("Barrier" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator (CFTR)"
     . SPARSER::PROTEIN)
    ("neuron-specific enolase (NSE)" . SPARSER::PROTEIN)
    ("Aqp1" . SPARSER::PROTEIN) ("NSE" . SPARSER::PROTEIN)
    ("MCT" . SPARSER::PROTEIN) ("MCTs" . SPARSER::PROTEIN)
    ("cotransporters" . SPARSER::PROTEIN)
    ("Monocarboxylate" . SPARSER::MOLECULE)
    ("Typical Corneal Endothelial Ion Transporters" . SPARSER::PROTEIN)
    ("Transporters" . SPARSER::PROTEIN) ("Ion" . SPARSER::MOLECULE)
    ("CDK4 and cyclin D" . SPARSER::COLLECTION)
    ("CDK4 and Cyclin D" . SPARSER::COLLECTION)
    ("hydroperoxide" . SPARSER::MOLECULE)
    ("a temperature-sensitive enzyme" . SPARSER::ENZYME)
    ("HCEnC" . SPARSER::PROTEIN) ("HCEnCs" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("CDK4-expressing HCEnCs" . SPARSER::PROTEIN)
    ("Viral oncogenes" . SPARSER::ONCOGENE)
    ("the viral oncogenes SV40 large T antigen and HPV E6/E7"
     . SPARSER::COLLECTION)
    ("T antigen and HPV" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG) ("medicine" . SPARSER::DRUG)
    ("cyclin D/CDK4" . SPARSER::COLLECTION)
    ("the post-mitotic state" . SPARSER::BIO-STATE)
    ("Human corneal endothelial cells (HCEnCs) form" . SPARSER::FORM)
    ("Bis-Tris" . SPARSER::MOLECULE) ("5–2" . SPARSER::PROTEIN)
    ("Reducing Agent" . SPARSER::MOLECULE) ("CA12" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aquaporin 1" . SPARSER::PROTEIN)
    ("soluble adenylyl cyclase" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("AE2" . SPARSER::PROTEIN) ("anion exchanger" . SPARSER::PROTEIN)
    ("neuron-specific enolase" . SPARSER::PROTEIN) ("MCT2" . SPARSER::PROTEIN)
    ("MCT1" . SPARSER::PROTEIN) ("MCT4" . SPARSER::PROTEIN)
    ("NHE1" . SPARSER::PROTEIN) ("carbonic anhydrase 2" . SPARSER::PROTEIN)
    ("type 8" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("tert -Butyl" . SPARSER::MOLECULE) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D" . SPARSER::PROTEIN) ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neutrophils" . SPARSER::PROTEIN) ("chemotaxis" . SPARSER::PROTEIN)
    ("RAC2 and KIF20A" . SPARSER::COLLECTION)
    ("further subpartitioning GABPA" . SPARSER::PROTEIN)
    ("KIS" . SPARSER::PROTEIN) ("the latter two genes" . SPARSER::GENE)
    ("RAC2 and RACGAP1" . SPARSER::COLLECTION)
    ("RHOF and KIF20A" . SPARSER::COLLECTION)
    ("RAC2 , RACGAP1 and KIF20A" . SPARSER::COLLECTION)
    ("RAC2 , RHOF , RACGAP1 and KIF20A" . SPARSER::COLLECTION)
    ("RHOF" . SPARSER::PROTEIN) ("the relevant GO" . SPARSER::PROTEIN)
    ("GABPA and ELK1" . SPARSER::COLLECTION)
    ("cytoskeletal genes" . SPARSER::GENE)
    ("mainly controls genes" . SPARSER::GENE) ("Jurkat" . SPARSER::PROTEIN)
    ("subcortical actin" . SPARSER::PROTEIN)
    ("those encoding ribosomal proteins" . SPARSER::PROTEIN)
    ("ETS1 and ELF1" . SPARSER::COLLECTION)
    ("ELK1 and GABPA" . SPARSER::COLLECTION)
    ("RAC1 and KIF20A" . SPARSER::COLLECTION) ("GABPA" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("NCOR2" . SPARSER::PROTEIN) ("SEMA3A" . SPARSER::PROTEIN)
    ("RACGAP1" . SPARSER::PROTEIN) ("RAC2" . SPARSER::PROTEIN)
    ("ELF1" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("KIF20A" . SPARSER::PROTEIN) ("RAC1" . SPARSER::PROTEIN)
    ("ELK1" . SPARSER::PROTEIN) ("ETV1, ATR or TERT" . SPARSER::COLLECTION)
    ("ATR-ETV1-TERT" . SPARSER::COLLECTION) ("STRAP" . SPARSER::PROTEIN)
    ("UNRIP" . SPARSER::PROTEIN)
    ("this hypomorphic ATR allele" . SPARSER::ALLELE)
    ("a hypomorphic allele" . SPARSER::ALLELE)
    ("p53 and ATR" . SPARSER::COLLECTION) ("SP1 and p53" . SPARSER::COLLECTION)
    ("E2F1 and MYC" . SPARSER::COLLECTION)
    ("E2F1 (NP_005216.1) and MYC (NP_002458.2)" . SPARSER::COLLECTION)
    ("SP1 (NP_612482.2), E2F1 (NP_005216.1) and MYC (NP_002458.2)"
     . SPARSER::COLLECTION)
    ("ETV1, ATR and TERT" . SPARSER::COLLECTION)
    ("a p53 dominant-negative mutant" . SPARSER::MUTANT)
    ("the TERT promoter and stimulation of TERT transcription"
     . SPARSER::COLLECTION)
    ("SQ" . SPARSER::MOLECULE) ("GST-ETV1" . SPARSER::COLLECTION)
    ("-ETV1" . SPARSER::COLLECTION) ("ATRIP" . SPARSER::PROTEIN)
    ("ATR or ATM" . SPARSER::COLLECTION) ("FLAG-ETV1" . SPARSER::COLLECTION)
    ("ETV1 and TERT, or ATR and TERT" . SPARSER::COLLECTION)
    ("TERT, or ATR and TERT" . SPARSER::COLLECTION)
    ("ATR and TERT" . SPARSER::COLLECTION) ("protein (GFP)" . SPARSER::PROTEIN)
    ("ETP" . SPARSER::PROTEIN) ("ETV1 as well as ATR" . SPARSER::COLLECTION)
    ("ATR or ETV1" . SPARSER::COLLECTION)
    ("ATR and ETV1" . SPARSER::COLLECTION)
    ("p53, and NCI-H522" . SPARSER::COLLECTION)
    ("ATR , ETV1 , GFPT2 , NT5C3 and UMPS" . SPARSER::COLLECTION)
    ("p53− or p53+" . SPARSER::COLLECTION)
    ("ETV1 and ATR" . SPARSER::COLLECTION)
    ("the original shRNA" . SPARSER::PROTEIN) ("ShRNAs" . SPARSER::RNA)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2 (NP_000050.2) as well as other components" . SPARSER::COLLECTION)
    ("BRCA1 (NP_009225.1), BRCA2 (NP_000050.2) as well as other components"
     . SPARSER::COLLECTION)
    ("-polymerase" . SPARSER::COLLECTION)
    ("only mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETV1, ATR, and TERT" . SPARSER::COLLECTION)
    ("ETV1 or ATR" . SPARSER::COLLECTION)
    ("the transcription factor ETV1 and the DNA damage kinase ATR"
     . SPARSER::COLLECTION)
    ("p53−" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("specific genes and regulatory pathways" . SPARSER::COLLECTION)
    ("X-Gal" . SPARSER::MOLECULE) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("CGK733" . SPARSER::DRUG)
    ("Na3VO4" . SPARSER::MOLECULE) ("B–H" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("receptor-associated protein" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("ETS family" . SPARSER::PROTEIN) ("NT5C3" . SPARSER::PROTEIN)
    ("GFPT2" . SPARSER::PROTEIN)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("tracheobronchial" . SPARSER::PROTEIN)
    ("severe tracheal cartilage malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("vasculature" . SPARSER::PROTEIN)
    ("DNER and HLA-DQB1" . SPARSER::COLLECTION)
    ("DNER and KCNJ2" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("HNF-1, CP2, Cdc5, and FOXF2" . SPARSER::COLLECTION)
    ("KCNJ2 (a potassium inwardly-rectifying channel also known as KIR2.1) and SOX9 (sex determining region Y-box 9)"
     . SPARSER::COLLECTION)
    ("HLA-DQB1/HLA-DQA2" . SPARSER::COLLECTION) ("Lmo2" . SPARSER::PROTEIN)
    ("DQ" . SPARSER::MOLECULE)
    ("the previously implicated PID1 gene" . SPARSER::GENE)
    ("Zic1" . SPARSER::PROTEIN) ("Zic" . SPARSER::PROTEIN)
    ("delta" . SPARSER::PROTEIN) ("were run" . SPARSER::PROTEIN-FAMILY)
    ("other complex quantitative traits" . SPARSER::PROTEIN)
    ("MFAP2 , MMP15 , NCR3 , PID1 , PTCH1 , RARB , SPATA9 , TGFB2 , THSD4 , TNS1 , and ZKSCAN3"
     . SPARSER::COLLECTION)
    ("INTS12-GSTCD-NPNT" . SPARSER::COLLECTION)
    ("AGER-PPT2" . SPARSER::COLLECTION) ("RARB" . SPARSER::PROTEIN)
    ("MECOM" . SPARSER::PROTEIN) ("NPNT" . SPARSER::PROTEIN)
    ("GSTCD" . SPARSER::PROTEIN) ("AGER" . SPARSER::PROTEIN)
    ("Cohorts" . SPARSER::MOLECULE) ("HHIP" . SPARSER::PROTEIN)
    ("antitrypsin" . SPARSER::PROTEIN)
    ("gene and gene-by-smoking interactions" . SPARSER::COLLECTION)
    ("DNER and SOX9" . SPARSER::COLLECTION)
    ("DNER , KCNJ2 , and SOX9" . SPARSER::COLLECTION)
    ("HLA-DQB1 and HLA-DQA2" . SPARSER::COLLECTION)
    ("KCNJ2 and SOX9" . SPARSER::COLLECTION) ("DNER" . SPARSER::PROTEIN)
    ("FEV" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("FOXF2" . SPARSER::PROTEIN) ("Cdc5" . SPARSER::PROTEIN)
    ("CP2" . SPARSER::PROTEIN) ("HNF-1" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("KIR2.1" . SPARSER::PROTEIN)
    ("potassium inwardly-rectifying channel" . SPARSER::PROTEIN)
    ("ZKSCAN3" . SPARSER::PROTEIN) ("TNS1" . SPARSER::PROTEIN)
    ("THSD4" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("SPATA9" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("PID1" . SPARSER::PROTEIN) ("NCR3" . SPARSER::PROTEIN)
    ("MMP15" . SPARSER::PROTEIN) ("MFAP2" . SPARSER::PROTEIN)
    ("EVI1" . SPARSER::PROTEIN) ("LRP1" . SPARSER::PROTEIN)
    ("KCNE2" . SPARSER::PROTEIN) ("INTS12" . SPARSER::PROTEIN)
    ("HTR 4" . SPARSER::PROTEIN) ("GPR126" . SPARSER::PROTEIN)
    ("FAM13A" . SPARSER::PROTEIN) ("CDC123" . SPARSER::PROTEIN)
    ("PPT2" . SPARSER::PROTEIN) ("ADAM19" . SPARSER::PROTEIN)
    ("SERPINA1" . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("KCNJ2" . SPARSER::PROTEIN) ("HLA-DQA2" . SPARSER::PROTEIN)
    ("HLA-DQB1" . SPARSER::PROTEIN)
    ("caspase-like apoptosis-regulatory protein kinase" . SPARSER::KINASE)
    ("Mapk14" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase-activated protein kinase"
     . SPARSER::COLLECTION)
    ("PL" . SPARSER::PROTEIN) ("OCT" . SPARSER::PROTEIN)
    ("NTS" . SPARSER::PROTEIN) ("NPL" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN)
    ("antibody and/or receptor antagonist" . SPARSER::COLLECTION)
    ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("mitogen-activated protein kinase-activated protein kinase"
     . SPARSER::COLLECTION)
    ("cytokines and cytokine-regulatory" . SPARSER::COLLECTION)
    ("several inflammatory cytokines" . SPARSER::PROTEIN)
    ("S-100-ir" . SPARSER::COLLECTION) ("Tenascin-C-ir" . SPARSER::COLLECTION)
    ("an oligomeric glycoprotein" . SPARSER::PROTEIN)
    ("Caspase-3-ir" . SPARSER::COLLECTION) ("TNF-α-ir" . SPARSER::COLLECTION)
    ("ir" . SPARSER::PROTEIN) ("IL-1β-ir" . SPARSER::COLLECTION)
    ("TNF-α and p38 MAPK" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("asparagine" . SPARSER::AMINO-ACID) ("aspartate" . SPARSER::PROTEIN)
    ("JNK, ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("RIP2/RICK/CARDIAK" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("kinase/RIP2/CARDIAK" . SPARSER::COLLECTION)
    ("CARDIAK" . SPARSER::PROTEIN) ("RICK" . SPARSER::PROTEIN)
    ("which targets both p38α and p38β" . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("p38α, p38β, p38γ, and p38δ" . SPARSER::COLLECTION)
    ("MEF2, CHOP, and ATF-2" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("MAPK kinase (MKK) and MAPK" . SPARSER::COLLECTION)
    ("MKK" . SPARSER::PROTEIN-FAMILY)
    ("these pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("Caspase-3 and Tenascin-C" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION) ("myelin" . SPARSER::PROTEIN)
    ("activating transcription factor 2" . SPARSER::PROTEIN)
    ("RIP2" . SPARSER::PROTEIN) ("SB 203580" . SPARSER::DRUG)
    ("ATF-2" . SPARSER::PROTEIN) ("MAPK kinase" . SPARSER::PROTEIN)
    ("MAPK kinase kinase" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tenascin-C" . SPARSER::PROTEIN)
    ("proliferative DR" . SPARSER::MOLECULE) ("severe DR" . SPARSER::MOLECULE)
    ("the major foci" . SPARSER::PROTEIN) ("Pima" . SPARSER::DRUG)
    ("plasminogen" . SPARSER::PROTEIN)
    ("aldose reductase 2 gene and P-selectin gene" . SPARSER::COLLECTION)
    ("advanced glycation end products gene, aldose reductase 2 gene and P-selectin gene"
     . SPARSER::COLLECTION)
    ("DR" . SPARSER::MOLECULE)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("aldose reductase" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("methylenetetrahydrofolate reductase" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("highly polymeric antigens" . SPARSER::PROTEIN)
    ("CD45-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("less oligomeric antigens" . SPARSER::PROTEIN)
    ("less oligomeric ligands" . SPARSER::LIGAND)
    ("weak ligands" . SPARSER::LIGAND)
    ("display oligomeric antigens" . SPARSER::PROTEIN)
    ("highly polymeric antigens or ligands" . SPARSER::COLLECTION)
    ("antigens or ligands" . SPARSER::COLLECTION)
    ("soluble ligands" . SPARSER::LIGAND)
    ("antigenic peptide-bound MHC" . SPARSER::PROTEIN)
    ("coreceptor-" . SPARSER::PROTEIN)
    ("less multivalent ligands" . SPARSER::LIGAND)
    ("phosphatases, CD45 and CD148" . SPARSER::COLLECTION)
    ("glutaraldehyde" . SPARSER::MOLECULE)
    ("lysozyme (HEL)" . SPARSER::PROTEIN)
    ("a monoclonal BCR" . SPARSER::PROTEIN) ("BCR-" . SPARSER::PROTEIN)
    ("the SFK inhibitor PP2 and the Syk inhibitor BAY 61–3606"
     . SPARSER::COLLECTION)
    ("neither Lck nor ZAP-70" . SPARSER::COLLECTION)
    ("the dimeric chimeric CD8ζ chain protein" . SPARSER::PROTEIN)
    ("ZAP-70 or Syk" . SPARSER::COLLECTION) ("HEK" . SPARSER::PROTEIN)
    ("ZAP-70 and Syk" . SPARSER::COLLECTION)
    ("Syk and ZAP-70" . SPARSER::COLLECTION)
    ("Syk, ZAP-70, and Src" . SPARSER::COLLECTION)
    ("genetic mutants or cell-based over-expression systems ( xref , xref – xref )"
     . SPARSER::COLLECTION)
    ("Vav, and Ca 2+" . SPARSER::COLLECTION) ("GEF" . SPARSER::GEF)
    ("BLNK" . SPARSER::PROTEIN) ("strong affinity antigens" . SPARSER::PROTEIN)
    ("its multivalent ligands" . SPARSER::LIGAND)
    ("Syk and SHP-1" . SPARSER::COLLECTION)
    ("antigen-BCR" . SPARSER::COLLECTION)
    ("phosphorylated-ITAMs (pITAMs) or coreceptors (such as CD22)"
     . SPARSER::COLLECTION)
    ("phosphorylated-ITAMs" . SPARSER::PROTEIN)
    ("can also trans-phosphorylate basally active" . SPARSER::ACTIVE)
    ("stimulatory antigens" . SPARSER::PROTEIN)
    ("multivalent ligands" . SPARSER::LIGAND) ("trimers" . SPARSER::TRIMER)
    ("Dimeric antigens" . SPARSER::PROTEIN)
    ("dimeric antigens" . SPARSER::PROTEIN)
    ("monomeric antigens" . SPARSER::PROTEIN)
    ("BCR-antigen-BCR-antigen" . SPARSER::COLLECTION)
    ("antigens" . SPARSER::PROTEIN) ("antigen" . SPARSER::PROTEIN)
    ("signaling-competent monomers" . SPARSER::MONOMER)
    ("BCR-antigen" . SPARSER::COLLECTION)
    ("stimulatory antigen molecules" . SPARSER::MOLECULE)
    ("smaller BCR" . SPARSER::PROTEIN) ("monomers" . SPARSER::MONOMER)
    ("the BCR and soluble monomeric and dimeric hen egg lysozyme (HEL) antigens"
     . SPARSER::COLLECTION)
    ("soluble monomeric ligands" . SPARSER::LIGAND)
    ("both soluble monomeric and multimeric ligands" . SPARSER::LIGAND)
    ("the activation loop tyrosine of Syk ( xref )" . SPARSER::PROTEIN)
    ("Syk-" . SPARSER::PROTEIN)
    ("phospholipase Cγ2, Vav, and Btk" . SPARSER::COLLECTION)
    ("Btk" . SPARSER::PROTEIN) ("Vav" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN) ("lysozyme" . SPARSER::PROTEIN)
    ("Igµ" . SPARSER::MOLECULE) ("Lyn" . SPARSER::PROTEIN)
    ("coreceptor" . SPARSER::PROTEIN)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("syngeneic alleles" . SPARSER::ALLELE)
    ("antigenic peptides" . SPARSER::PEPTIDE)
    ("CD4 and CD8" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("coreceptors" . SPARSER::PROTEIN)
    ("either CD45 or the T-cell SFKs Lck and Fyn" . SPARSER::COLLECTION)
    ("Lck and Fyn" . SPARSER::COLLECTION) ("Fyn" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN)
    ("the kinase ζ-associated protein" . SPARSER::PROTEIN)
    ("the kinase Csk and the receptor-like protein tyrosine phosphatases (PTPs) CD45 and CD148"
     . SPARSER::COLLECTION)
    ("CD45 and CD148" . SPARSER::COLLECTION) ("PTPs" . SPARSER::PROTEIN)
    ("Csk" . SPARSER::PROTEIN) ("tyrosines" . SPARSER::AMINO-ACID)
    ("Igα and Igβ" . SPARSER::COLLECTION)
    ("the Src family kinases (SFKs) and the kinase Syk ( xref )"
     . SPARSER::COLLECTION)
    ("monomeric ligands" . SPARSER::LIGAND)
    ("multimeric ligands" . SPARSER::LIGAND)
    ("Src family kinases (SFKs) and Syk" . SPARSER::COLLECTION)
    ("ITAMs" . SPARSER::PROTEIN) ("Src and Syk" . SPARSER::COLLECTION)
    ("Indo-1" . SPARSER::MOLECULE) ("Bay 61–3606" . SPARSER::DRUG)
    ("6B" . SPARSER::PROTEIN) ("anti−" . SPARSER::ANTIBODY)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G10" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("CD3ε" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("c-Src kinase" . SPARSER::PROTEIN) ("ZAP70" . SPARSER::PROTEIN)
    ("Gly-Ser" . SPARSER::MOLECULE) ("BAY61–3606" . SPARSER::DRUG)
    ("BAY 61–3606" . SPARSER::DRUG) ("CD22" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("phosphatase-1" . SPARSER::PROTEIN)
    ("phospholipase Cγ2" . SPARSER::PROTEIN) ("pre-BCR" . SPARSER::BIO-COMPLEX)
    ("pro-B" . SPARSER::DRUG)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("ZAP-70" . SPARSER::PROTEIN) ("CD148" . SPARSER::PROTEIN)
    ("Igβ" . SPARSER::PROTEIN) ("Igα" . SPARSER::PROTEIN)
    ("a powerful antagonist" . SPARSER::MOLECULE) ("Wnt/β" . SPARSER::PROTEIN)
    ("Dkk1 and Dkk2" . SPARSER::COLLECTION) ("Dkk2" . SPARSER::PROTEIN)
    ("Dkk" . SPARSER::PROTEIN) ("Dickkopf" . SPARSER::PROTEIN)
    ("ritonavir" . SPARSER::DRUG) ("saquinavir" . SPARSER::DRUG)
    ("OPG/RANKL" . SPARSER::COLLECTION)
    ("the principal regulator" . SPARSER::REGULATOR)
    ("TNF and TNF" . SPARSER::COLLECTION)
    ("RANK/RANKL/OPG" . SPARSER::COLLECTION) ("TNF" . SPARSER::PROTEIN)
    ("OPG" . SPARSER::PROTEIN) ("RANKL" . SPARSER::PROTEIN)
    ("RANK" . SPARSER::PROTEIN) ("TCF/LEF" . SPARSER::COLLECTION)
    ("media (p<0.0001) and control L-cell conditioned media (p=0.0262)"
     . SPARSER::COLLECTION)
    ("control L-cell conditioned media" . SPARSER::PROTEIN)
    ("Wnt-luciferase" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("LDL" . SPARSER::PROTEIN) ("LEF" . SPARSER::PROTEIN)
    ("TCF" . SPARSER::PROTEIN)
    ("intracytosolic and intranuclear β-catenin" . SPARSER::PROTEIN)
    ("ALP" . SPARSER::PROTEIN) ("Wnt 3a" . SPARSER::PROTEIN)
    ("Dkk-1" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("LRP5" . SPARSER::PROTEIN) ("Dkk1" . SPARSER::PROTEIN)
    ("Dickkopf-1" . SPARSER::PROTEIN) ("Sep 15" . SPARSER::PROTEIN)
    ("phospho-AKT and phosphor-Src" . SPARSER::COLLECTION)
    ("AKT and Src" . SPARSER::COLLECTION)
    ("proteases, cathepsin B and kallikrein 6" . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COS" . SPARSER::MOLECULE)
    ("phosphatases, PP1 and PP2A" . SPARSER::COLLECTION)
    ("-caveolin-1" . SPARSER::COLLECTION)
    ("P-I3 Kinase/AKT" . SPARSER::COLLECTION)
    ("late stage colon cancer" . SPARSER::PROTEIN)
    ("caveolin-1 Y14F" . SPARSER::PROTEIN)
    ("either a constitutively active RhoA mutant (RhoQ63L) or a dominant negative form of the protein (RhoT19N)"
     . SPARSER::COLLECTION)
    ("RhoT" . SPARSER::PROTEIN) ("RhoQ" . SPARSER::PROTEIN)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("an active K-RAS gene" . SPARSER::GENE) ("RhoA" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("extracellular proteases" . SPARSER::PROTEIN)
    ("caveolin-1 and Src" . SPARSER::COLLECTION)
    ("K-RAS and caveolin-1" . SPARSER::COLLECTION)
    ("Erk1/2 and Akt" . SPARSER::COLLECTION)
    ("another lipid raft-associated protein" . SPARSER::PROTEIN)
    ("Cav" . SPARSER::PROTEIN) ("sucrose" . SPARSER::MOLECULE)
    ("Grb2 and SOS" . SPARSER::COLLECTION)
    ("Grb2 and SOS1" . SPARSER::COLLECTION)
    ("Shc and Grb2" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("phosphorylated Sp1 and promoter-bound Sp1" . SPARSER::COLLECTION)
    ("Caco-Kras" . SPARSER::COLLECTION) ("Caco" . SPARSER::PROTEIN)
    ("Myr" . SPARSER::MOLECULE) ("Caco-Neo" . SPARSER::COLLECTION)
    ("AKT-Sp1" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("active (MYR)" . SPARSER::ACTIVE) ("MYR" . SPARSER::MOLECULE)
    ("Neo" . SPARSER::PROTEIN) ("PI-3 Kinase/AKT" . SPARSER::COLLECTION)
    ("PD98059 and LY294002" . SPARSER::COLLECTION)
    ("P-I3Kinase/AKT" . SPARSER::COLLECTION)
    ("Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("a shorter isoform" . SPARSER::ISOFORM)
    ("K-RAS/Caveolin-1" . SPARSER::COLLECTION)
    ("RhoA-ROCK" . SPARSER::PROTEIN-PAIR) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("PP1 and PP2A" . SPARSER::COLLECTION)
    ("Ras-Raf-Erk" . SPARSER::COLLECTION)
    ("K-RAS, H-RAS, V-ABL and SRC" . SPARSER::COLLECTION)
    ("SRC" . SPARSER::PROTEIN) ("P-I3 Kinase-AKT" . SPARSER::COLLECTION)
    ("kallikrein 6" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("GRB7" . SPARSER::PROTEIN) ("flotillin-1" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("PI-3 Kinase" . SPARSER::PROTEIN)
    ("P-I" . SPARSER::PROTEIN) ("P-I3Kinase" . SPARSER::PROTEIN)
    ("Y14" . SPARSER::PROTEIN) ("PGL2" . SPARSER::PROTEIN)
    ("CAV-1" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("PI-3-Kinase" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("Raf-Erk" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("V-ABL" . SPARSER::PROTEIN)
    ("H-RAS" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("P-I3 Kinase" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("the pharmacologic inhibitor enzastaurin" . SPARSER::DRUG)
    ("the bioenergenic state" . SPARSER::BIO-STATE)
    ("–ovalbumin" . SPARSER::COLLECTION) ("ovalbumin" . SPARSER::PROTEIN)
    ("TNP" . SPARSER::MOLECULE)
    ("the critical T cell–costimulatory molecules CD80 and CD86"
     . SPARSER::COLLECTION)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("antibodies and anti-dsDNA" . SPARSER::COLLECTION)
    ("GCs" . SPARSER::PROTEIN) ("the treated Sle1" . SPARSER::PROTEIN)
    ("a well-tolerated PKC β -specific inhibitor" . SPARSER::INHIBITOR)
    ("CD69 and CD86" . SPARSER::COLLECTION)
    ("ASCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKC β  −/− and Sle1" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("IgG1, IgG2b, and IgG2c" . SPARSER::COLLECTION)
    ("IgG2a and IgG2c" . SPARSER::COLLECTION) ("ANAs" . SPARSER::PROTEIN)
    ("ANA" . SPARSER::PROTEIN) ("Sle1 and Sle1" . SPARSER::COLLECTION)
    ("Sle1 , Sle3 , and PKC β" . SPARSER::COLLECTION)
    ("PKC β  −/− (homozygous for both the Sle locus and the PKC β locus) and Sle1"
     . SPARSER::COLLECTION)
    ("GC" . SPARSER::PROTEIN) ("PKC β and NF- κ B" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-x L , and A1" . SPARSER::COLLECTION)
    ("BCR and BAFF" . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("BAFF" . SPARSER::PROTEIN)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("autoantibodies" . SPARSER::PROTEIN) ("CD4:CD8" . SPARSER::BIO-COMPLEX)
    ("proteinuria" . SPARSER::PROTEIN) ("autoantibody" . SPARSER::PROTEIN)
    ("enzastaurin" . SPARSER::DRUG)
    ("Sle1 or Sle1 and Sle3" . SPARSER::COLLECTION)
    ("Sle1 and Sle3" . SPARSER::COLLECTION)
    ("interleukin-10" . SPARSER::PROTEIN) ("CD80" . SPARSER::PROTEIN)
    ("I κ B α" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("Toll-like receptor 4" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("CD138" . SPARSER::PROTEIN) ("IgG3" . SPARSER::BIO-COMPLEX)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("IgG2a" . SPARSER::PROTEIN)
    ("s 2" . SPARSER::MOLECULE) ("IgG2c" . SPARSER::BIO-COMPLEX)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("anti-IgM" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("B-1" . SPARSER::PROTEIN) ("Sle1" . SPARSER::PROTEIN)
    ("PKC β" . SPARSER::PROTEIN) ("GRP78 and AKT" . SPARSER::COLLECTION)
    ("membrane-associated GRP78" . SPARSER::PROTEIN)
    ("a multifunctional co-receptor" . SPARSER::PROTEIN)
    ("cell membrane-associated GRP78" . SPARSER::PROTEIN)
    ("AKT or GRP78" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("AKT and ERK 1/2" . SPARSER::COLLECTION)
    ("MEK/ERK 1/2" . SPARSER::COLLECTION) ("western blot" . SPARSER::PROTEIN)
    ("intact GRP78 protein" . SPARSER::PROTEIN)
    ("cisplatin, Ishikawa and AN3CA" . SPARSER::COLLECTION)
    ("cisplatin (or thapsigargin) only modestly induced GRP78"
     . SPARSER::PROTEIN)
    ("thapsigargin" . SPARSER::MOLECULE) ("Cisplatin" . SPARSER::DRUG)
    ("SMG" . SPARSER::PROTEIN) ("AKT and MAPK" . SPARSER::COLLECTION)
    ("Poly (ADP-ribose) polymerase (PARP) and caspase-3" . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("PI3K/mTOR/AKT" . SPARSER::COLLECTION)
    ("BIK and caspase-7" . SPARSER::COLLECTION) ("BIK" . SPARSER::PROTEIN)
    ("many pathological states" . SPARSER::BIO-STATE)
    ("PERK and IRE1" . SPARSER::COLLECTION)
    ("correct misfolded proteins" . SPARSER::PROTEIN)
    ("recurrent EC" . SPARSER::PROTEIN) ("SiRNA" . SPARSER::PROTEIN)
    ("AKT and GRP78" . SPARSER::COLLECTION) ("co-receptor" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GSK690693" . SPARSER::DRUG)
    ("− 3" . SPARSER::PROTEIN) ("AP3" . SPARSER::PROTEIN)
    ("GRP78 protein" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("caspase-9" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("ARK1" . SPARSER::PROTEIN) ("H2O2" . SPARSER::DRUG)
    ("co- receptor" . SPARSER::PROTEIN) ("caspase-7" . SPARSER::PROTEIN)
    ("IRE1" . SPARSER::PROTEIN)
    ("glucose regulated protein" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("GRP78" . SPARSER::PROTEIN) ("using Western blot" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("pcDNA" . SPARSER::PROTEIN)
    ("ERα or PR" . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and HER2" . SPARSER::COLLECTION)
    ("histological type" . TYPE) ("HER2 and VM" . SPARSER::COLLECTION)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("VE-cadherin" . SPARSER::PROTEIN) ("C–D" . SPARSER::PROTEIN)
    ("usp1" . SPARSER::PROTEIN) ("Rfc1" . SPARSER::PROTEIN)
    ("rfc1" . SPARSER::PROTEIN) ("Elg1p" . SPARSER::PROTEIN)
    ("Ctf18–RLC" . SPARSER::COLLECTION) ("Elg1–RLC" . SPARSER::COLLECTION)
    ("Repetitive DNAs" . SPARSER::DNA) ("centromeres" . SPARSER::PROTEIN)
    ("DNAs" . SPARSER::DNA) ("the soluble fraction" . SPARSER::COMPONENT)
    ("PCNA as well as RFC4" . SPARSER::COLLECTION)
    ("RFC1, RFC2, RFC3, or RFC4" . SPARSER::COLLECTION)
    ("RFC proteins as well as RLC proteins" . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("CPT" . SPARSER::PROTEIN)
    ("camptothecin" . SPARSER::DRUG) ("EdU" . SPARSER::DRUG)
    ("ethynyl" . SPARSER::MOLECULE) ("USP1–UAF1" . SPARSER::COLLECTION)
    ("PCNA-Ub" . SPARSER::COLLECTION) ("RAD17 or CTF18" . SPARSER::COLLECTION)
    ("PCNA and ATAD5" . SPARSER::COLLECTION)
    ("FEN1 and DNA ligase 1" . SPARSER::COLLECTION)
    ("mismatch repair protein, and MRE11" . SPARSER::COLLECTION)
    ("elg1" . SPARSER::PROTEIN) ("weak BrdU foci" . SPARSER::PROTEIN)
    ("the former type" . TYPE)
    ("sub-active and inactive" . SPARSER::COLLECTION)
    ("BrdU and PCNA" . SPARSER::COLLECTION)
    ("DNA synthesis–deficient PCNA foci" . SPARSER::PROTEIN)
    ("PCNA and BrdU" . SPARSER::COLLECTION)
    ("another replisome-associated protein" . SPARSER::PROTEIN)
    ("CAF-1, and MRE11" . SPARSER::COLLECTION) ("Inactive" . SPARSER::INACTIVE)
    ("si" . SPARSER::PROTEIN) ("si-Ctrl" . SPARSER::COLLECTION)
    ("si-ATAD5" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("GFP-PCNA" . SPARSER::COLLECTION) ("GFP-fused" . SPARSER::COLLECTION)
    ("PCNA and RPA" . SPARSER::COLLECTION)
    ("the helicase and replicative polymerases" . SPARSER::COLLECTION)
    ("DNA damage–induced foci" . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN)
    ("DNA damage–induced PCNA foci" . SPARSER::PROTEIN)
    ("chromatin and forms" . SPARSER::COLLECTION)
    ("The unusually brighter PCNA foci" . SPARSER::PROTEIN)
    ("RPE" . SPARSER::PROTEIN) ("ATAD5 and PCNA" . SPARSER::COLLECTION)
    ("Elg1p–RLC" . SPARSER::PROTEIN-PAIR) ("ATAD5–RLC" . SPARSER::COLLECTION)
    ("Atad5" . SPARSER::PROTEIN) ("Usp1" . SPARSER::PROTEIN)
    ("the ubiquitin-specific protease 1 (USP1)–USP1-associated factor (UAF1) complex"
     . SPARSER::BIO-COMPLEX)
    ("Elg1" . SPARSER::PROTEIN) ("CTF18–RLC" . SPARSER::COLLECTION)
    ("RAD9–RAD1–HUS1" . SPARSER::COLLECTION)
    ("RAD17–RLC" . SPARSER::COLLECTION)
    ("the canonical RFC1" . SPARSER::PROTEIN)
    ("RAD17, CTF18, or ELG1" . SPARSER::COLLECTION) ("RFC" . SPARSER::PROTEIN)
    ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("The eukaryotic sliding clamp" . SPARSER::PROTEIN-FAMILY)
    ("proliferating cell nuclear antigen (PCNA) and other replisome proteins"
     . SPARSER::COLLECTION)
    ("PCNA and other replisome proteins" . SPARSER::COLLECTION)
    ("replisome" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("anti–" . SPARSER::ANTIBODY)
    ("LIG1" . SPARSER::PROTEIN) ("Rad27" . SPARSER::PROTEIN)
    ("ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RFC4" . SPARSER::PROTEIN)
    ("RFC3" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("mismatch repair protein" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("CAF-1" . SPARSER::PROTEIN) ("DNA ligase 1" . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("p–RLC" . SPARSER::PROTEIN)
    ("UAF1" . SPARSER::PROTEIN) ("USP1" . SPARSER::PROTEIN)
    ("HUS1" . SPARSER::PROTEIN) ("RAD1" . SPARSER::PROTEIN)
    ("RAD9" . SPARSER::PROTEIN) ("ELG1" . SPARSER::PROTEIN)
    ("CTF18" . SPARSER::PROTEIN) ("RAD17" . SPARSER::PROTEIN)
    ("RFC2" . SPARSER::PROTEIN) ("RFC1" . SPARSER::PROTEIN)
    ("ATAD5" . SPARSER::PROTEIN)
    ("approximately 10,000 phosphoproteins" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("protein and forms" . SPARSER::COLLECTION)
    ("USP7 and Mdmx" . SPARSER::COLLECTION)
    ("preferable substrate" . SPARSER::SUBSTRATE)
    ("PPM1A, PPM1F and PPM1F" . SPARSER::COLLECTION)
    ("MKK6-p38" . SPARSER::COLLECTION) ("-JNK" . SPARSER::COLLECTION)
    ("PPM1A, PPM1F and PPM1J" . SPARSER::COLLECTION)
    ("ATM, Chk1 and Chk2" . SPARSER::COLLECTION)
    ("Chk1, Chk2, and Akt" . SPARSER::COLLECTION)
    ("proteins and protein" . SPARSER::COLLECTION)
    ("Mdm2-Mdmx" . SPARSER::COLLECTION)
    ("Mdmx and the Mdm2-containing complex" . SPARSER::COLLECTION)
    ("a preferable substrate" . SPARSER::SUBSTRATE)
    ("an authentic substrate" . SPARSER::SUBSTRATE)
    ("p53-Mdmx" . SPARSER::COLLECTION)
    ("the PP1’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP1-Mdmx" . SPARSER::COLLECTION)
    ("bacterial purified Mdmx and PP1α proteins" . SPARSER::PROTEIN)
    ("Mdmx and PP1α" . SPARSER::COLLECTION) ("Mdmx-PP1" . SPARSER::COLLECTION)
    ("PP1α, PP1β and PP1γ" . SPARSER::COLLECTION)
    ("PP1/PP2A" . SPARSER::COLLECTION) ("HA-Mdmx" . SPARSER::COLLECTION)
    ("FLAG-PP1" . SPARSER::COLLECTION)
    ("the reciprocal immunoprecipitation-Western blot" . SPARSER::PROTEIN)
    ("PP1 and Mdmx" . SPARSER::COLLECTION)
    ("Chk2 and other kinases [ xref , xref ]" . SPARSER::COLLECTION)
    ("ATM, Chk1, Chk2 and other kinases [ xref , xref ]" . SPARSER::COLLECTION)
    ("phosphatases, PPM1B and PP2Aα" . SPARSER::COLLECTION)
    ("PP1α, PP1β, PP1γ, PPM1A, PPM1D, POPX1 and PPM1J" . SPARSER::COLLECTION)
    ("neocarzinostatin" . SPARSER::PROTEIN)
    ("available reagents" . SPARSER::MOLECULE)
    ("Chk1, Chk2, and p38" . SPARSER::COLLECTION)
    ("ATM-p53" . SPARSER::COLLECTION) ("radiomimetic drugs" . SPARSER::DRUG)
    ("p53-Mdm2" . SPARSER::COLLECTION) ("Mdmx and Mdm2" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 and Mdmx" . SPARSER::COLLECTION)
    ("a pivotal tumor suppressor" . SPARSER::SUPPRESSOR)
    ("ATM-Chk2-p53" . SPARSER::COLLECTION)
    ("an intrinsic ligase activity" . SPARSER::PROTEIN)
    ("Mdmx" . SPARSER::PROTEIN)
    ("negative posttranslational modifiers" . SPARSER::MOLECULE)
    ("ligases, deubiquitinases, acetylases and deacetylases"
     . SPARSER::COLLECTION)
    ("acetylases" . SPARSER::PROTEIN)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE) ("USP7" . SPARSER::PROTEIN)
    ("ubiquitin specific peptidase 7" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("MKK6" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("PP2Cβ" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PPM1F" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("manganese dependent" . SPARSER::PROTEIN) ("PP2Aα" . SPARSER::PROTEIN)
    ("PPM1B" . SPARSER::PROTEIN) ("PPM1J" . SPARSER::PROTEIN)
    ("POPX1" . SPARSER::PROTEIN) ("PPM1D" . SPARSER::PROTEIN)
    ("PPM1A" . SPARSER::PROTEIN) ("PP1β" . SPARSER::PROTEIN)
    ("PP1α" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("PPP5C" . SPARSER::PROTEIN) ("PP1γ" . SPARSER::PROTEIN)
    ("Wip1" . SPARSER::PROTEIN) ("Mdm4" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("S2 and RLC" . SPARSER::COLLECTION) ("RLC" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("exogenous GSK3β" . SPARSER::PROTEIN) ("40kDa" . SPARSER::PROTEIN)
    ("GSK3β or PKA" . SPARSER::COLLECTION)
    ("the archetypical kinase" . SPARSER::KINASE)
    ("Pro-Ala" . SPARSER::COLLECTION) ("proline-alanine" . SPARSER::COLLECTION)
    ("Ala" . SPARSER::AMINO-ACID)
    ("Cardiac myosin binding protein C" . SPARSER::PROTEIN)
    ("Phos-tag" . SPARSER::DRUG) ("CT99021" . SPARSER::DRUG)
    ("ATP 4" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("Cardiac MyBP-C" . SPARSER::PROTEIN)
    ("myosin binding protein C" . SPARSER::PROTEIN)
    ("the young group and old group" . SPARSER::COLLECTION)
    ("the exon 2 and exon 20" . SPARSER::COLLECTION) ("Lv" . SPARSER::MOLECULE)
    ("PB" . SPARSER::PROTEIN)
    ("Chen
[ xref ] and Liu
[ xref ]"
     . SPARSER::COLLECTION)
    ("Chen" . SPARSER::PROTEIN)
    ("The partial DNA sequencing results of exon 2 and exon"
     . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN)
    ("the BRCA1 gene 2 and 20 exon" . SPARSER::COLLECTION)
    ("the young group and the old group" . SPARSER::COLLECTION)
    ("ER and PR, HER2, Ki67, BRCA1 and WWOX" . SPARSER::COLLECTION)
    ("PR, HER2, Ki67, BRCA1 and WWOX" . SPARSER::COLLECTION)
    ("ER, PR, HER2, and WWOX" . SPARSER::COLLECTION)
    ("ER, PR, C-erbB2, BRCA1 and WWOX" . SPARSER::COLLECTION)
    ("ER, PR, C-erbB2, BRCA1, and WWOX" . SPARSER::COLLECTION)
    ("the most common histopathologic type" . TYPE)
    ("the breast cancer susceptibility gene BRCA1 and the tumor suppressor gene WWOX"
     . SPARSER::COLLECTION)
    ("a new tumor suppressor gene" . SPARSER::PROTEIN)
    ("FHIT" . SPARSER::PROTEIN) ("shotgun" . SPARSER::PROTEIN)
    ("WWOX" . SPARSER::PROTEIN) ("genesis" . SPARSER::PROTEIN)
    ("claudin-6" . SPARSER::PROTEIN) ("gene 2" . SPARSER::PROTEIN)
    ("C-erbB2" . SPARSER::PROTEIN) ("Blast2" . SPARSER::PROTEIN)
    ("WW domain containing oxidoreductase" . SPARSER::PROTEIN)
    ("longer DNA" . SPARSER::DNA)
    ("ATXN1 and other polyQ disease proteins ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("literature-positive interactors" . SPARSER::PROTEIN)
    ("brain acid soluble protein 1 (BASP1) and the neuronal acetylcholine receptor subunit alpha-7 (CHRNA7)"
     . SPARSER::COLLECTION)
    ("included TSC1, orthodenticle homeobox 2 (OTX2), brain acid soluble protein 1 (BASP1) and the neuronal acetylcholine receptor subunit alpha-7 (CHRNA7)"
     . SPARSER::COLLECTION)
    ("YWHAE, YWHAZ and YWHAQ" . SPARSER::COLLECTION)
    ("YWHAQ" . SPARSER::PROTEIN) ("YWHAZ" . SPARSER::PROTEIN)
    ("YWHAE" . SPARSER::PROTEIN)
    ("protein LST8 homolog (MLST8) and the hamartin protein TSC1 ( xref C)"
     . SPARSER::COLLECTION)
    ("hamartin" . SPARSER::PROTEIN) ("Examples" . SPARSER::EXAMPLE)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one known prey protein" . SPARSER::PROTEIN)
    ("spectrin" . SPARSER::PROTEIN) ("monomer" . SPARSER::MONOMER)
    ("ERCC6L, EVL and HMG20A" . SPARSER::COLLECTION)
    ("PIAS1 and ZNF451" . SPARSER::COLLECTION)
    ("ligase and ZNF451" . SPARSER::COLLECTION) ("PML" . SPARSER::PROTEIN)
    ("Sumo" . SPARSER::PROTEIN) ("SNF2/RAD54" . SPARSER::COLLECTION)
    ("VASP" . SPARSER::PROTEIN)
    ("ERCC6L, EVL, HMG20A, PIAS1 and ZNF451" . SPARSER::COLLECTION)
    ("EVL" . SPARSER::PROTEIN) ("LUMIER or HIPPIE" . SPARSER::COLLECTION)
    ("LUMIER" . SPARSER::PROTEIN) ("optineurin (OPTN)" . SPARSER::PROTEIN)
    ("OPTN" . SPARSER::PROTEIN) ("optineurin" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY) ("biotin" . SPARSER::PROTEIN)
    ("Prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the systematic mapping" . SPARSER::PROTEIN)
    ("mapping (LUMIER)" . SPARSER::PROTEIN)
    ("HTT and ATXN1" . SPARSER::COLLECTION)
    ("the neurodegenerative disease proteins huntingtin (HTT) and ataxin-1 (ATXN1)"
     . SPARSER::COLLECTION)
    ("the neurodegenerative disease proteins huntingtin (HTT)"
     . SPARSER::PROTEIN)
    ("huntingtin (HTT)" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("HTT" . SPARSER::PROTEIN) ("diverse chemical" . SPARSER::MOLECULE)
    ("reporter genes that are scored by growth and color phenotypes (typically HIS3 and lacZ )"
     . SPARSER::COLLECTION)
    ("The reconstituted hybrid transcription factor" . SPARSER::PROTEIN)
    ("lacZ" . SPARSER::PROTEIN) ("HIS" . SPARSER::AMINO-ACID)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("systematic mapping" . SPARSER::PROTEIN)
    ("comprehensive maps" . SPARSER::PROTEIN)
    ("the human neurodegenerative disease proteins huntingtin and ataxin-1"
     . SPARSER::COLLECTION)
    ("huntingtin and ataxin-1" . SPARSER::COLLECTION)
    ("huntingtin" . SPARSER::PROTEIN) ("yeast)" . SPARSER::PROTEIN)
    ("ATXN-1" . SPARSER::PROTEIN) ("CHRNA7" . SPARSER::PROTEIN)
    ("neuronal acetylcholine receptor subunit alpha-7" . SPARSER::PROTEIN)
    ("BASP1" . SPARSER::PROTEIN) ("soluble protein 1" . SPARSER::PROTEIN)
    ("OTX2" . SPARSER::PROTEIN) ("orthodenticle homeobox 2" . SPARSER::PROTEIN)
    ("14–3–3" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("MLST8" . SPARSER::PROTEIN) ("LST8 homolog" . SPARSER::PROTEIN)
    ("STAM2" . SPARSER::PROTEIN)
    ("signal transducing adaptor molecule 2" . SPARSER::PROTEIN)
    ("ARID5" . SPARSER::PROTEIN) ("HIP10" . SPARSER::PROTEIN)
    ("PRPF40A" . SPARSER::PROTEIN) ("SPTAN1" . SPARSER::PROTEIN)
    ("PFN2" . SPARSER::PROTEIN) ("profilin-2" . SPARSER::PROTEIN)
    ("RAD54" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("ZNF451" . SPARSER::PROTEIN) ("HMG20A" . SPARSER::PROTEIN)
    ("ERCC6L" . SPARSER::PROTEIN) ("UBE2K" . SPARSER::PROTEIN)
    ("UBAC1" . SPARSER::PROTEIN) ("HIP14" . SPARSER::PROTEIN)
    ("ZDHHC17" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bdH 2" . SPARSER::PROTEIN)
    ("1−2" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("HD protein" . SPARSER::PROTEIN)
    ("ATXN1" . SPARSER::PROTEIN) ("ataxin-1" . SPARSER::PROTEIN)
    ("a labile protein and transcriptional repressor" . SPARSER::COLLECTION)
    ("gluconeogenic genes" . SPARSER::GENE) ("AHR-ARNT" . SPARSER::COLLECTION)
    ("AHRR and TiPARP" . SPARSER::COLLECTION)
    ("CHX and 26S-proteasome" . SPARSER::COLLECTION)
    ("axin" . SPARSER::PROTEIN) ("the reactive oxygen" . SPARSER::MOLECULE)
    ("Stat6-dependent transcription whereby non-stimulated PARP-14"
     . SPARSER::PROTEIN)
    ("Stat6" . SPARSER::PROTEIN)
    ("Sp1 and nuclear receptors" . SPARSER::COLLECTION)
    ("NF-κB, HES1, Oct-1, c-Myc, Sp1 and nuclear receptors"
     . SPARSER::COLLECTION)
    ("peroxisome proliferator-activated receptor γ, and thyroid hormone receptor"
     . SPARSER::RECEPTOR)
    ("Cyp1b1 and Ahrr" . SPARSER::COLLECTION)
    ("Cyp1a1 and Cyp1b1" . SPARSER::COLLECTION)
    ("Cyp1a1, Cyp1b1 and Ahrr" . SPARSER::COLLECTION)
    ("Cyp1b1" . SPARSER::PROTEIN) ("Cyp1a1" . SPARSER::PROTEIN)
    ("DMSO or TCDD" . SPARSER::COLLECTION) ("FLP" . SPARSER::PROTEIN)
    ("TREx" . SPARSER::PROTEIN-FAMILY)
    ("foci and co-localized" . SPARSER::COLLECTION)
    ("DMSO-" . SPARSER::MOLECULE) ("TCDD or DMSO" . SPARSER::COLLECTION)
    ("AHR and TiPARP" . SPARSER::COLLECTION) ("luc" . SPARSER::PROTEIN)
    ("PARP-1 or PARP-12" . SPARSER::COLLECTION)
    ("CYP1A1-luc" . SPARSER::COLLECTION)
    ("repressors or activators" . SPARSER::COLLECTION)
    ("PARP-1 and PARP-12" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("AHR or ARNT" . SPARSER::COLLECTION)
    ("AHR and ARNT" . SPARSER::COLLECTION) ("GFP-TiPARP" . SPARSER::COLLECTION)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION)
    ("TiPARP and CYP1A" . SPARSER::COLLECTION)
    ("DNAse-treated RNA" . SPARSER::RNA)
    ("GST-mTiparp or GST-chTiPARP" . SPARSER::COLLECTION)
    ("GST-chTiPARP" . SPARSER::PROTEIN-PAIR)
    ("GST-mTiparp" . SPARSER::PROTEIN-PAIR)
    ("DNAse-treated total RNA" . SPARSER::RNA) ("DNAse" . SPARSER::PROTEIN)
    ("DNA or RNA" . SPARSER::COLLECTION) ("GST-TiPARP" . SPARSER::COLLECTION)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("AHR, ARNT and AHRR" . SPARSER::COLLECTION) ("AHRR" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor repressor (AHRR) and TiPARP ( xref , xref )"
     . SPARSER::COLLECTION)
    ("response element (AHRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AHR/ARNT" . SPARSER::COLLECTION)
    ("aryl hydrocarbon receptor nuclear translocator (ARNT)"
     . SPARSER::PROTEIN)
    ("tryptophan" . SPARSER::AMINO-ACID) ("WWE" . SPARSER::PROTEIN-FAMILY)
    ("ARTD14/PARP-7" . SPARSER::COLLECTION)
    ("Extracellular membrane-associated ecto-mARTs" . SPARSER::COLLECTION)
    ("ecto-mARTs" . SPARSER::COLLECTION) ("ecto" . SPARSER::PROTEIN)
    ("mARTs" . SPARSER::PROTEIN)
    ("several different bacterial toxins" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("synthase" . SPARSER::PROTEIN)
    ("polymer" . SPARSER::MOLECULE) ("polymers" . SPARSER::MOLECULE)
    ("TiPARP and AHR" . SPARSER::COLLECTION)
    ("aryl hydrocarbon receptor (AHR)" . SPARSER::PROTEIN)
    ("TiPARP/ARTD14" . SPARSER::COLLECTION) ("-dioxin" . SPARSER::MOLECULE)
    ("AHR" . SPARSER::PROTEIN) ("TiPARP" . SPARSER::PROTEIN)
    ("TCDD" . SPARSER::PROTEIN) ("dioxin" . SPARSER::MOLECULE)
    ("ARTD6" . SPARSER::PROTEIN) ("PARP-5b" . SPARSER::PROTEIN)
    ("ARTD5" . SPARSER::PROTEIN) ("PARP-5a" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("Oct-1" . SPARSER::PROTEIN)
    ("HES1" . SPARSER::PROTEIN) ("PARP-14" . SPARSER::PROTEIN)
    ("ARTD10" . SPARSER::PROTEIN) ("CYP1A" . SPARSER::PROTEIN)
    ("P-40" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("PARP-12" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("aryl hydrocarbon receptor repressor" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN) ("PARP-7" . SPARSER::PROTEIN)
    ("ARTD1" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("CYP1B1" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("ARTD14" . SPARSER::PROTEIN) ("sunitinib" . SPARSER::DRUG)
    ("therapeutic anti-integrin [ xref ] and FAK inhibitors"
     . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION) ("FAK-KD" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("GFP-FAK" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("fragile or friable state" . SPARSER::BIO-STATE)
    ("BID" . SPARSER::PROTEIN) ("HEY" . SPARSER::PROTEIN-FAMILY)
    ("the fluorescent mCherry protein" . SPARSER::PROTEIN)
    ("FAK-Src" . SPARSER::COLLECTION)
    ("potential cell-associated protein" . SPARSER::PROTEIN)
    ("HEMA" . SPARSER::PROTEIN)
    ("cell surface-associated proteins" . SPARSER::PROTEIN)
    ("serous ovarian cancer patient mRNA" . SPARSER::PROTEIN)
    ("serous ovarian patient cohort" . SPARSER::MOLECULE)
    ("PND" . SPARSER::PROTEIN) ("ATP-competitive" . SPARSER::ATP)
    ("dasatinib" . SPARSER::DRUG) ("promoting adrenergic" . SPARSER::PROTEIN)
    ("tip" . SPARSER::PROTEIN)
    ("integrins and growth factor" . SPARSER::COLLECTION)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("FAK and c-Src" . SPARSER::COLLECTION) ("kinase (FAK)" . SPARSER::KINASE)
    ("Ptk2" . SPARSER::PROTEIN) ("Ptk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("beta-cyclodextrin" . SPARSER::MOLECULE) ("CD31" . SPARSER::PROTEIN)
    ("PF562,271" . SPARSER::DRUG) ("drugs and radiation" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("INrf2 and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 downstream cytoprotective proteins" . SPARSER::PROTEIN)
    ("NF-kB and Hepatocyte Growth Factor" . SPARSER::COLLECTION)
    ("BclxL" . SPARSER::PROTEIN)
    ("GATA1, AP1, AP4, NF-E2A and SP1" . SPARSER::COLLECTION)
    ("SP1" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("t-BHQ/Nrf2/Bcl-xL" . SPARSER::COLLECTION)
    ("t-BHQ/Nrf2" . SPARSER::COLLECTION)
    ("cytoprotective proteins" . SPARSER::PROTEIN)
    ("Bcl-2 and Nrf2" . SPARSER::COLLECTION)
    ("cytoprotective nuclear factor Nrf2" . SPARSER::PROTEIN)
    ("etoposide or etoposide" . SPARSER::COLLECTION)
    ("pcDNA-INrf2" . SPARSER::PROTEIN-PAIR) ("Cysteine" . SPARSER::AMINO-ACID)
    ("Glycine" . SPARSER::AMINO-ACID) ("Etoposide" . SPARSER::PROTEIN)
    ("pGL2b-1.565" . SPARSER::PROTEIN) ("Bcl-xL-1.565" . SPARSER::PROTEIN)
    ("siRNA or Bcl-xL" . SPARSER::COLLECTION)
    ("Nrf2 or Bcl-xL" . SPARSER::COLLECTION)
    ("Flag-Bcl-xL" . SPARSER::COLLECTION)
    ("DMSO or tBHQ" . SPARSER::COLLECTION)
    ("pro-apoptotic factors Bax and caspases3/7" . SPARSER::COLLECTION)
    ("Bax and caspases3/7" . SPARSER::COLLECTION)
    ("INrf2 and etoposide" . SPARSER::COLLECTION)
    ("Nrf2 or Keap1" . SPARSER::COLLECTION)
    ("Nrf2, Bcl-xL, Bax and actin" . SPARSER::COLLECTION)
    ("Bax and caspases" . SPARSER::COLLECTION)
    ("Nrf2, Bcl-xL, LDH and lamin B" . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN) ("tBHQ and Nrf2" . SPARSER::COLLECTION)
    ("Bax and Caspases 3/7" . SPARSER::COLLECTION)
    ("Nrf2, Bcl-xL and NQO1" . SPARSER::COLLECTION)
    ("The mutant plasmid Bcl-xL-1.565-MT-LUC and mutant ARE-F1-LUC"
     . SPARSER::COLLECTION)
    ("ARE-F1-LUC" . SPARSER::PROTEIN)
    ("plasmid Bcl-xL-1.565-MT-LUC" . SPARSER::PROTEIN)
    ("LUC" . SPARSER::PROTEIN) ("Bcl-xL or NQO1" . SPARSER::COLLECTION)
    ("Bcl-xL and NQO1" . SPARSER::COLLECTION)
    ("Flag-Nrf2" . SPARSER::COLLECTION) ("tetracycline" . SPARSER::DRUG)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NQO1-luciferase" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Nucleotide" . SPARSER::NUCLEOTIDE) ("BHQ" . SPARSER::PROTEIN)
    ("t-BHQ" . SPARSER::COLLECTION) ("tBHQ" . SPARSER::DRUG)
    ("pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("Bcl-2, and Bcl-xL" . SPARSER::COLLECTION)
    ("during chemical and radiation stress" . SPARSER::COLLECTION)
    ("INrf2:Nrf2" . SPARSER::BIO-COMPLEX)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("the prototypic anti-apoptotic proteins, and Bcl-xL"
     . SPARSER::COLLECTION)
    ("proteins, and Bcl-xL" . SPARSER::COLLECTION) ("redox" . SPARSER::PROTEIN)
    ("Nrf2 and its downstream proteins" . SPARSER::COLLECTION)
    ("glutathione S-transferase (GST)" . SPARSER::PROTEIN)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("thioredoxin reductase-1" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN) ("synthetase" . SPARSER::PROTEIN)
    ("oxidoreductase" . SPARSER::PROTEIN) ("quinine" . SPARSER::DRUG)
    ("Antioxidant" . SPARSER::PROTEIN)
    ("Nrf2 and downstream genes" . SPARSER::COLLECTION)
    ("downstream cytoprotective proteins" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID)
    ("cysteines of two INrf2 peptides" . SPARSER::PEPTIDE)
    ("thiol" . SPARSER::MOLECULE)
    ("a Cul3-Rbx1-dependent E3 ubiquitin ligase complex"
     . SPARSER::BIO-COMPLEX)
    ("INrf2 (inhibitor of Nrf2) or Keap1 (Kelch-like ECH-associated protein 1)"
     . SPARSER::COLLECTION)
    ("actin-associated cytosolic protein, INrf2 (inhibitor of Nrf2) or Keap1 (Kelch-like ECH-associated protein 1)"
     . SPARSER::COLLECTION)
    ("actin-associated cytosolic protein" . SPARSER::PROTEIN)
    ("Nrf2:INrf2" . SPARSER::BIO-COMPLEX)
    ("Nrf2 and Bcl-xL" . SPARSER::COLLECTION) ("etoposide" . SPARSER::PROTEIN)
    ("the proximal Bcl-xL promoter" . SPARSER::PROMOTER)
    ("cytoprotective genes" . SPARSER::GENE)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("AP4" . SPARSER::PROTEIN)
    ("PGAM5" . SPARSER::PROTEIN) ("caspases3" . SPARSER::PROTEIN)
    ("Caspases 3" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("P-20" . SPARSER::PROTEIN)
    ("H-5" . SPARSER::PROTEIN) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("b-1" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("NAD (P)H" . SPARSER::MOLECULE)
    ("protein kinase C delta" . SPARSER::PROTEIN) ("Cul3" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("INrf2" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG) ("Nrf2" . SPARSER::PROTEIN)
    ("EDL and TBC1D4" . SPARSER::COLLECTION)
    ("AS160/TBC1D4" . SPARSER::COLLECTION)
    ("nitric oxide and reactive oxygen species" . SPARSER::COLLECTION)
    ("Calcium" . SPARSER::CALCIUM) ("AMPK and ACC" . SPARSER::COLLECTION)
    ("GLUT4 and Rac1" . SPARSER::COLLECTION) ("TC10" . SPARSER::PROTEIN)
    ("the unspecific AMPK inhibitor compound C" . SPARSER::MOLECULE)
    ("AICAR and DNP" . SPARSER::COLLECTION)
    ("Rac1 and its downstream target" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myc" . SPARSER::PROTEIN) ("p-TBC1D1" . SPARSER::COLLECTION)
    ("Cre-recombinase" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("flox" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY)
    ("Rac1 or GLUT4" . SPARSER::COLLECTION)
    ("NSC23766 and Rac1" . SPARSER::COLLECTION)
    ("intact skeletal muscle" . SPARSER::PROTEIN) ("DNP" . SPARSER::DRUG)
    ("p-AMPK" . SPARSER::COLLECTION)
    ("AICAR and retinoic acid" . SPARSER::COLLECTION)
    ("basal or exercised EDL" . SPARSER::PROTEIN)
    ("p-PAK" . SPARSER::COLLECTION) ("p-PAK1" . SPARSER::COLLECTION)
    ("AICAR-" . SPARSER::PROTEIN)
    ("oxygen, and nitrogen" . SPARSER::COLLECTION)
    ("calcium-calmodulin–dependent kinases" . SPARSER::KINASE)
    ("calmodulin" . SPARSER::PROTEIN) ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wortmannin" . SPARSER::PROTEIN) ("phosphatidyl" . SPARSER::MOLECULE)
    ("EDL" . SPARSER::PROTEIN) ("AS160" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("PKC-α" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("retinoic acid" . SPARSER::MOLECULE) ("VAMP3" . SPARSER::PROTEIN)
    ("TBC1D4" . SPARSER::PROTEIN) ("TBC1D1" . SPARSER::PROTEIN)
    ("p-Rac1" . SPARSER::PROTEIN) ("p-ACC" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("N5" . SPARSER::PROTEIN) ("muscle specific" . SPARSER::PROTEIN)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY)
    ("Ras-related C3 botulinum toxin substrate 1" . SPARSER::PROTEIN)
    ("inositol 3-kinase" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterozygous BRAF V600E mutants" . SPARSER::MUTANT)
    ("Val" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("monoclonal antibodies (e.g., cetuximab, panitumumab) or small molecule tyrosine kinase inhibitors (e.g., erlotinib, gefitinib)"
     . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("gefitinib" . SPARSER::DRUG)
    ("panitumumab" . SPARSER::DRUG) ("the major histological type" . TYPE)
    ("ARMS" . SPARSER::PROTEIN) ("GGC" . SPARSER::PROTEIN)
    ("TGT" . SPARSER::PROTEIN) ("GAT" . SPARSER::PROTEIN)
    ("GGT" . SPARSER::PROTEIN) ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("PF1" . SPARSER::PROTEIN)
    ("V-Raf Murine Sarcoma Viral Oncogene Homolog B1" . SPARSER::PROTEIN)
    ("Ras 1" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("further shed light" . SPARSER::PROTEIN)
    ("chromatin- and H3K36" . SPARSER::COLLECTION)
    ("chromatin-" . SPARSER::PROTEIN) ("demethylases" . SPARSER::PROTEIN)
    ("those ‘bivalent’ or ’bimodal’ genes or loci" . SPARSER::COLLECTION)
    ("genes or loci" . SPARSER::COLLECTION)
    ("multivalent chromatin state genes" . SPARSER::GENE)
    ("PHF1 or PHF19" . SPARSER::COLLECTION)
    ("EED and JARID2" . SPARSER::COLLECTION) ("cofactors" . SPARSER::PROTEIN)
    ("JARID2 ( xref ; xref ; xref ; xref ) and noncoding RNAs ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("cofactor" . SPARSER::MOLECULE) ("H3K27me3-" . SPARSER::PROTEIN)
    ("BRPF1 and EAF3" . SPARSER::COLLECTION)
    ("PHF1 and PHF19" . SPARSER::COLLECTION)
    ("Otx2 and other tested target genes ( Meis1, Hoxa5, Fgf15 )"
     . SPARSER::COLLECTION)
    ("these bivalent genes" . SPARSER::GENE)
    ("‘multivalent’ development genes" . SPARSER::GENE)
    ("3 ‘bivalent’ genes" . SPARSER::GENE) ("Rps19" . SPARSER::PROTEIN)
    ("Rps" . SPARSER::PROTEIN)
    ("these ‘bivalent’ PRC-targeted genes" . SPARSER::GENE)
    ("Otx2, Meis1, Hoxa5 and Fgf15" . SPARSER::COLLECTION)
    ("Fgf15" . SPARSER::PROTEIN) ("Hoxa5" . SPARSER::PROTEIN)
    ("H3K27me3 and Phf19" . SPARSER::COLLECTION)
    ("Phf19 and H3K36" . SPARSER::COLLECTION) ("Jarid2" . SPARSER::PROTEIN)
    ("H3K27me3 and Phf19-repressed genes (with pvalue of <2.2e–16, data not shown)"
     . SPARSER::COLLECTION)
    ("Ezh2, Suz12 and Mtf2/Pcl2" . SPARSER::COLLECTION)
    ("Ezh2" . SPARSER::PROTEIN) ("Phf19" . SPARSER::PROTEIN)
    ("differentiation-associated genes" . SPARSER::GENE)
    ("TADA1/ADA1" . SPARSER::COLLECTION) ("proximal HOX" . SPARSER::PROTEIN)
    ("HOXB4, HOXB3 and HOXB1" . SPARSER::COLLECTION)
    ("HOXB6 and HOXB5" . SPARSER::COLLECTION)
    ("exogenous FLAG-tagged PHF1" . SPARSER::PROTEIN)
    ("HOXB9 and HOXB8" . SPARSER::COLLECTION)
    ("high H3K27me3 and low H3K36" . SPARSER::COLLECTION)
    ("three distal HOX" . SPARSER::PROTEIN)
    ("HOXB9, HOXB8 and HOXB7" . SPARSER::COLLECTION)
    ("HOXB" . SPARSER::PROTEIN)
    ("the distal HOX-B genes (from HOXB13 to HOXB7 ) and H3K36"
     . SPARSER::COLLECTION)
    ("the distal HOX-B genes" . SPARSER::GENE)
    ("H3K27me3 and H3K36" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("separate H3K27me3" . SPARSER::PROTEIN) ("DAPI-dense" . SPARSER::DRUG)
    ("DAPI" . SPARSER::DRUG) ("SUZ12 and EZH2" . SPARSER::COLLECTION)
    ("PRC2-" . SPARSER::PROTEIN)
    ("chromatin and soluble fractions" . SPARSER::COLLECTION)
    ("soluble fractions" . SPARSER::COMPONENT)
    ("distinct PRC2" . SPARSER::PROTEIN)
    ("proteins and JARID2" . SPARSER::COLLECTION)
    ("PHF1 or MTF2" . SPARSER::COLLECTION)
    ("EZH2 and SUZ12" . SPARSER::COLLECTION)
    ("PRC2-PHF1" . SPARSER::COLLECTION) ("EZH2 or EZH1" . SPARSER::COLLECTION)
    ("PHF1 and PRC2" . SPARSER::COLLECTION) ("PHF1-PRC2" . SPARSER::COLLECTION)
    ("Van" . SPARSER::PROTEIN) ("IPs" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID) ("drosophila" . SPARSER::PROTEIN)
    ("Asp" . SPARSER::AMINO-ACID) ("Phe" . SPARSER::AMINO-ACID)
    ("trimethylammonium" . SPARSER::MOLECULE)
    ("soluble cytoplasmic/ nucleoplasm fractions" . SPARSER::COMPONENT)
    ("JMJD2A/KDM4A" . SPARSER::COLLECTION) ("demethylase" . SPARSER::PROTEIN)
    ("nucleosomal substrates" . SPARSER::SUBSTRATE)
    ("GST-PHF1" . SPARSER::COLLECTION) ("tri-" . SPARSER::PROTEIN)
    ("other methylated histone peptides" . SPARSER::PEPTIDE)
    ("MTF2/PCL2" . SPARSER::COLLECTION) ("PHD" . SPARSER::PROTEIN)
    ("a known accessory component" . SPARSER::COMPONENT)
    ("NSD2 and MSH6" . SPARSER::COLLECTION)
    ("accessory components" . SPARSER::COMPONENT)
    ("JARID2 ( xref ; xref ; xref ; xref ) and non-coding RNAs ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("a reconstituted tetrameric PRC2 core complex" . SPARSER::BIO-COMPLEX)
    ("NURF55/RbAp48" . SPARSER::COLLECTION) ("EED" . SPARSER::PROTEIN)
    ("active genes" . SPARSER::GENE) ("optimal H3K27me3" . SPARSER::PROTEIN)
    ("‘poised’ developmental genes" . SPARSER::GENE)
    ("PRC2 and H3K27me3" . SPARSER::COLLECTION)
    ("PHF19/PCL3" . SPARSER::COLLECTION) ("PHF1/PCL1" . SPARSER::COLLECTION)
    ("PCL" . SPARSER::PROTEIN) ("polycomb-like 3" . SPARSER::PROTEIN)
    ("polycomb-like 1" . SPARSER::PROTEIN) ("β- Actin" . SPARSER::PROTEIN)
    ("EAF3" . SPARSER::PROTEIN) ("Meis1" . SPARSER::PROTEIN)
    ("E-H" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("Otx2" . SPARSER::PROTEIN) ("Mtf2" . SPARSER::PROTEIN)
    ("Suz12" . SPARSER::PROTEIN) ("ADA1" . SPARSER::PROTEIN)
    ("TADA1" . SPARSER::PROTEIN) ("PBX1" . SPARSER::PROTEIN)
    ("HOXB3" . SPARSER::PROTEIN) ("HOXB4" . SPARSER::PROTEIN)
    ("HOXB9" . SPARSER::PROTEIN) ("HOXB1" . SPARSER::PROTEIN)
    ("HOXB6" . SPARSER::PROTEIN) ("HOXB7" . SPARSER::PROTEIN)
    ("HOXB13" . SPARSER::PROTEIN) ("H3P" . SPARSER::PROTEIN)
    ("Eaf3" . SPARSER::PROTEIN) ("BRPF1" . SPARSER::PROTEIN)
    ("polycomb-like" . SPARSER::PROTEIN-FAMILY) ("KDM4A" . SPARSER::PROTEIN)
    ("JMJD2A" . SPARSER::PROTEIN) ("H2B" . SPARSER::PROTEIN)
    ("PCL2" . SPARSER::PROTEIN) ("MTF2" . SPARSER::PROTEIN)
    ("NSD2" . SPARSER::PROTEIN) ("JARID2" . SPARSER::PROTEIN)
    ("RbAp48" . SPARSER::PROTEIN) ("NURF55" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("PCL3" . SPARSER::PROTEIN)
    ("PHF19" . SPARSER::PROTEIN) ("PCL1" . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("ROS1 and RET" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("potential causative variants" . SPARSER::VARIANT)
    ("nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("three cholinergic nicotinereceptor genes" . SPARSER::GENE)
    ("CHRNA3 , CHRNA5 , and CHRNB4" . SPARSER::COLLECTION)
    ("a concurrent EGFR -T790M" . SPARSER::PROTEIN)
    ("cigarettes" . SPARSER::DRUG) ("EGFR and ALK" . SPARSER::COLLECTION)
    ("ROS1" . SPARSER::PROTEIN) ("GPC5" . SPARSER::PROTEIN)
    ("RGS17" . SPARSER::PROTEIN) ("CHRNB4" . SPARSER::PROTEIN)
    ("CHRNA5" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("fine-mapping" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("causative variants" . SPARSER::VARIANT) ("run" . SPARSER::PROTEIN-FAMILY)
    ("Cai" . SPARSER::DRUG) ("allele or GG" . SPARSER::COLLECTION)
    ("ERs" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("polyglutamine" . SPARSER::MOLECULE)
    ("AR and ER or PR" . SPARSER::COLLECTION)
    ("ER or PR" . SPARSER::COLLECTION) ("Pich" . SPARSER::PROTEIN)
    ("Wang" . SPARSER::PROTEIN)
    ("Estrogen and progesterone" . SPARSER::COLLECTION)
    ("Estrogen" . SPARSER::MOLECULE) ("DSF" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE) ("anti" . SPARSER::PROTEIN)
    ("aims" . SPARSER::PROTEIN)
    ("ER (81%) and progesterone receptor (PR) (74%)" . SPARSER::COLLECTION)
    ("ARs" . SPARSER::PROTEIN) ("glutamine" . SPARSER::AMINO-ACID)
    ("highly polymorphic three nucleotides" . SPARSER::NUCLEOTIDE)
    ("dihydrotestosterone" . SPARSER::DRUG) ("Androgens" . SPARSER::DRUG)
    ("Male" . SPARSER::MOLECULE) ("NH2" . SPARSER::MOLECULE)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Proteins" . SPARSER::PROTEIN) ("bipartite" . SPARSER::PROTEIN)
    ("a neutral or basic amino acid" . SPARSER::AMINO-ACID)
    ("the flexible loop-derived peptides" . SPARSER::PEPTIDE)
    ("the phosphoserine of the peptide ( xref )" . SPARSER::PEPTIDE)
    ("S16 and S18" . SPARSER::COLLECTION)
    ("phosphoserine and residue" . SPARSER::COLLECTION)
    ("PDB" . SPARSER::MOLECULE) ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Pin1 and the phosphorylated Bcl-2 peptide (pS87)" . SPARSER::COLLECTION)
    ("peptides (T56 and T74) and their cognate phosphorylated peptides (pT56 and pT74)"
     . SPARSER::COLLECTION)
    ("Chemical" . SPARSER::MOLECULE)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("proline" . SPARSER::AMINO-ACID)
    ("Such helical conformation" . SPARSER::BIO-CONFORMATION)
    ("alanine, leucine and serine" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("pS" . SPARSER::PROTEIN) ("amide" . SPARSER::MOLECULE)
    ("phosphoryl" . SPARSER::MOLECULE)
    ("Bcl-2 and pBcl-2" . SPARSER::COLLECTION)
    ("the Bcl-2 protein and loop peptides" . SPARSER::COLLECTION)
    ("ERK2 and JNK" . SPARSER::COLLECTION)
    ("the relevant kinases" . SPARSER::KINASE)
    ("relevant kinases and phosphatases" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("Ser-Pro" . SPARSER::COLLECTION) ("parvulin" . SPARSER::PROTEIN)
    ("cis and trans" . SPARSER::COLLECTION) ("cis-trans" . SPARSER::COLLECTION)
    ("PPIase" . SPARSER::PROTEIN) ("isomerases" . SPARSER::ISOMERASE)
    ("protein phosphatase (PP)" . SPARSER::PROTEIN)
    ("PP2A and PP2B" . SPARSER::COLLECTION)
    ("c-jun N-terminal kinase (JNK) and extracellular signal-regulated kinase 2 (ERK2)"
     . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("proteins, Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("JNK and ERK2" . SPARSER::COLLECTION)
    ("drugs, paclitaxel and colchicine" . SPARSER::COLLECTION)
    ("S18" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("pin1" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("H- 15" . SPARSER::PROTEIN)
    ("Pin 1" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("32 P" . SPARSER::|32P|) ("Thr-Pro" . SPARSER::MOLECULE)
    ("c-jun" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("Kaempferol" . SPARSER::DRUG)
    ("poorly-differentiated tumors expressed less SIRT3" . SPARSER::PROTEIN)
    ("Myc or Ras" . SPARSER::COLLECTION) ("Ku70-Bax" . SPARSER::COLLECTION)
    ("proteins and microRNAs" . SPARSER::COLLECTION)
    ("protein or mircoRNA" . SPARSER::COLLECTION)
    ("valuable biomarkers" . SPARSER::MOLECULE)
    ("primary HCC" . SPARSER::PROTEIN)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("well-differentiated HCC" . SPARSER::PROTEIN)
    ("poor-differentiated HCC" . SPARSER::PROTEIN) ("Oct" . SPARSER::PROTEIN)
    ("HBsAg" . SPARSER::DRUG) ("Western Blot" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN) ("Synthetase" . SPARSER::PROTEIN)
    ("nucleotide (NAD)" . SPARSER::NUCLEOTIDE)
    ("adenine" . SPARSER::NUCLEOBASE) ("Sirt3" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FoxC1" . SPARSER::PROTEIN) ("ZBP-89" . SPARSER::PROTEIN)
    ("Ku86" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("Acetyl-CoA" . SPARSER::MOLECULE)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIRT3" . SPARSER::PROTEIN)
    ("miR-21 and Akt" . SPARSER::COLLECTION) ("/NF-κB" . SPARSER::COLLECTION)
    ("helicase" . SPARSER::PROTEIN) ("pre-miR" . SPARSER::COLLECTION)
    ("pri-miR-21" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("androgens" . SPARSER::DRUG) ("MiR" . SPARSER::PROTEIN)
    ("substrate (MARCKS)" . SPARSER::SUBSTRATE)
    ("PDCD4, maspin and tropomyosin-1" . SPARSER::COLLECTION)
    ("MARCKS" . SPARSER::PROTEIN) ("myristoylated" . SPARSER::PROTEIN)
    ("androgen/androgen receptor" . SPARSER::COLLECTION)
    ("miR21" . SPARSER::PROTEIN) ("luciferin" . SPARSER::MOLECULE)
    ("matrigel" . SPARSER::PROTEIN)
    ("LY294002, a known inhibitor of Akt activity ( xref )"
     . SPARSER::MOLECULE)
    ("resveratrol and ∼73%" . SPARSER::COLLECTION)
    ("the mature miRNA" . SPARSER::PROTEIN)
    ("this RNA duplex forms" . SPARSER::FORM) ("RISC" . SPARSER::PROTEIN)
    ("Pre-miR-21" . SPARSER::COLLECTION)
    ("Further evidence supporting miR-21" . SPARSER::PROTEIN)
    ("iodide (PI)" . SPARSER::PROTEIN)
    ("LNCaP and DU145" . SPARSER::COLLECTION) ("FLII" . SPARSER::PROTEIN)
    ("BMPRII" . SPARSER::PROTEIN) ("MiRNAs" . SPARSER::PROTEIN)
    ("a polyphenolic antioxidant" . SPARSER::PROTEIN)
    ("trans-3" . SPARSER::COLLECTION)
    ("curcumin, isoflavone, resveratrol and epigallactocatechin-3-gallate"
     . SPARSER::COLLECTION)
    ("EGCG" . SPARSER::DRUG) ("isoflavone" . SPARSER::MOLECULE)
    ("curcumin" . SPARSER::DRUG) ("DU145 and LNCaP" . SPARSER::COLLECTION)
    ("Akt and PDCD4" . SPARSER::COLLECTION)
    ("miR-21 and pAkt" . SPARSER::COLLECTION)
    ("resveratrol and LY294002" . SPARSER::COLLECTION)
    ("pre-miR-21" . SPARSER::COLLECTION)
    ("PDCD4 and maspin" . SPARSER::COLLECTION) ("maspin" . SPARSER::PROTEIN)
    ("miRs" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN) ("p68" . SPARSER::PROTEIN)
    ("SMAD 2" . SPARSER::PROTEIN) ("SMAD 1" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("tropomyosin-1" . SPARSER::PROTEIN) ("RNAse III" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("inhibitor 1" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("LRRFIP1" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("programmed cell death 4" . SPARSER::PROTEIN)
    ("miR- 21" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase 1/2" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("androgen-receptor" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf-1/ERK" . SPARSER::COLLECTION)
    ("ATR and CHK1 and CHK2" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("shATM and shATR" . SPARSER::COLLECTION) ("shCon" . SPARSER::PROTEIN)
    ("shATM" . SPARSER::PROTEIN) ("mRNA and promoter" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("p53 and CDC25A" . SPARSER::COLLECTION)
    ("LNCaP-shATM" . SPARSER::PROTEIN-PAIR)
    ("LNCaP-shCon and shATR" . SPARSER::COLLECTION)
    ("LNCaP-shCon" . SPARSER::PROTEIN-PAIR)
    ("Chk2 (Thr 68) and Chk1 (Ser 317)" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN)
    ("ATM siRNA (siATM) or ATR siRNA (siATR)" . SPARSER::COLLECTION)
    ("ATM or ATR" . SPARSER::COLLECTION) ("ATM-ATR" . SPARSER::COLLECTION)
    ("Chk1 (Ser 317) and Chk2 (Thr 68)" . SPARSER::COLLECTION)
    ("ATM (Ser 1981) and ATR (Ser 426)" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("TMPRSS2/ERG" . SPARSER::COLLECTION)
    ("HPr-1" . SPARSER::PROTEIN) ("arm" . SPARSER::PROTEIN)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("TMPRSS2 and ERG" . SPARSER::COLLECTION)
    ("ATM/CHK1/CHK2" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("HPr-1AR" . SPARSER::COLLECTION) ("HPr" . SPARSER::PROTEIN)
    ("ATM/ATR" . SPARSER::COLLECTION)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("Histone H2A.X" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("TOP2B" . SPARSER::PROTEIN) ("ELK4" . SPARSER::PROTEIN)
    ("SLC45A3" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("FGFR3 and exons" . SPARSER::COLLECTION)
    ("P16INk4A and P14ARF" . SPARSER::COLLECTION)
    ("FGFR3 or TP53" . SPARSER::COLLECTION)
    ("mutated FGFR3 and wild-type TP53 (208/336; 61.9% of cases)"
     . SPARSER::COLLECTION)
    ("pTaG3, pT1G2, pT1G3 and pT2-4" . SPARSER::COLLECTION)
    ("pure CIS" . SPARSER::PROTEIN) ("CIS" . SPARSER::PROTEIN)
    ("pTaG" . SPARSER::PROTEIN) ("pTa" . SPARSER::PROTEIN)
    ("FGFR3 and TP53" . SPARSER::COLLECTION)
    ("TP53 and FGFR3" . SPARSER::COLLECTION) ("TaG2" . SPARSER::PROTEIN)
    ("TaG1" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("RB protein" . SPARSER::PROTEIN) ("p16INk4A" . SPARSER::PROTEIN)
    ("P14ARF" . SPARSER::PROTEIN) ("P16INk4A" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor family"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("–2" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN)
    ("a chloride channel and a regulator" . SPARSER::COLLECTION)
    ("mature CFTR" . SPARSER::PROTEIN) ("GRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response elements (GRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HSP90 or HSP70" . SPARSER::COLLECTION)
    ("dexamethasone or dexamethasone" . SPARSER::COLLECTION)
    ("chaperones, HSP70 and HSP90" . SPARSER::COLLECTION)
    ("Spironolactone" . SPARSER::DRUG)
    ("Mifepristone (1 µM) and spironolactone (1 µM)" . SPARSER::COLLECTION)
    ("glucocorticoid and mineralocorticoid" . SPARSER::COLLECTION)
    ("mineralocorticoid" . SPARSER::MOLECULE)
    ("spironolactone" . SPARSER::DRUG) ("Mifepristone" . SPARSER::DRUG)
    ("glucocorticoid and mineralocorticoid receptor" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("CFTR and αENaC" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("HSP70 and HSP90" . SPARSER::COLLECTION)
    ("normal CFTR" . SPARSER::PROTEIN)
    ("Mature wild-type CFTR protein" . SPARSER::PROTEIN)
    ("HSP90 and HSP70" . SPARSER::COLLECTION) ("Chaperone" . SPARSER::PROTEIN)
    ("mifepristone" . SPARSER::DRUG) ("dexamethasone" . SPARSER::PROTEIN)
    ("the wild-type cystic fibrosis channel transmembrane regulator (CFTR)"
     . SPARSER::REGULATOR)
    ("regulator (CFTR)" . SPARSER::REGULATOR) ("CFTR" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN) ("Dexamethasone" . SPARSER::PROTEIN)
    ("Na+" . SPARSER::MOLECULE) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("mineralocorticoid receptor" . SPARSER::PROTEIN)
    ("β- mercaptoethanol" . SPARSER::MOLECULE) ("P 40)" . SPARSER::PROTEIN)
    ("Sulfo- NHS" . SPARSER::DRUG) ("Surface protein" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("ATG-3" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("SGK1" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("chloride channel" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("surface protein" . SPARSER::PROTEIN) ("αENaC" . SPARSER::PROTEIN)
    ("SOX2 and Gankyrin" . SPARSER::COLLECTION)
    ("Albumin-Cre" . SPARSER::COLLECTION) ("Albumin" . SPARSER::PROTEIN)
    ("the pluripotent stem cell state" . SPARSER::BIO-STATE)
    ("Mice given TAA" . SPARSER::MOLECULE)
    ("MAPKAPK2 and phospho-MAPKAPK2" . SPARSER::COLLECTION)
    ("the hepatotoxic chemical" . SPARSER::MOLECULE) ("AFP" . SPARSER::PROTEIN)
    ("well-differentiated HCCs" . SPARSER::PROTEIN)
    ("All the p38 α F/F and p38 αΔ hep mice given TAA" . SPARSER::MOLECULE)
    ("gankyrin" . SPARSER::PROTEIN) ("oncoprotein" . SPARSER::PROTEIN)
    ("a pluripotent stem cell state" . SPARSER::BIO-STATE)
    ("SOX2 and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("IL-6, and TNFα and IL-1β" . SPARSER::COLLECTION)
    ("TNFα and IL-1β" . SPARSER::COLLECTION)
    ("c-Jun and JNK" . SPARSER::COLLECTION)
    ("SOX2, c-Jun and Gankyrin" . SPARSER::COLLECTION)
    ("butylated hydroxyanisole (BHA)" . SPARSER::MOLECULE)
    ("BHA" . SPARSER::MOLECULE) ("-chloromethyl-2" . SPARSER::COLLECTION)
    ("DCFDA" . SPARSER::DRUG) ("diacetate" . SPARSER::MOLECULE)
    ("more toxic metabolites" . SPARSER::PROTEIN) ("Cyp2E1" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE) ("Cyp" . SPARSER::PROTEIN)
    ("centrilobular (zone 3) hepatocytes" . SPARSER::PROTEIN)
    ("the fluorescent derivative" . SPARSER::DERIVATIVE)
    ("derivative" . SPARSER::DERIVATIVE) ("DHE" . SPARSER::DRUG)
    ("dihydroethidine" . SPARSER::DRUG) ("PDGFb" . SPARSER::PROTEIN)
    ("hydroxyproline" . SPARSER::MOLECULE) ("MPO" . SPARSER::PROTEIN)
    ("myeloperoxidase" . SPARSER::PROTEIN) ("Neutrophil" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("diethylnitrosamine (DEN)" . SPARSER::MOLECULE)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("a conditional p38 α" . SPARSER::PROTEIN)
    ("survival genes and anti-oxidants ( xref - xref )" . SPARSER::COLLECTION)
    ("SAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen and stress activated protein kinases (MAPK/SAPK) play"
     . SPARSER::COLLECTION)
    ("MAPK/SAPK" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mice given TAA" . SPARSER::MOLECULE)
    ("thioacetamide (TAA)" . SPARSER::MOLECULE)
    ("toxic chemicals" . SPARSER::MOLECULE)
    ("exogenous chemicals" . SPARSER::MOLECULE)
    ("HSP25/HSP27" . SPARSER::COLLECTION) ("chemicals" . SPARSER::MOLECULE)
    ("HCC" . SPARSER::PROTEIN) ("SOX2 and c-Jun" . SPARSER::COLLECTION)
    ("the liver oncoproteins c-Jun (Jun) and Gankyrin (Psmd10)"
     . SPARSER::COLLECTION)
    ("Psmd10" . SPARSER::PROTEIN) ("Gankyrin" . SPARSER::PROTEIN)
    ("TAA" . SPARSER::MOLECULE) ("protein (HSP)" . SPARSER::PROTEIN)
    ("mice given thioacetamide (TAA)" . SPARSER::MOLECULE)
    ("thioacetamide" . SPARSER::MOLECULE)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HCCs" . SPARSER::PROTEIN)
    ("26S proteasome non-ATPase regulatory subunit 10" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("MAPKAP kinase-2" . SPARSER::PROTEIN) ("CM-H" . SPARSER::MOLECULE)
    ("Cyp2B" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("TIMP1" . SPARSER::PROTEIN) ("α-actin" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("superoxide anions" . SPARSER::MOLECULE)
    ("JNK1" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("α-fetoprotein" . SPARSER::PROTEIN) ("p38 α" . SPARSER::PROTEIN)
    ("stress activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytochrome p450" . SPARSER::PROTEIN-FAMILY) ("HSP25" . SPARSER::PROTEIN)
    ("butylated hydroxyanisole" . SPARSER::MOLECULE)
    ("SOX2" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("Hspb1" . SPARSER::PROTEIN)
    ("stress activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E 2 and ERα" . SPARSER::COLLECTION)
    ("heterozygous mutants" . SPARSER::MUTANT)
    ("ERα and progesterone receptor" . SPARSER::COLLECTION)
    ("estrogen-" . SPARSER::MOLECULE) ("aromatase" . SPARSER::PROTEIN)
    ("proteins and estrogen" . SPARSER::COLLECTION)
    ("underwent BRCA" . SPARSER::PROTEIN-FAMILY)
    ("anti-estrogen" . SPARSER::DRUG)
    ("follicle stimulating hormone" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("BRCA2 protein" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE) ("ATP/AMP" . SPARSER::PROTEIN-PAIR)
    ("Akt and AMP" . SPARSER::COLLECTION)
    ("Phosphatases" . SPARSER::PHOSPHATASE) ("Leucine" . SPARSER::AMINO-ACID)
    ("nicotine and NNK -induced proliferation in pancreatic ductal cells"
     . SPARSER::COLLECTION)
    ("β-adrenergic receptors ( xref ) and nicotinic acethylcholine receptors (nAChR)"
     . SPARSER::COLLECTION)
    ("nicotinic acethylcholine receptors" . SPARSER::RECEPTOR)
    ("adrenergic" . SPARSER::PROTEIN)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("the autophagosomal LC3-II form" . SPARSER::FORM)
    ("the mitochondrial NADH dehydrogenase" . SPARSER::PROTEIN)
    ("pharmacological inhibitor DPI ( xref ) or molecular NADPH oxidase-p22 phox siRNA ( xref )"
     . SPARSER::COLLECTION)
    ("NADPH oxidase-p22 phox" . SPARSER::COLLECTION) ("DPI" . SPARSER::PROTEIN)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("both growth factors and extra-cellular matrix proteins"
     . SPARSER::COLLECTION)
    ("nicotine" . SPARSER::DRUG) ("CSE and NNK" . SPARSER::COLLECTION)
    ("4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone" . SPARSER::PROTEIN-PAIR)
    ("-1-butanone" . SPARSER::COLLECTION) ("PDAC" . SPARSER::MOLECULE)
    ("CSE or NNK" . SPARSER::COLLECTION) ("-1-" . SPARSER::PROTEIN)
    ("CSE" . SPARSER::PROTEIN) ("PaCa" . SPARSER::PROTEIN)
    ("Cigarette" . SPARSER::DRUG) ("creatine kinase" . SPARSER::PROTEIN)
    ("Akt-induced" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("NADH dehydrogenase" . SPARSER::PROTEIN) ("p22phox" . SPARSER::PROTEIN)
    ("p22 phox" . SPARSER::PROTEIN) ("Akt 1" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("type V" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("strong p73" . SPARSER::PROTEIN)
    ("the only C-terminal variant" . SPARSER::VARIANT)
    ("CGN" . SPARSER::PROTEIN) ("TRED" . SPARSER::PROTEIN)
    ("genipin" . SPARSER::DRUG) ("example" . SPARSER::EXAMPLE)
    ("urocortin" . SPARSER::PROTEIN) ("DOPA" . SPARSER::MOLECULE)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::LIPID) ("DNp" . SPARSER::DRUG)
    ("tau" . SPARSER::PROTEIN)
    ("the pro-apoptotic isoform and ΔNp73" . SPARSER::COLLECTION)
    ("isoform and ΔNp73" . SPARSER::COLLECTION)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("6-hydroxydopamine" . SPARSER::DRUG)
    ("Transcription Factor" . SPARSER::PROTEIN) ("6-OHDA" . SPARSER::MOLECULE)
    ("alpha-synuclein" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("P73" . SPARSER::PROTEIN)
    ("Water-soluble tetrazolium salt" . SPARSER::MOLECULE)
    ("Water" . SPARSER::MOLECULE) ("gC1qR and mutant" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax and the anti-apoptotic Bcl-2"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic Bax" . SPARSER::PROTEIN) ("Bax" . SPARSER::PROTEIN)
    ("defective mitochondria" . SPARSER::PROTEIN)
    ("The mature form" . SPARSER::FORM) ("mature gC1qR" . SPARSER::PROTEIN)
    ("whose first 73 amino acids" . SPARSER::AMINO-ACID)
    ("a conserved eukaryotic multifunctional protein" . SPARSER::PROTEIN)
    ("the gC1qR vector + p53 siRNA group and the empty vector + p53 siRNA group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the empty vector + negative siRNA group and the empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the empty vector + p53 siRNA group, the empty vector + negative siRNA group and the empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the gC1qR vector + negative siRNA group and the gC1qR vector group"
     . SPARSER::COLLECTION)
    ("the gC1qR vector group and the gC1qR vector + negative siRNA group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("p53 siRNA or negative siRNA" . SPARSER::COLLECTION)
    ("mutant p53 + gC1qR vector group and empty pCB6 vector + gC1qR vector group"
     . SPARSER::COLLECTION)
    ("empty vector + negative siRNA group and empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the empty vector + p53 siRNA group, empty vector + negative siRNA group and empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the gC1qR vector + p53 siRNA group and the empty vector + p53 siRNA group"
     . SPARSER::COLLECTION)
    ("empty vector + negative siRNA group and the empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the empty vector + p53 siRNA group, empty vector + negative siRNA group and the empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("p53 siRNA or negative siRNA (An unrelated gene siRNA as a negative control)"
     . SPARSER::COLLECTION)
    ("gC1qR and the trans-dominant negative p53 173 L mutant"
     . SPARSER::COLLECTION)
    ("the wild-type p53 and empty vector group" . SPARSER::COLLECTION)
    ("the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05)"
     . SPARSER::COLLECTION)
    ("the mutant p53 and empty vector group" . SPARSER::COLLECTION)
    ("p53 and gC1qR" . SPARSER::COLLECTION)
    ("Figure S2 and Additional file xref" . SPARSER::COLLECTION)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("suppressor of cytokine signaling (SOCS)" . SPARSER::PROTEIN)
    ("highly anionic cellular protein" . SPARSER::PROTEIN)
    ("gC1qR/p33" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 or p53" . SPARSER::COLLECTION) ("salt" . SPARSER::MOLECULE)
    ("Suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("JC-1" . SPARSER::MOLECULE)
    ("Fluo-4" . SPARSER::DRUG) ("H 2 DCFDA" . SPARSER::DRUG)
    ("2', 7'-dichlorodihydrofluorescein diacetate" . SPARSER::DRUG)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("p33" . SPARSER::PROTEIN) ("gC1qR" . SPARSER::PROTEIN)
    ("SWR1 (the S. cerevisiae homologue of p400) and Rad51"
     . SPARSER::COLLECTION)
    ("p400 and Rad54" . SPARSER::COLLECTION)
    ("the only factor explaining p400’s" . SPARSER::PROTEIN)
    ("the only factor explaining p400" . SPARSER::PROTEIN)
    ("Rad52, and BRCA1" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN)
    ("siRNA- and dominant-negative–based" . SPARSER::COLLECTION)
    ("siRNA-" . SPARSER::PROTEIN) ("RNF8/RNF168" . SPARSER::COLLECTION)
    ("nucleosome occupancy around DNA" . SPARSER::DNA)
    ("AsiSI" . SPARSER::PROTEIN) ("a sequence-specific DNA" . SPARSER::DNA)
    ("complement" . SPARSER::PROTEIN)
    ("I-SceI and p400 or p400dead" . SPARSER::COLLECTION)
    ("p400 or p400dead" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("ER-AsiSI" . SPARSER::PROTEIN-PAIR)
    ("Tip60 and p400" . SPARSER::COLLECTION)
    ("53BP1-GFP" . SPARSER::COLLECTION) ("mcherry-p400" . SPARSER::COLLECTION)
    ("GFP-Rad51" . SPARSER::COLLECTION) ("mcherry" . SPARSER::PROTEIN)
    ("p400–Rad51" . SPARSER::COLLECTION) ("FLIM" . SPARSER::PROTEIN-FAMILY)
    ("ethidium" . SPARSER::MOLECULE) ("Rad51 and p400" . SPARSER::COLLECTION)
    ("nearly no Rad51 foci" . SPARSER::PROTEIN)
    ("p400 and p21" . SPARSER::COLLECTION)
    ("Rad51 and BRCA1" . SPARSER::COLLECTION)
    ("the Rad51-associated protein BRCA1 foci" . SPARSER::PROTEIN)
    ("uncut chromatin" . SPARSER::PROTEIN)
    ("Rad51 and accessory proteins" . SPARSER::COLLECTION)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("Functional HR" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("DNA damage signaling around DNA" . SPARSER::DNA)
    ("foci or 53BP1" . SPARSER::COLLECTION)
    ("p400 or ATPase-inactive" . SPARSER::COLLECTION)
    ("53BP1 and ubiquitin" . SPARSER::COLLECTION)
    ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("ER-I-SceI" . SPARSER::COLLECTION) ("strong γH2AX" . SPARSER::PROTEIN)
    ("bleomycin" . SPARSER::DRUG) ("SWR1 and HR" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("a multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("p400 and INO80" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("ACF1 and SNF2H" . SPARSER::COLLECTION)
    ("CHD4 and MTA2" . SPARSER::COLLECTION) ("nucleosomes" . SPARSER::PROTEIN)
    ("RSC" . SPARSER::PROTEIN)
    ("ISWI, CHD/Mi2, and INO80" . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("CHD" . SPARSER::PROTEIN)
    ("ISWI" . SPARSER::PROTEIN) ("nucleosome" . SPARSER::PROTEIN)
    ("efficiently repair DNA" . SPARSER::DNA)
    ("Rad51 and a chromatin" . SPARSER::COLLECTION)
    ("p400 and Rad51" . SPARSER::COLLECTION) ("ATPase" . SPARSER::PROTEIN)
    ("rad51" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("Bis-tris" . SPARSER::MOLECULE) ("or 2 µ" . SPARSER::MOLECULE)
    ("ChK2" . SPARSER::PROTEIN) ("S33" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("lamin A/C" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("Rad54" . SPARSER::PROTEIN)
    ("ATP-dependent chromatin remodeling protein" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("H2Av" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("E–G" . SPARSER::PROTEIN) ("4-hydroxy-tamoxifen" . SPARSER::DRUG)
    ("I-SceI" . SPARSER::PROTEIN) ("SWR1" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("H2AZ" . SPARSER::PROTEIN)
    ("SNF2H" . SPARSER::PROTEIN) ("ACF1" . SPARSER::PROTEIN)
    ("MTA2" . SPARSER::PROTEIN) ("CHD4" . SPARSER::PROTEIN)
    ("Swr1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ino80" . SPARSER::PROTEIN)
    ("INO80" . SPARSER::PROTEIN) ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("Rad51" . SPARSER::PROTEIN) ("p400" . SPARSER::PROTEIN)
    ("hyperactive or activated platelets" . SPARSER::PROTEIN)
    ("proinflammatory cytokine" . SPARSER::PROTEIN)
    ("potentially making platelets" . SPARSER::PROTEIN)
    ("making platelets" . SPARSER::PROTEIN)
    ("soluble IL-6R" . SPARSER::PROTEIN) ("sIL" . SPARSER::PROTEIN)
    ("collagen or CRP" . SPARSER::COLLECTION)
    ("vice versa ( xref ) and STA21" . SPARSER::COLLECTION)
    ("versa" . SPARSER::PROTEIN) ("Syk and SLP-76" . SPARSER::COLLECTION)
    ("LAT" . SPARSER::PROTEIN) ("piceatannol" . SPARSER::DRUG)
    ("GPVI" . SPARSER::PROTEIN) ("VI/Fc receptor" . SPARSER::COLLECTION)
    ("ADP and TRAP" . SPARSER::COLLECTION)
    ("STA21 (a small molecule) and T40214 (a protein binding oligonucleotide G-quartet) dose-dependently"
     . SPARSER::COLLECTION)
    ("collagen- and CRP-" . SPARSER::COLLECTION)
    ("TRAP- or ADP" . SPARSER::COLLECTION) ("CRP-" . SPARSER::PROTEIN)
    ("The IL-6 and soluble IL-6 receptor complex" . SPARSER::COLLECTION)
    ("soluble IL-6 receptor complex" . SPARSER::BIO-COMPLEX)
    ("the IL-6 cytokine family gp130 ( xref ) and a complex"
     . SPARSER::COLLECTION)
    ("IL-6 and soluble IL-6 receptor" . SPARSER::COLLECTION)
    ("soluble IL-6 receptor" . SPARSER::PROTEIN) ("tri" . SPARSER::PROTEIN)
    ("PLCγ2 and STAT3" . SPARSER::COLLECTION)
    ("Syk and STAT3" . SPARSER::COLLECTION)
    ("STAT3, Syk, and PLCγ2" . SPARSER::COLLECTION)
    ("STAT3 and these two signal molecules" . SPARSER::COLLECTION)
    ("STAT1 and STAT5" . SPARSER::COLLECTION)
    ("collagen and CRP" . SPARSER::COLLECTION)
    ("β-galactosidase or eYFP" . SPARSER::COLLECTION)
    ("PF4-Cre" . SPARSER::COLLECTION) ("CXCL4-cre" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("adherent platelets" . SPARSER::PROTEIN)
    ("the adhesion receptors integrin αIIbβ 3 and GP Ibα ( xref )"
     . SPARSER::COLLECTION)
    ("Ib" . SPARSER::DRUG) ("serotonin" . SPARSER::MOLECULE)
    ("collagen and the collagen-related peptide (CRP) ( xref )"
     . SPARSER::COLLECTION)
    ("peptide (CRP)" . SPARSER::PEPTIDE) ("agonist" . SPARSER::AGONIST)
    ("thrombin" . SPARSER::PROTEIN) ("epinephrine" . SPARSER::DRUG)
    ("adenosine" . SPARSER::PROTEIN) ("JAK and STAT3" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("TPO" . SPARSER::PROTEIN) ("thrombopoietin" . SPARSER::PROTEIN)
    ("proinflammatory cytokine and hemostasis/thrombosis"
     . SPARSER::COLLECTION)
    ("cytokine and hemostasis/thrombosis" . SPARSER::COLLECTION)
    ("its soluble receptor" . SPARSER::RECEPTOR)
    ("inhibitors and mice" . SPARSER::COLLECTION)
    ("collagen- and a collagen-related peptide-" . SPARSER::COLLECTION)
    ("TRAP-" . SPARSER::PROTEIN) ("peptide-" . SPARSER::PEPTIDE)
    ("collagen-" . SPARSER::PROTEIN) ("Syk and PLCγ2" . SPARSER::COLLECTION)
    ("the kinase Syk and the substrate PLCγ2" . SPARSER::COLLECTION)
    ("Syk" . SPARSER::PROTEIN)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("IL-15" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("type1" . SPARSER::PROTEIN) ("SLP-76" . SPARSER::PROTEIN)
    ("Fc receptor" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("CXCL4" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PF4" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("GP 130" . SPARSER::PROTEIN) ("αIIbβ 3" . SPARSER::PROTEIN)
    ("thrombin receptor" . SPARSER::PROTEIN) ("STA21" . SPARSER::DRUG)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("Type 1" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("CD62P" . SPARSER::PROTEIN)
    ("αIIbβ3" . SPARSER::PROTEIN) ("potassium chloride" . SPARSER::MOLECULE)
    ("sodium bicarbonate" . SPARSER::DRUG) ("Mg 2+" . SPARSER::MOLECULE)
    ("Spleen Tyrosine Kinase" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("proto-oncogene c-Mpl" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("PLCγ2" . SPARSER::PROTEIN)
    ("inhibitors and compounds" . SPARSER::COLLECTION)
    ("alcohol and carbohydrate" . SPARSER::COLLECTION)
    ("elevated blood glucose and insulin levels" . SPARSER::COLLECTION)
    ("simple sugars" . SPARSER::MOLECULE) ("starch" . SPARSER::MOLECULE)
    ("sugars" . SPARSER::MOLECULE) ("dietary carbohydrate" . SPARSER::MOLECULE)
    ("glycogen" . SPARSER::PROTEIN) ("p300 or CBP" . SPARSER::COLLECTION)
    ("acetylase" . SPARSER::PROTEIN) ("glucagon" . SPARSER::PROTEIN)
    ("CBP" . SPARSER::PROTEIN) ("chromatin and ChREBP" . SPARSER::COLLECTION)
    ("extracellular ceramide" . SPARSER::MOLECULE)
    ("exogenous ceramide" . SPARSER::MOLECULE) ("dextrin" . SPARSER::MOLECULE)
    ("maltose" . SPARSER::MOLECULE) ("bHLH/LZ" . SPARSER::COLLECTION)
    ("LZ" . SPARSER::PROTEIN) ("bHLH" . SPARSER::PROTEIN)
    ("lipogenic genes" . SPARSER::GENE)
    ("ceramide and ethanol" . SPARSER::COLLECTION)
    ("ceramide and PP2A" . SPARSER::COLLECTION)
    ("ceramide" . SPARSER::MOLECULE) ("AMPK or PKA" . SPARSER::COLLECTION)
    ("fatty acid synthase and acetyl Co-A carboxylase" . SPARSER::COLLECTION)
    ("The larger form" . SPARSER::FORM)
    ("streptavidin-biotin" . SPARSER::PROTEIN-PAIR)
    ("streptavidin" . SPARSER::PROTEIN)
    ("glucose and ethanol" . SPARSER::COLLECTION)
    ("ChoRE-containing promoters" . SPARSER::PROMOTER)
    ("Promoters" . SPARSER::PROMOTER) ("kinase (PKA)" . SPARSER::KINASE)
    ("a unique form" . SPARSER::FORM) ("xylulose" . SPARSER::MOLECULE)
    ("AICAR" . SPARSER::PROTEIN)
    ("multiple hepatic lipogenic enzyme mRNAs" . SPARSER::PROTEIN)
    ("lipogenic enzymes" . SPARSER::ENZYME)
    ("ACC and FAS" . SPARSER::COLLECTION) ("FAS" . SPARSER::PROTEIN)
    ("KDa" . SPARSER::PROTEIN)
    ("glucose, which was designated" . SPARSER::MOLECULE)
    ("these lipogenic enzymes" . SPARSER::ENZYME)
    ("hepatocytes" . SPARSER::PROTEIN) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("ACC" . SPARSER::PROTEIN) ("sterol" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("Alcohol" . SPARSER::DRUG)
    ("cirrhosis" . SPARSER::PROTEIN) ("endotoxin" . SPARSER::MOLECULE)
    ("Ethanol" . SPARSER::PROTEIN) ("LPK" . SPARSER::PROTEIN)
    ("AMPK and PP2A" . SPARSER::COLLECTION)
    ("AMP-activated protein kinase (AMPK) and protein phosphatase 2A (PP2A)"
     . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("ChREBP" . SPARSER::PROTEIN)
    ("SKI2" . SPARSER::PROTEIN) ("SIK2" . SPARSER::PROTEIN)
    ("salt-inducible kinase 2" . SPARSER::PROTEIN) ("HNF4" . SPARSER::PROTEIN)
    ("L-PK" . SPARSER::PROTEIN) ("PP2As" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("compound C" . SPARSER::MOLECULE)
    ("acetyl Co-A carboxylase" . SPARSER::PROTEIN)
    ("ChREBP protein" . SPARSER::PROTEIN) ("MS-MS" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG) ("– 3" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("I-R" . SPARSER::PROTEIN)
    ("K-R" . SPARSER::PROTEIN)
    ("MLX interacting protein-like" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("sterol regulatory element binding transcription factor 1"
     . SPARSER::PROTEIN)
    ("Srebf1" . SPARSER::PROTEIN) ("potassium fluoride" . SPARSER::MOLECULE)
    ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("AMPKα1" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN)
    ("carbohydrate response element binding protein" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("SREBP-1c" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("PP2A" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN)
    ("Carbohydrate response element binding protein" . SPARSER::PROTEIN)
    ("LAMC1 , CCND2 , and TBX3" . SPARSER::COLLECTION)
    ("DNase" . SPARSER::PROTEIN) ("Laminins" . SPARSER::PROTEIN-FAMILY)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("TBX3 and rs11632715/15q13" . SPARSER::COLLECTION)
    ("EIF3H and rs4939827" . SPARSER::COLLECTION) ("Han" . SPARSER::PROTEIN)
    ("a sizable heritable component" . SPARSER::COMPONENT)
    ("AIMS" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("NABP2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("single-strand DNA binding protein" . SPARSER::PROTEIN)
    ("phosphatidylserine-binding protein" . SPARSER::PROTEIN)
    ("serum deprivation response" . SPARSER::PROTEIN)
    ("TXB3" . SPARSER::MOLECULE) ("NABP1" . SPARSER::PROTEIN)
    ("EIF3H" . SPARSER::PROTEIN) ("TBX3" . SPARSER::PROTEIN)
    ("LAMC1" . SPARSER::PROTEIN) ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("disco-interacting protein 2" . SPARSER::PROTEIN)
    ("alpha 5" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("gamma 1" . SPARSER::PROTEIN)
    ("nucleic acid binding protein 1" . SPARSER::PROTEIN)
    ("STAT3 and p300" . SPARSER::COLLECTION)
    ("ErbB2 and CD44" . SPARSER::COLLECTION) ("Part" . SPARSER::COMPONENT)
    ("Cetuximab" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("epsilon" . SPARSER::PROTEIN) ("nucleoside" . SPARSER::MOLECULE)
    ("guanine" . SPARSER::MOLECULE)
    ("an excellent therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("cisplatin and apoptosis" . SPARSER::COLLECTION)
    ("CD44- and EGFR-specific antibodies" . SPARSER::COLLECTION)
    ("CD44-" . SPARSER::PROTEIN)
    ("no matching secondary antibodies" . SPARSER::ANTIBODY)
    ("each secondary antibodies" . SPARSER::ANTIBODY)
    ("the Western blot" . SPARSER::PROTEIN)
    ("EGFR and ErbB2" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("heparin" . SPARSER::PROTEIN) ("transfectants" . SPARSER::PROTEIN)
    ("3A2-CD44" . SPARSER::PROTEIN-PAIR)
    ("Annexin-V and propidium" . SPARSER::COLLECTION)
    ("iodide" . SPARSER::PROTEIN) ("Staurosporine" . SPARSER::DRUG)
    ("CD44-STD" . SPARSER::COLLECTION) ("STD" . SPARSER::PROTEIN)
    ("SCC4" . SPARSER::PROTEIN) ("EGFR and CD44" . SPARSER::COLLECTION)
    ("CD44, HA, and ErbB" . SPARSER::COLLECTION)
    ("moesin (ERM) and merlin ( xref – xref )" . SPARSER::COLLECTION)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("growth factors and hyaluronan" . SPARSER::COLLECTION)
    ("merlin" . SPARSER::PROTEIN) ("hyaluronan" . SPARSER::PROTEIN)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN) ("cetuximab" . SPARSER::DRUG)
    ("soluble CD44" . SPARSER::PROTEIN) ("PI3-PTEN-AKT" . SPARSER::COLLECTION)
    ("MAPK, PI3K-PTEN-AKT, and phospholipase C pathways ( xref )"
     . SPARSER::COLLECTION)
    ("the most influential ErbB receptor" . SPARSER::RECEPTOR)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION) ("Ras-MAPK" . SPARSER::COLLECTION)
    ("tobacco and alcohol" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("tobacco" . SPARSER::DRUG) ("CD44 and EGFR" . SPARSER::COLLECTION)
    ("p300" . SPARSER::PROTEIN) ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("1B1" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-EGFR" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("any directional cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("the permeable peptide" . SPARSER::PEPTIDE)
    ("caveolin" . SPARSER::PROTEIN) ("Rac-GAP" . SPARSER::COLLECTION)
    ("Rac-GTPase activating protein" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD81 and other tetraspanins" . SPARSER::COLLECTION)
    ("dendritic actin" . SPARSER::PROTEIN) ("WAVE" . SPARSER::PROTEIN)
    ("Verprolin" . SPARSER::PROTEIN) ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("the same multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("CD81 and Rac" . SPARSER::COLLECTION)
    ("the permeable peptides" . SPARSER::PEPTIDE)
    ("Rac-CD81" . SPARSER::COLLECTION)
    ("cell-permeable peptide" . SPARSER::PEPTIDE)
    ("complete CD81" . SPARSER::PROTEIN)
    ("CD81-ΔCyt-GFP" . SPARSER::PROTEIN-PAIR)
    ("geometric cues" . SPARSER::PROTEIN-FAMILY)
    ("AqGFP-CD81" . SPARSER::COLLECTION) ("DsRed-CD81" . SPARSER::COLLECTION)
    ("DsRed" . SPARSER::PROTEIN) ("Raichu-Rac" . SPARSER::COLLECTION)
    ("GTP or GDP" . SPARSER::COLLECTION) ("GDP" . SPARSER::NUCLEOTIDE)
    ("GTP" . SPARSER::NUCLEOTIDE) ("CD81 and Rac1" . SPARSER::COLLECTION)
    ("the glycophosphatidylinositol (GPI)-linked receptor CD59"
     . SPARSER::PROTEIN)
    ("GPI" . SPARSER::PROTEIN) ("Rac and CD81" . SPARSER::COLLECTION)
    ("CD81/Rac" . SPARSER::COLLECTION) ("Cyt" . SPARSER::MOLECULE)
    ("CD81 and WT-Rac-1" . SPARSER::COLLECTION)
    ("GFP and mCherry" . SPARSER::COLLECTION)
    ("CD81 and wild type Rac (WT-Rac1)" . SPARSER::COLLECTION)
    ("mCherry-CD81" . SPARSER::COLLECTION)
    ("Rac1–glutathione S -transferase" . SPARSER::COLLECTION)
    ("other tetraspanin-associated membrane molecules" . SPARSER::MOLECULE)
    ("CD9, CD151, and CD82" . SPARSER::COLLECTION)
    ("ezrin, radixin, and moesin" . SPARSER::COLLECTION)
    ("ERM" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("CD9, CD53, CD81, CD82, and CD151" . SPARSER::COLLECTION)
    ("FAK, p130 cas , and paxillin" . SPARSER::COLLECTION)
    ("PKC" . SPARSER::PROTEIN)
    ("At least five tetraspanins—CD9" . SPARSER::COLLECTION)
    ("tetraspanins—CD9" . SPARSER::COLLECTION)
    ("endothelial nitric-oxide synthase" . SPARSER::PROTEIN)
    ("FAK, Src, p130 cas and paxillin" . SPARSER::COLLECTION)
    ("Integrin" . SPARSER::PROTEIN)
    ("immunoglobulin-like adhesion molecules and metalloproteinases"
     . SPARSER::COLLECTION)
    ("CD9/CD81" . SPARSER::COLLECTION) ("CD9 and CD151" . SPARSER::COLLECTION)
    ("anti-CD151 and anti-CD81" . SPARSER::COLLECTION)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("Tetraspanins" . SPARSER::PROTEIN)
    ("cell-permeable peptides" . SPARSER::PEPTIDE)
    ("a soluble peptide" . SPARSER::PEPTIDE) ("CD81-Rac" . SPARSER::COLLECTION)
    ("tetraspanins" . SPARSER::PROTEIN-FAMILY)
    ("Tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("SP5" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("F-12" . SPARSER::PROTEIN)
    ("Rho-GDI" . SPARSER::PROTEIN)
    ("Wiskott–Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("CD59" . SPARSER::PROTEIN) ("Rac-1" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("CD147" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("EWI-2" . SPARSER::PROTEIN) ("Rac2" . SPARSER::PROTEIN)
    ("syntenin-1" . SPARSER::PROTEIN) ("CD53" . SPARSER::PROTEIN)
    ("PI4K" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4-kinase" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("nitric-oxide synthase" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p130 cas" . SPARSER::PROTEIN) ("CD82" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("CD81" . SPARSER::PROTEIN) ("SNAP" . SPARSER::PROTEIN)
    ("HAO1 and PLCB1" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PITX1 , CATSPER3 , PCBD2 , MIR4461 , and H2AFY" . SPARSER::COLLECTION)
    ("both C12orf5 (also known as TIGAR, TP53-induced glycolysis and apoptosis regulator) and RAD51AP1"
     . SPARSER::COLLECTION)
    ("PARP11 , FGF23, FGF6 , C12orf5, and RAD51AP1" . SPARSER::COLLECTION)
    ("TIGAR" . SPARSER::PROTEIN) ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("the first ten principal components" . SPARSER::COMPONENT)
    ("MACH" . SPARSER::PROTEIN) ("QC" . SPARSER::PROTEIN)
    ("Quad" . SPARSER::DRUG)
    ("APC , SMAD4 , AXIN2 , BMPR1A , POLD1 , STK11 , MUTYH , and DNA"
     . SPARSER::COLLECTION)
    ("MUTYH" . SPARSER::PROTEIN) ("p12" . SPARSER::PROTEIN)
    ("PC2" . SPARSER::PROTEIN) ("beta 1" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN) ("PLCB1" . SPARSER::PROTEIN)
    ("HAO1" . SPARSER::PROTEIN) ("NEUROG1" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H2AFY" . SPARSER::PROTEIN)
    ("PCBD2" . SPARSER::PROTEIN) ("CATSPER3" . SPARSER::PROTEIN)
    ("PITX1" . SPARSER::PROTEIN)
    ("TP53-induced glycolysis and apoptosis regulator" . SPARSER::PROTEIN)
    ("RAD51AP1" . SPARSER::PROTEIN) ("C12orf5" . SPARSER::PROTEIN)
    ("FGF6" . SPARSER::PROTEIN) ("FGF23" . SPARSER::PROTEIN)
    ("PARP11" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin family" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("mach2" . SPARSER::DRUG) ("BMPR1A" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN)
    ("thiazolidinediones and metformin" . SPARSER::COLLECTION)
    ("metformin" . SPARSER::DRUG) ("thiazolidinediones" . SPARSER::PROTEIN)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("allopurinol" . SPARSER::DRUG)
    ("glycemic traits" . SPARSER::PROTEIN)
    ("GCKR , IGF1R and NFAT5" . SPARSER::COLLECTION) ("GCK" . SPARSER::PROTEIN)
    ("glucokinase and pyruvate" . SPARSER::COLLECTION)
    ("glucokinase" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("pentose" . SPARSER::MOLECULE)
    ("ABCG2 , SLC17A3 , SLC22A11 , SLC16A9 and PDZK1" . SPARSER::COLLECTION)
    ("carbohydrate" . SPARSER::MOLECULE)
    ("inhibins-activins receptors and their ligands" . SPARSER::COLLECTION)
    ("INHBE and ACVR2A" . SPARSER::COLLECTION)
    ("ACVRL1 , ACVR1C and BMPR2" . SPARSER::COLLECTION)
    ("INHBE" . SPARSER::PROTEIN) ("ARNT" . SPARSER::PROTEIN)
    ("B3GNT4 and ACVR1B" . SPARSER::COLLECTION) ("GRAIL" . SPARSER::PROTEIN)
    ("GCKR and BAZ1B" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("GCKR , BAZ1B and ATXN2" . SPARSER::COLLECTION)
    ("SLC2A9 , GCKR and IGF1R" . SPARSER::COLLECTION)
    ("NHS and HPFS" . SPARSER::COLLECTION) ("NHS" . SPARSER::PROTEIN)
    ("met" . SPARSER::AMINO-ACID)
    ("ABCG2 (rs1481012, P = 2.0 × 10 −32 ) and SLC2A9 (rs4475146, P = 4.1 × 10 −26 )"
     . SPARSER::COLLECTION)
    ("the organic anion transporter" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("SLC22A11-" . SPARSER::PROTEIN)
    ("transporter" . SPARSER::PROTEIN)
    ("urate concentration–associated variants" . SPARSER::VARIANT)
    ("PRPS1 (MIM 300661) and HPRT1 (MIM 300322)" . SPARSER::COLLECTION)
    ("VEGFA and ATXN2" . SPARSER::COLLECTION)
    ("ORC4L , OVOL1 and BCAS3" . SPARSER::COLLECTION)
    ("SHIP" . SPARSER::PROTEIN) ("SLC2A9 and ABCG2" . SPARSER::COLLECTION)
    ("PDZK1 , GCKR , SLC2A9 , ABCG2 , RREB1 , SLC17A1 , SLC16A9 , SLC22A11 , NRXN2 and INHBC"
     . SPARSER::COLLECTION)
    ("SLC16A9" . SPARSER::PROTEIN) ("INHBC" . SPARSER::PROTEIN)
    ("GCKR" . SPARSER::PROTEIN) ("SLC22A11-NRXN2" . SPARSER::COLLECTION)
    ("dl" . SPARSER::MOLECULE) ("refs" . SPARSER::PROTEIN)
    ("purine" . SPARSER::DRUG) ("inhibins-activins" . SPARSER::COLLECTION)
    ("activins" . SPARSER::PROTEIN) ("inhibins" . SPARSER::PROTEIN)
    ("ACVRL1 and B3GNT4" . SPARSER::COLLECTION) ("HLF" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN) ("INHBB" . SPARSER::PROTEIN)
    ("Urate" . SPARSER::MOLECULE) ("urate" . SPARSER::MOLECULE)
    ("SLC17A3" . SPARSER::PROTEIN) ("HNF-1α" . SPARSER::PROTEIN)
    ("PRPSAP1" . SPARSER::PROTEIN) ("BMPR2" . SPARSER::PROTEIN)
    ("ACVR1C" . SPARSER::PROTEIN) ("ACVR2A" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN) ("OAT2" . SPARSER::PROTEIN)
    ("SLC22A12" . SPARSER::PROTEIN) ("SLC22A7" . SPARSER::PROTEIN)
    ("HNF1A" . SPARSER::PROTEIN) ("HPRT1" . SPARSER::PROTEIN)
    ("PRPS1" . SPARSER::PROTEIN) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("QRICH2" . SPARSER::PROTEIN) ("OVOL1" . SPARSER::PROTEIN)
    ("ORC4L" . SPARSER::PROTEIN) ("16A" . SPARSER::PROTEIN)
    ("RREB1" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("SLC2A9" . SPARSER::PROTEIN) ("PDZK1" . SPARSER::PROTEIN)
    ("SLC17A1" . SPARSER::PROTEIN) ("LRRC16A" . SPARSER::PROTEIN)
    ("NRXN2" . SPARSER::PROTEIN) ("SLC22A11" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("Uric acid" . SPARSER::MOLECULE)
    ("B3GNT4" . SPARSER::PROTEIN) ("ACVRL1" . SPARSER::PROTEIN)
    ("ACVR1B" . SPARSER::PROTEIN) ("NFAT5" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("UBE2Q2" . SPARSER::PROTEIN)
    ("A1CF" . SPARSER::PROTEIN) ("HNF4G" . SPARSER::PROTEIN)
    ("STC1" . SPARSER::PROTEIN) ("PRKAG2" . SPARSER::PROTEIN)
    ("BAZ1B" . SPARSER::PROTEIN) ("TMEM171" . SPARSER::PROTEIN)
    ("SFMBT1" . SPARSER::PROTEIN) ("TRIM46" . SPARSER::PROTEIN)
    ("an essential structural component" . SPARSER::COMPONENT)
    ("an essential functional component" . SPARSER::COMPONENT)
    ("ATG16L1 and ATG16L2" . SPARSER::COLLECTION)
    ("elegans" . SPARSER::PROTEIN)
    ("ATG16L1 and ATG16L1ΔFBD" . SPARSER::COLLECTION)
    ("ATG16L1 or ATG16L1ΔFBD" . SPARSER::COLLECTION)
    ("ULK1 and ULK2" . SPARSER::COLLECTION) ("lysosomal" . SPARSER::PROTEIN)
    ("ammonia" . SPARSER::MOLECULE)
    ("ATG16L1 or ATG16L1" . SPARSER::COLLECTION)
    ("FIP200–ATG16L1" . SPARSER::COLLECTION) ("Rab33B" . SPARSER::PROTEIN)
    ("FIP200 and ATG5" . SPARSER::COLLECTION) ("CCD" . SPARSER::PROTEIN)
    ("ATG16L1–FIP200" . SPARSER::COLLECTION)
    ("ATG3 or ATG7" . SPARSER::COLLECTION)
    ("ATG5 and its ATG12 conjugation mutant (ATG5 K130R)"
     . SPARSER::COLLECTION)
    ("ATG5 ( xref and xref ) or ATG13 ( xref )" . SPARSER::COLLECTION)
    ("ATG5 and ATG13" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("the ATG16L1-containing ATG5 complex and the FIP200-containing ULK1 complex"
     . SPARSER::COLLECTION)
    ("down FIP200 as well as ATG13 ( xref )" . SPARSER::COLLECTION)
    ("ATG16L1 and FIP200" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("Vps34 and p150" . SPARSER::COLLECTION)
    ("ATG14 and ATG16L1" . SPARSER::COLLECTION)
    ("the ULK1 complex and the ATG5 complex" . SPARSER::COLLECTION)
    ("the protein kinase ULK1 and several regulatory components"
     . SPARSER::COLLECTION)
    ("ATG13 and FIP200" . SPARSER::COLLECTION)
    ("kinase, p150, Beclin and ATG14" . SPARSER::COLLECTION)
    ("Beclin" . SPARSER::PROTEIN) ("Vps34 and ULK1" . SPARSER::COLLECTION)
    ("Vps34" . SPARSER::PROTEIN) ("Vps" . SPARSER::PROTEIN)
    ("ATG5, ATG16L1 or ATG7" . SPARSER::COLLECTION)
    ("ATG7, ATG3 and ATG5–ATG12" . SPARSER::COLLECTION)
    ("ATG5–ATG12" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("FBD-deleted ATG16L1 mutant" . SPARSER::MUTANT)
    ("FBD" . SPARSER::PROTEIN-FAMILY)
    ("essential components" . SPARSER::COMPONENT)
    ("FIP200 and ATG16L1" . SPARSER::COLLECTION)
    ("ULK1 and ATG5" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("3XFLAG" . SPARSER::PROTEIN) ("S-tags" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("p70S6" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("SQSTM1" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("ATG8" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("GFP–LC3" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("Torin 1" . SPARSER::DRUG)
    ("ATG16L2" . SPARSER::PROTEIN) ("Rab33" . SPARSER::PROTEIN)
    ("ATG16" . SPARSER::PROTEIN) ("ATG13" . SPARSER::PROTEIN)
    ("ATG14" . SPARSER::PROTEIN) ("p150" . SPARSER::PROTEIN)
    ("ATG10" . SPARSER::PROTEIN) ("ATG12" . SPARSER::PROTEIN)
    ("ATG3" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("LC3–II" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("ATG16L1" . SPARSER::PROTEIN) ("FIP200" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("all other histologic subtypes" . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("bank" . SPARSER::PROTEIN)
    ("poly-ADP" . SPARSER::PROTEIN) ("RR 2" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE) ("RAD51C" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN) ("FoxO3 and/or Sirt1" . SPARSER::COLLECTION)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("either ERK1/2 (at S295, S354, S426) or IKKβ (at S644)"
     . SPARSER::COLLECTION)
    ("AKT, ERK1/2, and IκB" . SPARSER::COLLECTION)
    ("Gadd45a , and Sod2" . SPARSER::COLLECTION) ("Sod2" . SPARSER::PROTEIN)
    ("Bim/Bcl2l11" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("FoxO1 , FoxO3 , and FoxO4" . SPARSER::COLLECTION)
    ("that MVNP’s" . SPARSER::PROTEIN) ("Pagetic OCLs" . SPARSER::MOLECULE)
    ("FoxO3 and Sirt1in" . SPARSER::COLLECTION)
    ("a classic PI3K inhibitor" . SPARSER::INHIBITOR)
    ("TRAF6 and TRAF2" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("IL-1 and TNF-α" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("MVNP and Pagetic OCL [ xref ]" . SPARSER::COLLECTION)
    ("Pagetic OCL" . SPARSER::MOLECULE)
    ("FoxO3 and Sirt1" . SPARSER::COLLECTION) ("macrophage" . SPARSER::PROTEIN)
    ("the predominant FoxO" . SPARSER::PROTEIN-FAMILY)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY) ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("Forkhead" . SPARSER::PROTEIN) ("pagetic OCL" . SPARSER::MOLECULE)
    ("pagetic OCLs" . SPARSER::MOLECULE)
    ("abnormal osteoclasts (OCL)" . SPARSER::PROTEIN)
    ("OCLs" . SPARSER::MOLECULE) ("OCL" . SPARSER::MOLECULE)
    ("FoxO3/Sirt1" . SPARSER::COLLECTION) ("TRAP-MVNP" . SPARSER::COLLECTION)
    ("multi" . SPARSER::PROTEIN) ("TRAP" . SPARSER::PROTEIN)
    ("MVNP and FoxO3" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("Sirt1" . SPARSER::PROTEIN) ("MVNP" . SPARSER::PROTEIN)
    ("pagetic osteoclasts" . SPARSER::PROTEIN)
    ("protein (MVNP)" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("Gadd45a" . SPARSER::PROTEIN)
    ("l11" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("FoxO4" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN) ("IL-1R1" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("pGL2" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("M-CSF" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("calyculin A" . SPARSER::MOLECULE) ("α-tubulin" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("class O" . SPARSER::PROTEIN) ("Calyculin A" . SPARSER::MOLECULE)
    ("FoxO3" . SPARSER::PROTEIN) ("Il-6" . SPARSER::PROTEIN)
    ("Prism" . SPARSER::PROTEIN) ("paired two-tailed t" . SPARSER::PROTEIN)
    ("Iodine" . SPARSER::MOLECULE) ("Propidium" . SPARSER::MOLECULE)
    ("ethanol" . SPARSER::PROTEIN) ("Skp2 or p27" . SPARSER::COLLECTION)
    ("THS" . SPARSER::PROTEIN) ("RFP" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN)
    ("10% FBS and 1% pen-strep" . SPARSER::COLLECTION)
    ("SK-MEL" . SPARSER::COLLECTION) ("MEL" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("Melt" . SPARSER::DRUG)
    ("Melting" . SPARSER::DRUG) ("ramp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("melt" . SPARSER::DRUG) ("DTT" . SPARSER::MOLECULE)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EDTA" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("Peptide" . SPARSER::PEPTIDE) ("Chemicals" . SPARSER::MOLECULE)
    ("Roscovitine" . SPARSER::DRUG)
    ("ATP (2 mM) and 10 μM" . SPARSER::COLLECTION)
    ("CDK2/CyclinE1" . SPARSER::COLLECTION) ("Aldehyde" . SPARSER::MOLECULE)
    ("reagents" . SPARSER::MOLECULE) ("Flag-βTrCP" . SPARSER::COLLECTION)
    ("elongation" . SPARSER::PROTEIN) ("TNT" . SPARSER::PROTEIN)
    ("mouse monoclonal antisera" . SPARSER::PROTEIN)
    ("Skp2/p45" . SPARSER::COLLECTION) ("antisera" . SPARSER::PROTEIN)
    ("Antibodies" . SPARSER::ANTIBODY) ("doxycycline" . SPARSER::DRUG)
    ("HA-PDCD4" . SPARSER::COLLECTION) ("Flag-β-TrCP" . SPARSER::COLLECTION)
    ("Dr" . SPARSER::MOLECULE) ("ligands" . SPARSER::LIGAND)
    ("receptor and ligand" . SPARSER::COLLECTION) ("Pro" . SPARSER::AMINO-ACID)
    ("silico virtual ligand" . SPARSER::LIGAND)
    ("SCF-Skp2/p27" . SPARSER::COLLECTION)
    ("p27 and Skp2" . SPARSER::COLLECTION)
    ("Skp1-Skp2-Cks1" . SPARSER::COLLECTION) ("SPR" . SPARSER::PROTEIN)
    ("highlight key chemical" . SPARSER::MOLECULE)
    ("MDM2-p53" . SPARSER::COLLECTION) ("CyclinE/Cdk2" . SPARSER::COLLECTION)
    ("HTS" . SPARSER::PROTEIN) ("p27 and the inhibitors" . SPARSER::COLLECTION)
    ("lentiviral tet-inducible short hairpins" . SPARSER::PROTEIN-FAMILY)
    ("hairpins" . SPARSER::PROTEIN-FAMILY) ("tet" . SPARSER::PROTEIN)
    ("Skp2 and Skp1" . SPARSER::COLLECTION)
    ("MG-132 (a proteasome inhibitor) or MLN-4924 (the NEDD8-activating enzyme inhibitor)"
     . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION) ("MLN" . SPARSER::PROTEIN)
    ("p130, Cdt1, Tob1, and Cyclin E" . SPARSER::COLLECTION)
    ("each inhibitor (10 μM) or 0.1% DMSO (vehicle)" . SPARSER::COLLECTION)
    ("melting" . SPARSER::DRUG) ("Skp1 and Cul1" . SPARSER::COLLECTION)
    ("HA-Skp2" . SPARSER::COLLECTION)
    ("both the wild-type Cks1 and the Q52L-Cks1 mutant (data not shown)"
     . SPARSER::COLLECTION)
    ("the COOH-group" . SPARSER::MOLECULE) ("COOH-group" . SPARSER::MOLECULE)
    ("leucine" . SPARSER::AMINO-ACID) ("COOH" . SPARSER::MOLECULE)
    ("key 3D structural chemical" . SPARSER::MOLECULE)
    ("cation" . SPARSER::MOLECULE) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("CyclinE/CDK2" . SPARSER::COLLECTION) ("Ubc3" . SPARSER::PROTEIN)
    ("Ubc" . SPARSER::PROTEIN) ("the primary VLS" . SPARSER::PROTEIN)
    ("SCF-βTrCP" . SPARSER::COLLECTION) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("Skp2, Cks1, and p27" . SPARSER::COLLECTION)
    ("Skp2 and Cks1" . SPARSER::COLLECTION)
    ("Skp2-Cks1-p27" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("Inhibitor" . SPARSER::INHIBITOR) ("virtual ligand" . SPARSER::LIGAND)
    ("Skp2-Cks1" . SPARSER::COLLECTION) ("VLS" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN) ("the substrate’s" . SPARSER::SUBSTRATE)
    ("IAPs-caspases" . SPARSER::COLLECTION) ("Mdm2-p53" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("IAPs" . SPARSER::PROTEIN)
    ("this trimeric complex" . SPARSER::BIO-COMPLEX)
    ("Skp2 and an accessory protein" . SPARSER::COLLECTION)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("CyclinE-CDK2" . SPARSER::COLLECTION)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY)
    ("p27, p21, and p57" . SPARSER::COLLECTION)
    ("the scaffold protein Cullin-1 (Cul1) binds both the Ring-box protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclins and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("CKIs" . SPARSER::PROTEIN)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Velcade" . SPARSER::DRUG)
    ("Bortezomib" . SPARSER::DRUG)
    ("oncogenes and tumor suppressors in transformed cells"
     . SPARSER::COLLECTION)
    ("almost all cellular proteins" . SPARSER::PROTEIN)
    ("Skp2-p27" . SPARSER::COLLECTION) ("SCF-Skp2" . SPARSER::COLLECTION)
    ("SCF-Skp2-Cks1" . SPARSER::COLLECTION)
    ("its accessory protein Cks1" . SPARSER::PROTEIN)
    ("Skp2" . SPARSER::PROTEIN) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Skp" . SPARSER::PROTEIN) ("SCF" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("CyclinE1" . SPARSER::PROTEIN)
    ("UBE1" . SPARSER::PROTEIN) ("p45" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("PDB 2" . SPARSER::PROTEIN) ("Cdc34" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("Cyclin E" . SPARSER::PROTEIN) ("Tob1" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("Compound C" . SPARSER::MOLECULE) ("Ubc5" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("subunit 1" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("F-box protein Skp2" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Cullin-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cullin1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("Cks1" . SPARSER::PROTEIN)
    ("PI3K inhibitors and mTOR inhibitors" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("PTEN/PI3K" . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN) ("lox/lox" . SPARSER::COLLECTION)
    ("lox" . SPARSER::PROTEIN) ("LSL-Kras" . SPARSER::COLLECTION)
    ("Pdx1-Cre" . SPARSER::COLLECTION) ("LSL" . SPARSER::PROTEIN)
    ("Kras" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("effectors, NF-κB and MYC" . SPARSER::COLLECTION)
    ("phosphoinositide 3-kinase/AKT" . SPARSER::COLLECTION)
    ("SMAD4/DPC4" . SPARSER::COLLECTION) ("p16/INK4A" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("Smad4" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("PSD-95 and synapse" . SPARSER::COLLECTION)
    ("MEF2C , Fmr1 and Pcdh10" . SPARSER::COLLECTION)
    ("epileptic seizures" . SPARSER::PROTEIN)
    ("Mdm2, PSD-95 and synapse" . SPARSER::COLLECTION)
    ("Elegans" . SPARSER::PROTEIN) ("NMDAR" . SPARSER::PROTEIN)
    ("a postsynaptic scaffold" . SPARSER::SCAFFOLD)
    ("Pcdh8 and Pcdh10" . SPARSER::COLLECTION)
    ("cis or trans" . SPARSER::COLLECTION)
    ("Pcdh8 and N-cadherin" . SPARSER::COLLECTION)
    ("Pcdh8 or Arcadlin" . SPARSER::COLLECTION) ("cis" . SPARSER::PROTEIN)
    ("classical cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular domain 1" . SPARSER::PROTEIN)
    ("the traditional cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protocadherins and synapse" . SPARSER::COLLECTION)
    ("Protocadherins" . SPARSER::PROTEIN)
    ("scaffold, PSD-95, and synapse" . SPARSER::COLLECTION)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("a synaptic scaffolding protein" . SPARSER::PROTEIN)
    ("shRNA or EF1α" . SPARSER::COLLECTION)
    ("EF1α or a control shRNA" . SPARSER::COLLECTION)
    ("Mdm2, and EF1α" . SPARSER::COLLECTION)
    ("EF1α or PSD-95" . SPARSER::COLLECTION) ("homodimer" . SPARSER::HOMODIMER)
    ("GST-" . SPARSER::PROTEIN) ("EF1α and PSD-95" . SPARSER::COLLECTION)
    ("GST-EF1α" . SPARSER::COLLECTION) ("EF1α and Mdm2" . SPARSER::COLLECTION)
    ("mRNA and EF1α" . SPARSER::COLLECTION)
    ("eukaryotic translation elongation factor 1-alpha (EF1α) and Hdm2 ( xref )"
     . SPARSER::COLLECTION)
    ("PSD-95 and Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 and PSD-95" . SPARSER::COLLECTION)
    ("the relevant E3 ligase" . SPARSER::LIGASE)
    ("Flag-PIR" . SPARSER::COLLECTION) ("PIR" . SPARSER::PROTEIN)
    ("the essential proteasome protein component" . SPARSER::COMPONENT)
    ("Rpt6" . SPARSER::PROTEIN) ("Pcdh9" . SPARSER::PROTEIN)
    ("Ubl" . SPARSER::PROTEIN) ("GST-Ubl" . SPARSER::COLLECTION)
    ("Pcdh10 or other interacting proteins" . SPARSER::COLLECTION)
    ("GST-PSD-95" . SPARSER::COLLECTION)
    ("a lentiviral expressed shRNA" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("Pcdh10 and PSD-95" . SPARSER::COLLECTION)
    ("MG132 and lactacystin" . SPARSER::COLLECTION)
    ("MG132 (5 μM) or lactacystin (5 μM)" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG)
    ("other synaptic proteins" . SPARSER::PROTEIN)
    ("mGluR5, Homer and CaMKIIα" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("Homer" . SPARSER::PROTEIN-FAMILY)
    ("several postsynaptic scaffolding proteins" . SPARSER::PROTEIN)
    ("synaptic scaffolding proteins" . SPARSER::PROTEIN)
    ("proteins, Synapsin-1 and PSD-95 or PSD-95" . SPARSER::COLLECTION)
    ("PSD-95 or PSD-95" . SPARSER::COLLECTION) ("pre-" . SPARSER::PROTEIN)
    ("Flag-Pcdh10" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("PPF" . SPARSER::MOLECULE) ("EPSC" . SPARSER::PROTEIN)
    ("simultaneous whole cell patch clamp" . SPARSER::PROTEIN-FAMILY)
    ("CA1" . SPARSER::PROTEIN) ("mCherry" . SPARSER::PROTEIN)
    ("soma" . SPARSER::DRUG) ("FMRP and GFP" . SPARSER::COLLECTION)
    ("Pcdh10 and Microtubule-associated protein 2" . SPARSER::COLLECTION)
    ("Pcdh10 or Tubulin" . SPARSER::COLLECTION) ("Tubulin" . SPARSER::PROTEIN)
    ("Cys" . SPARSER::AMINO-ACID) ("Met" . SPARSER::AMINO-ACID)
    ("Pcdh10 and Nurr77" . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE)
    ("Pcdh10 mRNA and another MEF2 target gene Nurr77" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::DRUG) ("an RNA-immunoprecipitation" . SPARSER::RNA)
    ("RNA-immunoprecipitation" . SPARSER::RNA)
    ("FMRP and Pcdh10" . SPARSER::COLLECTION)
    ("protocadherins" . SPARSER::PROTEIN)
    ("the classical cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OL-protocadherin" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protocadherin" . SPARSER::PROTEIN-FAMILY) ("Fmr1" . SPARSER::PROTEIN)
    ("eukaryotic translation elongation factor 1-alpha" . SPARSER::PROTEIN)
    ("protein and FMRP" . SPARSER::COLLECTION)
    ("MEF2 and FMRP" . SPARSER::COLLECTION) ("Pcdh10" . SPARSER::PROTEIN)
    ("Fragile X Mental Retardation Protein (FMRP)" . SPARSER::PROTEIN)
    ("Protein (FMRP)" . SPARSER::PROTEIN) ("FMRP" . SPARSER::PROTEIN)
    ("MEF2C" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("Amino acids" . SPARSER::AMINO-ACID)
    ("Rpt1" . SPARSER::PROTEIN) ("Rad23" . SPARSER::PROTEIN-FAMILY)
    ("PSD95" . SPARSER::PROTEIN) ("Synapsin-1" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("MAP2" . SPARSER::PROTEIN)
    ("Microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("4-Hydroxytamoxifen" . SPARSER::DRUG) ("VP16" . SPARSER::DRUG)
    ("synaptic scaffolding molecule" . SPARSER::PROTEIN)
    ("post-synaptic density protein 95" . SPARSER::PROTEIN)
    ("Pcdh8" . SPARSER::PROTEIN) ("Protocadherin-10" . SPARSER::PROTEIN)
    ("Factor 2" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("elongation factor 1-alpha" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("protocadherin-10" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN)
    ("Mental Retardation" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("Pre" . SPARSER::PROTEIN) ("MKL" . SPARSER::PROTEIN)
    ("FB" . SPARSER::PROTEIN) ("MLM" . SPARSER::PROTEIN)
    ("part or all data" . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("Broad CGA and the GENEVA" . SPARSER::COLLECTION)
    ("Broad CGA" . SPARSER::PROTEIN) ("CGA" . SPARSER::PROTEIN)
    ("our younger Appalachian cohorts and comparatively older non-Appalachia cohorts"
     . SPARSER::COLLECTION)
    ("comparatively older non-Appalachia cohorts" . SPARSER::MOLECULE)
    ("our younger Appalachian cohorts" . SPARSER::MOLECULE)
    ("CDKN3/CNIH/GMFB" . SPARSER::COLLECTION) ("FZD" . SPARSER::PROTEIN-FAMILY)
    ("Tao" . SPARSER::DRUG) ("Bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("CDKN3, CNIH, GMFB and CGRRF1" . SPARSER::COLLECTION)
    ("GMFB" . SPARSER::PROTEIN) ("CNIH" . SPARSER::PROTEIN)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("RSK" . SPARSER::PROTEIN)
    ("the two largest cohorts" . SPARSER::MOLECULE)
    ("ACTN2 , MTR , and EDARADD , MPPED2, and LPO" . SPARSER::COLLECTION)
    ("EDARADD , MPPED2, and LPO" . SPARSER::COLLECTION)
    ("LPO" . SPARSER::PROTEIN) ("EDARADD" . SPARSER::PROTEIN)
    ("MTR" . SPARSER::PROTEIN)
    ("amelogenin ( AMELX ) 
[ xref , xref ] and tuftelin ( TUFT1 )"
     . SPARSER::COLLECTION)
    ("amelogenin ( AMELX )" . SPARSER::PROTEIN)
    ("proteins, and CD14" . SPARSER::COLLECTION)
    ("tuftelin" . SPARSER::PROTEIN) ("amelogenin" . SPARSER::PROTEIN)
    ("examples" . SPARSER::EXAMPLE) ("Genes" . SPARSER::GENE)
    ("TLR2" . SPARSER::PROTEIN) ("RPS6KA2 and PTK2B" . SPARSER::COLLECTION)
    ("RHOU and FZD1" . SPARSER::COLLECTION) ("RHOU" . SPARSER::PROTEIN)
    ("Appalachian cohorts" . SPARSER::MOLECULE) ("dentate" . SPARSER::PROTEIN)
    ("E-6" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("ZNF160" . SPARSER::PROTEIN) ("ADAMTS3" . SPARSER::PROTEIN)
    ("Wnt1" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("BMP4" . SPARSER::PROTEIN) ("CDKN3" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("E-5" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("MPPED2" . SPARSER::PROTEIN) ("ACTN2" . SPARSER::PROTEIN)
    ("TUFT1" . SPARSER::PROTEIN) ("TAS2R38" . SPARSER::PROTEIN)
    ("taste receptor" . SPARSER::PROTEIN) ("ISL1" . SPARSER::PROTEIN)
    ("FZD1" . SPARSER::PROTEIN) ("PTK2B" . SPARSER::PROTEIN)
    ("RPS6KA2" . SPARSER::PROTEIN)
    ("the mild TP53 Brazilian variant" . SPARSER::VARIANT)
    ("TP53 and other variants" . SPARSER::COLLECTION)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("array-CGH and SNP" . SPARSER::COLLECTION)
    ("classic LFS" . SPARSER::PROTEIN) ("XVIII" . SPARSER::PROTEIN)
    ("TP53 and MDM2" . SPARSER::COLLECTION) ("CGH" . SPARSER::PROTEIN)
    ("The Brazilian p" . SPARSER::PROTEIN) ("CFR" . SPARSER::DRUG)
    ("the polygenic component" . SPARSER::COMPONENT)
    ("CRC or EC" . SPARSER::COLLECTION)
    ("the family's" . SPARSER::PROTEIN-FAMILY)
    ("Mutation type and proband's" . SPARSER::COLLECTION)
    ("type and proband" . SPARSER::COLLECTION)
    ("Gene and sex" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("modifiers" . SPARSER::MOLECULE)
    ("MLH1 or MSH2" . SPARSER::COLLECTION) ("HNPCC" . SPARSER::PROTEIN)
    ("MSH2 , MLH1 , MSH6 or PMS2" . SPARSER::COLLECTION)
    ("MIM" . SPARSER::PROTEIN) ("MMR" . SPARSER::PROTEIN)
    ("CRC and EC" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION) ("male" . SPARSER::MOLECULE)
    ("CRC" . SPARSER::PROTEIN)
    ("166 MLH1 and 224 MSH2 mutation-carrying families" . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("Colon Cancer" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("many previously well-studied genes" . SPARSER::GENE)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("NOS" . SPARSER::PROTEIN) ("150 somatic p" . SPARSER::PROTEIN)
    ("the family’s" . SPARSER::PROTEIN-FAMILY)
    ("a second somatic p" . SPARSER::PROTEIN) ("HLA" . SPARSER::PROTEIN)
    ("72 heterozygous rare variants" . SPARSER::VARIANT)
    ("approximately 2400 rare variant alleles" . SPARSER::ALLELE)
    ("LFS" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("possible causative genes" . SPARSER::GENE)
    ("gene or genes" . SPARSER::COLLECTION)
    ("even well-studied genes" . SPARSER::GENE)
    ("acute lymphocytic leukemia (ALL)" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("vPARP" . SPARSER::PROTEIN)
    ("vault PARP ( xref ) and tankyrase ( xref )" . SPARSER::COLLECTION)
    ("PARP-1, PARP-2 ( xref ), vault PARP ( xref ) and tankyrase ( xref )"
     . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN) ("PARP-1/PARG" . SPARSER::COLLECTION)
    ("PARP-1 or PARG" . SPARSER::COLLECTION)
    ("ABT-888 and PARG" . SPARSER::COLLECTION)
    ("PARP-1 and the silencing/absence" . SPARSER::COLLECTION)
    ("PJ34 or ABT-888" . SPARSER::COLLECTION)
    ("PJ34 and ABT-888" . SPARSER::COLLECTION) ("hapten" . SPARSER::MOLECULE)
    ("functional PARG" . SPARSER::PROTEIN) ("BZ" . SPARSER::DRUG)
    ("PJ34 (1–8 μ M) and ABT-888 (10–120 μ M)" . SPARSER::COLLECTION)
    ("benzamide" . SPARSER::DRUG) ("-isoquinoline (DPQ)" . SPARSER::DRUG)
    ("-isoquinoline" . SPARSER::DRUG) ("Veliparib" . SPARSER::DRUG)
    ("carboxamide" . SPARSER::MOLECULE) ("benzimidazole" . SPARSER::DRUG)
    ("isoquinoline" . SPARSER::DRUG) ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chemosensitizers" . SPARSER::DRUG) ("biopolymers" . SPARSER::MOLECULE)
    ("PARP-1 and PARG" . SPARSER::COLLECTION) ("PARG" . SPARSER::PROTEIN)
    ("1–8" . SPARSER::PROTEIN)
    ("fibroblast growth factor-4" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("cancer 2" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PARP-2" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("PARP-1" . SPARSER::PROTEIN)
    ("SprT" . SPARSER::PROTEIN) ("POLD2 and POLD3" . SPARSER::COLLECTION)
    ("3xFlag-Rev1" . SPARSER::COLLECTION) ("3xFlag" . SPARSER::PROTEIN)
    ("POLD3 and Rev1" . SPARSER::COLLECTION)
    ("3xFlag-POLD3" . SPARSER::COLLECTION)
    ("Pol32 and Rev1" . SPARSER::COLLECTION)
    ("Rev1 and Rev3" . SPARSER::COLLECTION)
    ("Rev1 or Rev3" . SPARSER::COLLECTION) ("Rev3" . SPARSER::PROTEIN)
    ("Spartan or POLD3" . SPARSER::COLLECTION)
    ("POLD3 and Spartan" . SPARSER::COLLECTION)
    ("Spartan and POLD3" . SPARSER::COLLECTION)
    ("accessory subunits" . SPARSER::PROTEIN)
    ("POLD1, POLD2 and POLD3" . SPARSER::COLLECTION)
    ("POLD1, POLD2, POLD3, and POLD4" . SPARSER::COLLECTION)
    ("Peptides" . SPARSER::PEPTIDE) ("associated proteins" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("expressed either wild-type Spartan or the E112A mutant"
     . SPARSER::COLLECTION)
    ("Glu" . SPARSER::AMINO-ACID) ("endopeptidases" . SPARSER::PROTEIN)
    ("neurotoxin" . SPARSER::PROTEIN) ("water" . SPARSER::MOLECULE)
    ("histidine" . SPARSER::AMINO-ACID)
    ("DVC1 and C1orf124" . SPARSER::COLLECTION)
    ("Rev1 and Pol ζ" . SPARSER::COLLECTION)
    ("Pol η, Pol κ and Pol ι" . SPARSER::COLLECTION)
    ("Rev7 and the catalytic subunit Rev3" . SPARSER::COLLECTION)
    ("the catalytic subunit Rev3" . SPARSER::PROTEIN-FAMILY)
    ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("separate polymerases" . SPARSER::PROTEIN)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("Rev1 and the error-prone TLS polymerase Pol ζ" . SPARSER::COLLECTION)
    ("POLD3, Rev1 and Pol ζ" . SPARSER::COLLECTION)
    ("Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1–4" . SPARSER::PROTEIN)
    ("Pol32" . SPARSER::PROTEIN) ("POLD4" . SPARSER::PROTEIN)
    ("lethal factor" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("MMP13" . SPARSER::PROTEIN)
    ("MMP12" . SPARSER::PROTEIN) ("MMP8" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("Anti-S" . SPARSER::ANTIBODY)
    ("POLD2" . SPARSER::PROTEIN) ("POLD1" . SPARSER::PROTEIN)
    ("C1orf124" . SPARSER::PROTEIN) ("DVC1" . SPARSER::PROTEIN)
    ("Pol ι" . SPARSER::PROTEIN) ("Pol η" . SPARSER::PROTEIN)
    ("Rev7" . SPARSER::PROTEIN) ("accessory subunit" . SPARSER::PROTEIN)
    ("POLD3" . SPARSER::PROTEIN) ("α v β 3 and EGFR" . SPARSER::COLLECTION)
    ("PAK4 or MMP-2" . SPARSER::COLLECTION)
    ("NF-κB and ERK" . SPARSER::COLLECTION) ("TNFR" . SPARSER::PROTEIN)
    ("FADD" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN)
    ("integrin-binding domain (IBD)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IBD" . SPARSER::PROTEIN) ("protein and PAK4/MMP-2" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("c-Src, ERK1/2, EGFR and HGF" . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN) ("integrin and MMP-2" . SPARSER::COLLECTION)
    ("MMP-2 and phospho-EGFR" . SPARSER::COLLECTION)
    ("robust anoikis" . SPARSER::PROTEIN)
    ("EGF- or VN-adhesion-elevated" . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN)
    ("MMP-2, phospho-PAK4, phospho-EGFR, CyclinD1 and Bcl-xL"
     . SPARSER::COLLECTION)
    ("phospho-EGFR, CyclinD1 and Bcl-xL" . SPARSER::COLLECTION)
    ("EGF and GW2974" . SPARSER::COLLECTION) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("MMP-2, phospho-EGFR and CyclinD1" . SPARSER::COLLECTION)
    ("v-integrin" . SPARSER::COLLECTION)
    ("anti-PAK4 and anti-MMP-2" . SPARSER::COLLECTION) ("CRIB" . SPARSER::DRUG)
    ("PAK4-KD" . SPARSER::COLLECTION) ("GST-MMP-2" . SPARSER::COLLECTION)
    ("Tyr" . SPARSER::AMINO-ACID)
    ("MMP-2, phospho-EGFR, EGF, CyclinD1, PCNA and Bcl-xL"
     . SPARSER::COLLECTION)
    ("α v β 3 integrin (VN receptor) and other intermediate proteins"
     . SPARSER::COLLECTION)
    ("apoptotic proteins and tumor suppressors" . SPARSER::COLLECTION)
    ("KAL1, CDKN1A, TGFB1, TP53, RB1, CASP9, BAD, PTEN, RBL2, SHC1, SOS1, TCS1, PIAS1, PTPRC, SLA2 and SOCS5"
     . SPARSER::COLLECTION)
    ("PTPRC" . SPARSER::PROTEIN)
    ("CDH1, ICAM1, ITGA5, ITGAV, ITGB1, ITGB3, LAMA2, MMP2, CCNB1, CCND1, CHUK, EGFR, GRB2, FOS, MYC, MAPK14, MAX, ILK, RPS6KA1, TIRAP, GATA3, HMGA1, IL10RA, JAK1, NFKB1, STAT1 and STAT5B"
     . SPARSER::COLLECTION)
    ("TIRAP" . SPARSER::PROTEIN) ("ILK" . SPARSER::PROTEIN)
    ("MAX" . SPARSER::PROTEIN) ("FOS" . SPARSER::PROTEIN)
    ("CHUK" . SPARSER::PROTEIN) ("ITGAV" . SPARSER::PROTEIN)
    ("pSV-" . SPARSER::PROTEIN)
    ("VN (4910, ∼76% 5310, ∼74%) and FN (4910, ∼70.5% 5310, ∼70%)"
     . SPARSER::COLLECTION)
    ("pSV" . SPARSER::PROTEIN) ("phospho-PAK4 and PAK4" . SPARSER::COLLECTION)
    ("NB" . SPARSER::PROTEIN) ("PAK4 and phospho-PAK4" . SPARSER::COLLECTION)
    ("phospho-PAK4 and total-PAK4" . SPARSER::COLLECTION)
    ("phospho-EGFR, phospho-c-Src and phospho-FAK" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN)
    ("vitronectin (VN; 4910, ∼60.3% 5310, ∼60.6%) and fibronectin (FN; 4910, ∼53.3% 5310, ∼50.8%)"
     . SPARSER::COLLECTION)
    ("FN" . SPARSER::PROTEIN) ("VN" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN) ("cellular foci" . SPARSER::PROTEIN)
    ("PARP, caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("either adhered monolayers" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN) ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("GTPases" . SPARSER::GTPASE) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("endopeptidase" . SPARSER::PROTEIN)
    ("heterodimers" . SPARSER::HETERODIMER) ("Integrins" . SPARSER::PROTEIN)
    ("PAK4/MMP-2" . SPARSER::COLLECTION)
    ("PAK4 and MMP-2" . SPARSER::COLLECTION)
    ("α v β 3/EGFR" . SPARSER::COLLECTION)
    ("essential proteins" . SPARSER::PROTEIN)
    ("α v β 3-integrin" . SPARSER::COLLECTION) ("protein-G" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN) ("NF- κ B" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("β 1-integrin" . SPARSER::PROTEIN) ("α v β 5" . SPARSER::PROTEIN)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α 5 β 1" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("TNF α" . SPARSER::PROTEIN) ("LCH-7749944" . SPARSER::DRUG)
    ("PF-3758309" . SPARSER::DRUG) ("GW2974" . SPARSER::DRUG)
    ("anti- β" . SPARSER::PROTEIN) ("caspase3" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN) ("SLA2" . SPARSER::PROTEIN)
    ("PIAS1" . SPARSER::PROTEIN) ("TCS1" . SPARSER::PROTEIN)
    ("SOS1" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("RBL2" . SPARSER::PROTEIN) ("CASP9" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN) ("KAL1" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("NFKB1" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("IL10RA" . SPARSER::PROTEIN) ("HMGA1" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK14" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("LAMA2" . SPARSER::PROTEIN)
    ("ITGB3" . SPARSER::PROTEIN) ("ITGB1" . SPARSER::PROTEIN)
    ("ITGA5" . SPARSER::PROTEIN) ("ICAM1" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("α v β 3" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("p21-activated kinase 4" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("5-FU and FdUrd" . SPARSER::COLLECTION) ("APE" . SPARSER::PROTEIN)
    ("p-Chk1" . SPARSER::COLLECTION)
    ("salvageable thymidine" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("dUTPase" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("fluoropyrimidines" . SPARSER::DRUG) ("RNA and DNA" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN) ("SSBs or DSBs" . SPARSER::COLLECTION)
    ("p-CHK2" . SPARSER::COLLECTION) ("UNG or SMUG1" . SPARSER::COLLECTION)
    ("p-CHK1" . SPARSER::COLLECTION) ("SMUG1 or UNG" . SPARSER::COLLECTION)
    ("UNG-KD" . SPARSER::PROTEIN-PAIR) ("SMUG1-KD" . SPARSER::PROTEIN-PAIR)
    ("KD" . SPARSER::PROTEIN)
    ("5-FU or other TS inhibitors" . SPARSER::COLLECTION)
    ("RTX" . SPARSER::DRUG) ("antifolate" . SPARSER::MOLECULE)
    ("TDG or MBD4" . SPARSER::COLLECTION) ("TDG" . SPARSER::PROTEIN)
    ("genomic 5-FU" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("DNA glycosylase (UDG)" . SPARSER::PROTEIN)
    ("Uracil or 5-FU" . SPARSER::COLLECTION) ("UDG" . SPARSER::PROTEIN)
    ("Uracil" . SPARSER::DRUG) ("genomic uracil" . SPARSER::DRUG)
    ("raltitrexed (RTX) and pemetrexed" . SPARSER::COLLECTION)
    ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("thymidylate" . SPARSER::MOLECULE) ("pemetrexed" . SPARSER::DRUG)
    ("raltitrexed" . SPARSER::DRUG) ("antifolates" . SPARSER::MOLECULE)
    ("capecitabine" . SPARSER::DRUG) ("prodrug" . SPARSER::DRUG)
    ("fluorouracil" . SPARSER::DRUG) ("labile" . SPARSER::PROTEIN)
    ("UNG and SMUG1" . SPARSER::COLLECTION) ("UNG" . SPARSER::PROTEIN)
    ("uracil and 5-FU" . SPARSER::COLLECTION) ("UDGs" . SPARSER::PROTEIN)
    ("uracil" . SPARSER::DRUG) ("TTP" . SPARSER::PROTEIN)
    ("Fluorouracil" . SPARSER::DRUG) ("APE-1" . SPARSER::PROTEIN)
    ("type VII" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("Caspase-3" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("MBD4" . SPARSER::PROTEIN) ("N  5" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("SMUG1" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("Dynamin" . SPARSER::PROTEIN)
    ("Myc-MARCH5" . SPARSER::COLLECTION) ("GFP-Mfn1" . SPARSER::COLLECTION)
    ("cyclinB/Cdk1" . SPARSER::COLLECTION) ("cyclinB" . SPARSER::PROTEIN)
    ("Asy" . SPARSER::PROTEIN) ("nocodazole or taxol" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("nocodazole" . SPARSER::DRUG)
    ("punctate" . SPARSER::PROTEIN) ("double-thymidine" . SPARSER::PROTEIN)
    ("Cdk1/cyclin B1" . SPARSER::COLLECTION)
    ("hyper-fused" . SPARSER::PROTEIN-PAIR) ("Drosophila" . SPARSER::PROTEIN)
    ("Va" . SPARSER::MOLECULE) ("oxidase" . SPARSER::PROTEIN)
    ("cytochrome" . SPARSER::PROTEIN) ("Fis1 or MARCH5" . SPARSER::COLLECTION)
    ("Fis1 (fission 1) or Mff
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Mff" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("Mitochondria" . SPARSER::PROTEIN) ("Fission 1" . SPARSER::PROTEIN)
    ("Mitofusin1" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("Mfn2" . SPARSER::PROTEIN)
    ("serine 6" . SPARSER::PROTEIN)
    ("mitochondrial fission factor" . SPARSER::PROTEIN)
    ("CENP-F" . SPARSER::PROTEIN) ("MitoTracker Red" . SPARSER::MOLECULE)
    ("cyclin E" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("fission 1" . SPARSER::PROTEIN) ("Fis1" . SPARSER::PROTEIN)
    ("Drp1" . SPARSER::PROTEIN) ("Opa1" . SPARSER::PROTEIN)
    ("MARCH5" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("Mfn1" . SPARSER::PROTEIN) ("Mitofusin 1" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STK11/LKB1" . SPARSER::COLLECTION) ("MAPKAPK2/MK2" . SPARSER::COLLECTION)
    ("CDK4 or RB1" . SPARSER::COLLECTION)
    ("at least parts" . SPARSER::COMPONENT)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("residual p16" . SPARSER::PROTEIN) ("ARF, or PTEN" . SPARSER::COLLECTION)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("a principal effector" . SPARSER::EFFECTOR) ("CDKs" . SPARSER::PROTEIN)
    ("very numerous p-p53 foci" . SPARSER::PROTEIN)
    ("TIFs or other DDS foci (Figure  xref E,F)" . SPARSER::COLLECTION)
    ("subnuclear foci" . SPARSER::PROTEIN)
    ("several subnuclear foci" . SPARSER::PROTEIN) ("TIFs" . SPARSER::PROTEIN)
    ("significantly less p16" . SPARSER::PROTEIN) ("BIN" . SPARSER::PROTEIN)
    ("nucleolin" . SPARSER::PROTEIN) ("p-p53" . SPARSER::COLLECTION)
    ("Mediators" . SPARSER::PROTEIN) ("RGP" . SPARSER::PROTEIN)
    ("p53-p21" . SPARSER::COLLECTION) ("p53 and p21" . SPARSER::COLLECTION)
    ("p16 and p53" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("mitotic regulatory proteins" . SPARSER::PROTEIN)
    ("van" . SPARSER::PROTEIN) ("mediators" . SPARSER::PROTEIN)
    ("TERT" . SPARSER::PROTEIN)
    ("the protective repetitive DNA" . SPARSER::DNA) ("Ha" . SPARSER::PROTEIN)
    ("p16 (also called INK4A or CDKN2A, cyclin-dependent kinase inhibitor 2A) and ARF (alternative reading frame; Bennett, xref ; Peters, xref )"
     . SPARSER::COLLECTION)
    ("INK4A or CDKN2A" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("DNA-damage" . SPARSER::DNA)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STK11" . SPARSER::PROTEIN)
    ("TBX2" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("MAPKAPK2" . SPARSER::PROTEIN)
    ("CHEK1" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("CDKN2B" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("FOXM1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("INK4A" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN)
    ("class- or isoform-selective HDACIs" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC6" . SPARSER::COLLECTION)
    ("traditional HDACIs" . SPARSER::MOLECULE)
    ("the optimal HDACI" . SPARSER::MOLECULE)
    ("the relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("at least 11 other HDACIs" . SPARSER::MOLECULE)
    ("Vorinostat and Romidepsin" . SPARSER::COLLECTION)
    ("Food" . SPARSER::MOLECULE) ("Romidepsin" . SPARSER::DRUG)
    ("Vorinostat" . SPARSER::DRUG)
    ("both MC1568 and Tubastatin" . SPARSER::COLLECTION)
    ("biomarker" . SPARSER::MOLECULE)
    ("MGCD0103, or MGCD0103" . SPARSER::COLLECTION)
    ("MGCD0103 and MC1568" . SPARSER::COLLECTION)
    ("MC1568 and MGCD0103" . SPARSER::COLLECTION) ("HDAC4-" . SPARSER::PROTEIN)
    ("NTC-" . SPARSER::PROTEIN) ("NTC-shRNA" . SPARSER::COLLECTION)
    ("HDAC6-shRNA" . SPARSER::COLLECTION) ("HDAC4-shRNA" . SPARSER::COLLECTION)
    ("NTC" . SPARSER::PROTEIN)
    ("Class I- and Class II-Selective HDACIs" . SPARSER::COLLECTION)
    ("Class I-" . SPARSER::PROTEIN) ("Mocetinostat" . SPARSER::DRUG)
    ("FK" . SPARSER::MOLECULE) ("SAHA" . SPARSER::DRUG)
    ("the clinically relevant HDAC isoforms" . SPARSER::ISOFORM)
    ("a separate class" . CLASS) ("IIb" . SPARSER::DRUG) ("Class" . CLASS)
    ("homologues" . SPARSER::PROTEIN)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("acetyl" . SPARSER::MOLECULE)
    ("Histone" . SPARSER::PROTEIN) ("Gemcitabine" . SPARSER::DRUG)
    ("class- or isoform-selective inhibitors" . SPARSER::COLLECTION)
    ("class-" . CLASS) ("MC1568 or Tubastatin" . SPARSER::COLLECTION)
    ("MC1568 (a class IIa-selective HDACI) or Tubastatin"
     . SPARSER::COLLECTION)
    ("p21 and DNA" . SPARSER::COLLECTION) ("HDACI" . SPARSER::MOLECULE)
    ("alpha-tubulin, p21, and γH2AX" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN) ("MTT" . SPARSER::MOLECULE)
    ("HDAC" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("HDACIs" . SPARSER::MOLECULE) ("T-cell" . SPARSER::PROTEIN)
    ("beta-actin" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("HDAC10" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("M +2 µ" . SPARSER::MOLECULE) ("PANC-1" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG) ("LBH-589" . SPARSER::DRUG)
    ("HDAC11" . SPARSER::PROTEIN) ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC4" . SPARSER::PROTEIN) ("rpd3" . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("MC1568" . SPARSER::DRUG)
    ("MGCD0103" . SPARSER::DRUG) ("γH2AX" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN)
    ("Histone deacetylase" . SPARSER::PROTEIN)
    ("AP-1, STAT1 and ATF2" . SPARSER::COLLECTION)
    ("CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("Akt and IκB-α" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("neurotoxins" . SPARSER::PROTEIN) ("p-Akt" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE) ("p-IκB-α" . SPARSER::COLLECTION)
    ("p-IκBα" . SPARSER::COLLECTION)
    ("both mRNA as well as protein" . SPARSER::COLLECTION)
    ("mRNA ( xref ) or protein ( xref )" . SPARSER::COLLECTION)
    ("mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("IL-6 ( xref ) and IL-8 mRNA ( xref )" . SPARSER::COLLECTION)
    ("U0126 and JNK-MAPK inhibitor" . SPARSER::COLLECTION)
    ("ERK1/2-MAPK" . SPARSER::COLLECTION)
    ("STAT1, CHOP, Max and ATF2" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN) ("CHOP" . SPARSER::PROTEIN)
    ("both IL-6 ( xref ) and IL-8 ( xref )" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG) ("JNK-MAPK" . SPARSER::COLLECTION)
    ("ERK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38-MAPK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("IL-6, IL-8 and CCL5" . SPARSER::COLLECTION)
    ("IL-6, CCL5 and IL-8" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("TNF-α, IL-1β, IL-8 and IL-6" . SPARSER::COLLECTION)
    ("stimulant" . SPARSER::DRUG) ("illicit drugs" . SPARSER::DRUG)
    ("morphine" . SPARSER::MOLECULE) ("cocaine" . SPARSER::DRUG)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("IL-6, IL-8, IL-1β, and CCL5" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN) ("microglia" . SPARSER::PROTEIN)
    ("gp120 and MA" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("methamphetamine" . SPARSER::DRUG)
    ("various proinflammatory cytokines" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("mGluR5" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN) ("g protein" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("A- 3" . SPARSER::PROTEIN)
    ("p38δ" . SPARSER::PROTEIN) ("p38γ" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("SB203580" . SPARSER::DRUG)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CO2" . SPARSER::PROTEIN)
    ("Sodium bicarbonate" . SPARSER::DRUG) ("CCL5" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("Gp120" . SPARSER::DRUG)
    ("IL-8" . SPARSER::PROTEIN) ("gp120" . SPARSER::DRUG)
    ("envelope protein" . SPARSER::PROTEIN)
    ("the actual causal variants" . SPARSER::VARIANT)
    ("CHST8, KCTD15, MTCH2, SFRS10, SH2B1 and TMEM18" . SPARSER::COLLECTION)
    ("CRHR1, CRHR2, MCHR1, MC3R, MC4R and POMC" . SPARSER::COLLECTION)
    ("POMC" . SPARSER::PROTEIN) ("rhoGAP" . SPARSER::PROTEIN)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proopiomelanocortin" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("alleles" . SPARSER::ALLELE)
    ("thrombomodulin, TNF-α and ICAM-1" . SPARSER::COLLECTION)
    ("thrombomodulin" . SPARSER::PROTEIN) ("CCR2/CCR3" . SPARSER::COLLECTION)
    ("GREB1, DFNB31, RASGEF1A , and CCR3" . SPARSER::COLLECTION)
    ("cysteine-cysteine" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN) ("FOXE1 or thyroid" . SPARSER::COLLECTION)
    ("‘forkhead’" . SPARSER::PROTEIN) ("thyroid" . SPARSER::PROTEIN)
    ("proinsulin" . SPARSER::PROTEIN)
    ("neuropeptide and hormone" . SPARSER::COLLECTION)
    ("neuropeptide" . SPARSER::PROTEIN)
    ("HDL-C and ApoA-1" . SPARSER::COLLECTION) ("ApoA-1" . SPARSER::PROTEIN)
    ("statins" . SPARSER::DRUG) ("ApoA" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE) ("retina" . SPARSER::DRUG)
    ("tRNA" . SPARSER::PROTEIN)
    ("Genome-wide significant and suggestive genetic variants"
     . SPARSER::VARIANT)
    ("genome-wide significant genetic variants" . SPARSER::VARIANT)
    ("CTCFL" . SPARSER::PROTEIN) ("orf" . SPARSER::PROTEIN)
    ("Substrate" . SPARSER::SUBSTRATE) ("−1" . SPARSER::PROTEIN)
    ("MPRIP" . SPARSER::PROTEIN) ("24-h urinary dopamine" . SPARSER::PROTEIN)
    ("creatinine" . SPARSER::PROTEIN) ("nitrogen" . SPARSER::MOLECULE)
    ("Variants" . SPARSER::VARIANT) ("An intronic variant" . SPARSER::VARIANT)
    ("several endometabolic traits" . SPARSER::PROTEIN)
    ("Genome-wide significant variants" . SPARSER::VARIANT)
    ("Endometabolic Traits" . SPARSER::PROTEIN) ("Traits" . SPARSER::PROTEIN)
    ("NP" . SPARSER::PROTEIN) ("FFM and FM" . SPARSER::COLLECTION)
    ("their associated traits" . SPARSER::PROTEIN)
    ("genome-wide significant (p<1.0E-07) genetic variants" . SPARSER::VARIANT)
    ("families" . SPARSER::PROTEIN-FAMILY) ("nutrient" . SPARSER::MOLECULE)
    ("FM" . SPARSER::PROTEIN) ("FFM" . SPARSER::PROTEIN)
    ("an intronic variant" . SPARSER::VARIANT)
    ("APOA5-ZNF259" . SPARSER::COLLECTION) ("TSH" . SPARSER::PROTEIN)
    ("antioxidants" . SPARSER::DRUG) ("triglycerides" . SPARSER::MOLECULE)
    ("p  " . SPARSER::PROTEIN) ("INADL" . SPARSER::PROTEIN)
    ("localized novel genes" . SPARSER::GENE) ("ARHGAP11A" . SPARSER::PROTEIN)
    ("XPA/FOXE1" . SPARSER::COLLECTION) ("ZNF259/APOA5" . SPARSER::COLLECTION)
    ("MATK" . SPARSER::PROTEIN) ("DARC" . SPARSER::PROTEIN)
    ("XPA" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("LA" . SPARSER::PROTEIN)
    ("TMEM18" . SPARSER::PROTEIN) ("SH2B1" . SPARSER::PROTEIN)
    ("SFRS10" . SPARSER::PROTEIN) ("MTCH2" . SPARSER::PROTEIN)
    ("KCTD15" . SPARSER::PROTEIN) ("CHST8" . SPARSER::PROTEIN)
    ("MC4R" . SPARSER::PROTEIN) ("MC3R" . SPARSER::PROTEIN)
    ("MCHR1" . SPARSER::PROTEIN) ("CRHR2" . SPARSER::PROTEIN)
    ("CRHR1" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("alpha polypeptide 3" . SPARSER::PROTEIN)
    ("cholinergic receptor" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("E-selectin" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN)
    ("MCP-1 receptor" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("transcription factor 2" . SPARSER::PROTEIN) ("HDL-C" . SPARSER::PROTEIN)
    ("APOC3" . SPARSER::PROTEIN) ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPL7" . SPARSER::PROTEIN) ("TMEM229B" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("RASGEF1A" . SPARSER::PROTEIN)
    ("MCP1" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("KLKB1" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("GCH1" . SPARSER::PROTEIN)
    ("P11" . SPARSER::PROTEIN) ("ASS1" . SPARSER::PROTEIN)
    ("TSEN34" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("HOXB5" . SPARSER::PROTEIN) ("OLFM4" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("COL4A1" . SPARSER::PROTEIN)
    ("CHRNA3" . SPARSER::PROTEIN) ("PCSK2" . SPARSER::PROTEIN)
    ("CCR3" . SPARSER::PROTEIN) ("TTF-2" . SPARSER::PROTEIN)
    ("FOXE1" . SPARSER::PROTEIN) ("APOA5" . SPARSER::PROTEIN)
    ("ZNF259" . SPARSER::PROTEIN) ("MTNR1B" . SPARSER::PROTEIN)
    ("SNCG" . SPARSER::PROTEIN) ("ATM and SATB1" . SPARSER::COLLECTION)
    ("SATB1 and ATM" . SPARSER::COLLECTION) ("paclitaxel" . SPARSER::DRUG)
    ("hydroxyurea" . SPARSER::DRUG) ("ATM and ATR" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("p21 and MDM2" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("SATB1-shRNA" . SPARSER::COLLECTION)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("F-actin and α6- integrin" . SPARSER::COLLECTION)
    ("properly formed mammary acini" . SPARSER::PROTEIN)
    ("ß-catenin" . SPARSER::COLLECTION) ("pLSXN-SATB1" . SPARSER::COLLECTION)
    ("mixture" . SPARSER::MOLECULE) ("pLXSN-SATB1" . SPARSER::COLLECTION)
    ("- 1" . SPARSER::PROTEIN) ("HRAS" . SPARSER::PROTEIN)
    ("pyrene" . SPARSER::PROTEIN) ("examined SATB1's" . SPARSER::PROTEIN)
    ("transcriptional regulators and chromatin" . SPARSER::COLLECTION)
    ("states" . SPARSER::BIO-STATE) ("ATM" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-Tubulin" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("BubR1" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1D" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("1A" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("SATB1" . SPARSER::PROTEIN) ("AP1S1 and ABCC3" . SPARSER::COLLECTION)
    ("AP1S1" . SPARSER::PROTEIN) ("CYP3A4 and CYP1A1" . SPARSER::COLLECTION)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("CYP3A4 and CYP3A5" . SPARSER::COLLECTION)
    ("CYP3A4, CYP3A5, CYP3A7, and CYP3A43" . SPARSER::COLLECTION)
    ("CYP" . SPARSER::PROTEIN) ("MT1X and SULT1A1" . SPARSER::COLLECTION)
    ("sulfate" . SPARSER::MOLECULE) ("NF-κB and Akt" . SPARSER::COLLECTION)
    ("various dimeric complexes" . SPARSER::BIO-COMPLEX)
    ("Rel" . SPARSER::PROTEIN) ("trans-DDP" . SPARSER::COLLECTION)
    ("DDP and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("ions" . SPARSER::MOLECULE)
    ("metallothionein (MT)" . SPARSER::PROTEIN)
    ("cysteine" . SPARSER::AMINO-ACID)
    ("AKT , NFκB , BCR , TRADD , and CCT4" . SPARSER::COLLECTION)
    ("BCR" . SPARSER::PROTEIN)
    ("PI3K (LY2294002) or NFκB (Bay11-7082)" . SPARSER::COLLECTION)
    ("Our Western blot" . SPARSER::PROTEIN)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("PI3K/Akt/NFκB" . SPARSER::COLLECTION)
    ("PI3K (LY2294002 [50 µM]) or NFκB (Bay11-7082 [20 µM])"
     . SPARSER::COLLECTION)
    ("Akt and some types" . SPARSER::COLLECTION) ("MT1x" . SPARSER::PROTEIN)
    ("FITC and PI" . SPARSER::COLLECTION) ("PI" . SPARSER::PROTEIN)
    ("FITC" . SPARSER::MOLECULE) ("apoptosis-associated genes" . SPARSER::GENE)
    ("siRNAs" . SPARSER::PROTEIN) ("metallothionein" . SPARSER::PROTEIN)
    ("GST-TCRP1" . SPARSER::COLLECTION) ("TCRP1 or GST" . SPARSER::COLLECTION)
    ("MT1X and Akt" . SPARSER::COLLECTION)
    ("MT1X, NFκB, and Akt" . SPARSER::COLLECTION)
    ("our Western blot" . SPARSER::PROTEIN)
    ("MT1X, NFκB1, EGFR, Akt1, CYP3A5, HIF1A, and TP53" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN)
    ("CYP3A5 , HIF1A , and TP53" . SPARSER::COLLECTION)
    ("MT1X , NFκB1 , EGFR , and Akt1" . SPARSER::COLLECTION)
    ("Akt1, NFκB1 , NFκB2 , GADD45B, NFκBIA , NFκBIB , and TRADD"
     . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN)
    ("chaperones/heat shock proteins ( CCT3 , CCT4 , DNAJA2 , and DNAJC4 ) and drug"
     . SPARSER::COLLECTION)
    ("CCT3 , CCT4 , DNAJA2 , and DNAJC4" . SPARSER::COLLECTION)
    ("CYP1A1 , CHST4 , and CYP3A5" . SPARSER::COLLECTION)
    ("GO" . SPARSER::PROTEIN) ("PYM and DDP" . SPARSER::COLLECTION)
    ("MT1X and TCRP1" . SPARSER::COLLECTION)
    ("LUM , PDE3B , CCND1 , and RECQL" . SPARSER::COLLECTION)
    ("RECQL" . SPARSER::PROTEIN) ("LUM" . SPARSER::PROTEIN)
    ("DDP" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN) ("the largest class" . CLASS)
    ("Platinum" . SPARSER::MOLECULE) ("PI3K/Akt/NF-κB" . SPARSER::COLLECTION)
    ("TCRP1 and MT1X" . SPARSER::COLLECTION)
    ("metallothionein1X (MT1X) and Akt" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN) ("PYM" . SPARSER::PROTEIN)
    ("Drug" . SPARSER::DRUG) ("multidrug" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("MRP3" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein 3" . SPARSER::PROTEIN)
    ("ABCC3" . SPARSER::PROTEIN) ("CYP3A" . SPARSER::PROTEIN)
    ("CYP3A43" . SPARSER::PROTEIN) ("CYP3A7" . SPARSER::PROTEIN)
    ("CYP3A4" . SPARSER::PROTEIN) ("Cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("SULT1A1" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("c- Rel" . SPARSER::PROTEIN)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("MT2A" . SPARSER::PROTEIN)
    ("cis-DDP" . SPARSER::MOLECULE) ("Bay11-7082" . SPARSER::DRUG)
    ("MT1" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("NFκBIB" . SPARSER::PROTEIN) ("NFκ" . SPARSER::PROTEIN)
    ("GADD45B" . SPARSER::PROTEIN) ("NFκB2" . SPARSER::PROTEIN)
    ("CYP3A5" . SPARSER::PROTEIN) ("CHST4" . SPARSER::PROTEIN)
    ("CYP1A1" . SPARSER::PROTEIN) ("CCT3" . SPARSER::PROTEIN)
    ("CCT4" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("CCND1" . SPARSER::PROTEIN) ("PDE3B" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB" . SPARSER::PROTEIN)
    ("MT1X" . SPARSER::PROTEIN) ("metallothionein1X" . SPARSER::PROTEIN)
    ("TCRP1" . SPARSER::PROTEIN) ("IR and IRS" . SPARSER::COLLECTION)
    ("IR/IRS" . SPARSER::COLLECTION)
    ("the IGF-1 Receptor and this receptor" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("IRS 1/IRS 2" . SPARSER::COLLECTION)
    ("PSA" . SPARSER::PROTEIN) ("homology" . SPARSER::PROTEIN)
    ("IR and other receptor tyrosine kinases (e.g. IGF-1 receptor)"
     . SPARSER::COLLECTION)
    ("-1 and IRS-2" . SPARSER::COLLECTION)
    ("this hormone's" . SPARSER::MOLECULE) ("IGF" . SPARSER::PROTEIN)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE) ("p " . SPARSER::PROTEIN)
    ("RNA- and protein" . SPARSER::COLLECTION) ("RNA-" . SPARSER::RNA)
    ("radical" . SPARSER::MOLECULE) ("IRS" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("IRS 2" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1B" . SPARSER::PROTEIN)
    ("p27 kip1" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("Insulin receptor" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("intact fibronectin" . SPARSER::PROTEIN)
    ("more powerful inducers" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE) ("RANTES" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN)
    ("the RGD domain peptide and the control peptide" . SPARSER::COLLECTION)
    ("mutated peptides" . SPARSER::PEPTIDE) ("Fibronectin" . SPARSER::PROTEIN)
    ("integrin and fibronectin" . SPARSER::COLLECTION) ("mAb" . SPARSER::DRUG)
    ("integrin, or anti-" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("monocytes and fibronectin" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("either a transcriptional repressor or an activator"
     . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR)
    ("AML-1 and Egr-1" . SPARSER::COLLECTION) ("interferon" . SPARSER::PROTEIN)
    ("fibronectin or collagen" . SPARSER::COLLECTION)
    ("fibronectin and collagen" . SPARSER::COLLECTION)
    ("Sigma or BD" . SPARSER::COLLECTION)
    ("eNOS or Tie-2" . SPARSER::COLLECTION) ("eNOS" . SPARSER::PROTEIN)
    ("fibronectin- or collagen" . SPARSER::COLLECTION)
    ("fibronectin-" . SPARSER::PROTEIN) ("adipocytes" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN)
    ("collagen (I) and fibronectin (Sigma)" . SPARSER::COLLECTION)
    ("collagen (I) and type III collagen" . SPARSER::COLLECTION)
    ("CD34 and CD144" . SPARSER::COLLECTION)
    ("the collagen (I) or fibronectin" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("CFSE" . SPARSER::DRUG)
    ("Sigma and BD" . SPARSER::COLLECTION)
    ("CD34 and collagen" . SPARSER::COLLECTION)
    ("laminin, or poly-L-lysine" . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("FBS" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN)
    ("CD14, CD45, CD34, and type I" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("either anti- α  5 integrin antibody or a synthetic peptide"
     . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN)
    ("collagen, laminin, or poly-L-lysine" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN) ("monocytes" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("inflammatory protein-1" . SPARSER::PROTEIN) ("CS-1" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("IRF-7" . SPARSER::PROTEIN)
    ("Foxp1" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("PPAR γ" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD144" . SPARSER::PROTEIN) ("Tie-2" . SPARSER::PROTEIN)
    ("Sox-9" . SPARSER::PROTEIN) ("Cbfa1" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AML-1" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("early growth response" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN) ("CD34" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α  5  β  1" . SPARSER::PROTEIN)
    ("β  1 -integrin" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD14" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG) ("AKT and AKT2" . SPARSER::COLLECTION)
    ("TIMPs and MMPs" . SPARSER::COLLECTION)
    ("MMP-9, and AKT2" . SPARSER::COLLECTION)
    ("lipoprotein" . SPARSER::PROTEIN)
    ("three highly homologous isoforms" . SPARSER::ISOFORM)
    ("aortic ECM" . SPARSER::PROTEIN) ("lipid" . SPARSER::LIPID)
    ("MMP-9 and MMP-13" . SPARSER::COLLECTION) ("LPS" . SPARSER::PROTEIN)
    ("rapamycin" . SPARSER::DRUG) ("erythroid" . SPARSER::PROTEIN)
    ("TIMPs" . SPARSER::PROTEIN) ("BAD" . SPARSER::PROTEIN)
    ("human thoracic AAD" . SPARSER::MOLECULE)
    ("protein and AKT" . SPARSER::COLLECTION)
    ("aortic media" . SPARSER::PROTEIN) ("aortic SMCs" . SPARSER::PROTEIN)
    ("Wortmannin" . SPARSER::PROTEIN) ("whereasWT-AKT2" . SPARSER::COLLECTION)
    ("FOXO1 and GATA1" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("Promoter" . SPARSER::PROMOTER)
    ("DN-FOXO1 or FOXO1" . SPARSER::COLLECTION)
    ("DN-FOXO1 (dominant-negative FOXO1) or FOXO1 siRNA" . SPARSER::COLLECTION)
    ("MMP-9/TIMP-1" . SPARSER::COLLECTION)
    ("TIMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("the aortic media" . SPARSER::PROTEIN)
    ("MMP-9 protein ( xref ) and mRNA (Online Figure IIIA) and MMP-2 protein (Online Figure IIIB)"
     . SPARSER::COLLECTION)
    ("mRNA (Online Figure IIIA) and MMP-2 protein (Online Figure IIIB)"
     . SPARSER::COLLECTION)
    ("the aortic media and adventitia" . SPARSER::COLLECTION)
    ("adventitia" . SPARSER::PROTEIN) ("IIIB" . SPARSER::DRUG)
    ("key proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("media-adventitia" . SPARSER::PROTEIN-PAIR)
    ("Macrophages" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN) ("nick" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE) ("elastin" . SPARSER::PROTEIN)
    ("IB" . SPARSER::DRUG) ("IA" . SPARSER::MOLECULE)
    ("ApoE" . SPARSER::PROTEIN) ("spontaneous AAD" . SPARSER::MOLECULE)
    ("media and adventitia" . SPARSER::COLLECTION)
    ("AKT and active" . SPARSER::COLLECTION)
    ("AKT2 and Active" . SPARSER::COLLECTION)
    ("MMP-9 and tissue inhibitor" . SPARSER::COLLECTION)
    ("SMC" . SPARSER::PROTEIN)
    ("growth factors, and cytokines" . SPARSER::COLLECTION)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("ECM" . SPARSER::PROTEIN)
    ("SMCs" . SPARSER::PROTEIN) ("MMP-9 and TIMP-1" . SPARSER::COLLECTION)
    ("MMP" . SPARSER::PROTEIN) ("Akt2-" . SPARSER::PROTEIN)
    ("AKT2 and phospho-AKT" . SPARSER::COLLECTION) ("AAD" . SPARSER::MOLECULE)
    ("Marfan syndrome" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GATA-1" . SPARSER::PROTEIN)
    ("FOXO-1" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("MMP-13" . SPARSER::PROTEIN)
    ("PI3Kγ" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("AKT-induced" . SPARSER::PROTEIN) ("GATA1" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN)
    ("Forkhead Box Protein O1" . SPARSER::PROTEIN) ("SM22α" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("caspase 3" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AKT1" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("*/TP63" . SPARSER::COLLECTION) ("miRNA-" . SPARSER::PROTEIN)
    ("obviously not estrogen" . SPARSER::MOLECULE)
    ("hsa-miR196a2" . SPARSER::COLLECTION)
    ("pro-proliferative and anti-apoptotic genes" . SPARSER::GENE)
    ("estrogens" . SPARSER::MOLECULE)
    ("p53 and full length transcriptionally active TAp63"
     . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::MOLECULE) ("TA" . SPARSER::PROTEIN)
    ("estradiol and ERα" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE)
    ("ERα and extracellular regulated kinase" . SPARSER::COLLECTION)
    ("Estradiol and ERα" . SPARSER::COLLECTION)
    ("Estradiol" . SPARSER::PROTEIN) ("Matrigel" . SPARSER::PROTEIN)
    ("TP63 and hsa-miR-196-a2" . SPARSER::COLLECTION)
    ("this miRNA and its targets (TP63, TRAP2A, SPRY1, NEUROD1, MGAT4A, IGF1)"
     . SPARSER::COLLECTION)
    ("a-1, a-2 and a-2" . SPARSER::COLLECTION) ("a-2" . SPARSER::PROTEIN)
    ("a-1" . SPARSER::PROTEIN) ("ER and PR" . SPARSER::COLLECTION)
    ("ERα and MAPK" . SPARSER::COLLECTION)
    ("TP63 and hsa-miR-196a2" . SPARSER::COLLECTION)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("ERα, hsa-miR-196a2, and TP63" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("pre" . SPARSER::PROTEIN)
    ("antisense" . SPARSER::PROTEIN)
    ("TP63, SPRY1, and TFAP2A" . SPARSER::COLLECTION)
    ("E2 and this" . SPARSER::COLLECTION)
    ("the potential miRNA target genes" . SPARSER::GENE)
    ("potential hsa-miR-196a2" . SPARSER::PROTEIN)
    ("Targets" . SPARSER::TARGET-PROTEIN) ("microRNA" . SPARSER::RNA)
    ("the far more predominant form" . SPARSER::FORM)
    ("Hsa-miR-196a2 and hsa-miR-196a2" . SPARSER::COLLECTION)
    ("Pre-hsa-miR-196a2" . SPARSER::PROTEIN-PAIR) ("pSer" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN)
    ("hsa-miR-196a2, hsa-miR-135a2, hsa-miR-944 and hsa-miR-101-1"
     . SPARSER::COLLECTION)
    ("ERα or ERK2" . SPARSER::COLLECTION)
    ("miR-196a2, hsa-miR-135a, hsa-miR-944, hsa-miR-101, hsa-miR-938 and hsa-miR-615-3p"
     . SPARSER::COLLECTION)
    ("hsa-miR-21" . SPARSER::COLLECTION) ("hsa" . SPARSER::PROTEIN)
    ("miRNA genes and the involvement" . SPARSER::COLLECTION)
    ("the nuclear receptor ERα and the protein kinase ERK2"
     . SPARSER::COLLECTION)
    ("the predominant form" . SPARSER::FORM) ("ER" . SPARSER::PROTEIN)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("estrogen, progesterone and HER2/" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("mRNA-protein" . SPARSER::COLLECTION) ("chaperones" . SPARSER::PROTEIN)
    ("mRNAs" . SPARSER::PROTEIN) ("RNAs" . SPARSER::RNA)
    ("MicroRNAs" . SPARSER::RNA) ("endocrine" . SPARSER::PROTEIN)
    ("*-TP63" . SPARSER::COLLECTION) ("oligonucleotides" . SPARSER::MOLECULE)
    ("ERα and ERK" . SPARSER::COLLECTION) ("miRNA" . SPARSER::PROTEIN)
    ("ERα and ERK2" . SPARSER::COLLECTION) ("estradiol" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("miR196a2" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("MGAT4A" . SPARSER::PROTEIN)
    ("NEUROD1" . SPARSER::PROTEIN) ("TRAP2" . SPARSER::PROTEIN)
    ("TFAP2A" . SPARSER::PROTEIN) ("SPRY1" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("D-2" . SPARSER::PROTEIN) ("miR-196a2" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("L-15" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("activated protein kinase" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("hsa-miR-196a2" . SPARSER::PROTEIN) ("TP63" . SPARSER::PROTEIN)
    ("tumor protein p63" . SPARSER::PROTEIN)
    ("Hsa-miR-196a2" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα" . SPARSER::PROTEIN) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("DARPP32 and STAT5B" . SPARSER::COLLECTION)
    ("cohorts" . SPARSER::MOLECULE) ("AKT and survivin" . SPARSER::COLLECTION)
    ("STAT3 and STAT5B" . SPARSER::COLLECTION)
    ("dopamine and monoamine" . SPARSER::COLLECTION)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT5B and STAT3" . SPARSER::COLLECTION)
    ("DARPP32 and STAT3, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("STAT3, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("STAT5A, STAT5B, and STAT3" . SPARSER::COLLECTION)
    ("Stat5a and 5b" . SPARSER::COLLECTION) ("Stat5a" . SPARSER::PROTEIN)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("The present findings further support STAT3" . SPARSER::PROTEIN)
    ("pro-" . SPARSER::AMINO-ACID) ("STAT5B and DARPP32" . SPARSER::COLLECTION)
    ("DARPP32, STAT3, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("–1" . SPARSER::PROTEIN)
    ("the clinically secondary IDH1 p" . SPARSER::PROTEIN)
    ("STAT/STAT" . SPARSER::COLLECTION) ("Temozolomide" . SPARSER::DRUG)
    ("survivin and Ki-67" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN)
    ("lower DARPP32 (mean±SD, positive vs. negative pAKT: 0.12 ± 1.7 vs. 0.06 ± 0.09, p  = 0.0182) and STAT5A (mean±SD: 0.13 ± 0.12 vs. 0.08 ± 0.07, p  = 0.0316)"
     . SPARSER::COLLECTION)
    ("DARPP/STAT5B" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("parts" . SPARSER::COMPONENT) ("IDH1 and IDH2" . SPARSER::COLLECTION)
    ("DARPP32, STAT1, STAT3 and STAT5A" . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN) ("STAT1/STAT3" . SPARSER::COLLECTION)
    ("STAT5A/STAT3" . SPARSER::COLLECTION)
    ("STAT5A, STAT5B and DARPP32" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("oligodendroglial component" . SPARSER::COMPONENT)
    ("GUSB" . SPARSER::PROTEIN) ("SD" . SPARSER::PROTEIN)
    ("STAT5B/STAT5A" . SPARSER::COLLECTION)
    ("DARPP32 and STAT" . SPARSER::COLLECTION)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("STAT1/STAT5A" . SPARSER::COLLECTION)
    ("STAT3/STAT5A" . SPARSER::COLLECTION)
    ("STAT3/STAT1" . SPARSER::COLLECTION) ("/STAT5A" . SPARSER::COLLECTION)
    ("STAT5B/STAT1" . SPARSER::COLLECTION) ("RQ" . SPARSER::MOLECULE)
    ("DARPP" . SPARSER::PROTEIN)
    ("STAT1, STAT3, STAT5A, STAT5B and DARPP32" . SPARSER::COLLECTION)
    ("t-DARPP" . SPARSER::COLLECTION) ("t" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("a dual function protein" . SPARSER::PROTEIN)
    ("protein phosphatase 1, regulatory (inhibitor) subunit 1B or dopamine"
     . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("dopamine" . SPARSER::PROTEIN)
    ("molecule" . SPARSER::MOLECULE)
    ("the classical and mesenchymal subtypes" . SPARSER::PROTEIN)
    ("a potent inhibitor of cell growth and promoter" . SPARSER::COLLECTION)
    ("glial" . SPARSER::PROTEIN) ("Stat" . SPARSER::PROTEIN)
    ("C/EBPbeta and STAT3" . SPARSER::COLLECTION)
    ("astrocytes" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("STAT" . SPARSER::PROTEIN) ("DARPP32/STAT5A" . SPARSER::COLLECTION)
    ("STAT5B/STAT3" . SPARSER::COLLECTION) ("AKT/PKB" . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("DARPP32/STAT5B" . SPARSER::COLLECTION)
    ("DARPP32/STAT3" . SPARSER::COLLECTION)
    ("DARPP32/STAT1" . SPARSER::COLLECTION) ("IV" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN)
    ("DARPP32, STAT1, STAT3, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("temozolomide" . SPARSER::DRUG)
    ("STAT5 and STAT3" . SPARSER::COLLECTION) ("Stat5" . SPARSER::PROTEIN)
    ("Apoptosis Inhibitor Survivin" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("protein kinase-A" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN)
    ("regulatory (inhibitor) subunit 1B" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("Stat5b" . SPARSER::PROTEIN)
    ("C/EBPbeta" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("STAT5B" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("PPP1R1B" . SPARSER::PROTEIN)
    ("DARPP32" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DEK or MITF" . SPARSER::COLLECTION)
    ("a master regulator of melanocyte homeostasis and melanomagenesis [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("oncogenic chromatin-remodeling factor DEK [ xref ] or microphthalmia-associated transcription factor MITF"
     . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN) ("DEK" . SPARSER::PROTEIN)
    ("TS- and RR-dependent dNTP" . SPARSER::COLLECTION)
    ("TS-" . SPARSER::PROTEIN) ("Cdk2 and C-MYC" . SPARSER::COLLECTION)
    ("exogenous deoxyribonucleosides" . SPARSER::MOLECULE)
    ("C-MYC, TS, RRM1 or RRM2" . SPARSER::COLLECTION)
    ("deoxyadenosine, thymidine, deoxycytidine and deoxyguanosine"
     . SPARSER::COLLECTION)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("deoxycytidine" . SPARSER::PROTEIN)
    ("thymidine" . SPARSER::PROTEIN) ("deoxyadenosine" . SPARSER::MOLECULE)
    ("deoxyribonucleosides" . SPARSER::MOLECULE)
    ("TRR-MYC" . SPARSER::COLLECTION) ("dNTP" . SPARSER::MOLECULE)
    ("TRR" . SPARSER::PROTEIN) ("dNTPs" . SPARSER::MOLECULE)
    ("TS and RRM2" . SPARSER::COLLECTION)
    ("TS, RRM1 and RRM2" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::FRAGMENT)
    ("TS and ribonucleotide" . SPARSER::COLLECTION)
    ("deoxyribonucleotide" . SPARSER::MOLECULE)
    ("TS, IMPDH2, and PRPS2" . SPARSER::COLLECTION)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("p53 or p16 INK4A" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN)
    ("senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE) ("suppressors" . SPARSER::SUPPRESSOR)
    ("nucleosides" . SPARSER::MOLECULE) ("TS and RR" . SPARSER::COLLECTION)
    ("deoxyribonucleoside" . SPARSER::MOLECULE) ("RR" . SPARSER::MOLECULE)
    ("TS" . SPARSER::PROTEIN) ("MYC" . SPARSER::PROTEIN)
    ("HD2" . SPARSER::PROTEIN) ("Alpha-" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("V-MYC" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("RRM1" . SPARSER::PROTEIN) ("PRPS2" . SPARSER::PROTEIN)
    ("phosphoribosyl pyrophosphate synthetase 2" . SPARSER::PROTEIN)
    ("IMPDH2" . SPARSER::PROTEIN)
    ("inosine monophosphate dehydrogenase 2" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("β-Gal" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("hematoxylin and eosin" . SPARSER::COLLECTION) ("TMA" . SPARSER::MOLECULE)
    ("hematoxylin" . SPARSER::MOLECULE) ("log-rank" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("intestinal type" . TYPE)
    ("the intestinal type" . TYPE) ("FISH and IHC" . SPARSER::COLLECTION)
    ("FISH" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("Gene" . SPARSER::GENE) ("HER-3 and HER-4" . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("Oncogene" . SPARSER::ONCOGENE)
    ("HER-2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("HER - 2" . SPARSER::PROTEIN)
    ("HER-4" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("HER-1" . SPARSER::PROTEIN) ("chromosome 17" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("a larger cohort" . SPARSER::MOLECULE)
    ("cohort" . SPARSER::MOLECULE) ("KRAS and MAPK" . SPARSER::COLLECTION)
    ("a shorter OS-Ph1" . SPARSER::PROTEIN) ("EML4-ALK" . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("weaker" . SPARSER::PROTEIN)
    ("OS-Ph1, and DMFS" . SPARSER::COLLECTION) ("FDA" . SPARSER::PROTEIN)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("KRAS , NRAS , or BRAF" . SPARSER::COLLECTION) ("AG" . SPARSER::PROTEIN)
    ("GT" . SPARSER::PROTEIN) ("AA" . SPARSER::MOLECULE)
    ("TG" . SPARSER::PROTEIN)
    ("KRAS , or NRAS , or BRAF" . SPARSER::COLLECTION)
    ("NRAS , or BRAF" . SPARSER::COLLECTION)
    ("KRAS , NRAS or BRAF" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE)
    ("EGFR-targeting monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PR/CR" . SPARSER::COLLECTION) ("CR" . SPARSER::PROTEIN)
    ("simultaneous KRAS" . SPARSER::PROTEIN) ("exon" . SPARSER::PROTEIN)
    ("PIK3CA and MAPK" . SPARSER::COLLECTION)
    ("KRAS , NRAS , and BRAF" . SPARSER::COLLECTION)
    ("BRAF" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("type, gender, and age" . SPARSER::COLLECTION)
    ("type" . TYPE) ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("EML4" . SPARSER::PROTEIN) ("5-2" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("2-4" . SPARSER::PROTEIN)
    ("Ph1" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("disulfide" . SPARSER::MOLECULE) ("AKT and ERK" . SPARSER::COLLECTION)
    ("RTK" . SPARSER::PROTEIN)
    ("HER2 and AMF-interacting HER2" . SPARSER::COLLECTION)
    ("HER2 and AMF" . SPARSER::COLLECTION) ("exogenous AMF" . SPARSER::PROTEIN)
    ("media" . SPARSER::PROTEIN)
    ("AMF and anti-HER2-ECD antibodies" . SPARSER::COLLECTION)
    ("anti-HER2-ECD" . SPARSER::COLLECTION)
    ("either exogenous AMF or AMF-V5" . SPARSER::COLLECTION)
    ("AMF or AMF-V5" . SPARSER::COLLECTION)
    ("HER2 and exogenous AMF-V5 ( xref )" . SPARSER::COLLECTION)
    ("this interaction V5-tagged AMF" . SPARSER::PROTEIN)
    ("Exogenous AMF" . SPARSER::PROTEIN) ("AMF and HER2" . SPARSER::COLLECTION)
    ("linker" . SPARSER::LINKER) ("AMF/HER2/AKT" . SPARSER::COLLECTION)
    ("AKT/ERK" . SPARSER::COLLECTION) ("HER2 and AKT" . SPARSER::COLLECTION)
    ("p-HER2" . SPARSER::COLLECTION) ("exogenous EGF" . SPARSER::PROTEIN)
    ("EGFR/HER2" . SPARSER::COLLECTION)
    ("EGFR and/or HER2" . SPARSER::COLLECTION) ("Marimastat" . SPARSER::DRUG)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("p-AKT/p-ERK" . SPARSER::COLLECTION) ("partial" . SPARSER::PROTEIN)
    ("EGF" . SPARSER::PROTEIN) ("Lapatinib" . SPARSER::DRUG)
    ("G protein coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("yet another AMF receptor" . SPARSER::RECEPTOR)
    ("MMPs" . SPARSER::PROTEIN) ("metalloproteases" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("toxin" . SPARSER::MOLECULE)
    ("p-AKT" . SPARSER::COLLECTION) ("PI3K/MAPK" . SPARSER::COLLECTION)
    ("HER" . SPARSER::PROTEIN)
    ("yet another unidentified receptor" . SPARSER::RECEPTOR)
    ("gp78/AMFR" . SPARSER::COLLECTION) ("AMFR" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("cytokine" . SPARSER::PROTEIN) ("NLK" . SPARSER::PROTEIN)
    ("a housekeeping dimeric enzyme" . SPARSER::ENZYME)
    ("fructose" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("isomerase" . SPARSER::ISOMERASE) ("/AKT" . SPARSER::COLLECTION)
    ("Mucin" . SPARSER::PROTEIN) ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2-ECD" . SPARSER::COLLECTION) ("ECD" . SPARSER::PROTEIN)
    ("ERBB2/Neu" . SPARSER::COLLECTION) ("AMF-HER2" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("metalloprotease" . SPARSER::PROTEIN) ("AMF" . SPARSER::PROTEIN)
    ("trastuzumab" . SPARSER::DRUG) ("Herceptin" . SPARSER::DRUG)
    ("Trastuzumab" . SPARSER::DRUG) ("membrane-bound" . SPARSER::PROTEIN)
    ("G protein coupled receptor" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("Hema-3" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("p185" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("BB2516" . SPARSER::DRUG) ("MK1" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("p-ERK" . SPARSER::PROTEIN)
    ("gp78" . SPARSER::PROTEIN) ("neurotrophic factor" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERBB2" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("analogs" . SPARSER::ANALOG)
    ("NFκB, p53, and FOXO3" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("androgen-responsive LNCaP and androgen-independent C42B cells"
     . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("p53 and NFκB" . SPARSER::COLLECTION)
    ("HDACs" . SPARSER::PROTEIN) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("caspase-3, pStat3 or androgen receptor" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("food" . SPARSER::MOLECULE)
    ("the genitourinary complex" . SPARSER::BIO-COMPLEX)
    ("acini" . SPARSER::PROTEIN) ("mPIN" . SPARSER::PROTEIN)
    ("Akt/NFκB" . SPARSER::COLLECTION) ("tensin" . SPARSER::PROTEIN)
    ("4E-BP1, GSK3α/β and FOXO3α" . SPARSER::COLLECTION)
    ("SIRT1 and pS6K" . SPARSER::COLLECTION)
    ("S6K and pS6K" . SPARSER::COLLECTION)
    ("LNCaP and C42B cells" . SPARSER::COLLECTION)
    ("the cleaved faster-migrating form" . SPARSER::FORM)
    ("II" . SPARSER::PROTEIN)
    ("survivin, Akt, NFκB, and mitogen activated protein kinase"
     . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("nicotinamide" . SPARSER::PROTEIN)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("AMP" . SPARSER::AMP)
    ("AMPK" . SPARSER::PROTEIN) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("TRAMP" . SPARSER::PROTEIN) ("wine" . SPARSER::MOLECULE)
    ("Resveratrol" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("subunit" . SPARSER::FRAGMENT) ("SIRT1/S6K" . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("mTOR" . SPARSER::PROTEIN)
    ("prostatic" . SPARSER::PROTEIN) ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN) ("PTEN" . SPARSER::PROTEIN)
    ("a SIRT1 activator in preventing cardiovascular diseases and cancer"
     . SPARSER::COLLECTION)
    ("the calorie restriction mimetic resveratrol (RES)" . SPARSER::PROTEIN)
    ("resveratrol" . SPARSER::PROTEIN) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("NAD" . SPARSER::MOLECULE) ("colon cancer" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("PI-3 kinase" . SPARSER::PROTEIN)
    ("PI-3" . SPARSER::PROTEIN) ("pS6K" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki67" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("Forkhead box protein O1" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("coactivator 1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("SIRT1" . SPARSER::PROTEIN)
    ("the monoubiquitinated TLS pols and repair enzymes" . SPARSER::COLLECTION)
    ("considerably more polη" . SPARSER::PROTEIN)
    ("the polymerases and their respective UBZ or UBMs" . SPARSER::COLLECTION)
    ("the C-terminal ∼200 amino acids of each protein ( xref , xref )"
     . SPARSER::PROTEIN)
    ("GFP-polη-Ub" . SPARSER::COLLECTION) ("eCFP-polι" . SPARSER::PROTEIN-PAIR)
    ("polι and polη" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("polη and polι-Ub ( xref A)" . SPARSER::COLLECTION)
    ("glycine" . SPARSER::AMINO-ACID) ("polι-Ub" . SPARSER::COLLECTION)
    ("fused" . SPARSER::PROTEIN) ("ubiquitin or polι" . SPARSER::COLLECTION)
    ("polι, PCNA and ubiquitin" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID)
    ("physically target polι" . SPARSER::PROTEIN)
    ("ubiquitin or polη" . SPARSER::COLLECTION)
    ("polη and ubiquitin" . SPARSER::COLLECTION) ("class" . CLASS)
    ("classes" . CLASS) ("polι and ubiquitin" . SPARSER::COLLECTION)
    ("solution" . SPARSER::MOLECULE)
    ("free ubiquitin and K63-linked ubiquitin" . SPARSER::COLLECTION)
    ("the mutant polι’s" . SPARSER::PROTEIN)
    ("polη-binding-proficient P692R mutant" . SPARSER::MUTANT)
    ("ubiquitin and polη" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION)
    ("PCNA, or ubiquitin" . SPARSER::COLLECTION)
    ("Proline" . SPARSER::AMINO-ACID)
    ("the C635A/C638A double mutant and the C635A, C638A and D652A single polη UBZ mutants"
     . SPARSER::COLLECTION)
    ("polι–polη" . SPARSER::COLLECTION) ("‘suppressor’" . SPARSER::SUPPRESSOR)
    ("Polη" . SPARSER::PROTEIN) ("polη–polι" . SPARSER::COLLECTION)
    ("the last 230 amino acids of polη" . SPARSER::PROTEIN)
    ("the last 230 amino acids" . SPARSER::AMINO-ACID)
    ("polη and polι" . SPARSER::COLLECTION) ("polη" . SPARSER::PROTEIN)
    ("polη-Rev1" . SPARSER::PROTEIN-PAIR) ("mapping" . SPARSER::PROTEIN)
    ("the respective enzyme" . SPARSER::ENZYME)
    ("polι or Rev1" . SPARSER::COLLECTION)
    ("Polι and Rev1" . SPARSER::COLLECTION) ("Polι" . SPARSER::PROTEIN)
    ("damage-induced foci" . SPARSER::PROTEIN)
    ("enzyme and Rad18" . SPARSER::COLLECTION)
    ("the replicative polymerase" . SPARSER::PROTEIN)
    ("replicative polymerases" . SPARSER::PROTEIN)
    ("ultraviolet (UV)-induced cyclobutane pyrimidine dimers" . SPARSER::DIMER)
    ("CPDs" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("pyrimidine" . SPARSER::DRUG) ("cyclobutane" . SPARSER::MOLECULE)
    ("the most proficient TLS enzymes" . SPARSER::ENZYME)
    ("the respective polymerase" . SPARSER::PROTEIN)
    ("polι" . SPARSER::PROTEIN) ("polι-ubiquitin" . SPARSER::PROTEIN-PAIR)
    ("UBM" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("ultraviolet light and this co-localization" . SPARSER::COLLECTION)
    ("ultraviolet light" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("pols" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("ANTI-" . SPARSER::ANTIBODY) ("m 2" . SPARSER::MOLECULE)
    ("sodium chloride" . SPARSER::DRUG) ("Full-length" . SPARSER::PROTEIN)
    ("Trp-Leu" . SPARSER::MOLECULE) ("AH109" . SPARSER::DRUG)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("Rad6" . SPARSER::PROTEIN) ("Rev1" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("an essential protein" . SPARSER::PROTEIN)
    ("XRCC1 and OGG1" . SPARSER::COLLECTION)
    ("XRCC1 and XRCC1" . SPARSER::COLLECTION)
    ("PNKP, APTX and APLF" . SPARSER::COLLECTION)
    ("the neurodegenerative disease spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("TDP1 and APTX" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("APTX and TDP1" . SPARSER::COLLECTION) ("DNA-end" . SPARSER::DNA)
    ("Topoisomerase" . SPARSER::PROTEIN)
    ("polymorphic XRCC1" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("CAS" . SPARSER::PROTEIN)
    ("SSB" . SPARSER::PROTEIN) ("PARP1 and PARP2" . SPARSER::COLLECTION)
    ("PARPs" . SPARSER::MOLECULE) ("UNG2, MPG or OGG1" . SPARSER::COLLECTION)
    ("PARP1, MPG, and UNG2" . SPARSER::COLLECTION)
    ("a central scaffolding protein" . SPARSER::PROTEIN)
    ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XRCC1 and LIG3" . SPARSER::COLLECTION)
    ("PNKP and POL" . SPARSER::COLLECTION)
    ("LIG3 and APE1" . SPARSER::COLLECTION)
    ("AP-endonuclease activity" . SPARSER::COLLECTION)
    ("PNKP, and POL" . SPARSER::COLLECTION)
    ("PCNA and FEN1" . SPARSER::COLLECTION)
    ("XRCC1, PNKP and POl" . SPARSER::COLLECTION) ("POl" . SPARSER::PROTEIN)
    ("ε , FEN1, and PCNA in LP BER" . SPARSER::PROTEIN)
    ("SSBs" . SPARSER::PROTEIN)
    ("BER enzymes and their DNA substrates" . SPARSER::COLLECTION)
    ("mild in vivo formaldehyde" . SPARSER::MOLECULE)
    ("PCNA and PARP1" . SPARSER::COLLECTION)
    ("UNG2 and APE1" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("Condensin" . SPARSER::PROTEIN-FAMILY)
    ("XRCC1 and PCNA" . SPARSER::COLLECTION) ("group" . SPARSER::MOLECULE)
    ("PARP1 or LIG3" . SPARSER::COLLECTION) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("dimer" . SPARSER::DIMER) ("Ser/Thr" . SPARSER::COLLECTION)
    ("RNA binding proteins and metabolic enzymes [ xref ]"
     . SPARSER::COLLECTION)
    ("700 eukaryotic proteins" . SPARSER::PROTEIN)
    ("protein/protein" . SPARSER::COLLECTION)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aprataxin and PNKP like factor (APLF)" . SPARSER::PROTEIN)
    ("APLF" . SPARSER::PROTEIN) ("PNKP" . SPARSER::PROTEIN)
    ("APTX" . SPARSER::PROTEIN) ("aprataxin" . SPARSER::PROTEIN)
    ("FHA" . SPARSER::PROTEIN-FAMILY) ("forkhead" . SPARSER::PROTEIN)
    ("XRCC1/LIG3" . SPARSER::COLLECTION) ("tetramer" . SPARSER::TETRAMER)
    ("Ligase" . SPARSER::LIGASE) ("DDR" . SPARSER::PROTEIN)
    ("NTH1, OGG1, MPG and APE1" . SPARSER::COLLECTION)
    ("a central DNA glycosylase" . SPARSER::PROTEIN) ("MPG" . SPARSER::PROTEIN)
    ("VIII" . SPARSER::PROTEIN) ("homologue" . SPARSER::PROTEIN)
    ("AlkB" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("POL" . SPARSER::PROTEIN) ("discrete foci" . SPARSER::PROTEIN)
    ("approximately 70 kDa" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("AP-endonucleases" . SPARSER::COLLECTION)
    ("endonucleases" . SPARSER::PROTEIN) ("AP" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN)
    ("AP-endonuclease" . SPARSER::PROTEIN-PAIR)
    ("endonuclease" . SPARSER::PROTEIN) ("sugar" . SPARSER::MOLECULE)
    ("mitochondria" . SPARSER::PROTEIN)
    ("purines and pyrimidines" . SPARSER::COLLECTION)
    ("pyrimidines" . SPARSER::DRUG) ("purines" . SPARSER::DRUG)
    ("metabolites" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("cigarette" . SPARSER::DRUG) ("methionine" . SPARSER::AMINO-ACID)
    ("Transgene" . SPARSER::PROTEIN) ("mutagens" . SPARSER::MOLECULE)
    ("episodic seizures" . SPARSER::PROTEIN) ("mild ataxia" . SPARSER::PROTEIN)
    ("seizures" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("Nes–cre" . SPARSER::COLLECTION) ("Nes-cre" . SPARSER::COLLECTION)
    ("cre" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("SCE" . SPARSER::PROTEIN)
    ("ray" . SPARSER::PROTEIN) ("CHO" . SPARSER::PROTEIN)
    ("transgene" . SPARSER::PROTEIN) ("EM9" . SPARSER::PROTEIN)
    ("XRCC1 and its variants" . SPARSER::COLLECTION)
    ("Gln" . SPARSER::AMINO-ACID) ("His" . SPARSER::AMINO-ACID)
    ("Trp" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("Complementing" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN) ("TDP1" . SPARSER::PROTEIN)
    ("PJ34" . SPARSER::DRUG) ("amino acids" . SPARSER::AMINO-ACID)
    ("Zinc finger" . SPARSER::PROTEIN)
    ("endonuclease activity" . SPARSER::PROTEIN) ("FEN1" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("Checkpoint kinase 2" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("aprataxin and PNKP like factor" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("BRCA 1" . SPARSER::PROTEIN)
    ("N-methylpurine DNA glycosylase" . SPARSER::PROTEIN)
    ("UNG2" . SPARSER::PROTEIN) ("Uracil-DNA glycosylase" . SPARSER::PROTEIN)
    ("OGG1" . SPARSER::PROTEIN)
    ("8-oxoguanine DNA glycosylase" . SPARSER::PROTEIN)
    ("NTH1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("DNA polymerase beta" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("p18887" . SPARSER::PROTEIN) ("DNA glycosylase" . SPARSER::PROTEIN)
    ("LIG3" . SPARSER::PROTEIN) ("DNA ligase 3" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("Xrcc1" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("X-ray Repair" . SPARSER::PROTEIN)
    ("at least two spindle assembly checkpoint proteins" . SPARSER::PROTEIN)
    ("BRCA1 and mutant" . SPARSER::COLLECTION) ("Mutant" . SPARSER::MUTANT)
    ("Ubc13-MMS2" . SPARSER::COLLECTION) ("Parkin" . SPARSER::PROTEIN)
    ("types" . TYPE) ("NPM" . SPARSER::PROTEIN) ("Lys" . SPARSER::AMINO-ACID)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("H2A and H2AX, γ-tubulin and ER-α" . SPARSER::COLLECTION)
    ("H2AX, γ-tubulin and ER-α" . SPARSER::COLLECTION)
    ("chemical" . SPARSER::MOLECULE) ("SUMO" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("foci and G2/M" . SPARSER::COLLECTION)
    ("BRCA1 and cyclin" . SPARSER::COLLECTION)
    ("cyclin B1-Cdk1" . SPARSER::COLLECTION)
    ("two essential cell cycle proteins" . SPARSER::PROTEIN)
    ("MAD2 and USP44" . SPARSER::COLLECTION) ("inactive" . SPARSER::INACTIVE)
    ("a pivotal component" . SPARSER::COMPONENT)
    ("arginine" . SPARSER::AMINO-ACID) ("-mutant" . SPARSER::MUTANT)
    ("APC/Cdc20" . SPARSER::COLLECTION)
    ("degradable substrates" . SPARSER::SUBSTRATE)
    ("cyclosome" . SPARSER::PROTEIN) ("Cyclosome" . SPARSER::PROTEIN)
    ("lysine" . SPARSER::AMINO-ACID) ("acceptor" . SPARSER::MOLECULE)
    ("peptides" . SPARSER::PEPTIDE) ("UbcH5c and UbcH1" . SPARSER::COLLECTION)
    ("UbcH13-MMS2" . SPARSER::COLLECTION)
    ("IR or proteasome inhibitor" . SPARSER::COLLECTION)
    ("BRCA1 and UbcH1" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("MMS2-UbcH13" . SPARSER::COLLECTION)
    ("the promiscuous E2" . SPARSER::MOLECULE)
    ("MMS2-Ubc13" . SPARSER::COLLECTION) ("ube2k" . SPARSER::PROTEIN)
    ("Cdc25C and polyubiquitination" . SPARSER::COLLECTION)
    ("IR and HU" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("BRCA1, E1 or E2" . SPARSER::COLLECTION)
    ("analyses using anti-BRCA1 antibody ( xref ) and anti-BARD1 antibody ( xref )"
     . SPARSER::COLLECTION)
    ("BRCA1 and BARD1" . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION) ("his" . SPARSER::AMINO-ACID)
    ("the radiomimetic drug Neocarzinostatin (NCS)" . SPARSER::PROTEIN)
    ("Neocarzinostatin (NCS)" . SPARSER::PROTEIN) ("NCS" . SPARSER::PROTEIN)
    ("Neocarzinostatin" . SPARSER::PROTEIN) ("drug" . SPARSER::DRUG)
    ("HA-Ub" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("HA" . SPARSER::PROTEIN) ("lys" . SPARSER::PROTEIN)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("Characteristic poly-ubiquitin" . SPARSER::PROTEIN)
    ("ubiquitin or an antibody" . SPARSER::COLLECTION)
    ("the insoluble complexes" . SPARSER::BIO-COMPLEX)
    ("polypeptides" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PEPTIDE)
    ("the two latter recombinant proteins" . SPARSER::PROTEIN)
    ("serine/threonine" . SPARSER::COLLECTION) ("part" . SPARSER::COMPONENT)
    ("fragment" . SPARSER::FRAGMENT) ("aa" . SPARSER::MOLECULE)
    ("YFP" . SPARSER::PROTEIN) ("SCD" . SPARSER::PROTEIN)
    ("serine" . SPARSER::AMINO-ACID)
    ("antibody and propidium" . SPARSER::COLLECTION)
    ("propidium" . SPARSER::MOLECULE) ("CHX" . SPARSER::PROTEIN)
    ("shRNA-BRCA1" . SPARSER::COLLECTION) ("MCF7" . SPARSER::PROTEIN)
    ("Cdc25C and cyclin" . SPARSER::COLLECTION)
    ("which shuttles Cdc25C" . SPARSER::PROTEIN)
    ("Hydroxyurea (HU)" . SPARSER::DRUG) ("Hydroxyurea" . SPARSER::DRUG)
    ("ribonucleotide" . SPARSER::MOLECULE) ("IR" . SPARSER::PROTEIN)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cycloheximide" . SPARSER::PROTEIN) ("leu" . SPARSER::AMINO-ACID)
    ("Acetyl" . SPARSER::MOLECULE) ("Inhibitors" . SPARSER::INHIBITOR)
    ("the mitotic cyclin/Cdk" . SPARSER::COLLECTION)
    ("cyclin/Cdk" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SAC" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("KEN" . SPARSER::PROTEIN)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a mitotic inducer" . SPARSER::PROTEIN)
    ("cyclin B1/Cdk1" . SPARSER::COLLECTION) ("inducer" . SPARSER::MOLECULE)
    ("B/Cdk1 and Cdc25C" . SPARSER::COLLECTION)
    ("TFIIE [ xref – xref ] and the hormonally-regulated transcription factor"
     . SPARSER::COLLECTION)
    ("RPB1, RPB8, TFIIE [ xref – xref ] and the hormonally-regulated transcription factor"
     . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("the hormonally-regulated transcription factor" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TFIIE" . SPARSER::PROTEIN-FAMILY)
    ("CtIP" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("H2A and H2AX" . SPARSER::COLLECTION)
    ("γ-tubulin and estrogen receptor" . SPARSER::COLLECTION)
    ("BRCA1-BARD1" . SPARSER::COLLECTION) ("histones" . SPARSER::PROTEIN)
    ("enzymes" . SPARSER::ENZYME) ("RAP80-Abraxas" . SPARSER::COLLECTION)
    ("Ubiquitin" . SPARSER::PROTEIN)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1/BARD1" . SPARSER::COLLECTION) ("chromatin" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterodimer" . SPARSER::HETERODIMER) ("full–length" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("K33" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("Cdc25B" . SPARSER::PROTEIN) ("CDC20" . SPARSER::PROTEIN)
    ("USP44" . SPARSER::PROTEIN) ("MAD2" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("UbcH10" . SPARSER::PROTEIN) ("UbcH13" . SPARSER::PROTEIN)
    ("Ubc13" . SPARSER::PROTEIN) ("MMS2" . SPARSER::PROTEIN)
    ("E2s" . SPARSER::MOLECULE) ("UbcH5c" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("E1" . SPARSER::MOLECULE) ("E2" . SPARSER::MOLECULE)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("UCN-01" . SPARSER::DRUG) ("de-" . SPARSER::MOLECULE)
    ("Cdc25A" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("B/Cdk1" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN) ("RPB8" . SPARSER::PROTEIN)
    ("RPB1" . SPARSER::PROTEIN) ("estrogen receptor" . SPARSER::PROTEIN)
    ("γ-tubulin" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("RNF20" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("HERC2" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG) ("SDS" . SPARSER::PROTEIN)
    ("associated client proteins" . SPARSER::PROTEIN)
    ("polyubiquitination" . SPARSER::PROTEIN) ("chaperone" . SPARSER::PROTEIN)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("receptor" . SPARSER::RECEPTOR)
    ("microtubules" . SPARSER::PROTEIN)
    ("hZimp7, hZimp10 and SWI" . SPARSER::COLLECTION)
    ("ORC2, Cdt1 and Cdc6" . SPARSER::COLLECTION) ("drugs" . SPARSER::DRUG)
    ("SNF" . SPARSER::PROTEIN-FAMILY) ("SWI" . SPARSER::PROTEIN)
    ("Hsp90 or RNF6" . SPARSER::COLLECTION) ("colchicine" . SPARSER::DRUG)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines" . SPARSER::PROTEIN) ("Hsp70 or Hsp90" . SPARSER::COLLECTION)
    ("siCHIP-2" . SPARSER::COLLECTION) ("LNCap and C4-2" . SPARSER::COLLECTION)
    ("LNCap" . SPARSER::PROTEIN) ("proteasomal" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("Proteasomal" . SPARSER::PROTEIN)
    ("the replicative DNA polymerase" . SPARSER::PROTEIN)
    ("siAR-2" . SPARSER::COLLECTION) ("a 2-ME" . SPARSER::COLLECTION)
    ("LNCaP and C4-2" . SPARSER::COLLECTION) ("histone" . SPARSER::PROTEIN)
    ("LNCaP, C4-2 and 22RV1" . SPARSER::COLLECTION) ("RV" . SPARSER::MOLECULE)
    ("a naturally occurring estrogen metabolite" . SPARSER::MOLECULE)
    ("LNCaP" . SPARSER::PROTEIN) ("hormone" . SPARSER::MOLECULE)
    ("antiandrogens" . SPARSER::DRUG) ("coactivators" . SPARSER::PROTEIN)
    ("activators" . SPARSER::ACTIVATOR) ("antiandrogen" . SPARSER::DRUG)
    ("androgen" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("ligases" . SPARSER::LIGASE) ("siRNA" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("ligase" . SPARSER::LIGASE)
    ("metabolite" . SPARSER::MOLECULE) ("estrogen" . SPARSER::MOLECULE)
    ("ME" . SPARSER::PROTEIN) ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RNase A" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Triton X–100" . SPARSER::MOLECULE) ("a 37" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("Cdc6" . SPARSER::PROTEIN) ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ORC2" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("hZimp10" . SPARSER::PROTEIN) ("hZimp7" . SPARSER::PROTEIN)
    ("RNF6" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MG132" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G2/M" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p44" . SPARSER::PROTEIN) ("C4-2" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("double minute 2 protein" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("ΔNp63α-MKP3-Erk2" . SPARSER::COLLECTION)
    ("proteins, and p53 family" . SPARSER::COLLECTION)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("Dicer and miR-130b" . SPARSER::COLLECTION) ("miR" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("TAp63 and ΔNp63" . SPARSER::COLLECTION)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID)
    ("AP-1 and NF-kB" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("MMP1, MMP2, and MMP9" . SPARSER::COLLECTION)
    ("MKP3 or ΔNp63α" . SPARSER::COLLECTION)
    ("the disease-associated mutant derivatives" . SPARSER::DERIVATIVE)
    ("shp63" . SPARSER::PROTEIN) ("NeuT-shC" . SPARSER::COLLECTION)
    ("NeuT-shp63" . SPARSER::COLLECTION) ("shC" . SPARSER::PROTEIN)
    ("NeuT" . SPARSER::PROTEIN) ("MCF-10A-NeuT" . SPARSER::PROTEIN-PAIR)
    ("foci" . SPARSER::PROTEIN) ("Neu" . SPARSER::PROTEIN)
    ("Erk1 and Erk2" . SPARSER::COLLECTION)
    ("Erk1 or Erk2" . SPARSER::COLLECTION)
    ("ΔNp63α, ΔNp63γ, TAp63α, or TAp63γ" . SPARSER::COLLECTION)
    ("component" . SPARSER::COMPONENT) ("paxillin" . SPARSER::PROTEIN)
    ("Chromatin" . SPARSER::PROTEIN)
    ("gene and promoter" . SPARSER::COLLECTION)
    ("p63/p53" . SPARSER::COLLECTION) ("protein or Mek" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pan-p63 (shp63-1; referred to as shp63 hereafter) effectively ablated endogenous p63"
     . SPARSER::PROTEIN)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MCF-10A" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA) ("MMP1 and MMP9" . SPARSER::COLLECTION)
    ("strong nuclear phosphorylated Erk1/2" . SPARSER::PROTEIN)
    ("p63 and MKP3" . SPARSER::COLLECTION) ("maps" . SPARSER::PROTEIN)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP6 or Pyst1" . SPARSER::COLLECTION)
    ("suppressor" . SPARSER::SUPPRESSOR) ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("MAP" . SPARSER::PROTEIN) ("Mitogen" . SPARSER::MITOGEN)
    ("Kinases" . SPARSER::KINASE) ("variety" . SPARSER::VARIETY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("anoikis" . SPARSER::PROTEIN)
    ("PERP" . SPARSER::PROTEIN) ("integrins" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE)
    ("TAp63 +/− and TAp63 −/− mice" . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein-protein" . SPARSER::COLLECTION) ("SAM" . SPARSER::MOLECULE)
    ("Sterile" . SPARSER::PROTEIN-FAMILY) ("isoforms" . SPARSER::ISOFORM)
    ("exogenous ΔNp63α" . SPARSER::PROTEIN) ("Kinase" . SPARSER::KINASE)
    ("Protein" . SPARSER::PROTEIN)
    ("the predominant p63 isoform" . SPARSER::ISOFORM)
    ("isoform" . SPARSER::ISOFORM) ("Foxn1" . SPARSER::PROTEIN)
    ("C-11" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("serum albumin" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("l-glutamine" . SPARSER::MOLECULE)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("F12" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase activity" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-Cadherin" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("Id-3" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Pyst1" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1/2" . SPARSER::PROTEIN)
    ("MKP3" . SPARSER::PROTEIN) ("MAP Kinase Phosphatase 3" . SPARSER::PROTEIN)
    ("ΔNp63α" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Avastin" . SPARSER::DRUG)
    ("hypoxia and TGFβ1" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("a classical Wnt target gene" . SPARSER::GENE)
    ("pyruvate" . SPARSER::PROTEIN) ("enzyme" . SPARSER::ENZYME)
    ("ligand" . SPARSER::MOLECULE) ("phosphatases" . SPARSER::PHOSPHATASE)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("c-Met and VEGF" . SPARSER::COLLECTION) ("receptors" . SPARSER::RECEPTOR)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("state" . SPARSER::BIO-STATE)
    ("HIF1α and pY654-β-catenin" . SPARSER::COLLECTION)
    ("hypoxia-" . SPARSER::PROTEIN) ("promoters" . SPARSER::PROMOTER)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1α, β-catenin, and Src kinase" . SPARSER::COLLECTION)
    ("ROS and Src kinase" . SPARSER::COLLECTION)
    ("concurrently given NAC" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("NAC or control buffer" . SPARSER::COLLECTION)
    ("goat anti-VEGF antibody and the antioxidant NAC" . SPARSER::COLLECTION)
    ("antioxidant" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN)
    ("a goat anti-VEGF antibody or control IgG" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("goat" . SPARSER::PROTEIN)
    ("Tag2" . SPARSER::PROTEIN) ("RIP-Tag2" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("the invasive marker MMP-9" . SPARSER::PROTEIN)
    ("ROS inhibitors ( xref ) as well as Src inhibition ( xref )"
     . SPARSER::COLLECTION)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("Both ROS inhibitors EUK-134 and/or N-acetyl-cysteine (NAC)"
     . SPARSER::COLLECTION)
    ("NAC" . SPARSER::PROTEIN) ("fluorescein (APF)" . SPARSER::MOLECULE)
    ("APF" . SPARSER::PROTEIN) ("fluorescein" . SPARSER::MOLECULE)
    ("subsequent EMT" . SPARSER::PROTEIN)
    ("other classical HIF1α responsive genes" . SPARSER::GENE)
    ("hypoxia/normoxia" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN) ("forms" . SPARSER::FORM)
    ("®-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("mutants" . SPARSER::MUTANT)
    ("either β-catenin ( xref ) or HIF1α ( xref )" . SPARSER::COLLECTION)
    ("β-catenin and HIF1α" . SPARSER::COLLECTION)
    ("the invasive metalloproteinase" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("E-cadherin (green) and β-catenin (red)" . SPARSER::COLLECTION)
    ("Cre" . SPARSER::PROTEIN)
    ("HIF1α ( xref ) and pY654-β-catenin" . SPARSER::COLLECTION)
    ("mesenchymal genes" . SPARSER::GENE) ("latent TGFβ1" . SPARSER::PROTEIN)
    ("Src and HIF1α" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("HIF1α and β-catenin" . SPARSER::COLLECTION)
    ("HIF1α/β-catenin" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT)
    ("the subsequent total β-catenin" . SPARSER::PROTEIN)
    ("normoxia" . SPARSER::PROTEIN) ("HIF1α/Src" . SPARSER::COLLECTION)
    ("sequential total β-catenin" . SPARSER::PROTEIN)
    ("Indeed pY654-β-catenin immunoprecipitation co-precipitated HIF1α and Src"
     . SPARSER::COLLECTION)
    ("HIF1α or Src" . SPARSER::COLLECTION)
    ("phosphorylating β-catenin and the subsequent EMT" . SPARSER::COLLECTION)
    ("the subsequent EMT" . SPARSER::PROTEIN)
    ("Src, and Snail1/Twist" . SPARSER::COLLECTION)
    ("PP2 and SU6656" . SPARSER::COLLECTION)
    ("Src, pY654-β-catenin, and EMT" . SPARSER::COLLECTION)
    ("Src and EGFR" . SPARSER::COLLECTION) ("pro" . SPARSER::AMINO-ACID)
    ("epidermal growth factor receptor (EGFR) ( xref ) and hepatocyte growth factor receptor c-Met ( xref )"
     . SPARSER::COLLECTION)
    ("Src family kinases, epidermal growth factor receptor (EGFR) ( xref ) and hepatocyte growth factor receptor c-Met ( xref )"
     . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR" . SPARSER::PROTEIN) ("family" . SPARSER::PROTEIN-FAMILY)
    ("p-Smad2" . SPARSER::COLLECTION) ("TGF" . SPARSER::DRUG)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response element (HRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("regulator" . SPARSER::REGULATOR)
    ("the Snail and Twist promoter ( xref , xref )" . SPARSER::COLLECTION)
    ("promoter" . SPARSER::PROMOTER) ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("regulators" . SPARSER::REGULATOR) ("Snail" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagen" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("HIF1α and Src kinase" . SPARSER::COLLECTION)
    ("β-catenin/HIF" . SPARSER::COLLECTION)
    ("complexes" . SPARSER::BIO-COMPLEX) ("antibodies" . SPARSER::ANTIBODY)
    ("HIF1α and Src" . SPARSER::COLLECTION) ("ROS" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("HIF1α and active" . SPARSER::COLLECTION)
    ("Src" . SPARSER::PROTEIN) ("active" . SPARSER::ACTIVE)
    ("pY" . SPARSER::PROTEIN) ("tyrosine" . SPARSER::AMINO-ACID)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("HIFs" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG) ("anti-oxidant" . SPARSER::DRUG)
    ("HIF-1α" . SPARSER::PROTEIN) ("M2" . SPARSER::MOLECULE)
    ("PTP1B" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("N-cadherin" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("Anti-VEGF" . SPARSER::DRUG) ("MMP-9" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("EUK-134" . SPARSER::DRUG)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("α-SMA" . SPARSER::PROTEIN)
    ("Snail 1" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("SB431542" . SPARSER::DRUG) ("ALK5" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("Myc-tagged" . SPARSER::PROTEIN)
    ("SU6656" . SPARSER::PROTEIN) ("PP2" . SPARSER::DRUG)
    ("Snail1" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("Axin2" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ZEB2" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("N-acetylcysteine" . SPARSER::DRUG)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("Raf-1-MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("cAMP-PKA" . SPARSER::COLLECTION) ("forskolin" . SPARSER::PROTEIN)
    ("PKA and Epac2" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("cAMP" . SPARSER::PROTEIN) ("substrate" . SPARSER::SUBSTRATE)
    ("MLCK-MLC2" . SPARSER::COLLECTION) ("MLCK/MLC2" . SPARSER::COLLECTION)
    ("MLCK-myosin regulatory light chain 2" . SPARSER::COLLECTION)
    ("alternate PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fractions" . SPARSER::COMPONENT)
    ("electron" . SPARSER::MOLECULE) ("SNARE" . SPARSER::PROTEIN)
    ("PM" . SPARSER::PROTEIN) ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("blunted glucose-induced cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("30 mM KCl or 30 mM KCl" . SPARSER::COLLECTION)
    ("KCl" . SPARSER::MOLECULE) ("diazoxide" . SPARSER::DRUG)
    ("PD98059 or U0126" . SPARSER::COLLECTION) ("kinases" . SPARSER::PROTEIN)
    ("pMEK/MEK" . SPARSER::COLLECTION) ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ser" . SPARSER::AMINO-ACID) ("target" . SPARSER::TARGET-PROTEIN)
    ("activator" . SPARSER::ACTIVATOR) ("proteins" . SPARSER::PROTEIN)
    ("Raf-1 and MEK1/2" . SPARSER::COLLECTION)
    ("the cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("phalloidin" . SPARSER::MOLECULE) ("form" . SPARSER::FORM)
    ("actin" . SPARSER::PROTEIN) ("peptide" . SPARSER::PEPTIDE)
    ("Lifeact-GFP" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("trigger" . SPARSER::PROTEIN)
    ("glucose-induced cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("Cdc42-PAK1" . SPARSER::COLLECTION) ("DMSO" . SPARSER::MOLECULE)
    ("pERK/ERK" . SPARSER::COLLECTION) ("pERK" . SPARSER::PROTEIN)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("Thr" . SPARSER::AMINO-ACID)
    ("glucose-stimulated cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf/MEK1/2" . SPARSER::COLLECTION) ("p41-Arc" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAPK" . SPARSER::PROTEIN)
    ("MLCK" . SPARSER::PROTEIN) ("Arc" . SPARSER::PROTEIN)
    ("Filamin" . SPARSER::PROTEIN-FAMILY) ("LIMK" . SPARSER::PROTEIN)
    ("substrates" . SPARSER::SUBSTRATE)
    ("Cdc42 and PAK1" . SPARSER::COLLECTION)
    ("Glucose-induced cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("Glucose" . SPARSER::PROTEIN) ("cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("cortical filamentous actin" . SPARSER::BIO-COMPLEX)
    ("voltage-sensitive calcium" . SPARSER::CALCIUM)
    ("calcium" . SPARSER::CALCIUM) ("ATP:ADP" . SPARSER::BIO-COMPLEX)
    ("ADP" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("transporters" . SPARSER::PROTEIN) ("secretagogues" . SPARSER::MOLECULE)
    ("Raf-1, MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("Both IPA3 and a selective inhibitor of the Cdc42 GTPase"
     . SPARSER::COLLECTION)
    ("GTPase" . SPARSER::GTPASE)
    ("the glucose-induced cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("inhibitor" . SPARSER::INHIBITOR) ("glucose" . SPARSER::PROTEIN)
    ("kinase" . SPARSER::KINASE) ("effector" . SPARSER::EFFECTOR)
    ("Epac2" . SPARSER::PROTEIN) ("GLP-1 receptor" . SPARSER::PROTEIN)
    ("GLP-1" . SPARSER::PROTEIN) ("SAD-A" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("myosin regulatory light chain 2" . SPARSER::PROTEIN)
    ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potassium channel" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("PD98059" . SPARSER::MOLECULE) ("pRaf-1" . SPARSER::PROTEIN)
    ("Abp140" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("Triton X-100" . SPARSER::MOLECULE) ("-3" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("secretory granule" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("Nonidet P-40" . SPARSER::DRUG)
    ("MgCl2" . SPARSER::MOLECULE) ("NaHCO 3" . SPARSER::DRUG)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("L-glutamine" . SPARSER::MOLECULE) ("VAMP2" . SPARSER::PROTEIN)
    ("SNAP-25" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("Latrunculin B" . SPARSER::DRUG)
    ("p41" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("GLUT2" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Raf-1" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("IPA3" . SPARSER::MOLECULE)
    ("type 2" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("complex" . SPARSER::BIO-COMPLEX)
    ("components" . SPARSER::COMPONENT) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("simultaneously impact both 53BP1 and other genes" . SPARSER::COLLECTION)
    ("simultaneously impact both 53BP1" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("gene" . SPARSER::GENE)
    ("microRNAs or protein" . SPARSER::COLLECTION) ("microRNAs" . SPARSER::RNA)
    ("shRNA" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("seven" . SPARSER::PROTEIN) ("BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , or wildtype" . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT) ("defective HR" . SPARSER::PROTEIN)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("allele" . SPARSER::ALLELE) ("DNA" . SPARSER::DNA)
    ("platinum" . SPARSER::MOLECULE) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("mRNA" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION) ("brca2" . SPARSER::PROTEIN)
    ("inhibitors" . SPARSER::INHIBITOR) ("polymerase" . SPARSER::PROTEIN)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("HR" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("amino acid" . SPARSER::AMINO-ACID)
    ("monoclonal antibody" . SPARSER::DRUG) ("anti-" . SPARSER::ANTIBODY)
    ("Anti-" . SPARSER::ANTIBODY) (NIL . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("Tween 20" . SPARSER::MOLECULE)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("brca1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)))